Citrus Sinensis ID: 004388
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 757 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SW11 | 835 | U-box domain-containing p | yes | no | 0.977 | 0.886 | 0.553 | 0.0 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.969 | 0.868 | 0.508 | 0.0 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.943 | 0.896 | 0.500 | 0.0 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.931 | 0.860 | 0.495 | 0.0 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.630 | 0.595 | 0.493 | 1e-127 | |
| Q8GUH1 | 834 | U-box domain-containing p | no | no | 0.939 | 0.852 | 0.317 | 3e-99 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.557 | 0.524 | 0.376 | 2e-83 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.538 | 0.787 | 0.364 | 5e-71 | |
| Q9FID9 | 880 | Probable receptor-like pr | no | no | 0.389 | 0.335 | 0.374 | 8e-48 | |
| Q9FID8 | 873 | Putative receptor-like pr | no | no | 0.389 | 0.337 | 0.371 | 1e-46 |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 832 bits (2149), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/777 (55%), Positives = 554/777 (71%), Gaps = 37/777 (4%)
Query: 12 AIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVA 71
++ P+GN IPI +VRDDV AY+QE W+++ +L P+ + +R+V VEV VIESD+VA
Sbjct: 62 SVPTPMGNAIPISEVRDDVVTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVA 121
Query: 72 KAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVR 131
AIA+EV +I+++VIG S+ F+ +K ++ S IS +P+FCTVY V KGKLS VR
Sbjct: 122 AAIAEEVTRDSIDRIVIGGSSRSFFS---RKADICSVISALMPNFCTVYVVSKGKLSCVR 178
Query: 132 PSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSA 191
PSD + ++D S+ S+S SS S S + SA S S SLP +R+Q A
Sbjct: 179 PSDSDGNATIREDGSERTNSSSGSSGPTSDSSDVMSSAHDS--QSRPLSLPVRRMQHFPA 236
Query: 192 V-NKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGP--------------EVRQTV 236
+ + + ++ SS + +RC S D EE +D SS S E ++ +
Sbjct: 237 IAGQASVPMETSSVGSDETRCMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYEERKEAM 296
Query: 237 SRSSSYR--------------SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKL 281
S SSS R ++T + S QAS +D L S +++QV++NFE+EKL
Sbjct: 297 SSSSSNREYGNFGTRFSWSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKL 356
Query: 282 RIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKY 341
R ELRHV+ MYA+AQ E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +
Sbjct: 357 RAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNF 416
Query: 342 ETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESA 401
E ARR+AE R AE+E AQR+EAE K+ + KEKE LE L +Y++ WEEI +A
Sbjct: 417 EKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAA 476
Query: 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 461
T SFSE L+IGMG YG VYK HHT A VKVLQS N +KQF QELE+LSKIRHPHL+
Sbjct: 477 TSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLV 536
Query: 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
LLLGACP+ G LVYEYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPK
Sbjct: 537 LLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPK 596
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQ 580
PIIHRD+KP NILLDHN VSK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQ
Sbjct: 597 PIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQ 656
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKET 639
RTG IS KSD+Y++GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET
Sbjct: 657 RTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEET 716
Query: 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILK 699
+ELAAL L C ELR KDRPDLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK
Sbjct: 717 RELAALALCCTELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLK 776
Query: 700 EVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756
+VMNEPCVAADGYTYDR AIEEWL+E++ SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 777 DVMNEPCVAADGYTYDRHAIEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 747 bits (1929), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/788 (50%), Positives = 535/788 (67%), Gaps = 54/788 (6%)
Query: 13 IGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAK 72
I P+G + + ++R+DV +AYKQE W + +L P++ M +R+V+VEV +++S + A
Sbjct: 65 IPTPMGIAVAVSELREDVVSAYKQELDWSANEMLRPYKKMFERRKVQVEVLLLDSLEPAA 124
Query: 73 AIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRP 132
AIA+E+A + KLVIG +G F+ +K ++SS I+ VP FCTVY + KGKL+SVRP
Sbjct: 125 AIAEEIAGTGVTKLVIGMSLRGFFS---RKIDMSSLIATAVPRFCTVYVISKGKLASVRP 181
Query: 133 SDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAV 192
S+ + GS + + S + ++ S Q D SAV+ SP P + S
Sbjct: 182 SESDASGSIRFERSSSTSGSTDSPRLPPEYQ-DFLSAVSEAQSRVSPFSPALKH---SMG 237
Query: 193 NKTLLHLKPSST-------------EINHSRCQSFDVEEQKDAS--SSCLSGPEVRQTVS 237
+ + + SS+ EI HS + ++ KD S +S G E ++S
Sbjct: 238 SNAVAQMDTSSSGTDQEEVSTGRGMEIVHSGIEG---KKNKDESFSASFPMGTEAYNSMS 294
Query: 238 RSSSYRSMETE---------------NQDW-----------SDQAS--TTDVLPYDSSSE 269
+S +R E N DW S AS + +L S ++
Sbjct: 295 WTSKWRDHEDRREMRSSSSSNNHDLVNMDWGAVVPENYSWVSHTASHMSDGLLSVHSITD 354
Query: 270 SQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEK 329
+QV++NFE+EKLR EL+HV+ MYA+AQ E AS+K+ +LN+ + EE +L E++ EE
Sbjct: 355 NQVNLNFEIEKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEV 414
Query: 330 AIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQR 389
A + A +EK++YE A +EAE + KEA R+EAE KA+ +A+EK+ L+ +L +
Sbjct: 415 AKDTASKEKQRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQ 474
Query: 390 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQEL 449
Y++ TWEEI +AT F+ENL+IG+G YG+VYK HHT AVKVL + +KQF QEL
Sbjct: 475 YQHYTWEEIAAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQEL 534
Query: 450 EVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 509
E+LSKIRHPHL+LLLGACP+ GCLVYEYM+NGSL+DRL N+TPPIPWFER+RIA EVA
Sbjct: 535 EILSKIRHPHLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVA 594
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569
SAL FLH +KP+PIIHRD+KPGNILLDHN VSK+GDVGLSTM+N D T +K T PV
Sbjct: 595 SALVFLHKSKPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPV 654
Query: 570 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-NLAEILD 628
GTLCYIDPEYQRTG+ISPKSDVY+ G+VILQL+TAKPAIAITH VE AI +D ILD
Sbjct: 655 GTLCYIDPEYQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILD 714
Query: 629 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPA 688
+AG WPI +T+ELAALGL C E+RR+DRPDLK+Q++P LERL++VAD+A++ +
Sbjct: 715 KKAGSWPISDTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQNLLSRTPSG 774
Query: 689 PPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLL 748
PP+HFICP+LK VMNEPCVAADGYTYDR+AIEEWL++ D SP+T+LPLPNKNL+ NYTL
Sbjct: 775 PPSHFICPLLKGVMNEPCVAADGYTYDREAIEEWLRQKDTSPVTNLPLPNKNLIANYTLY 834
Query: 749 SAILDWKS 756
SAI++WKS
Sbjct: 835 SAIMEWKS 842
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 723 bits (1865), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/755 (50%), Positives = 509/755 (67%), Gaps = 41/755 (5%)
Query: 27 RDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKL 86
+D + YK++ KT +LLP R+M R V++++ V+ESDD+A AI+ V I++L
Sbjct: 56 KDLTTSVYKKDVDRKTREMLLPSRDMFVHREVQLDIMVLESDDIADAISKAVQDHGISEL 115
Query: 87 VIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSS 146
VIGA S IF+WK K++NLSSRI+ P FC+V+ + KGKL +VR SD+ + S DD S
Sbjct: 116 VIGASSSIIFSWKLKRSNLSSRIADATPRFCSVHVISKGKLLNVRKSDMDTETSIADDRS 175
Query: 147 DTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKTL------LHLK 200
+ S SS SH+ + S+ +S+ SS+P L QR+QAL+ VN+ + + +
Sbjct: 176 E---SRFSSDSHSGTV-----SSTSSHQFSSTPLL-FQRIQALTTVNQKVGTNIGKQNNE 226
Query: 201 PSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRS---SSYRSMETENQDWSDQAS 257
P N R S DV+E K + SS+RS + E +AS
Sbjct: 227 PHHHHHN--RAGSLDVDESKLLNQKGFYRTSSSGIGYGGSDISSWRSSQME------EAS 278
Query: 258 TTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEE 317
++ +SS SQ+ +FELEKL+IELRH++GMYA+AQ+E DAS+K+ DLN+ + EE
Sbjct: 279 SSSTYSDPTSSSSQIHKDFELEKLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSEEA 338
Query: 318 TRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKE 377
TRL + + EE+A E+ + E+++ E A EAE R E+E +R EAE +A+ KEK+
Sbjct: 339 TRLKNLTIREEEADEVVEMERERQEDAENEAELVRECIERETEERLEAEARAEEVRKEKQ 398
Query: 378 MLERALNG---TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL 434
LE AL G Q+Y WEEI AT SFS+ L+IG+GGYG+VY+ HHT AVKVL
Sbjct: 399 RLEDALEGGPLQRQQYMKFEWEEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVL 458
Query: 435 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKN--- 491
S + KQF QELE+LSKIRHPHLLLLLGACP+ G LVYEYM NGSLE+RL ++
Sbjct: 459 HSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNV 518
Query: 492 ---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
PP+ WFER+RIAWE+ASAL FLH +P+PI+HRD+KP NILLD N VSKIGDVGL
Sbjct: 519 DTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGL 578
Query: 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 608
S M+N DPS ST + TGPVGT YIDPEYQRTG+++P+SD+YA+G+++LQL+TA+ A+
Sbjct: 579 SKMVNLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAM 638
Query: 609 AITHKVETAIDEDN--LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP 666
+ H +E A+ + EILD AGDWP+KE KE+ +GL CAE+R++DRPDL ++LP
Sbjct: 639 GLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILP 698
Query: 667 VLERLKEVADRAR----DTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEW 722
VLERLKEVA AR D + H P HF CPI K+VM PCVA+DGYTY+++AI+EW
Sbjct: 699 VLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEW 758
Query: 723 LQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
LQ+N KSP+TDLP P+ +LLPN++LLSAI +W+S+
Sbjct: 759 LQKNHKSPMTDLPFPSDSLLPNHSLLSAIKEWRSQ 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 684 bits (1766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/773 (49%), Positives = 512/773 (66%), Gaps = 68/773 (8%)
Query: 18 GNFIPIEQVRDDVAAAYKQEEKWKTDRLLL-PFRNMCAQRR--------------VEVEV 62
GN + I + ++VAAAY+Q+ +T LL PF+ MC +++ V VE+
Sbjct: 80 GNIVSISEELEEVAAAYRQKVMQETKETLLKPFKKMCERKKLKIDETRFESSLTKVAVEL 139
Query: 63 KVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122
+V+ES+ VA AI EV I+ L+IG SQ + + ++++ IS V + CTVY V
Sbjct: 140 QVLESNSVAVAITKEVNQHLISNLIIGRSSQAASSRNY---DITASISASVSNLCTVYVV 196
Query: 123 EKGKLSSVRPSDLGSIGSTKDDSSDTGCSNSSSSS------HNSSSQTDLGSAVASYTHS 176
G + D+SDT +++S S + SS + S V S
Sbjct: 197 SNG-----------GVHILAKDTSDTERNDTSIESGFERTSSSCSSGSGANSDVMSNALK 245
Query: 177 SSP-SLPTQRLQALSAVNKTL-LHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQ 234
S+P +L +R+Q L + + + + ++ SSTE + ++ +S D E+ +S S PE +
Sbjct: 246 SNPHTLSNKRMQNLPTIVRGVSVPMETSSTESDETKKRSSDAAEE----ASKRSSPETSR 301
Query: 235 TVSRSSSYRSMETENQDWSDQASTTD----VLPYDSSSESQVDVNFELEKLRIELRHVRG 290
+VS + +R + S +S + V P D E+ KLR ELRH
Sbjct: 302 SVSWNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQDTLNEISKLRAELRHAHE 361
Query: 291 MYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAEC 350
MYA+AQ E DASRK+N+L + E+ LLE + +AK+E +K+E RRE
Sbjct: 362 MYAVAQVETLDASRKLNEL---------KFEELTLLEHETKGIAKKETEKFEQKRRE--- 409
Query: 351 ARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQ-RYRNLTWEEIESATLSFSENL 409
E+EAAQR+EAEMKA HEAKEKE LE + + +Y+ TWEEI +AT SFSE+L
Sbjct: 410 -----EREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDL 464
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 469
+IGMG YG VYK HHT AAVKVL S + +KQF QELE+LSKIRHPHL+LLLGACPD
Sbjct: 465 KIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPD 524
Query: 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529
HG LVYEYMENGSLEDRL++ N++ PIPWF R RIAWEVASAL FLH +KP PIIHRD+K
Sbjct: 525 HGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLK 584
Query: 530 PGNILLDHNLVSKIGDVGLSTMLN-SDP-SFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 587
P NILL+HN VSK+GDVGLSTM+ +DP S T YK T PVGTLCYIDPEYQRTG ISP
Sbjct: 585 PANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISP 644
Query: 588 KSDVYAYGMVILQLLTAKPAIAITHKVETAI---DEDNLAEILDAQAGDWPIKETKELAA 644
KSDVYA+GM+ILQLLT + A+A+T+ VETA+ ++D L +ILD +AG+WPI+ET++LAA
Sbjct: 645 KSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAA 704
Query: 645 LGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNE 704
L L C ELR KDRPDL++Q+LPVLE LK+VAD+AR+++ + PP+HF CP+LK+VM E
Sbjct: 705 LALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQPPSHFFCPLLKDVMKE 764
Query: 705 PCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
PC+AADGYTYDR+AIEEW++ + SP+T+ PL N NLLPN+TL +AI++W+++
Sbjct: 765 PCIAADGYTYDRRAIEEWMENHRTSPVTNSPLQNVNLLPNHTLYAAIVEWRNR 817
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 236/478 (49%), Positives = 318/478 (66%), Gaps = 1/478 (0%)
Query: 280 KLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKK 339
+L+ EL+ Y A E KV L+ L E R++ EE A EK+
Sbjct: 317 RLKNELQSTVFKYKQACEELFSTQNKVKMLSTEYLNESKRVNNAVEKEELQRNTAALEKE 376
Query: 340 KYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIE 399
+Y A +E E A+A +E QRQ AE+ A EK+ + L GT RYR T EEI
Sbjct: 377 RYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVIDQLLGTDHRYRKYTIEEIV 436
Query: 400 SATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH 459
+AT FS IG GGYG VY+ + T AAVKV++ + ++FL+E+EVLS++RHPH
Sbjct: 437 TATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPH 496
Query: 460 LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
++LLLGACP++GCLVYEY+ENGSLE+ ++ + N PP+PWF R+R+ +EVA LAFLH++K
Sbjct: 497 VVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSK 556
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
P+PI+HRD+KPGNILL+ N VSKI DVGL+ ++ T Y+N+ GTL YIDPEY
Sbjct: 557 PEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEY 616
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639
RTG I PKSD+YA+G++ILQLLTA+ I VE A+ + L E+LD DWP+ ET
Sbjct: 617 HRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAET 676
Query: 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILK 699
+ELA +GL CAE R +DRPDLK++V+PVL+RL E A+ S A P+H+ CPIL+
Sbjct: 677 EELARIGLKCAEFRCRDRPDLKSEVIPVLKRLVETANSKVKKEGSNLRA-PSHYFCPILR 735
Query: 700 EVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
E+M EP +AADG+TY+RKAI WL++++ SP+T L + L PN+TL SAI DWKS+
Sbjct: 736 EIMEEPEIAADGFTYERKAILAWLEKHNISPVTRQKLDHFKLTPNHTLRSAIRDWKSR 793
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 363 bits (932), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 244/768 (31%), Positives = 406/768 (52%), Gaps = 57/768 (7%)
Query: 17 VGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIAD 76
+G P+ V+++ ++++E+ K +L + +C QR V E IE + + I
Sbjct: 89 MGAKFPVGAVKEEEVRVFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQ 148
Query: 77 EVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICV----PSFCTVYGVEKGKLSSVRP 132
++ I KLV+GA + ++ + +L SR +I V P+ C ++ KG L R
Sbjct: 149 LISELGIRKLVMGAAADRHYSRRM--TDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTRE 206
Query: 133 SDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAV 192
+ T DD+ + +S S S +DL + +++ S R+Q+ +V
Sbjct: 207 A-------TMDDTE-----SEYASPRPSISASDL---LQTFSTPESEHQHISRVQSTDSV 251
Query: 193 NKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW 252
+ L+ S+ + S + +E++ S G EV + + SS S + D
Sbjct: 252 QQ-LVSNGSSTEQSGRVSDGSLNTDEEERESD----GSEVTGSATVMSSGHSSPSSFPDG 306
Query: 253 SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDAS-----RKVN 307
D + + S + S F E LR + + AI + + ++++ ++
Sbjct: 307 VDDSFNVKIRKATSEAHSSKQEAFA-ETLRRQKAEKNALDAIRRAKQSESAYSEELKRRK 365
Query: 308 DLNKCKLEEETRLSEIQ-----LLEEKAIELAKQEKKKYETARREAECARASAEKEAA-- 360
D +E+ R I+ ++EE +A++ + + A+ + + + + + A
Sbjct: 366 DTEIAVAKEKERFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVK 425
Query: 361 -------QRQEAEMKAKHEAKEKEMLE-RALNGTFQ---RYRNLTWEEIESATLSFSENL 409
+R+E + + +E E L A T Q + + ++ EIE AT F L
Sbjct: 426 LLQKLRDEREELQTERDRALREAEELRSHAETSTLQLPQYFTDFSFSEIEEATNHFDSTL 485
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 469
+IG GGYG++Y G HT A+K+L + ++ QE++VLSK+RHP+++ L+GACP+
Sbjct: 486 KIGEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPE 545
Query: 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529
LVYEY+ GSLEDRL K+N+PP+ W R RIA E+ +AL FLH+ K ++H D+K
Sbjct: 546 GWSLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLK 605
Query: 530 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS 589
P NILLD NLVSK+ D G ++L+ + S T GT+ Y+DPE +G ++PKS
Sbjct: 606 PANILLDSNLVSKLSDFGTCSLLHPNGS----KSVRTDVTGTVAYLDPEASSSGELTPKS 661
Query: 590 DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSC 649
DVY++G+++L+LLT +PA+ I+++V+ A+D L ++LD AGDWP + ++LA L L C
Sbjct: 662 DVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRC 721
Query: 650 AELRRKDRPDLKNQVLPVLE--RLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCV 707
E ++RPDL +V VLE R + + H P +FICPI +EVM +P V
Sbjct: 722 CETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHV 781
Query: 708 AADGYTYDRKAIEEWL-QENDKSPITDLPLPNKNLLPNYTLLSAILDW 754
AADG+TY+ +AI WL E+D SP+T++ L + +L+ N+ L SAI +W
Sbjct: 782 AADGFTYEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEW 829
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (796), Expect = 2e-83, Method: Compositional matrix adjust.
Identities = 171/454 (37%), Positives = 271/454 (59%), Gaps = 32/454 (7%)
Query: 320 LSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEA-EMKAKHE--AKEK 376
+ E+Q+++ + ++L Q +K + + E + E + RQ+ E++ HE KE
Sbjct: 367 MKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDEIRIDHENAVKEV 426
Query: 377 EMLERALNG-----TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAV 431
L R + G + + ++ EI AT F + ++G G YG+VYKG H AV
Sbjct: 427 NALRRLVKGETGESSGSEMLDYSFMEINEATNEFDPSWKLGEGKYGSVYKGNLQHLQVAV 486
Query: 432 KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKN 491
K+L S G++ + +F + +E+LS++RHP+L+ L+GACP+ L+Y+Y+ NGSLED +N
Sbjct: 487 KMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPESRSLIYQYIPNGSLEDCFSSEN 546
Query: 492 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551
N P + W R RIA E+ SAL FLH+ P IIH ++KP ILLD NLV+KI D G+S +
Sbjct: 547 NVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKPSKILLDSNLVTKINDYGISQL 605
Query: 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 611
+ D + P ++DP Y + ++ +SD+YA+G+++LQLLT +P I
Sbjct: 606 IPID------GLDKSDP-----HVDPHYFVSREMTLESDIYAFGIILLQLLTRRPVSGIL 654
Query: 612 HKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
V+ A++ DN++ +LD AGDWP+ K+LA + + C + +RPDL VL ++R+
Sbjct: 655 RDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCCKKNPMNRPDLA-VVLRFIDRM 713
Query: 672 K-------EVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQ 724
K E + A VP PP+H++CPI +EVM +P +AADG+TY+ +AI EWL
Sbjct: 714 KAPEVPSSETSSYANQNVPR---RPPSHYLCPIFQEVMKDPLIAADGFTYEAEAIREWLA 770
Query: 725 E-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
+D SP+T+L + + NL+PN+ L AI DW+++
Sbjct: 771 NGHDTSPMTNLKMEDCNLIPNHALHLAIQDWQNQ 804
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 269 bits (688), Expect = 5e-71, Method: Compositional matrix adjust.
Identities = 163/447 (36%), Positives = 246/447 (55%), Gaps = 39/447 (8%)
Query: 313 KLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECA--RASAEKEAAQRQEAEMKAK 370
K EE R ++ +LEE+ + L K + Y + +A A + E++ A +Q E++
Sbjct: 83 KTYEEVR--KVHILEEEIVTL-KHQADTYLVQKEKAVTAYDQLKHERDNAVQQVNELR-- 137
Query: 371 HEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAA 430
+ +L+ F R +++E AT F +G YG YKG H+
Sbjct: 138 -DQSTHIILD------FSR------KDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVL 184
Query: 431 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRK 490
+K+ S+ K F QE+ +L + RHP+++ +G C + LVYE++ NG+LEDR+
Sbjct: 185 IKLSSSQ-----KLFQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICT 239
Query: 491 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550
NN+ P+ W+ R +I E+ AL FLH+ K ++H D++P NIL+D N SKI + G+S
Sbjct: 240 NNSAPLSWYNRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSN 299
Query: 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 610
+ +F L Y+DPE+ TG ++ SDVY+ G++IL+LLT P + +
Sbjct: 300 LFLQLGTFPPNL------TARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTL 353
Query: 611 THKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670
+ KV A+ D+L ++D AGDWP E K+LA +GLSC + RK RPDL N+V V+E
Sbjct: 354 SEKVAEALGSDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEP 413
Query: 671 LKEVADRARDTVPSVHPAP-----PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE 725
L A T P + A P FICPI E+M +P VA+DG+TY+ +AI W
Sbjct: 414 LTRKPPAA--TWPYLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDR 471
Query: 726 N-DKSPITDLPLPNKNLLPNYTLLSAI 751
+SP+T+L LPN NL+PN L S I
Sbjct: 472 GISRSPMTNLALPNLNLVPNRVLRSFI 498
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 119/318 (37%), Positives = 176/318 (55%), Gaps = 23/318 (7%)
Query: 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQE 448
R + EI+SAT F E L IG+GG+G+VYKG T AVK L+ N K+F E
Sbjct: 511 RRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTE 570
Query: 449 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRI 504
LE+LSK+RH HL+ L+G C D LVYEYM +G+L+D L+R++ PP+ W R I
Sbjct: 571 LEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEI 630
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
A L +LH IIHRD+K NILLD N V+K+ D GLS + P+ S T+
Sbjct: 631 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVAKVSDFGLSRV---GPTSASQTHV 687
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVE 615
+T GT Y+DPEY R +++ KSDVY++G+V+L++L +P + V+
Sbjct: 688 STVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVK 747
Query: 616 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE---RL 671
+ ++ + +I+D+ D ++ + + C + R +RP + N V+ LE +L
Sbjct: 748 SNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRCVQDRGMERPPM-NDVVWALEFALQL 806
Query: 672 KEVADRARDTVPSVHPAP 689
E A + D V S+ P
Sbjct: 807 HETAKKKNDNVESLDLMP 824
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 1e-46, Method: Compositional matrix adjust.
Identities = 118/318 (37%), Positives = 176/318 (55%), Gaps = 23/318 (7%)
Query: 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQE 448
R + EI+SAT F + L IG+GG+G+VYKG T AVK L+ N K+F E
Sbjct: 504 RRFSIFEIKSATNDFEDKLIIGVGGFGSVYKGQIDGGATLVAVKRLEITSNQGAKEFETE 563
Query: 449 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRI 504
LE+LSK+RH HL+ L+G C + LVYEYM +G+L+D L+R++ T PP+ W R I
Sbjct: 564 LEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYMPHGTLKDHLFRRDKTSDPPLSWKRRLEI 623
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
A L +LH IIHRD+K NILLD N V+K+ D GLS + P+ S T+
Sbjct: 624 CIGAARGLQYLHTGAKYTIIHRDIKTTNILLDENFVTKVSDFGLSRV---GPTSASQTHV 680
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVE 615
+T GT Y+DPEY R +++ KSDVY++G+V+L++L +P + V+
Sbjct: 681 STVVKGTFGYLDPEYYRRQVLTEKSDVYSFGVVLLEVLCCRPIRMQSVPPEQADLIRWVK 740
Query: 616 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE---RL 671
+ + +I+D+ + D ++ + + C + R +RP + N V+ LE +L
Sbjct: 741 SNYRRGTVDQIIDSDLSADITSTSLEKFCEIAVRCVQDRGMERPPM-NDVVWALEFALQL 799
Query: 672 KEVADRARDTVPSVHPAP 689
E A + D V S+ P
Sbjct: 800 HETAKKKNDNVESLDLMP 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 757 | ||||||
| 147858097 | 804 | hypothetical protein VITISV_021538 [Viti | 0.969 | 0.912 | 0.671 | 0.0 | |
| 359490160 | 804 | PREDICTED: U-box domain-containing prote | 0.969 | 0.912 | 0.670 | 0.0 | |
| 297745064 | 784 | unnamed protein product [Vitis vinifera] | 0.943 | 0.910 | 0.660 | 0.0 | |
| 357455815 | 809 | U-box domain-containing protein [Medicag | 0.976 | 0.913 | 0.613 | 0.0 | |
| 449488729 | 1074 | PREDICTED: U-box domain-containing prote | 0.976 | 0.688 | 0.621 | 0.0 | |
| 449451988 | 836 | PREDICTED: U-box domain-containing prote | 0.981 | 0.888 | 0.618 | 0.0 | |
| 357455813 | 797 | U-box domain-containing protein [Medicag | 0.965 | 0.917 | 0.604 | 0.0 | |
| 356508200 | 785 | PREDICTED: U-box domain-containing prote | 0.948 | 0.914 | 0.612 | 0.0 | |
| 42567138 | 835 | U-box domain-containing protein 35 [Arab | 0.977 | 0.886 | 0.553 | 0.0 | |
| 297799476 | 832 | kinase family protein [Arabidopsis lyrat | 0.973 | 0.885 | 0.544 | 0.0 |
| >gi|147858097|emb|CAN78862.1| hypothetical protein VITISV_021538 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 993 bits (2566), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/743 (67%), Positives = 594/743 (79%), Gaps = 9/743 (1%)
Query: 16 PVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIA 75
P+GN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+V VIESDDVAKAIA
Sbjct: 67 PMGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKQVQVDVVVIESDDVAKAIA 126
Query: 76 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDL 135
+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY V KG+LSSVRPSD
Sbjct: 127 EEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYTVSKGQLSSVRPSDS 186
Query: 136 GSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKT 195
GS K+DSSD +S++SS + +S GSA ASY+H SPSLP QR QALS +N+T
Sbjct: 187 DKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSLPMQRFQALSTINRT 242
Query: 196 LLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW-SD 254
LLH + S E N SR QS D+ E++ S C S ++ S+ SS RS T++Q W SD
Sbjct: 243 LLHTRTGSIETNSSRRQSLDIREEESFMSPCPSNSDIGYAPSQVSSARSFLTDDQSWISD 302
Query: 255 QASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKL 314
QAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E DASRK+NDL+K +L
Sbjct: 303 QASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENIDASRKLNDLSKRRL 361
Query: 315 EEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAK 374
EE +L EI+L EE+A ELA++EK+KYE A+REA AR AEKEA QR+EAE+KA H+ K
Sbjct: 362 EEADKLKEIKLKEEEARELARKEKEKYEAAKREAXYARECAEKEALQRKEAEIKALHDVK 421
Query: 375 EKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL 434
EKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY+ HHT AAVKVL
Sbjct: 422 EKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVYRCNLHHTTAAVKVL 481
Query: 435 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTP 494
SK + K+F QELEVLSKIRHPHLLLLLGAC DHGCLVYEYMENGSLE+RL +K NT
Sbjct: 482 HSKEGHRTKEFQQELEVLSKIRHPHLLLLLGACSDHGCLVYEYMENGSLEERLLQKYNTA 541
Query: 495 PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554
PIPWFERYRIAWEVAS L FLHN+KP+ IIHRD+KP NILLDHNLVSKIGDVGLSTMLN
Sbjct: 542 PIPWFERYRIAWEVASTLVFLHNSKPRSIIHRDLKPANILLDHNLVSKIGDVGLSTMLNP 601
Query: 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV 614
D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQLLTAKPAIA+ H V
Sbjct: 602 DSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQLLTAKPAIALAHLV 658
Query: 615 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674
ETAI +D L EILD AG WP+KETKELA LGLSC ELRR+DRPDLK++VLP LERLK+V
Sbjct: 659 ETAIQDDQLMEILDPMAGQWPMKETKELALLGLSCLELRRRDRPDLKDEVLPALERLKDV 718
Query: 675 ADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDL 734
ADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE+W++END SP+T+L
Sbjct: 719 ADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIEKWVEENDNSPMTNL 778
Query: 735 PLPNKNLLPNYTLLSAILDWKSK 757
LPNKNL+PNYTLLSAI++WKS+
Sbjct: 779 ALPNKNLIPNYTLLSAIVEWKSQ 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359490160|ref|XP_002266973.2| PREDICTED: U-box domain-containing protein 35-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 992 bits (2565), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/743 (67%), Positives = 594/743 (79%), Gaps = 9/743 (1%)
Query: 16 PVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIA 75
P+GN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+V VIESDDVAKAIA
Sbjct: 67 PMGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKKVQVDVVVIESDDVAKAIA 126
Query: 76 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDL 135
+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY V KG+LSSVRPSD
Sbjct: 127 EEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYTVSKGQLSSVRPSDS 186
Query: 136 GSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKT 195
GS K+DSSD +S++SS + +S GSA ASY+H SPSLP QR QALS +N+T
Sbjct: 187 DKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSLPMQRFQALSTINRT 242
Query: 196 LLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW-SD 254
LLH + S E N SR QS D+ E++ S C S ++ S+ SS RS T++Q W SD
Sbjct: 243 LLHTRTGSIETNSSRRQSLDIREEESFMSPCPSNSDIGYAPSQVSSARSFLTDDQSWISD 302
Query: 255 QASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKL 314
QAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E DASRK+NDL+K +L
Sbjct: 303 QASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENIDASRKLNDLSKRRL 361
Query: 315 EEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAK 374
EE +L EI+L EE+A ELA++EK+KYE A+REAE AR AEKEA QR+EAE+KA H+ K
Sbjct: 362 EEADKLKEIKLKEEEARELARKEKEKYEAAKREAEYARECAEKEALQRKEAEIKALHDVK 421
Query: 375 EKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL 434
EKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY+ HHT AAVKVL
Sbjct: 422 EKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVYRCNLHHTTAAVKVL 481
Query: 435 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTP 494
SK + K+F QEL+VLSKIRHPHLLLLLGAC DHGCLVYEYMENGSLE+RL +K NT
Sbjct: 482 HSKEGHRTKEFQQELDVLSKIRHPHLLLLLGACSDHGCLVYEYMENGSLEERLLQKYNTA 541
Query: 495 PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554
PIPWFERYRIAWEVAS L FLHN+KPK IIHRD+KP NILLDHNLVSKIGDVGLSTMLN
Sbjct: 542 PIPWFERYRIAWEVASTLVFLHNSKPKSIIHRDLKPANILLDHNLVSKIGDVGLSTMLNL 601
Query: 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV 614
D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQLLTAKPAIA+ H V
Sbjct: 602 DSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQLLTAKPAIALAHLV 658
Query: 615 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674
ETAI +D L +ILD AG WP+KETKELA LGLSC ELRR+DRPDLK++VLP LERLK+
Sbjct: 659 ETAIQDDQLMKILDPMAGQWPMKETKELALLGLSCLELRRRDRPDLKDEVLPALERLKDA 718
Query: 675 ADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDL 734
ADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE+W++END SP+T+L
Sbjct: 719 ADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIEKWVEENDNSPMTNL 778
Query: 735 PLPNKNLLPNYTLLSAILDWKSK 757
LPNKNL+PNYTLLSAI++WKS+
Sbjct: 779 ALPNKNLIPNYTLLSAIMEWKSQ 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745064|emb|CBI38656.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 968 bits (2502), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 491/743 (66%), Positives = 583/743 (78%), Gaps = 29/743 (3%)
Query: 16 PVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIA 75
P+GN IP+ QVRDDVAAAY +E W+T +LLP++ M ++V+V+V VIESDDVAKAIA
Sbjct: 67 PMGNSIPLSQVRDDVAAAYLEEMGWQTSEMLLPYKTMFLHKKVQVDVVVIESDDVAKAIA 126
Query: 76 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDL 135
+E+A I+KLVIGA S G+F+ K K +LS RIS C PSFCTVY V KG+LSSVRPSD
Sbjct: 127 EEIAKSTIHKLVIGASSSGMFSRKVKGQSLSLRISECTPSFCTVYTVSKGQLSSVRPSDS 186
Query: 136 GSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKT 195
GS K+DSSD +S++SS + +S GSA ASY+H SPSLP QR QALS +N+T
Sbjct: 187 DKNGSIKEDSSDA---SSTTSSSSHTSSPHAGSA-ASYSHFHSPSLPMQRFQALSTINRT 242
Query: 196 LLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW-SD 254
LLH + S E N SR + S+ SS RS T++Q W SD
Sbjct: 243 LLHTRTGSIETNSSR--------------------HIGYAPSQVSSARSFLTDDQSWISD 282
Query: 255 QASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKL 314
QAST+D +SSS SQV++NFELEKLR+ELRHVRG+YA+AQ+E DASRK+NDL+K +L
Sbjct: 283 QASTSDAFT-ESSSGSQVNINFELEKLRVELRHVRGIYAMAQSENIDASRKLNDLSKRRL 341
Query: 315 EEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAK 374
EE +L EI+L EE+A ELA++EK+KYE A+REAE AR AEKEA QR+EAE+KA H+ K
Sbjct: 342 EEADKLKEIKLKEEEARELARKEKEKYEAAKREAEYARECAEKEALQRKEAEIKALHDVK 401
Query: 375 EKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL 434
EKE LE AL G Q Y+ TWEEI SAT SFSENL+IG G +GTVY+ HHT AAVKVL
Sbjct: 402 EKEKLENALVGPVQSYQEFTWEEIVSATSSFSENLQIGKGAHGTVYRCNLHHTTAAVKVL 461
Query: 435 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTP 494
SK + K+F QEL+VLSKIRHPHLLLLLGAC DHGCLVYEYMENGSLE+RL +K NT
Sbjct: 462 HSKEGHRTKEFQQELDVLSKIRHPHLLLLLGACSDHGCLVYEYMENGSLEERLLQKYNTA 521
Query: 495 PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554
PIPWFERYRIAWEVAS L FLHN+KPK IIHRD+KP NILLDHNLVSKIGDVGLSTMLN
Sbjct: 522 PIPWFERYRIAWEVASTLVFLHNSKPKSIIHRDLKPANILLDHNLVSKIGDVGLSTMLNL 581
Query: 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV 614
D S + NTGPVGTLCYIDPEYQRTGL+SPKSDVYA+GMV+LQLLTAKPAIA+ H V
Sbjct: 582 DSSICNI---NTGPVGTLCYIDPEYQRTGLVSPKSDVYAFGMVVLQLLTAKPAIALAHLV 638
Query: 615 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674
ETAI +D L +ILD AG WP+KETKELA LGLSC ELRR+DRPDLK++VLP LERLK+
Sbjct: 639 ETAIQDDQLMKILDPMAGQWPMKETKELALLGLSCLELRRRDRPDLKDEVLPALERLKDA 698
Query: 675 ADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDL 734
ADR+RD+ P V APPNHF+CPILK+VM++PCVAADGYTYDR+AIE+W++END SP+T+L
Sbjct: 699 ADRSRDSAPKVQLAPPNHFVCPILKDVMHDPCVAADGYTYDRRAIEKWVEENDNSPMTNL 758
Query: 735 PLPNKNLLPNYTLLSAILDWKSK 757
LPNKNL+PNYTLLSAI++WKS+
Sbjct: 759 ALPNKNLIPNYTLLSAIMEWKSQ 781
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455815|ref|XP_003598188.1| U-box domain-containing protein [Medicago truncatula] gi|355487236|gb|AES68439.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/753 (61%), Positives = 580/753 (77%), Gaps = 14/753 (1%)
Query: 11 LAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDV 70
+ + P+GN +PI QVRDDVAAAYK+E + +T+++LLPF+ MC QR+V VEV VIESDDV
Sbjct: 63 VGVPTPMGNMLPISQVRDDVAAAYKKEIECETNQMLLPFKQMCEQRKVHVEVVVIESDDV 122
Query: 71 AKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSV 130
A A+A+EV + KLV+GA + G+F K K +S++IS+C P FCTVY V KGKL +
Sbjct: 123 ASAVAEEVTKYAVTKLVVGASTGGLF--KSKHKGMSAKISVCTPRFCTVYAVSKGKLL-I 179
Query: 131 RPSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALS 190
RPSD+ S DD+S+ S+SSSS++ S++QTD GS VASY S SL TQR QALS
Sbjct: 180 RPSDVQIDESITDDTSEISFSSSSSSNYTSTTQTDSGS-VASYAALHSSSLATQRFQALS 238
Query: 191 AVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQ 250
++N+ LL PS E NHSR QS D+ A+SS + + + +SR+SS+RS+ ++
Sbjct: 239 SMNQNLLSTNPSLNETNHSRGQSIDLGRGNVATSSARNS-DFDRGLSRASSFRSIVSDTD 297
Query: 251 DW-SDQASTTDVLPYDS---SSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKV 306
W DQ S D P S S Q + N ELEKLRIELRH +GM+A+AQ E DASRK+
Sbjct: 298 TWIYDQISLKDA-PLTSKLASPNRQENFNLELEKLRIELRHAQGMHAVAQTENIDASRKL 356
Query: 307 NDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAE 366
N+L+K + E ++ EI EE A ELA+QE +KYE A REA + AE+EA++R+E E
Sbjct: 357 NELSKRRSGESMKMKEIIAKEEVAKELARQEIEKYEAAAREASYLKECAEREASERKETE 416
Query: 367 MKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH 426
+KA AKEK+ LE AL+G+ +YR TW+EI SAT SFSE+LRIGMG YG VYK T HH
Sbjct: 417 LKAIRAAKEKDKLEDALSGSTPQYRKFTWDEIVSATSSFSEDLRIGMGAYGMVYKCTLHH 476
Query: 427 TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDR 486
T AVKVL S G Q+KQF QELE+LS+IRHP+LLLLLGACPDHGCLVYEYMENGSLEDR
Sbjct: 477 TTVAVKVLHSAGISQSKQFQQELEILSRIRHPNLLLLLGACPDHGCLVYEYMENGSLEDR 536
Query: 487 LYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546
L++KN+T PI WF+R+R+AWE+ASAL+FLH++KP+PIIHRD+KP NILL NLVSKIGD+
Sbjct: 537 LFQKNSTTPIRWFDRFRVAWEIASALSFLHSSKPQPIIHRDLKPANILLGGNLVSKIGDI 596
Query: 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
GLST+LNSD +ST YK+T PVGTL YIDPEYQR+GLIS KSDVYA+G+V+LQLLTAKP
Sbjct: 597 GLSTVLNSDE--LSTMYKDTAPVGTLSYIDPEYQRSGLISTKSDVYAFGLVMLQLLTAKP 654
Query: 607 AIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP 666
A A+TH VETAI++ NL +ILD +AG WP +ET +LA L LSCAELRR+DRPDL + VLP
Sbjct: 655 ATALTHVVETAIEDGNLTDILDPKAGLWPFQETLDLARLALSCAELRRRDRPDLLDHVLP 714
Query: 667 VLERLKEVADRARD--TVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQ 724
LERLKEVADRA ++ ++ P PPNHFICPIL++VM++PCVAADGYTYDRKAIE+WL+
Sbjct: 715 TLERLKEVADRAHHSASMVAIKPKPPNHFICPILQDVMDDPCVAADGYTYDRKAIEKWLE 774
Query: 725 ENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
E DKSP+T++PLP+K L+PNYTLLSAIL+WKSK
Sbjct: 775 EKDKSPMTNIPLPHKILIPNYTLLSAILEWKSK 807
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449488729|ref|XP_004158155.1| PREDICTED: U-box domain-containing protein 35-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2313), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/745 (62%), Positives = 569/745 (76%), Gaps = 6/745 (0%)
Query: 16 PVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIA 75
P+GN IPI QVR+DVAAAY++E W T LLPF+ M AQR+V ++V +E+DDVA AI
Sbjct: 303 PMGNAIPISQVREDVAAAYRKEIWWHTSEKLLPFKKMFAQRKVHLDVVTLEADDVAGAII 362
Query: 76 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDL 135
+EV C+INKLVIG SQG+F+ K + LSSRIS P +CTVY + KGKL+S+RP D+
Sbjct: 363 EEVTKCSINKLVIGVSSQGLFSRKL--SGLSSRISALAPRYCTVYAISKGKLASIRPPDM 420
Query: 136 GSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTH--SSSPSLPTQRLQALSAVN 193
+ S +DD+S+ ++S SS +SS S +SY+H S SPSLP QR QALS +N
Sbjct: 421 DTNVSIRDDASEESSASSYSSYTSSSLTDGSSSLTSSYSHFPSPSPSLPLQRFQALSTIN 480
Query: 194 KTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDW- 252
+ LL KPS + +HSRCQS D+E Q D S + QT+SR+SS +S EN+ W
Sbjct: 481 QPLLTKKPSPIKADHSRCQSVDIENQVDGVHSSSYVSDCIQTLSRASSSKSSPAENKSWN 540
Query: 253 SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKC 312
SD+AS++ + SS ESQ DV+FELEKLRIELRH RGM+AIAQ E DASR++N LN
Sbjct: 541 SDEASSSGMFNDYSSCESQADVSFELEKLRIELRHARGMFAIAQRETIDASRELNHLNNQ 600
Query: 313 KLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHE 372
+ EE +L EI A E A++E+ K+E RREA+ + AE+E R+EAEMKA
Sbjct: 601 RSEEARKLEEINNKAVAAKEFAREERVKHEALRREAKYVKERAEREGIYRKEAEMKALQN 660
Query: 373 AKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVK 432
AKEK E AL G Q+Y++ WE+I SAT SFSE+L+IGMG +GTVYK + HHT AVK
Sbjct: 661 AKEKGKHENALQGPLQQYQHFQWEDIVSATSSFSEDLKIGMGAHGTVYKCSLHHTTVAVK 720
Query: 433 VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNN 492
VL S+ + + Q LQELEVLS+I HPHLLLLLGACPD CLVYEYMENGSLEDRLYR+ N
Sbjct: 721 VLHSRDSHKQMQLLQELEVLSRIHHPHLLLLLGACPDKNCLVYEYMENGSLEDRLYRRGN 780
Query: 493 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552
TP IPW+ER+RIAWE+ASAL FLH++KPK IIHRD+KP NILLD NLVSKIGDVGLST+
Sbjct: 781 TPAIPWYERFRIAWEIASALVFLHSSKPKSIIHRDLKPANILLDQNLVSKIGDVGLSTVF 840
Query: 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
NSDPS +ST + N+GPVGTLCYIDPEYQRTGLISPKSDVYA+GMVILQLLTAKPA+A+TH
Sbjct: 841 NSDPS-MSTAFMNSGPVGTLCYIDPEYQRTGLISPKSDVYAFGMVILQLLTAKPAVALTH 899
Query: 613 KVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672
VETAID NL +LD +AG WP++ET ELA LGL CAE++RKDRPDLK+QVLP+L LK
Sbjct: 900 VVETAIDNSNLINVLDIEAGHWPLEETYELARLGLRCAEMQRKDRPDLKDQVLPLLMTLK 959
Query: 673 EVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPIT 732
+VAD+AR+ V A PNHFICPIL++VMN+PCVAADGYTYDR+AIE+WLQ+ND SP+T
Sbjct: 960 KVADKARNLASKVPAAIPNHFICPILQDVMNDPCVAADGYTYDRQAIEKWLQKNDNSPMT 1019
Query: 733 DLPLPNKNLLPNYTLLSAILDWKSK 757
LPLP+KNL+PNY+LLSAI++W SK
Sbjct: 1020 KLPLPDKNLIPNYSLLSAIVEWNSK 1044
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451988|ref|XP_004143742.1| PREDICTED: U-box domain-containing protein 35-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 894 bits (2309), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/749 (61%), Positives = 571/749 (76%), Gaps = 6/749 (0%)
Query: 12 AIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVA 71
++ + VGN IPI QVR+DVAAAY++E W T LLPF+ M AQR+V ++V +E+DDVA
Sbjct: 61 SVPNAVGNAIPISQVREDVAAAYRKEIWWHTSEKLLPFKKMFAQRKVHLDVVTLEADDVA 120
Query: 72 KAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVR 131
AI +EV C+INKLVIG SQG+F+ K + LSSRIS P +CTVY + KGKL+S+R
Sbjct: 121 GAIIEEVTKCSINKLVIGVSSQGLFSRKL--SGLSSRISALAPRYCTVYAISKGKLASIR 178
Query: 132 PSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTH--SSSPSLPTQRLQAL 189
P D+ + S +DD+S+ ++S SS +SS S +SY+H S SPSLP QR QAL
Sbjct: 179 PPDMDTNVSIRDDASEESSASSYSSYTSSSLTDGSSSLTSSYSHFPSPSPSLPLQRFQAL 238
Query: 190 SAVNKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETEN 249
S +N+ LL KPS + +HSRCQS D+E Q D S + QT+SR+SS +S EN
Sbjct: 239 STINQPLLTKKPSPIKADHSRCQSVDIENQVDGVHSSSYVSDCIQTLSRASSSKSSPAEN 298
Query: 250 QDW-SDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVND 308
+ W SD+AS++ + SS ESQ DV+FELEKLRIELRH RGM+AIAQ E DASR++N
Sbjct: 299 KSWNSDEASSSGMFNDYSSCESQADVSFELEKLRIELRHARGMFAIAQRETIDASRELNH 358
Query: 309 LNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMK 368
LN + EE +L EI A E A++E+ K+E RREA+ + AE+E R+EAEMK
Sbjct: 359 LNNQRSEEARKLEEINNKAVAAKEFAREERVKHEALRREAKYVKERAEREGIYRKEAEMK 418
Query: 369 AKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTF 428
A AKEK E AL G Q+Y++ WE+I SAT SFSE+L+IGMG +GTVYK + HHT
Sbjct: 419 ALQNAKEKGKHENALQGPLQQYQHFQWEDIVSATSSFSEDLKIGMGAHGTVYKCSLHHTT 478
Query: 429 AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLY 488
AVKVL S+ + + Q LQELEVLS+I HPHLLLLLGACPD CLVYEYMENGSLEDRLY
Sbjct: 479 VAVKVLHSRDSHKQMQLLQELEVLSRIHHPHLLLLLGACPDKNCLVYEYMENGSLEDRLY 538
Query: 489 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
R+ NTP IPW+ER+RIAWE+ASAL FLH++KPK IIHRD+KP NILLD NLVSKIGDVGL
Sbjct: 539 RRGNTPAIPWYERFRIAWEIASALVFLHSSKPKSIIHRDLKPANILLDQNLVSKIGDVGL 598
Query: 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 608
ST+ NSDPS +ST + N+GPVGTLCYIDPEYQRTGLISPKSDVYA+GMVILQLLTAKPA+
Sbjct: 599 STVFNSDPS-MSTAFMNSGPVGTLCYIDPEYQRTGLISPKSDVYAFGMVILQLLTAKPAV 657
Query: 609 AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668
A+TH VETAID NL +LD +AG WP++ET ELA LGL CAE++RKDRPDLK+QVLP+L
Sbjct: 658 ALTHVVETAIDNSNLINVLDIEAGHWPLEETYELARLGLRCAEMQRKDRPDLKDQVLPLL 717
Query: 669 ERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDK 728
LK+VAD+AR+ V A PNHFICPIL++VMN+PCVAADGYTYDR+AIE+WLQ+ND
Sbjct: 718 MTLKKVADKARNLASKVPAAIPNHFICPILQDVMNDPCVAADGYTYDRQAIEKWLQKNDN 777
Query: 729 SPITDLPLPNKNLLPNYTLLSAILDWKSK 757
SP+T LPLP+KNL+PNY+LLSAI++W SK
Sbjct: 778 SPMTKLPLPDKNLIPNYSLLSAIVEWNSK 806
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357455813|ref|XP_003598187.1| U-box domain-containing protein [Medicago truncatula] gi|355487235|gb|AES68438.1| U-box domain-containing protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/748 (60%), Positives = 585/748 (78%), Gaps = 17/748 (2%)
Query: 16 PVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIA 75
P+G +P+ QVR+DVA A+K+E +W+T+++LLPF+++C QR+V V+V VIESDDVA A+A
Sbjct: 60 PMGEVLPLSQVRNDVATAFKREVEWQTNQMLLPFKSLCEQRKVHVDVVVIESDDVATAVA 119
Query: 76 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDL 135
+EVA I KLV+GA S GIF K K +S++IS+C P FCTVY V KGKLS +RPSD
Sbjct: 120 EEVAREAITKLVLGASSSGIFRSKHK--GISAKISVCTPRFCTVYAVAKGKLS-IRPSDT 176
Query: 136 GSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSAVNKT 195
GS D++S+T S+SSSS++ S+SQTD ++VAS S + TQR++A S++++T
Sbjct: 177 EIDGSIIDNTSETSFSSSSSSNYTSTSQTD-SASVASCNALHSYAKETQRVRAHSSMDQT 235
Query: 196 LLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSM-ETEN----Q 250
LL PS E NH R QS D+ +K+A++S ++ +S++SS S+ +TE+ Q
Sbjct: 236 LLSTSPSLNETNHFRGQSLDLG-RKNAAASSSRKSDIDHALSQASSCGSISDTESFFYEQ 294
Query: 251 DWSDQASTTDVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLN 310
+ + A+ + LP S Q ++N ELEKLRIELRH +GM+A+AQ+E DAS+K+N+LN
Sbjct: 295 NHAKDATRVNRLP---PSNRQENINLELEKLRIELRHAQGMHAVAQSENVDASQKLNELN 351
Query: 311 KCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAK 370
K +LEE ++ EI EE A+ELA QE++KYE A REA + AE+EAA+R+E E KA
Sbjct: 352 KRRLEESMKVKEIMAKEEMAMELANQEREKYEAAAREATYLKECAEREAAERKETEFKAI 411
Query: 371 HEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAA 430
AKEKE LE AL+G+ +YR TW+EI SAT SFSE+LR+GMG YG VYK T HHT A
Sbjct: 412 RAAKEKEKLEDALSGSTPQYRIFTWDEIVSATSSFSEDLRLGMGAYGIVYKCTLHHTTVA 471
Query: 431 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRK 490
VKVL S GN +NKQF QELE+LS+I HP+LLLLLGACPDHGCLVYEYMENG+LEDRL +K
Sbjct: 472 VKVLHSTGNCKNKQFQQELEILSRIHHPNLLLLLGACPDHGCLVYEYMENGNLEDRLLQK 531
Query: 491 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550
N+ PIPWF R++IAWEVASAL+FLH++KP+PIIHRD+KP NILLD NLVSKIGDVGLST
Sbjct: 532 NSNSPIPWFNRFQIAWEVASALSFLHSSKPQPIIHRDLKPANILLDGNLVSKIGDVGLST 591
Query: 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 610
+L+SD +S YK+T PVGTL YIDPEYQR+GLIS KSDVYA+G+VILQLLTAKPAIA+
Sbjct: 592 ILDSDE--LSAMYKDTAPVGTLSYIDPEYQRSGLISTKSDVYAFGLVILQLLTAKPAIAL 649
Query: 611 THKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670
TH VETAID NLA+ILD +AG WP++ET ++A L L CAE+RRKDRPDL + VLP+LER
Sbjct: 650 THIVETAIDGGNLADILDPKAGSWPLQETLDIARLALGCAEMRRKDRPDLNDHVLPMLER 709
Query: 671 LKEVADRARD--TVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDK 728
LKEVAD+A+ ++ ++ PPNHFICPIL++VM++PCVAADGYTYDR AIE+WL+ENDK
Sbjct: 710 LKEVADKAQHSASIVTIKSRPPNHFICPILQDVMDDPCVAADGYTYDRNAIEKWLEENDK 769
Query: 729 SPITDLPLPNKNLLPNYTLLSAILDWKS 756
SP+T++ LP+K+L+PNYTLLSAIL+WK+
Sbjct: 770 SPMTNMVLPHKHLIPNYTLLSAILEWKT 797
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508200|ref|XP_003522847.1| PREDICTED: U-box domain-containing protein 35-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/738 (61%), Positives = 566/738 (76%), Gaps = 20/738 (2%)
Query: 31 AAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGA 90
+ A+K+E +W+T+++LLPF+ MC QR+V V+V VIESDDVA AIADEVA I KLV+GA
Sbjct: 55 STAFKKEVEWQTNQMLLPFKRMCEQRKVHVDVIVIESDDVATAIADEVAKGAITKLVVGA 114
Query: 91 QSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVRPSDLGSIGSTKDDSSDTGC 150
S+G+F K K+ +S+RIS+ P FCT+Y + KGKLS +RPSD+ G+ DD+S++
Sbjct: 115 SSRGLF--KSKQKGMSTRISVSTPRFCTIYAISKGKLS-IRPSDMPIDGNIIDDASESET 171
Query: 151 SNSSSSSHNSSSQTDLGSA-VASYTHSSSPSLPTQRLQALSAVNKTLLHLKPSSTEINHS 209
S S+SSS N +S + SA V+SY S SL TQR QALS++N LL PS + NHS
Sbjct: 172 SLSTSSSSNYTSTSQTESASVSSYAALQSSSLTTQRFQALSSINSALLSTNPSFADTNHS 231
Query: 210 RCQSFDVEEQKDASSSCLSGPEVRQTVSRSSSYRSMETENQDWS-DQASTTDV-----LP 263
R QS D+ + ASSS + ++ +SR SS +S ++ + W DQ S DV LP
Sbjct: 232 RGQSLDLGRENTASSSARNS-DIDHALSRVSSCKSFISDTESWMYDQNSCKDVQLATTLP 290
Query: 264 YDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEI 323
S Q N ELEKLRIELRH +G++A+AQ E +ASRK+NDL+K + EE R+ EI
Sbjct: 291 ---SPNRQAKYNLELEKLRIELRHAQGLHAVAQTEKIEASRKLNDLSKRRSEETMRMKEI 347
Query: 324 QLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERAL 383
EEKA ELAK E++KY+ A REAE + AE+EAA+++E E++A AKEKE LE AL
Sbjct: 348 ISKEEKAKELAKLEREKYQDASREAEYLKECAEREAAEKKEMELRAIRAAKEKEKLEDAL 407
Query: 384 NGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI--Q 441
+G+ +YR TW+EI AT SFSE+L+IGMG YG VYK +HT AVKVL N+ +
Sbjct: 408 SGSTPQYRKFTWDEIILATSSFSEDLKIGMGAYGVVYKCNLYHTTVAVKVLTLNTNVNSK 467
Query: 442 NKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFER 501
KQF QELE+LS+IRHP+LLLLLGACPDHGCLVYEYMENG+LEDRL RKNNT PIPWFER
Sbjct: 468 RKQFQQELEILSRIRHPNLLLLLGACPDHGCLVYEYMENGNLEDRLLRKNNTSPIPWFER 527
Query: 502 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561
+RIA EVAS+LAFLH++KP+PIIHRD+KP NILLD NLVSKIGD+GLST+LNSD +S
Sbjct: 528 FRIALEVASSLAFLHSSKPEPIIHRDLKPANILLDRNLVSKIGDIGLSTVLNSDN--LSI 585
Query: 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621
K+T PVGTLCYIDPEYQRTGLISPKSD+YA+GMVILQLLTAKPAIA+ HKVETAID
Sbjct: 586 MSKDTAPVGTLCYIDPEYQRTGLISPKSDIYAFGMVILQLLTAKPAIALAHKVETAIDSG 645
Query: 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR-- 679
NL +ILD +AG WP +ET +LA LGLSCAELRR+DRPDL++ VLP LERLKEV DRA+
Sbjct: 646 NLTDILDPEAGAWPYQETLDLALLGLSCAELRRRDRPDLQDHVLPTLERLKEVVDRAQCS 705
Query: 680 DTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNK 739
++ ++ PPNHFICPIL++VM++PCVAADGYTYDRKAIE+WL+ENDKSP+T++ LP+K
Sbjct: 706 ASIVTIKSKPPNHFICPILQDVMDDPCVAADGYTYDRKAIEKWLEENDKSPMTNMALPHK 765
Query: 740 NLLPNYTLLSAILDWKSK 757
+L+PNYTLLSAIL+WKS+
Sbjct: 766 HLIPNYTLLSAILEWKSR 783
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42567138|ref|NP_194246.2| U-box domain-containing protein 35 [Arabidopsis thaliana] gi|172044784|sp|Q9SW11.2|PUB35_ARATH RecName: Full=U-box domain-containing protein 35; AltName: Full=Plant U-box protein 35; Includes: RecName: Full=E3 ubiquitin ligase; Includes: RecName: Full=Serine/threonine-protein kinase gi|332659618|gb|AEE85018.1| U-box domain-containing protein 35 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2149), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/777 (55%), Positives = 554/777 (71%), Gaps = 37/777 (4%)
Query: 12 AIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVA 71
++ P+GN IPI +VRDDV AY+QE W+++ +L P+ + +R+V VEV VIESD+VA
Sbjct: 62 SVPTPMGNAIPISEVRDDVVTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVA 121
Query: 72 KAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVR 131
AIA+EV +I+++VIG S+ F+ +K ++ S IS +P+FCTVY V KGKLS VR
Sbjct: 122 AAIAEEVTRDSIDRIVIGGSSRSFFS---RKADICSVISALMPNFCTVYVVSKGKLSCVR 178
Query: 132 PSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSA 191
PSD + ++D S+ S+S SS S S + SA S S SLP +R+Q A
Sbjct: 179 PSDSDGNATIREDGSERTNSSSGSSGPTSDSSDVMSSAHDS--QSRPLSLPVRRMQHFPA 236
Query: 192 V-NKTLLHLKPSSTEINHSRCQSFDVEEQKDASSSCLSGP--------------EVRQTV 236
+ + + ++ SS + +RC S D EE +D SS S E ++ +
Sbjct: 237 IAGQASVPMETSSVGSDETRCMSLDAEEARDVSSINRSSTDTTSRWTPRRRDYEERKEAM 296
Query: 237 SRSSSYR--------------SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKL 281
S SSS R ++T + S QAS +D L S +++QV++NFE+EKL
Sbjct: 297 SSSSSNREYGNFGTRFSWSGMGVDTTHSRASQQASNMSDALSEQSYTDNQVNLNFEVEKL 356
Query: 282 RIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKY 341
R ELRHV+ MYA+AQ E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+ +
Sbjct: 357 RAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNF 416
Query: 342 ETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESA 401
E ARR+AE R AE+E AQR+EAE K+ + KEKE LE L +Y++ WEEI +A
Sbjct: 417 EKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQLQYQHFAWEEIMAA 476
Query: 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 461
T SFSE L+IGMG YG VYK HHT A VKVLQS N +KQF QELE+LSKIRHPHL+
Sbjct: 477 TSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLV 536
Query: 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
LLLGACP+ G LVYEYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPK
Sbjct: 537 LLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPK 596
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP-SFVSTTYKNTGPVGTLCYIDPEYQ 580
PIIHRD+KP NILLDHN VSK+GDVGLSTM+ DP S T YK T PVGTLCYIDPEYQ
Sbjct: 597 PIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQ 656
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKET 639
RTG IS KSD+Y++GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET
Sbjct: 657 RTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEET 716
Query: 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILK 699
+ELAAL L C ELR KDRPDLK+Q+LP LE LK+VA++AR++ V PP HFICP+LK
Sbjct: 717 RELAALALCCTELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICPLLK 776
Query: 700 EVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756
+VMNEPCVAADGYTYDR AIEEWL+E++ SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 777 DVMNEPCVAADGYTYDRHAIEEWLKEHNTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 833
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297799476|ref|XP_002867622.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297313458|gb|EFH43881.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2119), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/777 (54%), Positives = 553/777 (71%), Gaps = 40/777 (5%)
Query: 12 AIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVA 71
++ P+GN IPI +VRDDV A++QE W+++ +L PF + +++V VEV VIESD++A
Sbjct: 62 SVPTPMGNAIPISEVRDDVVTAFRQEILWQSEEMLKPFTKLFVRKKVAVEVLVIESDNLA 121
Query: 72 KAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGKLSSVR 131
AIA+EV +I+++VIG S+ F+ +K ++ S IS +P+FCTVY V KGKLS VR
Sbjct: 122 AAIAEEVTRDSIDRIVIGGSSRSFFS---RKADMCSAISALMPNFCTVYVVSKGKLSCVR 178
Query: 132 PSDLGSIGSTKDDSSDTGCSNSSSSSHNSSSQTDLGSAVASYTHSSSPSLPTQRLQALSA 191
PSD + +DD G ++SSS +S +D+ S+V + S + SLP +R+Q
Sbjct: 179 PSDSDGNATIRDD----GSERTNSSSGSSGPTSDVMSSVHD-SQSRALSLPVRRMQNFPT 233
Query: 192 VNKTL-LHLKPSSTEINHSRCQSFDVEEQKDASSSCLSG--------PEVR------QTV 236
+ + + ++ SS + +RC S D EE +D SS S P +R + +
Sbjct: 234 IARQASVPMETSSVGSDETRCMSLDAEEARDVSSINRSSTDTTSRWTPRLRDYEERKEAM 293
Query: 237 SRSSSYR--------------SMETENQDWSDQAST-TDVLPYDSSSESQVDVNFELEKL 281
S SSS R ++ + S QAS +D L S ++SQV++NFE+EKL
Sbjct: 294 SSSSSNREYGNIGSRFSWTGMGVDNTHSRASQQASNMSDALSEQSYTDSQVNLNFEVEKL 353
Query: 282 RIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKY 341
R ELRHV+ MYA+AQ E DASRK+ +LN+ +LEE +L E++L E +A ELA++EK+
Sbjct: 354 RAELRHVQEMYAMAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEREKQNV 413
Query: 342 ETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESA 401
E ARR+AE R AE+E AQR+E E K+ + KE+E L+ L +Y++ WEEI +A
Sbjct: 414 EKARRDAESMRERAEREIAQRREVERKSARDTKEREKLKGTLGSPQLQYQHFAWEEIMAA 473
Query: 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 461
T SFSE L+IGMG YG VYK HHT AAVKVL S + +KQF QELE+LSKIRHPHL+
Sbjct: 474 TSSFSEELKIGMGAYGAVYKCNLHHTTAAVKVLHSAESRLSKQFQQELEILSKIRHPHLV 533
Query: 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
LLLGACP+ G LVYEYMENGSLEDRL++ NN+PP+PWFER+RIAWEVA+AL FLH +KPK
Sbjct: 534 LLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPK 593
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD-PSFVSTTYKNTGPVGTLCYIDPEYQ 580
PIIHRD+KP NILLD N VSK+GDVGLSTM+ D S T YK T PVGTLCYIDPEYQ
Sbjct: 594 PIIHRDLKPANILLDQNFVSKVGDVGLSTMVQVDLLSTKFTIYKQTSPVGTLCYIDPEYQ 653
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-DNLAEILDAQAGDWPIKET 639
RTG+IS KSDVY++GM++LQLLTAKPAIA+TH VE+A+D D +ILD +AG+WPI+ET
Sbjct: 654 RTGMISSKSDVYSFGMIVLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEET 713
Query: 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILK 699
+EL AL L C ELR KDRPDLKNQ+LP LE LK+VA+ AR+++ V PP HFICP+LK
Sbjct: 714 RELTALALCCTELRGKDRPDLKNQILPALENLKKVAEMARNSLSGVSTQPPTHFICPLLK 773
Query: 700 EVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756
+VMNEPCVAADGYTYDR+AIEEWL+E+D SP+TD PL +KNLLPNYTL +AI++W+S
Sbjct: 774 DVMNEPCVAADGYTYDRRAIEEWLEEHDTSPMTDSPLHSKNLLPNYTLYTAIMEWRS 830
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SW11 | PUB35_ARATH | 2, ., 7, ., 1, 1, ., - | 0.5534 | 0.9775 | 0.8862 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 757 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 8e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-19 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-16 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 5e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-12 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 7e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| pfam13445 | 55 | pfam13445, zf-RING_LisH, RING-type zinc-finger, Li | 2e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 3e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 4e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-05 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-04 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-04 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 5e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 6e-04 | |
| pfam03763 | 112 | pfam03763, Remorin_C, Remorin, C-terminal region | 6e-04 | |
| PRK09510 | 387 | PRK09510, tolA, cell envelope integrity inner memb | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| TIGR02794 | 346 | TIGR02794, tolA_full, TolA protein | 0.002 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.002 | |
| PRK00409 | 782 | PRK00409, PRK00409, recombination and DNA strand e | 0.002 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| COG3064 | 387 | COG3064, TolA, Membrane protein involved in colici | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PTZ00121 | 2084 | PTZ00121, PTZ00121, MAEBL; Provisional | 0.004 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.004 | |
| COG4942 | 420 | COG4942, COG4942, Membrane-bound metallopeptidase | 0.004 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-47
Identities = 73/198 (36%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 467
+G GG+GTVY T A+K+++ + + + L+E+E+L K+ HP+++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 468 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
+H LV EY E GSL+D K N + E RI ++ L +LH+ IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 526 RDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 583
RD+KP NILLD N K+ D GLS +L SD S + T VGT Y+ PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI------VGTPAYMAPEVLLGKG 169
Query: 584 LISPKSDVYAYGMVILQL 601
S KSD+++ G+++ +L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 76/204 (37%), Positives = 110/204 (53%), Gaps = 19/204 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
++G G +GTVYK T AVK+L +S+ + +++ +E+ +L ++ HP+++ L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 466 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
A DH LV EY E G L D L R P+ E +IA ++ L +LH+ I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS---NGI 119
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 582
IHRD+KP NILLD N V KI D GL+ L S T VGT Y+ PE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS------SLTTFVGTPWYMAPEVLLGG 173
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
PK DV++ G+++ +LLT KP
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKP 197
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 29/260 (11%)
Query: 411 IGMGGYGTVYKGT------FHHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLL 463
+G G +G VYKGT T AVK L+ + + ++ FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 464 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
LG C +V EYM G L D L + + ++A ++A + +L + K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLES---K 121
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
+HRD+ N L+ NLV KI D GLS + D + P+ ++ PE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG-GGKLPI---KWMAPESLK 177
Query: 582 TGLISPKSDVYAYGMVILQLLT--AKP-AIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
G + KSDV+++G+++ ++ T +P +V +++ P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR--------PENC 229
Query: 639 TKELAALGLSCAELRRKDRP 658
EL L L C +DRP
Sbjct: 230 PDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 78/260 (30%), Positives = 121/260 (46%), Gaps = 29/260 (11%)
Query: 411 IGMGGYGTVYKGTF------HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +G VYKGT AVK L+ Q ++FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 464 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
LG C + +V EYM G L D L RKN + + A ++A + +L + K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES---K 122
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
IHRD+ N L+ NLV KI D GLS L D YK G + ++ PE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYKVKGGKLPIRWMAPESLK 177
Query: 582 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDEDNLAEILDAQAGDWPIKE 638
G + KSDV+++G+++ ++ T +P +++ V + + P
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK--------PPNC 229
Query: 639 TKELAALGLSCAELRRKDRP 658
EL L L C +DRP
Sbjct: 230 PPELYKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 75/260 (28%), Positives = 120/260 (46%), Gaps = 30/260 (11%)
Query: 411 IGMGGYGTVYKGT------FHHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +G VYKG AVK L+ Q ++FL+E ++ K+ HP+++ L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 464 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
LG C + +V EYME G L L + N P + + A ++A + +L + K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES---K 121
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
IHRD+ N L+ NLV KI D GLS L D Y+ G + ++ PE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-----DYYRKRGGKLPIRWMAPESLK 176
Query: 582 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDEDNLAEILDAQAGDWPIKE 638
G + KSDV+++G+++ ++ T +P ++++ V + P
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQ--------PPNC 228
Query: 639 TKELAALGLSCAELRRKDRP 658
EL L L C +DRP
Sbjct: 229 PPELYDLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G VY T A+KV++ K ++ L+E+++L K++HP+++ L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 468 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLHNTKPKPII 524
D LV EY E G L D L ++ + R ++ SAL +LH+ K I+
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSE----DEARFYLRQILSALEYLHS---KGIV 119
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 584
HRD+KP NILLD + K+ D GL+ L+ T VGT Y+ PE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-------TTFVGTPEYMAPEVLLGKG 172
Query: 585 ISPKSDVYAYGMVILQLLTAKP 606
D+++ G+++ +LLT KP
Sbjct: 173 YGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 411 IGMGGYGTVYKGTF-----HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
+G G +G VYKG T AVK L+ + K FL+E V+ K+ HP+++ LL
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 465 GACPDHG--CLVYEYMENGSLEDRL------YRKNNTPPIPWFERYRIAWEVASALAFLH 516
G C + LV EYME G L D L + + + A ++A + +L
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ K +HRD+ N L+ +LV KI D GLS + D + T G I
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-------GGKLPIR 172
Query: 577 ---PEYQRTGLISPKSDVYAYGMVI 598
PE + G+ + KSDV+++G+++
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLL 197
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 466
+G G +G+VY T AVK ++ G+ + + +E+ +LS ++HP+++ G+
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 467 C----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ + EY+ GSL L +K P P +Y ++ LA+LH+
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKY--TRQILEGLAYLHS---NG 121
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
I+HRD+K NIL+D + V K+ D G + L + T GT ++ PE R
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGD----IETGEGTGSVRGTPYWMAPEVIRG 177
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
+D+++ G ++++ T KP
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 3e-32
Identities = 91/359 (25%), Positives = 144/359 (40%), Gaps = 28/359 (7%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHL---LLLL 464
+G G +G VY A+KVL K ++K +FL+E+++L+ + HP L
Sbjct: 8 LGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 465 GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
LV EY++ GSLED L + P+ E I ++ SAL +LH K II
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGII 123
Query: 525 HRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY---Q 580
HRD+KP NILLD + V K+ D GL+ +L S S + VGT Y+ PE
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDAQAGDW 634
S SD+++ G+ + +LLT P + T + I E + +
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSN 243
Query: 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFI 694
P +K + L K+R + + L ++ + + + P
Sbjct: 244 PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLS 303
Query: 695 CPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILD 753
P + A + + AI + D S + PN + S +L
Sbjct: 304 --------LPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLS 354
|
Length = 384 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 53/111 (47%), Positives = 71/111 (63%)
Query: 15 HPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAI 74
HP IP + +VA+AYKQEE + LLLP+R C+++ V+ E V+E DDVAKAI
Sbjct: 36 HPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAI 95
Query: 75 ADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 125
+ VA I KLV+GA S F+ KFKK++++S + P FCTVY V KG
Sbjct: 96 VEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLGAC 467
+G G G VYK T A+K + G+ + KQ L+EL+ L P+++ GA
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 468 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 523
G +V EYM+ GSL D L + IP E IA ++ L +LH + I
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKK---VGKIP--EPVLAYIARQILKGLDYLHTKRH--I 121
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
IHRD+KP N+L++ KI D G+S +L + + NT VGT+ Y+ PE +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLEN-----TLDQCNTF-VGTVTYMSPERIQGE 175
Query: 584 LISPKSDVYAYGMVILQLLTAK 605
S +D+++ G+ +L+ K
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 26/206 (12%)
Query: 410 RIGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG GG+G VYK H A+KV++ + + ++ + E+++L K +HP+++ G
Sbjct: 7 KIGKGGFGEVYKA--RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 466 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKP 520
+ D +V E+ GSL+D L + N +IA+ E+ L +LH+
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKD-LLKSTNQT----LTESQIAYVCKELLKGLEYLHSNG- 118
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
IIHRD+K NILL + K+ D GLS +S T VGT ++ PE
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSA-------QLSDTKARNTMVGTPYWMAPEVI 169
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKP 606
K+D+++ G+ ++L KP
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKP 195
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 44/218 (20%)
Query: 411 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF-LQELEVLSKIRHPHLLLLLGA 466
IG G +G VY + ++ S + + ++ L E+++L K+ HP+++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII----K 63
Query: 467 C------PDHGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRI-AW--EVASALAFL 515
C+V EY + G L ++ +K P F +I W ++ AL +L
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP----FPEEQILDWFVQLCLALKYL 119
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H+ K I+HRD+KP NI L N + K+GD G+S +L+S T VGT Y+
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV------VGTPYYL 170
Query: 576 DPE------YQRTGLISPKSDVYAYGMVILQLLTAKPA 607
PE Y + KSD+++ G V+ +L T K
Sbjct: 171 SPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 72/219 (32%), Positives = 100/219 (45%), Gaps = 30/219 (13%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNI--QNKQ--FLQELEVLSKI-RHPHLLLL 463
IG G + TV T A+K+L K + + K E EVL+++ HP ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 464 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
D L V EY NG L + RK + R+ A E+ AL +LH+ K
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCT-RFYAA-EILLALEYLHS---K 121
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP------------- 568
IIHRD+KP NILLD ++ KI D G + +L+ + S S T
Sbjct: 122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFAS 181
Query: 569 -VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
VGT Y+ PE SD++A G +I Q+LT KP
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 68/203 (33%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G G V K T AVK ++ + N KQ L+EL++L K P+++ GA
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 468 PDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
++G C+ EYM+ GSL+ K IP +IA V L +LH I
Sbjct: 69 YNNGDISICM--EYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--I 122
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
IHRD+KP NIL++ K+ D G+S L NS ++ T+ VGT Y+ PE +
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTF-----VGTSSYMAPERIQG 173
Query: 583 GLISPKSDVYAYGMVILQLLTAK 605
S KSD+++ G+ +++L T +
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
IG G +G VYKG T F A+K L+ K +QE+++L ++HP+++ +G+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 467 CPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKPKPI 523
L + EY ENGSL + K P P Y + +V LA+LH +
Sbjct: 68 IETSDSLYIILEYAENGSLRQII--KKFGPFPESLVAVY-VY-QVLQGLAYLHEQG---V 120
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
IHRD+K NIL + V K+ D G++T LN + VGT ++ PE
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSK------DDASVVGTPYWMAPEVIEMS 174
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
S SD+++ G +++LLT P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 8e-24
Identities = 29/63 (46%), Positives = 41/63 (65%)
Query: 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAI 751
F+CPI EVM +P + G TY+R AIE+WL + P+T PL +++L+PN L SAI
Sbjct: 1 EFLCPISLEVMKDPVILPSGQTYERSAIEKWLLSHGTDPVTGQPLTHEDLIPNLALKSAI 60
Query: 752 LDW 754
+W
Sbjct: 61 QEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLL 463
+G G +G V K T +A +KVL+ K I+ K+ E +LS+I HP ++ L
Sbjct: 1 LGKGSFGKVLLVRKKDT-GKLYA-MKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
A + LV EY G L L K Y A E+ AL +LH+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFY-AA-EIVLALEYLHS---L 112
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-Q 580
II+RD+KP NILLD + K+ D GL+ L+S+ S +T GT Y+ PE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT------FCGTPEYLAPEVLL 166
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKP 606
G D ++ G+++ ++LT KP
Sbjct: 167 GKG-YGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 74/259 (28%), Positives = 122/259 (47%), Gaps = 28/259 (10%)
Query: 410 RIGMGGYGTVYKGTFH---HTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G +G V+K +A ++ L + ++ + E VL+K+ +++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 466 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
+ D G +V EY ENG L L + P+P + +R ++ LA LH+ K I
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
+HRD+K N+ LD KIGD+G++ +L+ + +F +T VGT Y+ PE
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI------VGTPYYLSPELCEDK 176
Query: 584 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---IKETK 640
+ KSDV+A G+V+ + T K H + + A IL G +P ++
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK------HPFDA---NNQGALILKIIRGVFPPVSQMYSQ 227
Query: 641 ELAALGLSCAELRRKDRPD 659
+LA L C + RPD
Sbjct: 228 QLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 404 SFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
S ++G G +G V+ GT++ T AVK L+ G + + FLQE +++ K+RH L+
Sbjct: 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 463 LLGACPDHG--CLVYEYMENGSLEDRLY----RKNNTPPIPWFERYRIAWEVASALAFLH 516
L C + +V EYM GSL D L +K P + +A ++A +A+L
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLE 120
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ IHRD+ NIL+ NLV KI D GL+ ++ D K P+ +
Sbjct: 121 SRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIK---WTA 172
Query: 577 PEYQRTGLISPKSDVYAYGMVILQLLT 603
PE G + KSDV+++G+++ +++T
Sbjct: 173 PEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 80/272 (29%), Positives = 120/272 (44%), Gaps = 45/272 (16%)
Query: 410 RIGMGGYGTVYK------GTFHHTFAAVKVLQSK----GNIQNK---QFLQELEVLSKIR 456
IG G +GTV K G K+L K GN+ K Q + E+ +L +++
Sbjct: 7 TIGKGSFGTVRKVRRKSDG---------KILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57
Query: 457 HPHLLLLLGACPDHGC----LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVAS 510
HP+++ D +V EY E G L + +K I +RI ++
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLL 116
Query: 511 ALAFLHN-TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
AL HN + P ++HRD+KP NI LD N K+GD GL+ +L D SF + TY
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF-AKTY----- 170
Query: 569 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-IL 627
VGT Y+ PE KSD+++ G +I +L P TA ++ LA I
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-------TARNQLQLASKIK 223
Query: 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPD 659
+ + P + + EL + S + RP
Sbjct: 224 EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 8e-22
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 456
I S L IG G +G V G + AVK L+ + FL E V++ +R
Sbjct: 2 AINSKELKLGA--TIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAA-QAFLAEASVMTTLR 58
Query: 457 HPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
HP+L+ LLG L V EYM GSL D L R I ++ A +V + +
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
L K +HRD+ N+L+ +LV+K+ D GL+ + + +
Sbjct: 118 LEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKW 165
Query: 575 IDPEYQRTGLISPKSDVYAYGMVI 598
PE R S KSDV+++G+++
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 23/206 (11%)
Query: 411 IGMGGYGTVYKGTFHHTF--------AAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLL 461
+G G +G V + AVK L S F +E+E+L + H +++
Sbjct: 12 LGEGHFGKVELC--RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 462 LLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
G C G L+ EY+ +GSL D L R + + + + ++ + +L +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF--SSQICKGMDYLGS 127
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+ IHRD+ NIL++ + KI D GL+ +L D + P+ + P
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI---FWYAP 181
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLT 603
E RT S SDV+++G+ + +L T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 69/229 (30%), Positives = 117/229 (51%), Gaps = 30/229 (13%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSK 454
E+E ++ L G G YG VY+G + + AVK L+ ++ ++FL+E V+ +
Sbjct: 2 EMERTDITMKHKL--GGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKE 58
Query: 455 IRHPHLLLLLGAC----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 510
I+HP+L+ LLG C P + ++ E+M G+L D L R+ N + +A +++S
Sbjct: 59 IKHPNLVQLLGVCTREPPFY--IITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISS 115
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 570
A+ +L + K IHRD+ N L+ N + K+ D GLS ++ D TY T G
Sbjct: 116 AMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TY--TAHAG 164
Query: 571 T---LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT----AKPAIAITH 612
+ + PE S KSDV+A+G+++ ++ T P I ++
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 9e-21
Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-AVKVLQSKGNIQNKQFLQELEVLS 453
WE I+ ++ ++G G +G V++G +++T AVK L+ G + K FL E +++
Sbjct: 1 WE-IDRTSIQLLR--KLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMK 56
Query: 454 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
K+RHP L+ L C +V E M+ GSL + L + + + +A +VAS
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASG 115
Query: 512 LAFL--HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGP 568
+A+L N IHRD+ N+L+ N + K+ D GL+ ++ D Y+ G
Sbjct: 116 MAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKED------IYEAREGA 164
Query: 569 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ + PE S KSDV+++G+++ +++T
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 9e-21
Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 411 IGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +GTVYKG + A+KVL + NK+ L E V++ + HPH++ L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 464 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 520
LG C L+ + M G L D Y +N+ I +Y + W ++A +++L
Sbjct: 75 LGICLSSQVQLITQLMPLGCLLD--YVRNHKDNIG--SQYLLNWCVQIAKGMSYLEE--- 127
Query: 521 KPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
K ++HRD+ N+L+ V KI D GL+ +L+ D Y G + ++ E
Sbjct: 128 KRLVHRDLAARNVLVKTPQHV-KITDFGLAKLLDVD----EKEYHAEGGKVPIKWMALES 182
Query: 580 QRTGLISPKSDVYAYGMVILQLLT--AKP 606
+ + KSDV++YG+ + +L+T AKP
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 66/271 (24%), Positives = 119/271 (43%), Gaps = 41/271 (15%)
Query: 411 IGMGGYGTVYKGTFH-----HTF--AAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLL 462
+G G +G VY+G A+K + ++ + +FL E V+ + H++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 463 LLGACPD--HGCLVYEYMENGSLEDRLY------RKNNTPPIPWFER-YRIAWEVASALA 513
LLG +V E M G L+ L N P ++ ++A E+A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG----PV 569
+L K +HRD+ N ++ +L KIGD G++ + + Y+ G PV
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-----TDYYRKGGKGLLPV 185
Query: 570 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEIL 627
++ PE + G+ + KSDV+++G+V+ ++ T +P +++ E+ L ++
Sbjct: 186 R---WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFVI 235
Query: 628 DAQAGDWPIKETKELAALGLSCAELRRKDRP 658
D D P +L L C + K RP
Sbjct: 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 411 IGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 466
IG G +G VY AVK ++ + N K+ E++VL ++HP+L+ G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 467 --CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
+ + EY G+LE+ L Y + ++ LA+LH+ I+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEH-VIRVYTL--QLLEGLAYLHSHG---IV 121
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 584
HRD+KP NI LDHN V K+GD G + L ++ + + ++ GT Y+ PE G
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL--AGTPAYMAPEVITGGK 179
Query: 585 ISPK---SDVYAYGMVILQLLTAKP 606
+D+++ G V+L++ T K
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 39/229 (17%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 466
IG G YG VYK T A+K++ + + ++ +E +L K HP++ GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 467 -------CPDHGCLVYEYMENGSLED---RLYRKNNTPPIPWFERYRIAW---EVASALA 513
D LV E GS+ D L +K W IA+ E LA
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGLA 127
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTL 572
+LH K +IHRD+K NILL N K+ D G+S L+ ST + NT +GT
Sbjct: 128 YLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTF-IGTP 177
Query: 573 CYIDPE-----YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616
++ PE Q +SDV++ G+ ++L KP + H +
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 70/203 (34%), Positives = 114/203 (56%), Gaps = 24/203 (11%)
Query: 411 IGMGGYGTVYKGTFH---HTFAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+G G G+V K H T A KV + +K +++ KQ L+EL+++ + R P+++ G
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVR-KQILRELQIMHECRSPYIVSFYG 70
Query: 466 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
A ++ C+ E+M+ GSL DR+Y+K PIP +IA V L +L+N I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR--I 125
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+HRD+KP NIL++ K+ D G+S ++NS ++ T+ VGT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTF-----VGTSTYMSPERIQG 176
Query: 583 GLISPKSDVYAYGMVILQLLTAK 605
G + KSDV++ G+ I++L K
Sbjct: 177 GKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 410 RIGMGGYGTVYKGT-----FHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLL 462
++G G +G V +G AVK L+S + + FL+E ++ + H +L+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 463 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
L G H +V E GSL DRL RK+ A ++A+ + +L + K
Sbjct: 61 LYGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLES---K 116
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
IHRD+ NILL + KIGD GL L ++ +V + + PE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV----PFAWCAPESL 172
Query: 581 RTGLISPKSDVYAYGMVILQLLT 603
RT S SDV+ +G+ + ++ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 446 LQELEVLSKIRHPHLLLLLGACPDHGCLV--YEYMENGSLEDRLYRKNNTPPIPWFERYR 503
L E+ +LS ++HP+++ D L+ EY G+L D++ R+ FE
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ----LFEEEM 102
Query: 504 IAW---EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560
+ W ++ SA++++H I+HRD+K NI L + K+GD G+S +L S+ S
Sbjct: 103 VLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159
Query: 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620
T VGT Y+ PE + + KSD++A G V+ +LLT K D
Sbjct: 160 TV------VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK----------RTFDA 203
Query: 621 DNLAEILDA-QAGDW-PIKE--TKELAALGLSCAELRRKDRP 658
N ++ G++ P+ + EL +L S + + RP
Sbjct: 204 TNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 410 RIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
++G G +G V++G + + A+K+L+S ++ + F +E++ L ++RH HL+ L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 469 DHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
G VY E ME GSL L R +P +A +VA +A+L IH
Sbjct: 73 V-GEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIH 127
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 585
RD+ NIL+ +LV K+ D GL+ ++ D V + P + PE G
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKED---VYLSSDKKIPYK---WTAPEAASHGTF 181
Query: 586 SPKSDVYAYGMVILQLLT 603
S KSDV+++G+++ ++ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 65/232 (28%), Positives = 112/232 (48%), Gaps = 40/232 (17%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQNKQ-FLQE 448
EI + + F E L G G +G VYKG T A+K L+ + +Q F QE
Sbjct: 1 EIPLSAVRFLEEL--GEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 449 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTP------------ 494
E++S ++HP+++ LLG C C+++EY+ +G L + L R N+P
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVR--NSPHSDVGAESGDET 116
Query: 495 ---PIPWFERYRIAWEVASALAFL--HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
+ + IA ++A+ + +L H+ +HRD+ N L+ L KI D GLS
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL 601
+ S + K+ PV ++ PE G + +SD++++G+V+ ++
Sbjct: 172 RDIYSA-DYYRVQSKSLLPVR---WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF--------LQELEVLSKI-RHP 458
++G G +G+VY T A+K + K+F L+E++ L K+ HP
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 459 HLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
+++ L ++ L V+EYME G+L L + P I +++ LA +H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYME-GNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
HRD+KP N+L+ V KI D GL+ + S P + T Y V T Y
Sbjct: 117 KHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDY-----VSTRWYRA 166
Query: 577 PE-YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE R+ S D++A G ++ +L T +P
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 3e-19
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPHLLLLLGA 466
+G G +G V+ + +K + + ++++ E +VL + HP+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 467 CPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
+ L V EY G+L + + ++ N+ + I L LH+ K I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 525 HRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
HRD+K NILLD H +V KIGD G+S +L S+ K VGT CYI PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVVGTPCYISPELCEGK 176
Query: 584 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL-AEILDAQAGDW-PIKE--T 639
+ KSD++A G V+ +L + ++ A + NL A +L +G + PI + +
Sbjct: 177 PYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAPISDRYS 226
Query: 640 KELAALGLSCAELRRKDRPDLKNQVL 665
+L L LS L RP L +Q++
Sbjct: 227 PDLRQLILSMLNLDPSKRPQL-SQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLG 465
+G G YG V K T V + + K K L+E++VL ++RH +++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 466 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
A G LV+EY+E LE PP W++ A+A+ H+ I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHSHN---I 121
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
IHRD+KP NIL+ + V K+ D G + L + P+ T Y V T Y PE
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY-----VATRWYRAPEL---- 172
Query: 584 LISPKS-----DVYAYGMVILQLLTAKP 606
L+ + DV+A G ++ +LL +P
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 411 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLL 463
I G YG V+ K + +A +KV+ K ++ K Q L E ++LS+ + P+++ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYA-IKVI-KKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
+ + LV EY+ G L L + R IA E+ AL +LH+
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDV-ARIYIA-EIVLALEYLHSNG-- 113
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTM-LNSDPSFVS-TTYKNTGPVGTLCYIDPEY 579
IIHRD+KP NIL+D N K+ D GLS + L ++ ++ VGT YI PE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
S D ++ G ++ + L P
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 6e-19
Identities = 73/259 (28%), Positives = 121/259 (46%), Gaps = 32/259 (12%)
Query: 430 AVKVLQS---KGNIQNKQFLQELEVLSKIRHPHLLLLL--GACPDHGCL--VYEYMENGS 482
A+K+L++ + Q +F +E + +++ HP+++ LL G P G L V+EY+ +
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYVPGRT 65
Query: 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNL 539
L + L P E R+ +V ALA HN + I+HRD+KP NI++
Sbjct: 66 LREVLAADGALPAG---ETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRP 119
Query: 540 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
+K+ D G+ T+L T T V GT Y PE R ++P SD+YA+G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 599 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 658
L+ LT + V+ A ++AEIL Q + +A L LR+
Sbjct: 180 LECLTGQRV------VQGA----SVAEILYQQLSPVDVSLPPWIAGHPLG-QVLRKALNK 228
Query: 659 DLKNQVLP---VLERLKEV 674
D + + + ER + +
Sbjct: 229 DPRQRAASAPALAERFRAL 247
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLLGACP 468
+IG G G VYK T T V + + + QNK+ + E+ ++ +HP+++ +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 469 DHGCL--VYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
L V EYM+ GSL D + + N P I + EV L +LH+ + +
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-----YVCREVLQGLEYLHS---QNV 137
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
IHRD+K NILL + K+ D G + L + S K VGT ++ PE +
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS------KRNSVVGTPYWMAPEVIKRK 191
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
PK D+++ G++ +++ +P
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLL 464
RIG G +G V+K T A+K + + G I N Q L+E++ L +HP+++ LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN-QALREIKALQACQHPYVVKLL 65
Query: 465 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
P LV EYM L + L + P + Y + +A++H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMR--MLLKGVAYMHANG--- 119
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY--- 579
I+HRD+KP N+L+ + V KI D GL+ + + + + + V T Y PE
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-----QVATRWYRAPELLYG 174
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
R P D++A G + +LL P
Sbjct: 175 ARK--YDPGVDLWAVGCIFAELLNGSP 199
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 75/287 (26%), Positives = 130/287 (45%), Gaps = 36/287 (12%)
Query: 392 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH---HTFA----AVKVLQSKGNIQNKQ 444
+L WE LSF + L G G +G V + T + + A AVK+L+ + ++
Sbjct: 27 DLKWE-FPRNNLSFGKTL--GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 445 FL-QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFE 500
L EL+++S + H +++ LLGAC G ++ EY G L + L RK + F
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-----FL 138
Query: 501 RYR----IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556
+++VA +AFL + K IHRD+ N+LL H + KI D GL+ + +D
Sbjct: 139 TLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS 195
Query: 557 SFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615
++V N PV ++ PE + + +SDV++YG+++ ++ + +
Sbjct: 196 NYVVK--GNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPG 246
Query: 616 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662
+D I + P E+ + +C + RP K
Sbjct: 247 MPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQ 293
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 72/224 (32%), Positives = 106/224 (47%), Gaps = 49/224 (21%)
Query: 400 SATLSFSENLR---IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEV 451
SA S SE R IG G GTVYK T A+KV+ GN ++ +Q +E+E+
Sbjct: 68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY--GNHEDTVRRQICREIEI 125
Query: 452 LSKIRHPHLLLLLGACPD---HGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERY--R 503
L + HP+++ C D H ++ E+M+ GSLE E++
Sbjct: 126 LRDVNHPNVV----KCHDMFDHNGEIQVLLEFMDGGSLEGTHI---------ADEQFLAD 172
Query: 504 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS--DPSFVST 561
+A ++ S +A+LH I+HRD+KP N+L++ KI D G+S +L DP S
Sbjct: 173 VARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYA-----YGMVILQ 600
VGT+ Y+ PE T L D YA G+ IL+
Sbjct: 229 -------VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 65/203 (32%), Positives = 97/203 (47%), Gaps = 25/203 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
R+G G G+V K +T FA + KQ L+ELE+ + P+++ GA
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 467 CPD-HGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKP 520
D + EY E GSL D +Y+K E+ +IA V L++LH+ K
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK- 125
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NS-DPSFVSTTYKNTGPVGTLCYIDPE 578
IIHRD+KP NILL K+ D G+S L NS +F T++ Y+ PE
Sbjct: 126 --IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF----------YMAPE 173
Query: 579 YQRTGLISPKSDVYAYGMVILQL 601
+ S SDV++ G+ +L++
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 40/220 (18%)
Query: 411 IGMGGYGTVYKGTFHH-------TFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLL 462
+G G +G V+ G +H AVK L+ + N K F +E E+L+ +H +++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 463 LLGACPDHGCL--VYEYMENGSLEDRLYRKNN-------TPPIPWFERYR-----IAWEV 508
G C + V+EYME+G L ++ R + +P P E IA ++
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG- 567
AS + +L + +HRD+ N L+ ++LV KIGD G+S +T Y G
Sbjct: 132 ASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYRVGG 182
Query: 568 ----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
P+ ++ PE + +SDV+++G+V+ ++ T
Sbjct: 183 HTMLPIR---WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 66/230 (28%), Positives = 93/230 (40%), Gaps = 41/230 (17%)
Query: 411 IGMGGYGTVYKGTFHHT---FA-----AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
IG G +G V T FA K + KG+++N L E +L ++ HP L+
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-EKGSVRN--VLNERRILQELNHPFLVN 64
Query: 463 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 517
L + D LV + + G L L +K F E+ + E+ AL +LH+
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK------FSEEQVKFWICEIVLALEYLHS 118
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
K IIHRD+KP NILLD I D ++T V+ T GT Y+ P
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATK-------VTPDTLTTSTSGTPGYMAP 168
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAK---------PAIAITHKVETAI 618
E S D ++ G+ + L K I K ETA
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (212), Expect = 4e-18
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 37/213 (17%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 463
++G G YG VYK T A+K + + + + + L+E+ +L +++HP+++ L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALK--KIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 464 LGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L LV+EY + D + Y P+ I +++ LA+ H+ +
Sbjct: 64 LDVIHTERKLYLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 578
I+HRD+KP NIL++ + V K+ D GL+ +F T V TL Y PE
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLAR------AFGIPLRTYTHEVVTLWYRAPEIL 170
Query: 579 -----YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y S D+++ G + +++T KP
Sbjct: 171 LGSKHY------STAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 71/215 (33%), Positives = 101/215 (46%), Gaps = 46/215 (21%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHPHLLL 462
+G G +G V +KG+ + A+K+L SK I Q + L E +L IRHP L+
Sbjct: 9 LGTGSFGRVMLVRHKGSGK--YYALKIL-SKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 463 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L G+ D L V EY+ G L L RK+ P P Y A +V AL +LH+
Sbjct: 66 LYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLALEYLHS--- 119
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 576
I++RD+KP N+LLD + KI D G + + TY TLC Y+
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------TY-------TLCGTPEYLA 166
Query: 577 PEYQRTGLISPK-----SDVYAYGMVILQLLTAKP 606
PE +I K D +A G++I ++L P
Sbjct: 167 PE-----IILSKGYGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 398 IESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 456
I + L+ + IG G +G V+ G + A+K ++ +G + + F++E +V+ K+
Sbjct: 1 IHPSELTLVQ--EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLS 57
Query: 457 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER---YRIAWEVASA 511
HP L+ L G C + CLV+E+ME+G L D L + F + + +V
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-----FSQETLLGMCLDVCEG 112
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+A+L ++ +IHRD+ N L+ N V K+ D G++ + D ST K PV
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVK- 166
Query: 572 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ PE S KSDV+++G+++ ++ +
Sbjct: 167 --WSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 61/203 (30%), Positives = 107/203 (52%), Gaps = 14/203 (6%)
Query: 404 SFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
S +++G G +G V+ GT++ T A+K L+ G + + FLQE +V+ K+RH L+
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 463 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKP 520
L + +V EYM GSL D L + +P + +A ++AS +A++
Sbjct: 66 LYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMN- 122
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
+HRD++ NIL+ NLV K+ D GL+ ++ D + + G + + PE
Sbjct: 123 --YVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAA 175
Query: 581 RTGLISPKSDVYAYGMVILQLLT 603
G + KSDV+++G+++ +L T
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 411 IGMGGYGTVYKG---TFHHTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G G YG+VYK + + +A +V L S + + + E+ +L+ + HP+++ A
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 467 CPDHG--CLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
D C+V EY G L + RK IP E +RI ++ L LH K I
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---I 124
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
+HRD+K NILL N + KIGD+G+S +L T +GT Y+ PE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLKK-------NMAKT-QIGTPHYMAPEVWKGR 176
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
S KSD+++ G ++ ++ T P
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 6e-18
Identities = 78/273 (28%), Positives = 129/273 (47%), Gaps = 30/273 (10%)
Query: 411 IGMGGYGTVYKGTF-----HHTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLL 464
IG G +G V G A+K L++ Q + FL E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 465 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G +V EYMENGSL D RK++ + + +AS + +L +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQ-FTVIQLVGMLRGIASGMKYLSDMG--- 126
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+HRD+ NIL++ NLV K+ D GLS +L DP TT P+ + PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR---WTAPEAIAY 183
Query: 583 GLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDED-NLAEILDAQAGDWPIKE 638
+ SDV++YG+V+ ++++ +P ++++ V AI+E L +D A
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAA------ 237
Query: 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
L L L C + R +RP Q++ +L++L
Sbjct: 238 ---LHQLMLDCWQKDRNERPKF-EQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 7e-18
Identities = 59/202 (29%), Positives = 109/202 (53%), Gaps = 12/202 (5%)
Query: 404 SFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
S ++++G G +G V+ GT++ T A+K L+ G + + FLQE +++ K+RH L+
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 463 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
L + +V E+M GSL D L ++ + + + +A ++A +A++
Sbjct: 66 LYAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMN-- 122
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
IHRD++ NIL+ NLV KI D GL+ ++ D + + G + + PE
Sbjct: 123 -YIHRDLRAANILVGDNLVCKIADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAAL 176
Query: 582 TGLISPKSDVYAYGMVILQLLT 603
G + KSDV+++G+++ +L+T
Sbjct: 177 YGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG VYK T A K+ + K L+E+++L ++ HP+++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 466 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
G LV+E+M+ + L + + +++ LAF H+ I
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKS-YLYQLLQGLAFCHSHG---I 119
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 582
+HRD+KP N+L++ V K+ D GL+ S T Y V T Y PE
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THY-----VVTRWYRAPELLLGD 173
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
S D+++ G + +LL+ +P
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
RIG G YG VYK T A+KV L+ + + Q QE+ +L + RHP+++ G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ--QEISMLKECRHPNIVAYFG 67
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKP 520
+ L V EY GSL+D +Y+ P +IA+ E LA+LH T
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGP----LSELQIAYVCRETLKGLAYLHETG- 121
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY- 579
IHRD+K NILL + K+ D G+S L +T K +GT ++ PE
Sbjct: 122 --KIHRDIKGANILLTEDGDVKLADFGVSAQLT------ATIAKRKSFIGTPYWMAPEVA 173
Query: 580 --QRTGLISPKSDVYAYGMVILQLLTAKP 606
+R G K D++A G+ ++L +P
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 14/209 (6%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 455
E+ TL + ++G G +G V+ G ++ HT A+K L+ G++ + FL E ++ ++
Sbjct: 2 EVPRETLKLVK--KLGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQL 58
Query: 456 RHPHLLLLLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
+HP L+ L ++ EYMENGSL D L + + + +A ++A +AF
Sbjct: 59 QHPRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
+ K IHRD++ NIL+ L KI D GL+ ++ + K P+ +
Sbjct: 118 IER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIK---W 169
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PE G + KSDV+++G+++ +++T
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 75/260 (28%), Positives = 121/260 (46%), Gaps = 27/260 (10%)
Query: 410 RIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLL 463
+G G +G+V KG + AVK L+ + K+ FL+E V++++ HP ++ L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 464 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+G C LV E G L L ++ P E +A +VA +A+L +
Sbjct: 62 IGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYLESKH--- 115
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCYIDPEYQR 581
+HRD+ N+LL + +KI D G+S L + S Y+ T L + PE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG----SDYYRATTAGRWPLKWYAPECIN 171
Query: 582 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639
G S KSDV++YG+ + + + AKP + A+ E E L P +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG--ERLPR-----PEECP 224
Query: 640 KELAALGLSCAELRRKDRPD 659
+E+ ++ LSC + R +DRP
Sbjct: 225 QEIYSIMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 42/280 (15%)
Query: 411 IGMGGYGTVYKGTFHH-----TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLL 464
IG G +G V +G F A+K L+S Q + FL E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 465 G----ACPDHGCLVYEYMENGSLEDRLYRKNNT--PPIPWFERYRIAWEVASALAFLHNT 518
G + P ++ E+MENG+L D R+N+ I R +A+ + +L
Sbjct: 72 GVVTKSRPV--MIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEM 125
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG---TLCYI 575
+HRD+ NIL++ NLV K+ D GLS L D S TY T +G + +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTY--TSSLGGKIPIRWT 178
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHK-VETAIDED-NLAEILDAQA 631
PE + SDV++YG+V+ ++++ +P ++++ V AI++D L +D
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT 238
Query: 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
L L L C + R RP Q++ L+++
Sbjct: 239 A---------LHQLMLDCWQKDRNARPKFG-QIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 46/219 (21%)
Query: 410 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNIQNK------QFLQELEVLSKIRHPHLL 461
+IG G YG VYK A+K K ++N+ ++E+++L K+RHP+++
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALK----KIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 462 LLLGACPDHGC----LVYEYME---NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
L G +V+EYM+ G L+ + T + ++ L +
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKF--TES----QIKCYMKQLLEGLQY 115
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH+ I+HRD+K NIL++++ V K+ D GL+ S T + V TL Y
Sbjct: 116 LHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNR----VITLWY 167
Query: 575 IDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE Y P+ D+++ G ++ +L KP
Sbjct: 168 RPPELLLGATRY------GPEVDMWSVGCILAELFLGKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 72/264 (27%), Positives = 122/264 (46%), Gaps = 33/264 (12%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN------KQFLQELEVLSKIRHPHLLLLL 464
+G G YG V H + + K N++N K QE ++LS+++HP+++
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 465 GACPDHGCLVYEYM---ENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTK 519
+ L+Y M E G L +L ++ +P E + W ++A AL +LH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLP--ENQVVEWFVQIAMALQYLHE-- 120
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
K I+HRD+K N+ L + K+GD+G++ +L + ST +GT Y+ PE
Sbjct: 121 -KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL------IGTPYYMSPEL 173
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA-EILDAQAGDWPIKE 638
+ KSDV+A G + ++ T K A A D ++L I++ + P
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAF-------NAKDMNSLVYRIIEGKLPPMPKDY 226
Query: 639 TKELAALGLSCAELRRKDRPDLKN 662
+ EL L + R + RP +K+
Sbjct: 227 SPELGELIATMLSKRPEKRPSVKS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 16/195 (8%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 469
IG G +G V +G + AVK + K ++ + FL+E V++K+ H +L+ LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 470 HGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM 528
+G +V E M G+L + L R + + + + +VA + +L + K ++HRD+
Sbjct: 71 NGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126
Query: 529 KPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPK 588
NIL+ + V+K+ D GL+ + V + PV + PE + S K
Sbjct: 127 AARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL---PVK---WTAPEALKHKKFSSK 177
Query: 589 SDVYAYGMVILQLLT 603
SDV++YG+++ ++ +
Sbjct: 178 SDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 28/272 (10%)
Query: 411 IGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL 464
IG G +G V++G A+K L+ + +Q FL E ++ + H +++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 465 GACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G ++ EYMENG+L D+ R ++ ++ + +A+ + +L +
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSS-YQLVGMLRGIAAGMKYLSDMN--- 127
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+HRD+ NIL++ NL K+ D GLS +L DP TY +G + + PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---EGTYTTSGGKIPIRWTAPEAIAY 184
Query: 583 GLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDEDNLAEILDAQAGDWPIKET 639
+ SDV+++G+V+ ++++ +P ++ H+V AI++ L A P+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND---GFRLPA-----PMDCP 236
Query: 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
+ L L C + R RP + ++ +L++L
Sbjct: 237 SAVYQLMLQCWQQDRARRPRFVD-IVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 8e-17
Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 49/273 (17%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ------FLQELEVLSKIRHPHLLL 462
+G G + + Y + T AVK + N ++Q +E+ +++++ HPH++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 463 LLGA-CPD-HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNT 518
+LGA C D H L E+M GS+ L + + E I + ++ L++LH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN 122
Query: 519 KPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCY 574
+ IIHRD+K N+L+D L +I D G + L + + + G +GT+ +
Sbjct: 123 Q---IIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAK---GTGAGEFQGQLLGTIAF 174
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA---------IAITHKVETAIDEDNLAE 625
+ PE R DV++ G VI+++ TAKP +A+ K+ +A ++ E
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 626 ILDAQAGDWPIKETKELAALGLSCAELRRKDRP 658
L D + L C EL+ +DRP
Sbjct: 235 HLSPGLRD-----------VTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
+G G YG+VYK T A+KV+ + ++Q ++E+ +L + P+++ G+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIVKYYGSYF 68
Query: 469 DHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA---LAFLHNTKPKPI 523
+ L V EY GS+ D + N T IA + L +LH+ K
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGLEYLHSNK---K 120
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-QRT 582
IHRD+K GNILL+ +K+ D G+S L + +NT +GT ++ PE Q
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTD-----TMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
G + K+D+++ G+ +++ KP
Sbjct: 175 GYNN-KADIWSLGITAIEMAEGKP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 53/187 (28%), Positives = 95/187 (50%), Gaps = 21/187 (11%)
Query: 430 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSL--- 483
AVK+L++ + FL+E++++S++++P+++ LLG C D C++ EYMENG L
Sbjct: 48 AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 484 ------EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 537
E NN P + +A ++AS + +L + +HRD+ N L+ +
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGN 164
Query: 538 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGM 596
+ KI D G+S L S Y+ G V + ++ E G + SDV+A+G+
Sbjct: 165 HYTIKIADFGMSRNLYS-----GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 597 VILQLLT 603
+ ++ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 68/263 (25%), Positives = 122/263 (46%), Gaps = 39/263 (14%)
Query: 411 IGMGGYGTVYKG--TFHHTFAAVKVL-------QSKGNIQNKQFLQELEVLSKIRHPHLL 461
+G G +G+VY+G F AVK + + + KQ QE+ +LSK++HP+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV--KQLEQEIALLSKLQHPNIV 65
Query: 462 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
LG + + E + GSL +L +K + P P Y ++ L +LH+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEPVIRLY--TRQILLGLEYLHDRN 122
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS---TMLNSDPSFVSTTYKNTGPVGTLCYID 576
+HRD+K NIL+D N V K+ D G++ + SF + Y ++
Sbjct: 123 ---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY----------WMA 169
Query: 577 PEY-QRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDA 629
PE + G +D+++ G +L++ T KP +A K+ + + + + L
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229
Query: 630 QAGDWPIKETKELAALGLSCAEL 652
+A D+ +K + +L + AEL
Sbjct: 230 EAKDFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 59/196 (30%), Positives = 104/196 (53%), Gaps = 12/196 (6%)
Query: 410 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
++G G +G V+ GT++ +T AVK L+ G + + FL+E +++ K+RH L+ L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 469 DHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 527
+ +V EYM GSL D L + + +A +VA+ +A++ IHRD
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 528 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 587
++ NIL+ LV KI D GL+ ++ D + + G + + PE G +
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEYTA----RQGAKFPIKWTAPEAALYGRFTI 182
Query: 588 KSDVYAYGMVILQLLT 603
KSDV+++G+++ +L+T
Sbjct: 183 KSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 411 IGMGGYGTVYKGTFHHTFA--------AVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLL 461
+G G +G VY+GT AVK L+ Q K +FL+E ++S HP+++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 462 LLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPP--IPWFERYRIAWEVASALAFL 515
LLG C + ++ E ME G L R R P + E I +VA +L
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 516 HNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--- 567
IHRD+ N L+ D + V KIGD GL+ + + S Y+ G
Sbjct: 123 EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-----YKSDYYRKEGEGL 174
Query: 568 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PV ++ PE G + +SDV+++G+++ ++LT
Sbjct: 175 LPVR---WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 72/275 (26%), Positives = 124/275 (45%), Gaps = 35/275 (12%)
Query: 411 IGMGGYGTVYKGTFHHTF-----AAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLL 462
IG G +G V +G A+K L K +KQ FL E ++ + HP+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 463 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L G ++ EYMENGSL D+ R+N+ + + +AS + +L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL-DKFLRENDGK-FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
+HRD+ NIL++ NLV K+ D GLS L TY G + + PE
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLED----SEATYTTKGGKIPIRWTAPEAI 180
Query: 581 RTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDED-NLAEILDAQAGDWPI 636
+ SDV+++G+V+ ++++ +P ++ V A+++ L +D +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSA---- 236
Query: 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
L L L C + R +RP Q++ L+++
Sbjct: 237 -----LYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 12/163 (7%)
Query: 447 QELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI 504
+E+ VLS ++HP+++ + ++G L V +Y E G L ++ N + + E +
Sbjct: 48 KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQIL 104
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
W V LA H + I+HRD+K NI L + K+GD G++ +LNS T
Sbjct: 105 DWFVQICLALKH-VHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-- 161
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 607
+GT Y+ PE + KSD++A G V+ ++ T K A
Sbjct: 162 ----IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)
Query: 398 IESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 456
I+ + L+F + L G G +G V+ G + A+K+++ +G + F++E +V+ K+
Sbjct: 1 IDPSELTFLKEL--GSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDDFIEEAKVMMKLS 57
Query: 457 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW------EV 508
HP+L+ L G C +V EYM NG L + L + + W +V
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK--------GKLGTEWLLDMCSDV 109
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
A+ +L + IHRD+ N L+ + V K+ D GL+ + D S K P
Sbjct: 110 CEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--P 164
Query: 569 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
V + PE S KSDV+++G+++ ++ +
Sbjct: 165 VK---WAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 27/198 (13%)
Query: 411 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGA 466
+G G GTVYK +H AVKV+ ++ KQ + ELE+L K P+++ GA
Sbjct: 9 LGHGNGGTVYK-AYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 467 --CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
+ + E+M+ GSL+ +YRK IP RIA V L +L + K I+
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRK-----IPEHVLGRIAVAVVKGLTYLWSLK---IL 117
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
HRD+KP N+L++ K+ D G+ST L NS ++ TY VGT Y+ PE
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTY-----VGTNAYMAPERISGE 168
Query: 584 LISPKSDVYAYGMVILQL 601
SDV++ G+ ++L
Sbjct: 169 QYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-16
Identities = 26/69 (37%), Positives = 35/69 (50%), Gaps = 1/69 (1%)
Query: 690 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPNYTLL 748
P+ F+ PI E+M +P + G TYDR IE L D + P T PL + L+PN L
Sbjct: 2 PDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLELK 61
Query: 749 SAILDWKSK 757
I W +
Sbjct: 62 EKIDAWLEE 70
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 38/224 (16%)
Query: 411 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLL 462
+G G +G V K T T AVK+L+ + + + L E +L ++ HPH++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 463 LLGACPDHG--CLVYEYMENGSLED--RLYRK-------------------NNTPPIPWF 499
L GAC G L+ EY + GSL R RK + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559
+ AW+++ + +L K ++HRD+ N+L+ KI D GLS + + S+V
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ K PV ++ E + + +SDV+++G+++ +++T
Sbjct: 185 KRS-KGRIPVK---WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 53/283 (18%)
Query: 411 IGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLL 462
IG G +G V++ T AVK+L+ + + F +E ++++ HP+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 463 LLGACPDHG--CLVYEYMENGSLEDRLYRKN-------------------NTPPIPWFER 501
LLG C CL++EYM G L + L ++ N P+ E+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 502 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561
IA +VA+ +A+L K +HRD+ N L+ N+V KI D GLS + S +
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYS-----AD 184
Query: 562 TYK-NTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVE 615
YK + + ++ PE Y R + +SDV+AYG+V+ ++ + +P + H
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYYGMAH--- 238
Query: 616 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 658
E+ + + D P EL L C DRP
Sbjct: 239 ----EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRP 277
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 410 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 467
+IG G +G VYKG +T AVK +S K+ FLQE E+L + HP+++ L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 468 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
+ V E + GSL L +K N + + +++ + A+ + +L + K IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLES---KNCIH 116
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 585
RD+ N L+ N V KI D G+S VS K P+ + PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIK---WTAPEALNYGRY 172
Query: 586 SPKSDVYAYGMVILQLLT 603
+ +SDV++YG+++ + +
Sbjct: 173 TSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 411 IGMGGYGTVYKGTF--HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
IG+G VY ++ A+K + K + +E++ +S+ HP+++ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 468 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
L V Y+ GSL D + + + EV L +LH+ IH
Sbjct: 69 VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIH 125
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTG 583
RD+K GNILL + KI D G+S L +D + + T VGT C++ PE Q G
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKT-FVGTPCWMAPEVMEQVHG 183
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
K+D++++G+ ++L T
Sbjct: 184 YDF-KADIWSFGITAIELATGAA 205
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQ-SKGNIQNKQFLQ-ELEVLSKIRHPHLLLLLGA 466
IG G +G +Y K +K + +K ++ K+ + E+ +L+K++HP+++ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 467 CPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPI 523
++G L V EY + G L R+ R+ F +I +W V +L H + I
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGV----LFSEDQILSWFVQISLGLKH-IHDRKI 122
Query: 524 IHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+HRD+K NI L N +V+K+GD G++ LN T VGT Y+ PE +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC------VGTPYYLSPEICQN 176
Query: 583 GLISPKSDVYAYGMVILQLLTAK 605
+ K+D+++ G V+ +L T K
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 31/207 (14%)
Query: 411 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G G YG+VYK H T A ++ + Q + EL++L K P+++ GA
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 467 CPDHGCLVY--EYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFL---HNTKP 520
G + EYM+ GSL D+LY T IP RI + V L FL HN
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
IIHRD+KP N+L++ N K+ D G+S L V++ K +G Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTN--IGCQSYMAPERI 173
Query: 581 RTG------LISPKSDVYAYGMVILQL 601
++G + +SDV++ G+ IL++
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 63/209 (30%), Positives = 105/209 (50%), Gaps = 28/209 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
+G G +G VYK T FAA K++Q + + + F+ E+++LS+ +HP+++ L A
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 469 DHGCL--VYEYMENGSLE---DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
L + E+ + G+L+ L R P I RY + ++ AL FLH+ K +
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQI----RY-VCRQMLEALNFLHSHK---V 124
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLC--YIDP 577
IHRD+K GNILL + K+ D G+S S +F+ T Y P C + D
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYW-MAPEVVACETFKDN 183
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y K+D+++ G+ +++L +P
Sbjct: 184 PYDY------KADIWSLGITLIELAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 58/210 (27%), Positives = 110/210 (52%), Gaps = 16/210 (7%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 455
EI +L + ++G G +G V+ T++ HT AVK ++ G++ + FL E V+ +
Sbjct: 2 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 58
Query: 456 RHPHLLLLLGACPDHGC-LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALA 513
+H L+ L ++ E+M GSL D L + + P+P + + ++A +A
Sbjct: 59 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMA 116
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
F+ + IHRD++ NIL+ +LV KI D GL+ ++ D + + G +
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTA----REGAKFPIK 168
Query: 574 YIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ PE G + KSDV+++G+++++++T
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 34/217 (15%)
Query: 411 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +G V+ H+ AVK L+ + F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 464 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTP-------------PIPWFERYRIAWEV 508
G C + L V+EYM +G L +R R + + + IA ++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
AS + +L + +HRD+ N L+ LV KIGD G+S ST Y G
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSR------DIYSTDYYRVGG 182
Query: 569 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
L ++ PE + +SD++++G+V+ ++ T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 411 IGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL 464
IG G +G VY GT AVK L +++ +QFL+E ++ HP++L LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 465 GAC-PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
G C P G +V YM++G L + + + + P + + +VA + +L + K
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVK--DLIGFGLQVAKGMEYLASKK-- 118
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--PVGTLCYIDPEY 579
+HRD+ N +LD + K+ D GL+ + D + S PV ++ E
Sbjct: 119 -FVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVK---WMALES 173
Query: 580 QRTGLISPKSDVYAYGMVILQLLT 603
+T + KSDV+++G+++ +L+T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/230 (28%), Positives = 108/230 (46%), Gaps = 38/230 (16%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTF----HHTFAAVKVLQSKGNIQN-KQFLQEL 449
WE+I+ + IG G +G V + AA+K+L+ + + + F EL
Sbjct: 1 WEDIKFEDV-------IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGEL 53
Query: 450 EVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER----- 501
EVL K+ HP+++ LLGAC + G L EY G+L D L + P F +
Sbjct: 54 EVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTA 113
Query: 502 --------YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553
+ A +VA+ + +L K IHRD+ N+L+ NL SKI D GLS
Sbjct: 114 STLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLS---R 167
Query: 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ +V T PV + Y + + KSDV+++G+++ ++++
Sbjct: 168 GEEVYVKKTMGRL-PVRWMAIESLNYS---VYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 51/284 (17%)
Query: 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHL 460
TL F N+R G AVK+L+ N + FL+E+++LS+++ P++
Sbjct: 34 TLQFPFNVRKG------------RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81
Query: 461 LLLLGAC--PDHGCLVYEYMENGS---------LEDRLYRKNNT-------PPIPWFERY 502
+ LLG C D C++ EYMENG L+D+ N+ P I +
Sbjct: 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLL 141
Query: 503 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562
+A ++AS + +L + +HRD+ N L+ NL KI D G+S L +
Sbjct: 142 HVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNL-----YAGDY 193
Query: 563 YKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV---ILQLLTAKPAIAITHKVETAI 618
Y+ G V + ++ E G + SDV+A+G+ IL L +P +T E I
Sbjct: 194 YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD--EQVI 251
Query: 619 DEDNLAEILDAQAGD----WPIKETKELAALGLSCAELRRKDRP 658
+N E Q P + L L L C ++RP
Sbjct: 252 --ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERP 293
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 23/210 (10%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVK-VLQSKGNIQNKQ--------FLQELEVLSKIRHPH 459
IG G +G+VY G + AVK V + +K +E+ +L +++H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 460 LLLLLGACPD--HGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAFL 515
++ LG+ D H + EY+ GS+ L Y + F R ++ L +L
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-----QILKGLNYL 122
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
HN + IIHRD+K NIL+D+ KI D G+S L ++ T G++ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
PE + + K+D+++ G +++++LT K
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-CPD 469
IG G +G V G + AVK +++ Q FL E V++++RH +L+ LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 470 HGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 527
G L V EYM GSL D L R + + + +V A+ +L +HRD
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127
Query: 528 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 587
+ N+L+ + V+K+ D GL+ +S K T PE R S
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA---------PEALREKKFST 178
Query: 588 KSDVYAYGMVILQL 601
KSDV+++G+++ ++
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLL 463
+G G Y VYK T A+K L + + N L+E+++L +++HP+++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 464 LGACPDHG--CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTK 519
L LV+E+ME LE + K+ TP + L +LH+
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA----DIKSYMLMTLRGLEYLHS-- 120
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 578
I+HRD+KP N+L+ + V K+ D GL+ SF S K T V T Y PE
Sbjct: 121 -NWILHRDLKPNNLLIASDGVLKLADFGLAR------SFGSPNRKMTHQVVTRWYRAPEL 173
Query: 579 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y D+++ G + +LL P
Sbjct: 174 LFGARHY------GVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
+G G +G VYK T AA KV+++K + + ++ E+E+L+ HP+++ LLGA
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 469 DHGCL--VYEYMENGSLED---RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
G L + E+ G+++ L R P I I ++ AL +LH+ K I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLHSMK---I 131
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLST----MLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
IHRD+K GN+LL + K+ D G+S L SF+ T Y P +C E
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYW-MAPEVVMC----ET 186
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
+ K+D+++ G+ ++++ +P
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 66/257 (25%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLL 464
+G GG+G V T A K L K ++ ++ L E ++L K+ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKK-RLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTK 519
A D CLV M G L+ +Y P F R A ++ L LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
I++RD+KP N+LLD + +I D+GL+ L K G GT Y+ PE
Sbjct: 116 ---IVYRDLKPENVLLDDHGNVRISDLGLAVEL-------KGGKKIKGRAGTPGYMAPEV 165
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639
+ + D +A G + +++ + K ++++ L A ++P K +
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFR-QRK--EKVEKEELKRRTLEMAVEYPDKFS 222
Query: 640 KELAALGLSCAELRRKD 656
E L C L +KD
Sbjct: 223 PEAKDL---CEALLQKD 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 67/265 (25%), Positives = 110/265 (41%), Gaps = 36/265 (13%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK-------QFLQELEVLSKIRHPHLLLL 463
+G G +G VY T + V Q + + E+++L ++H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 464 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
G + + EYM GS++D+L K R + ++ + +LH+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTR-KYTRQILEGVEYLHSNM-- 124
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 578
I+HRD+K NIL D K+GD G S L + S S T + GT ++ PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS--SGTGMKS-VTGTPYWMSPEVIS 180
Query: 579 ---YQRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVETAIDEDNLAEILDA 629
Y R K+DV++ G ++++LT KP A+A K+ T L +
Sbjct: 181 GEGYGR------KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSP 234
Query: 630 QAGDWPIKETKELAALGLSCAELRR 654
A ++ + E A S EL R
Sbjct: 235 DARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 411 IGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +G V+ ++ AVK L+ + K F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 464 LGAC--PDHGCLVYEYMENGSLE--------DRLYRKNNTPP--IPWFERYRIAWEVASA 511
G C D +V+EYM++G L D + P + + IA ++A+
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+ +L + + +HRD+ N L+ NL+ KIGD G+S ST Y G
Sbjct: 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSR------DVYSTDYYRVGGHTM 183
Query: 572 LC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
L ++ PE + +SDV++ G+V+ ++ T
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 26/214 (12%)
Query: 398 IESATLSFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIR 456
I+ L+F + L G G +G V G + + A+K+++ +G++ +F++E +V+ K+
Sbjct: 1 IDPKDLTFLKEL--GTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLS 57
Query: 457 HPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASAL 512
H L+ L G C +V EYM NG L + R + K P + + +V +
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGM 113
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT- 571
A+L + K IHRD+ N L+D K+ D GLS + D + T VG+
Sbjct: 114 AYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--------EYTSSVGSK 162
Query: 572 --LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ + PE S KSDV+A+G+++ ++ +
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-14
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 398 IESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH 457
I S E I G G YKG ++ + + N N E+ + K++H
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKN--GMQFVVKEINDVNSIPSSEIADMGKLQH 742
Query: 458 PHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 515
P+++ L+G C L++EY+E +L + L N + W R +IA +A AL FL
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---RN---LSWERRRKIAIGIAKALRFL 796
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS-FVSTTYKNTGPVGTLCY 574
H ++ ++ P I++D + + L +L +D F+S+ Y
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSAY----------- 844
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
+ PE + T I+ KSD+Y +G+++++LLT K
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 65/275 (23%), Positives = 116/275 (42%), Gaps = 36/275 (13%)
Query: 404 SFSENLRIGMGGYGTVYKG-------TFHHTFAAVKVLQS-KGNIQNKQFLQELEVLSKI 455
+ E +G G +G V+ T VK LQ K +F +EL++ K+
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 456 RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL------YRKNNTPPIPWFERYRIAWE 507
H +++ LLG C + ++ EY + G L+ L K PP+ ++ + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 508 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 567
+A + L N + +HRD+ N L+ K+ + LS + + + +N
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY---KLRNA- 178
Query: 568 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627
+ L ++ PE + S KSDV+++G+++ ++ T + + DE+ L
Sbjct: 179 -LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG---ELPFYGLS--DEEVLN--- 229
Query: 628 DAQAGD--WPIKET--KELAALGLSCAELRRKDRP 658
QAG P+ E L L C + KDRP
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 62/224 (27%), Positives = 103/224 (45%), Gaps = 52/224 (23%)
Query: 407 ENL-RIGMGGYGTVYKGTFHHT--FAAVKV-LQSKGN-IQNKQFLQELEVLSKIRHPHLL 461
ENL +G G YG V K T A+K L+S+ + + K ++E+ +L ++RH +L+
Sbjct: 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 462 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY----------RIAWEVA 509
L+ LV+E++++ L+D E+Y + +++
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDD-------------LEKYPNGLDESRVRKYLFQIL 110
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569
+ F H+ IIHRD+KP NIL+ + V K+ D G + L + P V T Y V
Sbjct: 111 RGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDY-----V 161
Query: 570 GTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
T Y PE Y R D++A G ++ ++LT +P
Sbjct: 162 ATRWYRAPELLVGDTKYGRA------VDIWAVGCLVTEMLTGEP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 58/222 (26%)
Query: 411 IGMGGYGTVYKGTFHH---TFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHP----- 458
+G+GG+G V TFA V K +I Q + E E+L + HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCV--KKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 459 --------HLLLLLGACPDHGCLVYEYM-ENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 509
++ +L+ C G ++ + + G ++ + R+ IA V
Sbjct: 59 YRTFKDKKYIYMLMEYCL--GGELWTILRDRGLFDE------------YTARFYIA-CVV 103
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569
A +LHN + II+RD+KP N+LLD N K+ D G + L T+
Sbjct: 104 LAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTF---C 153
Query: 570 GTLCYIDPEYQRTGLISPK-----SDVYAYGMVILQLLTAKP 606
GT Y+ PE +I K D ++ G+++ +LLT +P
Sbjct: 154 GTPEYVAPE-----IILNKGYDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 26/217 (11%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 459
F++ RIG G +G VYKG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 460 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFL 515
+ G+ L + EY+ GS D L P P E Y I E+ L +L
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYL 117
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H+ + IHRD+K N+LL K+ D G++ L T K VGT ++
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT------DTQIKRNTFVGTPFWM 168
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
PE + K+D+++ G+ ++L +P + H
Sbjct: 169 APEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 411 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLL 464
IG G +G V K AA+K ++ + + + F ELEVL K+ HP+++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER-------------YRIAWEVA 509
GAC G L EY +G+L D L + P F A +VA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569
+ +L K IHRD+ NIL+ N V+KI D GLS +V T PV
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRL-PV 175
Query: 570 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ Y + + SDV++YG+++ ++++
Sbjct: 176 RWMAIESLNYS---VYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 430 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLE 484
AVK L+ + QN + +E+ +L + H +++ G C + G L+ EY+ GSL
Sbjct: 37 AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96
Query: 485 DRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543
D L + N + F A ++ +A+LH+ + IHRD+ N+LLD++ + KI
Sbjct: 97 DYLPKHKLNLAQLLLF-----AQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKI 148
Query: 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
GD GL+ + + PV + E + S SDV+++G+ + +LLT
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPV---FWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 430 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDR 486
AVK+L+ N + FL+E++++S+++ P+++ LL C D C++ EYMENG L
Sbjct: 50 AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQF 109
Query: 487 LYR--------KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 538
L R K + I + +A ++AS + +L + +HRD+ N L+ N
Sbjct: 110 LSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN 166
Query: 539 LVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
KI D G+S L S Y+ G V + ++ E G + SDV+A+G+
Sbjct: 167 YTIKIADFGMSRNLYS-----GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 598 ILQLLT 603
+ ++LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 54/186 (29%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 430 AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMENGSLEDR 486
AVKVL+ + ++ FL+E+++LS++ P++ LLG C C++ EYMENG L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 487 LYR--------KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 538
L + N+ + + +A ++AS + +L + +HRD+ N L+ N
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKN 166
Query: 539 LVSKIGDVGLSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
KI D G+S L + S Y+ G + ++ E G + KSDV+A+G+
Sbjct: 167 YTIKIADFGMSRNL-----YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 598 ILQLLT 603
+ ++LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 24/205 (11%)
Query: 410 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLL 464
+IG G + VYK A+K +Q + K L+E+++L ++ HP+++ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
+ ++ L V E + G L R+ + K IP ++ ++ SAL +H+
Sbjct: 69 ASFIENNELNIVLELADAGDLS-RMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--- 124
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
K I+HRD+KP N+ + V K+GD+GL F S T VGT Y+ PE
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYMSPERI 178
Query: 581 RTGLISPKSDVY-----AYGMVILQ 600
+ KSD++ Y M LQ
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQ 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 41/284 (14%)
Query: 411 IGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLL 462
+G G +G VY+G T AVK + +++ + +FL E V+ H++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 463 LLGACP--DHGCLVYEYMENGSLEDRLY-----RKNNT--PPIPWFERYRIAWEVASALA 513
LLG +V E M +G L+ L +NN PP E ++A E+A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL- 572
+L+ K +HRD+ N ++ H+ KIGD G++ T Y G G L
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR------DIYETDYYRKGGKGLLP 184
Query: 573 -CYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDNLAEILDA 629
++ PE + G+ + SD++++G+V+ ++ L +P ++ +E L ++D
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDG 237
Query: 630 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
D P + + L C + K RP L ++ LK+
Sbjct: 238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTF----LEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
RIG G YG VYK +T AA+KV++ + QE+ ++ +H +++ G+
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 468 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
D + E+ GSL+D +Y + T P+ + ++ E L +LH+ K +H
Sbjct: 76 LRRDKLWICMEFCGGGSLQD-IY--HVTGPLSESQIAYVSRETLQGLYYLHS---KGKMH 129
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRT 582
RD+K NILL N K+ D G+S + +T K +GT ++ PE +R
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQIT------ATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITH 612
G + D++A G+ ++L +P + H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 63/207 (30%), Positives = 93/207 (44%), Gaps = 28/207 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
IG G +G VYK T A+KV+ +++ I++ Q QE++ LS+ R P++
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ--QEIQFLSQCRSPYITKYY 65
Query: 465 GACPDHGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTK 519
G G ++ EY GS D L P E Y I EV L +LH
Sbjct: 66 G-SFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
IHRD+K NILL K+ D G+S L ST K VGT ++ PE
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT------STMSKRNTFVGTPFWMAPEV 169
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
+ K+D+++ G+ ++L +P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEP 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 30/209 (14%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V KGT AVKVL+ +Q+ + E VL+ L
Sbjct: 3 LGKGSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 519
L +C D V EY+ G L + R R R A E+ L FLH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFYAAEIVLGLQFLHE-- 114
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLST--MLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+ II+RD+K N+LLD KI D G+ +L ++T+ GT YI P
Sbjct: 115 -RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---TTSTF-----CGTPDYIAP 165
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKP 606
E P D +A G+++ ++L +
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQS 194
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 459
F++ IG G +G VY T A+K + G N+++ ++E+ L ++RHP+
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 460 LLLLLGAC--PDHGC-LVYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAF 514
+ G C +H LV EY GS D L ++K P+ E I LA+
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAY 130
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH+ + IHRD+K GNILL K+ D G +++++ SFV T Y V +
Sbjct: 131 LHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEV--ILA 185
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
+D E Q G K DV++ G+ ++L KP
Sbjct: 186 MD-EGQYDG----KVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF-LQELEVLSKIRHPHLLLLLG 465
+IG G YG V+K T V K ++S+ + K+ L+E+ +L +++HP+L+ L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 466 ACPD----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
H LV+EY ++ ++ + L + N +P +I W+ A+ F H
Sbjct: 68 VFRRKRKLH--LVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHN-- 120
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
IHRD+KP NIL+ K+ D G + +L P T Y V T Y PE
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDY-----VATRWYRAPE--- 170
Query: 582 TGLI------SPKSDVYAYGMVILQLLTAKP 606
L+ P DV+A G V +LLT +P
Sbjct: 171 --LLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 411 IGMGGYGTVYKG-------TFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +G V+ T AVK L+ K F +E E+L+ ++H H++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 464 LGACPDHGCL--VYEYMENGSLE--------DRLYRKNNTP-----PIPWFERYRIAWEV 508
G C D L V+EYM++G L D + + P + + IA ++
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
AS + +L + + +HRD+ N L+ NL+ KIGD G+S ST Y G
Sbjct: 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR------DVYSTDYYRVGG 183
Query: 569 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
L ++ PE + +SDV+++G+++ ++ T
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGNIQN-KQFLQEL 449
E+ + + F E L G +G +YKG H A+K L+ N Q +F QE
Sbjct: 1 ELPLSAVRFMEEL--GECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 450 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN--------------T 493
+++++ HP+++ LLG C+++EY+ G L + L ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 494 PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553
+ + IA ++A+ + +L + +H+D+ NIL+ L KI D+GLS +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
S + K+ P+ ++ PE G S SD++++G+V+ ++ +
Sbjct: 176 S-ADYYRVQPKSLLPIR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 55/191 (28%), Positives = 88/191 (46%), Gaps = 42/191 (21%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ------FLQELEVLSKIR---HP 458
IG G YGTVYK +T F A+K K + + L+E+ +L ++ HP
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALK----KVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 459 HLLLLLGACPDHGC---------LVYEYMENGSLED-RLYRKNNTPP-IPWFERYRIAWE 507
+++ LL C HG LV+E+++ +D Y P +P + +
Sbjct: 62 NIVRLLDVC--HGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 508 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 567
+ + FLH+ + I+HRD+KP NIL+ + KI D GL+ + + + + S
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSV------ 166
Query: 568 PVGTLCYIDPE 578
V TL Y PE
Sbjct: 167 -VVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 45/290 (15%)
Query: 410 RIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHL 460
+G G +G V K + AVK+L+ ++ + E+E++ I +H ++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 461 LLLLGACPDHGCL--VYEYMENGSLEDRLYRK----------NNTPPIPWFERYRI---A 505
+ LLG C G L V EY +G+L D L + + PP + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565
++VA + FL + K IHRD+ N+L+ + V KI D GL+ ++ Y+
Sbjct: 139 YQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHH-----IDYYRK 190
Query: 566 TG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621
T PV ++ PE + + +SDV+++G+++ ++ T + VE
Sbjct: 191 TTNGRLPVK---WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--K 245
Query: 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
L E + P T+EL L C RP K Q++ L+R+
Sbjct: 246 LLKE---GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 32/214 (14%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQ----SKGNIQNKQ------FLQELEVLSKIRHP 458
IG G YG VY T AVK ++ G ++Q E+E L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 459 HLLLLLG--ACPDHGCLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASALAF 514
+++ LG ++ + EY+ GS+ R Y + + +F +V LA+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGLAY 123
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH+ K I+HRD+K N+L+D + + KI D G+S SD + + +N G++ +
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDN--DQNMSMQGSVFW 176
Query: 575 IDPEY---QRTGLISPKSDVYAYGMVILQLLTAK 605
+ PE G S K D+++ G V+L++ +
Sbjct: 177 MAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 50/197 (25%), Positives = 100/197 (50%), Gaps = 13/197 (6%)
Query: 410 RIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
++G G +G V+ G +++ T AVK L+ G + + FL+E ++ ++H L+ L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 469 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526
++ EYM GSL D L + + + + + ++A +A++ K IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 127
Query: 527 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 586
D++ N+L+ +L+ KI D GL+ ++ + G + + PE G +
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDN-----EYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 587 PKSDVYAYGMVILQLLT 603
KSDV+++G+++ +++T
Sbjct: 183 IKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 68/205 (33%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSK-IRHPHLLLLL 464
IG G +G V K F AVKVLQ K + + K + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 521
+ D V +Y+ G L L R+ + P R R A E+ASAL +LH+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLHSLN-- 116
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
II+RD+KP NILLD + D GL + S ++T+ GT Y+ PE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTF-----CGTPEYLAPEVLR 169
Query: 582 TGLISPKSDVYAYGMVILQLLTAKP 606
D + G V+ ++L P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 39/283 (13%)
Query: 411 IGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLL 463
+G G +GTVYKG + A+KVL+ + + NK+ L E V++ + P++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 464 LGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 520
LG C LV + M G L D Y + N I + + W ++A +++L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLD--YVRENKDRIG--SQDLLNWCVQIAKGMSYLEEVR- 129
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
++HRD+ N+L+ KI D GL+ +L+ D T Y G + ++ E
Sbjct: 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLDID----ETEYHADGGKVPIKWMALESI 183
Query: 581 RTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIK 637
+ +SDV++YG+ + +L+T AKP I + + ++L+ + P
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------EIPDLLEKGERLPQPPI 235
Query: 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 680
T ++ + + C + + RP + E + E + ARD
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFR-------ELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 403 LSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRH- 457
L E L G G YG V K H T AVK +++ N Q K+ L +L++ +
Sbjct: 3 LEVIEEL--GRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 458 PHLLLLLGACPDHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALA 513
P+ + GA G V+ ME + SL D+ Y+K + E +IA + AL
Sbjct: 60 PYTVTFYGALFREGD-VWICMEVMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
+LH +K +IHRD+KP N+L++ N K+ D G+S L S T P
Sbjct: 118 YLH-SKLS-VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPE 173
Query: 574 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
I+PE + G KSDV++ G+ +++L T +
Sbjct: 174 RINPELNQKGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 405 FSENLRIGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 459
FS+ IG G +G VY + + A+K + G N+++ ++E+ L K+RHP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 460 LLLLLGA-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
+ G +H LV EY GS D L + + P+ E + LA+LH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+IHRD+K GNILL + K+GD G ++++ FV T Y ++ P
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY----------WMAP 180
Query: 578 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAI 608
E G K DV++ G+ ++L KP +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 411 IGMGGYGTVYKG-TFHHTFAAVKVL------QSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G YGTVY G T AVK + + ++ +E+++L ++H +++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 464 LGACPDHGCLVYEYME---NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
LG C D + +ME GS+ L R P P F +Y ++ +A+LHN
Sbjct: 68 LGTCLDD-NTISIFMEFVPGGSISSILNRFGPLPE-PVFCKY--TKQILDGVAYLHNNC- 122
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
++HRD+K N++L N + K+ D G + L + + GT ++ PE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIA 609
KSD+++ G + ++ T KP +A
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLA 209
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 411 IGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLL 463
+G G +GTVYKG + A+K L+ + + NK+ L E V++ + +PH+ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 464 LGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 520
LG C L+ + M G L D Y + + I +Y + W ++A + +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLD--YVREHKDNIG--SQYLLNWCVQIAKGMNYLEE--- 127
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
+ ++HRD+ N+L+ KI D GL+ +L +D Y G + ++ E
Sbjct: 128 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD----EKEYHAEGGKVPIKWMALESI 183
Query: 581 RTGLISPKSDVYAYGMVILQLLT--AKP 606
+ + +SDV++YG+ + +L+T +KP
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 51/176 (28%), Positives = 87/176 (49%), Gaps = 24/176 (13%)
Query: 434 LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN 491
L+ K I+N Q ++EL+VL + P+++ GA G + E+M+ GSL+ L +
Sbjct: 36 LEIKPAIRN-QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 94
Query: 492 NTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
P E +I+ V L +L I+HRD+KP NIL++ K+ D G+S
Sbjct: 95 RIP-----ENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 147
Query: 550 TML-NS-DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
L +S SF VGT Y+ PE + + +SD+++ G+ ++++
Sbjct: 148 GQLIDSMANSF----------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 60/204 (29%), Positives = 81/204 (39%), Gaps = 46/204 (22%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLL 463
+G G G V+ KGT A+KVL K I+ K+ L E E+L+ + HP L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGK--LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 464 LG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLHN 517
+ CLV +Y G L +R P R+ A EV AL +LH
Sbjct: 67 YASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHL 121
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP--------- 568
I++RD+KP NILL + + D LS + +P VS +
Sbjct: 122 ---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 569 --------------VGTLCYIDPE 578
VGT YI PE
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 62/209 (29%), Positives = 87/209 (41%), Gaps = 27/209 (12%)
Query: 410 RIGMGGYGTVYKG---TFHHTFAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
RIG G YG VY+ T A KV + I L+E+ +L +RHP+++ L
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS-LREITLLLNLRHPNIVELK 72
Query: 465 ----GACPDHGCLVYEYMEN--GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
G D LV EY E SL D N P + + ++ L +LH
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQYLHE- 126
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
IIHRD+K N+LL KI D GL+ ++ V TL Y PE
Sbjct: 127 --NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK------VVTLWYRAPE 178
Query: 579 YQRTGLISPKS-DVYAYGMVILQLLTAKP 606
+ D++A G ++ +LL KP
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 459
F++ RIG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 460 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
+ G+ L + EY+ GS D L P F+ + E+ L +LH+
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
K IHRD+K N+LL K+ D G++ L T K VGT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAP 170
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
E + K+D+++ G+ ++L +P + H
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA- 466
R+G G YG VYK HT AAVK+++ + QE+ ++ + +H +++ G+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 467 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
+ + EY GSL+D +Y + T P+ + + E LA+LH +K K +H
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IY--HVTGPLSELQIAYVCRETLQGLAYLH-SKGK--MH 129
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRT 582
RD+K NILL N K+ D G++ + +T K +GT ++ PE ++
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKIT------ATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITH 612
G + D++A G+ ++L +P + H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 432 KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRK 490
KVL S + F + ++S++ H HL+ L G C D +V EY++ G L+ L+R+
Sbjct: 36 KVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHRE 94
Query: 491 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550
N + W +A ++ASAL +L + K ++H GN+ + LV++ G
Sbjct: 95 KNNVSLHWK--LDVAKQLASALHYLEDKK---LVH-----GNVCGKNILVARYGLNEGYV 144
Query: 551 MLN--SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS--DVYAYGMVILQL 601
SDP T V + +I PE R G S D +++G +L++
Sbjct: 145 PFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 410 RIGMGGYGTVY--KGTFHHTFAAVKVLQ--SKGNIQNKQFLQ---ELEVLSKIRHPHLLL 462
R+G G +GTVY K +KVL+ G + + +Q E ++LSK+ HP ++
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 463 LLGAC--PDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTK 519
+ D C++ EY E L+ +L K+ + E W + L +H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLS--ENQVCEWFIQLLLG-VHYMH 123
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
+ I+HRD+K NI L +NL+ KIGD G+S +L +T GT Y+ PE
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF------TGTPYYMSPEA 176
Query: 580 QRTGLISPKSDVYAYGMVILQL 601
+ KSD+++ G ++ ++
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 411 IGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +GTVYKG + A+K+L ++ G N +F+ E +++ + HPHL+ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 464 LGACPDHGC-LVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAW--EVASALAFLHNTK 519
LG C LV + M +G L D ++ K+N + + W ++A + +L +
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIG-----SQLLLNWCVQIAKGMMYLEERR 129
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
++HRD+ N+L+ KI D GL+ +L D Y G + ++ E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD----EKEYNADGGKMPIKWMALEC 182
Query: 580 QRTGLISPKSDVYAYGMVILQLLT 603
+ +SDV++YG+ I +L+T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 411 IGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLL 462
+G G +G VY+G T A+K + +++ + +FL E V+ + H++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 463 LLGACPDH--GCLVYEYMENGSLEDRLY----RKNNTP---PIPWFERYRIAWEVASALA 513
LLG ++ E M G L+ L N P P + ++A E+A +A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
+L+ K +HRD+ N ++ + KIGD G++ T Y G G L
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR------DIYETDYYRKGGKGLLP 184
Query: 574 --YIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
++ PE + G+ + SDV+++G+V+ ++ T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 411 IGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLGACP 468
+G G +G V+KGT T AVK + + K +FL E +L + HP+++ L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 469 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526
+V E + G L +K + ++ A + A+ +A+L + K IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLES---KNCIHR 117
Query: 527 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 586
D+ N L+ N V KI D G+S D S++ P+ + PE G S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIK---WTAPEALNYGRYS 172
Query: 587 PKSDVYAYGMVILQLLT 603
+SDV++YG+++ + +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSK 454
E E E + +G G YG VY T A+K + + + + +E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 455 IRHPHLLLLLGACPDHGCLVYEYMEN---GSLEDRLYRK-----NNTPPIPWFERYRIAW 506
++H +++ LG+ ++G +ME GSL L K +N I ++ +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKI-FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK----- 115
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNS-DPSFVSTTYK 564
++ L +LH+ + I+HRD+K N+L++ ++ V KI D G S L +P + T+
Sbjct: 116 QILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFT 170
Query: 565 NTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKP 606
GTL Y+ PE G +D+++ G I+++ T KP
Sbjct: 171 -----GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 27/204 (13%)
Query: 411 IGMGGYGTVYKGTFHHTF-----AAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL 464
IG G +G VY+G + AVK ++ + ++ FLQE ++ + HPH++ L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 465 GACPDHGCLVYEYMENGSL-EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
G ++ V+ ME L E R Y + N + ++++++ALA+L + +
Sbjct: 74 GVITENP--VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC--YIDPE--- 578
+HRD+ N+L+ K+GD GLS L + + YK + G L ++ PE
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-----SYYKAS--KGKLPIKWMAPESIN 181
Query: 579 YQRTGLISPKSDVYAYGMVILQLL 602
++R + SDV+ +G+ + ++L
Sbjct: 182 FRR---FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 26/208 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 465
IG G +G VY T HT AVK + G N+++ ++E++ L +++HP+ + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 466 A-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
+H LV EY GS D L + + P+ E I LA+LH+ +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS---HNM 142
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY---Q 580
IHRD+K GNILL K+ D G ++ + SFV T Y ++ PE
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY----------WMAPEVILAM 192
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAI 608
G K DV++ G+ ++L KP +
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 50/219 (22%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQ------SKGNIQNKQFLQELEVLSKIRHPHLLL 462
IG G YG VY+G T A+K++ +IQ +E+ +LS++R
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-----REVALLSQLRQ----- 58
Query: 463 LLGACPD----HGCL--------VYEYMENGSLEDRLYRKNNTPPIPWFERYR--IAWEV 508
P+ +G + EY E GS+ + P E+Y I EV
Sbjct: 59 --SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM------KAGPIAEKYISVIIREV 110
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
AL ++H +IHRD+K NIL+ + K+ D G++ +LN + K +
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN------QNSSKRSTF 161
Query: 569 VGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKP 606
VGT ++ PE G K+D+++ G+ I ++ T P
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 51/227 (22%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF--------------LQELEVLSKIR 456
IG G YG VYK A K + K+F +E+ +L +++
Sbjct: 8 IGRGTYGRVYK-------AKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 457 HPHLLLLLGACPDHGC----LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASA 511
H +++ L+ +H L+++Y E+ + + +R+ IP + W++ +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 512 LAFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566
+ +LH+ ++HRD+KP NIL+ + +V KIGD+GL+ + N+
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVV-KIGDLGLARLFNAPL---KPLADLD 173
Query: 567 GPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
V T+ Y PE Y + D++A G + +LLT +P
Sbjct: 174 PVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPH 459
F++ +IG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPY 63
Query: 460 LLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
+ G+ L + EY+ GS D L P+ + I E+ L +LH+
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS 119
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
K IHRD+K N+LL + K+ D G++ L T K VGT ++ P
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAP 170
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615
E + K+D+++ G+ ++L +P + H ++
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 50/178 (28%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 430 AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLED 485
AVK LQ + F +E+E+L ++H +++ G C G LV EY+ GSL D
Sbjct: 37 AVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD 96
Query: 486 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545
Y + + + + A ++ + +L + K +HRD+ NIL++ KIGD
Sbjct: 97 --YLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGD 151
Query: 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
GL+ +L D + P+ + PE S SDV+++G+V+ +L T
Sbjct: 152 FGLTKVLPQDKEYYKVREPGESPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 50/231 (21%)
Query: 411 IGMGGYGTVYKG--TFHHTFAAVKVLQ----SKGNIQNKQF----------LQELEVLSK 454
+G G YG V K T A+K ++ S +++Q L+EL+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 455 IRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR--IAWEVAS 510
I+H +++ L+ + LV + M L+ + RK I E I ++ +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILN 130
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY------- 563
L LH +HRD+ P NI ++ + KI D GL+ P + +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 564 -KNTGPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
+ T V TL Y PE Y D+++ G + +LLT KP
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKY------HFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 64/263 (24%), Positives = 117/263 (44%), Gaps = 25/263 (9%)
Query: 409 LRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLL 462
+ +G G +G V KG + A+KVL++ N ++ + ++E E++ ++ +P+++
Sbjct: 1 VELGSGNFGCVKKGVYKMRKKQIDVAIKVLKN-ENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 463 LLGACPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
++G C LV E G L L K + I + +V+ + +L K
Sbjct: 60 MIGVCEAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEG---K 114
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
+HRD+ N+LL + +KI D GLS L +D S+ P L + PE
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP---LKWYAPECIN 171
Query: 582 TGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639
S +SDV++YG+ + + + KP + + ++ I + D P +
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-------GPEVMSFIEQGKRLDCPAECP 224
Query: 640 KELAALGLSCAELRRKDRPDLKN 662
E+ AL C + +DRP+
Sbjct: 225 PEMYALMKDCWIYKWEDRPNFAK 247
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLL 464
I G +G+VY K + A+KVL+ I Q + ++ + P++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ D+ LV EY+ G L + P W ++Y EV + LH +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQ---RG 117
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
IIHRD+KP N+L+D K+ D GLS + F VGT Y+ PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF----------VGTPDYLAPETILG 167
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
SD ++ G VI + L P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 466
+G G YG VYKG T AA+KV+ G+ + ++ QE+ +L K H ++ GA
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 467 -------CPDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNT 518
D LV E+ GS+ D + K NT W I E+ L+ LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLCY 574
K +IHRD+K N+LL N K+ D G+S L+ +F+ T Y P C
Sbjct: 131 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW-MAPEVIACD 186
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
+P+ KSD+++ G+ +++ P + H
Sbjct: 187 ENPD----ATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQEL-------EVLSKIRHPHLL 461
+G G +G V + T A+K L+ KG+I + ++ L E + RHP L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALK-KGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 462 LLLGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
L AC DH C V EY G L ++ + P F Y A V L +LH
Sbjct: 66 NLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF--Y--AACVVLGLQYLHEN 120
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
K I++RD+K N+LLD KI D GL F T T C PE
Sbjct: 121 K---IVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRT-------STFCGT-PE 166
Query: 579 YQRTGLISPKS-----DVYAYGMVILQLL 602
+ +++ S D + G++I ++L
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 411 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 465
IG G +G V G H VK L++ + FLQE++ ++ HP++L LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 466 ACPDHG--CLVYEYMENGSLEDRLYRKNNT----PPIPWFERYRIAWEVASALAFLHNTK 519
C + LV E+ G L++ L R N + R+A EVAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQ-RMACEVASGLLWLHQAD 120
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
IH D+ N L +L KIGD GL+ + +++ L ++ PE
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH----AVPLRWLAPEL 173
Query: 580 Q-------RTGLISPKSDVYAYGMVILQLLTA 604
+ KS++++ G+ + +L TA
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 66/205 (32%), Positives = 95/205 (46%), Gaps = 22/205 (10%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLLL 464
IG G +G V K +F AVKVLQ K ++ K+ + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPK 521
+ + V +Y+ G L L R+ P F A EVASA+ +LH+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF----YAAEVASAIGYLHSLN-- 116
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
II+RD+KP NILLD + D GL +P ++T+ GT Y+ PE R
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTF-----CGTPEYLAPEVLR 169
Query: 582 TGLISPKSDVYAYGMVILQLLTAKP 606
D + G V+ ++L P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 65/222 (29%), Positives = 100/222 (45%), Gaps = 49/222 (22%)
Query: 410 RIGMGGYGTVYKGT---FHHTFAAVKVLQSKGNIQNKQ-------FLQELEVLSKIRHPH 459
++G G YG V+K A K+ + N + Q FLQEL HP+
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPN 68
Query: 460 LLLLLG---ACPDHGC-LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVASALA 513
++ LL A D LV+EYME D + R N + +RY I +++ AL
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMET----DLHAVIRANILEDV--HKRY-IMYQLLKALK 121
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL----STMLNSDPSFVSTTYKNTGPV 569
++H+ +IHRD+KP NILL+ + K+ D GL S + + + V T Y V
Sbjct: 122 YIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY-----V 173
Query: 570 GTLCYIDPEYQRTGLISPKS-----DVYAYGMVILQLLTAKP 606
T Y PE L+ D+++ G ++ ++L KP
Sbjct: 174 ATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 467
+G G +G VYK T AA KV+ +K + + ++ E+++L+ HP+++ LL A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 468 -PDHGCLVYEYMENGSLED---RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
++ ++ E+ G+++ L R P I + + AL +LH K I
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIR-----VVCKQTLEALNYLHENK---I 124
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLST----MLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
IHRD+K GNIL + K+ D G+S + SF+ T Y P +C E
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW-MAPEVVMC----ET 179
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
+ K+DV++ G+ ++++ +P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFL--QELEVLSKIRHPHLLLLLGA- 466
+IG G GTVY T V + Q Q K+ L E+ V+ + +HP+++ L +
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 467 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 522
D +V EY+ GSL D + + +IA E AL FLH+ +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSNQ--- 135
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+IHRD+K NILL + K+ D G + + S K + VGT ++ PE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------KRSTMVGTPYWMAPEVVTR 189
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
PK D+++ G++ ++++ +P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 48/218 (22%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI-QNKQFLQELEVLSKIRH--PHLLLLLG 465
IG G G VYK F T AVK ++ GN +NK+ L +L+V+ K H P+++
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIV---- 77
Query: 466 ACPDHGCLVYEY-----ME-NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL---H 516
C +G + + ME + D+L ++ P IP ++ + AL +L H
Sbjct: 78 KC--YGYFITDSDVFICMELMSTCLDKLLKRIQGP-IPEDILGKMTVAIVKALHYLKEKH 134
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+IHRD+KP NILLD + K+ D G+S L + T G Y+
Sbjct: 135 G-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-------KTRSAGCAAYMA 182
Query: 577 PEYQRTGLISPK---------SDVYAYGMVILQLLTAK 605
PE I P +DV++ G+ +++L T +
Sbjct: 183 PER-----IDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 42/141 (29%), Positives = 66/141 (46%), Gaps = 20/141 (14%)
Query: 407 ENLRIGMGGYGTVYKGT---------FHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH 457
E+L G G + ++KG H T +KVL ++ F + ++S++ H
Sbjct: 1 ESL--GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH 58
Query: 458 PHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF- 514
HL+L G C D +V EY++ GSL+ L + N I W EVA LA+
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW------KLEVAKQLAWA 112
Query: 515 LHNTKPKPIIHRDMKPGNILL 535
LH + K + H ++ N+LL
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 67/235 (28%), Positives = 104/235 (44%), Gaps = 38/235 (16%)
Query: 390 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQN-KQ 444
Y L W +I+ + IG G +G V K AA+K ++ + + +
Sbjct: 1 YPVLEWNDIKFQDV-------IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 53
Query: 445 FLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWF-- 499
F ELEVL K+ HP+++ LLGAC G L EY +G+L D L + P F
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113
Query: 500 -----------ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
+ A +VA + +L K IHRD+ NIL+ N V+KI D GL
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 170
Query: 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
S +V T PV + Y + + SDV++YG+++ ++++
Sbjct: 171 S---RGQEVYVKKTMGRL-PVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLL---- 461
RI G YG VY+ T V + + K + + F L+E+ +L K++HP+++
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
+++G+ D +V EY+E+ L+ + + P E + ++ S +A LH+
Sbjct: 72 VVVGSNLDKIYMVMEYVEH-DLKSLM--ETMKQPFLQSEVKCLMLQLLSGVAHLHD---N 125
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 578
I+HRD+K N+LL++ + KI D GL+ + S T V TL Y PE
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAR------EYGSPLKPYTQLVVTLWYRAPELLL 179
Query: 579 ----YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y S D+++ G + +LLT KP
Sbjct: 180 GAKEY------STAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 38/211 (18%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 465
+G G +G V+ + + A+KV+ I+ KQ E VL ++ HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 466 ACPDHGCL--VYEYMENGSLEDRLY---RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
D L + EY+ G L L R +N+ + + A E+ AL +LH+
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVCALEYLHS--- 119
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 576
K I++RD+KP NILLD K+ D G + L T+ TLC Y+
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL------RDRTW-------TLCGTPEYLA 166
Query: 577 PE-YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE Q G + D +A G++I ++L P
Sbjct: 167 PEVIQSKGH-NKAVDWWALGILIYEMLVGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 22/212 (10%)
Query: 398 IESATLSFSENLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQNKQFLQELEVLSKIR 456
I + L+F + L G G +G V+ G + A+K + +G + + F++E +V+ K+
Sbjct: 1 INPSELTFMKEL--GSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLS 57
Query: 457 HPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFER---YRIAWEVASA 511
HP L+ L G C L V E+MENG L + L ++ + + +V
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGK-----LSKDMLLSMCQDVCEG 112
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+ +L IHRD+ N L+ V K+ D G++ + D S+ K PV
Sbjct: 113 MEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVK- 166
Query: 572 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ PE S KSDV+++G+++ ++ T
Sbjct: 167 --WSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 404 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 458
+F +IG G + VY+ T A+K +Q + K ++E+++L ++ HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 459 HLLLLLGACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFL 515
+++ + + L V E + G L + + K IP ++ ++ SAL +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H+ + ++HRD+KP N+ + V K+GD+GL F S T VGT Y+
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYM 173
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQL 601
PE + KSD+++ G ++ ++
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 431 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLY 488
+++ +S +++ + +E +L+K++HP+++ + G L V EY + G L ++
Sbjct: 33 IRLPKSSSAVEDSR--KEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIK 90
Query: 489 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
+ + E + W V L H + K ++HRD+K NI L N K+GD G
Sbjct: 91 LQRGKL---FPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGS 146
Query: 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
+ +L + P + TY VGT Y+ PE + KSD+++ G ++ +L T K
Sbjct: 147 ARLL-TSPGAYACTY-----VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 51/255 (20%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQ 65
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR------IAWEVASALAF 514
L +C D V EY+ G L +Y I +++ A E+A L F
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYH------IQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH+ K II+RD+K N++LD KI D G+ N + T+ GT Y
Sbjct: 117 LHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTF-----CGTPDY 167
Query: 575 IDPE---YQRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630
I PE YQ G KS D +A+G+++ ++L +P DED L + +
Sbjct: 168 IAPEIIAYQPYG----KSVDWWAFGVLLYEMLAGQPPF-------DGEDEDELFQSIMEH 216
Query: 631 AGDWPIKETKELAAL 645
+P +KE ++
Sbjct: 217 NVSYPKSLSKEAVSI 231
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 404 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 458
+F + +G GG+G V T A K L+ K + K L E ++L K+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 459 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
++ L A D CLV M G L+ +Y N P FE R + A L L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFEEERALFYAAEILCGLE 116
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ + ++RD+KP NILLD +I D+GL+ + S G VGT+ Y+
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI-------RGRVGTVGYMA 169
Query: 577 PEY---QRTGLISPKSDVYAYGMVILQLLTAK 605
PE QR L SP D + G +I +++ +
Sbjct: 170 PEVLNNQRYTL-SP--DYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLGA 466
RIG G +G V+ G +T AVK + K +FLQE +L + HP+++ L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 467 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
C +V E ++ G L + P + E ++ A+ + +L + K I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 584
HRD+ N L+ V KI D G+S D + ST PV + PE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVK---WTAPEALNYGR 172
Query: 585 ISPKSDVYAYGMVILQL--LTAKPAIAITHK 613
S +SDV+++G+++ + L A P ++++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQ 203
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 411 IGMGGYGTVYKGTFHH---TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRH-PHLLLLLG 465
IG G +GTV K H T AVK ++S + K+ L +L+V+ + P+++ G
Sbjct: 12 IGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 466 ACPDHG-CLV-YEYMENGSLEDRLYR-----KNNTPPIPWFERY--RIAWEVASALAFLH 516
A G C + E M+ SL D+ Y+ + P E +IA AL +L
Sbjct: 71 ALFREGDCWICMELMDI-SL-DKFYKYVYEVLKSVIP----EEILGKIAVATVKALNYLK 124
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
IIHRD+KP NILLD N K+ D G+S L V + K T G Y+
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL------VDSIAK-TRDAGCRPYMA 175
Query: 577 PEYQRTGLISP---KSDVYAYGMVILQLLTAK 605
PE +SDV++ G+ + ++ T K
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 16/195 (8%)
Query: 411 IGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQ--NKQFLQELEVLSKIRHPHLLLLL 464
+G G +GTV KG + AVK+L++ N + L+E V+ ++ +P+++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 465 GACP-DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
G C + LV E E G L L + + E + +V+ + +L T
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETN---F 116
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
+HRD+ N+LL +KI D GLS L +D ++ PV + PE
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK---WYAPECMNYY 173
Query: 584 LISPKSDVYAYGMVI 598
S KSDV+++G+++
Sbjct: 174 KFSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 410 RIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
+IG G + VY+ T V++ + + ++E+++L ++ HP+++ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 465 GACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
+ + L V E + G L + Y K IP ++ ++ SA+ +H+ +
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR-- 126
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
++HRD+KP N+ + V K+GD+GL F S T VGT Y+ PE
Sbjct: 127 -VMHRDIKPANVFITATGVVKLGDLGLGRF------FSSKTTAAHSLVGTPYYMSPERIH 179
Query: 582 TGLISPKSDVYAYGMVILQL 601
+ KSD+++ G ++ ++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 67/226 (29%), Positives = 98/226 (43%), Gaps = 33/226 (14%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 465
+G G +G V + AVKVL+ +Q+ + E +LS R+ L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 466 AC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTK 519
C PD V E++ G L + + F+ R A E+ SAL FLH+
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR------FDEARARFYAAEITSALMFLHD-- 114
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
K II+RD+K N+LLDH K+ D G+ + ST GT YI PE
Sbjct: 115 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF------CGTPDYIAPEI 167
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625
+ L P D +A G+++ ++L H A +ED+L E
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG-------HAPFEAENEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSK---GNIQNKQFLQELEVLSK-IRHPHLLLLL 464
IG G +G V K AVKVLQ K + K + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ + V +++ G L L ++ + P P Y A E+ASAL +LH+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL-QRERSFPEPRARFY--AAEIASALGYLHSIN--- 116
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
I++RD+KP NILLD + D GL ++ + T GT Y+ PE R
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK------EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
D + G V+ ++L P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 48/204 (23%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLLG 465
+IG G G V T T V V K +++ +Q E+ ++ +HP+++ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAV--KKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 466 A--CPDHGCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ D +V E++E G+L D + N I V AL+FLH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLA-----VLKALSFLHAQG--- 135
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+IHRD+K +ILL + K+ D G ++ + + VGT ++ PE
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSLVGTPYWMAPEVISR 189
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
+ D+++ G+++++++ +P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLLL 464
IG G +G V + F AVKVLQ K ++ K+ + E VL K ++HP L+ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE-RYRI-AWEVASALAFLHNTKP 520
+ D V +Y+ G L L R+ + E R R A E+ASAL +LH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERC-----FLEPRARFYAAEIASALGYLHSLN- 116
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
I++RD+KP NILLD + D GL N + + ++T+ GT Y+ PE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTF-----CGTPEYLAPEVL 168
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKP 606
D + G V+ ++L P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLP 194
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPH 459
F++ IG G +G VY T A+K + G N+++ ++E++ L +I+HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 460 LLLLLGA-CPDHGC-LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
+ G +H LV EY GS D L + + P+ E I LA+LH+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+IHRD+K GNILL K+ D G +++ + SFV T Y ++ P
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY----------WMAP 190
Query: 578 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAI 608
E G K DV++ G+ ++L KP +
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 46/211 (21%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 411 IGMGGYGTVYKGTFHH---TF--AAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLL 463
+G G +G+V +G + AVK ++ + + ++FL E + HP+++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 464 LGAC--------PDHGCLVYEYMENGSLEDRLYR---KNNTPPIPWFERYRIAWEVASAL 512
+G C ++ +M++G L L +P + ++A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
+L N + IHRD+ N +L ++ + D GLS + S + PV
Sbjct: 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPVK-- 180
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+I E + + KSDV+A+G+ + ++ T
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 410 RIGMGGYGTVYK------GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+IG G + V K G ++ K +S + N + +Q L LS HP++L L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSP--HPNILRL 63
Query: 464 LGACPD--HGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
+ D G LV+E M+ +L + K P+P +++ +L +H
Sbjct: 64 IEVLFDRKTGRLALVFELMD-MNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-- 118
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
I HRD+KP NIL+ +++ K+ D G + S P + T Y + T Y PE
Sbjct: 119 -NGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPY--TEY-----ISTRWYRAPEC 169
Query: 580 QRT-GLISPKSDVYAYGMVILQLLTAKP 606
T G PK D++A G V ++L+ P
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGA 466
IG G YG VYK T V + + + + + + F ++E+++L ++ H +++ L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 467 CPDHGC------------LVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
D LV+EYM++ G LE L + + + ++
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK------QLLEG 128
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
L + H K +HRD+K NILL++ K+ D GL+ + NS+ S Y N V T
Sbjct: 129 LNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE---SRPYTNK--VIT 180
Query: 572 LCYIDPEY----QRTGLISPKSDVYAYGMVILQLLTAKP 606
L Y PE +R G P DV++ G ++ +L T KP
Sbjct: 181 LWYRPPELLLGEERYG---PAIDVWSCGCILGELFTKKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 466
+IG G GTVY T V + Q Q K+ + E+ V+ + ++P+++ L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 467 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
D +V EY+ GSL D + + + + E AL FLH+ + +IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ---VIH 139
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 585
RD+K NILL + K+ D G + + S K + VGT ++ PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQS------KRSTMVGTPYWMAPEVVTRKAY 193
Query: 586 SPKSDVYAYGMVILQLLTAKP 606
PK D+++ G++ ++++ +P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 466
+IG G GTVY T V + Q Q K+ + E+ V+ + ++P+++ L +
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 467 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
D +V EY+ GSL D + + + + E AL FLH+ + +IH
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ---VIH 138
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 585
RD+K NILL + K+ D G + + S ST VGT ++ PE
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTRKAY 192
Query: 586 SPKSDVYAYGMVILQLLTAKP 606
PK D+++ G++ ++++ +P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 38/248 (15%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLL 463
IG+G YGTVYK H+ F A+K ++ + N + + + L+ L HP+++ L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 464 LGACPD-------HGCLVYEYMENGSLEDRLYRKNNTPP-IPWFERYRIAWEVASALAFL 515
+ C LV+E+++ + R Y PP +P + + L FL
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H I+HRD+KP NIL+ K+ D GL+ + + + T V TL Y
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL-------TPVVVTLWYR 174
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD----AQA 631
PE + D+++ G + ++ KP + D L +I D
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS------EADQLGKIFDLIGLPPE 228
Query: 632 GDWPIKET 639
DWP T
Sbjct: 229 DDWPRDVT 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ--FLQELEVLSKIRHPHLLLLLGA- 466
+IG G GTV+ T V + Q Q K+ + E+ V+ ++++P+++ L +
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 467 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 522
D +V EY+ GSL D + + +IA E AL FLH +
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHANQ--- 135
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+IHRD+K N+LL + K+ D G + + S ST VGT ++ PE
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTR 189
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
PK D+++ G++ ++++ +P
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEP 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGA 466
+G G YG V K T V + + K + +N++ L+EL++L ++ +++ L A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 467 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLHNTKPKPI 523
G LV+EY+E LE N PP E+ R +++ A+ + H I
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPP----EKVRSYIYQLIKAIHWCHKND---I 121
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
+HRD+KP N+L+ HN V K+ D G + L+ + T Y V T Y PE
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEY-----VATRWYRSPELLLGA 176
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
D+++ G ++ +L +P
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 54/235 (22%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 404 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQ---SKGNIQNKQFLQELEVLSKIRHP 458
+F + ++G G Y TVYKG T A+K + +G ++E+ ++ +++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA--IREISLMKELKHE 58
Query: 459 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
+++ L + LV+EYM+ L+ + + +++ +AF H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ ++HRD+KP N+L++ K+ D GL+ +F + V TL Y
Sbjct: 118 ENR---VLHRDLKPQNLLINKRGELKLADFGLAR------AFGIPVNTFSNEVVTLWYRA 168
Query: 577 PEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628
P+ RT S D+++ G ++ +++T +P T+ +ED L +I
Sbjct: 169 PDVLLGSRT--YSTSIDIWSVGCIMAEMITGRPLFPGTN------NEDQLLKIFR 215
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 411 IGMGGYGTV--YKGTFHHTFAAVKVLQS--KGNIQNKQFLQELEVLSKIRHPHLLLL--- 463
+GMG +G V + A+K + + K+ +EL++L +RH +++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 464 -LGACPDHGCLVYEYMENGSLEDRLYRKNNTPPI-PWFERYRIAWEVASALAFLHNTKPK 521
+ D +Y E L L+R + P+ F +Y +++ L ++H+
Sbjct: 78 FISPLED----IYFVTE--LLGTDLHRLLTSRPLEKQFIQY-FLYQILRGLKYVHSAG-- 128
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 578
++HRD+KP NIL++ N KI D GL+ + DP TG V T Y PE
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARI--QDPQM-------TGYVSTRYYRAPEIML 178
Query: 579 -YQRTGLISPKSDVYAYGMVILQLLTAKP 606
+Q+ + + D+++ G + ++L KP
Sbjct: 179 TWQKYDV---EVDIWSAGCIFAEMLEGKP 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 38/263 (14%)
Query: 430 AVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLED 485
AVK+L+ ++ + E+E++ I +H +++ LLGAC G L + EY G+L +
Sbjct: 51 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 110
Query: 486 RL-----------YRKNNTP--PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 532
L Y P + + + ++VA + +L + K IHRD+ N
Sbjct: 111 YLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167
Query: 533 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVY 592
+L+ N V KI D GL+ +N+ + TT PV ++ PE + + +SDV+
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRL-PVK---WMAPEALFDRVYTHQSDVW 223
Query: 593 AYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLS 648
++G+++ ++ T P I + E+ + + D P T EL +
Sbjct: 224 SFGVLMWEIFTLGGSPYPGIPV---------EELFKLLKEGHRMDKPANCTNELYMMMRD 274
Query: 649 CAELRRKDRPDLKNQVLPVLERL 671
C RP K Q++ L+R+
Sbjct: 275 CWHAIPSHRPTFK-QLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 31/203 (15%)
Query: 448 ELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRL--YRKNNTPPIPWFER 501
E+++L ++H ++ G D + EYM GS++D+L Y + R
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 502 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG----LSTMLNSDPS 557
++ +++LH+ I+HRD+K NIL D K+GD G L T+ S
Sbjct: 114 -----QILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AIAIT 611
S T GT ++ PE K+DV++ G ++++LT KP A+A
Sbjct: 166 IRSVT-------GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI 218
Query: 612 HKVETAIDEDNLAEILDAQAGDW 634
K+ T L + A D+
Sbjct: 219 FKIATQPTNPQLPSHISEHARDF 241
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA- 466
+G G YG VYKG T AA+KV+ + + ++ E+ +L K H ++ GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 467 ---CP----DHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNT 518
P D LV E+ GS+ D + K N W I E+ LA LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH 140
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD----PSFVSTTYKNTGPVGTLCY 574
K +IHRD+K N+LL N K+ D G+S L+ +F+ T Y P C
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW-MAPEVIACD 196
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
+P+ +SD+++ G+ +++ P + H
Sbjct: 197 ENPD----ATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 48/183 (26%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 430 AVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC----LVYEYMENGSL 483
AVK L +S GN +E+E+L + H +++ G C + G L+ E++ +GSL
Sbjct: 37 AVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSL 95
Query: 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543
++ L R N + +Y A ++ + +L + + +HRD+ N+L++ KI
Sbjct: 96 KEYLPRNKNKINLKQQLKY--AVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKI 150
Query: 544 GDVGLSTMLNSDPSFVSTTYKNTGPV---GTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 600
GD GL+ + +D + + PV C I ++ SDV+++G+ + +
Sbjct: 151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA------SDVWSFGVTLYE 204
Query: 601 LLT 603
LLT
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 16/177 (9%)
Query: 434 LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN 491
L+ K I+N Q ++EL+VL + P+++ GA G + E+M+ GSL D++ ++
Sbjct: 40 LEIKPAIRN-QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEA 97
Query: 492 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551
P + IA V LA+L + I+HRD+KP NIL++ K+ D G+S
Sbjct: 98 KRIPEEILGKVSIA--VLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153
Query: 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 608
L ++ ++ VGT Y+ PE + S +SD+++ G+ +++L + I
Sbjct: 154 LIDS---MANSF-----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 20/210 (9%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHL 460
F + +G G G V+K + + A K+ L+ K I+N Q ++EL+VL + P++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN-QIIRELQVLHECNSPYI 65
Query: 461 LLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
+ GA G + E+M+ GSL D++ +K P + IA V L +L
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIA--VIKGLTYLR-- 120
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
+ I+HRD+KP NIL++ K+ D G+S L ++ ++ VGT Y+ PE
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF-----VGTRSYMSPE 172
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAI 608
+ S +SD+++ G+ ++++ + I
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 50/214 (23%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK---QFLQELE----VLSKIRHPHLLLL 463
+G G +GTV+KG + ++K+ + IQ++ Q QE+ + + H +++ L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 464 LGACPDHGC-LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAW--EVASALAFLHNTK 519
LG CP LV + GSL D + +++ P + + W ++A + +L +
Sbjct: 75 LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDP-----QRLLNWCVQIAKGMYYLEEHR 129
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTLCYIDPE 578
++HR++ NILL + + +I D G++ +L D + + +K + ++ E
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT-----PIKWMALE 181
Query: 579 YQRTGLISPKSDVYAYGMVILQLLT--AKPAIAI 610
G + +SDV++YG+ + ++++ A+P +
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 20/203 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLLLLL 464
+G GG+G V T A K L+ K I+ ++ L E ++L K+ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKK-RIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
A D CLV M G L+ +Y N P F+ R + A L + +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHRER 122
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
I++RD+KP NILLD +I D+GL+ + + G VGT+ Y+ PE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI-------RGRVGTVGYMAPEVVKN 175
Query: 583 GLISPKSDVYAYGMVILQLLTAK 605
+ D + G +I +++ K
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 61/237 (25%), Positives = 107/237 (45%), Gaps = 46/237 (19%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----------AVKVLQSKGNIQ-NKQF 445
EI +T+ F E L G +G VYKG H F A+K L+ K ++F
Sbjct: 1 EINLSTVRFMEEL--GEDRFGKVYKG---HLFGTAPGEQTQAVAIKTLKDKAEGPLREEF 55
Query: 446 LQELEVLSKIRHPHLLLLLGA-------------CPD---HGCLVYE--YMENGSLEDRL 487
E + S+++HP+++ LLG C H LV + + GS +D
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 488 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547
K+ P + I ++A+ + FL + ++H+D+ N+L+ L KI D+G
Sbjct: 116 TVKSTLEPADFVH---IVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLG 169
Query: 548 LSTMLNSDPSFVSTTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
L + + + YK G + + ++ PE G S SD+++YG+V+ ++ +
Sbjct: 170 LFREV-----YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 55/229 (24%), Positives = 100/229 (43%), Gaps = 46/229 (20%)
Query: 430 AVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----------------CL 473
AVK + K L+E++++ ++ H +++ + G +
Sbjct: 34 AVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI 93
Query: 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 533
V EYME L P+ +++ L ++H+ ++HRD+KP N+
Sbjct: 94 VQEYMETD-----LANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANV 145
Query: 534 LLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS--- 589
++ +LV KIGD GL+ ++ DP + Y + G V T Y P L+SP +
Sbjct: 146 FINTEDLVLKIGDFGLARIV--DPHYSHKGYLSEGLV-TKWYRSPRL----LLSPNNYTK 198
Query: 590 --DVYAYGMVILQLLTAKPAIAITHKVE---------TAIDEDNLAEIL 627
D++A G + ++LT KP A H++E + E++ E+L
Sbjct: 199 AIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 4e-09
Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
IG G YG V T A+K V I K+ L+E+++L +RH +++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL--IDAKRILREIKLLRHLRHENIIGLL 65
Query: 465 GACPDHGC-------LVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFL 515
+V E ME D L++ K+ P +Y +++ L +L
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLTDDHIQY-FLYQILRGLKYL 119
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557
H+ +IHRD+KP NIL++ N KI D GL+ ++ D
Sbjct: 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 28/207 (13%)
Query: 411 IGMGGYGTVYKGTFHHT---FAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G GG+G V +T +A K+ L+ K K L E E+L K+ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNT 518
A H CLV M G L+ +Y E R+ ++ + LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSM 114
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I++RDMKP N+LLD ++ D+GL+ L + T + GT Y+ PE
Sbjct: 115 D---IVYRDMKPENVLLDDQGNCRLSDLGLAVEL---KDGKTITQR----AGTNGYMAPE 164
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAK 605
+ S D +A G I +++ +
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 411 IGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 462
+G G +G VY+G + AVK L + Q++ FL E ++SK H +++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 463 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR----IAWEVASALAFLH 516
L+G + ++ E M G L+ L P P + A +VA +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 517 NTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGLSTMLNSDPSFVSTTYKNTG----PV 569
IHRD+ N LL V+KI D G++ + + ++ Y+ G P+
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-----YRASYYRKGGRAMLPI 185
Query: 570 GTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
++ PE G+ + K+DV+++G+++
Sbjct: 186 K---WMPPEAFLDGIFTSKTDVWSFGVLL 211
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 67/244 (27%), Positives = 102/244 (41%), Gaps = 46/244 (18%)
Query: 394 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEV 451
TWE IE+ IG G YG VYK T + AAVK+L ++ +++ E +
Sbjct: 23 TWEIIET----------IGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNI 71
Query: 452 LSKI-RHPHLLLLLGAC--PDHGC-----LVYEYMENGSLED------RLYRKNNTPPIP 497
L + HP+++ G D LV E GS+ + ++ + I
Sbjct: 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131
Query: 498 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557
+ I + L LHN + IIHRD+K NILL K+ D G+S L
Sbjct: 132 Y-----ILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT---- 179
Query: 558 FVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
ST + VGT ++ PE Q + DV++ G+ ++L P + H
Sbjct: 180 --STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
Query: 613 KVET 616
V+T
Sbjct: 238 PVKT 241
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 67/264 (25%), Positives = 124/264 (46%), Gaps = 34/264 (12%)
Query: 430 AVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLED 485
AVK+L+ ++ + E+E++ I +H +++ LLGAC G L + EY G+L +
Sbjct: 48 AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107
Query: 486 RLYRKNNTPPIPW-FERYRI-------------AWEVASALAFLHNTKPKPIIHRDMKPG 531
L R P + + F+ ++ A++VA + +L + K IHRD+
Sbjct: 108 YL-RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163
Query: 532 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 591
N+L+ + V KI D GL+ +++ + TT PV ++ PE + + +SDV
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRL-PVK---WMAPEALFDRVYTHQSDV 219
Query: 592 YAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKETKELAALGLSCA 650
+++G+++ ++ T + I + L ++L + D P T EL + C
Sbjct: 220 WSFGVLLWEIFTLGGS------PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECW 273
Query: 651 ELRRKDRPDLKNQVLPVLERLKEV 674
RP K Q++ L+R+ V
Sbjct: 274 HAVPSQRPTFK-QLVEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 404 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP 458
+F + +G GG+G V T A K L+ K + K L E ++L K+
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 459 HLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
++ L A D CLV M G L+ +Y FE R + A L
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLE 116
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ + I++RD+KP NILLD + +I D+GL+ + + G VGT+ Y+
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-------KGRVGTVGYMA 169
Query: 577 PEYQRTGLISPKSDVYAYGMVILQLLTAK 605
PE + + D +A G ++ +++ +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIR-HPHLLL 462
+G G +G V KGT A+KVL+ +Q+ + E +L+ HP L
Sbjct: 3 LGKGSFGKVMLAELKGT--DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYR---IAWEVASALAFLHN 517
L D V EY+ G L ++ R F+ R A EV AL FLH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK------FDEPRSRFYAAEVTLALMFLHR 114
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+I+RD+K NILLD K+ D G+ +TT+ GT YI P
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTF-----CGTPDYIAP 165
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625
E + P D +A G+++ +++ +P A +ED+L E
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPF-------EADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 8e-09
Identities = 63/215 (29%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 411 IGMGGYGTVY---KGTFHH--TFAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRH-PHL 460
+G G YG V+ K H A+KVL+ +Q + + E +VL +R P L
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 461 LLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAF 514
+ L A L + +Y+ G L LY++ + F R IA E+ AL
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH------FTESEVRVYIA-EIVLALDH 120
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH II+RD+K NILLD + D GLS ++ + GT+ Y
Sbjct: 121 LHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-----EEERAYSFCGTIEY 172
Query: 575 IDPEYQRTGLISPKS--DVYAYGMVILQLLT-AKP 606
+ PE R G D ++ G++ +LLT A P
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV--GTL 572
+H+ K +IHRD+K NILL N + K+GD G S M + +T + G GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM------YAATVSDDVGRTFCGTP 209
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
Y+ PE R S K+D+++ G+++ +LLT K
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
|
Length = 496 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 36/190 (18%)
Query: 410 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLL 462
+IG G +G V+K T A KVL + + F L+E+++L ++H +++
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVN 75
Query: 463 LLGAC-----PDHGC-----LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
L+ C P + LV+E+ E+ L L KN + E ++ + + L
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS--EIKKVMKMLLNGL 132
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL----STMLNSDPSFVSTTYKNTGP 568
++H K I+HRDMK NIL+ + + K+ D GL S NS P+ + T
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN------RYTNR 183
Query: 569 VGTLCYIDPE 578
V TL Y PE
Sbjct: 184 VVTLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 18/199 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 465
+G GG+G V T A K L+ K + K L E +L K+ ++ L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 466 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
A D CLV M G L+ +Y N P F+ R + A L + + + I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQRERI 123
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
++RD+KP NILLD +I D+GL+ + + G VGT+ Y+ PE
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV-------RGRVGTVGYMAPEVINNE 176
Query: 584 LISPKSDVYAYGMVILQLL 602
+ D + G +I +++
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 67/268 (25%), Positives = 121/268 (45%), Gaps = 42/268 (15%)
Query: 427 TFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGS 482
T AVK+L+S ++ + E+E++ I +H +++ LLGAC G L + EY G+
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 483 LEDRLYRKNNTPP---------------IPWFERYRIAWEVASALAFLHNTKPKPIIHRD 527
L R Y + PP + + + A++VA + +L + K IHRD
Sbjct: 111 L--REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRD 165
Query: 528 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP 587
+ N+L+ + V KI D GL+ ++ + TT PV ++ PE + +
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL-PVK---WMAPEALFDRIYTH 221
Query: 588 KSDVYAYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 643
+SDV+++G+++ ++ T P + + E+ + + D P T EL
Sbjct: 222 QSDVWSFGVLLWEIFTLGGSPYPGVPV---------EELFKLLKEGHRMDKPSNCTNELY 272
Query: 644 ALGLSCAELRRKDRPDLKNQVLPVLERL 671
+ C RP K Q++ L+R+
Sbjct: 273 MMMRDCWHAVPSQRPTFK-QLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 570
AL +LH K K I+HRD+ P NI+L + I D GL+ + K T VG
Sbjct: 125 ALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTSVVG 175
Query: 571 TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630
T+ Y PE + K+DV+A+G ++ Q+ T +P T+ + A +I++A
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KIVEAV 229
Query: 631 AGDWPIKE---TKELAALGLSCAELRRKDRPDL 660
P+ E ++++ + SC + RPD+
Sbjct: 230 YE--PLPEGMYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 43/272 (15%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNI------QNKQFLQELEVLSKIRHPHLLLLL 464
+G G +G+V +G + + +KV I + + FL E + + HP+++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 465 GACPDHG--------CLVYEYMENGSLEDRLY--RKNNTPP-IPWFERYRIAWEVASALA 513
G C ++ +M++G L L R + P +P + ++AS +
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML-NSDPSFVSTTYKNTGPVGTL 572
+L + K IHRD+ N +L+ N+ + D GLS + N D Y G + +
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-------YYRQGRIAKM 176
Query: 573 C--YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630
+I E + + KSDV+++G+ + ++ T + +T +EI D
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT---------RGQTPYPGVENSEIYDYL 227
Query: 631 AGDWPIKETKE----LAALGLSCAELRRKDRP 658
+K+ + L +L SC L KDRP
Sbjct: 228 RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRP 259
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 28/225 (12%)
Query: 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 532
+V EYM G L + + N P W R+ A EV AL +H+ IHRD+KP N
Sbjct: 120 MVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIHSMG---FIHRDVKPDN 172
Query: 533 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT----GLISPK 588
+LLD + K+ D G ++++ T VGT YI PE ++ G +
Sbjct: 173 MLLDKSGHLKLADFGTCMKMDANGMVRCDT-----AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 589 SDVYAYGMVILQLLTAKP---AIAITHKVETAIDEDNLAEILDAQAGDWPI-KETKELAA 644
D ++ G+ + ++L A ++ +D N D D I K+ K+L
Sbjct: 228 CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPD----DIEISKQAKDLIC 283
Query: 645 LGLSCAELR--RKDRPDLKNQVLPVLERLKEVADRARDTVPSVHP 687
L+ E+R R ++K+ P + + D R+TV V P
Sbjct: 284 AFLTDREVRLGRNGVDEIKSH--PFFKNDQWTFDNIRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG VYKG T A+K L+S+ ++E+ +L +++HP+++ L
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 466 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA---WEVASALAFLHNTKP 520
L++E++ S++ + Y ++ P + + + +++ + F H+ +
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY- 579
++HRD+KP N+L+D+ V K+ D GL+ +F T V TL Y PE
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR------AFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 580 ---QRTGLISPKSDVYAYGMVILQLLTAKP 606
R S D+++ G + ++ T KP
Sbjct: 174 LGSPR---YSTPVDIWSIGTIFAEMATKKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 465
+G GG+G V T A K L K + K + + E +L+K+ ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 466 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
A CLV M G L +Y + P F R + A ++ L + + I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
I+RD+KP N+LLD++ +I D+GL+ L S K G GT ++ PE +
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS------KTKGYAGTPGFMAPELLQGE 172
Query: 584 LISPKSDVYAYGMVILQLLTAK-PAIAITHKVE 615
D +A G+ + +++ A+ P A KVE
Sbjct: 173 EYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 66/248 (26%), Positives = 104/248 (41%), Gaps = 31/248 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQE---LEVLSKIRHPHLL 461
IG GG+G VY T A+K L K I+ KQ L E L ++S P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 462 LLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
+ A PD + + M G L Y + E A E+ L +HN
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLH---YHLSQHGVFSEAEMRFYAAEIILGLEHMHN-- 115
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
+ +++RD+KP NILLD + +I D+GL+ + S VGT Y+ PE
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEV 166
Query: 580 QRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
+ G+ S D ++ G ++ +LL HK + + D + + + P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVE---LPDSF 222
Query: 639 TKELAALG 646
+ EL +L
Sbjct: 223 SPELRSLL 230
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-08
Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 44/227 (19%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSK------GN-IQNKQFLQELEVLSKIRHPHLLLL 463
IG GG G VY + + +V K N + K+FL+E ++ + + HP ++ +
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 464 LGACPDHGCLVY---EYMENGSLEDRL---YRKNNTP-------PIPWFERYRIAWEVAS 510
C D G VY Y+E +L+ L ++K + + F I ++ +
Sbjct: 68 YSICSD-GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF--LSIFHKICA 124
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK--IGDVGLSTMLN---SDPSFVSTTYKN 565
+ ++H+ K ++HRD+KP NILL L + I D G + D + +N
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 566 ------TGP---VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
T P VGT Y+ PE S +D+YA G+++ Q+LT
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 67/280 (23%), Positives = 122/280 (43%), Gaps = 42/280 (15%)
Query: 415 GYGTVYKGTFHHTFAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHPHLLLLLGACPDHGC 472
YG AVK+L+ ++ + E+E++ I +H +++ LLG C G
Sbjct: 33 AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92
Query: 473 L--VYEYMENGSLEDRLYRKNNTPPIP--WFERYRI-------------AWEVASALAFL 515
L + EY G+L R + + PP P F+ ++ A++VA + +L
Sbjct: 93 LYVIVEYAAKGNL--REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
+ + IHRD+ N+L+ + V KI D GL+ ++ D + T PV ++
Sbjct: 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVH-DIDYYKKTSNGRLPVK---WM 203
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLT----AKPAIAITHKVETAIDEDNLAEILDAQA 631
PE + + +SDV+++G+++ ++ T P I + E+ + +
Sbjct: 204 APEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---------EELFKLLREGHR 254
Query: 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
D P T EL L C RP K Q++ L+++
Sbjct: 255 MDKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 28/244 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ----FLQELEVLSKIRH---PHLL 461
IG GG+G VY T A+K L K I+ KQ L E +LS + P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKK-RIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 462 LLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
+ A PD C + + M G L Y + E A E+ L +HN
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH---YHLSQHGVFSEKEMRFYATEIILGLEHMHN-- 115
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
+ +++RD+KP NILLD + +I D+GL+ + S VGT Y+ PE
Sbjct: 116 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--------VGTHGYMAPEV 166
Query: 580 QRTGLISPKS-DVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
+ G S D ++ G ++ +LL HK + + D + ++ + D E
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPDSFSPE 225
Query: 639 TKEL 642
K L
Sbjct: 226 LKSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 67/240 (27%), Positives = 98/240 (40%), Gaps = 46/240 (19%)
Query: 394 TWEEIESATLSFSENLRIGMGGYGTVYK--GTFHHTFAAVKVLQSKGNIQNKQFLQELEV 451
TWE IE+ IG G YG V+K + + AAVK+L +I +++ E +
Sbjct: 19 TWEIIET----------IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIEAEYNI 67
Query: 452 LSKIR-HPHLLLLLG-------ACPDHGCLVYEYMENGSLED------RLYRKNNTPPIP 497
L + HP+++ G D LV E GS+ D + + P I
Sbjct: 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIA 127
Query: 498 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557
+ I E L LH K IHRD+K NILL K+ D G+S L
Sbjct: 128 Y-----ILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLT---- 175
Query: 558 FVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
ST + VGT ++ PE Q + DV++ G+ ++L P +A H
Sbjct: 176 --STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 463
+G G +G V +KGT + A+K L+ + ++ KQ QE +L ++ HP ++ +
Sbjct: 26 LGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 464 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
+ + D + + E++ G L L RK P + Y E+ A +LH+ K
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHA--ELVLAFEYLHS---K 137
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
II+RD+KP N+LLD+ K+ D G + + D +F TLC PEY
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF------------TLCGT-PEYLA 183
Query: 582 TGLISPKS-----DVYAYGMVILQLLTAKP 606
+I K D + G+++ + + P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 69/250 (27%), Positives = 106/250 (42%), Gaps = 41/250 (16%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQ 65
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNT 518
L +C D V EY+ G L + + K P ++ A E++ L FLH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY-----AAEISVGLFFLHR- 119
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
+ II+RD+K N++LD KI D G+ D + T+ GT YI PE
Sbjct: 120 --RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTF-----CGTPDYIAPE 171
Query: 579 ---YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635
YQ G D +AYG+++ ++L +P DED L + + +P
Sbjct: 172 IIAYQPYGK---SVDWWAYGVLLYEMLAGQPPF-------DGEDEDELFQSIMEHNVSYP 221
Query: 636 IKETKELAAL 645
+KE ++
Sbjct: 222 KSLSKEAVSI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 46/203 (22%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 409 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
++IG G G V T + AVK + + + + E+ ++ +H +++ + +
Sbjct: 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 467 --CPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
D +V E++E G+L D + + + N I + V AL+ LH + +
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGV 137
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
IHRD+K +ILL H+ K+ D G ++ + + VGT ++ PE
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------VPRRKSLVGTPYWMAPELISRL 191
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
P+ D+++ G+++++++ +P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 15/154 (9%)
Query: 430 AVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENGSLE 484
A+KV++ F +E ++LS P + L A D + LV EY G L
Sbjct: 30 AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89
Query: 485 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544
L R + F+ + +A + +H+ +HRD+KP N+L+D K+
Sbjct: 90 SLLNRYEDQ-----FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLA 144
Query: 545 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
D G + L ++ S PVGT YI PE
Sbjct: 145 DFGSAARLTANKMVNSKL-----PVGTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 48/150 (32%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 411 IGMGGYGTVYKGT----FHHTFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 465
IG G +G V G + VK L+ ++Q + +FL+E + ++H +LL LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 466 ACPDHG--CLVYEYMENGSLEDRLYR----KNNTPPIPWFERYRIAWEVASALAFLHNTK 519
C + LV E+ G L+ L + TP +R +A E+A L LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLHKNN 120
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
IH D+ N LL +L KIGD GLS
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 411 IGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQ----FLQELEVLSKIRHPHLL 461
+G GGYG V++ G A+KVL+ ++N++ E +L ++HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 462 LLLGACPDHG--CLVYEYMENGSLEDRLYRK----NNTPPIPWFERYRIAWEVASALAFL 515
L+ A G L+ EY+ G L L R+ +T + ++ E++ AL L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA------CFYLS-EISLALEHL 116
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H + II+RD+KP NILLD K+ D GL + + V+ T+ GT+ Y+
Sbjct: 117 HQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTF-----CGTIEYM 167
Query: 576 DPE-YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE R+G D ++ G ++ +LT P
Sbjct: 168 APEILMRSGH-GKAVDWWSLGALMYDMLTGAP 198
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 47/270 (17%)
Query: 414 GGYGTVYKGTFHHTF------AAVK-VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
G +G ++ G VK V IQ LQE +L + H ++L +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 467 C---PDHGCLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
C + ++Y YM G+L+ RL NN + + +A ++A +++LH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-----PVGTLC 573
+ +IH+D+ N ++D L KI D LS L F Y G PV
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDL-----FPM-DYHCLGDNENRPVK--- 184
Query: 574 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD----- 628
++ E S SDV+++G+++ +L+T + T VE ID +A L
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMT----LGQTPYVE--IDPFEMAAYLKDGYRL 238
Query: 629 AQAGDWPIKETKELAALGLSCAELRRKDRP 658
AQ PI EL A+ C L ++RP
Sbjct: 239 AQ----PINCPDELFAVMACCWALDPEERP 264
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 431 VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSLEDRLY 488
+KVL + F + ++ ++ H H++LL G C +V E++E G L+ ++
Sbjct: 37 LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH 96
Query: 489 RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
RK++ PW ++++A ++ASAL++L + K ++H ++ NILL + G+ G
Sbjct: 97 RKSDVLTTPW--KFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGID--GECGP 149
Query: 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVILQLLTAKPA 607
L SDP T V + +I PE + + +S +D +++G + +
Sbjct: 150 FIKL-SDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE------- 201
Query: 608 IAITHKVETAIDEDNLAEILDAQAGDWPI--KETKELAALGLSCAELRRKDRP 658
I + E + + LAE G + KELA L C RP
Sbjct: 202 --ICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 1e-07
Identities = 59/200 (29%), Positives = 82/200 (41%), Gaps = 38/200 (19%)
Query: 410 RIGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 463
IG G +G V+ +A +KVL+ I+ Q E ++L+ P ++ L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYA-MKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 464 LGACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
+ D H LV EYM G L + L RK+ P R+ IA E+ AL +H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE--TARFYIA-ELVLALDSVHKLG-- 121
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS--DPSFVSTTYKNTG------------ 567
IHRD+KP NIL+D + K+ D GL +N D + N
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 568 ---------PVGTLCYIDPE 578
VGT YI PE
Sbjct: 181 KQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 411 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 465
+G G +G V + + A+K+L+ + I + L E VL RHP L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 466 A--CPDHGCLVYEYMENGSL-----EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
+ D C V EY+ G L +R++ ++ T R+ A E+ SAL +LH+
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT-------RFYGA-EIVSALDYLHSG 114
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
K I++RD+K N++LD + KI D GL +D + + T GT Y+ PE
Sbjct: 115 K---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF------CGTPEYLAPE 165
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAK 605
D + G+V+ +++ +
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 50/239 (20%)
Query: 400 SATLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQELEVL 452
S + ++G G +G VYK T V K+L + F L+E+++L
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN---EKDGFPITALREIKIL 61
Query: 453 SKIRHPHLLLLL--------GACPDHGC--LVYEYME---NGSLEDRLYRKNNTPPIPWF 499
K++HP+++ L+ + G +V YM+ +G LE+ T
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--SVKLTES---- 115
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL-------STML 552
+ ++ + +LH I+HRD+K NIL+D+ + KI D GL
Sbjct: 116 QIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 553 NSDPSFVSTTYKNTGPVGTLCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKP 606
+ Y T V T Y PE + T + D++ G V ++ T +P
Sbjct: 173 KGGGGGGTRKY--TNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRRP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V K
Sbjct: 180 SFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR---K 233
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDN 622
+ + L ++ PE + + +SDV+++G+++ ++ L A P + I+E+
Sbjct: 234 GSARL-PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------INEEF 286
Query: 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 658
+ D P T E+ + L+C + K+RP
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V +
Sbjct: 179 SFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----R 231
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDN 622
L ++ PE + + +SDV+++G+++ ++ + A P + IDE+
Sbjct: 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ------IDEEF 285
Query: 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP 658
+ + P T E+ ++ L C +DRP
Sbjct: 286 CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNI----QNKQFLQELEVLSKIRHPHLLL 462
I G YG VY K T FA K+ +K N+ Q +Q E ++L+ +P ++
Sbjct: 9 ISNGAYGAVYLVRHKET-RQRFAMKKI--NKQNLILRNQIQQVFVERDILTFAENPFVVS 65
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW-EVASALAFLHNTK 519
+ + H C+V EY+E G L N +P + R+ + E AL +LHN
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLL---KNIGALP-VDMARMYFAETVLALEYLHNYG 121
Query: 520 PKPIIHRDMKPGNILL---------DHNLVSKIGDVGLSTMLNSDPSFVST-TYKNTGPV 569
I+HRD+KP N+L+ D L SKIG + L+T L T + +
Sbjct: 122 ---IVHRDLKPDNLLITSMGHIKLTDFGL-SKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 570 GTLCYIDPEY-QRTGLISPKSDVYAYGMVILQLL 602
GT YI PE R G P D +A G+++ + L
Sbjct: 178 GTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 37/236 (15%)
Query: 411 IGMGGYGTVY-----KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLL 462
+G G +G V+ G A+KVL+ K ++ + ++ E ++L+++ HP ++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLK-KATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 463 LLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFE---RYRIAWEVASALAFLHN 517
L A G L+ +++ G L RL ++ + + E ++ +A E+A AL LH+
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLA-ELALALDHLHS 116
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
II+RD+KP NILLD K+ D GLS + K GT+ Y+ P
Sbjct: 117 LG---IIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGTVEYMAP 167
Query: 578 E-YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632
E R G + +D +++G+++ ++LT + ET + IL A+ G
Sbjct: 168 EVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILKAKLG 216
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 51/188 (27%), Positives = 83/188 (44%), Gaps = 37/188 (19%)
Query: 448 ELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRL-----YRKNNTPPIPW 498
E+++L +RH ++ G D + EYM GS++D+L +N T
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT----- 108
Query: 499 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS----TMLNS 554
R ++ +++LH+ I+HRD+K NIL D K+GD G S T+ S
Sbjct: 109 ---RRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AI 608
S T GT ++ PE K+DV++ ++++LT KP A+
Sbjct: 163 GTGIKSVT-------GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
Query: 609 AITHKVET 616
A K+ T
Sbjct: 216 AAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 411 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 465
IG G +G V + A+K+L I+ F +E ++++ P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
A D L V EYM G L + + N P W R+ A EV AL +H+
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHSMG---F 163
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT- 582
IHRD+KP N+LLD + K+ D G +N + T VGT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPEVLKSQ 218
Query: 583 ---GLISPKSDVYAYGMVILQLLTA 604
G + D ++ G+ + ++L
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 11/160 (6%)
Query: 445 FLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY 502
F + ++S++ H HL + G C +V E++E+G L+ L ++ P+ W +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 503 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562
+A ++ASAL++L + K ++H ++ NILL + + + SDP T
Sbjct: 121 TVAQQLASALSYLED---KNLVHGNVCAKNILLAR---LGLAEGTSPFIKLSDPGVSFTA 174
Query: 563 YKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQL 601
V + +I PE G +S +D +++G +L++
Sbjct: 175 LSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 411 IGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNK-QFLQELEVLSKIRHPHLLLLLG 465
IG G +G V + VK L++ + + + +FLQ+ + ++HP++L LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 466 ACPDH--GCLVYEYMENGSL------EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
C + LV+EY E G L E R + R+A E+A+ + +H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL-----LLLQRMACEIAAGVTHMHK 117
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+H D+ N L +L K+GD G+ ++ T P L ++ P
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVP---LRWLAP 170
Query: 578 EY---QRTGLISPK----SDVYAYGMVILQLL 602
E GLI+ + S+V+A G+ + +L
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 51/212 (24%), Positives = 95/212 (44%), Gaps = 33/212 (15%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG VYK T + + L+ + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 466 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFER-YRIA----WEVASALAFLHNT 518
LV+EY++ L K + P F + R+ +++ +A+ H+
Sbjct: 69 VVHSEKRLYLVFEYLD-------LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 519 KPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+ ++HRD+KP N+L+D + K+ D GL+ +F T V TL Y P
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLAR------AFGIPVRTFTHEVVTLWYRAP 172
Query: 578 EY---QRTGLISPKSDVYAYGMVILQLLTAKP 606
E R S D+++ G + +++ KP
Sbjct: 173 EILLGSRH--YSTPVDIWSVGCIFAEMVNQKP 202
|
Length = 294 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 66/245 (26%), Positives = 100/245 (40%), Gaps = 31/245 (12%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V KGT A+K+L+ IQ+ + E VL+ P L
Sbjct: 8 LGKGSFGKVMLAERKGT--DELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQ 65
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L +C D V EY+ G L +Y+ A E+A L FLH+
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS--- 119
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
K II+RD+K N++LD KI D G+ N + T+ GT YI PE
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTF-----CGTPDYIAPEII 173
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640
D +A+G+++ ++L + DED L + + +P +K
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPF-------EGEDEDELFQSIMEHNVAYPKSMSK 226
Query: 641 ELAAL 645
E A+
Sbjct: 227 EAVAI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 48/203 (23%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 409 LRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
++IG G G V T HT AVK + + + + E+ ++ H +++ + +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 467 --CPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
D +V E++E G+L D + + + N I + V AL++LHN + +
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QGV 139
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
IHRD+K +ILL + K+ D G ++ + K VGT ++ PE
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSLVGTPYWMAPEVISRL 193
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
+ D+++ G+++++++ +P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 44/199 (22%), Positives = 86/199 (43%), Gaps = 27/199 (13%)
Query: 419 VYKGTFHHTFAAVKVLQ--SKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 469
+YKG F++ ++ + KG + E++ L +I ++L + G D
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529
L+ EY G L + L ++ + + + + +A + L L+ KP ++++
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 530 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP-- 587
+ L+ N KI GL +L+S P +KN V + Y + + S
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPP------FKN---VNFMVYFSYKML-NDIFSEYT 200
Query: 588 -KSDVYAYGMVILQLLTAK 605
K D+Y+ G+V+ ++ T K
Sbjct: 201 IKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 8e-07
Identities = 56/181 (30%), Positives = 82/181 (45%), Gaps = 42/181 (23%)
Query: 504 IAWEVASALAFLHNTKPKP----IIHRDMKPGNILLD-------------HNL----VSK 542
I ++ ALA+ HN K P ++HRD+KP NI L +NL ++K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQ 600
IGD GLS + + S VGT Y PE T KSD++A G +I +
Sbjct: 183 IGDFGLSKNIGIESMAHSC-------VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 601 LLTAKPAIAITHKVETAIDEDNLAEILD--AQAGDWPIK-ETKELAALGLSCAELRRKDR 657
L + K HK +N ++++ + D PIK ++KEL L + L K+R
Sbjct: 236 LCSGKTPF---HKA------NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286
Query: 658 P 658
P
Sbjct: 287 P 287
|
Length = 1021 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 411 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 465
IG G +G V + A+K+L I+ F +E ++++ P ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 466 ACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
A D + +V EYM G L + + N P W + Y EV AL +H+ +
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTA--EVVLALDAIHSMG---L 163
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT- 582
IHRD+KP N+LLD + K+ D G ++ T VGT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-----AVGTPDYISPEVLKSQ 218
Query: 583 ---GLISPKSDVYAYGMVILQLLTA 604
G + D ++ G+ + ++L
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 27/159 (16%)
Query: 430 AVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL- 483
A+K+L+ + I + L E VL RHP L L + H C V EY G L
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 484 ----EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 539
+R++ ++ R+ A E+ SAL +LH+ +++RD+K N++LD +
Sbjct: 84 FHLSRERVFSEDRA-------RFYGA-EIVSALGYLHSCD---VVYRDLKLENLMLDKDG 132
Query: 540 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
KI D GL SD + + T GT Y+ PE
Sbjct: 133 HIKITDFGLCKEGISDGATMKTF------CGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 34/210 (16%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V K T + A+K+L+ + + + L E VL RHP L L
Sbjct: 3 LGKGTFGKVILVKEKATGR--YYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 464 LGACPDHG--CLVYEYMENGSL-----EDRLYRKNNTPPIPWFERYRI-AWEVASALAFL 515
+ H C V EY G L +R++ + +R R E+ SAL +L
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE---------DRARFYGAEIVSALDYL 111
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H+ K +++RD+K N++LD + KI D GL D + + T GT Y+
Sbjct: 112 HSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGTPEYL 163
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
PE D + G+V+ +++ +
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 411 IGMGGYGTVYK-------GTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLL 461
+G G +G+V + G+F AVK+L++ + ++FL+E + + HP+++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKV--AVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 462 LLLGACPDHGC--------LVYEYMENGSLE-----DRLYRKNNTPPIPWFERYRIAWEV 508
L+G ++ +M++G L R+ + T P+ R+ I ++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DI 122
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
AS + +L + K IHRD+ N +L+ N+ + D GLS + S Y G
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKI------YSGDYYRQGC 173
Query: 569 VGTLC--YIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
L ++ E + + SDV+A+G+ + +++T
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 37/244 (15%)
Query: 411 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQF--LQELEVLSKIR---HPHLLL 462
IG G YG V+K F A+K ++ + + ++E+ VL + HP+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 463 LLGACP-------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 515
L C LV+E+++ L L K P +P + +++ L FL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H+ + ++HRD+KP NIL+ + K+ D GL+ + SF T V TL Y
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY----SFQMAL---TSVVVTLWYR 176
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA----QA 631
PE + D+++ G + ++ KP + D D L +ILD
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF------RGSSDVDQLGKILDVIGLPGE 230
Query: 632 GDWP 635
DWP
Sbjct: 231 EDWP 234
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 428 FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482
+ A+K+L+ + I + + E VL RHP L L A H C V EY G
Sbjct: 22 YYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81
Query: 483 LEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541
L L R+ + ER R E+ SAL +LH+ + +++RD+K N++LD +
Sbjct: 82 LFFHLSRER----VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHI 134
Query: 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL 601
KI D GL SD + + T GT Y+ PE D + G+V+ ++
Sbjct: 135 KITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
Query: 602 LTAK 605
+ +
Sbjct: 189 MCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 40/216 (18%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF-----LQELEVLSKIRHPHLLLLLG 465
IG G YG V T T VKV K + Q L+E+++L + +H +++ +L
Sbjct: 13 IGEGAYGMVCSATHKPT--GVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 466 A-CPDHGC------LVYEYMENGSLEDRLYRKNNTPP-----IPWFERYRIAWEVASALA 513
P +V E ME LY+ T I +F +++ L
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYF-----LYQILRGLK 120
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGT 571
++H+ ++HRD+KP N+LL+ N KI D GL D + T Y V T
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY-----VAT 172
Query: 572 LCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 606
Y PE K+ D+++ G ++ ++L+ +P
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|222135 pfam13445, zf-RING_LisH, RING-type zinc-finger, LisH dimerisation motif | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-06
Identities = 17/41 (41%), Positives = 23/41 (56%), Gaps = 4/41 (9%)
Query: 692 HFICPILKEVM----NEPCVAADGYTYDRKAIEEWLQENDK 728
F+CPI KEVM N P + G+ Y RKA+E+ + K
Sbjct: 10 IFVCPISKEVMTDEENPPVMLPCGHVYSRKALEKLAKNGGK 50
|
This zinc-finger is the dimerisation motif for LisH proteins, and is also a typical RING-type of plant ubiquitin ligases. Length = 55 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 43/190 (22%)
Query: 411 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL-- 464
IG G YG V + V K+ + K+ L+EL++L +H +++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 465 ----GACPDHGCLVYEYME---------NGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
GA +V + ME + L + R + Y++
Sbjct: 73 LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIR---------YFLYQLL----RG 119
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP---SFVSTTYKNTGP 568
L ++H+ +IHRD+KP N+L++ + +IGD G++ L+S P + T Y
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY----- 171
Query: 569 VGTLCYIDPE 578
V T Y PE
Sbjct: 172 VATRWYRAPE 181
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 35/243 (14%)
Query: 410 RIGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLL 461
++G GGYG V+ K T A+K + K + + L E ++L+ + L+
Sbjct: 8 QVGQGGYGQVFLAKKKDT--GEIVALKRM-KKSLLFKLNEVRHVLTERDILTTTKSEWLV 64
Query: 462 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE-RYRIAWEVASALAFLHNT 518
LL A ++ L EY+ G L NN + R+ +A E+ A+ LH
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMA-EMFEAVDALHEL 120
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
IHRD+KP N L+D + K+ D GLS V TY N+ VG+ Y+ PE
Sbjct: 121 G---YIHRDLKPENFLIDASGHIKLTDFGLSK------GIV--TYANS-VVGSPDYMAPE 168
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
R D ++ G ++ + L P + + ET + E L P+ +
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL-----QRPVYD 223
Query: 639 TKE 641
Sbjct: 224 DPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 410 RIGMGGYGTVYKG---TFHHTFAAVKV-LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG VYK A K+ L+++ ++E+ +L ++ HP+++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 466 ACPDHGCL--VYEY--MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
L V+E+ ++ D PP+ + Y +++ +A+ H+ +
Sbjct: 66 VVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL--IKSY--LYQLLQGIAYCHSHR-- 119
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGL 548
++HRD+KP N+L+D K+ D GL
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 41/218 (18%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHP------HL 460
IG G YG V HT V + + ++ + L+E+++L +RHP H+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 461 LLLLGACPDHG-----CLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRI-AWEVASAL 512
+L P +V+E ME S ++ + N+ TP E ++ +++ AL
Sbjct: 68 ML----PPSRREFKDIYVVFELME--SDLHQVIKANDDLTP-----EHHQFFLYQLLRAL 116
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVS-TTYKNTGPVG 570
++H + HRD+KP NIL + + KI D GL+ N P+ + T Y V
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY-----VA 168
Query: 571 TLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKP 606
T Y PE + +P D+++ G + ++LT KP
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 296 QNEANDASRKVNDLNKCKLEEETRLSEI--QLLEEKAIELAKQEKKKYETARREAECARA 353
Q ++ + K + E+ R E+ + EKA + A+Q K+ E +++AE A+A
Sbjct: 67 QERQKKLEQQAEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAEEKQKQAEEAKA 126
Query: 354 SAEKEAAQRQEA--EMKAKHEAKEKEMLERA 382
EA + EA E KAK EAK++ E
Sbjct: 127 KQAAEAKAKAEAEAEKKAKEEAKKQAEEEAK 157
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 46/228 (20%)
Query: 407 ENLRIGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 461
E ++G G YG VYK G +A + Q +G + +E+ +L +++HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYA---LKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 462 LLLGACPDHG----CLVYEYMENGSLE----DRLYRKNNTP-PIPWFERYRIAWEVASAL 512
L H L+++Y E+ R + N P +P + +++ +
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 513 AFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNS--------DPSFV 559
+LH ++HRD+KP NIL+ + V KI D+G + + NS DP V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV 177
Query: 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 606
T Y PE K+ D++A G + +LLT++P
Sbjct: 178 -----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 404 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPH 459
+F + +IG G YG VYK T V + + + + + + ++E+ +L ++ HP+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 460 LLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTP----PIPWFERYRIAWEVASALA 513
++ LL LV+E++ +D + +P P+P + Y +++ LA
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASPLSGIPLPLIKSY--LFQLLQGLA 114
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
F H+ + ++HRD+KP N+L++ K+ D GL+ +F T V TL
Sbjct: 115 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR------AFGVPVRTYTHEVVTLW 165
Query: 574 YIDPE-YQRTGLISPKSDVYAYGMVILQLLTAK 605
Y PE S D+++ G + +++T +
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 410 RIGMGGYGTVYKGT--FHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPHLLLLLG 465
++G G Y TVYKG + A+KV+ K + F ++E +L ++H +++LL
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
L V+EYM + Y + + + +++ LA++H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQ---YMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---I 124
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
+HRD+KP N+L+ + K+ D GL+ S S TY + V TL Y P+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLA----RAKSIPSQTY--SSEVVTLWYRPPDVLLGA 178
Query: 584 L-ISPKSDVYAYGMVILQLLTAKPAIA 609
S D++ G + +++L +PA
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVK----VLQSKGNIQNKQFLQELEVLSKIR-HPHLL 461
+G G YG V T A+K V K I K+ L+EL++L R H ++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKK--ILAKRALRELKLLRHFRGHKNIT 65
Query: 462 LLLG---ACPDHGCLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLH 516
L P + +Y Y E +E L++ ++ P + I +++ L ++H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ ++HRD+KPGN+L++ + KI D GL+ + + T V T Y
Sbjct: 123 SAN---VLHRDLKPGNLLVNADCELKICDFGLARGFS--ENPGENAGFMTEYVATRWYRA 177
Query: 577 PE----YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE +Q + DV++ G ++ +LL KP
Sbjct: 178 PEIMLSFQS---YTKAIDVWSVGCILAELLGRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 15/148 (10%)
Query: 411 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLLL 464
IG+G +G V K + +A +K L+ + Q E ++L++ + ++ L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYA-MKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ D L V +Y+ G + L R R+ IA E+ A+ +H
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED--LARFYIA-ELTCAIESVHKMG--- 121
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLST 550
IHRD+KP NIL+D + K+ D GL T
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 42/228 (18%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK-----IRHPHLLLLLG 465
IG G +G V AV ++ I + L + E+L + R +L+ G
Sbjct: 9 IGRGAFGEV----------AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG 58
Query: 466 AC------------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 513
C ++ LV +Y G L L + + P Y +A +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----IAEMVL 113
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
+H+ +HRD+KP N+LLD N ++ D G +N D T +++ VGT
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD-----GTVQSSVAVGTPD 168
Query: 574 YIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616
YI PE + G P+ D ++ G+ + ++L + VET
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 29/168 (17%)
Query: 448 ELEVLSKIRHPHLLLLLGA-------C---PDHGCLVYEYMENGSLEDRLYRKNNTPPIP 497
E+++L I H ++ L+ A C P + C ++ Y++ P+P
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG------------PLP 183
Query: 498 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557
+ I + ALA+LH + IIHRD+K NI LD + +GD G + L++ P
Sbjct: 184 LEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240
Query: 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
T + G GTL PE K+D+++ G+V+ ++
Sbjct: 241 ----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 46/228 (20%)
Query: 407 ENLRIGMGGYGTVYK-----GTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL 461
E ++G G YG VYK G +A + Q +G + +E+ +L +++HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYA---LKQIEGTGISMSACREIALLRELKHPNVI 61
Query: 462 LLLGACPDHG----CLVYEYMENGSLE----DRLYRKNNTP-PIPWFERYRIAWEVASAL 512
L H L+++Y E+ R + N P +P + +++ +
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 513 AFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNS--------DPSFV 559
+LH ++HRD+KP NIL+ + V KI D+G + + NS DP V
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVV 177
Query: 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKS-DVYAYGMVILQLLTAKP 606
T Y PE K+ D++A G + +LLT++P
Sbjct: 178 -----------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRH-PHLLLLL 464
+IG G YG VYK +T V + +++ + + L+E+ +L + +++ LL
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 465 GACPDHG---------CLVYEYMENG--SLEDRLYRKNNTP-PIPWFERYRIAWEVASAL 512
+H LV+EY+++ D R P P + + +++ +
Sbjct: 68 --DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF--MYQLLKGV 123
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
A H ++HRD+KP N+L+D + KI D+GL +F T + T
Sbjct: 124 AHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR------AFSIPVKSYTHEIVT 174
Query: 572 LCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKP 606
L Y PE S D+++ G + ++ +P
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/99 (30%), Positives = 57/99 (57%), Gaps = 7/99 (7%)
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
+++VA ++FL + K IHRD+ NILL H ++KI D GL+ + +D ++V
Sbjct: 220 SYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PV ++ PE + + +SDV++YG+++ ++ +
Sbjct: 277 RL-PVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 28/180 (15%)
Query: 469 DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFLHNTKPKPIIH 525
+H V E++ G L + K F+ YR A E+ L FLH+ K II+
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQDKGR------FDLYRATFYAAEIVCGLQFLHS---KGIIY 119
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 585
RD+K N++LD + KI D G+ V + + GT YI PE +
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCK------ENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 586 SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---IKETKEL 642
+ D +++G+++ ++L + DED L E + +P KE+K++
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFH-------GDDEDELFESIRVDTPHYPRWITKESKDI 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 14/156 (8%)
Query: 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPG 531
LV EY+ G L + R+ P E R A E+ AL FLH + II+RD+K
Sbjct: 73 LVIEYVNGGDLMFHMQRQRKLPE----EHARFYAAEICIALNFLHE---RGIIYRDLKLD 125
Query: 532 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 591
N+LLD + K+ D G+ P ++T+ GT YI PE R D
Sbjct: 126 NVLLDADGHIKLTDYGMCKE-GLGPGDTTSTF-----CGTPNYIAPEILRGEEYGFSVDW 179
Query: 592 YAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627
+A G+++ +++ + I ED L +++
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQE-------LEVLSKIRHPHLLLL 463
+G G +G VY T + V Q + + ++ + +E +++L + H ++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 464 LGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
G D + E+M GS++D+L K+ R + ++ +++LH+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR-KYTRQILEGVSYLHSNM 126
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVG----LSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
I+HRD+K NIL D K+GD G L T+ S S T GT ++
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-------GTPYWM 176
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP------AIAITHKVET 616
PE K+D+++ G ++++LT KP A+A K+ T
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 29/212 (13%)
Query: 411 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRH-PHL 460
+G G YG V+ K T H T A+KVLQ +Q + ++ E VL +R P L
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 461 LLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHN 517
+ L A L+ +Y+ G + LY+++N + R + E+ AL LH
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILALEHLHK 123
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCYID 576
I++RD+K NILLD + D GLS F+S + T GT+ Y+
Sbjct: 124 LG---IVYRDIKLENILLDSEGHVVLTDFGLSK------EFLSEEKERTYSFCGTIEYMA 174
Query: 577 PEYQRTGLISPKS-DVYAYGMVILQLLT-AKP 606
PE R K+ D ++ G++I +LLT A P
Sbjct: 175 PEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 10/133 (7%)
Query: 473 LVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPG 531
L+ EY G L ++ R P +E + +++ AL +H+ K ++HRD+K
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSA 198
Query: 532 NILLDHNLVSKIGDVGLSTMLNSDPSF-VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSD 590
NI L + K+GD G S + S V++++ GT Y+ PE S K+D
Sbjct: 199 NIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF-----CGTPYYLAPELWERKRYSKKAD 253
Query: 591 VYAYGMVILQLLT 603
+++ G+++ +LLT
Sbjct: 254 MWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 60/252 (23%), Positives = 98/252 (38%), Gaps = 45/252 (17%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
+G G +G V T F A+K L+ L++ +V + +L L P
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALK------KDVVLEDDDVECTMVERRVLALAWEHP 56
Query: 469 ------------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALA 513
+H V EY+ G L + F+ R A E+ L
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR------FDEARARFYAAEIICGLQ 110
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
FLH K II+RD+K N+LLD + KI D G+ N + ++T+ GT
Sbjct: 111 FLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKASTF-----CGTPD 161
Query: 574 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633
YI PE + + D +++G+++ ++L + DED L + +
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-------HGEDEDELFDSILNDRPH 214
Query: 634 WPIKETKELAAL 645
+P +KE
Sbjct: 215 FPRWISKEAKDC 226
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 41/154 (26%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLLGA 466
IG G +G V+ T V + + QN K+ +EL++L +H ++L L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 467 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPI 523
P Y+ ++ L++ +P + ++ +++ L +LH+ I
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---I 124
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557
+HRD+KPGN+L++ N V KI D GL+ + D S
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 295 AQNEANDASRKVNDLNKCKLE---EETRLSEIQLLEEKAIELAKQEKKKYETARREAECA 351
+ A A+++ K E + Q E KA A+ EKK E A+++AE
Sbjct: 96 QRAAAEKAAKQAEQAAKQAEEKQKQAEEAKAKQAAEAKAKAEAEAEKKAKEEAKKQAEEE 155
Query: 352 RASAEKEAAQRQEAEMKAKHEAKEKE 377
+ A+++ AE K K EA+ K
Sbjct: 156 AKAKAAAEAKKKAAEAKKKAEAEAKA 181
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 18/100 (18%)
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
L ++H+ ++HRD+KP N+LL+ N KI D GL+ + F+ T Y V T
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEY-----VVT 171
Query: 572 LCYIDPEY-----QRTGLISPKSDVYAYGMVILQLLTAKP 606
Y PE + T I DV++ G + +LL KP
Sbjct: 172 RWYRAPELLLNCSEYTTAI----DVWSVGCIFAELLGRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHL 460
+ + ++G G YGTV T A V + + Q++ F +EL +L ++H ++
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 461 LLLLGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
+ LL PD LV +M G+ +L + RI + V L
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEK------LSEDRIQFLVYQML 128
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
L IIHRD+KPGN+ ++ + KI D GL+ +S+ TG V T
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---------MTGYVVTR 179
Query: 573 CYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y PE Y +T D+++ G ++ ++LT KP
Sbjct: 180 WYRAPEVILNWMHYTQT------VDIWSVGCIMAEMLTGKP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 29/91 (31%), Positives = 43/91 (47%), Gaps = 22/91 (24%)
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 578
IIHRD+KP NI ++ + KI D GL+ + + TG V T Y PE
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDD---------EMTGYVATRWYRAPEIMLN 189
Query: 579 ---YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y +T D+++ G ++ +LLT K
Sbjct: 190 WMHYNQT------VDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
+++VA + FL + K IHRD+ NILL N V KI D GL+ + DP +V +
Sbjct: 185 SFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----R 237
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL--LTAKPAIAITHKVETAIDEDN 622
L ++ PE + + +SDV+++G+++ ++ L A P + IDE+
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEF 291
Query: 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664
+ + P T E+ L C RP V
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 57/271 (21%), Positives = 112/271 (41%), Gaps = 28/271 (10%)
Query: 411 IGMGGYGTVYKGTF-----HHTFAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
+G G +G + +G A+ L+ + Q + FL E L + H +++ L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G + V EYM NG+L+ L + + + + +AS + +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLASGMKYLSEMG--- 127
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+H+ + +L++ +LV KI G + + TT PV + PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKIS--GFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQY 182
Query: 583 GLISPKSDVYAYGMVILQLLT--AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640
S SDV+++G+V+ ++++ +P ++ +D + + D P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDGFRLPAPRNCPN 235
Query: 641 ELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
L L L C + R +RP +Q+ +L ++
Sbjct: 236 LLHQLMLDCWQKERGERPRF-SQIHSILSKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLLL 464
++G G Y TV+KG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLH 69
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 521
CL V+EY+++ D +N + +I +++ L++ H K
Sbjct: 70 DIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--Y 579
I+HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 124 -ILHRDLKPQNLLINEKGELKLADFGLARA----KSVPTKTYSNE--VVTLWYRPPDVLL 176
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
T +P D++ G ++ ++ T +P
Sbjct: 177 GSTEYSTP-IDMWGVGCILYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 411 IGMGGYGTVYKGTF---HHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLL 464
+G G +G V T+ A+K + I+ KQ E ++L+ I HP + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAWEVASALAFLHNTKPK 521
G+ D L V E++ G L R P + F A ++ +L +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF----YAAQIVLIFEYLQSLN-- 151
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YIDP 577
I++RD+KP N+LLD + K+ D G + +++ + TY TLC YI P
Sbjct: 152 -IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD------TRTY-------TLCGTPEYIAP 197
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKP 606
E +D + G+ I ++L P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 35/130 (26%), Positives = 64/130 (49%), Gaps = 15/130 (11%)
Query: 490 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
++ P+ + R + +VA + FL K IHRD+ N+LL V+KI D GL+
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 550 TMLNSDPSFVSTTYKNTG--PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQL----LT 603
+ +D ++V K PV ++ PE + + +SDV++YG+++ ++ +
Sbjct: 260 RDIMNDSNYV---VKGNARLPVK---WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
Query: 604 AKPAIAITHK 613
P I + K
Sbjct: 314 PYPGILVNSK 323
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 50/204 (24%), Positives = 81/204 (39%), Gaps = 29/204 (14%)
Query: 414 GGYGTVYKGTFHHTFAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG 471
+ K +T AVK L S K QE+ +++HP++L + +
Sbjct: 13 LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72
Query: 472 CL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKPIIHR 526
L V M GS ED L K + P IA+ +V +AL ++H+ K IHR
Sbjct: 73 ELYVVSPLMAYGSCEDLL--KTHFPE--GLPELAIAFILKDVLNALDYIHS---KGFIHR 125
Query: 527 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG-------TLCYIDPE- 578
+K +ILL + + GL + S + + L ++ PE
Sbjct: 126 SVKASHILLSGDGKVVLS--GLRYSV----SMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 579 -YQRTGLISPKSDVYAYGMVILQL 601
Q + KSD+Y+ G+ +L
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 31/93 (33%), Positives = 40/93 (43%), Gaps = 7/93 (7%)
Query: 293 AIAQNEAN-DASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECA 351
A+ +A +A K K K E + +E E KA AK K K E A+ +AE A
Sbjct: 146 EEAKKQAEEEAKAKAAAEAKKKAAEAKKKAEA---EAKAKAEAK-AKAKAEEAKAKAEAA 201
Query: 352 RASAEKEAAQ--RQEAEMKAKHEAKEKEMLERA 382
+A A EAA EA A EA+ K
Sbjct: 202 KAKAAAEAAAKAEAEAAAAAAAEAERKADEAEL 234
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 42/311 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLS-KIRHPHL--LL 462
+G G +G V+ T F A+K L+ + + + E VLS HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 463 LLGACPDHGCLVYEYMENGSLEDRLY--RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
++ V EY+ G L + K + P ++ A E+ L FLH+
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY-----AAEIICGLQFLHS--- 114
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
K I++RD+K NILLD + KI D G+ ML K GT YI PE
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--------KTCTFCGTPDYIAPE 166
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL---DAQAGDWP 635
+ D +++G+++ ++L + DE+ L + + + W
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH-------GHDEEELFQSIRMDNPCYPRWL 219
Query: 636 IKETKE-LAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFI 694
+E K+ L L + E R + D++ P + A R+ P P +
Sbjct: 220 TREAKDILVKLFVREPERRLGVKGDIRQH--PFFREIDWSALEEREIEPPFKPKVKSAND 277
Query: 695 CPIL-KEVMNE 704
C KE +NE
Sbjct: 278 CSNFDKEFLNE 288
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 28/158 (17%)
Query: 457 HPHLLLLLGACPDHGC--------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWE 507
HP L+ L H C V E++ G L + R+ P E R + E
Sbjct: 55 HPFLVGL------HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPE----EHARFYSAE 104
Query: 508 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 567
++ AL FLH + II+RD+K N+LLD K+ D G+ P ++T+
Sbjct: 105 ISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTF---- 156
Query: 568 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
GT YI PE R D +A G+++ +++ +
Sbjct: 157 -CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 39/135 (28%), Positives = 62/135 (45%), Gaps = 15/135 (11%)
Query: 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 532
LV +Y G L L + + P R+ +A E+ A+ +H +HRD+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLP-EDMARFYLA-EMVLAIDSVHQLG---YVHRDIKPDN 132
Query: 533 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISP 587
+LLD N ++ D G L +D + S VGT YI PE + G P
Sbjct: 133 VLLDKNGHIRLADFGSCLRLLADGTVQSNV-----AVGTPDYISPEILQAMEDGKGRYGP 187
Query: 588 KSDVYAYGMVILQLL 602
+ D ++ G+ + ++L
Sbjct: 188 ECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 411 IGMGGYGTVYKGTFH---HTFA----AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 462
+G G +G V + T H H+ + AVK+L+S KQ + EL+++S + PHL +
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHL-GPHLNI 103
Query: 463 --LLGACPDHG--CLVYEYMENGSLEDRLYRKNNT 493
LLGAC G ++ EY G L D L+R +T
Sbjct: 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHT 138
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 31/115 (26%), Positives = 55/115 (47%), Gaps = 10/115 (8%)
Query: 488 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547
Y + P+P + I ++ L +LH + IIHRD+K NI ++ IGD+G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLG 202
Query: 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLL 602
+ P+F+ G GT+ PE + K+D+++ G+V+ ++L
Sbjct: 203 AAQFPVVAPAFL-------GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 16/148 (10%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKV----LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YGTV+K T V + L L+E+ +L +++H +++ L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 466 ACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
H LV+EY + L+ N + + +++ LAF H+
Sbjct: 67 VL--HSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSF--MFQLLKGLAFCHSHN-- 119
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLS 549
++HRD+KP N+L++ N K+ D GL+
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 7/85 (8%)
Query: 295 AQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYET--ARREAECAR 352
Q +A +A K K K E E + +E+A + A++E K A+++A A+
Sbjct: 117 KQKQAEEAKAKQAAEAKAKAEAE----AEKKAKEEAKKQAEEEAKAKAAAEAKKKAAEAK 172
Query: 353 ASAEKEAAQRQEAEMKAKHE-AKEK 376
AE EA + EA+ KAK E AK K
Sbjct: 173 KKAEAEAKAKAEAKAKAKAEEAKAK 197
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 43/203 (21%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 409 LRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
++IG G G V H+ AVK++ + + + E+ ++ +H +++ + +
Sbjct: 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 467 --CPDHGCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
+ ++ E+++ G+L D + + + N I + V AL +LH+ + +
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQALCYLHS---QGV 138
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
IHRD+K +ILL + K+ D G ++ D K VGT ++ PE
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKSLVGTPYWMAPEVISRT 192
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
+ D+++ G+++++++ +P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 48/178 (26%), Positives = 71/178 (39%), Gaps = 22/178 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 465
IG G +G VY+ T A+KVL K + K+ + E +L + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 466 -----ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
LV +YM G L L ++ F R + +A + L +
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR------FSEDRAKFYIAELVLALEHLHK 114
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I++RD+KP NILLD + D GLS + NT GT Y+ PE
Sbjct: 115 YDIVYRDLKPENILLDATGHIALCDFGLSK-----ANLTDNKTTNTF-CGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 59/258 (22%), Positives = 102/258 (39%), Gaps = 29/258 (11%)
Query: 401 ATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNI-----QNKQFLQELE 450
A+L+ R G+ G TF FA + ++ ++ Q E
Sbjct: 77 ASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDN-KTCEHVVIKAGQRGGTATEAH 135
Query: 451 VLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV 508
+L I HP ++ L G + CL+ + L L K N I + I V
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRN---IAICDILAIERSV 191
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
A+ +LH + IIHRD+K NI ++H +GD G + P + K G
Sbjct: 192 LRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF----PVDI-NANKYYGW 243
Query: 569 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628
GT+ PE P D+++ G+V+ ++ T ++ ++ D D +++
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303
Query: 629 AQAG----DWPIKETKEL 642
++G ++PI L
Sbjct: 304 RRSGTHPNEFPIDAQANL 321
|
Length = 391 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 31/211 (14%)
Query: 411 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLL 461
+G G YG V+ K + H + A+KVL+ +Q + + E +VL IR L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 462 LLLGACPDHGC---LVYEYMENGSLEDRLYRKNNTPPIPWFERYRI---AWEVASALAFL 515
+ L L+ +Y+ G L L ++ F+ + + E+ AL L
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRER------FKEQEVQIYSGEIVLALEHL 121
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H II+RD+K NILLD N + D GLS + D + ++ GT+ Y+
Sbjct: 122 HKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF-----CGTIEYM 173
Query: 576 DPEYQRTGLISPKS--DVYAYGMVILQLLTA 604
P+ R G D ++ G+++ +LLT
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLLL 464
++G G Y TVYKG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 465 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
LV+EY++ + + Y + I +++ L + H K
Sbjct: 71 DIIHTEKSLTLVFEYLDK---DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--- 124
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
++HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARA----KSIPTKTYSNE--VVTLWYRPPDILLG 178
Query: 583 GL-ISPKSDVYAYGMVILQLLTAKP 606
S + D++ G + ++ T +P
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 24/206 (11%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLLL- 463
++G G Y TV+KG T V + + + +++++ ++E+ +L ++H +++ L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 464 -LGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPK 521
+ LV+EY++ +D ++ I +I +++ LA+ H K
Sbjct: 71 DIVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK-- 124
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
++HRD+KP N+L++ K+ D GL+ S + TY N V TL Y P+
Sbjct: 125 -VLHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTYSNE--VVTLWYRPPDVLL 177
Query: 582 -TGLISPKSDVYAYGMVILQLLTAKP 606
+ S + D++ G + ++ + +P
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGRP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLLL 464
IG G +G V + T A+K ++ K +I ++ L E VL+++ P ++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIR-KAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ P+ LV ++ G L L R+ F+ R + A L L N
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGR------FDLSRARFYTAELLCALENLHKFN 113
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+I+RD+KP NILLD+ + D GL LN + T+ GT Y+ PE
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTF-----CGTPEYLAPELLLG 167
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
+ D + G+++ ++LT P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 15/149 (10%)
Query: 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 532
LV +Y G L L + + P R+ +A E+ A+ +H +HRD+KP N
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPED-MARFYLA-EMVIAIDSVHQLH---YVHRDIKPDN 132
Query: 533 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISP 587
IL+D N ++ D G L D T +++ VGT YI PE + G P
Sbjct: 133 ILMDMNGHIRLADFGSCLKLMED-----GTVQSSVAVGTPDYISPEILQAMEDGKGKYGP 187
Query: 588 KSDVYAYGMVILQLLTAKPAIAITHKVET 616
+ D ++ G+ + ++L + VET
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS--TTY 563
++VA + FL + K +HRD+ N+LL + KI D GL+ + D ++VS +T+
Sbjct: 244 YQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PV ++ PE L + SDV++YG+++ ++ +
Sbjct: 301 L---PVK---WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 52/221 (23%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 462
++G G Y TVYKG T A+K ++ +++++ ++E +L ++H +++
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIR----LEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 463 LLGACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALA 513
L H LV+EY++ D ++ R+ +++ LA
Sbjct: 68 L------HDIIHTKKTLTLVFEYLDT----DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
+ H + ++HRD+KP N+L+ K+ D GL+ S S TY N V TL
Sbjct: 118 YCHQRR---VLHRDLKPQNLLISERGELKLADFGLARA----KSVPSKTYSNE--VVTLW 168
Query: 574 YIDP-------EYQRTGLISPKSDVYAYGMVILQLLTAKPA 607
Y P EY S D++ G + ++ T +P
Sbjct: 169 YRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGRPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 3e-04
Identities = 17/68 (25%), Positives = 31/68 (45%), Gaps = 1/68 (1%)
Query: 27 RDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKL 86
AA + + + LL R A+ V+VE V+E D A+AI + + +
Sbjct: 39 PPSSAAELAELLEEEARALLEALREALAEAGVKVETVVLE-GDPAEAILEAAEELGADLI 97
Query: 87 VIGAQSQG 94
V+G++ +
Sbjct: 98 VMGSRGRS 105
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 29/115 (25%), Positives = 62/115 (53%), Gaps = 11/115 (9%)
Query: 491 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550
N +P + + + +++VA+ + FL + K +HRD+ N+L+ + KI D GL+
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLAR 287
Query: 551 MLNSDPSFVS--TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
+ D +++S +T+ L ++ PE L + SDV+++G+++ ++ T
Sbjct: 288 DIMRDSNYISKGSTFL------PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 443 KQFLQELEVLSKIRHPHLLL--LLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPW 498
+E+ +L + L + +L + G L+ E++E +L++
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SE 85
Query: 499 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536
E+ IA ++A LA LH + H D+ PGNIL+D
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 404 SFSENLRIGMGGYGTVYKGT--FHHTFAAVKVLQSKGNIQNKQF--LQELEVLSKIRHPH 459
S+ + ++G G Y TVYKG + A+KV++ + + F ++E +L ++H +
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHAN 64
Query: 460 LLLL--LGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
++LL + + LV+EY+ + Y + + +++ L+++H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQ---YMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+ I+HRD+KP N+L+ K+ D GL+ S S TY N V TL Y P
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLARA----KSVPSHTYSNE--VVTLWYRPP 172
Query: 578 E 578
+
Sbjct: 173 D 173
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 5e-04
Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 1/74 (1%)
Query: 304 RKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQ 363
+K ++ K K EE + E + E+A + A KKK E A++ AE A+A AE A + +
Sbjct: 1302 KKADEAKK-KAEEAKKADEAKKKAEEAKKKADAAKKKAEEAKKAAEAAKAEAEAAADEAE 1360
Query: 364 EAEMKAKHEAKEKE 377
AE KA+ K+KE
Sbjct: 1361 AAEEKAEAAEKKKE 1374
|
Length = 2084 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 27/75 (36%), Positives = 39/75 (52%), Gaps = 3/75 (4%)
Query: 311 KCKLEEETRLSEIQL---LEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEM 367
+ K E+ RL+ + EE A + A ++K+ E A + A A+A AE EA + A
Sbjct: 102 RLKQLEKERLAAQEQKKQAEEAAKQAALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAK 161
Query: 368 KAKHEAKEKEMLERA 382
KA EAK+K E A
Sbjct: 162 KAAAEAKKKAEAEAA 176
|
Length = 387 |
| >gnl|CDD|190741 pfam03763, Remorin_C, Remorin, C-terminal region | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 6e-04
Identities = 25/67 (37%), Positives = 36/67 (53%), Gaps = 4/67 (5%)
Query: 308 DLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEM 367
+ K K E E + E +L ++KA K K K A ++AE RA+AE A+R E E
Sbjct: 37 NKKKAKAEAELKKIERKLEKKKAEAAEKL-KNKLAAAHKKAEEKRATAE---AKRGEEEA 92
Query: 368 KAKHEAK 374
KA+ +A
Sbjct: 93 KAEEKAA 99
|
Remorins are plant-specific plasma membrane-associated proteins. In tobacco remorin co-purifies with lipid rafts. Most remorins have a variable, proline-rich C-half and a more conserved N-half that is predicted to form coiled coils. Consistent with this, circular dichroism studies have demonstrated that much of the protein is alpha-helical. Remorins exist in plasma membrane preparations as oligomeric structures and form filaments in vitro. The proteins can bind polyanions including the extracellular matrix component oligogalacturonic acid (OGA). In vitro, remorin in plasma membrane preparations is phosphorylated (principally on threonine residues) in the presence of OGA and thus co-purifies with a protein kinases(s). The biological functions of remorins are unknown but roles as components of the membrane/cytoskeleton are possible. Length = 112 |
| >gnl|CDD|236545 PRK09510, tolA, cell envelope integrity inner membrane protein TolA; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 13/103 (12%)
Query: 293 AIAQNEANDASRKVNDLNKCKLEEETRLSEI---QLLEE-KAIELAKQEKKKYETARREA 348
A+ Q +A +A+ K K K E E + + + E K A+ KK A+++A
Sbjct: 128 ALKQKQAEEAAAKAAAAAKAKAEAEAKRAAAAAKKAAAEAKKKAEAEAAKKAAAEAKKKA 187
Query: 349 EC---------ARASAEKEAAQRQEAEMKAKHEAKEKEMLERA 382
E A+ AE EA ++ AE K K A+ K +A
Sbjct: 188 EAEAAAKAAAEAKKKAEAEAKKKAAAEAKKKAAAEAKAAAAKA 230
|
Length = 387 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 29/87 (33%), Positives = 40/87 (45%), Gaps = 14/87 (16%)
Query: 473 LVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLHNTKPKPIIHRDM 528
L+ EY+ G + L +K+ F R+ IA E A+ +H IHRD+
Sbjct: 78 LIMEYLPGGDMMTLLMKKDT------FTEEETRFYIA-ETILAIDSIHKLG---YIHRDI 127
Query: 529 KPGNILLDHNLVSKIGDVGLSTMLNSD 555
KP N+LLD K+ D GL T L
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKS 154
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 28/163 (17%)
Query: 457 HPHLLLLLGACPDHGCL--------VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWE 507
HP L+ L H C V EY+ G L + R+ P E R + E
Sbjct: 55 HPFLVGL------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAE 104
Query: 508 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 567
++ AL +LH + II+RD+K N+LLD K+ D G+ P ++T+
Sbjct: 105 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTF---- 156
Query: 568 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 610
GT YI PE R D +A G+++ +++ + I
Sbjct: 157 -CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 49/153 (32%), Positives = 74/153 (48%), Gaps = 27/153 (17%)
Query: 411 IGMGGYGTVY---KGTFHHTFAAVKVLQSKGNIQNK----QFLQELEVLSKIRHP---HL 460
I G +G VY K +A VKV++ K ++ NK Q E + L+ + P HL
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYA-VKVVK-KADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 461 LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFE----RYRIAWEVASALAFLH 516
L + ++ LV EY+ G ++ L+ +F+ I+ EVA AL +LH
Sbjct: 70 YYSLQSA-NNVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYIS-EVALALDYLH 121
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
IIHRD+KP N+L+ + K+ D GLS
Sbjct: 122 R---HGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|234017 TIGR02794, tolA_full, TolA protein | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 20/86 (23%), Positives = 40/86 (46%), Gaps = 5/86 (5%)
Query: 296 QNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASA 355
Q + A++K + K ++ + + E+ + +Q + A++ + A+ +
Sbjct: 56 QQQKKPAAKKEQERQKKLEQQAEEAEKQRAAEQARQKELEQRAAAEKAAKQAEQAAKQAE 115
Query: 356 EK-----EAAQRQEAEMKAKHEAKEK 376
EK EA +Q AE KAK EA+ +
Sbjct: 116 EKQKQAEEAKAKQAAEAKAKAEAEAE 141
|
TolA couples the inner membrane complex of itself with TolQ and TolR to the outer membrane complex of TolB and OprL (also called Pal). Most of the length of the protein consists of low-complexity sequence that may differ in both length and composition from one species to another, complicating efforts to discriminate TolA (the most divergent gene in the tol-pal system) from paralogs such as TonB. Selection of members of the seed alignment and criteria for setting scoring cutoffs are based largely conserved operon struction. //The Tol-Pal complex is required for maintaining outer membrane integrity. Also involved in transport (uptake) of colicins and filamentous DNA, and implicated in pathogenesis. Transport is energized by the proton motive force. TolA is an inner membrane protein that interacts with periplasmic TolB and with outer membrane porins ompC, phoE and lamB [Transport and binding proteins, Other, Cellular processes, Pathogenesis]. Length = 346 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (97), Expect = 0.002
Identities = 28/84 (33%), Positives = 48/84 (57%), Gaps = 1/84 (1%)
Query: 298 EANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEK 357
+A + +KV L K + EE+ + E++ EE+ A +E KK E +++AE A+ AE+
Sbjct: 1627 KAEEEKKKVEQLKKKEAEEKKKAEELKKAEEENKIKAAEEAKKAEEDKKKAEEAK-KAEE 1685
Query: 358 EAAQRQEAEMKAKHEAKEKEMLER 381
+ + EA K EAK+ E L++
Sbjct: 1686 DEKKAAEALKKEAEEAKKAEELKK 1709
|
Length = 2084 |
| >gnl|CDD|234750 PRK00409, PRK00409, recombination and DNA strand exchange inhibitor protein; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.002
Identities = 30/113 (26%), Positives = 49/113 (43%), Gaps = 26/113 (23%)
Query: 278 LEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQE 337
LE+L E + +A +A + + K K E LEEK +L ++E
Sbjct: 525 LEELERE----------LEQKAEEAEALLKEAEKLKEE----------LEEKKEKLQEEE 564
Query: 338 KKKYETARREAECARASAEKEAAQ----RQEAEMKAKHEAKEKEMLE--RALN 384
K E A +EA+ A A+KEA + ++ + K E++E + LN
Sbjct: 565 DKLLEEAEKEAQQAIKEAKKEADEIIKELRQLQKGGYASVKAHELIEARKRLN 617
|
Length = 782 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 36/264 (13%)
Query: 407 ENLR-IGMGGYGTV---YKGTFHHTFAAVKVLQS-KGNIQNKQFLQELEVLSKIRHPHLL 461
+NL+ IG G G V Y A K+ + + K+ +EL ++ + H +++
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPW-FERYRIAWEVASALAFLHNTKP 520
LL L E ++ L L N I + R+++ + L + +
Sbjct: 80 SLLNVFTPQKSL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
IIHRD+KP NI++ + KI D GL+ + SF+ T Y V T Y PE
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPY-----VVTRYYRAPEVI 190
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640
D+++ G ++ +++ K I ID+ N K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWN-----------------K 229
Query: 641 ELAALGLSCAELRRKDRPDLKNQV 664
+ LG C E +K +P ++N V
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYV 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 31/132 (23%), Positives = 61/132 (46%), Gaps = 19/132 (14%)
Query: 474 VYEYMENGSLE--DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPG 531
+Y +M + + + DR P+ R I ++ A+ ++H+ K +IHRD+K
Sbjct: 249 LYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLE 296
Query: 532 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDV 591
NI L+ + +GD G + + + G VGT+ PE +D+
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKE-----REAFDYGWVGTVATNSPEILAGDGYCEITDI 351
Query: 592 YAYGMVILQLLT 603
++ G+++L +L+
Sbjct: 352 WSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|225606 COG3064, TolA, Membrane protein involved in colicin uptake [Cell envelope biogenesis, outer membrane] | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 24/63 (38%), Positives = 35/63 (55%), Gaps = 2/63 (3%)
Query: 316 EETRLSEIQLLEEKAIELAKQEKKKYETARRE--AECARASAEKEAAQRQEAEMKAKHEA 373
E+ E + EE+A + A ++KKK E A+ + AE A+ A EA ++ E KA EA
Sbjct: 124 EKQAQLEQKQQEEQARKAAAEQKKKAEAAKAKAAAEAAKLKAAAEAKKKAEEAAKAAEEA 183
Query: 374 KEK 376
K K
Sbjct: 184 KAK 186
|
Length = 387 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 13/147 (8%)
Query: 411 IGMGGYGTV--YKGTFHHTFAAVKVLQSKGNIQNKQFLQ---ELEVLSKIRHPHLLLLLG 465
+G+G +G V H A+K L+ K + Q E ++L++ + ++ L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
+ D L V +Y+ G + L R P + R+ IA E+ A+ +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEV--LARFYIA-ELTLAIESVHKMG---F 122
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLST 550
IHRD+KP NIL+D + K+ D GL T
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173412 PTZ00121, PTZ00121, MAEBL; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.004
Identities = 27/86 (31%), Positives = 46/86 (53%), Gaps = 4/86 (4%)
Query: 295 AQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE--KAIELAK-QEKKKYETARREAECA 351
A+ +A +A +K ++ K E + + E + EE KA E K +E KK + A++ E
Sbjct: 1488 AKKKAEEAKKKADEAKK-AAEAKKKADEAKKAEEAKKADEAKKAEEAKKADEAKKAEEKK 1546
Query: 352 RASAEKEAAQRQEAEMKAKHEAKEKE 377
+A K+A + ++AE K K E +K
Sbjct: 1547 KADELKKAEELKKAEEKKKAEEAKKA 1572
|
Length = 2084 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 10/64 (15%)
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH+ IIHRD+KP NI++ + KI D GL+ + SF+ T Y V T Y
Sbjct: 134 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPY-----VVTRYY 183
Query: 575 IDPE 578
PE
Sbjct: 184 RAPE 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|227278 COG4942, COG4942, Membrane-bound metallopeptidase [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.004
Identities = 29/110 (26%), Positives = 40/110 (36%), Gaps = 9/110 (8%)
Query: 277 ELEKLRIELRHVRGMYAIAQNE---ANDASRKVNDLNKCKLEEETRL-----SEIQLLEE 328
L+ +L VR A Q E R LEE + SE+ ++
Sbjct: 165 ALKATLKQLAAVRAEIAAEQAELTTLLSEQRAQQAKLAQLLEERKKTLAQLNSELSADQK 224
Query: 329 KAIELAKQEKK-KYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKE 377
K EL E + K E A EA A+A AA+ A +A + E
Sbjct: 225 KLEELRANESRLKNEIASAEAAAAKAREAAAAAEAAAARARAAEAKRTGE 274
|
Length = 420 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 28/126 (22%), Positives = 44/126 (34%), Gaps = 10/126 (7%)
Query: 277 ELEKLRIELRHVRGMYAIAQNEANDASRKVN----DLNKCKLEEETRLSEIQLLE----- 327
L +LR EL + + E + SR+++ DL + + E E I L
Sbjct: 699 ALAELRKELEELEEELEQLRKELEELSRQISALRKDLARLEAEVEQLEERIAQLSKELTE 758
Query: 328 -EKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGT 386
E IE ++ ++ E EAE E + Q +E + E LN
Sbjct: 759 LEAEIEELEERLEEAEEELAEAEAEIEELEAQIEQLKEELKALREALDELRAELTLLNEE 818
Query: 387 FQRYRN 392
R
Sbjct: 819 AANLRE 824
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 757 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.12 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.11 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 98.89 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 98.84 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 98.82 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 98.67 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 98.67 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 98.55 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 98.53 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.48 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.43 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.42 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 98.4 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.39 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.3 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.27 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 98.19 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 98.07 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.01 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.85 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.71 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.55 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.52 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.37 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.32 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.31 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.1 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.93 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 96.69 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 96.65 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=447.94 Aligned_cols=274 Identities=43% Similarity=0.752 Sum_probs=236.0
Q ss_pred cccCCCHHHHHHhhcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccc
Q 004388 389 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467 (757)
Q Consensus 389 ~~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~ 467 (757)
..+.|++.++..||++|+..+.||+||||.||+|...+ +.||||.+.........+|.+|+++|.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999987 79999988765543145599999999999999999999999
Q ss_pred cCC---ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEe
Q 004388 468 PDH---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544 (757)
Q Consensus 468 ~~~---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~ 544 (757)
.+. .+||||||++|+|.++|+..... +++|..|++||.++|.||+|||...+++||||||||+|||||.++.+||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 754 58999999999999999876654 79999999999999999999999887899999999999999999999999
Q ss_pred eecCccccCC-CCCCccccccccCC-cccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccc---------cch
Q 004388 545 DVGLSTMLNS-DPSFVSTTYKNTGP-VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI---------THK 613 (757)
Q Consensus 545 DFGla~~~~~-~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~---------~~~ 613 (757)
|||+|+..+. .... ... .||.+|+||||..++.++.|+|||||||+|+||+||++|.+. ..+
T Consensus 220 DFGLa~~~~~~~~~~-------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV-------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCccccce-------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999976553 2111 111 799999999999999999999999999999999999988863 233
Q ss_pred hhhhhchhhHHHHhhhhcC--CCCh-hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 614 VETAIDEDNLAEILDAQAG--DWPI-KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~~~--~~p~-~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
....+..+.+.+++|+... .++. .....+..++.+|++.+|++||+|.+ |+..|+.+
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~-Vv~~L~~~ 352 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ-VVKELEGI 352 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH-HHHHHHhh
Confidence 3455666788999999863 5554 57888999999999999999999985 66666444
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=403.18 Aligned_cols=251 Identities=33% Similarity=0.525 Sum_probs=211.1
Q ss_pred ceeeccCCcEEEEEEEECCeE-EEEEEEccCCchh--hHHHHHHHHHHHhcCCCceeeecccccCC---ceEEEEecCCC
Q 004388 408 NLRIGMGGYGTVYKGTFHHTF-AAVKVLQSKGNIQ--NKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYMENG 481 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~-vAvK~l~~~~~~~--~~~f~~Ev~il~~l~Hpniv~l~g~~~~~---~~LV~Ey~~~g 481 (757)
...||.|+||+||+|.++++. ||||++....... .+.|.+|+.+|.+++|||||+|+|+|.+. .+||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 345999999999999999998 9999997653222 56899999999999999999999999775 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCccccCCCCCCcc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~~~~~~~~~ 560 (757)
+|.++|+.. ....+++..+++|+.|||.||.|||+.+| ||||||||+||||+.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---- 198 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---- 198 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence 999999875 34569999999999999999999999885 99999999999999998 99999999998765431
Q ss_pred ccccccCCcccccCCCccccc--cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH-hhhhcCCCChh
Q 004388 561 TTYKNTGPVGTLCYIDPEYQR--TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI-LDAQAGDWPIK 637 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~-ld~~~~~~p~~ 637 (757)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||...+....+ ..+ ........|..
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~------~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA------SAVVVGGLRPPIPKE 270 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhcCCCCCCCcc
Confidence 2234578999999999999 568999999999999999999999999755442211 111 12233455666
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.+..+..|+.+||..+|..||++. +++..|+.+...
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~-ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFL-EIVSRLESIMSH 306 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHH-HHHHHHHHHHHh
Confidence 889999999999999999999998 577777777653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=377.32 Aligned_cols=240 Identities=31% Similarity=0.401 Sum_probs=201.0
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC---ceEEEEecCCC
Q 004388 408 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCLVYEYMENG 481 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~---~~LV~Ey~~~g 481 (757)
...||+|..|+|||+.++ +..+|+|++.... ....+++.+|++|+..++|||||.+||+|... .+|+||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 346999999999999997 5699999996543 44567899999999999999999999998543 47999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
||++++...+ .+++....+|+.+|++||.|||. .+ ||||||||+||||+..|.+||||||.++.+.+.
T Consensus 164 SLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----- 232 (364)
T KOG0581|consen 164 SLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----- 232 (364)
T ss_pred CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-----
Confidence 9999987653 48999999999999999999996 66 999999999999999999999999999887654
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh-HH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK-ET 639 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~-~~ 639 (757)
...+.+||..|||||.+.+..|+.++||||||++++||.+|+.||......... -...+..+++...+..|.. .+
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-~~~Ll~~Iv~~ppP~lP~~~fS 308 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-IFELLCAIVDEPPPRLPEGEFS 308 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-HHHHHHHHhcCCCCCCCcccCC
Confidence 225679999999999999999999999999999999999999999654110000 1123334444444555665 88
Q ss_pred HHHHHHHHHHhhccCCCCCccch
Q 004388 640 KELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+++..++..||+.||.+||++.+
T Consensus 309 ~ef~~FV~~CL~Kdp~~R~s~~q 331 (364)
T KOG0581|consen 309 PEFRSFVSCCLRKDPSERPSAKQ 331 (364)
T ss_pred HHHHHHHHHHhcCCcccCCCHHH
Confidence 99999999999999999999985
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=386.39 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=206.0
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccC---CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
..|...+.||+|||+.||.+++ .+..||+|++... .....+...+||+|.+.|.|||||+|+++|.|.. |||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588889999999999999998 3669999998764 2345677899999999999999999999998765 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|+|.+|+|..++.+. .++++.++..++.||+.||.|||+++ |||||||..||||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999988643 36999999999999999999999998 999999999999999999999999999988754
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. +..+.||||.|+|||++....++..+||||+|||||-||+|+|||.... ++. .+. .+....-..|
T Consensus 172 ~E------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-vke-----ty~-~Ik~~~Y~~P 238 (592)
T KOG0575|consen 172 GE------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-VKE-----TYN-KIKLNEYSMP 238 (592)
T ss_pred cc------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-HHH-----HHH-HHHhcCcccc
Confidence 32 3355799999999999999899999999999999999999999996332 111 111 1112223356
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
...+.+.++||.++|+.+|.+||++.+++
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL 267 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVL 267 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 67888999999999999999999998644
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=371.19 Aligned_cols=241 Identities=30% Similarity=0.477 Sum_probs=195.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
..+|....+||.|+||+||+|+++ ++.||||.+... .....+.+..|+.+|+.|+|||||.|++++.... ||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 346778888999999999999985 569999998766 3344566789999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC------CceEEeeecCc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN------LVSKIGDVGLS 549 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~------~~~KL~DFGla 549 (757)
|||.||+|.++|.+.+ .++..+...++.|||.||.+||.++ ||||||||.||||+.+ -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999998876 3889999999999999999999998 9999999999999764 46899999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
+.+.+.. .....+|+|.|||||++..++|+.|+|+||+|+|||+|+||++||......+-.. .+..
T Consensus 163 R~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-------~~~k 228 (429)
T KOG0595|consen 163 RFLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL-------YIKK 228 (429)
T ss_pred hhCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-------HHhc
Confidence 9987432 2345799999999999999999999999999999999999999997443322211 1111
Q ss_pred h---cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 Q---AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 ~---~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ....+......+.+|+...+..++.+|-++.+
T Consensus 229 ~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 229 GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred cccccCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 1 12223344555667777788888877776653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=367.16 Aligned_cols=240 Identities=27% Similarity=0.315 Sum_probs=201.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|...+.||+|+||.||.++.. ++.+|+|++++.... ..+....|..||.+++||+||.|+..|++.. |||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457999999999999999999875 459999999876433 3456788999999999999999999998765 999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
+||+.||.|...|.+.+. +++..+.-++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||||+..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999987664 788888889999999999999988 99999999999999999999999999986543
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ...+.+||+.|||||++....|+..+|+|||||++||||||.+||...+... ....++.......
T Consensus 178 ~~~------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k~~~~ 245 (357)
T KOG0598|consen 178 DGD------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGKLPLP 245 (357)
T ss_pred CCC------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCcCCCC
Confidence 322 1234799999999999999999999999999999999999999997544221 1222333323344
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCc
Q 004388 635 PIKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
|.-.+.+..+++.+.+..+|++|-.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhcC
Confidence 4457889999999999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=355.74 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=202.7
Q ss_pred CCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeeccc-ccCC---ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGA-CPDH---GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~-~~~~---~~LV~ 475 (757)
+|.+..+||+|.||.||++.. ++..+|.|.++... ....+....|+.+|++|+|||||++++. +.+. .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 467778899999999999875 57799999887553 3345668899999999999999999994 4333 37999
Q ss_pred EecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC-CCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 476 EYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKP-KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 476 Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~-~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|||.+|+|...+.. +....-+++..+++++.|++.||..+|+.-| ..|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999998875 2334568999999999999999999999432 249999999999999999999999999999987
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 632 (757)
.... ..+..+|||.||+||.+....|+.+|||||+||++|||+.-++||...+..+ +..-+... .+
T Consensus 180 s~~t------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qgd~~ 246 (375)
T KOG0591|consen 180 SKTT------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQGDYP 246 (375)
T ss_pred chhH------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcCCCC
Confidence 6443 2356799999999999999999999999999999999999999997553221 11122211 12
Q ss_pred CCC-hhHHHHHHHHHHHHhhccCCCCCccchhhhh
Q 004388 633 DWP-IKETKELAALGLSCAELRRKDRPDLKNQVLP 666 (757)
Q Consensus 633 ~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~ 666 (757)
..| .-++..|..|+..|+..||..||+....|..
T Consensus 247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d 281 (375)
T KOG0591|consen 247 PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD 281 (375)
T ss_pred CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence 223 5679999999999999999999996543333
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=363.53 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=192.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchh-------hHHHHHHHHHHHhcCCCceeeecccccC--Cc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ-------NKQFLQELEVLSKIRHPHLLLLLGACPD--HG 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~-------~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~ 471 (757)
+.|-..+.||.|+||.|-+|... +..||||+++...... .....+|++||++|+|||||+++++|.. ..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 35667788999999999999876 4599999997653222 2235799999999999999999999954 44
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---CceEEeeecC
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGL 548 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~---~~~KL~DFGl 548 (757)
|||||||+||.|.+.+..++. +....-.-++.|++.||.|||+.| |+||||||+|||+..+ ..+||+|||+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 899999999999999976553 555566779999999999999998 9999999999999765 8899999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCC---CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHH
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL---ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
|+..... + .+.+.||||.|.|||++.++. +..++|+||+||+||-+|+|.+||..... ...+.+
T Consensus 326 AK~~g~~-s------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~------~~sl~e 392 (475)
T KOG0615|consen 326 AKVSGEG-S------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT------DPSLKE 392 (475)
T ss_pred hhccccc-e------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC------CccHHH
Confidence 9987632 2 346679999999999997664 34588999999999999999999963211 111122
Q ss_pred -HhhhhcCCCC---hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 626 -ILDAQAGDWP---IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 626 -~ld~~~~~~p---~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
++.......| ...+.+..+||.+||..||+.||++.+.
T Consensus 393 QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 393 QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 2222212222 2467889999999999999999999863
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=373.26 Aligned_cols=249 Identities=29% Similarity=0.464 Sum_probs=205.1
Q ss_pred ccceeeccCCcEEEEEEEECCe-EEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCC
Q 004388 406 SENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~~~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
...+.||+|-||.||.|.++++ .||+|.++... ...+.|.+|++||++|+|+|||+|+|+|.... |||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3456799999999999999977 99999998763 34577999999999999999999999997644 99999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~ 562 (757)
|.++|.. .....+.....+.++.|||.|++||++++ +|||||-..||||++++.+||+|||||+...++. +.
T Consensus 288 Ll~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~-Y~--- 359 (468)
T KOG0197|consen 288 LLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE-YT--- 359 (468)
T ss_pred HHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc-ee---
Confidence 9999986 23345888899999999999999999998 9999999999999999999999999999544332 11
Q ss_pred ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
...+..-...|.|||.+..+.++.+||||||||+||||+| |+.|+......+ .+..+-.......|..++..
T Consensus 360 -~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~GyRlp~P~~CP~~ 432 (468)
T KOG0197|consen 360 -ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLERGYRLPRPEGCPDE 432 (468)
T ss_pred -ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhccCcCCCCCCCCHH
Confidence 1123344667999999999999999999999999999998 888876443221 12222223345678889999
Q ss_pred HHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 642 LAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+.+|+..||+.+|++|||+. .+...|+.+
T Consensus 433 vY~lM~~CW~~~P~~RPtF~-~L~~~l~~~ 461 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFE-TLREVLEDF 461 (468)
T ss_pred HHHHHHHHhhCCcccCCCHH-HHHHHHHHh
Confidence 99999999999999999998 455555544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.29 Aligned_cols=246 Identities=28% Similarity=0.356 Sum_probs=207.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV 474 (757)
.+|.....||.|+|++||+|+.. ++.||||++.+.... ..+-+..|-++|.+| .||.|++||..|+|.. |+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 46777888999999999999886 459999999765432 223467899999999 8999999999998865 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
+||++||+|.++|.+.+. |+......++.+|+.||+|||++| ||||||||+|||||.||++||+|||.|+.+++
T Consensus 153 Le~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999987764 788888889999999999999998 99999999999999999999999999999875
Q ss_pred CCCC-------ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 555 DPSF-------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 555 ~~~~-------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
.... .........++||..|.+||++..+..++.+|+|+||||||+|+.|+|||...+.. .+.+-+
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------liFqkI 299 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------LIFQKI 299 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------HHHHHH
Confidence 4322 11222235689999999999999999999999999999999999999999654332 222333
Q ss_pred hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 628 d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
....-.||...++.+.+|+.+.|..||.+|++..
T Consensus 300 ~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 300 QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred HHhcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 3344567888889999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.40 Aligned_cols=247 Identities=25% Similarity=0.307 Sum_probs=197.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchh---hHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
..++|.....||+|+||.||+|+-+ |..+|+|++++..... ......|-.+|...++|+||+||..|++.. ||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4557888889999999999999875 4599999998765443 345678999999999999999999998765 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||++||++..+|.+.+ .|+......++.+++.|+..||+.| +|||||||+|+|||..|++||+|||||..+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998765 4888888999999999999999998 9999999999999999999999999996443
Q ss_pred CCC---------------------CCcc--cc------------------ccccCCcccccCCCccccccCCCCCcchhh
Q 004388 554 SDP---------------------SFVS--TT------------------YKNTGPVGTLCYIDPEYQRTGLISPKSDVY 592 (757)
Q Consensus 554 ~~~---------------------~~~~--~~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvw 592 (757)
... .... +. ......+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 200 0000 00 001124899999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh--hHHHHHHHHHHHHhhccCCCCCc
Q 004388 593 AYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI--KETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 593 SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~--~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
|||||+||||.|.|||......+..-..-++...+ .+|. ..+.+..+||.+||. ||.+|-.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-----~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-----KFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-----cCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999997655443322212222111 2232 346889999999999 9999977
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=337.36 Aligned_cols=233 Identities=26% Similarity=0.363 Sum_probs=201.5
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchh---hHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.+|...+.||.|+||.|.+++.+ +..+|+|++....... .+...+|..+|+.+.||++++|++.|.+.. +|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46788889999999999999886 4599999998765443 345678999999999999999999998765 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||.|..+|.+.+. ++.....-++.||+.||+|||+.+ |++|||||+|||||.+|++||+|||+|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999976553 888899999999999999999998 999999999999999999999999999987653
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.-..||||.|+|||.+....|+.++|+|||||++|||+.|.+||...... .....++. ..-.+|
T Consensus 198 ---------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~~-~~v~fP 261 (355)
T KOG0616|consen 198 ---------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKILE-GKVKFP 261 (355)
T ss_pred ---------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHHh-CcccCC
Confidence 23569999999999999999999999999999999999999999755432 22333333 334577
Q ss_pred hhHHHHHHHHHHHHhhccCCCC
Q 004388 636 IKETKELAALGLSCAELRRKDR 657 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~R 657 (757)
.-.+..+.+|+...++.|-..|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 7888999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=353.85 Aligned_cols=249 Identities=27% Similarity=0.426 Sum_probs=200.9
Q ss_pred cCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeeccc--ccCC--ceEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA--CPDH--GCLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~--~~~~--~~LV~E 476 (757)
.++...+.||+|+||.||++...+ ...|||..........+.+.+|+.+|++++|||||+++|. ..+. .++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 346667789999999999999875 7999998776533335668999999999999999999996 3443 479999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecCccccCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGla~~~~~~ 555 (757)
|+++|||.+++.+.+. .++...+.++..||+.||.|||+++ ||||||||+||||+. +|.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999987664 5999999999999999999999988 999999999999999 799999999999876631
Q ss_pred CCCccccccccCCcccccCCCccccccCC-CCCcchhhhHHHHHHHHHhCCCCcccc-chhhhhhchhhHHHHhhhhcCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAIT-HKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~-~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
. ..........||+.|||||++..+. ..+++|||||||+++||+||++||... ..... .+........+.
T Consensus 172 ~---~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~-----~~~ig~~~~~P~ 243 (313)
T KOG0198|consen 172 G---TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA-----LLLIGREDSLPE 243 (313)
T ss_pred c---ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH-----HHHHhccCCCCC
Confidence 1 1111234568999999999998643 345999999999999999999999642 11111 111111223456
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+|...+.+..+++.+|+..+|..|||+.+.+
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL 274 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELL 274 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 7778899999999999999999999998633
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=338.19 Aligned_cols=248 Identities=26% Similarity=0.368 Sum_probs=195.8
Q ss_pred CCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.|+...++|+|+||.||+++++. ..||||++.... ....+-.++|+.+|++|+|||+|.|+.+|.... +||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 45666789999999999999864 599999987543 234455789999999999999999999997654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|+..=| +.|.+..+ .++...+..+++|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+.....
T Consensus 83 ~dhTvL-~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVL-HELERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHH-HHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 987544 44655444 4888899999999999999999998 99999999999999999999999999999884332
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch----h----hHHHHhh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE----D----NLAEILD 628 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~----~l~~~ld 628 (757)
. .|..+.|.+|.|||.+.+ ..|+..+||||+||++.||+||.+-|.....++..+.. | ...+++.
T Consensus 157 ~------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 N------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred h------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 1 255689999999998877 68999999999999999999999999876666554321 1 1111111
Q ss_pred hh-------cCC----CC-----hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 629 AQ-------AGD----WP-----IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 629 ~~-------~~~----~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.. .+. .| +..+.-+.+|+..|+++||.+|++-.+.
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence 10 000 01 1335578999999999999999997753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=356.35 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=201.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCC--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH-- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~-- 470 (757)
.++|...++||.|+||.||+|.+. +..||||++..... .....+.+|+.+|.++ +||||++++|+|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 456888899999999999999752 24799999875432 2345689999999999 899999999988643
Q ss_pred -ceEEEEecCCCCHHHHHhhcCC---------------------------------------------------------
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNN--------------------------------------------------------- 492 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~--------------------------------------------------------- 492 (757)
.++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 3789999999999999875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcc
Q 004388 493 --TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 570 (757)
Q Consensus 493 --~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~g 570 (757)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....... ......+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~----~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchh----cccCCCC
Confidence 135788899999999999999999987 9999999999999999999999999998654332111 1123356
Q ss_pred cccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHH
Q 004388 571 TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSC 649 (757)
Q Consensus 571 t~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~C 649 (757)
++.|+|||++.+..++.++|||||||+||||+| |..||......+. ....+.+......|...+..+.+|+.+|
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~c 313 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRMRAPENATPEIYRIMLAC 313 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 788999999988889999999999999999997 9999964322111 1111112212223445677899999999
Q ss_pred hhccCCCCCccchhhhhHHHHHH
Q 004388 650 AELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 650 l~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
|..+|.+||++. +++..|+.+.
T Consensus 314 l~~dp~~RPs~~-el~~~l~~~~ 335 (338)
T cd05102 314 WQGDPKERPTFS-ALVEILGDLL 335 (338)
T ss_pred ccCChhhCcCHH-HHHHHHHHHH
Confidence 999999999998 5777776653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.75 Aligned_cols=255 Identities=19% Similarity=0.288 Sum_probs=203.8
Q ss_pred cCCCHHHHHHhhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchh---hHHHHHHHHHHHhcCCCceeeecccc
Q 004388 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGAC 467 (757)
Q Consensus 391 ~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~Hpniv~l~g~~ 467 (757)
+.++.++| +......||+|++|.||+|.+++..||||++....... .+.|.+|+.+|.+++||||++++|++
T Consensus 13 ~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 13 KCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred eecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 44455555 33334679999999999999999999999987543322 46688999999999999999999998
Q ss_pred cC------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCc
Q 004388 468 PD------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 468 ~~------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~ 540 (757)
.+ ..++||||+++|+|.+++.... .+++.....++.+++.||.|||.. + ++||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYK 161 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCc
Confidence 65 2379999999999999986543 488999999999999999999985 5 789999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI 618 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~ 618 (757)
+||+|||+++.+.... ....||+.|+|||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 162 ~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---- 228 (283)
T PHA02988 162 LKIICHGLEKILSSPP---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---- 228 (283)
T ss_pred EEEcccchHhhhcccc---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----
Confidence 9999999998654321 23468999999999876 67999999999999999999999999643211
Q ss_pred chhhHHHHhhh-hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 619 DEDNLAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 619 ~~~~l~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
..+..++.. .....|...+..+.+|+.+||+.+|.+||++. +++..|+.+.
T Consensus 229 --~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell~~l~~~~ 280 (283)
T PHA02988 229 --EIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK-EILYNLSLYK 280 (283)
T ss_pred --HHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHH-HHHHHHHHHH
Confidence 111111111 11233445788999999999999999999998 5777776654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=354.48 Aligned_cols=241 Identities=25% Similarity=0.395 Sum_probs=205.3
Q ss_pred CCccceeeccCCcEEEEEEEECCe--EEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||+|+||.||||+.+++ .||+|.+.+... .....+.+|++|++.|+|||||.++.+|.... ++|.||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 456666799999999999988765 899999876543 34556899999999999999999999997644 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+.| +|..+|...+. +++..+..|+.++..||.|||+.. |+|||+||.||||+.+|++|+||||+|+......
T Consensus 83 a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t- 154 (808)
T KOG0597|consen 83 AVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT- 154 (808)
T ss_pred hhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence 986 99999976554 899999999999999999999988 9999999999999999999999999999876532
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
...+...|||.|||||+..++.|+..+|+||||||+|||++|+|||..... -.+.+.+-.....||..
T Consensus 155 -----~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-------~~Lv~~I~~d~v~~p~~ 222 (808)
T KOG0597|consen 155 -----SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-------TQLVKSILKDPVKPPST 222 (808)
T ss_pred -----eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-------HHHHHHHhcCCCCCccc
Confidence 233567899999999999999999999999999999999999999953321 12333333344678999
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+..+..++.-.+..||..|-++.+.+
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 999999999999999999999988543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=353.05 Aligned_cols=240 Identities=27% Similarity=0.413 Sum_probs=202.6
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeeccccc--CCceEEEEecC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYME 479 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~--~~~~LV~Ey~~ 479 (757)
.|....+||+|+.|.||.+... +..||||.+........+-+.+|+.+|+..+|||||.++..|. +....|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3555568999999999999875 4589999998877667777899999999999999999999874 45589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
||+|.|.+.... +++.++..|+.+++.||.|||..+ |+|||||.+||||+.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999885443 888999999999999999999988 99999999999999999999999999988776543
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--CCCChh
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIK 637 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~ 637 (757)
+....+|||+|||||+.....|++++||||||++++||+-|.|||........ +.-+-+... ...|..
T Consensus 425 ----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~ng~P~lk~~~k 494 (550)
T KOG0578|consen 425 ----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTPKLKNPEK 494 (550)
T ss_pred ----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhhcCCCCcCCccc
Confidence 44667999999999999999999999999999999999999999964322221 111222211 124556
Q ss_pred HHHHHHHHHHHHhhccCCCCCccch
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..|.+++.+||+.|+.+||++.+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHH
Confidence 7899999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.70 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=195.5
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~ 475 (757)
.|....+||+|.||.||++++. +..||+|.+..+.. ....-..+||.||++|+||||++|.+...+. .|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3555567999999999999986 45799999887642 2333457899999999999999999988654 38999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|||++ +|.-++...+ -.|+..++..++.||+.||.|||..+ |+|||||.+|||||.+|.+||+|||||+++...
T Consensus 198 eYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred ecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99986 7877775433 34889999999999999999999998 999999999999999999999999999988765
Q ss_pred CCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGD 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~ 633 (757)
... ..|..+-|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.....+++.-. +.+++-.. ...
T Consensus 272 ~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k---IfklcGSP~e~~ 343 (560)
T KOG0600|consen 272 GSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK---IFKLCGSPTEDY 343 (560)
T ss_pred CCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH---HHHHhCCCChhc
Confidence 432 24667899999999987664 699999999999999999999999987665554211 11111100 011
Q ss_pred CC------------------------hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 634 WP------------------------IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 634 ~p------------------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|+ ...+....+|+..+|.+||.+|.++.+.+
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 22 02345678899999999999999987533
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.48 Aligned_cols=243 Identities=24% Similarity=0.322 Sum_probs=199.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC----Cc-hhhHHHHHHHHHHHhcC-CCceeeecccccC--C
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK----GN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPD--H 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~----~~-~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~ 470 (757)
....|...+.||+|+||.||.|... +..||+|++... .. ...+.+.+|+.++++++ ||||++++.++.. .
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4557888999999999999999874 569999977654 12 23455678999999999 9999999999854 4
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLS 549 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla 549 (757)
.++||||+.||+|.+++...+ .+.+.....++.|+++|+.|||+.+ |+||||||+|||||.+ +.+||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 589999999999999998743 4777899999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCC-CC-CcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-IS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
........ .....+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||....... +...+
T Consensus 169 ~~~~~~~~------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki 235 (370)
T KOG0583|consen 169 AISPGEDG------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKI 235 (370)
T ss_pred cccCCCCC------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHH
Confidence 98741111 224569999999999998866 75 88999999999999999999997532211 12223
Q ss_pred hhhcCCCChhH-HHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQAGDWPIKE-TKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~~~~~p~~~-~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....-..|... +.++..|+.+|+..+|..|+++.+
T Consensus 236 ~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 236 RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 33333445555 899999999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.69 Aligned_cols=248 Identities=25% Similarity=0.385 Sum_probs=201.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhH-HHHHHHHHHHhcC-CCceeeecccccCCc---eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNK-QFLQELEVLSKIR-HPHLLLLLGACPDHG---CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~-~f~~Ev~il~~l~-Hpniv~l~g~~~~~~---~LV 474 (757)
.++|...++||.|+||.||+|+.. +..||||.++.......+ --++|+..|++|+ |||||+|..++.|.. ++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 346777889999999999999875 558999998766443222 2368999999999 999999999997655 889
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||||+ .+|..++..+ ...++...+..|+.||+.||+|+|.+| +.||||||+|||+..+..+||+|||||+.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99996 6999988665 457999999999999999999999998 99999999999999999999999999998876
Q ss_pred CCCCccccccccCCcccccCCCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch-------------
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------------- 620 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~------------- 620 (757)
.+.+ |..+.|.+|.|||++ +.+.|+.+.|||++|||++|+.+-+|.|...+.++..+..
T Consensus 163 kpPY-------TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 KPPY-------TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred CCCc-------chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 5432 566899999999965 6788999999999999999999999999876655543221
Q ss_pred --hhHHHHhhhhcCCC--------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 --DNLAEILDAQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 --~~l~~~ld~~~~~~--------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...+.-..+.. -...+.++.+|+.+||..||.+||++.+
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence 12222222111110 1136788999999999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.89 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=195.7
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|...+.||+|+||.||+|... +..||+|.+..... .....+.+|+.+|.+++||||+.+++++.+.. ++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677789999999999999874 66999998865422 22345789999999999999999999886544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998876543 235899999999999999999999988 9999999999999999999999999998754322
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. .....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+...+.......+.
T Consensus 157 ~-------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (285)
T cd05631 157 T-------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQEEYSE 226 (285)
T ss_pred e-------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccccCCc
Confidence 1 1234799999999999999999999999999999999999999974322110 01111112122233455
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccc
Q 004388 637 KETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+..+.+|+.+||..+|.+||+..
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 6678999999999999999999854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=340.59 Aligned_cols=234 Identities=24% Similarity=0.309 Sum_probs=195.3
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|.....||+|+||.||+|... +..||+|++.... ......+.+|+.+|++++||||+++++++.+.. ++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6788889999999999999986 6799999986432 223456889999999999999999999987654 79999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++...+ .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 82 YVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999999986543 4888999999999999999999988 9999999999999999999999999998654321
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
....||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+......+|.
T Consensus 156 ---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~ 219 (291)
T cd05612 156 ---------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-------GIYEKILAGKLEFPR 219 (291)
T ss_pred ---------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcCCCc
Confidence 2347999999999998888999999999999999999999999643221 111222222334566
Q ss_pred hHHHHHHHHHHHHhhccCCCCCc
Q 004388 637 KETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
..+..+.+|+.+||+.||.+||+
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccC
Confidence 66788999999999999999997
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=352.71 Aligned_cols=252 Identities=33% Similarity=0.485 Sum_probs=197.3
Q ss_pred CCccceeeccCCcEEEEEEEECCeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecCC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 480 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~~ 480 (757)
.+....+||+|.||+||+|.|.| .||||+++.... ...+.|.+||.++++-+|-||+.|.|+|.... .||..+|+|
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeG 471 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEG 471 (678)
T ss_pred Hhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccC
Confidence 34456689999999999999987 499999987643 35677999999999999999999999996654 789999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
-+|+.+|+-... .|.....+.|+.|||.|+.|||..+ |||||||..||||.+++.+||+||||+..-..- .
T Consensus 472 sSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w----~ 542 (678)
T KOG0193|consen 472 SSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW----S 542 (678)
T ss_pred chhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeee----c
Confidence 999999986543 4778889999999999999999988 999999999999999999999999999653311 1
Q ss_pred ccccccCCcccccCCCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-hchhhHHHHhhhhcCCCCh
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-IDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~l~~~ld~~~~~~p~ 636 (757)
.........|...|||||+++. .+|++.+|||||||++|||+||..||.+. ..+.. +..+.- .+.+.......
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmVGrG--~l~pd~s~~~s 619 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMVGRG--YLMPDLSKIRS 619 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEeccc--ccCccchhhhc
Confidence 1112234578999999998764 46899999999999999999999999732 22211 111111 00111111223
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+++.++.+|+..||..++++||.+.+ |+..|+
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~-il~~l~ 651 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQ-LLSKLE 651 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHH-HHHHHH
Confidence 56789999999999999999999985 444333
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.77 Aligned_cols=241 Identities=23% Similarity=0.301 Sum_probs=200.7
Q ss_pred HhhcCCccceeeccCCcEEEEEEEECCe--EEEEEEEccCCch---hhHHHHHHHHHHHhcC-CCceeeecccccC--Cc
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI---QNKQFLQELEVLSKIR-HPHLLLLLGACPD--HG 471 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~~ 471 (757)
....+|....+||+|.||.|+++.++++ .+|||+++++... ..+..+.|..|+.... ||.++.|++.|+. +.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3456799999999999999999998754 9999999987544 3455678999888775 9999999999965 45
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
|+||||+.||++..+. ....++.....-++.+|+.||.|||.++ |||||||.+|||||.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 8999999999944322 2234888888899999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
.-...+ ...+.+|||.|||||++....|+..+|+|||||+|||||+|.+||...+. +.+.+.|-..-
T Consensus 518 ~m~~g~------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------ee~FdsI~~d~ 584 (694)
T KOG0694|consen 518 GMGQGD------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------EEVFDSIVNDE 584 (694)
T ss_pred cCCCCC------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCC
Confidence 543222 23567999999999999999999999999999999999999999965432 22233332333
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
..+|...+.+...|+.+++..+|.+|-..
T Consensus 585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 45788889999999999999999999877
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.91 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=195.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC------------------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeee
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH------------------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLL 463 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~------------------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l 463 (757)
..|....+||+|+||.||+|.+. +..||+|++.... ......|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 35777889999999999999753 2369999987653 2345679999999999999999999
Q ss_pred cccccCC--ceEEEEecCCCCHHHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEE
Q 004388 464 LGACPDH--GCLVYEYMENGSLEDRLYRKN----------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525 (757)
Q Consensus 464 ~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH 525 (757)
+++|.+. .++||||+++|+|.+++.... ....++|..+..|+.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9998654 489999999999999886432 1234788899999999999999999988 999
Q ss_pred cCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh--
Q 004388 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-- 603 (757)
Q Consensus 526 rDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-- 603 (757)
|||||+|||++.++.+||+|||+++.+...... .......++..|+|||++..+.++.++|||||||++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999865433211 11123456889999999988899999999999999999987
Q ss_pred CCCCccccchhhhhhchhhHHHHhhhh----cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 604 AKPAIAITHKVETAIDEDNLAEILDAQ----AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 604 G~~Pf~~~~~~~~~~~~~~l~~~ld~~----~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
|..||........ + ......+... ....|...+..+.+|+.+||..+|.+||++.+ |...|
T Consensus 238 ~~~p~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~-i~~~l 302 (304)
T cd05096 238 KEQPYGELTDEQV-I--ENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD-IHAFL 302 (304)
T ss_pred CCCCCCcCCHHHH-H--HHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH-HHHHH
Confidence 5567753322111 0 0111111111 11223456678999999999999999999984 55554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=344.19 Aligned_cols=236 Identities=21% Similarity=0.305 Sum_probs=195.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.+|.....||.|+||.||+|.+. +..||||++.... ......+.+|+.+|.+++||||+++++++.+.. ++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999985 5689999987532 223456889999999999999999999986554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++...+ .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987543 4788889999999999999999988 999999999999999999999999999866432
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
. ....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .+..+.. .....|
T Consensus 172 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~-~~~~~p 235 (329)
T PTZ00263 172 T---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKILA-GRLKFP 235 (329)
T ss_pred c---------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHhc-CCcCCC
Confidence 1 23479999999999998889999999999999999999999996432211 1112222 222345
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 636 IKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
...+..+.+|+.+||+.||.+||+.
T Consensus 236 ~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 236 NWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 4567789999999999999999984
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=342.79 Aligned_cols=231 Identities=26% Similarity=0.318 Sum_probs=189.8
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
.||+|+||.||++... +..||||++.... ......+.+|+.+|.+++||||+++++++.+.. |+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5999999999999874 5689999987542 223356788999999999999999999886554 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~ 562 (757)
|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 82 LFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-----
Confidence 999886543 4889999999999999999999988 99999999999999999999999999875332211
Q ss_pred ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHH
Q 004388 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 642 (757)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ..+...+.......|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05571 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred -cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCCCCCCCCCHHH
Confidence 12345799999999999988999999999999999999999999964321 1112222222334566678899
Q ss_pred HHHHHHHhhccCCCCCc
Q 004388 643 AALGLSCAELRRKDRPD 659 (757)
Q Consensus 643 ~~Li~~Cl~~~p~~RPs 659 (757)
.+|+.+||+.||.+||+
T Consensus 223 ~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 223 KSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHccCCHHHcCC
Confidence 99999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=313.88 Aligned_cols=242 Identities=26% Similarity=0.331 Sum_probs=204.8
Q ss_pred hcCCccceeeccCCcEEEEEEEECCe--EEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
.++|+..+.||+|.||.||.|+.+.+ .||+|++.... .....++.+|++|-+.|+||||+++||+|.+.. ||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 45788999999999999999998754 89999987543 223467899999999999999999999998765 999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
+||.++|+|...|..... ..++......++.|+|.||.|+|..+ ||||||||+|+|++.++.+||+|||.+-..+.
T Consensus 101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999975433 34777788889999999999999988 99999999999999999999999999875442
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.+....+||..|.+||...+..++..+|+|++|++.||+|.|.+||.... ....+. -+.......
T Consensus 177 --------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~------~~etYk-rI~k~~~~~ 241 (281)
T KOG0580|consen 177 --------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS------HSETYK-RIRKVDLKF 241 (281)
T ss_pred --------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh------hHHHHH-HHHHccccC
Confidence 23466799999999999999999999999999999999999999996332 222222 333333456
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
|...+...+++|.+|+..+|.+|..+.+
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~ 269 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTE 269 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHH
Confidence 7778899999999999999999998875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=361.77 Aligned_cols=253 Identities=28% Similarity=0.499 Sum_probs=208.5
Q ss_pred ccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 406 SENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.....||+|.||.||+|... .+.||||.++..... ...+|++|+++|..|+|||||+|+|+|.+.. |+|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 34457999999999999764 348999999987666 7889999999999999999999999997665 9999
Q ss_pred EecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEe
Q 004388 476 EYMENGSLEDRLYRKNN-----------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~ 544 (757)
|||..|+|..+|..... .++|+..+.+.||.|||.|+.||-++. +|||||-..|+||+++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEec
Confidence 99999999999974321 234888899999999999999999998 9999999999999999999999
Q ss_pred eecCccccCCCCCCcccccccc-CCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 004388 545 DVGLSTMLNSDPSFVSTTYKNT-GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 545 DFGla~~~~~~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 622 (757)
||||++.+-..+ -|+.. ...-...||+||.+..++|+.+||||||||+|||++| |+.||..... .+-
T Consensus 646 DfGLsRdiYssD-----YYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------~EV 714 (774)
T KOG1026|consen 646 DFGLSRDIYSSD-----YYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------QEV 714 (774)
T ss_pred ccccchhhhhhh-----hhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch------HHH
Confidence 999998655332 22222 2344678999999999999999999999999999996 8888863321 122
Q ss_pred HHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 623 l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+.-+-.......|..++.++.+|+..||+..|++||+++ +|-..|+....
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~-eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFK-EIHSRLQAWAQ 764 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHHHHHh
Confidence 233333444567888999999999999999999999999 47677766544
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=338.19 Aligned_cols=232 Identities=24% Similarity=0.293 Sum_probs=189.8
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 483 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL 483 (757)
||+|+||.||+|... +..||+|++.... ......+.+|+.+|.+++||||++++++|.+.. ++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999985 4589999986432 233456788999999999999999999886544 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------ 148 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------ 148 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------
Confidence 99987543 4889999999999999999999988 99999999999999999999999999976432211
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 643 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 643 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||++||......+ .+..++ .....+|...+..+.
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~-~~~~~~~~~~~~~~~ 221 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKIL-QEPLRFPDGFDRDAK 221 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHH-cCCCCCCCcCCHHHH
Confidence 1234579999999999998899999999999999999999999996432211 111122 122344556778899
Q ss_pred HHHHHHhhccCCCCCccc
Q 004388 644 ALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 644 ~Li~~Cl~~~p~~RPs~~ 661 (757)
+++.+||..+|.+||++.
T Consensus 222 ~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred HHHHHHcCCCHHHcCCCC
Confidence 999999999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.13 Aligned_cols=248 Identities=23% Similarity=0.310 Sum_probs=201.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~E 476 (757)
...|.....||.|..++||+|+.. +..||||++..+... ..+.+.+|+..|+.++||||+.++..|... .++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 446888889999999999999874 679999999866433 357789999999999999999999988544 378999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
||.+||+.+++...-. ..+.+..+..|+.+++.||.|||++| .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999876443 24899999999999999999999998 9999999999999999999999999987666544
Q ss_pred CCccccccccCCcccccCCCcccc--ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQ--RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.. ..++....+||++|||||++ +...|+.|+|||||||+.+||.+|..||......+.. +....+..
T Consensus 181 ~R--~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL---------l~tLqn~p 249 (516)
T KOG0582|consen 181 DR--QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL---------LLTLQNDP 249 (516)
T ss_pred ce--eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH---------HHHhcCCC
Confidence 22 22222677999999999984 3456999999999999999999999999754433321 11111111
Q ss_pred C------------hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 P------------IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
| ......+.+++..||..||.+||++.+.+
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 1 23466899999999999999999998533
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=345.29 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=199.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc-
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~- 471 (757)
.++|....+||+|+||.||+|++. +..||||++.... ....+.+.+|+.+|..+ +||||++++|+|.+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 346888899999999999999742 3489999987543 23445688999999999 8999999999996654
Q ss_pred -eEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 004388 472 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 492 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 492 (757)
++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 899999999999998864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 493 --------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 493 --------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999987 999999999999999999999999999876543221
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 636 (757)
. ......++..|+|||++.+..++.++|||||||++|||+| |.+||...... ..+...+... ....|.
T Consensus 271 ~----~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 271 V----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRMLSPE 340 (375)
T ss_pred c----ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCCCCC
Confidence 1 1122345678999999998999999999999999999998 88998643211 1112222221 122233
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
..+.++.+|+.+||..+|.+||++.+ |+..|++
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~e-il~~l~~ 373 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQ-IVQLIEQ 373 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHH-HHHHHHh
Confidence 45678999999999999999999984 6666654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=345.92 Aligned_cols=237 Identities=26% Similarity=0.373 Sum_probs=202.2
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
-|...+.||.|+.|.|-+|++. |+.+|||++.... ......+.+||-||+-|.|||+++||++|.++. |||.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4667788999999999999985 5699999987652 223456789999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++||.|.++|.+++ +++..+..++++||+.|+.|||..+ |+||||||+|+|||..+.+||+|||+|.+..++.
T Consensus 93 yv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred ecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 999999999998876 4889999999999999999999999 9999999999999999999999999998765543
Q ss_pred CCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh---hcC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA---QAG 632 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~---~~~ 632 (757)
- -.+.||+|.|.+||++.+.+| +.++||||.|||||.||||+.||+. +++..++.. ..-
T Consensus 167 l-------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----------dNir~LLlKV~~G~f 229 (786)
T KOG0588|consen 167 L-------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----------DNIRVLLLKVQRGVF 229 (786)
T ss_pred c-------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----------ccHHHHHHHHHcCcc
Confidence 1 134599999999999998877 4799999999999999999999962 233333332 233
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
+.|...+.++.+|+.+|+..||..|.++.++
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI 260 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEI 260 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHH
Confidence 5677889999999999999999999999853
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.00 Aligned_cols=251 Identities=21% Similarity=0.325 Sum_probs=198.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV 474 (757)
.+|.....||+|+||.||+|.+. +..||+|.++.... .....|.+|+.++.+++||||++++|++... .++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45778889999999999999764 35899999876532 3345689999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 35899999999999999999999987 99999999999999999999999998765432
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
... +......++..|+|||++.++.++.++|||||||++|||++ |.+||....... .+..+.+.....
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 228 (266)
T cd05064 160 EAI-----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAVEDGFRLP 228 (266)
T ss_pred cch-----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCCC
Confidence 111 11123345778999999998999999999999999999775 999996432211 111111111223
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
.|...+..+.+++.+||+.+|.+||++. ++...|.+
T Consensus 229 ~~~~~~~~~~~li~~c~~~~p~~RP~~~-~i~~~l~~ 264 (266)
T cd05064 229 APRNCPNLLHQLMLDCWQKERGERPRFS-QIHSILSK 264 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCCCHH-HHHHHHHh
Confidence 3455678899999999999999999997 56666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=332.15 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=193.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--------------hhhHHHHHHHHHHHhcCCCceeeec
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--------------IQNKQFLQELEVLSKIRHPHLLLLL 464 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--------------~~~~~f~~Ev~il~~l~Hpniv~l~ 464 (757)
..++|.....||.|.||.|-+|+.. ++.||||++..... ...+...+||.||++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3457888889999999999999874 67999999864321 1125688999999999999999999
Q ss_pred ccccC----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 465 GACPD----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 465 g~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
.+..+ ..|||+|||..|.+.. .....+.++..+...++.++..||.|||.++ ||||||||+|+||+.+|+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 99754 4499999999887743 2333344899999999999999999999998 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCC----CCCcchhhhHHHHHHHHHhCCCCccccchhhh
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----ISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 616 (757)
+||+|||.+...+......... .-...+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||......+
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~-~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~- 326 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDD-QLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE- 326 (576)
T ss_pred EEeeccceeeecccCCccccHH-HHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence 9999999998774332111111 112369999999999876633 4578899999999999999999996443222
Q ss_pred hhchhhHHHHhhhhcCCCCh--hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 617 AIDEDNLAEILDAQAGDWPI--KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 617 ~~~~~~l~~~ld~~~~~~p~--~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.+.+++... ...|. +....+.+||.++|+.||..|-++.++
T Consensus 327 -----l~~KIvn~p-L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 327 -----LFDKIVNDP-LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred -----HHHHHhcCc-ccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence 122222221 12232 467899999999999999999988753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=344.06 Aligned_cols=234 Identities=26% Similarity=0.438 Sum_probs=193.0
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCHHHH
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDR 486 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL~~~ 486 (757)
..||.|+.|.||+|++++..||||+.+.-. ..+|.-|++|+||||+.|.|+|.... |||||||..|.|..+
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 469999999999999999999999765321 24778899999999999999998766 799999999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccccccc
Q 004388 487 LYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566 (757)
Q Consensus 487 L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~ 566 (757)
|.... ++.-.....|..+||.|+.|||.++ |||||||.-||||..+..+||+|||-++.+.+.. ...
T Consensus 203 Lka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------TkM 269 (904)
T KOG4721|consen 203 LKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------TKM 269 (904)
T ss_pred HhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-------hhh
Confidence 96543 3666677889999999999999999 9999999999999999999999999998776431 234
Q ss_pred CCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHH
Q 004388 567 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 646 (757)
Q Consensus 567 ~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li 646 (757)
.++||..|||||++.+.+.+.|+|||||||+|||||||..||...+...-.+.-+ ...| -...|..++..|.-|+
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG--sNsL---~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG--SNSL---HLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc--CCcc---cccCcccCchHHHHHH
Confidence 5799999999999999999999999999999999999999996433221111111 0011 1234667889999999
Q ss_pred HHHhhccCCCCCccchhhhhHH
Q 004388 647 LSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 647 ~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.+||.-.|+.||++.+ ++..|
T Consensus 345 Kqcw~sKpRNRPSFrq-il~Hl 365 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQ-ILLHL 365 (904)
T ss_pred HHHHhcCCCCCccHHH-HHHHH
Confidence 9999999999999994 55444
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=333.38 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=200.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--Ce----EEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~----~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV 474 (757)
.+|+....||+|+||.||+|.+. +. .||+|++.... ......|.+|+.+++.++||||++++|+|... .++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 35888899999999999999863 22 48999987543 33456789999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
+||+++|+|.+++.... ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999987543 34888999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 632 (757)
.... .......++..|+|||++....++.++|||||||++|||+| |+.||...... .+..++... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~ 230 (316)
T cd05108 162 DEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGERL 230 (316)
T ss_pred CCcc----eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHhCCCCC
Confidence 3221 11123345778999999998999999999999999999998 99999643211 112222211 12
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
..+...+..+.+++.+||..+|.+||++.+ ++..+..+.
T Consensus 231 ~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-l~~~l~~~~ 269 (316)
T cd05108 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMA 269 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHH-HHHHHHHHH
Confidence 234456678999999999999999999984 555555554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.50 Aligned_cols=231 Identities=26% Similarity=0.309 Sum_probs=188.7
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||++++++|.+.. ||||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5999999999999874 5689999987542 223456778999999999999999999886544 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~ 562 (757)
|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 82 LFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----
Confidence 998886543 4889999999999999999999988 99999999999999999999999999875322111
Q ss_pred ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHH
Q 004388 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 642 (757)
......||+.|+|||++.++.++.++|||||||++|+|+||+.||...... .+...+.......|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~~~~p~~~~~~~ 222 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIRFPRTLSPEA 222 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCCCCCCCCCHHH
Confidence 123457999999999999889999999999999999999999999643211 111222222234556678899
Q ss_pred HHHHHHHhhccCCCCCc
Q 004388 643 AALGLSCAELRRKDRPD 659 (757)
Q Consensus 643 ~~Li~~Cl~~~p~~RPs 659 (757)
.+++.+||..+|.+||+
T Consensus 223 ~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 223 KSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHccCCHHHhCC
Confidence 99999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.49 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=200.5
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc-
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~- 471 (757)
.++|...+.||+|+||.||+|...+ ..||||++.... ......+.+|+.+++.+ +|||||+++++|.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 3468888999999999999987532 379999987543 23345688999999999 8999999999987654
Q ss_pred -eEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 004388 472 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 492 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 492 (757)
++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 899999999999998864321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 493 ---------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 493 ---------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
..++++..+.+|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~---- 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---- 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee----
Confidence 124788889999999999999999987 9999999999999999999999999998654332110
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKE 641 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~ 641 (757)
......+++.|+|||++..+.++.++|||||||++|+|++ |+.||...... ..+...+... ....|...+..
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------SKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc------HHHHHHHHcccCccCCCCCCHH
Confidence 1122345678999999988899999999999999999997 99999643211 1122222221 12233345688
Q ss_pred HHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 642 LAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+.+++.+||+.+|.+||++. .|++.|+++
T Consensus 344 l~~li~~cl~~dp~~RPs~~-~l~~~l~~~ 372 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFS-QISQLIQRQ 372 (374)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHHHH
Confidence 99999999999999999998 577777654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=309.59 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=195.0
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.|....+||+|.||.||+|++. ++.||||.++..... ......+||..|+.++||||+.|+++|+... .||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4556678999999999999986 559999998765322 2345689999999999999999999997655 689999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|+ .+|+..+..+. ..++-..+..++.+++.||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 97 69999886543 46888899999999999999999998 99999999999999999999999999999875543
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-hhcCCCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDWP 635 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p 635 (757)
.. +..+-|.+|.|||.+.+ ..|+..+||||.|||+.||+-|.|-|.....+++... +...+- +....||
T Consensus 157 ~~------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 157 IQ------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGTPTPDQWP 227 (318)
T ss_pred cc------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCCCCcccCc
Confidence 21 23378999999997755 5699999999999999999999988876655544211 111110 1111232
Q ss_pred h-----------------------hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 I-----------------------KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~-----------------------~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ..+..+.+|+..++.+||.+|.+..+
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 1 34667899999999999999999885
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.70 Aligned_cols=248 Identities=27% Similarity=0.349 Sum_probs=195.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.++|....+||+|+||.||++.+. +..+|+|++.... ......|.+|+++|.+++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357888899999999999999986 4589999987643 234567899999999999999999999986543 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999886543 4888999999999999999999853 39999999999999999999999999997654321
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hhch--------------
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDE-------------- 620 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~-------------- 620 (757)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||......+. .+..
T Consensus 159 --------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred --------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 1334799999999999988899999999999999999999999963321110 0000
Q ss_pred --------------------hhHHHHhhhh----cCCCC-hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 --------------------DNLAEILDAQ----AGDWP-IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 --------------------~~l~~~ld~~----~~~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+.++++.. ....+ ...+.++.+|+.+||..+|++||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~e 297 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKM 297 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHH
Confidence 0011111111 11111 135678999999999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=342.28 Aligned_cols=235 Identities=23% Similarity=0.307 Sum_probs=194.1
Q ss_pred cCCccceeeccCCcEEEEEEEECC---eEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH---TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~---~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
++|.....||+|+||.||+|.+.+ ..||+|++.... ......+.+|+.++..++||||+++++++.+.. ++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998643 479999886432 223456889999999999999999999997654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999987543 4889999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
. .....||+.|+|||++.+..++.++|||||||++|+|+||++||....... ....+. .....+
T Consensus 184 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~-~~~~~~ 247 (340)
T PTZ00426 184 R---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKIL-EGIIYF 247 (340)
T ss_pred C---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHh-cCCCCC
Confidence 2 123579999999999988889999999999999999999999997443211 111122 222334
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCc
Q 004388 635 PIKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
|...+..+.+++.+|++.+|.+|++
T Consensus 248 p~~~~~~~~~li~~~l~~dp~~R~~ 272 (340)
T PTZ00426 248 PKFLDNNCKHLMKKLLSHDLTKRYG 272 (340)
T ss_pred CCCCCHHHHHHHHHHcccCHHHcCC
Confidence 5566778999999999999999974
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=353.14 Aligned_cols=248 Identities=20% Similarity=0.283 Sum_probs=201.0
Q ss_pred CCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
.|.....||+|+||.||++... +..||+|.+..........+.+|+.+|+.++|||||+++++|.+.. ||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3788889999999999999764 4578888776555555566788999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 479 ENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 479 ~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+||+|.++|... ....++++.....++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 23446889999999999999999999987 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
. ......+||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ..+..++.......|..
T Consensus 225 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~~~~~ 294 (478)
T PTZ00267 225 L----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLYGKYDPFPCP 294 (478)
T ss_pred c----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCCcc
Confidence 1 1123457999999999999899999999999999999999999999643221 11222222222334455
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+..+.+++.+||..+|.+||++.+++
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l 321 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLL 321 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHH
Confidence 678899999999999999999998654
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=340.03 Aligned_cols=242 Identities=24% Similarity=0.276 Sum_probs=194.9
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|....+||.|+||.||+|.+. +..||||++.... ......+.+|+.++..++||||+++++++.+.. |||||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888899999999999999985 5699999987542 223456889999999999999999999986654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999986543 4888899999999999999999988 99999999999999999999999999976543
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC-
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP- 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p- 635 (757)
......||+.|+|||++.+..++.++|||||||++|||+||++||......+...........+.. ..+.
T Consensus 154 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~ 224 (333)
T cd05600 154 -------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--PVYDD 224 (333)
T ss_pred -------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC--CCCCc
Confidence 123457999999999999889999999999999999999999999644322111000000000100 1111
Q ss_pred --hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 --IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 --~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+|+.+||..+|.+||++.+
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 134778999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=337.68 Aligned_cols=231 Identities=25% Similarity=0.300 Sum_probs=188.9
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
.||+|+||.||++... +..||+|++.... ......+.+|+.+|+.++||||+++++++.+.. ++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999875 5699999987542 223456788999999999999999999886544 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~ 562 (757)
|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 82 LFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----
Confidence 998886543 4889999999999999999999988 99999999999999999999999999875432211
Q ss_pred ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHH
Q 004388 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 642 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+.......|...+..+
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~~~~~~~~~~~~~p~~~~~~~ 222 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEDIKFPRTLSADA 222 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-------HHHHHhccCCccCCCCCCHHH
Confidence 123457999999999999889999999999999999999999999643221 111222222234555677889
Q ss_pred HHHHHHHhhccCCCCCc
Q 004388 643 AALGLSCAELRRKDRPD 659 (757)
Q Consensus 643 ~~Li~~Cl~~~p~~RPs 659 (757)
.+++.+||..+|.+||+
T Consensus 223 ~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 223 KSLLSGLLIKDPNKRLG 239 (328)
T ss_pred HHHHHHHcCCCHHHcCC
Confidence 99999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=327.26 Aligned_cols=251 Identities=25% Similarity=0.468 Sum_probs=200.2
Q ss_pred CCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~L 473 (757)
+|.....||+|+||.||+|...+ ..||+|.+..... .....|.+|+.++.+++||||+++++++.+. .++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 56777889999999999998743 3689998875432 3446689999999999999999999998654 389
Q ss_pred EEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 474 VYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
+|||+++|+|.+++..... ...+++.....++.|++.||.|||..+ |+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999875422 135888999999999999999999988 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhc
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 619 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 619 (757)
+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||+| |..||.....
T Consensus 163 ~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05048 163 VKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------ 232 (283)
T ss_pred EEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999865432211 11233467889999999988889999999999999999998 9999864321
Q ss_pred hhhHHHHh-hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 620 EDNLAEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 620 ~~~l~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
..+...+ .......|...+..+.+|+.+||..+|.+||++.+ |+..|+
T Consensus 233 -~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~-i~~~l~ 281 (283)
T cd05048 233 -QEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKD-IHTRLR 281 (283)
T ss_pred -HHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHH-HHHHHh
Confidence 1122222 22223345567889999999999999999999984 655554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.37 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=193.1
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCCH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSL 483 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gsL 483 (757)
||+|+||.||++.+. +..||+|++..... .....+..|+.+++.++||||+++++++... .++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999875 56899999865422 2235678899999999999999999988654 4899999999999
Q ss_pred HHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccc
Q 004388 484 EDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562 (757)
Q Consensus 484 ~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~ 562 (757)
.+.+.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 98875432 3346899999999999999999999988 99999999999999999999999999976653321
Q ss_pred ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHH
Q 004388 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 642 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ .......++. .....+...+..+
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~ 228 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN-DSVTYPDKFSPAS 228 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc-cCCCCcccCCHHH
Confidence 12345799999999999999999999999999999999999999964321110 0011111111 1123445577889
Q ss_pred HHHHHHHhhccCCCCCccchhhhhHH
Q 004388 643 AALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 643 ~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.+++.+||+.+|.+||++.+.....+
T Consensus 229 ~~li~~~l~~~P~~R~~~~~~~~~~~ 254 (280)
T cd05608 229 KSFCEALLAKDPEKRLGFRDGNCDGL 254 (280)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence 99999999999999998765333333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.28 Aligned_cols=245 Identities=33% Similarity=0.566 Sum_probs=191.7
Q ss_pred ceeeccCCcEEEEEEEEC------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 408 NLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
...||.|.||.||+|.+. +..|+||++..... ...+.|.+|++++++++||||++++|+|.+. .++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999998 56999999966433 3467899999999999999999999999743 38999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.++|.... ...+++..+..|+.||+.||.|||+.+ |+||||+|.|||++.++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999998762 345899999999999999999999988 999999999999999999999999999876322211
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.......+...|+|||++....++.++||||||+++|||+| |+.||..... ......+.+......+..
T Consensus 160 ----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (259)
T PF07714_consen 160 ----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKLKQGQRLPIPDN 229 (259)
T ss_dssp ----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHHHTTEETTSBTT
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccceeccc
Confidence 12234467889999999998989999999999999999999 7788753311 112223333333444555
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
.+..+.+++.+||..+|.+||++.+ ++..
T Consensus 230 ~~~~~~~li~~C~~~~p~~RPs~~~-i~~~ 258 (259)
T PF07714_consen 230 CPKDIYSLIQQCWSHDPEKRPSFQE-ILQE 258 (259)
T ss_dssp SBHHHHHHHHHHT-SSGGGS--HHH-HHHH
T ss_pred hhHHHHHHHHHHcCCChhhCcCHHH-HHhc
Confidence 6788999999999999999999984 5443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=334.42 Aligned_cols=240 Identities=23% Similarity=0.258 Sum_probs=193.3
Q ss_pred CCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhcCCC-ceeeecccccCC--ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHP-HLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hp-niv~l~g~~~~~--~~LV~ 475 (757)
+|...+.||+|+||.||+|...+ ..||||++.... ......+..|+.++..+.|+ +|+.+++++.+. .|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47778899999999999999864 489999987542 23345678899999999765 577888877544 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886543 4788999999999999999999987 999999999999999999999999998753221
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+.......|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-------~~~~~i~~~~~~~~ 221 (324)
T cd05587 155 GK------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQSIMEHNVSYP 221 (324)
T ss_pred CC------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 11 123457999999999999889999999999999999999999999643321 11122222234456
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+++.+||..+|.+||+...
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGP 248 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCC
Confidence 667888999999999999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.85 Aligned_cols=234 Identities=26% Similarity=0.329 Sum_probs=189.4
Q ss_pred eeeccCCcEEEEEEEE-----CCeEEEEEEEccCC----chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 409 LRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++||+|+||.||++.. .+..||||++.... ......+.+|+.+|+.++||||++++++|.+.. ++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999875 35689999987532 223345788999999999999999999986554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999886543 4778888899999999999999988 99999999999999999999999999875432211
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..++.. ....|..
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~-~~~~~~~ 222 (323)
T cd05584 156 ------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKG-KLNLPPY 222 (323)
T ss_pred ------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcC-CCCCCCC
Confidence 1234579999999999988889999999999999999999999996443221 12222222 2334556
Q ss_pred HHHHHHHHHHHHhhccCCCCCccc
Q 004388 638 ETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.+..+.+++.+||+.+|.+||+..
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~ 246 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAG 246 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCC
Confidence 678899999999999999999543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=334.28 Aligned_cols=239 Identities=23% Similarity=0.270 Sum_probs=193.8
Q ss_pred CCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~ 475 (757)
+|.....||+|+||.||+|...+ ..||||++.... ......+..|..++..+ +||+|+.+++++.+.. ++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47778899999999999998864 489999987542 22334567788888877 5899999999886544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 4888999999999999999999988 999999999999999999999999999754322
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+......+|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------~~~~~i~~~~~~~p 221 (323)
T cd05616 155 GV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------ELFQSIMEHNVAYP 221 (323)
T ss_pred CC------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCC
Confidence 11 123457999999999999999999999999999999999999999643321 11222222234456
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
...+..+.+|+.+|++.+|.+|++..
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 67788999999999999999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.01 Aligned_cols=236 Identities=23% Similarity=0.301 Sum_probs=189.1
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|.+.+ ..||||++.... ......+..|..++..+ +||||+++++++.... ++||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 69999999999999864 589999987542 22334456677777654 8999999999986544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---- 151 (316)
T cd05592 82 DLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---- 151 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC----
Confidence 9999886543 4888899999999999999999987 99999999999999999999999999976432221
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-------ELFDSILNDRPHFPRWISKE 222 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCCCCCCCCHH
Confidence 123457999999999999888999999999999999999999999643321 11122222233445556788
Q ss_pred HHHHHHHHhhccCCCCCccchhh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.+++.+||..+|.+||++.+.+
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHH
Confidence 99999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=325.01 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=198.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-- 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-- 470 (757)
++++|+....||+|+||.||+|.+.+ ..||||++.... ......|.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45678999999999999999998643 479999886432 23445688999999999999999999998654
Q ss_pred ceEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 471 GCLVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 4899999999999999865322 234678889999999999999999987 999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 622 (757)
+|||+++......... ......+++.|+|||++.++.++.++|||||||++|||+| |..||...... ..
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~ 230 (277)
T cd05062 161 GDFGMTRDIYETDYYR----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QV 230 (277)
T ss_pred CCCCCccccCCcceee----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence 9999997654322111 1122356788999999988889999999999999999999 78888533211 11
Q ss_pred HHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 623 l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
+..+........+...+..+.+++.+||+.+|.+||++.+ ++..|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e-~l~~l 275 (277)
T cd05062 231 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSI 275 (277)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHh
Confidence 1112222222334456778999999999999999999984 44444
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=342.50 Aligned_cols=256 Identities=22% Similarity=0.404 Sum_probs=201.2
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCceeeecccccCCc-
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~- 471 (757)
...|...++||.|+||.||+|.+.+ ..||||++..... ...+.|.+|+.+|.++. ||||++++|+|.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4567888899999999999998642 2699999875432 23467899999999996 999999999997654
Q ss_pred -eEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 004388 472 -CLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 492 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 492 (757)
||||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 899999999999998865321
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC
Q 004388 493 -----------------------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 537 (757)
Q Consensus 493 -----------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~ 537 (757)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999987 999999999999999
Q ss_pred CCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhh
Q 004388 538 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVET 616 (757)
Q Consensus 538 ~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~ 616 (757)
++.+||+|||+++.+....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYV----SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred CCEEEEEeCCcceecccccccc----ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 9999999999998764332211 1123457889999999988889999999999999999997 98998532111
Q ss_pred hhchhhHHHHh-hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 617 AIDEDNLAEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 617 ~~~~~~l~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+...+ .......+...+..+.+++.+||..+|.+||++. .|.+.|+++
T Consensus 347 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~~l~~l 397 (400)
T cd05105 347 ----STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFL-HLSDIVESL 397 (400)
T ss_pred ----HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHH-HHHHHHHHH
Confidence 1111111 1112233445678899999999999999999998 477777654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=325.40 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=203.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
.+|...+.||+|+||.||++... +..+|+|.+..........|.+|++++.+++||||++++++|.+.. ++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778889999999999999752 2468999887665555677999999999999999999999986544 89
Q ss_pred EEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 474 VYEYMENGSLEDRLYRKN----------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
||||+++++|.+++...+ ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986543 1234899999999999999999999987 999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 622 (757)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|+| |.+||....... .
T Consensus 162 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~ 231 (288)
T cd05093 162 GDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------V 231 (288)
T ss_pred ccCCccccccCCcee----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------H
Confidence 999999865432211 11223456788999999988889999999999999999998 999986432211 1
Q ss_pred HHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 623 l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+..+........+...+..+.+|+.+||+.+|.+||++. ++...|+.+..
T Consensus 232 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~v~~~l~~~~~ 281 (288)
T cd05093 232 IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIK-EIHSLLQNLAK 281 (288)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHHHH
Confidence 111221112223344567899999999999999999998 56777776653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=334.70 Aligned_cols=244 Identities=21% Similarity=0.282 Sum_probs=192.6
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHH---HhcCCCceeeecccccCCc--eEE
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVL---SKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il---~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.++ +.++||||+++++++.+.. |+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556788999999999999885 5689999987542 22234566676655 5668999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999887743 24899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .+..+. ......
T Consensus 154 ~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~-~~~~~~ 220 (324)
T cd05589 154 FGD------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIV-NDEVRY 220 (324)
T ss_pred CCC------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCCCC
Confidence 211 1234579999999999998889999999999999999999999996432211 111121 222335
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
|...+..+.+++.+||..+|.+||+..+..+..+
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 254 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDV 254 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence 5567788999999999999999998765443333
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=333.39 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=190.4
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC-------Cce
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------HGC 472 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------~~~ 472 (757)
.|....+||+|+||.||+|... +..||||.+.... ......+.+|+.+|++++||||+++++++.. ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3677889999999999999875 5689999986432 2234568899999999999999999998732 238
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988886443 4899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCCccccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-------------
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------------- 617 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~------------- 617 (757)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........
T Consensus 154 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCc---cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 432211 111234579999999998865 67899999999999999999999999643321110
Q ss_pred ----hchhhHHHHhhhhcCCCC-------hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 618 ----IDEDNLAEILDAQAGDWP-------IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 618 ----~~~~~l~~~ld~~~~~~p-------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+........+.......+ ...+..+.+++.+||..+|.+||++.+++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 000111111111111011 12356788999999999999999998533
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.75 Aligned_cols=243 Identities=24% Similarity=0.412 Sum_probs=194.8
Q ss_pred eeccCCcEEEEEEEEC----CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~gs 482 (757)
.||+|+||.||+|.+. +..+|+|++..... ...+.|.+|+.+++.+.||||++++|++.+. .++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999763 46899999865432 2456789999999999999999999998654 489999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~ 562 (757)
|.+++.... .+++..+..++.|++.||.|||..+ |+||||||.|||++.++.+||+|||++..+........
T Consensus 82 L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~-- 153 (257)
T cd05116 82 LNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-- 153 (257)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee--
Confidence 999886543 4889999999999999999999988 99999999999999999999999999987654332111
Q ss_pred ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhHHH
Q 004388 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETK 640 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~ 640 (757)
......+++.|+|||++..+.++.++|||||||++|||+| |++||...... .+...+... ....|...+.
T Consensus 154 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 225 (257)
T cd05116 154 -AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------EVTQMIESGERMECPQRCPP 225 (257)
T ss_pred -ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHCCCCCCCCCCCCH
Confidence 1122345689999999988889999999999999999998 99999643211 122222222 2345556788
Q ss_pred HHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 641 ELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
.+.+++.+||+.+|.+||++. .|...|+
T Consensus 226 ~l~~li~~~~~~~p~~Rp~~~-~i~~~l~ 253 (257)
T cd05116 226 EMYDLMKLCWTYGVDERPGFA-VVELRLR 253 (257)
T ss_pred HHHHHHHHHhccCchhCcCHH-HHHHHHh
Confidence 999999999999999999998 4555554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=334.62 Aligned_cols=244 Identities=25% Similarity=0.297 Sum_probs=192.3
Q ss_pred CCccceeeccCCcEEEEEEEE-----CCeEEEEEEEccCC----chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--
Q 004388 404 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~-- 471 (757)
+|...++||+|+||.||++.. .+..||+|++.... ....+.+..|+.++..+ +||||+.+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477888999999999999876 35689999986432 22345678899999999 4999999999886554
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 79999999999999886543 4888999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||........ ...+...+...
T Consensus 155 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~ 226 (332)
T cd05614 155 FLSEEKE-----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC 226 (332)
T ss_pred ccccCCC-----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC
Confidence 5432211 11345799999999988764 478899999999999999999999964321111 01111111122
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
....|...+..+.+++.+||..+|.+||+..
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 2334455678899999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.04 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=196.2
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~E 476 (757)
+|+..++||+|+||.||++... ++.||+|++..... .....+.+|+.+++.++||||+++++.+.+. .++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999875 56999999865422 2234578899999999999999999988654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886543 245899999999999999999999987 9999999999999999999999999998754322
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+...+.......+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~ 226 (285)
T cd05605 157 T-------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQEEYSE 226 (285)
T ss_pred c-------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcccccCc
Confidence 1 123478999999999988889999999999999999999999996432111 001122222222334455
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccc
Q 004388 637 KETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+..+.+|+.+||..||.+||+..
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCC
Confidence 6778899999999999999999644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=326.44 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=192.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|.....||+|+||.||+|++. +..||+|++.... ......+.+|+.+++.++||||++++++|.+.. ++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888899999999999999986 4589999987542 233466889999999999999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++++.|..+.. .. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~-~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE-MP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh-cC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999877765432 22 34888999999999999999999988 9999999999999999999999999998764322
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH--------HHHh-
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL--------AEIL- 627 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l--------~~~l- 627 (757)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|++||..............+ ....
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 NA-----NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc-----cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 11 113357899999999998888999999999999999999999999754322211100000 0000
Q ss_pred -hhh--cCCC-------------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 -DAQ--AGDW-------------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 -d~~--~~~~-------------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
++. ...+ ....+..+.+|+.+||+.+|++||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 000 0001 1124567999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.91 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=201.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
++|.....||+|+||.||+|.+. ...||||++.... ......|.+|+.++.+++||||+++++++.+.. ++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46888899999999999999874 2379999887543 334567899999999999999999999886544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999865432 5899999999999999999999987 99999999999999999999999999988753
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... +......+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .....+.......
T Consensus 159 ~~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~ 228 (266)
T cd05033 159 SEAT----YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDGYRLP 228 (266)
T ss_pred cccc----eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHHHcCCCCC
Confidence 2211 11123355788999999988889999999999999999998 99998532211 1111122222223
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.+...+..+.+++.+|++.+|.+||++. +++..|+++
T Consensus 229 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~-ei~~~l~~~ 265 (266)
T cd05033 229 PPMDCPSALYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265 (266)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 3455678899999999999999999998 566666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=336.13 Aligned_cols=231 Identities=25% Similarity=0.311 Sum_probs=187.9
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
.||+|+||.||++... +..||+|++.... ......+..|+.++..++||||+++++++.+.. ||||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5899999999999874 5699999987542 223456788999999999999999999886544 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 82 LFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc----
Confidence 998886543 48899999999999999999997 56 99999999999999999999999999875432211
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.++.++.++|||||||+||+|+||+.||..... ..+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~~~p~~~~~~ 222 (325)
T cd05594 152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIRFPRTLSPE 222 (325)
T ss_pred --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCCCCCCCCCHH
Confidence 11335799999999999988999999999999999999999999964321 112222222233445567788
Q ss_pred HHHHHHHHhhccCCCCCc
Q 004388 642 LAALGLSCAELRRKDRPD 659 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs 659 (757)
+.+|+.+||+.+|.+|++
T Consensus 223 ~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred HHHHHHHHhhcCHHHhCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=334.00 Aligned_cols=239 Identities=23% Similarity=0.282 Sum_probs=190.4
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|... +..||||++.... ......+..|+.++..+ +||||++++++|.+.. +|||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999885 5589999987542 22345578899999998 7999999999986554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---- 151 (329)
T cd05588 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---- 151 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC----
Confidence 9998886543 4899999999999999999999988 99999999999999999999999999874322111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hhchhhHHHHhhhhcCCCChhHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ......+...+.......|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 229 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCC
Confidence 12345799999999999988999999999999999999999999964221110 00111222222222334455667
Q ss_pred HHHHHHHHHHhhccCCCCCcc
Q 004388 640 KELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
..+.+++.+||..+|.+||+.
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCC
Confidence 889999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.93 Aligned_cols=240 Identities=25% Similarity=0.297 Sum_probs=193.6
Q ss_pred eeeccCCcEEEEEEEE-----CCeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 409 LRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
+.||+|+||.||++.. .+..||+|++..... .....+.+|+++|++++||||+++++++.+.. |+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999865 357899999875422 23345778999999999999999999986554 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999999886543 4899999999999999999999988 99999999999999999999999999976543211
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .+..+. ......|...+
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~-~~~~~~p~~~~ 222 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMIL-KAKLGMPQFLS 222 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHH-cCCCCCCCCCC
Confidence 1134579999999999988889999999999999999999999996433211 111122 12223455567
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
..+.+|+.+||+.+|.+||++.++.+..
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~ 250 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEE 250 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence 8899999999999999999987644333
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.86 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=196.4
Q ss_pred cCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
+.|...+.||+|+||.||++.+.. ..+|+|.+.... .....|.+|+.+|++++||||++++++|.+.. ++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 347777889999999999998865 489999876432 33567899999999999999999999986544 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886543 24889999999999999999999988 999999999999999999999999999865432211
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
......++..|+|||++.+..++.++||||||+++|+|+| |++||......+ .+..+........|...
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~~ 226 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------VVEMISRGFRLYRPKLA 226 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCCCCCCCCC
Confidence 1123346678999999988889999999999999999999 899996433211 11112211122234445
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
+..+.+++.+||..+|.+||++.+ ++..
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~-l~~~ 254 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAE-LLRA 254 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHH-HHHh
Confidence 678999999999999999999985 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=323.00 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=199.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCCc--e
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~ 472 (757)
.+|.....||+|+||.||+|... +..||||.+...... ....|.+|+++|..++||||+++++++.+.. +
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 35667788999999999999763 257999998765443 4568999999999999999999999986544 8
Q ss_pred EEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 473 LVYEYMENGSLEDRLYRKNN-----------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
+||||+++|+|.+++...+. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999975431 245788999999999999999999988 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 620 (757)
||+|||++..+...... .......+++.|+|||++.++.++.++|||||||++|+|++ |..||.......
T Consensus 162 kl~d~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~----- 232 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE----- 232 (280)
T ss_pred EECCcccceecccCcce----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----
Confidence 99999999765332211 01123356789999999999999999999999999999999 999985332211
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
....+........+...+..+.+++.+||..+|.+||++.+ |+..|
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e-il~~l 278 (280)
T cd05049 233 -VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKD-IHERL 278 (280)
T ss_pred -HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHh
Confidence 11111111222334456788999999999999999999984 55544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=330.82 Aligned_cols=236 Identities=24% Similarity=0.305 Sum_probs=189.0
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|.+.+ ..||||++.... ......+..|..++..+ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 69999999999999864 589999987542 22344567788888764 8999999999986554 7999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05619 82 DLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---- 151 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----
Confidence 9999886532 4888999999999999999999988 99999999999999999999999999875322111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 222 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNPCYPRWLTRE 222 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCccCCHH
Confidence 113457999999999999888999999999999999999999999643221 11122222223344456778
Q ss_pred HHHHHHHHhhccCCCCCccchhh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.+++.+||+.+|.+||++.+.+
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHH
Confidence 99999999999999999997434
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.85 Aligned_cols=247 Identities=27% Similarity=0.328 Sum_probs=197.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|.....||.|+||.||+|... +..||||++.... ......+.+|+.++..++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999999999999986 6799999987542 233456889999999999999999999986554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998765 35888999999999999999999987 999999999999999999999999999876543
Q ss_pred CCC-----------------------ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccc
Q 004388 556 PSF-----------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612 (757)
Q Consensus 556 ~~~-----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~ 612 (757)
... ...........||+.|+|||++.+..++.++|||||||+||+|+||+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000112234579999999999999999999999999999999999999997543
Q ss_pred hhhhhhchhhHHHHhhh-hcCCCCh--hHHHHHHHHHHHHhhccCCCCCc-cch
Q 004388 613 KVETAIDEDNLAEILDA-QAGDWPI--KETKELAALGLSCAELRRKDRPD-LKN 662 (757)
Q Consensus 613 ~~~~~~~~~~l~~~ld~-~~~~~p~--~~~~~l~~Li~~Cl~~~p~~RPs-~~~ 662 (757)
.... ...+... .....|. ..+..+.+|+.+|+. +|.+||+ +.+
T Consensus 235 ~~~~------~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ 281 (350)
T cd05573 235 LQET------YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEE 281 (350)
T ss_pred HHHH------HHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHH
Confidence 2211 1122210 0011122 247889999999997 9999999 664
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.83 Aligned_cols=243 Identities=25% Similarity=0.378 Sum_probs=200.4
Q ss_pred cCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
..|+....||+|.||.||+|.+.. ..||+|++..+.. ...+++++|+.+|.++++|||..+||.+..+. .++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346666789999999999999875 4899999987643 34678899999999999999999999986554 689999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|.||++.+.|.... .+.+....-|+.+++.||.|||..+ .+|||||+.||||..+|.+||+|||.+-.+....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV- 165 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh-
Confidence 99999999885433 3467777889999999999999988 9999999999999999999999999998776543
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCCCCh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 636 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 636 (757)
.+...++|||.|||||++....|+.++||||||++.+||++|.||+...|.....+ ++... .+....
T Consensus 166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-------lIpk~~PP~L~~ 233 (467)
T KOG0201|consen 166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-------LIPKSAPPRLDG 233 (467)
T ss_pred -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-------eccCCCCCcccc
Confidence 23467799999999999998899999999999999999999999997665533211 11111 112222
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..++.|++++..||..+|+.||++.+.+
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LL 261 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELL 261 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 5678899999999999999999998533
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=331.42 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=190.2
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|.+. +..||+|++.... ......+..|..++..+ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 6999999999999985 4589999987542 22344567788888764 8999999999986654 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05620 82 DLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---- 151 (316)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC----
Confidence 9999886543 4788899999999999999999988 99999999999999999999999999874322111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+.+.+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~ 222 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------ELFESIRVDTPHYPRWITKE 222 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCCCCCCCCHH
Confidence 123457999999999999889999999999999999999999999643221 12222222233345556788
Q ss_pred HHHHHHHHhhccCCCCCccchhhh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQVL 665 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~vl 665 (757)
+.+++.+||+.+|.+||++.+.++
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 999999999999999999865443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.99 Aligned_cols=241 Identities=26% Similarity=0.415 Sum_probs=188.9
Q ss_pred CCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCCc--hhhHHHHHHHHHHHhc---CCCceeeeccccc-------
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACP------- 468 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l---~Hpniv~l~g~~~------- 468 (757)
+|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5778889999999999999873 46899998865432 2234567788887766 6999999999873
Q ss_pred CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 469 DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 469 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
...++||||+. ++|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 12389999996 68999886543 235899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
++...... ......||+.|+|||++....++.++|||||||++|+|+||++||........ +..+++
T Consensus 157 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~------~~~i~~ 223 (290)
T cd07862 157 ARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ------LGKILD 223 (290)
T ss_pred eEeccCCc-------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH------HHHHHH
Confidence 98654321 12345789999999999888899999999999999999999999975432221 111111
Q ss_pred hhc----CCC----------------------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 AQA----GDW----------------------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ~~~----~~~----------------------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... ..| ....+..+.+|+.+||+.+|++||++.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 100 001 1124567889999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.90 Aligned_cols=244 Identities=24% Similarity=0.432 Sum_probs=193.7
Q ss_pred eeccCCcEEEEEEEEC----CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCCCCH
Q 004388 410 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSL 483 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~gsL 483 (757)
.||+|+||.||+|.+. +..||+|++..... ...+.|.+|+.++++++||||++++++|... .++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999764 34699999876532 2346689999999999999999999998654 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.+++.... ..+++..+.+++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++..+........
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--- 153 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK--- 153 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcccee---
Confidence 99886433 35899999999999999999999987 99999999999999999999999999986554322111
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh-hhcCCCChhHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKETKE 641 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~~~~ 641 (757)
......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...... .+...+. ......|...+.+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGKRLDCPAECPPE 226 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCCCCCCCCCCHH
Confidence 1122344678999999988889999999999999999996 99999643221 1111221 1223445566789
Q ss_pred HHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 642 LAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+.+++.+||..+|++||++.+ |...|+
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~-i~~~l~ 253 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAK-VEERMR 253 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHH-HHHHHh
Confidence 999999999999999999984 555554
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.14 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=202.6
Q ss_pred CCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
+|.....||+|+||.||+|... +..+++|.+..........|.+|++++++++||||+++++++.+.. ++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4666788999999999999753 2368888887665555677999999999999999999999986554 899
Q ss_pred EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 475 YEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
|||+++++|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 999999999999875431 234899999999999999999999988 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 620 (757)
||+|||++......... .......|++.|+|||++.+..++.++|||||||++|+|+| |+.||.......
T Consensus 163 ~l~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 233 (291)
T cd05094 163 KIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE----- 233 (291)
T ss_pred EECCCCcccccCCCcee----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999765432211 11233467889999999988889999999999999999999 999985432211
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.+..+........+...+..+.+++.+||+.+|.+||++. .|+..|+.+.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~v~~~l~~~~ 283 (291)
T cd05094 234 -VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK-EIYKILHALG 283 (291)
T ss_pred -HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHH
Confidence 1111112222233445577899999999999999999998 5777777664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=332.81 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=189.9
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|... +..||+|++.... ......+..|+.++.++ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5999999999999885 4589999987542 22345577899998877 7999999999986544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---- 151 (329)
T cd05618 82 DLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---- 151 (329)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC----
Confidence 9998876543 4889999999999999999999988 99999999999999999999999999875332111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hhchhhHHHHhhhhcCCCChhHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ......+...+.......|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~ 229 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 229 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCC
Confidence 11345799999999999999999999999999999999999999953211110 01111222222222334566677
Q ss_pred HHHHHHHHHHhhccCCCCCccc
Q 004388 640 KELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+.+++.+||..+|.+||+..
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~~ 251 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGCH 251 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCCC
Confidence 8899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=347.90 Aligned_cols=256 Identities=23% Similarity=0.276 Sum_probs=204.9
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-
Q 004388 396 EEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH- 470 (757)
Q Consensus 396 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~- 470 (757)
..+.....+|.....||+|+||.||+|.. .+..||||++.... ......+.+|+.+|..++|+|++++++.+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 34455667899999999999999999987 46799999986543 33445688999999999999999998766321
Q ss_pred ---------ceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 471 ---------GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 471 ---------~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
.++||||+++|+|.+++.... ....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 268999999999999886532 3346899999999999999999999987 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||+||+.||......
T Consensus 182 vkL~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------ 251 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------ 251 (496)
T ss_pred EEEEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence 999999999876532211 1123457999999999999989999999999999999999999999643211
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..++.......|...+..+.+|+.+||..+|.+||++.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell 295 (496)
T PTZ00283 252 EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295 (496)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 11122222222334556778999999999999999999998643
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.90 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=197.7
Q ss_pred CCccceeeccCCcEEEEEEEEC--Ce----EEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~----~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~ 475 (757)
+|.....||.|+||.||+|.+. +. .+++|.+..... .....+..|+.++.+++||||++++|++.+.. ++++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~ 87 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT 87 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence 5667788999999999999873 33 477787754322 23356778888999999999999999986544 7899
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.+...
T Consensus 88 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 88 QLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999987543 35899999999999999999999987 999999999999999999999999999876533
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhc-CC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQA-GD 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~ 633 (757)
... .......++..|++||++.++.++.++|||||||++|||+| |+.||...... .+.+++.... ..
T Consensus 163 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~ 231 (279)
T cd05111 163 DKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA 231 (279)
T ss_pred Ccc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC
Confidence 211 11233467789999999988899999999999999999998 99999643221 1222222211 12
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.+...+..+..++.+||..+|.+||++.+ ++..|..+.
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rps~~e-l~~~l~~~~ 269 (279)
T cd05111 232 QPQICTIDVYMVMVKCWMIDENVRPTFKE-LANEFTRMA 269 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHHHH
Confidence 23345667899999999999999999984 666666554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=330.26 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=194.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.++|+...+||.|+||.||++.+. +..+|+|++.... ......+.+|+.+|++++||||++++++|.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 357888899999999999999986 4588999887542 234467899999999999999999999986554 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++...+ .+++.....++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999986543 4788899999999999999999753 29999999999999999999999999997654321
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--hc---------------
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--ID--------------- 619 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~--------------- 619 (757)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +.
T Consensus 159 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred --------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 12347899999999998888999999999999999999999998633211000 00
Q ss_pred -----------------hhhHHHHhhhhcCC----CCh-hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 620 -----------------EDNLAEILDAQAGD----WPI-KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 620 -----------------~~~l~~~ld~~~~~----~p~-~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
......+.+..... .+. ..+.++.+|+.+||+.+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell 297 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLM 297 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHh
Confidence 00001111111111 111 2356799999999999999999998633
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.38 Aligned_cols=251 Identities=23% Similarity=0.395 Sum_probs=198.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
++|....+||+|+||.||+|... +..||+|.+.... ...+.+.+|+.++++++||||+++++.+.+.. ++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46788899999999999999875 4579999876543 24567899999999999999999999886544 79999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999886543 235888899999999999999999987 999999999999999999999999999876532211
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
......++..|+|||++..+.++.++|||||||++|+|+| |+.||....... ....+........+...
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 229 (261)
T cd05072 160 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD------VMSALQRGYRMPRMENC 229 (261)
T ss_pred ----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCCCCCCCCC
Confidence 1123456788999999988889999999999999999998 999985322111 11111111111112245
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
+..+.+++.+||..+|.+||++. ++...|+.
T Consensus 230 ~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 260 (261)
T cd05072 230 PDELYDIMKTCWKEKAEERPTFD-YLQSVLDD 260 (261)
T ss_pred CHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 67899999999999999999998 57666654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=331.27 Aligned_cols=236 Identities=28% Similarity=0.352 Sum_probs=187.0
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHH-HHHhcCCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~-il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++.+.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999985 56899999865321 22234555555 467899999999999886544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC----
Confidence 9999886543 4888899999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||++||......+ .+..++.. ....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~-~~~~~~~~~~~ 222 (323)
T cd05575 152 --TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNK-PLRLKPNISVS 222 (323)
T ss_pred --ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcC-CCCCCCCCCHH
Confidence 1234579999999999999899999999999999999999999996432111 11122221 12234456788
Q ss_pred HHHHHHHHhhccCCCCCccchhh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.+++.+|++.+|.+||+..+.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~ 245 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAKDDF 245 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCCCCH
Confidence 99999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.53 Aligned_cols=240 Identities=24% Similarity=0.277 Sum_probs=190.8
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|... +..||+|++.... ......+.+|+.++.++ +||||+.+++++.+.. |+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999875 4589999987542 22345578899999888 6999999999886544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---- 151 (327)
T cd05617 82 DLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---- 151 (327)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC----
Confidence 9998886543 4899999999999999999999988 99999999999999999999999999875322111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||+||+|+||+.||..............+...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 229 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVK 229 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 113457999999999999899999999999999999999999999632211111111122222222233455566788
Q ss_pred HHHHHHHHhhccCCCCCccc
Q 004388 642 LAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~ 661 (757)
+.+++.+||..+|.+||+..
T Consensus 230 ~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 99999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.60 Aligned_cols=245 Identities=26% Similarity=0.346 Sum_probs=192.7
Q ss_pred cCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCceeeecccc----cCCceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGAC----PDHGCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpniv~l~g~~----~~~~~LV 474 (757)
++|...++|++|+||.||+|+++. ..||+|.++.+... ..-.-++||.+|.+++|||||.+-.+. .+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 357777899999999999999874 58999998765422 112247999999999999999886554 4566999
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||||+. +|..++.... .++...++..++.|++.||.|||.+. |+||||||+|+|++..|.+||+|||||+.+..
T Consensus 156 Me~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999985 8888886554 46888899999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh-hcC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~ 632 (757)
... ..+..+-|.+|.|||.+.+. .|+...|+||+|||+.||++++|-|.......+.- .+..++-. .-.
T Consensus 230 p~k------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~---~If~llGtPte~ 300 (419)
T KOG0663|consen 230 PLK------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD---KIFKLLGTPSEA 300 (419)
T ss_pred Ccc------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH---HHHHHhCCCccc
Confidence 532 34667899999999977654 69999999999999999999999997554433211 11111100 001
Q ss_pred CCC--------------------------hh-HHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 DWP--------------------------IK-ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 ~~p--------------------------~~-~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.|| .. .+..-.+|+...+.+||++|-|+.+
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 121 11 2356788999999999999999885
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=331.02 Aligned_cols=233 Identities=24% Similarity=0.307 Sum_probs=189.1
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|... ++.||||++.... ......+..|+.++..+ +||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999885 5689999987532 23345677899999876 6999999999986554 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---- 151 (320)
T cd05590 82 DLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---- 151 (320)
T ss_pred hHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC----
Confidence 9999886543 4888999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... +...+.......|...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~ 222 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVVYPTWLSQD 222 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-------HHHHHhcCCCCCCCCCCHH
Confidence 1234579999999999998889999999999999999999999996443211 1122222222344456788
Q ss_pred HHHHHHHHhhccCCCCCccc
Q 004388 642 LAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~ 661 (757)
+.+++.+||+.+|.+||+..
T Consensus 223 ~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHcccCHHHCCCCC
Confidence 99999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.07 Aligned_cols=250 Identities=22% Similarity=0.372 Sum_probs=194.0
Q ss_pred ccceeeccCCcEEEEEEEECCe----EEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC--------Cc
Q 004388 406 SENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------HG 471 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~~~----~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--------~~ 471 (757)
....+||+|+||.||+|.+... .+|+|.+.... ......|.+|+.+++.++||||++++++|.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4567899999999999987543 58999876542 3345678899999999999999999998632 23
Q ss_pred eEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 472 CLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
++||||+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 79999999999998875321 2235899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
++.+....... ......+++.|++||+.....++.++|||||||++|+|++ |+.||...... .+.+.+
T Consensus 159 ~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~ 227 (272)
T cd05075 159 SKKIYNGDYYR----QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYL 227 (272)
T ss_pred ccccCccccee----cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH
Confidence 98765432110 1123356778999999998889999999999999999999 88998643211 111111
Q ss_pred h-hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 628 D-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 628 d-~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
. ......+...+..+.+++.+||..+|.+||++.+ ++..|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-l~~~l~~ 270 (272)
T cd05075 228 RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFET-LRCELEK 270 (272)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHHHh
Confidence 1 1111233456678999999999999999999984 6555554
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.80 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=186.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
.+|...++||+|+||.||++.+. +..||+|... ...+.+|+.+|++++|||||++++++... .|+||||+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 46888899999999999999885 4589999643 23577899999999999999999988544 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
. ++|..++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 5 78888876543 4889999999999999999999987 99999999999999999999999999975432211
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh--------------------
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-------------------- 618 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-------------------- 618 (757)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..........
T Consensus 238 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 ----NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ----cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 11234589999999999998899999999999999999999998764221110000
Q ss_pred --c-hhhHHHHh----hhh------cCCCC--hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 619 --D-EDNLAEIL----DAQ------AGDWP--IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 619 --~-~~~l~~~l----d~~------~~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ...+.... ... ...|. ...+.++.+|+.+||+.||.+||++.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~e 372 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHH
Confidence 0 00011111 000 00111 124568999999999999999999985
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=336.18 Aligned_cols=239 Identities=26% Similarity=0.402 Sum_probs=185.2
Q ss_pred ccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCC
Q 004388 406 SENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
...++||.|+||.||+|.+. +..||||++..... .....|.+|+++|+.++||||+++++++.+.. ++||||+++
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 34467999999999999885 56999999865432 34567899999999999999999999986654 799999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+.. ...+..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 157 ~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--- 223 (353)
T PLN00034 157 GSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--- 223 (353)
T ss_pred Ccccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc---
Confidence 9986532 2456677889999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccCCcccccCCCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
......||+.|+|||++.. ...+.++|||||||++|||++|+.||......... .....+........+
T Consensus 224 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~ 297 (353)
T PLN00034 224 ---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA---SLMCAICMSQPPEAP 297 (353)
T ss_pred ---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH---HHHHHHhccCCCCCC
Confidence 1134579999999998743 23456899999999999999999999732211100 001111111122234
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+..+.+|+.+||..+|.+||++.++
T Consensus 298 ~~~~~~l~~li~~~l~~~P~~Rpt~~el 325 (353)
T PLN00034 298 ATASREFRHFISCCLQREPAKRWSAMQL 325 (353)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 4567889999999999999999999853
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=331.19 Aligned_cols=233 Identities=25% Similarity=0.319 Sum_probs=188.0
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|...+ ..||||++.... ......+..|..++..+ +||||+++++++.+.. ||||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 58999999999999864 589999987542 22345577899999876 7999999999986544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence 9999886543 4888999999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||++||...... ..+..+. ......|...+.+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~-~~~~~~p~~~~~~ 222 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESIL-HDDVLYPVWLSKE 222 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCCCCCCCCCHH
Confidence 123457999999999999889999999999999999999999999644321 1111222 1122334456788
Q ss_pred HHHHHHHHhhccCCCCCccc
Q 004388 642 LAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~ 661 (757)
+.+++.+||+.+|.+||+..
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~ 242 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCV 242 (321)
T ss_pred HHHHHHHHhccCHHHcCCCC
Confidence 99999999999999999643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.46 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=208.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCceeeecccccCCc---eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG---CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~---~LV~ 475 (757)
.+|.....||+|+||.++.++.+ +..+++|.+...... .+....+|+.++++++|||||.+.+.|.+.. ||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777889999999999987764 568999988765432 3345788999999999999999999997655 7899
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
+|++||+|.+.+.+.. ..-++...+..|+.|++.|+.|||... |+|||||+.|||++.++.+||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998765 345899999999999999999999877 999999999999999999999999999998866
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.+. ....+|||.||.||.+.+.+|+.|+|||||||++|||++-+++|...+.. +...++........|
T Consensus 160 ~~~------a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 160 DSL------ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELILKINRGLYSPLP 227 (426)
T ss_pred hhh------hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHHHHhhccCCCCC
Confidence 432 24569999999999999999999999999999999999999999644322 122333333345567
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchhhh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQVL 665 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl 665 (757)
..++.+|..|+..|+..+|..||++.+.+.
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 788999999999999999999999986443
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.15 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=189.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.++|...++||.|+||.||+|... +..||||++..... .....+.+|+.+++.++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999985 56899999875432 23345788999999999999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+. ++|.+++.... ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 68888776533 34788899999999999999999988 9999999999999999999999999987543221
Q ss_pred CCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh-hcCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~ 634 (757)
. ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||.........+.. +...+.. ....|
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~ 229 (303)
T cd07869 158 H------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER--IFLVLGTPNEDTW 229 (303)
T ss_pred c------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhCCCChhhc
Confidence 1 1234578999999998764 45889999999999999999999999754332221110 0000000 00000
Q ss_pred ------------------C---------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 ------------------P---------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 ------------------p---------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+ ...+..+.+|+.+|++.+|++||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~ 284 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHH
Confidence 0 012356889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.78 Aligned_cols=241 Identities=24% Similarity=0.330 Sum_probs=188.4
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 483 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL 483 (757)
||+|+||.||++... +..||+|.+.... ......+..|++++++++||||+++++++.+.. ++||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 6699999886432 122344567999999999999999999886543 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------
Confidence 988865432 35889999999999999999999988 99999999999999999999999999976653221
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 643 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 643 (757)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ........+...........+.++.
T Consensus 151 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05607 151 -ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDEVKFEHQNFTEESK 227 (277)
T ss_pred -eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccccccccccCCHHHH
Confidence 1234789999999999888899999999999999999999999964321100 0111111111111111123567899
Q ss_pred HHHHHHhhccCCCCCccchhh
Q 004388 644 ALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 644 ~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+|+.+||+.+|.+||++.+.+
T Consensus 228 ~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 228 DICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHhccCHhhCCCCccch
Confidence 999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=316.33 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=199.6
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
+|...++||.|+||.||+|.+. ++.||+|++... ......+.+|+.++.+++||||++++++|.... ++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4677789999999999999875 568999998754 334567899999999999999999999986543 79999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 999999886543 245899999999999999999999987 999999999999999999999999999876532211
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhh-hcCCCChh
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIK 637 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~ 637 (757)
......++..|+|||++.+..++.++|||||||++|||+| |..||...... .+...+.. .....|..
T Consensus 161 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~ 229 (263)
T cd05052 161 ----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKGYRMERPEG 229 (263)
T ss_pred ----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCCCCCCCC
Confidence 1112234678999999988899999999999999999998 99998643211 11122221 12334555
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
.+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~-~l~~~l~~ 261 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFA-EIHQAFET 261 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHH-HHHHHHHh
Confidence 678999999999999999999998 46666654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.68 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=200.1
Q ss_pred cCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCC---
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH--- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~--- 470 (757)
.+|...+.||.|+||.||+|...+ +.||+|++..... .....+..|+.++.++ +||||++++++|...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 357788899999999999997532 4799999875432 2345678899999999 899999999988543
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 004388 471 GCLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 492 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 492 (757)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 3789999999999998864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccc
Q 004388 493 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572 (757)
Q Consensus 493 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 572 (757)
..+++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....... ......++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~----~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----hccCCCCCc
Confidence 126899999999999999999999987 9999999999999999999999999998765332211 122345678
Q ss_pred cCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHh
Q 004388 573 CYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCA 650 (757)
Q Consensus 573 ~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl 650 (757)
.|+|||++.+..++.++|||||||+||+|+| |..||...... ..+...+... ....|...+..+.+++.+||
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 313 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------EEFCRRLKEGTRMRAPEYATPEIYSIMLDCW 313 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------HHHHHHHhccCCCCCCccCCHHHHHHHHHHc
Confidence 8999999999999999999999999999998 99998532211 1111222111 12223445678999999999
Q ss_pred hccCCCCCccchhhhhHHHHHH
Q 004388 651 ELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 651 ~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
+.+|.+||++. +++..|+++.
T Consensus 314 ~~~p~~RPs~~-ell~~l~~~~ 334 (337)
T cd05054 314 HNNPEDRPTFS-ELVEILGDLL 334 (337)
T ss_pred cCChhhCcCHH-HHHHHHHHHH
Confidence 99999999998 5777776653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=338.67 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=189.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...++||.|+||.||++... +..||||++.... ......+.+|+.++.+++||||+++++++.+.. ||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999874 5689999986432 223456788999999999999999999987654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999886543 4888889999999999999999988 999999999999999999999999999643211
Q ss_pred CCCc----------cc-------------------------------cccccCCcccccCCCccccccCCCCCcchhhhH
Q 004388 556 PSFV----------ST-------------------------------TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 594 (757)
Q Consensus 556 ~~~~----------~~-------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSl 594 (757)
.... .. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 0000 00 000012479999999999988889999999999
Q ss_pred HHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCCCCh--hHHHHHHHHHHHHhhccCCCC---Cccch
Q 004388 595 GMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI--KETKELAALGLSCAELRRKDR---PDLKN 662 (757)
Q Consensus 595 Gvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~--~~~~~l~~Li~~Cl~~~p~~R---Ps~~~ 662 (757)
||+||||+||++||....... .+..++... ...+|. ..+..+.+|+.+|+. +|.+| |++.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE------TYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 999999999999996433211 111122110 111222 356789999999997 67765 46654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=338.84 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=191.4
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.|.....||+|+||.||+|... +..||||++.... ......+.+|+.+|.+++||||+++++++.+.. ++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778889999999999999885 4589999987542 223456889999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++||+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987543 4888889999999999999999988 9999999999999999999999999986432110
Q ss_pred CCc-----------------------------------------cccccccCCcccccCCCccccccCCCCCcchhhhHH
Q 004388 557 SFV-----------------------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 595 (757)
Q Consensus 557 ~~~-----------------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlG 595 (757)
... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 000 000011235799999999999888899999999999
Q ss_pred HHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCCCC--hhHHHHHHHHHHH--HhhccCCCCCccchh
Q 004388 596 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLS--CAELRRKDRPDLKNQ 663 (757)
Q Consensus 596 vil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~Li~~--Cl~~~p~~RPs~~~~ 663 (757)
|++|||+||++||........ ...++... ....| ...+.++.+|+.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999975432211 11122111 11122 2356788999988 445566679998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.61 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=194.5
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcC-CCceeeecccccCC--ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~--~~LV~ 475 (757)
+|+..+.||+|+||.||+|... +..||+|++.... ......+..|+.++..+. ||+|+.+++++.+. .++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677789999999999999875 5689999987542 223355778999998886 56777888887554 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999886543 4899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. ......||+.|+|||++.+..++.++|||||||++|+|+||++||...... ..+..++ .....+|
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~-~~~~~~p 221 (323)
T cd05615 155 GV------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIM-EHNVSYP 221 (323)
T ss_pred Cc------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCCCCC
Confidence 11 123457999999999999888999999999999999999999999643221 1112222 2223456
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchhhhh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQVLP 666 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~ 666 (757)
...+..+.+++.+||..+|.+|++..+....
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 252 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPEGER 252 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCCCHH
Confidence 6677889999999999999999997643333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=337.69 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=191.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||.|+||.||+|... ++.||||++.... ......+.+|+.+|..++||||+++++++.+.. +|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999885 5699999987532 223455788999999999999999999986654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987643 4889999999999999999999988 999999999999999999999999999765422
Q ss_pred CCCcc--------------------------------ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh
Q 004388 556 PSFVS--------------------------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603 (757)
Q Consensus 556 ~~~~~--------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt 603 (757)
..... ........+||+.|+|||++....++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000 0001123479999999999988899999999999999999999
Q ss_pred CCCCccccchhhhhhchhhHHHHhhhhc-CCCC--hhHHHHHHHHHHHHhhccCCCCCc
Q 004388 604 AKPAIAITHKVETAIDEDNLAEILDAQA-GDWP--IKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 604 G~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
|.+||........ +..++.... ...| ...+..+.+|+.+|+. +|.+|++
T Consensus 235 G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 235 GYPPFCSDNPQET------YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCCHHHH------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 9999975432211 111221110 0111 2346788999999996 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.03 Aligned_cols=233 Identities=25% Similarity=0.290 Sum_probs=189.3
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|.+. +..||||++.... ......+..|+.++..+ +||||+++++++.+.. |+||||++||
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5999999999999885 4589999987542 22345577899999888 6999999999886544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 151 (318)
T cd05570 82 DLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---- 151 (318)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----
Confidence 9998886543 4899999999999999999999988 99999999999999999999999999875322111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... .+...+.......|...+..
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~ 222 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------ELFQSILEDEVRYPRWLSKE 222 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCCCCCcCCHH
Confidence 113347999999999999999999999999999999999999999643321 11122222223345556788
Q ss_pred HHHHHHHHhhccCCCCCccc
Q 004388 642 LAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~ 661 (757)
+.+|+.+||..+|.+||++.
T Consensus 223 ~~~li~~~l~~dP~~R~s~~ 242 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCL 242 (318)
T ss_pred HHHHHHHHccCCHHHcCCCC
Confidence 99999999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.69 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=189.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.+|....+||.|+||.||+|... +..||+|++.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 35788889999999999999875 5689999986543 223456789999999999999999999986654 799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++ |+|.+++...+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CC-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 97 48988886543 24788899999999999999999988 99999999999999999999999999976543221
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-----------------
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------------- 619 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----------------- 619 (757)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......+....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1134578999999998765 5689999999999999999999999964322111000
Q ss_pred -hhhHHHHhhhhc-C----CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 -EDNLAEILDAQA-G----DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 -~~~l~~~ld~~~-~----~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+...+.+.. . ......+.++.+|+.+|+..+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 000000000000 0 001123567899999999999999999885
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=315.57 Aligned_cols=253 Identities=23% Similarity=0.372 Sum_probs=197.6
Q ss_pred CccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC--C-----
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--H----- 470 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~----- 470 (757)
|...+.||+|+||.||+|.... ..||+|.+.... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4566789999999999998742 479999987543 2334678999999999999999999998733 1
Q ss_pred -ceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 471 -GCLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
.++||||+++|+|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 379999999999999886432 2235899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
|+++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |.+||...... ..+..
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~ 227 (273)
T cd05035 158 GLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDY 227 (273)
T ss_pred cceeecccccccc----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 9998765432211 1122345678999999988889999999999999999999 88998543221 11122
Q ss_pred HhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 626 ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 626 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+........|...+..+.+++.+||..+|.+||++. +++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFT-KLREVLENI 272 (273)
T ss_pred HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 222222234456678999999999999999999998 466665543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=312.57 Aligned_cols=243 Identities=28% Similarity=0.406 Sum_probs=198.9
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||+|+||.||+|... +..|++|.+... .......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677788999999999999884 568999988643 2334567889999999999999999999987654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987642 346889999999999999999999987 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
......|++.|+|||++.++.++.++|+|||||++|+|+||+.||....... ....+........+..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKIIRGVFPPVSQM 224 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCCCCccc
Confidence 1133468899999999998889999999999999999999999997443211 1122222222233335
Q ss_pred HHHHHHHHHHHHhhccCCCCCccch
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+.+++.+||+.+|.+||++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ 249 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQ 249 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHH
Confidence 6788999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.89 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=197.6
Q ss_pred ccceeeccCCcEEEEEEEE------CCeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEE
Q 004388 406 SENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLV 474 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~------~~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV 474 (757)
.....||+|+||.||++.+ .+..||+|++..... .....|.+|+++|++++||||++++++|... .++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778899999999988764 245899999876532 3456788999999999999999999987532 3799
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999988643 3899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch-hhhh-------hchhhHHHH
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK-VETA-------IDEDNLAEI 626 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~-------~~~~~l~~~ 626 (757)
...... ......++..|+|||++....++.++||||||+++|+|+||..||..... .... .....+.+.
T Consensus 160 ~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYR---VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhc---cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 321100 01223456779999999888899999999999999999999999853221 1110 011122222
Q ss_pred hhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 627 LDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 627 ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
++... ...+...+..+.+++.+||+.+|.+||++. .++..|+.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR-SLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHH-HHHHHHHHhh
Confidence 22211 122345578999999999999999999998 4667766553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.39 Aligned_cols=250 Identities=22% Similarity=0.417 Sum_probs=196.3
Q ss_pred CCccceeeccCCcEEEEEEEE------CCeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLV 474 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~------~~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV 474 (757)
+|+...+||+|+||.||+|.+ .+..+++|.+.... ......|.+|+.+++.++||||+++++++... .++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 466778899999999999985 23588999887543 23346788999999999999999999997654 4899
Q ss_pred EEecCCCCHHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 475 YEYMENGSLEDRLYRKNN--------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~--------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
|||+++|+|.+++..... ...+++.....++.+++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 999999999999864321 224788899999999999999999987 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhc
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 619 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 619 (757)
+||+|||+++........ .......++..|+|||++.++.++.++|||||||++|||+| |.+||.....
T Consensus 163 ~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05090 163 VKISDLGLSREIYSADYY----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------ 232 (283)
T ss_pred EEeccccccccccCCcce----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999876432211 11123356788999999988889999999999999999998 9999853221
Q ss_pred hhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 620 EDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 620 ~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
..+.+.+... ....+...+..+.+++.+||..+|.+||++.+ |+..|
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l 280 (283)
T cd05090 233 -QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKD-IHTRL 280 (283)
T ss_pred -HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH-HHHHh
Confidence 1112222221 22334456788999999999999999999985 55544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.82 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=199.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC----Cce
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HGC 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~~ 472 (757)
.+|.....||+|+||.||+|... +..||+|.+..........|.+|++++.+++||||+++++++.. ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777889999999999999752 45899999877665566789999999999999999999997632 247
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999986543 34899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchh-hhhhc--------hhhH
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV-ETAID--------EDNL 623 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~-~~~~~--------~~~l 623 (757)
........ ......++..|+|||++.++.++.++|||||||++|||++|..|+...... ..... ...+
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYYK---VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCccee---ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 54332111 011223456699999998888999999999999999999997765422111 00000 0112
Q ss_pred HHHhhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 624 AEILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 624 ~~~ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.+.+.... ...+...+..+.+|+.+||..+|.+||++. +|+..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS-ELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHhc
Confidence 22222211 112334567899999999999999999998 466666543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=314.16 Aligned_cols=246 Identities=28% Similarity=0.462 Sum_probs=195.8
Q ss_pred eeeccCCcEEEEEEEECC-----eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCCC
Q 004388 409 LRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENG 481 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~g 481 (757)
++||+|+||.||+|.+.. ..+|+|.+..... .....+.+|+.+++++.||||+++++++... .++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 369999999999998632 4799999876544 2456789999999999999999999988644 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..++.|++.||.|||..+ ++||||||+|||++.++.+||+|||+++.+........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~- 153 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR- 153 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc-
Confidence 9999997544 5899999999999999999999988 99999999999999999999999999987654332111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKET 639 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~ 639 (757)
......++..|+|||.+.+..++.++|||||||++|+|+| |.+||...... .+...+... ....|...+
T Consensus 154 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd05060 154 --ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-------EVIAMLESGERLPRPEECP 224 (257)
T ss_pred --cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-------HHHHHHHcCCcCCCCCCCC
Confidence 1122334678999999988889999999999999999998 99999643221 111122111 123344567
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+.+++.+||..+|.+||++. .++..|+.+
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 255 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFS-ELESTFRRD 255 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHH-HHHHHHHhc
Confidence 8899999999999999999998 466666543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.56 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=199.0
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
..+|.....||.|+||.||+|.+.+ +.||+|.+.... ...+.|.+|+.++++++||||+++++++... .++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 3468888999999999999998754 579999987543 3456789999999999999999999988654 38999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986544 345899999999999999999999987 999999999999999999999999999876532110
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 636 (757)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||...... .+...++.. ....+.
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~ 227 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-------EVLQQVDQGYRMPCPP 227 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCCCCC
Confidence 1122234568999999988889999999999999999999 99999643211 111122211 112344
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
..+..+.+++.+|+..+|.+||++.+ +...|+
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~-l~~~l~ 259 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFET-LQWKLE 259 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHH-HHHHHh
Confidence 56788999999999999999999984 555554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.00 Aligned_cols=247 Identities=26% Similarity=0.316 Sum_probs=200.6
Q ss_pred CCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchh---hHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~---~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.|...++||.|.-|+||++.+.+ ..+|+|++....... ..+.+.|-+||+.++||.++.||..+.... |||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45556789999999999999987 489999998765433 345677999999999999999999996544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
||+||+|..+++++. ...++...+..++.+|+.||+|||..| ||+|||||+||||-++|++.|+||.|+......+
T Consensus 158 yCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999877655 356899999999999999999999998 9999999999999999999999999986543211
Q ss_pred CC--------------------------------------------------ccccccccCCcccccCCCccccccCCCC
Q 004388 557 SF--------------------------------------------------VSTTYKNTGPVGTLCYIDPEYQRTGLIS 586 (757)
Q Consensus 557 ~~--------------------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 586 (757)
.. ..+..+...++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 0011223346899999999999999999
Q ss_pred CcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--CCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 587 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 587 ~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.++|+|+|||+|||||.|..||..... +..+..++-... +..| ..+..+.+||.+.|.+||.+|-...
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~------~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN------KETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc------hhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccc
Confidence 999999999999999999999975543 334455554332 2222 5678999999999999999998844
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.77 Aligned_cols=252 Identities=27% Similarity=0.465 Sum_probs=204.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..+|...++||.|+||.||+|.+. +..+++|++..........+..|+.+++.++||||+++++++.+.. ++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 456788889999999999999875 4689999988766555677899999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++.... ...+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 85 EKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred ccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999987643 345899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
......++..|++||++..+.++.++||||||+++|+|++ |+.||...... ..+..+........+..
T Consensus 160 -----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 228 (261)
T cd05148 160 -----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQITAGYRMPCPAK 228 (261)
T ss_pred -----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHHhCCcCCCCCC
Confidence 1123456788999999988889999999999999999998 89999543211 11222222222333456
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
.+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~-~l~~~L~~ 260 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFK-ALREELDN 260 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHH-HHHHHHhc
Confidence 678899999999999999999998 46666653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.41 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=196.4
Q ss_pred CCccceeeccCCcEEEEEEEECCe-EEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
+|.....||+|+||.||+|.+.+. .+|+|.+.... .....|.+|+.++.+++||||++++++|.+.. ++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466778899999999999988654 69999876543 33467999999999999999999999986544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++..... .+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--- 155 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce---
Confidence 999998865432 5899999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
.......++..|++||++.++.++.++|||||||++|+|+| |+.||....... ....+........+...+
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKVSQGLRLYRPHLAS 227 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHhcCCCCCCCCCCC
Confidence 01123356778999999988889999999999999999999 999986332211 111122222222344457
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
..+.+++.+||..+|.+||++.+ ++..
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~-ll~~ 254 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQ-LLSS 254 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHH-HHHh
Confidence 88999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.89 Aligned_cols=238 Identities=28% Similarity=0.330 Sum_probs=187.3
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHH-HHHhcCCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~-il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|... +..||+|++..... .....+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999985 56899999865321 22334555554 578899999999999886544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+.+.... .++...+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 82 ELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----
Confidence 9998886533 4778888899999999999999987 99999999999999999999999999875322111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||++||...+... ....++ ......|......
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~-~~~~~~~~~~~~~ 222 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNIL-HKPLQLPGGKTVA 222 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHh-cCCCCCCCCCCHH
Confidence 1234579999999999988889999999999999999999999996432111 111122 1223345556788
Q ss_pred HHHHHHHHhhccCCCCCccchhhhh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQVLP 666 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~vl~ 666 (757)
+.+++.+|++.+|.+||+....+++
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCCHHH
Confidence 9999999999999999997654443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=320.13 Aligned_cols=253 Identities=25% Similarity=0.461 Sum_probs=199.0
Q ss_pred CCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
+|.....||+|+||.||+|.... ..+++|.+..... .....+.+|+.+++.++||||+++++.|.... ++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 36677889999999999998642 4688888765432 33467889999999999999999999986544 89
Q ss_pred EEEecCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCC
Q 004388 474 VYEYMENGSLEDRLYRKN---------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 532 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~N 532 (757)
||||+.+|+|.+++.... ...++++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1235889999999999999999999987 9999999999
Q ss_pred eeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCcccc
Q 004388 533 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAIT 611 (757)
Q Consensus 533 ILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~ 611 (757)
||+++++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYV----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchh----cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999998654332211 1123356778999999888889999999999999999999 99998533
Q ss_pred chhhhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 612 HKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 612 ~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.. ..+.+.+... ....|...+..+.+++.+|++.+|.+||++. +++..|+.+
T Consensus 234 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~-~i~~~l~~~ 286 (290)
T cd05045 234 AP-------ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFA-DISKELEKM 286 (290)
T ss_pred CH-------HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHH
Confidence 21 1222222221 1223445677899999999999999999998 466666654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=337.91 Aligned_cols=253 Identities=28% Similarity=0.433 Sum_probs=204.2
Q ss_pred CCccceeeccCCcEEEEEEEECC------eEEEEEEEccC---CchhhHHHHHHHHHHHhcCCCceeeecccccCC--ce
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GC 472 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~------~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~ 472 (757)
+....++||+|.||.||+|.+.- ..||||..+.. ......+|++|.++|++++|||||+|||++... .+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34445799999999999998742 13899988853 345667899999999999999999999998544 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
||||+|.||+|.++|.+.+. .++..++.+++.++|.||+|||+.+ +|||||-..|+|++.++.+||+||||++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999987664 4899999999999999999999988 999999999999999999999999998754
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHH-hhhh
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEI-LDAQ 630 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~-ld~~ 630 (757)
.... .. .....-...|+|||.+..+.|+.++|||||||++||+++ |..||......+ ....+ ....
T Consensus 313 ~~~~---~~---~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~kI~~~~~ 380 (474)
T KOG0194|consen 313 SQYV---MK---KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKAKIVKNGY 380 (474)
T ss_pred ccee---ec---cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHHHHHhcCc
Confidence 3111 00 011134678999999999999999999999999999998 888986443321 11222 2233
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
....|...+..+..++.+||..+|.+||+|. .+...|+.+...
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~-~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMS-TIKKKLEALEKK 423 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCHH-HHHHHHHHHHhc
Confidence 3445667788999999999999999999998 577777777654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=321.38 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=202.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
..++|.....||+|+||.||++...+ ..+|+|.+.... ......+.+|++++.++ +||||++++++|.+..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34567888899999999999998642 478999887543 23345688999999999 7999999999986654
Q ss_pred --eEEEEecCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 472 --CLVYEYMENGSLEDRLYRK-------------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 8999999999999998643 22346899999999999999999999987 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 615 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~ 615 (757)
.++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYR----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE- 241 (293)
T ss_pred CCCeEEeCcccccccccccccee----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-
Confidence 99999999999998765432111 1122345678999999888889999999999999999997 99998533211
Q ss_pred hhhchhhHHHHhh-hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 616 TAIDEDNLAEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 616 ~~~~~~~l~~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.+...+. ......+...+..+.+|+.+||..+|.+||++. +++..|+.+
T Consensus 242 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-eil~~l~~~ 291 (293)
T cd05053 242 ------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291 (293)
T ss_pred ------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHHHHh
Confidence 1112222 112334556678899999999999999999998 466666554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.86 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=196.3
Q ss_pred CCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC---CceEEEEecCC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCLVYEYMEN 480 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~LV~Ey~~~ 480 (757)
+|.....||+|+||.||+|...+..+|+|.+.... ..+.|.+|+.++++++|||++++++++.. ..++||||+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 57778899999999999999999999999986543 34578999999999999999999997632 34899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++..... ..+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 85 GSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence 999998865432 35889999999999999999999987 9999999999999999999999999987644321
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh-hhcCCCChhH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKE 638 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~ 638 (757)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... +...+. ......+...
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 224 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPDGC 224 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhcCCCCCCCCCC
Confidence 12345678999999988889999999999999999998 999985322111 111111 1112334456
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+..+.+++.+||..+|.+||++.+ ++..|+
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l~ 254 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQ-LREQLE 254 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHH-HHHHHh
Confidence 788999999999999999999984 555554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.11 Aligned_cols=238 Identities=27% Similarity=0.341 Sum_probs=186.7
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHH-HHHhcCCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~-il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|.+. +..||+|++..... .....+..|.. +++.++||||+++++++.+.. ++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5999999999999885 45899999865321 12233444544 567889999999999886544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 82 ELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----
Confidence 9999886543 3777888889999999999999988 99999999999999999999999999975432211
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|++|++||......+ .+..+.. .....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~~~~~~~~~~~~ 222 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILN-KPLQLKPNITNS 222 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHh-CCcCCCCCCCHH
Confidence 1234579999999999998899999999999999999999999996432211 1112221 122233456788
Q ss_pred HHHHHHHHhhccCCCCCccchhhhh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQVLP 666 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~vl~ 666 (757)
+.+++.+|++.+|.+||+..+.+..
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHH
Confidence 9999999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=314.87 Aligned_cols=255 Identities=25% Similarity=0.448 Sum_probs=200.3
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
.++|+..+.||+|+||.||+|.... ..+|+|.+.... ......|.+|+.++.+++|||++++++++.+.. ++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3467888899999999999998742 268999886543 334567899999999999999999999986544 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999886533 35899999999999999999999987 9999999999999999999999999998665
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
..... .........++.|+|||++.++.++.++|||||||++|+|+| |+.||...... .....+......
T Consensus 159 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~~~~ 229 (268)
T cd05063 159 DDPEG---TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGFRL 229 (268)
T ss_pred ccccc---ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcCCCC
Confidence 33211 111122234567999999988889999999999999999998 99999533211 111112111122
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+...+..+.+++.+||..+|.+||++. .|+..|+++
T Consensus 230 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~i~~~l~~~ 267 (268)
T cd05063 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267 (268)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 33445678899999999999999999998 466666543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=319.01 Aligned_cols=238 Identities=22% Similarity=0.351 Sum_probs=197.9
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.|.+...||+|.||.|-++..+ ++.||||.++.+... +.-.+.+||+||+.|+||||+.+|.+|.... .||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 4666778999999999999864 679999998876443 3445789999999999999999999997554 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|..+|.|+|++...+. |+..+...++.||.+|+.|+|.+. ++|||||.+|||||.|+.+||+||||+.++....
T Consensus 134 YaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 134 YASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred ecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999987664 899999999999999999999988 9999999999999999999999999998876543
Q ss_pred CCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
+ -+.+||+|.|.+||+.++..| ++.+|-|||||+||-|+.|.-||+..+. ..+..-+....- ..
T Consensus 208 -f------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------k~lvrQIs~GaY-rE 272 (668)
T KOG0611|consen 208 -F------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------KRLVRQISRGAY-RE 272 (668)
T ss_pred -H------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-------HHHHHHhhcccc-cC
Confidence 2 245799999999999998877 5889999999999999999999975432 222222222111 12
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+..+....-||.+||-.+|..|.++.+
T Consensus 273 P~~PSdA~gLIRwmLmVNP~RRATieD 299 (668)
T KOG0611|consen 273 PETPSDASGLIRWMLMVNPERRATIED 299 (668)
T ss_pred CCCCchHHHHHHHHHhcCcccchhHHH
Confidence 234567788999999999999999875
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=317.72 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=199.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--Ce----EEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~----~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV 474 (757)
.+|....+||.|+||.||+|.+. +. .||+|++..... .....+.+|+.++..+.||||++++++|... .+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 46777889999999999999863 22 489999875433 3456788999999999999999999998654 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999886533 35899999999999999999999988 99999999999999999999999999987754
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 632 (757)
.... .......+++.|++||+..+..++.++|||||||++|||+| |.+||..... ..+...+... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~ 230 (279)
T cd05109 162 DETE----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------REIPDLLEKGERL 230 (279)
T ss_pred ccce----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCcC
Confidence 3221 11123345788999999988889999999999999999998 9999853221 1122222221 11
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+...+..+.+++.+||..+|..||++.+ ++..|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~-l~~~l~~~ 268 (279)
T cd05109 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRE-LVDEFSRM 268 (279)
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHh
Confidence 223456778999999999999999999985 55665544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=333.51 Aligned_cols=248 Identities=22% Similarity=0.285 Sum_probs=189.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||++... +..||||++.... ......+.+|+.++.+++||||+++++.+.+.. ||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999999999999875 5689999987532 223356788999999999999999999987654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999987643 4889999999999999999999988 999999999999999999999999999765421
Q ss_pred CCCc-----------------------------cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCC
Q 004388 556 PSFV-----------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606 (757)
Q Consensus 556 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~ 606 (757)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 00000124589999999999988899999999999999999999999
Q ss_pred CccccchhhhhhchhhHHHHhhhh-cCCCC--hhHHHHHHHHHHHHhh--ccCCCCCccch
Q 004388 607 AIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLSCAE--LRRKDRPDLKN 662 (757)
Q Consensus 607 Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~Li~~Cl~--~~p~~RPs~~~ 662 (757)
||......+ .+..++... ....| ...+..+.+++.+++. .++..||++.+
T Consensus 235 Pf~~~~~~~------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~e 289 (363)
T cd05628 235 PFCSETPQE------TYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCCHHH------HHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence 996433221 111121100 01112 1245678888887543 23345677764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=317.24 Aligned_cols=254 Identities=23% Similarity=0.304 Sum_probs=200.4
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEc--cCCchhhHHHHHHHHHHHhcCCCceeeecccccC------
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQ--SKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------ 469 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~--~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------ 469 (757)
.....|.....||.|+||.|..+.+. +..||||.+. .......++..+|+.+|+.++|+||+.+++.+..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34445666778999999999999885 5699999987 4555666788999999999999999999998743
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
..|+|+|+| +.+|...+.... .++......++.||+.||.|+|+.+ |+||||||+|+|++.+..+||||||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 228999999 478888876543 3888888999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh----------
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA---------- 617 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---------- 617 (757)
|+..... .....+|..+.|.+|.|||++ ....|+...||||.||||.|||+|++-|...+.+.+.
T Consensus 172 AR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 172 ARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 9988654 223345778999999999965 4567999999999999999999999999755444331
Q ss_pred -------hchhhHHHHhhhhc--CCCC-----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 618 -------IDEDNLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 618 -------~~~~~l~~~ld~~~--~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+........+.... ...| +...+...+|+.+||..||.+|+|..+.+
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL 308 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEAL 308 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHh
Confidence 11111222222111 1111 14567889999999999999999988633
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=319.35 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=198.2
Q ss_pred CCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
+|....+||+|+||.||++... +..+|+|.+..........|.+|+++++.++||||+++++++.+.. ++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4566778999999999999642 3478999887666566678999999999999999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceE
Q 004388 475 YEYMENGSLEDRLYRKNN------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 542 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~K 542 (757)
|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence 999999999999875431 134889999999999999999999988 99999999999999999999
Q ss_pred EeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchh
Q 004388 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDED 621 (757)
Q Consensus 543 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 621 (757)
|+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|+| |++||.......
T Consensus 163 L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------ 232 (280)
T cd05092 163 IGDFGMSRDIYSTDYY----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------ 232 (280)
T ss_pred ECCCCceeEcCCCcee----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------
Confidence 9999999765432211 01122345788999999988889999999999999999998 999985332211
Q ss_pred hHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 622 ~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.+..+........+...+..+.+|+.+||..+|.+||++.+ |+..|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~-l~~~l 278 (280)
T cd05092 233 AIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKD-IHSRL 278 (280)
T ss_pred HHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHH-HHHHH
Confidence 11222222222233456788999999999999999999984 55544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=320.47 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=197.8
Q ss_pred CccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCC--ceEE
Q 004388 405 FSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLV 474 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV 474 (757)
|....+||.|+||.||+|.+. +..||+|++...... ....|.+|+.++..++||||+++++++.+. .+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 555678999999999999864 257999998755432 345688999999999999999999998654 4889
Q ss_pred EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 475 YEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
+||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999985321 1234788899999999999999999988 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 620 (757)
||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||+| |.+||..... .
T Consensus 164 kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~ 233 (283)
T cd05091 164 KISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------Q 233 (283)
T ss_pred Eecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------H
Confidence 99999998865432211 11123456789999999988889999999999999999998 8888853321 1
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+.+..+.+......+...+..+.+|+.+||+.+|.+||++.+ |+..|+
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~-i~~~l~ 281 (283)
T cd05091 234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKD-IHSRLR 281 (283)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH-HHHHhh
Confidence 122233333333445667888999999999999999999984 555543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=314.38 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=198.9
Q ss_pred cCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMEN 480 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~ 480 (757)
.+|....+||+|+||.||+|.+.+ ..||+|++..... ....|.+|+.++++++||||+++++++.+. .++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 458888999999999999998764 4799999875332 346789999999999999999999987544 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+......
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-- 158 (262)
T cd05071 85 GSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 158 (262)
T ss_pred CcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc--
Confidence 99999987532 235789999999999999999999987 999999999999999999999999999876533211
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......++..|++||+..++.++.++|||||||++|+|+| |.+||...... ..+..+........+...+
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~ 229 (262)
T cd05071 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYRMPCPPECP 229 (262)
T ss_pred ---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCCCCCCccccC
Confidence 1123456788999999988889999999999999999999 88888533211 1111111111112234567
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
..+.+++.+|++.+|.+||++. +++..|+.
T Consensus 230 ~~l~~li~~~l~~~p~~Rp~~~-~~~~~l~~ 259 (262)
T cd05071 230 ESLHDLMCQCWRKEPEERPTFE-YLQAFLED 259 (262)
T ss_pred HHHHHHHHHHccCCcccCCCHH-HHHHHHHH
Confidence 8899999999999999999998 46555543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=317.22 Aligned_cols=253 Identities=22% Similarity=0.373 Sum_probs=198.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-- 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-- 470 (757)
.+++|...+.||+|+||.||+|.+.. ..|++|.+..... .....|.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678888999999999999998854 4788888765432 2345689999999999999999999987654
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC---ceEE
Q 004388 471 GCLVYEYMENGSLEDRLYRKNN----TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKI 543 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~---~~KL 543 (757)
.++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 4899999999999999876432 235899999999999999999999988 99999999999998754 6899
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 622 (757)
+|||+++.+...... .......+++.|+|||++.++.++.++|||||||++|+|+| |..||..... ..
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-------~~ 229 (277)
T cd05036 161 ADFGMARDIYRASYY----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-------QE 229 (277)
T ss_pred ccCccccccCCccce----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HH
Confidence 999999876432110 01122344678999999988899999999999999999997 9999864321 11
Q ss_pred HHHHhhh-hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 623 LAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 623 l~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
+...+.. ....+|...+..+.+++.+|++.+|.+||++.+ |+..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~-vl~~l 275 (277)
T cd05036 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT-ILERI 275 (277)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHh
Confidence 2222221 223455667789999999999999999999985 54443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.50 Aligned_cols=236 Identities=28% Similarity=0.318 Sum_probs=186.7
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHH-HHHhcCCCceeeecccccCC--ceEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELE-VLSKIRHPHLLLLLGACPDH--GCLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~-il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~g 481 (757)
.||+|+||.||+|... +..+|+|++.... ......+..|.. +++.++||||+++++++.+. .++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5999999999999874 5689999986542 223344556655 46779999999999988654 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 82 ELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC----
Confidence 9998886533 4889999999999999999999988 99999999999999999999999999875332111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
......||+.|+|||++.+..++.++|||||||++|+|++|++||......+ .+..++.. ....+...+..
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~-~~~~~~~~~~~ 222 (325)
T cd05604 152 --TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHK-PLVLRPGASLT 222 (325)
T ss_pred --CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcC-CccCCCCCCHH
Confidence 1234579999999999999999999999999999999999999996432211 11122221 11223346778
Q ss_pred HHHHHHHHhhccCCCCCccchhh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.+++.+|++.+|.+||++.+.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCH
Confidence 99999999999999999987533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=322.00 Aligned_cols=285 Identities=23% Similarity=0.361 Sum_probs=210.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--Ce----EEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HT----FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~----~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV 474 (757)
.+|...+.||.|+||.||+|.+. +. .+|+|.+..... .....+.+|+.+++.++||||++++|+|... .+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 35667788999999999999873 22 578888865433 2334688999999999999999999998653 4799
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
+||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999986543 24889999999999999999999987 99999999999999999999999999987653
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhc-C
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQA-G 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~ 632 (757)
.... .......++..|+|||++.+..++.++|||||||++|||+| |..||..... ..+.+++.... .
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~ 230 (303)
T cd05110 162 DEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERL 230 (303)
T ss_pred cccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCC
Confidence 3211 11223456789999999988889999999999999999997 8899853211 11122222111 1
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhhccccCCCCCCCCCCCCccCccchhcccC
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNE 704 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~~~~~~~~~~~~~~p~~ficPi~~evM~d 704 (757)
..+...+..+.+++.+||..+|.+||++.+ ++..|..+...........+-.....|.....|.+++.|.+
T Consensus 231 ~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (303)
T cd05110 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKE-LAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLDE 301 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHHhchhhheeeccCCcCCCCCCchhhHHhccccc
Confidence 122345678999999999999999999985 66677665433222111111122333444555666665554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=311.31 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=200.9
Q ss_pred cCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMEN 480 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~ 480 (757)
.+|.....||.|+||.||+|...+..||+|.+..... ...++.+|+.++..++||||+++++++.+. .++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4677788999999999999999999999999976644 567789999999999999999999998643 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999998865442 35899999999999999999999988 9999999999999999999999999998764221
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh-hhcCCCChhH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKE 638 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~ 638 (757)
....++..|+|||++.++.++.++||||||+++|+|++ |..||...... .+...+. ......+...
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRMEAPEGC 224 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCCCCccCC
Confidence 12245678999999988889999999999999999997 99998533211 1111111 1112234455
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
+..+.+++.+||..+|.+||++. +++..|+.
T Consensus 225 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 255 (256)
T cd05039 225 PPEVYKVMKDCWELDPAKRPTFK-QLREQLAL 255 (256)
T ss_pred CHHHHHHHHHHhccChhhCcCHH-HHHHHHhc
Confidence 78899999999999999999997 46666543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.61 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=196.7
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
|+..+.||.|+||.||+|.+. +..+|+|.+..... .....+.+|+++|++++|+|++.+++++.+.. |+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999885 56899999865422 22345788999999999999999998876543 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++...+ ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999998886543 235999999999999999999999987 99999999999999999999999999976543211
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.....|++.|+|||++.+..++.++|+|||||++|+|+||..||........ ...+...+......++..
T Consensus 158 -------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 158 -------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEEVYSAK 227 (285)
T ss_pred -------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccccccCcc
Confidence 1234789999999999888899999999999999999999999964322111 011111111112233445
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.+..+.+|+.+|+..+|.+||+..+..+..|
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l 258 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEV 258 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHH
Confidence 6678999999999999999999764433333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=312.14 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=198.3
Q ss_pred CCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCCC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENG 481 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~g 481 (757)
+|...++||+|+||.||+|... +..+|+|.+..... ....|.+|+.++++++|||++++++++.+. .++||||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCC
Confidence 5677789999999999999875 45789998876433 346799999999999999999999988554 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++..+......
T Consensus 86 ~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~--- 158 (260)
T cd05070 86 SLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT--- 158 (260)
T ss_pred cHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc---
Confidence 9999886533 235899999999999999999999988 999999999999999999999999999876532211
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 640 (757)
......++..|+|||++.+..++.++||||||+++|+|++ |.+||......+ .+..+........+...+.
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 230 (260)
T cd05070 159 --ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------VLEQVERGYRMPCPQDCPI 230 (260)
T ss_pred --cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCCCcCCH
Confidence 1122345678999999988889999999999999999999 899996432111 1111211112234455678
Q ss_pred HHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 641 ELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
.+.+|+.+|+..+|.+||++. .+...|+
T Consensus 231 ~~~~li~~~l~~~p~~Rpt~~-~l~~~l~ 258 (260)
T cd05070 231 SLHELMLQCWKKDPEERPTFE-YLQSFLE 258 (260)
T ss_pred HHHHHHHHHcccCcccCcCHH-HHHHHHh
Confidence 899999999999999999998 4555553
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=320.47 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=196.5
Q ss_pred cCCccceeeccCCcEEEEEEEECCe----EEEEEEEccC-CchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSK-GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~----~vAvK~l~~~-~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV 474 (757)
++|.....||.|+||.||+|..... .+++|.+... .....+.|.+|+.++.++ +||||+++++++.+.. ++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 4678888999999999999987532 4688877643 233456789999999999 7999999999986654 899
Q ss_pred EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 475 YEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
|||+++|+|.+++.... ....+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1135889999999999999999999987 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 620 (757)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|+|+| |..||.......
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~----- 226 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE----- 226 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 999999986432110 0111233567999999988889999999999999999997 999995332211
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.+..+........|...+..+.+|+.+||..+|.+||++.+ ++..|+.+.
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l~~~~ 276 (297)
T cd05089 227 -LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQ-ISVQLSRML 276 (297)
T ss_pred -HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHHH
Confidence 11112111122334456788999999999999999999984 555565554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=316.78 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=199.4
Q ss_pred cCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--e
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~ 472 (757)
++|.....||.|+||.||+|...+ ..||+|.+.... ......|.+|+.+|..++||||+++++++.+.. +
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 467788899999999999998753 579999986543 234457889999999999999999999986544 8
Q ss_pred EEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEee
Q 004388 473 LVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~D 545 (757)
+||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECC
Confidence 99999999999999875332 234788999999999999999999987 99999999999999999999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHH
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLA 624 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~ 624 (757)
||+++.+....... ......+|..|+|||++.++.++.++|||||||++|||+| |.+||....... .+.
T Consensus 163 fg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~ 232 (277)
T cd05032 163 FGMTRDIYETDYYR----KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VLK 232 (277)
T ss_pred cccchhhccCcccc----cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HHH
Confidence 99998665432110 1123456889999999988889999999999999999998 999985322111 111
Q ss_pred HHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 625 EILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 625 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.+.+......|...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-l~~~l 275 (277)
T cd05032 233 FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLE-IVSSL 275 (277)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHH-HHHHh
Confidence 12222223345556789999999999999999999984 54444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=338.04 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=190.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|...++||+|+||.||++... +..||||++.... ......+.+|+.+|.+++||||+++++.+.+.. |+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888899999999999999875 5689999986432 223456789999999999999999999986654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++...+ .++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999986543 4788888899999999999999988 9999999999999999999999999985432100
Q ss_pred CC-------------------------------------ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHH
Q 004388 557 SF-------------------------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 599 (757)
Q Consensus 557 ~~-------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ 599 (757)
.. ..........+||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00 00001112457999999999999888999999999999999
Q ss_pred HHHhCCCCccccchhhhhhchhhHHHHhhhh---cCCCChhHHHHHHHHHHHHhhccCCCCC---ccch
Q 004388 600 QLLTAKPAIAITHKVETAIDEDNLAEILDAQ---AGDWPIKETKELAALGLSCAELRRKDRP---DLKN 662 (757)
Q Consensus 600 elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~---~~~~p~~~~~~l~~Li~~Cl~~~p~~RP---s~~~ 662 (757)
+|+||+.||......+.. ..+.... ........+..+.+++.+|+ .+|.+|+ ++.+
T Consensus 236 ell~G~~Pf~~~~~~~~~------~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 236 EMLVGQPPFLADTPAETQ------LKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred ehhhCCCCCCCCCHHHHH------HHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 999999999754322211 1111100 01112245678889998876 4999999 5553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=312.19 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=195.3
Q ss_pred CCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
+|...+.||+|+||.||+|.+.. ..+|+|++.... .....|.+|++++++++||||+++++++.+.. ++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46677889999999999998864 479999886432 23457889999999999999999999986544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
++|.+++..... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc--
Confidence 999999875432 5899999999999999999999988 999999999999999999999999999865432111
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||......+ ....+........|...+
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVESVSAGYRLYRPKLAP 227 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHHHHcCCcCCCCCCCC
Confidence 1122234568999999988889999999999999999999 899986432211 111111111223445567
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
..+.+++.+||..+|.+||++.+ ++..
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~-~l~~ 254 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKK-LLSQ 254 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHH-HHHH
Confidence 89999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=311.00 Aligned_cols=242 Identities=25% Similarity=0.370 Sum_probs=191.1
Q ss_pred eeccCCcEEEEEEEE--CCeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCHH
Q 004388 410 RIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLE 484 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL~ 484 (757)
+||+|+||.||+|.+ .++.+|+|...... ......|.+|++++++++||||++++++|.+.. ++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 589999999999987 46789999876443 234567899999999999999999999986544 8999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccccc
Q 004388 485 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564 (757)
Q Consensus 485 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~ 564 (757)
+++...+ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... . .
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~---~ 152 (252)
T cd05084 82 TFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-S---T 152 (252)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc-c---c
Confidence 9886543 35889999999999999999999988 999999999999999999999999998765432110 0 0
Q ss_pred ccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhHHHHH
Q 004388 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKEL 642 (757)
Q Consensus 565 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l 642 (757)
.....++..|+|||++.++.++.++|||||||++|+|++ |.+||..... ......+... ....+...+..+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~ 225 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-------QQTREAIEQGVRLPCPELCPDAV 225 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-------HHHHHHHHcCCCCCCcccCCHHH
Confidence 111233567999999998889999999999999999998 8888853321 1111222211 223444567889
Q ss_pred HHHHHHHhhccCCCCCccchhhhhHH
Q 004388 643 AALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 643 ~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.+|+.+|+..+|.+||++.+ ++..|
T Consensus 226 ~~li~~~l~~~p~~Rps~~~-~~~~l 250 (252)
T cd05084 226 YRLMERCWEYDPGQRPSFST-VHQEL 250 (252)
T ss_pred HHHHHHHcCCChhhCcCHHH-HHHHH
Confidence 99999999999999999984 55544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=355.37 Aligned_cols=254 Identities=27% Similarity=0.498 Sum_probs=207.0
Q ss_pred CCccceeeccCCcEEEEEEEECCe-------EEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT-------FAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~-------~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
+......||+|.||.||.|.+.+. .||||.+... ......+|++|..+|+.++|||||+++|.|.+.. +|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 344567899999999999987432 4899988765 3456678999999999999999999999997754 89
Q ss_pred EEEecCCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 474 VYEYMENGSLEDRLYRKN----NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
++|||+||+|..+|.... ....++....+.|+.+||.|+.||++.+ +|||||-..|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999997652 1345888999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCC-cccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHh
Q 004388 550 TMLNSDPSFVSTTYKNTGP-VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
+.+.... .|+.... .-...|||||.+..+.++.++|||||||+|||++| |..||...+..+ .+..++
T Consensus 850 rDiy~~~-----yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~ 918 (1025)
T KOG1095|consen 850 RDIYDKD-----YYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVL 918 (1025)
T ss_pred Hhhhhch-----heeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHH
Confidence 9444322 1222222 33467999999999999999999999999999998 889997554332 223344
Q ss_pred hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 628 d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.....+.|..++..+.+++..||+.+|++||++.. ++..+..+.
T Consensus 919 ~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~-i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRT-IVEQDPAIS 962 (1025)
T ss_pred hCCccCCCCCCChHHHHHHHHHccCChhhCccHHH-HHhhhhhhh
Confidence 44456778889999999999999999999999994 555554443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.18 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=188.7
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.|...++||+|+||.||+|... +..||+|++.... ......+.+|+.+|++++||||++++++|.+.. +||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 4689999987542 223456889999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.+.+ .++......++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999886543 4788888999999999999999988 9999999999999999999999999986432100
Q ss_pred CC-----------------------------------------ccccccccCCcccccCCCccccccCCCCCcchhhhHH
Q 004388 557 SF-----------------------------------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 595 (757)
Q Consensus 557 ~~-----------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlG 595 (757)
.. ..........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 0000011235799999999999888999999999999
Q ss_pred HHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCCCC--hhHHHHHHHHHHHHhhccCCCCCc
Q 004388 596 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP--IKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 596 vil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
|+||||+||++||......+. ...++... ....| ...+.++.+++.+|+ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 999999999999975433221 11121110 01111 235678888888876 49999997
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=353.87 Aligned_cols=264 Identities=22% Similarity=0.246 Sum_probs=202.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.+|...++||+|+||.||+|.+. +..||||++.... ......|.+|+.++++++||||+++++++.+.. ++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999999999999885 5689999987542 223467899999999999999999999986654 8999
Q ss_pred EecCCCCHHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 476 EYMENGSLEDRLYRKN--------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
||++||+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234567788999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCC------------ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 004388 548 LSTMLNSDPSF------------VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615 (757)
Q Consensus 548 la~~~~~~~~~------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 615 (757)
+++........ ..........+||+.|+|||++.+..++.++|||||||++|||+||++||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876321110 000111123579999999999999999999999999999999999999996422111
Q ss_pred hhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 616 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
... .. .+.++.........+..+.+++.+|+..+|.+||+..++++..|+....
T Consensus 239 i~~-~~---~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISY-RD---VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh-hh---hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 100 00 0111110001124567899999999999999999888788777776643
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=343.01 Aligned_cols=258 Identities=23% Similarity=0.288 Sum_probs=203.2
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeeccccc-----CC---
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACP-----DH--- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~-----~~--- 470 (757)
..++++.+.|.+|||+.||++.+.+ ..||+|.+-.......+...+||++|++|. |||||.+++... +.
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4456778889999999999999853 699999988777778888999999999997 999999999431 11
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.+|.||||.||+|-|++..+.... |+..++++|+.++|.|+.+||... .||||||||-+||||+.+|..||||||.|
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 158899999999999998655444 999999999999999999999998 58999999999999999999999999999
Q ss_pred cccCCCCCCcc-c--cccccCCcccccCCCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 550 TMLNSDPSFVS-T--TYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 550 ~~~~~~~~~~~-~--~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
........... . ....-...-|+.|.+||.+ .+...+.|+|||+|||+||-|+....||+... -
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg----------~ 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG----------K 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------c
Confidence 75433221000 0 0000112568999999954 56679999999999999999999999996321 1
Q ss_pred HHHhhhhcCCCC-hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 624 AEILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 624 ~~~ld~~~~~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
..++...-.-.| ..++..|.+||..||+.+|..||++. +|+..+-+|.
T Consensus 264 laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~-Qv~~~~~~l~ 312 (738)
T KOG1989|consen 264 LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIY-QVLEEIFELA 312 (738)
T ss_pred eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHH-HHHHHHHHHh
Confidence 223332222222 47899999999999999999999988 4555555443
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=320.83 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=202.3
Q ss_pred cCCccceeeccCCcEEEEEEEECC---------eEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~---------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
.+|...+.||+|+||.||++...+ ..+|+|++.... ......+.+|+.++.++ +||||++++++|.+..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 468888999999999999997532 369999987643 33455688999999999 7999999999986554
Q ss_pred --eEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 472 --CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 899999999999999976431 134889999999999999999999987 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 615 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~ 615 (757)
.++.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-- 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 248 (307)
T ss_pred CCCcEEECCCcccccccccchhh----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence 99999999999997654322110 1122245678999999988889999999999999999998 8888853321
Q ss_pred hhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 616 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+...+... ....|...+..+.+|+.+||..+|.+||++. .|+..|+++...
T Consensus 249 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~~l~~~~~~ 302 (307)
T cd05098 249 -----EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILAL 302 (307)
T ss_pred -----HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHHH
Confidence 1112222211 2234455678999999999999999999998 577777776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=319.43 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=195.1
Q ss_pred cCCccceeeccCCcEEEEEEEECC----------------eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH----------------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLG 465 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~----------------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g 465 (757)
..|....+||+|+||.||++...+ ..||+|.+.... ......|.+|+++|.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467778899999999999987643 258999987653 234457899999999999999999999
Q ss_pred cccCC--ceEEEEecCCCCHHHHHhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCee
Q 004388 466 ACPDH--GCLVYEYMENGSLEDRLYRKN---------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 534 (757)
Q Consensus 466 ~~~~~--~~LV~Ey~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 534 (757)
++... .++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 98654 389999999999999886432 1234788999999999999999999988 999999999999
Q ss_pred ecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh--CCCCccccc
Q 004388 535 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAITH 612 (757)
Q Consensus 535 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--G~~Pf~~~~ 612 (757)
++.++.+||+|||++..+...... .......+++.|+|||++.++.++.++|||||||++|+|+| |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcce----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999765432211 11123355788999999988889999999999999999998 567775432
Q ss_pred hhhhhhchhhHHHHhhh----hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 613 KVETAIDEDNLAEILDA----QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 613 ~~~~~~~~~~l~~~ld~----~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
.... +. ........ .....+...+..+.+|+.+||..+|.+||++. .|++.|+
T Consensus 238 ~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~~~l~ 294 (295)
T cd05097 238 DEQV-IE--NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN-KIHHFLR 294 (295)
T ss_pred hHHH-HH--HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHh
Confidence 2111 00 00111111 01112334567899999999999999999998 4655553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.85 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=200.9
Q ss_pred cCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~ 475 (757)
.+|....+||.|+||.||+|.+.. ..|+||...... ....+.|.+|+.++++++||||++++++|.+. .++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 357778899999999999998743 368999887654 34556799999999999999999999988654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999986543 24899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.. +..+...+++.|+|||++....++.++|||||||++|+|++ |.+||......+. +..+........
T Consensus 161 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~~ 229 (270)
T cd05056 161 SY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERLPM 229 (270)
T ss_pred cc-----eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcCCC
Confidence 21 11223345678999999888889999999999999999996 9999964432211 111111111223
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
+...+..+.+++.+|+..+|.+||++. .++..|+.+.
T Consensus 230 ~~~~~~~~~~li~~~l~~~P~~Rpt~~-~~~~~l~~~~ 266 (270)
T cd05056 230 PPNCPPTLYSLMTKCWAYDPSKRPRFT-ELKAQLSDIL 266 (270)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 445678899999999999999999998 4666666554
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=320.76 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=194.8
Q ss_pred cCCccceeeccCCcEEEEEEEECC--e--EEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--T--FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~--~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV 474 (757)
++|+....||+|+||.||+|.+.. . .+++|.+.... ......|.+|++++.++ +||||+++++++.+.. ++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 467788899999999999998743 3 45777665432 23446788999999999 8999999999986554 899
Q ss_pred EEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 475 YEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
|||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999875431 235889999999999999999999987 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 620 (757)
||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|+| |..||......+
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----- 231 (303)
T cd05088 164 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 231 (303)
T ss_pred EeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----
Confidence 999999986432110 1112234678999999988889999999999999999998 999985332211
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
....+........+...+..+.+|+.+||..+|.+||++.+ ++..|.++
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-il~~l~~~ 280 (303)
T cd05088 232 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ-ILVSLNRM 280 (303)
T ss_pred -HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH-HHHHHHHH
Confidence 11111111112233445678999999999999999999985 55555554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=313.44 Aligned_cols=253 Identities=27% Similarity=0.471 Sum_probs=198.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
.+|...+.||.|+||.||+|.+. +..+|+|.+.... ......|.+|+.++.+++||||+++++++.+.. ++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 35777889999999999999863 2378999886543 233467899999999999999999999985443 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999987543 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
..... .......++..|++||++.++.++.++|+|||||++|++++ |..||......+ ....+.+.....
T Consensus 159 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~~ 229 (267)
T cd05066 159 DPEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYRLP 229 (267)
T ss_pred cccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHHHhCCCcCC
Confidence 32211 11122344678999999998889999999999999999886 999985332111 111122221223
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
.+...+..+.+++.+|++.+|.+||++. .++..|+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 265 (267)
T cd05066 230 APMDCPAALHQLMLDCWQKDRNERPKFE-QIVSILDK 265 (267)
T ss_pred CCCCCCHHHHHHHHHHcccCchhCCCHH-HHHHHHHh
Confidence 3445577899999999999999999998 46666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.45 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=203.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEC---------CeEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCC
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~ 470 (757)
..+|.....||+|+||.||+|... +..||+|++.... ......+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456778889999999999999742 2368999887543 33456788999999999 899999999998655
Q ss_pred c--eEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 471 G--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 471 ~--~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
. ++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 4 899999999999999876421 235788999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 004388 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 614 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~ 614 (757)
+.++.+||+|||+++.+....... ......+++.|+|||++.+..++.++||||||+++|+|+| |..||......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred cCCCcEEECCCccceecccccccc----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 999999999999998765432111 1123456788999999988889999999999999999998 78887532211
Q ss_pred hhhhchhhHHHHhh-hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 615 ETAIDEDNLAEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 615 ~~~~~~~~l~~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.+...+. ......+...+..+.+|+.+||..+|.+||++. +++..|+++...
T Consensus 247 -------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~l~~l~~~~~~ 299 (304)
T cd05101 247 -------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFK-QLVEDLDRILTL 299 (304)
T ss_pred -------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHHHHh
Confidence 1111121 112223445678899999999999999999998 577777776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=317.61 Aligned_cols=255 Identities=24% Similarity=0.416 Sum_probs=198.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc-
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~- 471 (757)
...+|....+||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999754 23799998764432 23446889999999999999999999886544
Q ss_pred -eEEEEecCCCCHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 472 -CLVYEYMENGSLEDRLYRKNN-------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
++||||+++|+|.+++..... .+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 899999999999999975321 244677788999999999999999987 999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 622 (757)
+|||+++......... ......++..|+|||++.++.++.++|||||||++|||++ |.+||...... +.
T Consensus 161 ~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYR----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QV 230 (288)
T ss_pred CcCCcccccccccccc----ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HH
Confidence 9999998654322111 1122345778999999988889999999999999999998 78888533211 11
Q ss_pred HHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 623 l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+..+.+......+...+..+.+++.+|++.+|.+||++.+ ++..|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-ll~~l~ 276 (288)
T cd05061 231 LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLE-IVNLLK 276 (288)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHH
Confidence 1222222223334455688999999999999999999984 544444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=332.02 Aligned_cols=256 Identities=24% Similarity=0.435 Sum_probs=201.0
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCceeeecccccCC--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDH-- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~-- 470 (757)
..+|....+||+|+||.||+|++.+ ..||||++..... .....+.+|+.+|.++. |||||+++|+|...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 3467777899999999999998643 4799999975432 23456889999999997 99999999999754
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 004388 471 GCLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 492 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 492 (757)
.++||||+++|+|.+++.....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 4899999999999999975321
Q ss_pred -------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 493 -------------------------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 493 -------------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
...+++.....|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 124678888999999999999999977 9999999999999
Q ss_pred cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 004388 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 614 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~ 614 (757)
+.++.+||+|||+++.+....... ......+++.|+|||++....++.++|||||||++|||++ |..||......
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYI----SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eCCCEEEEEecCcceecccccccc----cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999999999999998654322111 1123457889999999988889999999999999999998 88898533211
Q ss_pred hhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 615 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 615 ~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+ .+...+... ....|...+..+.+|+.+||..+|.+||++. .|+..|+.+
T Consensus 349 ~------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~L~~~ 399 (401)
T cd05107 349 E------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS-QLVHLVGDL 399 (401)
T ss_pred H------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHH
Confidence 1 111222211 1223445678999999999999999999998 577777655
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.11 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=199.0
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--e
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~ 472 (757)
|++.+++++.....||+|+||.||+|.+. +..|++|.+..........+.+|+.++++++||||+++++++.... +
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567788888889999999999999875 4579999887666556678999999999999999999999986544 7
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecCccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTM 551 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGla~~ 551 (757)
+||||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999875432211277888899999999999999987 999999999999976 67999999999976
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
...... ......|++.|+|||++..+. ++.++||||||+++|+|++|++||.......... .......
T Consensus 159 ~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~~~~~~ 228 (268)
T cd06624 159 LAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FKVGMFK 228 (268)
T ss_pred cccCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hhhhhhc
Confidence 543221 112346899999999886543 7899999999999999999999996332111100 0001111
Q ss_pred hcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 ~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....|......+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 229 IHPEIPESLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 123345556788999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.04 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=202.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECC------eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccC---Cc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~ 471 (757)
.++|.....||+|+||.||+|.+.. ..|++|.+.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567888899999999999998754 588999876543 3345668899999999999999999998754 34
Q ss_pred eEEEEecCCCCHHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 472 CLVYEYMENGSLEDRLYRKNNT-----PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
+++++|+++|+|.+++...... ..+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998764322 46899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
|+++.+...... .......++..|+|||++.+..++.++|||||||++|++++ |++||....... +..
T Consensus 162 g~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~ 230 (280)
T cd05043 162 ALSRDLFPMDYH----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-------MAA 230 (280)
T ss_pred CCcccccCCceE----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-------HHH
Confidence 999866433211 01122356778999999988889999999999999999999 999996432211 111
Q ss_pred Hh-hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 626 IL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 626 ~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.+ +......+...+..+.+++.+||..+|.+||++. +++..|+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~~~~l~~~~ 277 (280)
T cd05043 231 YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFS-QLVQCLTDFH 277 (280)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 11 1112223445567899999999999999999998 5777776654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.21 Aligned_cols=244 Identities=31% Similarity=0.532 Sum_probs=199.2
Q ss_pred eeccCCcEEEEEEEEC-----CeEEEEEEEccCCchh-hHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|... +..+++|++....... ...+.+|+.++..++|||++++++++.+.. ++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6899999999999886 6689999988664433 677899999999999999999999987643 8999999999
Q ss_pred CHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 482 SLEDRLYRKNN------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 482 sL~~~L~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999876521 256899999999999999999999987 999999999999999999999999999877654
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... .......+++.|+|||.+....++.++|||||||++|+|++ |..||...... .....+........
T Consensus 159 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~ 228 (262)
T cd00192 159 DYY----RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRKGYRLPK 228 (262)
T ss_pred ccc----ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCCCC
Confidence 321 11234567899999999988889999999999999999999 69999654221 11222222223344
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
|...+..+.+++.+||..+|.+||++.+ ++..
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~-l~~~ 260 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSE-LVER 260 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHH-HHHh
Confidence 5566789999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=340.30 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=215.1
Q ss_pred ccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 406 SENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.+.+.||.|.||.||+|+++ ...||||.|+... ..++.+|+.|..||.++.||||++|.|+..... .||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 45678999999999999985 2389999998764 446778999999999999999999999986654 789999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|+||+|+.+|..+.+ .+.+.+..-+++.||.|+.||-..+ +|||||-..||||+.|..+|++||||++.+.++..
T Consensus 712 MENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999977653 4888899999999999999999988 99999999999999999999999999998876552
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHH-hCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLL-TAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. .|...+..=...|.|||.+...+++.+||||||||+|||.+ .|..||... .+.+-+..+-+......|+
T Consensus 787 ~---~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm------SNQdVIkaIe~gyRLPpPm 857 (996)
T KOG0196|consen 787 A---AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------SNQDVIKAIEQGYRLPPPM 857 (996)
T ss_pred c---cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc------chHHHHHHHHhccCCCCCC
Confidence 2 22223333357899999999999999999999999999987 588888532 2334445555556677899
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
+++..|..|++.||+++...||.+. +|+..|++|.....
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~-qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFA-QIVSTLDKLIRNPN 896 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHH-HHHHHHHHHhcCch
Confidence 9999999999999999999999998 68888888865433
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.95 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=193.2
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
|...+.||+|+||.||++... +..||||.+..... .....+.+|+.++.+++|||++.+++.+.+.. |+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666788999999999999886 45899998865422 22345778999999999999999999886544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 35889999999999999999999987 99999999999999999999999999876543221
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........++.......+..
T Consensus 158 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05630 158 -------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK---IKREEVERLVKEVQEEYSEK 227 (285)
T ss_pred -------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc---chHHHHHhhhhhhhhhcCcc
Confidence 12347899999999999889999999999999999999999999643211 01111222222222223445
Q ss_pred HHHHHHHHHHHHhhccCCCCCcc
Q 004388 638 ETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
.+..+.+|+.+||+.+|.+||++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCC
Confidence 66789999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.44 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=197.1
Q ss_pred cCCccceeeccCCcEEEEEEEECC------------------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeee
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH------------------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLL 463 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~------------------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l 463 (757)
..|.....||+|+||.||++.+.. ..||+|++..... .....|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467788899999999999987643 3589999876543 345678999999999999999999
Q ss_pred cccccCC--ceEEEEecCCCCHHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCe
Q 004388 464 LGACPDH--GCLVYEYMENGSLEDRLYRKN--------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 533 (757)
Q Consensus 464 ~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NI 533 (757)
+++|.+. .++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 9998654 489999999999999987643 1235899999999999999999999987 99999999999
Q ss_pred eecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh--CCCCcccc
Q 004388 534 LLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT 611 (757)
Q Consensus 534 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--G~~Pf~~~ 611 (757)
|++.++.++|+|||+++........ .......+++.|+|||++.++.++.++|||||||++|+|++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999765433211 11123456789999999988889999999999999999998 67787533
Q ss_pred chhhhhhchhhHHHHhhh-------hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 612 HKVETAIDEDNLAEILDA-------QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 612 ~~~~~~~~~~~l~~~ld~-------~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.... .+...... .....+...+.++.+++.+||+.+|.+||++.+ |+..|
T Consensus 238 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e-l~~~L 294 (296)
T cd05051 238 TDQQ------VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE-IHLFL 294 (296)
T ss_pred ChHH------HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHH-HHHHh
Confidence 2111 11111110 011223345678999999999999999999984 55554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.88 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=198.5
Q ss_pred cCCccceeeccCCcEEEEEEEECCe-EEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 480 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~~ 480 (757)
.+|....+||.|+||.||+|.+.++ .+|+|.+.... ...+.|.+|+.++++++|||++++++++.+.. ++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 3577778999999999999988654 78999876543 23467899999999999999999999886544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc--
Confidence 99999987543 235889999999999999999999987 999999999999999999999999999876432210
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......++..|+|||+..++.++.++|||||||++|+|+| |+.||....... .+..+........+...+
T Consensus 159 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 229 (260)
T cd05069 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVERGYRMPCPQGCP 229 (260)
T ss_pred ---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCcccC
Confidence 1123356788999999988889999999999999999999 899986432211 111121111122344567
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
..+.+++.+||..+|.+||++. .|.+.|+
T Consensus 230 ~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 258 (260)
T cd05069 230 ESLHELMKLCWKKDPDERPTFE-YIQSFLE 258 (260)
T ss_pred HHHHHHHHHHccCCcccCcCHH-HHHHHHh
Confidence 8899999999999999999997 4666554
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.29 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=199.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMEN 480 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~ 480 (757)
++|...++||.|+||.||+|... +..||+|.+..... ....|.+|+.++++++||||+++++++.+. .++||||+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCC
Confidence 46778889999999999999874 46899999875443 356789999999999999999999987543 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05067 85 GSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc--
Confidence 99999886544 346899999999999999999999987 999999999999999999999999999776532210
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhh-hcCCCChhH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDWPIKE 638 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p~~~ 638 (757)
......++..|+|||++.++.++.++||||||+++|+|+| |++||....... +...+.. .....+...
T Consensus 159 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 228 (260)
T cd05067 159 ---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERGYRMPRPDNC 228 (260)
T ss_pred ---cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcCCCCCCCCCC
Confidence 1123356788999999988889999999999999999999 999996332111 1111111 111223345
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+..+.+++.+|+..+|.+||++. .+...|+
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~ 258 (260)
T cd05067 229 PEELYELMRLCWKEKPEERPTFE-YLRSVLE 258 (260)
T ss_pred CHHHHHHHHHHccCChhhCCCHH-HHHHHhh
Confidence 67899999999999999999998 4555554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.20 Aligned_cols=244 Identities=26% Similarity=0.369 Sum_probs=195.3
Q ss_pred eeccCCcEEEEEEEECC---e--EEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFHH---T--FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~---~--~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~gs 482 (757)
.||.|+||.||+|.+.. + .||||.+..... ...+.|.+|+.++++++||||+++++.+.+. .++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 58999999999998743 2 689999887655 5567899999999999999999999988763 379999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~ 562 (757)
|.+++..... ..+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+.........
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~- 156 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM- 156 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec-
Confidence 9999876543 46899999999999999999999987 999999999999999999999999999877543321111
Q ss_pred ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHh-hhhcCCCChhHHH
Q 004388 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKETK 640 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~~~p~~~~~ 640 (757)
.....++..|+|||++.+..++.++|||||||++|+|+| |+.||......+. +..+. .......+...+.
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 228 (257)
T cd05040 157 --EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI------LKKIDKEGERLERPEACPQ 228 (257)
T ss_pred --ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhcCCcCCCCccCCH
Confidence 123467889999999988889999999999999999999 9999853322111 11111 1111223344568
Q ss_pred HHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 641 ELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
.+.+++.+||..+|.+||++.+ ++..
T Consensus 229 ~~~~li~~~l~~~p~~Rps~~~-~~~~ 254 (257)
T cd05040 229 DIYNVMLQCWAHNPADRPTFAA-LREF 254 (257)
T ss_pred HHHHHHHHHCCCCcccCCCHHH-HHHH
Confidence 8999999999999999999985 4443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.64 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=200.4
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~ 475 (757)
.+|.....||.|+||.||+|+. .++.||||.+.... ......|.+|+.+++.++||||+++++++.+. .++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999987 46799999875422 23345688999999999999999999988644 48999
Q ss_pred EecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||+++|+|.+++.... ....++...+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886422 2345788899999999999999999987 99999999999999999999999999987653
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~ 633 (757)
... ......|++.|+|||++.+..++.++|+||||+++|+|+||+.||...... ...+...+... ...
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~ 227 (267)
T cd08228 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LFSLCQKIEQCDYPP 227 (267)
T ss_pred hhH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-----HHHHHHHHhcCCCCC
Confidence 221 112346889999999998888999999999999999999999998532211 01111111111 111
Q ss_pred -CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 634 -WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 634 -~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.+...+..+.+++.+||..+|.+||++. +|+..++.+
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIG-YVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHH-HHHHHHHHh
Confidence 1224567899999999999999999998 577777665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=329.36 Aligned_cols=243 Identities=24% Similarity=0.291 Sum_probs=194.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|.....||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++.+.. ++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999999999999875 56899999875422 23456788999999999999999999886544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999987642 35889999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccc------cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQR------TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
... ......||+.|+|||++. ...++.++|||||||++|+|+||+.||....... .+..++..
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~ 224 (330)
T cd05601 156 KMV-----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNF 224 (330)
T ss_pred Cce-----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcC
Confidence 211 123357999999999876 4567899999999999999999999996443221 11222221
Q ss_pred h-cCCCC--hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 Q-AGDWP--IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 ~-~~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ...+| ...+..+.+|+.+|+. +|.+||++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~ 259 (330)
T cd05601 225 QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEG 259 (330)
T ss_pred CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHH
Confidence 1 11122 2457789999999998 9999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.94 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=197.4
Q ss_pred cCCccceeeccCCcEEEEEEEE-------CCeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCC---
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH--- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~-------~~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~--- 470 (757)
.+|...+.||.|+||.||+|.+ .++.||||+++.... .....+.+|+.+|.++ +||||++++++|...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688889999999999999974 245899999975432 2345688999999999 689999999988543
Q ss_pred ceEEEEecCCCCHHHHHhhcCC----------------------------------------------------------
Q 004388 471 GCLVYEYMENGSLEDRLYRKNN---------------------------------------------------------- 492 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~---------------------------------------------------------- 492 (757)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 3789999999999999865321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccccccc
Q 004388 493 ------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566 (757)
Q Consensus 493 ------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~ 566 (757)
...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....... ...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~----~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV----RKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchh----hcC
Confidence 124688888999999999999999987 9999999999999999999999999998654322111 112
Q ss_pred CCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHH
Q 004388 567 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAAL 645 (757)
Q Consensus 567 ~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~L 645 (757)
...+++.|+|||++.+..++.++|||||||++|+|++ |..||........ ....+........|...+..+.++
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 314 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPDYTTPEMYQT 314 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhccCCCCCCCCCCHHHHHH
Confidence 2346778999999988889999999999999999997 9999854321111 111111111122233346789999
Q ss_pred HHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 646 GLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 646 i~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
+.+||+.+|.+||++. +|+..|+.+.
T Consensus 315 ~~~cl~~~p~~Rps~~-eil~~l~~~~ 340 (343)
T cd05103 315 MLDCWHGEPSQRPTFS-ELVEHLGNLL 340 (343)
T ss_pred HHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 9999999999999998 4666666553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=318.72 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=196.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeeccccc---CC--c--
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP---DH--G-- 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~---~~--~-- 471 (757)
.+..|...+.+|.|+||.||+|.... ..||||..-.+.... .+|+++|+++.|||||+|+-+|. +. .
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 34567888899999999999998864 599999876654322 36999999999999999988873 12 2
Q ss_pred eEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCc
Q 004388 472 CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLS 549 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla 549 (757)
.||||||+ .+|...+... .....++...+.-+.+||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 58999998 4898888642 12334777788889999999999999987 9999999999999976 99999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh-------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED------- 621 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~------- 621 (757)
+.+..+... .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+.+.+....-
T Consensus 174 K~L~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 174 KVLVKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred eeeccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 988765432 33478999999997665 569999999999999999999999998655444332110
Q ss_pred --hHHHHh-------hhhc--CC----CChhHHHHHHHHHHHHhhccCCCCCccchhhh-hHHHHHHHh
Q 004388 622 --NLAEIL-------DAQA--GD----WPIKETKELAALGLSCAELRRKDRPDLKNQVL-PVLERLKEV 674 (757)
Q Consensus 622 --~l~~~l-------d~~~--~~----~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl-~~L~~l~~~ 674 (757)
.+..+- .+.. .. +....++++.+|+.+++.++|.+|.+..+.+. +..+.+++.
T Consensus 247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000000 0000 11 22346789999999999999999999876443 344555443
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.83 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=199.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--c
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--G 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~ 471 (757)
.++|.....||.|+||.||+|... +..+|+|++..... .....|.+|+.++++++||||++++++|.+. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888899999999999999863 46899999875432 3346789999999999999999999998654 4
Q ss_pred eEEEEecCCCCHHHHHhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCC
Q 004388 472 CLVYEYMENGSLEDRLYRKN-------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGN 532 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~N 532 (757)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 89999999999999986431 1235788899999999999999999987 9999999999
Q ss_pred eeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCcccc
Q 004388 533 ILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAIT 611 (757)
Q Consensus 533 ILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~ 611 (757)
||++.++.+||+|||++..+....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYK----ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCcccc----ccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999987654322110 0122345678999999988889999999999999999998 88888532
Q ss_pred chhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 612 HKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 612 ~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
... ..+..+.+......+...+..+.+|+.+||..+|.+||++.+ ++..|+
T Consensus 237 ~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e-l~~~l~ 287 (288)
T cd05050 237 AHE------EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS-INRILQ 287 (288)
T ss_pred CHH------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHH-HHHHhh
Confidence 211 111122222222234456788999999999999999999984 666654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=313.62 Aligned_cols=241 Identities=29% Similarity=0.351 Sum_probs=189.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
+|.....||.|+||.||+|.+. +..||+|++.... ......|.+|+.++.+++||||++++++|... .++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999874 5689999986542 23345688999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|..+. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 3678888999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-hhhHHHHhhhhcCCC-Ch
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-EDNLAEILDAQAGDW-PI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~l~~~ld~~~~~~-p~ 636 (757)
.....||..|+|||++.+..++.++|||||||++|+|+||+.||........... ......+.+...... ..
T Consensus 150 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 150 ------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred ------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 1345789999999999888899999999999999999999999964221111111 111111111111111 12
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+..+.+++.+|++.+|.+||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 35678999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.00 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=200.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
..++|...+.||+|+||.||+|... ...+|||++.... ......|.+|+.+++++ +||||++++++|....
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3457888999999999999999752 2378999887543 23346789999999999 7999999999986544
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 472 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
++||||+++|+|.+++..... ..+++.++..++.+++.||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 899999999999999875432 34899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+.+....... ......+++.|+|||++..+.++.++|||||||++|+|+| |.+||...... ..+...+.
T Consensus 189 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~ 258 (302)
T cd05055 189 RDIMNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIK 258 (302)
T ss_pred ccccCCCcee----ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHH
Confidence 8665432111 1123356788999999988889999999999999999998 99998643211 11122222
Q ss_pred hh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 629 AQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 629 ~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
.. ....+...+..+.+++.+||..+|.+||++. +++..|++
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ell~~l~~ 300 (302)
T cd05055 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFK-QIVQLIGK 300 (302)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHh
Confidence 11 1122334567899999999999999999998 46666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.04 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=201.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|.....||.|+||.||+|... +..||+|.++... ......+.+|+.++++++|||++++++++.+.. ++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999985 6789999876422 223567899999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||+++|+|.+++... .....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 22345899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh-hcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~ 633 (757)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.+.+.. ....
T Consensus 159 ~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~ 227 (267)
T cd08224 159 KTTA------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEKCDYPP 227 (267)
T ss_pred CCcc------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH-----HHHHhhhhcCCCCC
Confidence 2211 123468899999999988889999999999999999999999985332110 001111111 1112
Q ss_pred CCh-hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 634 WPI-KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 634 ~p~-~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.|. ..+..+.+++.+||..+|.+||++. .|+..|+.+
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~-~il~~~~~~ 265 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDIS-YVLQVAKEM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHH-HHHHHHHHh
Confidence 222 4567899999999999999999998 466666654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.44 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=192.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
.+|....+||+|+||.||+|... +..||+|++..........+.+|+.++.+++||||+++++++.... ++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888899999999999999874 5689999987655445566889999999999999999999986544 7999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++...+ ++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999999886433 4889999999999999999999987 99999999999999999999999999986643211
Q ss_pred ccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
......|++.|+|||.+. ...++.++|||||||++|+|+||++||............. ...+.......+
T Consensus 162 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (267)
T cd06646 162 -----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--KSNFQPPKLKDK 234 (267)
T ss_pred -----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--cCCCCCCCCccc
Confidence 123457899999999874 4457889999999999999999999985332211110000 000000000111
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+++.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 234578999999999999999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=311.94 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=193.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCc-eeeecccccC--------C
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPH-LLLLLGACPD--------H 470 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpn-iv~l~g~~~~--------~ 470 (757)
.|....+||+|+||+||+|+.. +..||+|++...... ......+|+.+|+.|+|+| ||.|++++.. .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 4556667999999999999875 568999998866442 3445689999999999999 9999999854 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.+||+||+. .+|.+++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+.+|.+||+|||+|
T Consensus 92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 368999996 6899988765422 34666889999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+...-... ..+..++|.+|.|||++.+. .|+...||||+|||++||+++++-|......+... .+..++.
T Consensus 168 ra~~ip~~------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lG 238 (323)
T KOG0594|consen 168 RAFSIPMR------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLG 238 (323)
T ss_pred HHhcCCcc------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcC
Confidence 96653221 13556899999999988766 79999999999999999999999997665543321 1111111
Q ss_pred hh-cCCCCh-------------------------hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 AQ-AGDWPI-------------------------KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ~~-~~~~p~-------------------------~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. ...||. .......+++.+|++++|++|.++..
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~ 298 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKG 298 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHH
Confidence 11 112221 11247889999999999999999874
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.46 Aligned_cols=244 Identities=25% Similarity=0.283 Sum_probs=187.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||++... +..||+|++.... ......|.+|+.++..++||||+.++++|.+.. |+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999885 5689999986421 223455889999999999999999999986554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999986533 24888899999999999999999988 999999999999999999999999999765432
Q ss_pred CCCccccccccCCcccccCCCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
... ......||+.|+|||++.. +.++.++|||||||++|+|++|+.||......+. +..++...
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~ 224 (331)
T cd05597 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHK 224 (331)
T ss_pred CCc-----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCC
Confidence 211 1123469999999998863 4578899999999999999999999964332211 11111110
Q ss_pred ----cCCCChhHHHHHHHHHHHHhhccC--CCCCccch
Q 004388 631 ----AGDWPIKETKELAALGLSCAELRR--KDRPDLKN 662 (757)
Q Consensus 631 ----~~~~p~~~~~~l~~Li~~Cl~~~p--~~RPs~~~ 662 (757)
........+..+.+++.+|+..++ ..||++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~ 262 (331)
T cd05597 225 EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQD 262 (331)
T ss_pred CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 011112356788999999876533 33667654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.03 Aligned_cols=257 Identities=23% Similarity=0.411 Sum_probs=200.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC---------CeEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
.+|....+||+|+||.||+|... ...+|+|++.... ......+.+|+.++.++ +||||++++++|.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778889999999999999752 2368999887543 23455688999999999 6999999999986544
Q ss_pred --eEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 472 --CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 899999999999999865321 235889999999999999999999987 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 615 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~ 615 (757)
.++.+||+|||+++......... ......+++.|+|||++.++.++.++|||||||++|+|+| |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYK----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred CCCcEEEcccccccccccccccc----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999998665322111 0112234578999999988889999999999999999999 8888853321
Q ss_pred hhhchhhHHHHhhh-hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 616 TAIDEDNLAEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 616 ~~~~~~~l~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+...+.. .....+...+..+.+++.+||..+|.+||++. .++..|..+...
T Consensus 243 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~~l~~~~~~ 296 (314)
T cd05099 243 -----EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKVLAA 296 (314)
T ss_pred -----HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHHHH
Confidence 111111111 11233445677899999999999999999998 577777776543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.18 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=189.4
Q ss_pred eeccCCcEEEEEEEEC-----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccC---CceEEEEecCC
Q 004388 410 RIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCLVYEYMEN 480 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~LV~Ey~~~ 480 (757)
.||+|+||.||+|.+. ...+|+|.+.... ......|.+|+.+++.++||||++++++|.. ..++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 2479999875432 3345678899999999999999999997742 24899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 82 ~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~- 155 (262)
T cd05058 82 GDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS- 155 (262)
T ss_pred CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee-
Confidence 999999865432 3677788899999999999999987 9999999999999999999999999997654322110
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhC-CCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
........+++.|+|||++.+..++.++|||||||++|||+|| .+||....... ....+........+...+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 228 (262)
T cd05058 156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD------ITVYLLQGRRLLQPEYCP 228 (262)
T ss_pred -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhcCCCCCCCCcCC
Confidence 0111234567889999999888899999999999999999995 56664322111 111111111122233456
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+.+++.+||..+|.+||++. .++..|+.+
T Consensus 229 ~~~~~li~~cl~~~p~~Rp~~~-~il~~l~~~ 259 (262)
T cd05058 229 DPLYEVMLSCWHPKPEMRPTFS-ELVSRIEQI 259 (262)
T ss_pred HHHHHHHHHHcCCChhhCCCHH-HHHHHHHHH
Confidence 7899999999999999999998 466666554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=330.70 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=193.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
...+|....+||+|+||.||++... +..||+|++.... ......+.+|+.+++.++||||+++++++.+.. ++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457888999999999999999885 5689999986431 223345788999999999999999999886654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||++||+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988543 3777888889999999999999988 9999999999999999999999999998664
Q ss_pred CCCCCccccccccCCcccccCCCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
.... .......||+.|+|||++.+. .++.++|||||||+||||+||++||...... ..+..++..
T Consensus 194 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~ 262 (370)
T cd05596 194 ANGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDH 262 (370)
T ss_pred CCCc-----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcC
Confidence 3221 112345799999999987543 4789999999999999999999999754322 122233322
Q ss_pred h-cCCCCh--hHHHHHHHHHHHHhhccCCC--CCccch
Q 004388 630 Q-AGDWPI--KETKELAALGLSCAELRRKD--RPDLKN 662 (757)
Q Consensus 630 ~-~~~~p~--~~~~~l~~Li~~Cl~~~p~~--RPs~~~ 662 (757)
. ...+|. ..+..+.+|+.+|+..+|.+ ||++.+
T Consensus 263 ~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~e 300 (370)
T cd05596 263 KNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDE 300 (370)
T ss_pred CCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHH
Confidence 1 122332 45789999999999988887 998875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=339.18 Aligned_cols=246 Identities=20% Similarity=0.312 Sum_probs=185.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC--------C--
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------H-- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--------~-- 470 (757)
.+|....+||+|+||.||+|... +..||||++.... ....+|+.+|+.++|||||++++++.. .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 46888899999999999999874 5689999875432 234579999999999999999887521 1
Q ss_pred ceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecC
Q 004388 471 GCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGL 548 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGl 548 (757)
.++||||++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecccc
Confidence 258999997 4777766432 23346899999999999999999999988 9999999999999866 4799999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch-------
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE------- 620 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~------- 620 (757)
|+.+..... .....||+.|+|||++.+ ..++.++|||||||+||||+||++||......+.....
T Consensus 218 a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 218 AKNLLAGQR-------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred chhccCCCC-------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 987653321 133578999999998765 46899999999999999999999999754322211100
Q ss_pred --hhHHHHhhhh--------c------CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 --DNLAEILDAQ--------A------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 --~~l~~~ld~~--------~------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.+.. +.+. . ..+|...+.++.+|+.+||..+|.+||++.+.+
T Consensus 291 ~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 291 TEDQLKE-MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CHHHHHH-hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000 0000 0 011223457899999999999999999998643
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=307.57 Aligned_cols=245 Identities=23% Similarity=0.313 Sum_probs=196.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-----hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-----IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-----~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
.+|...+.||.|+||.||+|... +..+|+|.+..... .....+.+|+.++++++||||+++++++.+.. ++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999864 56999998864321 12356889999999999999999999986554 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++++|.+.+.... .+++.....++.|++.||.|||..+ |+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999886543 4788899999999999999999988 9999999999999999999999999997654
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh-hhhcC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~ 632 (757)
..... ........|+..|+|||++.+..++.++||||||+++|+|++|+.||......... .... .....
T Consensus 156 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~~ 226 (263)
T cd06625 156 TICSS---GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQPTNP 226 (263)
T ss_pred ccccc---cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhccCCCC
Confidence 32111 00112346889999999999888999999999999999999999999643222111 1111 11122
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..|...+..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 345566788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.38 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=197.2
Q ss_pred CCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.|...+.||+|+||.||+|.+.. ..||||++.... ......|..|+.++++++||||+++++++.+.. ++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 36677889999999999998752 369999987542 334567999999999999999999999986554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..+...
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999886543 35899999999999999999999987 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
...... .......++..|+|||++.++.++.++|||||||++|||++ |..||....... ....+........
T Consensus 160 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~------~~~~i~~~~~~~~ 232 (269)
T cd05065 160 TSDPTY-TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------VINAIEQDYRLPP 232 (269)
T ss_pred cccccc-ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH------HHHHHHcCCcCCC
Confidence 221110 00111123467999999998899999999999999999986 999986432211 1111111111223
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
+...+..+.+++.+||..+|.+||++. .++..|+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 267 (269)
T cd05065 233 PMDCPTALHQLMLDCWQKDRNARPKFG-QIVSTLDK 267 (269)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHh
Confidence 445677899999999999999999998 46555554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.01 Aligned_cols=243 Identities=24% Similarity=0.325 Sum_probs=187.6
Q ss_pred CCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|....+||+|+||.||++.+.+ ..+|+|++.... ......|.+|+.++..++||||+.+++++.+.. ++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 67888999999999999999864 589999986421 222345788999999999999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.+.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 y~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred ccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999997533 24888899999999999999999988 9999999999999999999999999997654322
Q ss_pred CCccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ- 630 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~- 630 (757)
. .......||+.|+|||++. .+.++.++|||||||+||||++|+.||......+. +..++...
T Consensus 157 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~ 225 (332)
T cd05623 157 T-----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKE 225 (332)
T ss_pred c-----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCc
Confidence 1 1123357999999999875 34688999999999999999999999964432221 11222111
Q ss_pred cCCCC---hhHHHHHHHHHHHHhhccCC--CCCccch
Q 004388 631 AGDWP---IKETKELAALGLSCAELRRK--DRPDLKN 662 (757)
Q Consensus 631 ~~~~p---~~~~~~l~~Li~~Cl~~~p~--~RPs~~~ 662 (757)
...+| ...+..+.+|+.+|+..++. .||++.+
T Consensus 226 ~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~ 262 (332)
T cd05623 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIED 262 (332)
T ss_pred cccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHH
Confidence 01122 24577899999998865433 3566653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=309.22 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=195.6
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch---------hhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---------QNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---------~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
|.....||.|+||.||+|... +..+|+|.+...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556678999999999999874 568999988654322 1245788999999999999999999986544
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++++|.+++...+ .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 89999999999999986543 4788899999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
+.................|+..|+|||++.++.++.++|+|||||++|+|+||+.||....... .+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~ 229 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIGENAS 229 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHhccCC
Confidence 7532211111111223468899999999988889999999999999999999999996433221 1122222222
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...|...+..+.+++.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 3344556788999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=352.07 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=195.5
Q ss_pred HhhcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC----Cc
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HG 471 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~ 471 (757)
....+|....+||.|+||.||++.+.. ..+|+|++.... ......|..|+.+|.+|+|||||+++++|.+ ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345679999999999999999999864 588999886542 2345678999999999999999999998743 23
Q ss_pred eEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCC----CCEEEcCCCCCCeeecC---------
Q 004388 472 CLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKP----KPIIHRDMKPGNILLDH--------- 537 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~----~~ivHrDLKp~NILld~--------- 537 (757)
||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.++ .+||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999987532 23469999999999999999999998652 35999999999999964
Q ss_pred --------CCceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCC
Q 004388 538 --------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPA 607 (757)
Q Consensus 538 --------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~P 607 (757)
.+.+||+|||++..+..... .....||+.|+|||++.. ..++.++||||||||||+|+||+.|
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~-------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESM-------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccccc-------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 34589999999986543211 134579999999998754 4588999999999999999999999
Q ss_pred ccccchhhhhhchhhHHHHhhhhcCCCC-hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 608 IAITHKVETAIDEDNLAEILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 608 f~~~~~~~~~~~~~~l~~~ld~~~~~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|........ +...+... ...| ...+..+.+|+..||..+|.+||++.+.+
T Consensus 243 F~~~~~~~q------li~~lk~~-p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 243 FHKANNFSQ------LISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCcCCcHHH------HHHHHhcC-CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 964332221 11112111 1122 23467899999999999999999998643
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.45 Aligned_cols=259 Identities=21% Similarity=0.363 Sum_probs=197.5
Q ss_pred cCCccceeeccCCcEEEEEEEEC------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC----c
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~ 471 (757)
..|...+.||+|+||.||++.+. +..||+|.+.... ......|.+|+.++++++|||++++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677889999999999999752 4589999987543 33446789999999999999999999998653 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||++|++|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 79999999999999886543 35899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--------hhchhhH
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--------AIDEDNL 623 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--------~~~~~~l 623 (757)
+........ ......|+..|+|||++.+..++.++|||||||++|+|+|++.|+........ .......
T Consensus 159 ~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYYT---VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCcccee---ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 654322111 11234677889999998888899999999999999999998876532111000 0000111
Q ss_pred HHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 624 AEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 624 ~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
...+... ....+...+..+.+|+.+||+.+|.+||++.+ ++..|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-il~~l~~ 282 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQN-LIEGFEA 282 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHH-HHHHHHh
Confidence 1111111 11123346788999999999999999999984 5555544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.44 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=195.4
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
+|+....||.|+||.||++.+. +..||+|.+.... ......+.+|+.++.+++||||+++++++.... ++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667788999999999999986 6799999886542 233467899999999999999999999886544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++++|..++........+++..+..++.+++.||.|||.. + |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999988886543334689999999999999999999964 5 9999999999999999999999999997654221
Q ss_pred CccccccccCCcccccCCCccccccC------CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTG------LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
.....|++.|+|||++.+. .++.++|||||||++|+|+||+.||....... ....+..+.....
T Consensus 158 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 227 (286)
T cd06622 158 -------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIVDGDP 227 (286)
T ss_pred -------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHhhcCC
Confidence 1234688999999987544 35889999999999999999999995332111 0112222333333
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+...+..+.+++.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (286)
T cd06622 228 PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQ 258 (286)
T ss_pred CCCCcccCHHHHHHHHHHcccCcccCCCHHH
Confidence 3445567889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=329.53 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=191.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
...+|.....||+|+||.||++... +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.. ++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3457888999999999999999986 4589999986421 223445789999999999999999999986654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999988543 3788889999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCCccccccccCCcccccCCCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
.... .......||+.|+|||++.+. .++.++|||||||+||+|+||++||...... +.+..+++.
T Consensus 194 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~ 262 (370)
T cd05621 194 ETGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDH 262 (370)
T ss_pred cCCc-----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhC
Confidence 3221 112345799999999988653 3789999999999999999999999644321 222333332
Q ss_pred h-cCCCCh--hHHHHHHHHHHHHhhccCC--CCCccch
Q 004388 630 Q-AGDWPI--KETKELAALGLSCAELRRK--DRPDLKN 662 (757)
Q Consensus 630 ~-~~~~p~--~~~~~l~~Li~~Cl~~~p~--~RPs~~~ 662 (757)
. ...+|. ..+..+.+++.+|+..++. .||++.+
T Consensus 263 ~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 263 KNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred CcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 2 122333 3477889999999975443 3777764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.96 Aligned_cols=245 Identities=28% Similarity=0.438 Sum_probs=189.6
Q ss_pred eeccCCcEEEEEEEECCe----EEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMGGYGTVYKGTFHHT----FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~~----~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||+|+||.||+|.+.++ .+++|.+.... ......|.+|++++.++ +||||++++++|.... ++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 589999999999987542 46888876432 33446788999999999 7999999999986654 8999999999
Q ss_pred CHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 482 SLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 482 sL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
+|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999987532 1234789999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
+....... .......++.|+|||++....++.++|||||||++|+|+| |..||...... ..+..+.
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~ 225 (270)
T cd05047 159 SRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLP 225 (270)
T ss_pred ccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHh
Confidence 86322110 1112234677999999988889999999999999999997 99999533211 1111111
Q ss_pred hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 628 d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.......+...+..+.+|+.+|+..+|.+||++. .++..|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l~~~ 268 (270)
T cd05047 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 268 (270)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHh
Confidence 1111223334567899999999999999999998 466666544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.59 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=196.7
Q ss_pred cCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecCCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENG 481 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~~g 481 (757)
.+|.....||.|+||.||+|...+..+|+|.+.... ....|.+|+.++.+++|||++++++++... .++||||+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 357778899999999999999988999999986543 346789999999999999999999988654 48999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 9999987543 235889999999999999999999987 9999999999999999999999999987643211
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKET 639 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~ 639 (757)
.....+..|+|||++.++.++.++|+|||||++|+|++ |++||......+ +...+... ....+...+
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 223 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRMEPPEGCP 223 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCCCCCCCCCcCC
Confidence 12244678999999988899999999999999999998 999996433211 11111111 122344567
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
..+.+++.+||..+|..||++.+ ++..|
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~-l~~~l 251 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHK-LREKL 251 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHH-HHHHH
Confidence 88999999999999999999984 44444
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=310.13 Aligned_cols=234 Identities=23% Similarity=0.382 Sum_probs=182.9
Q ss_pred eeccCCcEEEEEEEECC--------------eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceE
Q 004388 410 RIGMGGYGTVYKGTFHH--------------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCL 473 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~--------------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~L 473 (757)
.||+|+||.||+|.... ..|++|++..........|.+|+.++..++||||++++++|.+. .++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998531 25889988766555556788999999999999999999998654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc-------eEEeee
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV-------SKIGDV 546 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~-------~KL~DF 546 (757)
||||+++|+|..++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +|++||
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999988876533 35889999999999999999999987 999999999999987664 899999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccc-cCCCCCcchhhhHHHHHHHHH-hCCCCccccchhhhhhchhhHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLL-TAKPAIAITHKVETAIDEDNLA 624 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~l~ 624 (757)
|++...... ....|+..|+|||++. +..++.++|||||||++|+|+ +|..||......+. .
T Consensus 157 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~ 219 (262)
T cd05077 157 GIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------E 219 (262)
T ss_pred CCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------H
Confidence 998754321 2346788999999876 466899999999999999998 58888753221110 0
Q ss_pred HHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 625 EILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 625 ~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
...... ..........+.+|+.+||+.+|.+||++.+ ++..
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~-il~~ 260 (262)
T cd05077 220 RFYEGQ-CMLVTPSCKELADLMTHCMNYDPNQRPFFRA-IMRD 260 (262)
T ss_pred HHHhcC-ccCCCCChHHHHHHHHHHcCCChhhCcCHHH-HHHh
Confidence 111111 1111223567899999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.64 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=194.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC------------------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeee
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH------------------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLL 463 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~------------------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l 463 (757)
++|+...+||+|+||.||++... ...+|+|++.... ......|.+|+.+|+.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888889999999999998543 2368999987543 3345679999999999999999999
Q ss_pred cccccCC--ceEEEEecCCCCHHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCe
Q 004388 464 LGACPDH--GCLVYEYMENGSLEDRLYRKNN--------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 533 (757)
Q Consensus 464 ~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NI 533 (757)
++++.+. .++||||+++|+|.+++..... ...+++.....++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9998654 4899999999999999875331 124778899999999999999999988 99999999999
Q ss_pred eecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh--CCCCcccc
Q 004388 534 LLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT 611 (757)
Q Consensus 534 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt--G~~Pf~~~ 611 (757)
|++.++.++|+|||+++.+....... ......+++.|++||+...+.++.++|||||||++|||+| |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR----IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee----ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999998654322110 1122345678999998888889999999999999999998 67888533
Q ss_pred chhhhhhchhhHHH-HhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 612 HKVETAIDEDNLAE-ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 612 ~~~~~~~~~~~l~~-~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
...+.....+.... .........+...+..+.+|+.+||..+|.+||++.+ |...|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~-i~~~l 294 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE-IHATL 294 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHH
Confidence 22111100000000 0000011123345688999999999999999999984 55544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.82 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=194.2
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccC-------
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------- 469 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~------- 469 (757)
.++..|.....||.|+||.||+|... +..||+|++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45667888889999999999999875 5689999986543 3345688999999998 69999999999853
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 2379999999999999887533 235889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
+........ ......|++.|+|||++. ...++.++|||||||++|+|++|+.||..........
T Consensus 158 ~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----- 226 (272)
T cd06637 158 SAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 226 (272)
T ss_pred ceecccccc------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----
Confidence 986543211 123457899999999875 3458889999999999999999999996433221111
Q ss_pred HHHhhh-hcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..... .....+...+..+.+|+.+||..+|.+||++.+
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 227 -LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred -HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 11111 111112234578999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.08 Aligned_cols=246 Identities=24% Similarity=0.378 Sum_probs=194.9
Q ss_pred CccceeeccCCcEEEEEEEE-CCeEEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 405 FSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~-~~~~vAvK~l~~~~~------~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
|.....||.|+||.||+|.. .+..+|+|.+..... .....+.+|++++++++||||++++++|.+.. ++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 66778899999999999987 456899998764421 12355889999999999999999999987654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++++|.+++.+.. ++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 82 EFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 9999999999986543 4788899999999999999999988 999999999999999999999999999865432
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh--hcCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA--QAGD 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~--~~~~ 633 (757)
..............|+..|+|||++.+..++.++|||||||++|+|+||+.||......... ..+... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~ 229 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAHRGLMPR 229 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhccCCCCC
Confidence 11111111123457899999999998888999999999999999999999999643322211 111111 1122
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+...+..+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 258 (265)
T cd06631 230 LPDSFSAAAIDFVTSCLTRDQHERPSALQ 258 (265)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 34456788999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.61 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=196.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
.+|.....||.|+||.||+|... +..+++|.+..........+.+|+.+++.++||||+++++.|.+. .++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46788889999999999999864 568999998776555567789999999999999999999988544 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999988532 3788899999999999999999988 999999999999999999999999998765432211
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh-hhh-cCCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQ-AGDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l-d~~-~~~~p~ 636 (757)
.....|++.|+|||++.+..++.++|||||||++|+|+||++||........ +.... ... ....+.
T Consensus 173 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~ 240 (296)
T cd06654 173 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPE 240 (296)
T ss_pred ------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------HHHHhcCCCCCCCCcc
Confidence 1234789999999999888899999999999999999999999964432111 11111 110 011233
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..+.+++.+||..+|.+||++.+++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil 268 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHh
Confidence 4567899999999999999999988533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=316.35 Aligned_cols=194 Identities=25% Similarity=0.408 Sum_probs=157.1
Q ss_pred ceeeccCCcEEEEEEEEC----CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEEEecC
Q 004388 408 NLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYEYME 479 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~Ey~~ 479 (757)
..+||+|+||.||+|... +..||+|.+.... ....+.+|+.+|++++||||+++++++... .++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999864 3589999886543 234578899999999999999999987432 379999996
Q ss_pred CCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee----cCCCceEEeeecCc
Q 004388 480 NGSLEDRLYRKN------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLS 549 (757)
Q Consensus 480 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl----d~~~~~KL~DFGla 549 (757)
++|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888765321 1235888999999999999999999988 9999999999999 45689999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccc
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAI 610 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~ 610 (757)
+.+...... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCcc---ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 876533211 111234578999999998866 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.23 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=201.1
Q ss_pred CCccceeeccCCcEEEEEEEEC------CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccC----Cce
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD----HGC 472 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~------~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~~ 472 (757)
.|.....||+|+||.||+|.+. +..+|||++...... ....|.+|+.+++.+.||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566678999999999999864 458999998766543 46679999999999999999999998865 348
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+++++|.+++..... .+++..+..++.|++.||.|||..+ |+||||||+|||++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999875432 4899999999999999999999987 999999999999999999999999999877
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--------hchhhHH
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--------IDEDNLA 624 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--------~~~~~l~ 624 (757)
........ ......++..|++||++.+..++.++||||||+++|+|+||+.|+......... .....+.
T Consensus 160 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYYY---VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCccee---ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 64322111 112234567799999998888999999999999999999999988532111100 0011222
Q ss_pred HHhhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 625 EILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 625 ~~ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+.... ...+...+..+.+++.+||..+|.+||++. +|+..|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA-DLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHH-HHHHHHhhc
Confidence 2222211 122334567899999999999999999998 476666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.49 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=199.4
Q ss_pred CCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~E 476 (757)
+|.....||.|+||.||+|.. .+..++||.+.... ......|.+|+.+++.++||||+++++++.+. .++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 577778899999999999986 46799999876432 22345788999999999999999999998654 389999
Q ss_pred ecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 477 YMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 477 y~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|+++++|.+++... .....+++..+..++.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999988642 22346899999999999999999999988 999999999999999999999999998866533
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh-hcCC-
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGD- 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~- 633 (757)
... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ..+...+.. ....
T Consensus 160 ~~~------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~ 228 (267)
T cd08229 160 TTA------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQCDYPPL 228 (267)
T ss_pred Ccc------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-----HHHhhhhhcCCCCCC
Confidence 211 123468999999999988889999999999999999999999985322110 011111111 1111
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.+...+..+.+++.+||..+|.+||++. .|+..++++
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDIT-YVYDVAKRM 265 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHH-HHHHHHhhh
Confidence 1224567899999999999999999998 576766654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=311.63 Aligned_cols=241 Identities=23% Similarity=0.383 Sum_probs=191.7
Q ss_pred CccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCC
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
|+....||.|+||.||+|.+.. ..+++|.+..........|.+|+++++.++|||+++++++|.+.. ++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 4556679999999999999864 578888887655555677899999999999999999999886544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|..++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc---
Confidence 99998876532 35899999999999999999999987 99999999999999999999999999876543211
Q ss_pred ccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh--cCC
Q 004388 561 TTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGD 633 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~ 633 (757)
......||+.|+|||++. +..++.++|||||||++|+|++|++||........ ...+.... ...
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~~ 229 (282)
T cd06643 159 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEPPTLA 229 (282)
T ss_pred ---ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcCCCCCC
Confidence 123347899999999873 34578899999999999999999999964332211 11111111 111
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.|...+..+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 23345678999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.30 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=191.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++|...++||+|+||.||++.+. +..+|+|.+.... .....++.+|++++.+++||||++++++|.+.. ++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999885 4578888876542 233456889999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999998654 3488899999999999999999974 5 9999999999999999999999999987653321
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hhch--------------
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDE-------------- 620 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~-------------- 620 (757)
.....|++.|+|||++.+..++.++|||||||++|+|+||+.||........ .+..
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 1234789999999998888899999999999999999999999853221100 0000
Q ss_pred ----------hhHHHHhhhhcC----CCC-hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 ----------DNLAEILDAQAG----DWP-IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ----------~~l~~~ld~~~~----~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+.++.... ..| ...+..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 000111111110 111 124567999999999999999999885
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.71 Aligned_cols=248 Identities=21% Similarity=0.253 Sum_probs=189.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccC-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------- 469 (757)
...+|.....||+|+||.||++... +..||||++... .......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3467999999999999999999875 568999998643 22345568899999999999999999998742
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
..|+||||+++ +|...+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 23899999975 56665532 3778888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc------h--
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID------E-- 620 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~------~-- 620 (757)
++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........... .
T Consensus 170 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTNF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccCc-------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 97543221 12345789999999999988999999999999999999999999974432111000 0
Q ss_pred --------hhHHHHhhhh-----------cCCC--------ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 --------DNLAEILDAQ-----------AGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 --------~~l~~~ld~~-----------~~~~--------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+....... ...| +...+..+.+|+.+||..||.+||++.+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 0000000000 0011 011246789999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.84 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=191.3
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc-
Q 004388 398 IESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 471 (757)
Q Consensus 398 i~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~- 471 (757)
+....++|.....||+|+||.||++... +..+|+|++.... ......+.+|+.++..++||||+++++++.+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 3445578999999999999999999986 4589999986422 223445788999999999999999999986654
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
++||||++||+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 8999999999999988543 3778888899999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
.+..... .......||+.|+|||++... .++.++|||||||++|+|++|++||....... .+..+
T Consensus 191 ~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i 259 (371)
T cd05622 191 KMNKEGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKI 259 (371)
T ss_pred EcCcCCc-----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 7653221 112345799999999988643 37899999999999999999999997543221 12222
Q ss_pred hhhh-cCCCC--hhHHHHHHHHHHHHhhccCCC---CCccc
Q 004388 627 LDAQ-AGDWP--IKETKELAALGLSCAELRRKD---RPDLK 661 (757)
Q Consensus 627 ld~~-~~~~p--~~~~~~l~~Li~~Cl~~~p~~---RPs~~ 661 (757)
+... ...+| ...+..+.+++.+|+. +|.. ||++.
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ 299 (371)
T cd05622 260 MNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVE 299 (371)
T ss_pred HcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHH
Confidence 2211 11222 2467889999999998 5554 55655
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.59 Aligned_cols=246 Identities=23% Similarity=0.331 Sum_probs=192.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
++|....+||.|+||.||+|... +..||+|++..........+.+|+.++..++||||+++++++.+.. ++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777788999999999999874 5689999987665445566889999999999999999999886544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++...+ .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 9999999886543 4889999999999999999999988 99999999999999999999999999876543211
Q ss_pred ccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
......|++.|+|||++. .+.++.++|||||||++|+|++|.+||............ ......+......
T Consensus 162 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~ 234 (267)
T cd06645 162 -----KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TKSNFQPPKLKDK 234 (267)
T ss_pred -----ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hccCCCCCccccc
Confidence 123457899999999874 456889999999999999999999998533221110000 0000000000011
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+++.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 235 MKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 134567899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.71 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=190.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||.|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999885 5689999986542 223456889999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++ ++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 689888865544456899999999999999999999988 99999999999999999999999999976543211
Q ss_pred CccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch----------------
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------------- 620 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------------- 620 (757)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||............
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 ------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 11234678999999987654 4789999999999999999999999644322111100
Q ss_pred --hhHHHHhhhhc----CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 --DNLAEILDAQA----GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 --~~l~~~ld~~~----~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
........... .......+.++.+++.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 278 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 00000000000 0011124677889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=335.84 Aligned_cols=250 Identities=20% Similarity=0.278 Sum_probs=186.6
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCC------Cceeeecccc
Q 004388 396 EEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH------PHLLLLLGAC 467 (757)
Q Consensus 396 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H------pniv~l~g~~ 467 (757)
+++...+.+|....+||+|+||.||+|.+. +..||||+++... .....+..|+.++..++| ++++.++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556778999999999999999999874 5689999986432 223446678888877754 4588888887
Q ss_pred cCC---ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCC----
Q 004388 468 PDH---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL---- 539 (757)
Q Consensus 468 ~~~---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~---- 539 (757)
... .|+|||++ +++|.+++...+ .+++..+..|+.||+.||.|||+ .+ ||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 543 48999988 678988886543 48999999999999999999997 46 99999999999998765
Q ss_pred ------------ceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCC
Q 004388 540 ------------VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 607 (757)
Q Consensus 540 ------------~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~P 607 (757)
.+||+|||++..... ..+..+||+.|+|||++.+..++.++|||||||+||||+||++|
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 499999998864321 12346899999999999999999999999999999999999999
Q ss_pred ccccchhhhhhch-----------------hhHHHHhhhhcC------------------CCChhHHHHHHHHHHHHhhc
Q 004388 608 IAITHKVETAIDE-----------------DNLAEILDAQAG------------------DWPIKETKELAALGLSCAEL 652 (757)
Q Consensus 608 f~~~~~~~~~~~~-----------------~~l~~~ld~~~~------------------~~p~~~~~~l~~Li~~Cl~~ 652 (757)
|......+..... .....+.+.... .........+.+|+.+||..
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 9643322110000 000001100000 00001245678999999999
Q ss_pred cCCCCCccch
Q 004388 653 RRKDRPDLKN 662 (757)
Q Consensus 653 ~p~~RPs~~~ 662 (757)
||.+||++.+
T Consensus 425 dP~~R~ta~e 434 (467)
T PTZ00284 425 DRQKRLNARQ 434 (467)
T ss_pred ChhhCCCHHH
Confidence 9999999985
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.70 Aligned_cols=244 Identities=22% Similarity=0.283 Sum_probs=190.4
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|...+.||+|+||.||++... +..||||++.... ......+.+|+.++..++||||+++++.+.+.. +||||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 6788899999999999999885 5689999987432 223456788999999999999999999987654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++||+|.+++.+.+ .+++.....++.|++.||.|||+.+ |+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 82 FLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999999986543 4888899999999999999999988 9999999999999999999999999987553211
Q ss_pred CCc-----------------------------cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCC
Q 004388 557 SFV-----------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 607 (757)
Q Consensus 557 ~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~P 607 (757)
... .........+||+.|+|||++.+..++.++|||||||++|||+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 000 000011235799999999999988999999999999999999999999
Q ss_pred ccccchhhhhhchhhHHHHhhhh-cCCCCh--hHHHHHHHHHHHHhhccCCCCCcc
Q 004388 608 IAITHKVETAIDEDNLAEILDAQ-AGDWPI--KETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 608 f~~~~~~~~~~~~~~l~~~ld~~-~~~~p~--~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
|....... .+..++... ....|. ..+..+.+|+.+|+. +|.+|++.
T Consensus 236 f~~~~~~~------~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 236 FCSETPQE------TYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCCHHH------HHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 96443221 111122111 111121 246788999988774 99999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=305.83 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=197.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
++|.....||.|+||.||+|... +..+++|++..........+.+|+.++++++||||+++++++.+.. +++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 46888899999999999999875 4689999988665556678899999999999999999999886544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++.... ..++...+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 9999999886542 35889999999999999999999988 99999999999999999999999999976543211
Q ss_pred ccccccccCCcccccCCCccccccC---CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
......++..|+|||.+.+. .++.++|||||||++|+|+||++||............. ...+.......+
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 229 (262)
T cd06613 157 -----KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--KSNFPPPKLKDK 229 (262)
T ss_pred -----ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccCCCccccch
Confidence 12345789999999998766 78999999999999999999999996443222211000 000011111123
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATK 256 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHH
Confidence 345678999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=308.85 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=200.1
Q ss_pred cCCccceeeccCCcEEEEEEEECC------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV 474 (757)
..|.....||+|+||.||+|.+.. ..+|+|++..... .....+.+|+.++.+++||||++++++|... .++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 356777889999999999998642 2689998876543 3456788999999999999999999998653 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999876433 4899999999999999999999977 99999999999999999999999999987653
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 632 (757)
.... +......++..|++||.+..+.++.++|+|||||++|||+| |+.||...... .+...+... ..
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~ 230 (279)
T cd05057 162 DEKE----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-------EIPDLLEKGERL 230 (279)
T ss_pred cccc----eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHhCCCCC
Confidence 3221 11122345678999999988889999999999999999999 99999643211 112222211 12
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..|...+..+.+++.+||..+|..||++. .++..|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~-~l~~~l~~~ 268 (279)
T cd05057 231 PQPPICTIDVYMVLVKCWMIDAESRPTFK-ELINEFSKM 268 (279)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHH
Confidence 23444567899999999999999999998 466666655
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=311.27 Aligned_cols=241 Identities=26% Similarity=0.408 Sum_probs=187.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhc---CCCceeeecccccCC------
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACPDH------ 470 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l---~Hpniv~l~g~~~~~------ 470 (757)
+|.....||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999885 55899998875422 1234566788877765 699999999987431
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 379999997 58888876543 245899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|++||........ +..++..
T Consensus 156 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~------~~~~~~~ 222 (288)
T cd07863 156 RIYSCQMA-------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ------LGKIFDL 222 (288)
T ss_pred ccccCccc-------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH------HHHHHHH
Confidence 87653221 1334789999999999888899999999999999999999999964322111 1111110
Q ss_pred h----cCCC----------------------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 Q----AGDW----------------------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 ~----~~~~----------------------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ...| ....+..+.+++.+|++.||.+||++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 281 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence 0 0000 1134567899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=311.82 Aligned_cols=234 Identities=24% Similarity=0.398 Sum_probs=181.7
Q ss_pred eeccCCcEEEEEEEEC--------------------------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeee
Q 004388 410 RIGMGGYGTVYKGTFH--------------------------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--------------------------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l 463 (757)
.||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999998742 12588998876554445678899999999999999999
Q ss_pred cccccCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC--
Q 004388 464 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-- 539 (757)
Q Consensus 464 ~g~~~~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-- 539 (757)
+++|.+.. ++||||+++|+|..++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99996544 89999999999998886533 35888999999999999999999987 99999999999997644
Q ss_pred -----ceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHH-hCCCCccccc
Q 004388 540 -----VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLL-TAKPAIAITH 612 (757)
Q Consensus 540 -----~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~ell-tG~~Pf~~~~ 612 (757)
.+||+|||++...... ....+++.|+|||++.+ ..++.++|||||||++|||+ +|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 4799999998643321 12357888999998865 56899999999999999995 7999986432
Q ss_pred hhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 613 KVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 613 ~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
... ....+... ...|......+.+++.+||+.+|.+||++.+ |+..
T Consensus 227 ~~~-------~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~-il~~ 272 (274)
T cd05076 227 PSE-------KERFYEKK-HRLPEPSCKELATLISQCLTYEPTQRPSFRT-ILRD 272 (274)
T ss_pred hHH-------HHHHHHhc-cCCCCCCChHHHHHHHHHcccChhhCcCHHH-HHHh
Confidence 211 11111111 1122233467999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=325.28 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=190.3
Q ss_pred CCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------ce
Q 004388 404 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 472 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-------~~ 472 (757)
+|+..++||.|+||.||++.. .+..||||++.... ......+.+|+.+|+.++||||+++++++... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477888999999999999986 46799999886432 23345788999999999999999999998543 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5788877543 35889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh------chh----
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------DED---- 621 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~------~~~---- 621 (757)
...... ......+|+.|+|||++.+. .++.++|||||||++|||+||++||.......... ...
T Consensus 154 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDESK-----HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCccc-----cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 433211 12345789999999988764 57899999999999999999999996443221100 000
Q ss_pred ------hHHHHhhhhcC---------CCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 622 ------NLAEILDAQAG---------DWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 622 ------~l~~~ld~~~~---------~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.....+..... ......+..+.+|+.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 00000100000 01112356789999999999999999998644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.90 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=195.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
+|....+||.|+||.||++... +..+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+.. ++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 568999988643 2334567889999999999999999999986554 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++.... ...++......++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999886433 335788899999999999999999988 999999999999999999999999999766533211
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
.....|++.|+|||++.+..++.++|+||||+++|+|++|++||........ ...+........|...
T Consensus 157 ------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (255)
T cd08219 157 ------ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQGSYKPLPSHY 224 (255)
T ss_pred ------cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHhcCCCCCCCccc
Confidence 1235789999999999888899999999999999999999999964332111 1111111122233445
Q ss_pred HHHHHHHHHHHhhccCCCCCccch
Q 004388 639 TKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+..+.+++.+||+.+|.+||++.+
T Consensus 225 ~~~~~~li~~~l~~~P~~Rp~~~~ 248 (255)
T cd08219 225 SYELRSLIKQMFKRNPRSRPSATT 248 (255)
T ss_pred CHHHHHHHHHHHhCCcccCCCHHH
Confidence 678999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.64 Aligned_cols=248 Identities=25% Similarity=0.322 Sum_probs=183.8
Q ss_pred eeccCCcEEEEEEEECC----eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFHH----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~----~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gs 482 (757)
.||+|+||.||+|.+.+ ..+|+|.+..... .....|.+|+.++++++||||++++++|.+. .++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 3689998865432 2335688999999999999999999998654 389999999999
Q ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 483 LEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 483 L~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|.+++..... ....++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 9999875332 234667788899999999999999987 999999999999999999999999999754332211
Q ss_pred ccccccCCcccccCCCccccccC-------CCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHH-hhhhc
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTG-------LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEI-LDAQA 631 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~-ld~~~ 631 (757)
.......|++.|+|||++... .++.++||||||+++|||++ |+.||......+.. .. ..... .....
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~~-~~~~~~~~~~~ 232 (269)
T cd05087 157 --VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL-TY-TVREQQLKLPK 232 (269)
T ss_pred --ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH-HH-HhhcccCCCCC
Confidence 111334678899999987532 35789999999999999996 99999643222110 00 00000 00000
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
+......+..+.+++.+|+ .+|.+||++.+ |+..|
T Consensus 233 ~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~-l~~~l 267 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEE-VHLLL 267 (269)
T ss_pred CccCCCCChHHHHHHHHHh-cCcccCCCHHH-HHHHh
Confidence 1112234567889999999 68999999985 44443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=303.28 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=190.5
Q ss_pred eeccCCcEEEEEEEEC-CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCCHHH
Q 004388 410 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSLED 485 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gsL~~ 485 (757)
.||.|+||.||+|... +..+|+|++..... .....|.+|+.++..++||||++++++|.+. .++||||+++|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 5899999999999864 46899998875543 2344688999999999999999999998654 489999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccc
Q 004388 486 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565 (757)
Q Consensus 486 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~ 565 (757)
++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (250)
T cd05085 82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS 151 (250)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence 886543 34789999999999999999999987 999999999999999999999999998754432110 11
Q ss_pred cCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHH
Q 004388 566 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 644 (757)
Q Consensus 566 ~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~ 644 (757)
....+++.|+|||++.++.++.++||||||+++|+|++ |..||........ ...+........+...+..+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------REQVEKGYRMSCPQKCPDDVYK 225 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------HHHHHcCCCCCCCCCCCHHHHH
Confidence 12244678999999998899999999999999999998 9999963322111 1111111122234456789999
Q ss_pred HHHHHhhccCCCCCccchhhhhHH
Q 004388 645 LGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 645 Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
++.+|+..+|.+||++.+ ++..|
T Consensus 226 li~~~l~~~p~~Rp~~~~-l~~~l 248 (250)
T cd05085 226 VMQRCWDYKPENRPKFSE-LQKEL 248 (250)
T ss_pred HHHHHcccCcccCCCHHH-HHHHh
Confidence 999999999999999984 54443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=327.23 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=204.2
Q ss_pred ceeeccCCcEEEEEEEECC-----eEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecCC
Q 004388 408 NLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 480 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~~ 480 (757)
..+||+|.||.|++|.|+. -.||||.+..+... ...+|++|+.+|.+|+|||+++|||...+.. .+|||+++.
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl 194 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL 194 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc
Confidence 3469999999999999963 38999999887654 6788999999999999999999999998655 789999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|||.++|.. .....|.......++.|||.|+.||.+.+ +|||||-..||||-....+|||||||++.+.......
T Consensus 195 GSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y- 269 (1039)
T KOG0199|consen 195 GSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY- 269 (1039)
T ss_pred chHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce-
Confidence 999999987 44566888889999999999999999988 9999999999999999999999999999988765543
Q ss_pred ccccccC-CcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChh
Q 004388 561 TTYKNTG-PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIK 637 (757)
Q Consensus 561 ~~~~~~~-~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~ 637 (757)
.+.. ..-.+.|+|||.++...++.++|||+|||+||||+| |..||.... ...+.+.+|.. ....|..
T Consensus 270 ---vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-------g~qIL~~iD~~erLpRPk~ 339 (1039)
T KOG0199|consen 270 ---VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-------GIQILKNIDAGERLPRPKY 339 (1039)
T ss_pred ---EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-------HHHHHHhccccccCCCCCC
Confidence 2222 234677999999999999999999999999999997 567875332 22334444532 3456788
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
++..+++++..||..+|.+||++..++
T Consensus 340 csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHHHHH
Confidence 999999999999999999999998543
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.11 Aligned_cols=237 Identities=25% Similarity=0.325 Sum_probs=185.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||+.+++++.+.. ||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 4589999986421 223345788999999999999999999986554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997533 24888899999999999999999988 999999999999999999999999999876533
Q ss_pred CCCccccccccCCcccccCCCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
... ......||+.|+|||++.+ +.++.++|||||||+||+|+||+.||......+ .+..+....
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~ 224 (331)
T cd05624 156 GTV-----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHE 224 (331)
T ss_pred Cce-----eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCC
Confidence 211 1123579999999998865 568899999999999999999999996433221 111222111
Q ss_pred -cCCCC---hhHHHHHHHHHHHHhhccCC
Q 004388 631 -AGDWP---IKETKELAALGLSCAELRRK 655 (757)
Q Consensus 631 -~~~~p---~~~~~~l~~Li~~Cl~~~p~ 655 (757)
...+| ...+..+.+++.+|+..+++
T Consensus 225 ~~~~~p~~~~~~~~~~~~li~~ll~~~~~ 253 (331)
T cd05624 225 ERFQFPSHITDVSEEAKDLIQRLICSRER 253 (331)
T ss_pred CcccCCCccccCCHHHHHHHHHHccCchh
Confidence 01112 23467899999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=295.53 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=203.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC-------Cce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------HGC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------~~~ 472 (757)
.+.|.+.+.||+|||+-||++.. .+..||+|++......+.+..++|++..++++|||+++++.++.. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 45688899999999999999874 456899999887777778889999999999999999999998731 238
Q ss_pred EEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 473 LVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
|+++|...|||.+.+..... +..+++.+.+.|+.+|++||.+||...| |+.||||||.|||+.+.+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999876433 3368999999999999999999999884 799999999999999999999999999976
Q ss_pred cCCCCC---CccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHH
Q 004388 552 LNSDPS---FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 552 ~~~~~~---~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
..-.-. ............+|..|.|||.+. +...+.++|||||||+||.|+.|..||...-. ..+.+.-
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSlaL 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSLAL 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeEEE
Confidence 542111 111111123346899999999775 34578999999999999999999999962211 1122211
Q ss_pred HhhhhcCCCCh--hHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 626 ILDAQAGDWPI--KETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 626 ~ld~~~~~~p~--~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
.+....-.||. .++..+.+++.+|++.||.+||++.+ ++..++
T Consensus 254 Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~-ll~~~d 298 (302)
T KOG2345|consen 254 AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE-LLSKLD 298 (302)
T ss_pred eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH-HHHHHH
Confidence 11111112222 37889999999999999999999984 444443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.88 Aligned_cols=244 Identities=27% Similarity=0.379 Sum_probs=182.7
Q ss_pred eeccCCcEEEEEEEEC----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
.||+|+||.||+|... ...+++|.+.... ......|.+|+.+++.++||||+++++.|.+.. ++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 2368888765433 233456889999999999999999999986554 89999999999
Q ss_pred HHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 483 LEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 483 L~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 9999876432 223467778899999999999999988 9999999999999999999999999987543322111
Q ss_pred ccccccCCcccccCCCcccccc-------CCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh--
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRT-------GLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-- 630 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-- 630 (757)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||......+ .+...+...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~ 228 (269)
T cd05042 158 ---TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQDI 228 (269)
T ss_pred ---ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccCc
Confidence 1123456788999998642 356889999999999999999 788885332111 111111111
Q ss_pred ---cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 631 ---AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 631 ---~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
....+...+..+.+++..|| .+|.+||++.+ |+..|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~-v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEE-VHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHH-HHHHh
Confidence 11233355677888999998 59999999884 54443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.89 Aligned_cols=243 Identities=25% Similarity=0.373 Sum_probs=196.4
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC-C--ceEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-H--GCLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-~--~~LV~E 476 (757)
+|...+.||.|+||.||++... +..+|+|.+.... ......+.+|++++++++|||++++++.+.. . .++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777889999999999999875 4589999986542 2334568899999999999999999988753 2 379999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++++|.+++.... ...+++.++..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999887533 345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. ......|++.|+|||++.+..++.++|||||||++++|+||+.||....... ....+........+.
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~ 224 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRIIEGKLPPMPK 224 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhcCCCCCcc
Confidence 1 1234568999999999998889999999999999999999999996432111 111122222223345
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+..+.+++.+|+..+|.+||++.+
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 250 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKS 250 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHH
Confidence 56788999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=324.03 Aligned_cols=247 Identities=25% Similarity=0.452 Sum_probs=204.2
Q ss_pred ccceeeccCCcEEEEEEEECC------eEEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEe
Q 004388 406 SENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEY 477 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~~------~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey 477 (757)
...++||.|-||.||+|.+.. -.||||..+.+ .....+.|++|..+|++++|||||+|+|.|.+.. .||||+
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL 471 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMEL 471 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEec
Confidence 345679999999999998742 27899988764 3445788999999999999999999999998876 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++-|.|..+|..+... ++......++.||+.||.|||+.. +|||||-..|||+..+-.+||+||||++.+.+..-
T Consensus 472 ~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 472 APLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 9999999999876654 788888999999999999999988 99999999999999999999999999999876532
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
|+.+...-...|||||-++...++.+||||.|||++||+|. |..||......+ -+..+-.......|.
T Consensus 547 -----YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------VI~~iEnGeRlP~P~ 615 (974)
T KOG4257|consen 547 -----YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------VIGHIENGERLPCPP 615 (974)
T ss_pred -----hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------eEEEecCCCCCCCCC
Confidence 33344455678999999999999999999999999999985 999996432211 111111223456788
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
.+++.|..|+.+||.++|.+||.+.+ +...|.
T Consensus 616 nCPp~LYslmskcWayeP~kRPrfte-i~~~ls 647 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTE-IKAILS 647 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHH-HHHHHH
Confidence 89999999999999999999999985 444433
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=312.63 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=198.7
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
.+|+....||.|+||.||+|.. .+..|++|.+..........+.+|+.+++.++|||++.+++++.+. .++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688888999999999999986 4678999998766555567789999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++... .+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 999999987532 4889999999999999999999988 99999999999999999999999999886553321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh--cCCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~~p~ 636 (757)
......|++.|+|||.+.+..++.++|||||||++|+|+||+.||......... ..+.... ....+.
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~~~~~~~~~ 239 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGTPELQNPE 239 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCCcccCCcc
Confidence 112346899999999998888999999999999999999999999754432221 1111111 112234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..+.+++.+||..+|.+||++.+++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 4567899999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=304.62 Aligned_cols=251 Identities=29% Similarity=0.467 Sum_probs=199.5
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
.++|....+||.|+||.||+|.+.+ ..+|||.+.... .....+.+|+.++++++||||+++++++.+. .++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 3578888999999999999998764 478999887543 3456799999999999999999999998653 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++.... ...+++..+..++.+++.||.|||..+ |+||||||+||+++.++.+||+|||++..+.....
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 9999999986543 235899999999999999999999988 99999999999999999999999999987653210
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.......++..|+|||.+.+..++.++||||||+++|+|+| |+.||..... ...+..+........+..
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05034 159 ----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVLEQVERGYRMPRPPN 228 (261)
T ss_pred ----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCCCCCC
Confidence 11122345678999999988889999999999999999999 9999853321 111122221112223444
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
.+..+.+++.+|+..+|.+||++. .+...|+
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~l~ 259 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFE-YLQSFLE 259 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHH-HHHHHHh
Confidence 577899999999999999999998 4655554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.24 Aligned_cols=233 Identities=25% Similarity=0.447 Sum_probs=184.9
Q ss_pred eeccCCcEEEEEEEECCe------------EEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC-CceEEEE
Q 004388 410 RIGMGGYGTVYKGTFHHT------------FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-HGCLVYE 476 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~~------------~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-~~~LV~E 476 (757)
.||+|+||.||+|.+.++ .+++|++...... ...|.+|+.+|++++||||++++++|.. ..++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 589999999999998644 3788877655433 6778999999999999999999998864 3489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-------ceEEeeecCc
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-------VSKIGDVGLS 549 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-------~~KL~DFGla 549 (757)
|+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999876543 5889999999999999999999987 99999999999999888 7999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccC--CCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHH
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
...... ....++..|+|||++... .++.++|||||||++|+|++ |..||........ ...
T Consensus 156 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~ 218 (259)
T cd05037 156 ITVLSR----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERF 218 (259)
T ss_pred cccccc----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHH
Confidence 865431 223567889999998776 78999999999999999999 5777753321110 000
Q ss_pred hhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 627 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 627 ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
.. .....+......+.+++.+||..+|.+||++.+ ++..
T Consensus 219 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~-il~~ 257 (259)
T cd05037 219 YQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFRA-ILRD 257 (259)
T ss_pred Hh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHHH-HHHh
Confidence 10 112223333478999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=315.04 Aligned_cols=194 Identities=25% Similarity=0.406 Sum_probs=156.5
Q ss_pred ceeeccCCcEEEEEEEECC----eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC----CceEEEEecC
Q 004388 408 NLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HGCLVYEYME 479 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~----~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~~LV~Ey~~ 479 (757)
..+||+|+||.||+|.... ..||+|.+.... ....+.+|+.+|++++||||+++++++.. ..++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999998642 579999886543 23457899999999999999999998742 2379999986
Q ss_pred CCCHHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee----cCCCceEEeeecCc
Q 004388 480 NGSLEDRLYRK------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLS 549 (757)
Q Consensus 480 ~gsL~~~L~~~------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl----d~~~~~KL~DFGla 549 (757)
++|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5777776422 11235888999999999999999999988 9999999999999 56789999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccc
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAI 610 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~ 610 (757)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876543211 111234578999999998866 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=318.36 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=201.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC---------CeEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
..|...+.||+|+||.||++... ...||+|++.... ......+.+|+.++.++ +||||++++++|.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35788889999999999999752 1368999887543 23456789999999999 7999999999986654
Q ss_pred --eEEEEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 472 --CLVYEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
++||||+++|+|.+++.... ....++|..+..++.|++.||.|||..+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 89999999999999987532 1234889999999999999999999987 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 615 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~ 615 (757)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceecccccccc----cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999998664322111 1122345678999999988889999999999999999998 888885332111
Q ss_pred hhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 616 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+..+........+...+..+.+++.+||+.+|.+||++. +++..|+.+..
T Consensus 245 ------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-ell~~l~~~~~ 295 (334)
T cd05100 245 ------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK-QLVEDLDRVLT 295 (334)
T ss_pred ------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHhh
Confidence 1111112222233445677899999999999999999998 57777776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=308.49 Aligned_cols=240 Identities=28% Similarity=0.358 Sum_probs=195.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
+|.....||.|+||.||+|.+. +..+|+|++.... ......+.+|+.+++.++||||+++++++.+.. ++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5677788999999999999875 5689999987553 334466889999999999999999999886554 7999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++... ++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 999999988643 5899999999999999999999987 99999999999999999999999999987764321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh-
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK- 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~- 637 (757)
......|++.|+|||++.+..++.++|||||||++|+|+||++||...+... ....+........+..
T Consensus 154 -----~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~ 222 (274)
T cd06609 154 -----KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPKNNPPSLEGNK 222 (274)
T ss_pred -----ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhhcCCCCCcccc
Confidence 1234578999999999988889999999999999999999999996443211 1111111111122222
Q ss_pred HHHHHHHHHHHHhhccCCCCCccch
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~ 247 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKE 247 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHH
Confidence 5678999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.83 Aligned_cols=244 Identities=26% Similarity=0.453 Sum_probs=191.8
Q ss_pred eeccCCcEEEEEEEECC--------eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 410 RIGMGGYGTVYKGTFHH--------TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~--------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
.||.|+||.||+|.... ..+|+|.+.... ......|.+|+.+++.++||||++++++|.+. .++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998753 468999876443 23456789999999999999999999998654 38999999
Q ss_pred CCCCHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-----ceEEeeecCc
Q 004388 479 ENGSLEDRLYRKN----NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-----VSKIGDVGLS 549 (757)
Q Consensus 479 ~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-----~~KL~DFGla 549 (757)
++|+|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999987532 2234788999999999999999999987 99999999999999887 8999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
..+....... ......++..|+|||++.++.++.++|||||||++|+|+| |+.||....... ....+.
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~ 227 (269)
T cd05044 159 RDIYKSDYYR----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVT 227 (269)
T ss_pred cccccccccc----cCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-------HHHHHh
Confidence 7654322110 1123356788999999999999999999999999999998 999985332111 111111
Q ss_pred -hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 629 -AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 629 -~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
......+...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~-i~~~l 267 (269)
T cd05044 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDR-IQEIL 267 (269)
T ss_pred cCCccCCcccchHHHHHHHHHHcCCCcccCCCHHH-HHHHH
Confidence 1122334456788999999999999999999984 55554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=310.69 Aligned_cols=247 Identities=29% Similarity=0.414 Sum_probs=194.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.+|...++||+|+||.||++... +..+|+|++.... ......|.+|++++..++||||+++++++.+.. +|||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 35667788999999999999886 6789999876543 334567899999999999999999999986654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++...+ ++++.....++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999876533 5899999999999999999999742 29999999999999999999999999987543221
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh-hhch----hhHHHHhhhhcC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET-AIDE----DNLAEILDAQAG 632 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~----~~l~~~ld~~~~ 632 (757)
.....|+..|+|||++.++.++.++|||||||++|+|+||+.||........ .... +.+..++.....
T Consensus 159 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 159 -------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred -------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 1234789999999999888899999999999999999999999974322100 0001 111222221112
Q ss_pred CCCh-hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 DWPI-KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 ~~p~-~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+. ..+..+.+|+.+|+..+|.+||++.+
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 2222 25678999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.33 Aligned_cols=235 Identities=23% Similarity=0.243 Sum_probs=182.4
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhc---CCCceeeecccccCC--ceEEEEecCC
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKI---RHPHLLLLLGACPDH--GCLVYEYMEN 480 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l---~Hpniv~l~g~~~~~--~~LV~Ey~~~ 480 (757)
||+|+||.||+|... +..||||++..... .....+..|..++.++ +||||+.+++++.+. .++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 56999999864321 1223455677777765 699999999988654 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 151 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--- 151 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---
Confidence 99999886543 4888999999999999999999988 99999999999999999999999999875432221
Q ss_pred ccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC-hhH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP-IKE 638 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p-~~~ 638 (757)
.....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||......+ .+..+.. .....| ...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~-~~~~~~~~~~ 221 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAF-GKVRFPKNVL 221 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHc-CCCCCCCccC
Confidence 12345799999999988654 48999999999999999999999996432211 1111111 111222 235
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhh
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+..+.+++.+||..+|.+||+....+
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~ 247 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDA 247 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCH
Confidence 67889999999999999999765433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.60 Aligned_cols=240 Identities=21% Similarity=0.360 Sum_probs=203.0
Q ss_pred CCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC--CceEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~~LV~Ey 477 (757)
-|...+.||+|.|+.|-++++ .|..||||++.... ......+.+|+..|+-++|||||+||.+... ..|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 366677899999999998865 67899999997653 3345678899999999999999999999754 45999999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee-cCCCceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl-d~~~~~KL~DFGla~~~~~~~ 556 (757)
-++|+|.|++.+... .+.+....+++.||+.|+.|+|+.+ +|||||||+|+.+ ..-|-+||+|||++..+.++.
T Consensus 99 GD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999987654 4888899999999999999999999 9999999999866 667999999999998776654
Q ss_pred CCccccccccCCcccccCCCccccccCCCC-CcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLIS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
. -+..+|++.|-|||++.+..|+ +++||||||||||-|++|++||.-.+. .+.+..++|-. -..|
T Consensus 174 k-------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND------SETLTmImDCK-YtvP 239 (864)
T KOG4717|consen 174 K-------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND------SETLTMIMDCK-YTVP 239 (864)
T ss_pred h-------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc------hhhhhhhhccc-ccCc
Confidence 3 2456999999999999988886 689999999999999999999964443 34455555532 3457
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+.+..+||..||..||++|.++.+
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEe 266 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEE 266 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHH
Confidence 778999999999999999999998764
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=303.87 Aligned_cols=241 Identities=25% Similarity=0.405 Sum_probs=196.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
++|....+||.|+||.||+|... +..+++|.+..... ...|.+|++++++++||||+++++.+.+.. +++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 56888889999999999999986 46899999875433 678999999999999999999999986554 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999886533 35899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--CCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~ 636 (757)
......|+..|+|||++.+..++.++|||||||++|+|+||++||.......... .+..... ...+.
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~~~~~~ 223 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------MIPNKPPPTLSDPE 223 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------hhccCCCCCCCchh
Confidence 1123468899999999988889999999999999999999999996432221110 0000000 11123
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....+.+++.+||+.+|.+||++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~ 249 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQ 249 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHH
Confidence 44578999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=323.24 Aligned_cols=246 Identities=18% Similarity=0.219 Sum_probs=189.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------- 469 (757)
..++|.....||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4568999999999999999999875 5689999987532 2334568899999999999999999998743
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 23899999974 77776632 3778889999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch--------
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 620 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-------- 620 (757)
++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||............
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98654321 123457899999999999889999999999999999999999999744322110000
Q ss_pred hhHHH--------Hhhhhc-------------------CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 DNLAE--------ILDAQA-------------------GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ~~l~~--------~ld~~~-------------------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+.. ...... ..........+.+|+.+|+..||.+||++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e 314 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHH
Confidence 00000 000000 0001112457899999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.80 Aligned_cols=242 Identities=23% Similarity=0.343 Sum_probs=197.2
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
.+|...++||.|+||.||+|.. .+..||+|.+........+.+.+|+.+++.++||||++++++|... .++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5688889999999999999986 4679999998766555567788999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++... .+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 999999988542 4788899999999999999999987 999999999999999999999999999765433211
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh--cCCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~~p~ 636 (757)
.....|++.|+|||++.+..++.++|+|||||++|+|+||++||.......... ...... ....|.
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~~~~~~~~ 239 (297)
T cd06656 172 ------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTPELQNPE 239 (297)
T ss_pred ------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCCCCCCCcc
Confidence 123468999999999988889999999999999999999999996443221111 000000 112234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
..+..+.+++.+||..+|.+||++.++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKEL 266 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 456778999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=299.95 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=201.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchh-------hHHHHHHHHHHHhcCCCceeeeccccc---C
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQ-------NKQFLQELEVLSKIRHPHLLLLLGACP---D 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~-------~~~f~~Ev~il~~l~Hpniv~l~g~~~---~ 469 (757)
...|-....||+|||+.||++.+ .+++||||+-....... .+...+|..|.+.|+||.||++|++|. +
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 34466667899999999999986 46799999976443221 234578999999999999999999983 4
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEeee
Q 004388 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDV 546 (757)
Q Consensus 470 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~DF 546 (757)
..|-|+|||+|.+|+-+|.... .++..+...|+.||+.||.||...+ .||||-||||.||||-. -|.+||+||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 5599999999999998887644 3889999999999999999999988 58999999999999954 488999999
Q ss_pred cCccccCCCCCC-ccccccccCCcccccCCCccccccC----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh
Q 004388 547 GLSTMLNSDPSF-VSTTYKNTGPVGTLCYIDPEYQRTG----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621 (757)
Q Consensus 547 Gla~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 621 (757)
||++++.++... ..........+||.+|++||++.-+ +.+.++||||+|||+|++|.|+.||+....-...+...
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999998765422 1122223456899999999987654 47889999999999999999999998665544444444
Q ss_pred hHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 622 ~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+........+..| ..+.+...+|.+||++..++|.+..+
T Consensus 698 TIlkAtEVqFP~KP-vVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 698 TILKATEVQFPPKP-VVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred chhcceeccCCCCC-ccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 44333322222222 45788999999999999999988764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.12 Aligned_cols=247 Identities=19% Similarity=0.219 Sum_probs=190.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------- 469 (757)
...+|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999875 5689999986542 2334567899999999999999999998742
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 23899999975 67666632 3788888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------- 619 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--------- 619 (757)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........
T Consensus 166 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 166 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred cccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98654321 12345789999999999888899999999999999999999999964332111000
Q ss_pred -------hhhHHHHhhhhc-------------------CCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 620 -------EDNLAEILDAQA-------------------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 620 -------~~~l~~~ld~~~-------------------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+...++... ...+...+..+.+|+.+|+..+|.+||++.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 000001110000 00111234678999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.85 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=207.7
Q ss_pred CCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
+.....+||.|-||.||.|.|+. -.||||.++.+.. ..++|+.|..+|+.|+|||+|+|+|+|.... |||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 45566789999999999999975 4899999987654 4678999999999999999999999996543 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.|+|.+... ..++....+.++.||.+|+.||...+ +|||||-..|.|+..+..+||+||||++++..+.-
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-- 420 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-- 420 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce--
Confidence 9999999986543 35777788899999999999999988 99999999999999999999999999999875421
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChh
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIK 637 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~ 637 (757)
+ ...+..-...|.|||-+....++.|+|||+|||+|||+.| |..||... +......+|... ..+.|..
T Consensus 421 -T--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-------dlSqVY~LLEkgyRM~~PeG 490 (1157)
T KOG4278|consen 421 -T--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYGLLEKGYRMDGPEG 490 (1157)
T ss_pred -e--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-------cHHHHHHHHhccccccCCCC
Confidence 0 1123344677999999999999999999999999999997 78888533 233344455443 3566788
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+++.+.+|+..||+.+|.+||++. ++-..++.+
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFa-eiHqafEtm 523 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFA-EIHQAFETM 523 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHH-HHHHHHHHH
Confidence 999999999999999999999998 466666554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.67 Aligned_cols=248 Identities=19% Similarity=0.306 Sum_probs=188.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey 477 (757)
.+|....+||+|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++.+. .++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45788889999999999999875 45899999875432 2334678899999999999999999998644 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++ +|.+++...+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 974 8888776543 34788899999999999999999988 99999999999999999999999999976543221
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------hhhHHHH-
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------EDNLAEI- 626 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------~~~l~~~- 626 (757)
......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||......+.... ...+..+
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1123468999999998754 4688999999999999999999999964332111000 0000000
Q ss_pred -----hhhhcCC--------CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 -----LDAQAGD--------WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 -----ld~~~~~--------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..... .....+..+.+|+.+|+..+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 282 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEE 282 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHH
Confidence 0000000 01124567899999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=327.19 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=187.1
Q ss_pred cCCccceeeccCCcEEEEEEEECC----eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~----~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~E 476 (757)
..|....+||.|+||.||++...+ ..||+|.+... ..+.+|+.+|++++||||+++++++... .|+|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 358888999999999999997643 47888887543 2356899999999999999999988654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+. ++|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 167 ~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 995 6888888432 35899999999999999999999988 9999999999999999999999999997665432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hh--------------ch
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AI--------------DE 620 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~--------------~~ 620 (757)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ .+ ..
T Consensus 240 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 240 DT----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cc----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 11 112345799999999999988999999999999999999999999853221100 00 00
Q ss_pred ---hhHHHHhhhh----cCCCC-------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 ---DNLAEILDAQ----AGDWP-------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ---~~l~~~ld~~----~~~~p-------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...+... ...++ ......+.+++.+||..+|.+||++.+
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e 371 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQD 371 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHH
Confidence 0000000000 01111 123467889999999999999999986
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.67 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=193.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..|....+||.|+||.||+|... +..+++|++..........+.+|+.+++.++||||+++++.+.... ++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45777889999999999999885 4689999987766556677899999999999999999999875443 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|..++.... ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988775543 34899999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC-
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG- 632 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~- 632 (757)
.......+++.|+|||++. ...++.++|||||||++|+|+||.+||........ +..+......
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 234 (292)
T cd06644 165 ----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEPPT 234 (292)
T ss_pred ----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcCCCcc
Confidence 1123456889999999874 34578899999999999999999999964432211 1111111111
Q ss_pred -CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 -DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 -~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...+..+.+++.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 112345578999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=326.64 Aligned_cols=240 Identities=27% Similarity=0.392 Sum_probs=195.9
Q ss_pred eeeccCCcEEEEEEEECCe--EEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCce--EEEEecCCCCHH
Q 004388 409 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGC--LVYEYMENGSLE 484 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~~--LV~Ey~~~gsL~ 484 (757)
.+||+|.||+||-|++.++ ..|||-+........+-+..||.+.++|+|.|||+++|.|.++++ +.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 4699999999999999876 568888876666566668899999999999999999999988885 689999999999
Q ss_pred HHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceEEeeecCccccCCCCCCccc
Q 004388 485 DRLYRKNNTPPI--PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 485 ~~L~~~~~~~~l--~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
++|..+= .|+ .+.+.-.+..||+.||.|||.++ |||||||-+|+|++ -.|.+||+|||-++.+..-..
T Consensus 661 sLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP---- 731 (1226)
T KOG4279|consen 661 SLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP---- 731 (1226)
T ss_pred HHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc----
Confidence 9886532 345 67778888999999999999999 99999999999996 579999999999987764332
Q ss_pred cccccCCcccccCCCccccccC--CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh-hhhcCCCChhH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKE 638 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~~~p~~~ 638 (757)
....+.||..|||||++..| .|+.++|||||||++.||.||+|||.-......++ .++= -..-+..|...
T Consensus 732 --~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-----FkVGmyKvHP~iPeel 804 (1226)
T KOG4279|consen 732 --CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-----FKVGMYKVHPPIPEEL 804 (1226)
T ss_pred --cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-----hhhcceecCCCCcHHH
Confidence 12346899999999998766 48999999999999999999999995322222211 1110 01124567788
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhh
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.+...+|++|++.+|.+||++.+.+
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLL 830 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhc
Confidence 99999999999999999999998643
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.56 Aligned_cols=250 Identities=24% Similarity=0.414 Sum_probs=197.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCC--ce
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDH--GC 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~ 472 (757)
.+|.....||.|+||.||+|+.. ...+++|.+...... ....|.+|+.++++++||||++++++|.+. .+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778889999999999999864 347899988654433 456799999999999999999999998764 48
Q ss_pred EEEEecCCCCHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 473 LVYEYMENGSLEDRLYRKNNT------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998755422 25899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
|++....... .+......+++.|++||.+.++.++.++||||||+++|+|++ |..||..... ..+..
T Consensus 162 ~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~ 229 (275)
T cd05046 162 SLSKDVYNSE-----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLN 229 (275)
T ss_pred ccccccCccc-----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHH
Confidence 9987543221 112233467888999999888888999999999999999999 7888853211 11111
Q ss_pred HhhhhcCCC--ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 626 ILDAQAGDW--PIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 626 ~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.+......| +...+..+.+++.+||..+|.+||++.+ ++..|
T Consensus 230 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~-~l~~l 273 (275)
T cd05046 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE-LVSAL 273 (275)
T ss_pred HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH-HHHHh
Confidence 111111112 3345678999999999999999999984 54444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.63 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=192.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCceeeecccccCC----c
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~ 471 (757)
.+|.....||+|+||.||+|... +..|++|.+.... ......+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999874 5689999876432 12335688899999999999999999987542 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
+++|||+++++|.+++.... .+++.....++.|++.||.|||..+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999886543 4788899999999999999999987 99999999999999999999999999976
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-hh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~ 630 (757)
+....... .......++..|+|||++.+..++.++|||||||++|+|+||++||........ +..... ..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~~ 226 (266)
T cd06651 156 LQTICMSG---TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQPT 226 (266)
T ss_pred cccccccC---CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCCC
Confidence 54321110 011234689999999999888899999999999999999999999964322211 111111 11
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....|......+..++ +||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 2333445567778887 788899999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=320.95 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=202.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHHHHhcC-CCceeeecccccCCc--e
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--C 472 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~ 472 (757)
....|.....||.|.||.||+++.. +..+|+|++...... ....+.+|+.||+++. |||||.++++|.+.. +
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3446777889999999999999986 458999998766443 3457899999999998 999999999997665 8
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC----CCceEEeeecC
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDVGL 548 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~----~~~~KL~DFGl 548 (757)
+|||++.||.|.+.+... .++......++.||+.++.|||+.+ |+||||||+|+|+.. ++.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 2889999999999999999999988 999999999999953 35899999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+...... ......+||+.|+|||++....|+..+||||+||++|.|++|.+||......... ..++.
T Consensus 186 a~~~~~~-------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i~~ 252 (382)
T KOG0032|consen 186 AKFIKPG-------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAILR 252 (382)
T ss_pred ceEccCC-------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHHHc
Confidence 9987652 2335679999999999999999999999999999999999999999755433222 12222
Q ss_pred ----hhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 ----AQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ----~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....|+. .+..+.+++..|+..||..|+++.+
T Consensus 253 ~~~~f~~~~w~~-is~~akd~i~~ll~~dp~~R~ta~~ 289 (382)
T KOG0032|consen 253 GDFDFTSEPWDD-ISESAKDFIRKLLEFDPRKRLTAAQ 289 (382)
T ss_pred CCCCCCCCCccc-cCHHHHHHHHHhcccCcccCCCHHH
Confidence 22344553 5889999999999999999999985
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.32 Aligned_cols=235 Identities=23% Similarity=0.380 Sum_probs=184.9
Q ss_pred eeccCCcEEEEEEEECC---------eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC--CceEEEEec
Q 004388 410 RIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYM 478 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~---------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~~LV~Ey~ 478 (757)
.||.|+||.||+|.... ..+++|.+........+.|.+|+.+++.+.||||+++++++.. ..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999997642 2488888765544555678999999999999999999999864 448999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc--------eEEeeecCcc
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--------SKIGDVGLST 550 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~--------~KL~DFGla~ 550 (757)
++|+|.+++...+. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999875443 5889999999999999999999987 999999999999987765 6999999986
Q ss_pred ccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCC-CCccccchhhhhhchhhHHHHhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. +||........ .....
T Consensus 157 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~~ 219 (258)
T cd05078 157 TVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFYE 219 (258)
T ss_pred ccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHHH
Confidence 54321 22467889999998876 45799999999999999999995 66643222111 11111
Q ss_pred hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 629 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 629 ~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
.....|......+.+|+.+||+.+|.+||++.+ ++..|
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~-il~~l 257 (258)
T cd05078 220 -DRHQLPAPKWTELANLINQCMDYEPDFRPSFRA-IIRDL 257 (258)
T ss_pred -ccccCCCCCcHHHHHHHHHHhccChhhCCCHHH-HHHhc
Confidence 122334445578999999999999999999985 54443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=305.70 Aligned_cols=245 Identities=31% Similarity=0.483 Sum_probs=191.7
Q ss_pred CccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhH--HHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNK--QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~--~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
|...+.||+|+||.||++...+ ..+|+|++......... ...+|+.++.+++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567889999999999999865 47999999876544332 3456999999999999999999986543 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-- 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-- 152 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 999999999733 34899999999999999999999988 9999999999999999999999999997642111
Q ss_pred ccccccccCCcccccCCCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-hchhhHHHHhhhhcCCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-IDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~l~~~ld~~~~~~p~ 636 (757)
.......+|+.|+|||++. +..++.++||||||+++|+|++|..||......... .-.......+.... ....
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 227 (260)
T PF00069_consen 153 ----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-QQSR 227 (260)
T ss_dssp ----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-TSHT
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-cccc
Confidence 1123457899999999988 788999999999999999999999999754111110 00011111111111 1111
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHH
Confidence 12489999999999999999999885
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=318.22 Aligned_cols=245 Identities=20% Similarity=0.285 Sum_probs=188.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------- 469 (757)
..++|.....||.|+||.||+|... +..||||++.... ......+.+|+.+|++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467888889999999999999875 4589999986532 2234567889999999999999999998742
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
..+++++++ +++|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 237899988 7899887743 24889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh---------
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI--------- 618 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~--------- 618 (757)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 165 ~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 165 ARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred ceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9865432 134578999999998866 568999999999999999999999996433211100
Q ss_pred --------chhhHHHHhhhhcCCCCh--------hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 619 --------DEDNLAEILDAQAGDWPI--------KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 619 --------~~~~l~~~ld~~~~~~p~--------~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
........+.. ....+. ...+.+.+|+.+|+..+|.+||++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el 295 (343)
T cd07878 236 SPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295 (343)
T ss_pred CHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 00000000000 011111 123457899999999999999998853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=309.10 Aligned_cols=244 Identities=26% Similarity=0.410 Sum_probs=196.5
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
++|....+||.|+||.||+|.+. +..+|+|++..........|.+|+.++++++||||+++++++.+.. ++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45777888999999999999885 5689999987766556678999999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999886543 35899999999999999999999988 99999999999999999999999999876543211
Q ss_pred ccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-- 631 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-- 631 (757)
......||+.|++||++. ...++.++|||||||++|+|++|++||........ +..+.....
T Consensus 159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~ 227 (280)
T cd06611 159 -----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKILKSEPPT 227 (280)
T ss_pred -----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHHhcCCCCC
Confidence 123457899999999864 34577899999999999999999999964432211 111111111
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...|...+..+.+++.+||..+|.+||++.++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 259 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 11233456789999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=308.51 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=193.7
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecC
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 479 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~ 479 (757)
|+....||.|+||.||+|.+. +..||+|.+.... ......+.+|+.++++++||||+++++++.+. .++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455567999999999999874 5689999987543 33445788999999999999999999998654 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 86 GGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 9999998743 34889999999999999999999987 99999999999999999999999999976653221
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......|+..|+|||++.+..++.++|||||||++|+|+||+.||........ ...+........+...+
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (277)
T cd06642 157 ----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFLIPKNSPPTLEGQYS 226 (277)
T ss_pred ----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------HhhhhcCCCCCCCcccC
Confidence 12234689999999999888899999999999999999999999863322111 11111111222334567
Q ss_pred HHHHHHHHHHhhccCCCCCccchhh
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+.+++.+||..+|.+||++.+++
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELL 251 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHH
Confidence 7899999999999999999998654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.90 Aligned_cols=243 Identities=25% Similarity=0.359 Sum_probs=196.5
Q ss_pred CCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|+..+.||.|+||.||.+.. .+..+++|.+.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477888999999998888776 45689999876542 344567889999999999999999999987655 789999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999887643 345889999999999999999999988 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
......|++.|+|||++.+..++.++||||||+++|+|++|..||......+ ....+........+..
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 224 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKIVQGNYTPVVSV 224 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCCCCCccc
Confidence 1234578999999999988888999999999999999999999996432211 1112222112222334
Q ss_pred HHHHHHHHHHHHhhccCCCCCccch
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+.+++.+||..+|.+||++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ 249 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADE 249 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHH
Confidence 5678999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.41 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=194.2
Q ss_pred CCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
.|+....||.|+||.||+|.+. +..+|+|.+.... .....|.+|++++++++|||++++++++.+.. ++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5677788999999999999875 6789999876443 23457899999999999999999999986543 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++.... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--- 155 (256)
T cd05112 84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY--- 155 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc---
Confidence 99999886543 35889999999999999999999988 99999999999999999999999999976543211
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
.......++..|+|||++.++.++.++||||||+++|+|++ |+.||....... .+..+........|...+
T Consensus 156 --~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05112 156 --TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETINAGFRLYKPRLAS 227 (256)
T ss_pred --cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHhCCCCCCCCCCCC
Confidence 01123345678999999988889999999999999999998 999986332111 111111111111233356
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPV 667 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~ 667 (757)
..+.+|+.+||..+|.+||++.+ ++..
T Consensus 228 ~~~~~l~~~~l~~~p~~Rp~~~~-~l~~ 254 (256)
T cd05112 228 QSVYELMQHCWKERPEDRPSFSL-LLHQ 254 (256)
T ss_pred HHHHHHHHHHcccChhhCCCHHH-HHHh
Confidence 78999999999999999999984 4443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=308.98 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=197.3
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeeccccc---
Q 004388 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACP--- 468 (757)
Q Consensus 395 ~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~--- 468 (757)
++.+..++++|.....||+|+||.||+|... ++.+|+|++..... ....+.+|+.++..+ +||||++++++|.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999874 56899998765322 345688899999999 6999999999873
Q ss_pred ----CCceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 469 ----DHGCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 469 ----~~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
+..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 1248999999999999987642 22345888899999999999999999987 999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI 618 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~ 618 (757)
+|||++..+..... ......|++.|+|||++.. ..++.++|||||||++|+|+||+.||...+......
T Consensus 166 ~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 166 VDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred ccCCceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 99999986643211 1233478999999998753 457889999999999999999999986443222111
Q ss_pred chhhHHHHhhhhc--CCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 619 DEDNLAEILDAQA--GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 619 ~~~~l~~~ld~~~--~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
....... ...|...+..+.+++.+||+.+|.+||++.++
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el 280 (286)
T cd06638 240 ------KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280 (286)
T ss_pred ------hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence 1111000 01122345679999999999999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.42 Aligned_cols=244 Identities=22% Similarity=0.274 Sum_probs=193.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCceeeecccccCC----c
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~ 471 (757)
.+|.....||+|+||.||+|... +..||||.+.... ......+.+|+.++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999875 5689999875432 12345688899999999999999999988653 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++|+|.+++.+.. .+++.....++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 68999999999999886543 3788888999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH-hhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI-LDAQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~-ld~~ 630 (757)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||........ +... ....
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~ 226 (265)
T cd06652 156 LQTICLS---GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQPT 226 (265)
T ss_pred ccccccc---ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcCCC
Confidence 5432110 0011334689999999998888899999999999999999999999964322211 1111 1112
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....|......+.+++.+|+. +|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 233455667788999999994 9999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.08 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=196.9
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC--C--ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--H--GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~--~~LV~ 475 (757)
+|.....||.|+||.||++... +..+|+|++.... ....+.+..|+.++++++||||+++++++.. . .+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4667788999999999999874 4689999886532 3345568899999999999999999997743 2 37999
Q ss_pred EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTK--PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
||+++++|.+++... ....++++..+..++.+|+.||.|||..+ ..+|+||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22346899999999999999999999331 234999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
...... .....|++.|++||++.+..++.++|+||||+++|+|++|+.||...... .....+......
T Consensus 161 ~~~~~~------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~ 228 (265)
T cd08217 161 GHDSSF------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL------QLASKIKEGKFR 228 (265)
T ss_pred cCCccc------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH------HHHHHHhcCCCC
Confidence 543211 12347899999999998888999999999999999999999999744311 111112222223
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...+..+.+++.+|+..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 445567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=301.60 Aligned_cols=249 Identities=26% Similarity=0.449 Sum_probs=197.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMEN 480 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~~ 480 (757)
..|...++||+|+||.||+|.+. +..+|+|.+.... .....|.+|+.++++++||||+++++.+.+.. +++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCC
Confidence 46778889999999999999865 4579999876542 24567899999999999999999999887644 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 158 (260)
T cd05073 85 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc--
Confidence 99999987643 345888999999999999999999987 999999999999999999999999999766432211
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKE 638 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~ 638 (757)
......++..|+|||++..+.++.++|+|||||++|+|+| |+.||....... +...+... ....+...
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~ 228 (260)
T cd05073 159 ---AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMPRPENC 228 (260)
T ss_pred ---cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCCCCCCcccC
Confidence 1123356678999999988889999999999999999999 999996432211 11111111 11223345
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+..+.+++.+|+..+|.+||++. .+...|+
T Consensus 229 ~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~L~ 258 (260)
T cd05073 229 PEELYNIMMRCWKNRPEERPTFE-YIQSVLD 258 (260)
T ss_pred CHHHHHHHHHHcccCcccCcCHH-HHHHHHh
Confidence 67899999999999999999998 4666664
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=300.11 Aligned_cols=242 Identities=30% Similarity=0.513 Sum_probs=194.8
Q ss_pred ccceeeccCCcEEEEEEEECC------eEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 406 SENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~~------~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+....||.|+||.||++.+.. ..+|+|++...... ....+.+|+.++..++||||+++++++.+.. +++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 455689999999999999865 67999999766443 5678999999999999999999999987644 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999865432 12899999999999999999999987 9999999999999999999999999998766442
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. ......+++.|+|||.+.+..++.++||||||+++++|++ |.+||...... ..+..+........+
T Consensus 158 ~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 226 (258)
T smart00219 158 YY-----KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE------EVLEYLKKGYRLPKP 226 (258)
T ss_pred cc-----ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhcCCCCCCC
Confidence 21 1112347889999999988889999999999999999998 88888642111 111111111122234
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+++.+|+..+|.+||++.+
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 446788999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.39 Aligned_cols=253 Identities=21% Similarity=0.373 Sum_probs=195.1
Q ss_pred CccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 405 FSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
|...+.||+|+||.||+|.+. +..+|||++.... ....+++.+|+.++++++||||+++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999863 4589999987543 33456788999999999999999999987431
Q ss_pred -ceEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 471 -GCLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
.+++++|+.+|+|.+++.... ....+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 268899999999998875322 2224788899999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
|+++......... ......+++.|++||.+....++.++|||||||++|+|++ |++||....... ....
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~~~~ 227 (273)
T cd05074 158 GLSKKIYSGDYYR----QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------IYNY 227 (273)
T ss_pred cccccccCCccee----cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------HHHH
Confidence 9998664322111 1123345678999999988889999999999999999999 889986332211 1111
Q ss_pred HhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 626 ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 626 ~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+........+...+..+.+++.+||..+|.+||++. +++..|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~-~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQ-HLRDQLELI 272 (273)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 111111223345667899999999999999999998 466666543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.14 Aligned_cols=243 Identities=24% Similarity=0.358 Sum_probs=195.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCc-----h---hhHHHHHHHHHHHhc-CCCceeeecccccCC
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN-----I---QNKQFLQELEVLSKI-RHPHLLLLLGACPDH 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~-----~---~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~ 470 (757)
..+|.....||+|+.+.|.++..+. ..+|+|++..... . ..+.-.+|+.||+++ .||||+.+.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3456667789999999999988764 4788888754321 1 224457899999998 599999999999766
Q ss_pred c--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 471 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 471 ~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
. ++|+|.|+.|.|.|+|...- .++.....+|+.|+..|+.|||..+ ||||||||+|||+|+|..+||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 5 78999999999999997654 4889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCcccccc------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 622 (757)
|+.+..+.. -...||||+|+|||.+.. ..|+..+|+|++|||+|.||.|.+||...... .
T Consensus 170 a~~l~~Gek-------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------l 235 (411)
T KOG0599|consen 170 ACQLEPGEK-------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------L 235 (411)
T ss_pred eeccCCchh-------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------H
Confidence 998876543 356799999999997643 35888999999999999999999999632211 1
Q ss_pred HHHHhhh-----hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhh
Q 004388 623 LAEILDA-----QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 665 (757)
Q Consensus 623 l~~~ld~-----~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl 665 (757)
+..++.. ..+.|. +.+...++||.+||+.||.+|.+..+.+.
T Consensus 236 MLR~ImeGkyqF~speWa-dis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 MLRMIMEGKYQFRSPEWA-DISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHHhcccccCCcchh-hccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1222222 123343 56788999999999999999999986543
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.10 Aligned_cols=241 Identities=25% Similarity=0.386 Sum_probs=195.3
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
.|+...+||.|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666778999999999999874 5689999987543 334567889999999999999999999987554 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++.. .++++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998853 24788899999999999999999987 99999999999999999999999999976643221
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-hhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~ 637 (757)
......++..|+|||++.+..++.++|+|||||++|+|+||++||........ ...+. ......+..
T Consensus 157 -----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~ 224 (277)
T cd06640 157 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-------LFLIPKNNPPTLTGE 224 (277)
T ss_pred -----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-------hhhhhcCCCCCCchh
Confidence 12334688999999999888899999999999999999999999964322111 11111 111223345
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+..+.+++.+||..+|.+||++.+.+
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELL 251 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHH
Confidence 678899999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.07 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=186.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey 477 (757)
..+|.....||.|+||.||++.+.+ ..||||... ...+.+|+.+|++|+|||||++++++... .+|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4578888999999999999999864 579999532 23467899999999999999999987544 3899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+. ++|.+++.... ..++|..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 78888876533 35999999999999999999999988 99999999999999999999999999987643221
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccc-hhhhhhchhhHHHHhhhh------
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH-KVETAIDEDNLAEILDAQ------ 630 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~-~~~~~~~~~~l~~~ld~~------ 630 (757)
. .......||+.|+|||++.+..++.++|||||||+||||++|..|+.... ..........+..++...
T Consensus 316 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 T----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred c----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1 11134579999999999998899999999999999999999886553211 000000000111111100
Q ss_pred --------------------------cCCCCh--hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 --------------------------AGDWPI--KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 --------------------------~~~~p~--~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...|.. .....+.+|+.+||+.||.+||++.+
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~e 451 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAE 451 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHH
Confidence 001111 22357889999999999999999985
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.81 Aligned_cols=255 Identities=27% Similarity=0.341 Sum_probs=200.7
Q ss_pred CCCHHHHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeeccccc
Q 004388 392 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACP 468 (757)
Q Consensus 392 ~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~ 468 (757)
.++..++..++++|.....||.|+||.||++... +..+|+|++.... .....+.+|+.++.++ +|||+++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3556677788999999999999999999999884 5689999986542 2345678899999999 7999999999874
Q ss_pred C-------CceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 469 D-------HGCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 469 ~-------~~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
. ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 2 248999999999999988642 22345899999999999999999999987 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 615 (757)
+||+|||++........ ......|+..|+|||++..+ .++.++|||||||++|+|++|++||.......
T Consensus 167 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred EEEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 99999999986543221 11234689999999987543 36889999999999999999999996443221
Q ss_pred hhhchhhHHHHhhhhcC--CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 616 TAIDEDNLAEILDAQAG--DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~~~--~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. +..+...... ..+......+.+++.+||+.+|.+||++.+
T Consensus 241 ~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 241 T------LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred H------HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 1 1111111111 112344567999999999999999999885
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.68 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=198.8
Q ss_pred CccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchh-hHHHHHHHHHHHhcCCCceeeeccccc--CCceEEEEecCC
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~Hpniv~l~g~~~--~~~~LV~Ey~~~ 480 (757)
.....+||+|-||.|.++...+ +.||||.++...... +..|..|+.+|.+|+|||||.|+|+|. +..|+|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 3455689999999999999887 899999999876554 488999999999999999999999994 344999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|..+|..... +.+.-..-.+|+.||++|++||.+.+ +|||||.+.|+|+|.++++||+|||+++-+-..+.+..
T Consensus 620 GDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 620 GDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred CcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999976532 11233445679999999999999998 99999999999999999999999999996654432211
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHH--hCCCCccccchhhhhhchhhHHHHhhhh----cCCC
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLL--TAKPAIAITHKVETAIDEDNLAEILDAQ----AGDW 634 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ell--tG~~Pf~~~~~~~~~~~~~~l~~~ld~~----~~~~ 634 (757)
. ...+-...|||||.+..++++.++|||+||++|||++ +...||...+.-. + .++...+++.. ....
T Consensus 696 q----gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--v-ven~~~~~~~~~~~~~l~~ 768 (807)
T KOG1094|consen 696 Q----GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--V-VENAGEFFRDQGRQVVLSR 768 (807)
T ss_pred e----cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--H-HHhhhhhcCCCCcceeccC
Confidence 1 2235578899999999999999999999999999986 4678886332211 0 11222333322 1234
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLP 666 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~ 666 (757)
|..++..+.+++++||..+.++||++.++.+.
T Consensus 769 P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~ 800 (807)
T KOG1094|consen 769 PPACPQGLYELMLRCWRRESEQRPSFEQLHLF 800 (807)
T ss_pred CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence 66788899999999999999999999864443
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.46 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=197.5
Q ss_pred CHHHHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccC-
Q 004388 394 TWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD- 469 (757)
Q Consensus 394 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~- 469 (757)
+..++......|+....||.|+||.||+|.+. +..+|+|++.... .....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45566667788999999999999999999984 5689999886543 2345688899999998 69999999999842
Q ss_pred -------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceE
Q 004388 470 -------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 542 (757)
Q Consensus 470 -------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~K 542 (757)
..++||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 2389999999999999886543 234788888999999999999999988 99999999999999999999
Q ss_pred EeeecCccccCCCCCCccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh
Q 004388 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA 617 (757)
Q Consensus 543 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~ 617 (757)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|+|+||++||.........
T Consensus 162 l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred EeeCcchhhhhcccc------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 999999876542211 123357899999999875 346788999999999999999999999643222111
Q ss_pred hchhhHHHHhhhhcC-CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 618 IDEDNLAEILDAQAG-DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 618 ~~~~~l~~~ld~~~~-~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...... ..+...+..+.+|+.+||..+|.+||++.+
T Consensus 236 ------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 236 ------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred ------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 111111111 111235678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.38 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=182.0
Q ss_pred eeccCCcEEEEEEEECC----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCC
Q 004388 410 RIGMGGYGTVYKGTFHH----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
.||+|+||.||+|.... ..+++|.+.... ......|.+|+.+++.++||||+++++.|.+.. ++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 58999999999997532 246677665443 234567999999999999999999999987544 89999999999
Q ss_pred HHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 483 LEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 483 L~~~L~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
|.+++..... ...+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 9999875432 234667778899999999999999987 99999999999999999999999999864322110
Q ss_pred cccccCCcccccCCCcccccc-------CCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh---
Q 004388 562 TYKNTGPVGTLCYIDPEYQRT-------GLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ--- 630 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~--- 630 (757)
........|++.|+|||++.. ..++.++|||||||++|||++ |.+||......+ .+..++...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~~~ 228 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKDQQVK 228 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhhcccc
Confidence 011134578899999998742 245789999999999999997 577885332211 111111111
Q ss_pred --cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 631 --AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 631 --~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
....+......+.+++..|| .+|.+||++.+ |++.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~-i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEE-VHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH-HHHHh
Confidence 12233345678899999999 68999999984 55544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=297.74 Aligned_cols=242 Identities=26% Similarity=0.421 Sum_probs=191.8
Q ss_pred eeccCCcEEEEEEEEC-CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCHHH
Q 004388 410 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED 485 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL~~ 485 (757)
+||.|+||.||++.+. +..||+|.+...... ....|.+|+.+++++.||||+.+++++.+.. ++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6899999999999876 689999988765433 4567899999999999999999999986554 89999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccc
Q 004388 486 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565 (757)
Q Consensus 486 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~ 565 (757)
++..... .+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++......... ...
T Consensus 82 ~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~----~~~ 152 (251)
T cd05041 82 FLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT----VSD 152 (251)
T ss_pred HHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce----ecc
Confidence 9865432 5788899999999999999999988 999999999999999999999999999765422110 000
Q ss_pred cCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCChhHHHHHH
Q 004388 566 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELA 643 (757)
Q Consensus 566 ~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~ 643 (757)
....++..|+|||++.++.++.++|||||||++|+|+| |..||..... ......+... ....|...+..+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-------QQTRERIESGYRMPAPQLCPEEIY 225 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-------HHHHHHHhcCCCCCCCccCCHHHH
Confidence 12234677999999988889999999999999999999 8888853321 1112222221 1123345567899
Q ss_pred HHHHHHhhccCCCCCccchhhhhHH
Q 004388 644 ALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 644 ~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
+++.+|+..+|.+||++.+ ++..|
T Consensus 226 ~li~~~l~~~p~~Rp~~~e-ll~~l 249 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSE-IYNEL 249 (251)
T ss_pred HHHHHHhccChhhCcCHHH-HHHHh
Confidence 9999999999999999974 54444
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.85 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=189.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
..|....+||.|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 35788889999999999999875 5689999886443 223446788999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 58988886543 34888999999999999999999988 99999999999999999999999999976443221
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh---------chhhHHHHh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---------DEDNLAEIL 627 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---------~~~~l~~~l 627 (757)
......+++.|+|||++.+ ..++.++|||||||++|+|+||++||......+... ....+..++
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 1123467899999998765 457889999999999999999999996433211100 000011111
Q ss_pred hhh------cCC--------CChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 628 DAQ------AGD--------WPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 628 d~~------~~~--------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
... ... +....+..+.+|+.+|+..+|.+||++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000 000 111345678999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=320.16 Aligned_cols=236 Identities=27% Similarity=0.413 Sum_probs=192.1
Q ss_pred CccceeeccCCcEEEEEEEECC--eEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC-c-eEEEEe
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-G-CLVYEY 477 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~-~LV~Ey 477 (757)
|...+.||.|+||.||.+++.. ..||||.+..... ....+++.||..|.+++|||+|.+-|+|... . .|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 6677789999999999998854 4899999876543 3456789999999999999999999998543 3 799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|- ||-.|+|.-.. +++...++.-|..+.+.||.|||+++ .||||||..||||.++|.+||+|||.|.+..+.
T Consensus 108 Cl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred Hh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 95 78888775432 46888899999999999999999998 999999999999999999999999999887654
Q ss_pred CccccccccCCcccccCCCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC-
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD- 633 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~- 633 (757)
..++|||+|||||++ ..|.|+-++|||||||+..||.-.+||+...+.....+ .+-....+.
T Consensus 180 --------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------HIAQNesPtL 245 (948)
T KOG0577|consen 180 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNESPTL 245 (948)
T ss_pred --------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------HHHhcCCCCC
Confidence 345999999999976 45789999999999999999999999986443332211 111111111
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....+..|..++..||+.-|.+||+..+
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence 12355788999999999999999999763
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.54 Aligned_cols=248 Identities=29% Similarity=0.343 Sum_probs=194.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~ 475 (757)
++|....+||.|+||.||+|.+. ++.+|+|.+..... .....+.+|++++++++||||++++++|.+. .++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778889999999999999984 56899999875433 3456789999999999999999999988532 38999
Q ss_pred EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||+++++|.+++... .....++......|+.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 23345888999999999999999999988 99999999999999999999999999875542
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh---c
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ---A 631 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~---~ 631 (757)
.. .....++..|+|||.+.+..++.++|||||||++|+|+||+.||..... ...........+.... .
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE-PPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC-CCCChHHHHHHHhcCCchhh
Confidence 21 1234678899999999888999999999999999999999999975422 0000011111111101 1
Q ss_pred CCCC---hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWP---IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p---~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+ ...+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e 262 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHH
Confidence 1111 134678999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=306.06 Aligned_cols=236 Identities=27% Similarity=0.355 Sum_probs=194.3
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|.....||.|+||.||++.+. +..+|+|++.... ......+.+|+++|++++||||+++++++.+.. ++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 6778889999999999999885 5689999986532 223466889999999999999999999986554 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++++|.+++.... .++...+..++.||+.||.|||+.+ |+||||+|.|||++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999999987653 4888999999999999999999987 999999999999999999999999999876533
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
.....|++.|+|||++.+..++.++||||||+++|+|+||+.||...... .....+. ......|.
T Consensus 155 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~ 219 (290)
T cd05580 155 --------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKIL-EGKVRFPS 219 (290)
T ss_pred --------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh-cCCccCCc
Confidence 12346899999999988888899999999999999999999999644311 1111122 11223444
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccc
Q 004388 637 KETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+..+.+++.+||..+|.+||+..
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcc
Confidence 5578999999999999999999543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.09 Aligned_cols=187 Identities=25% Similarity=0.382 Sum_probs=158.0
Q ss_pred cCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
.+|.....||.|+||.||+|...+ ..||+|+.... .+..|+.++++++||||+++++++.+.. ++||||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 368888999999999999999864 48999975432 2356999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
. |+|.+++.... ..+++..+..|+.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++......
T Consensus 140 ~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 140 S-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred C-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 5 68888876533 35899999999999999999999988 9999999999999999999999999997543221
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCc
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 608 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 608 (757)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 113457999999999999889999999999999999999865443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.80 Aligned_cols=239 Identities=25% Similarity=0.373 Sum_probs=194.1
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
|.....||.|+||.||+|... +..|++|.+.... ......+.+|+.+++.++||||+++++++.+.. ++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566678999999999999885 6799999886543 123467889999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 9999999999886543 4889999999999999999999988 999999999999999999999999998875433
Q ss_pred CCCccccccccCCcccccCCCccccccCC-CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-hhcCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGD 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~ 633 (757)
. ......|++.|++||.+.... ++.++|+|||||++|+|++|++||.......... .... .....
T Consensus 156 ~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~ 222 (258)
T cd06632 156 S-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF------KIGRSKELPP 222 (258)
T ss_pred c-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH------HHHhcccCCC
Confidence 2 113456899999999887666 8999999999999999999999996543222111 1111 11223
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+......+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 251 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAE 251 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHH
Confidence 34456788999999999999999999885
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=308.81 Aligned_cols=248 Identities=27% Similarity=0.341 Sum_probs=197.6
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|...+.||.|+||.||+|... +..+|+|.+...... ....+..|++++..++||||+++++.+.+.. |+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5788889999999999999885 469999998765322 4456889999999999999999999986554 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 82 YCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred ecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999886432 346899999999999999999999988 9999999999999999999999999987654322
Q ss_pred CCcc-----------------------ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch
Q 004388 557 SFVS-----------------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK 613 (757)
Q Consensus 557 ~~~~-----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~ 613 (757)
.... .........||..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 1110 00111234789999999999888899999999999999999999999964432
Q ss_pred hhhhhchhhHHHHhhhhcCCCChh--HHHHHHHHHHHHhhccCCCCCccch
Q 004388 614 VETAIDEDNLAEILDAQAGDWPIK--ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~~~~~p~~--~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ..+..++... ..++.. .+..+.+++.+||..+|.+||+...
T Consensus 238 ~------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 281 (316)
T cd05574 238 D------ETFSNILKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281 (316)
T ss_pred H------HHHHHHhcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence 2 1222222221 222322 5788999999999999999999554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.94 Aligned_cols=235 Identities=19% Similarity=0.309 Sum_probs=190.3
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCCH
Q 004388 408 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSL 483 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gsL 483 (757)
..+||.|+||.||++... +..||+|++..........+.+|+.++..++||||+++++++... .++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 346999999999999874 679999998765555566788999999999999999999988544 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~------ 172 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------ 172 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc------
Confidence 987743 24889999999999999999999988 99999999999999999999999999976543221
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc---CCCChhHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA---GDWPIKETK 640 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~---~~~p~~~~~ 640 (757)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ +. .+.... ...+...+.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~ 245 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MK-RLRDSPPPKLKNAHKISP 245 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH-HHhccCCCCccccCCCCH
Confidence 12335789999999999888899999999999999999999999964332211 11 111111 111223467
Q ss_pred HHHHHHHHHhhccCCCCCccch
Q 004388 641 ELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+.+++.+||..+|.+||++.+
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQE 267 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHH
Confidence 7999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.50 Aligned_cols=250 Identities=25% Similarity=0.265 Sum_probs=206.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHH---HHHHHHHHHhcCCCceeeecccccC--CceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLGACPD--HGCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~---f~~Ev~il~~l~Hpniv~l~g~~~~--~~~LV~ 475 (757)
++|...+.||+|.||.|.+++-+ +..+|+|+++.......++ -+.|-.+|...+||.+..|-..|+. ..|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 46777889999999999999876 5699999999876655544 4668899999999999998777754 459999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||..||.|.-+|.+.. .++......+-.+|..||.|||+.+ ||+||||.+|+|||.+|++||+||||++.--..
T Consensus 248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999988886644 3666666678899999999999988 999999999999999999999999999753322
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
. ..+...+|||.|+|||++....|+..+|+|.+||++|||++|+.||... +.+.+.+++-..-..+|
T Consensus 322 g------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~-------dh~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 322 G------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK-------DHEKLFELILMEDLKFP 388 (516)
T ss_pred c------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-------chhHHHHHHHhhhccCC
Confidence 2 2346689999999999999999999999999999999999999999643 34566677666556788
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
...+++...|+.-.|..||++|-.-...=..++.+.
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 888999999999999999999966543333333333
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.11 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=202.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++|.....||.|+||.||+|... +..++||++..... .....+.+|+.++.+++|||++++++++.... ++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788889999999999999886 56899999876544 44577999999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
+++++|.+++... .+++...+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998754 358899999999999999999999 88 9999999999999999999999999998765432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
.. .....++..|+|||.+.+..++.++|+||||+++|+|+||+.||....... .......+........+.
T Consensus 155 ~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (264)
T cd06623 155 DQ------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAICDGPPPSLPA 225 (264)
T ss_pred Cc------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHhcCCCCCCCc
Confidence 21 123468899999999998899999999999999999999999996543200 011122222222333444
Q ss_pred h-HHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 K-ETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~-~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
. .+..+.+++.+||..+|.+||++.+.+
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 4 678999999999999999999998533
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=298.63 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=197.6
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|+...+||.|+||.||++... +..||+|.+.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777889999999999999874 5689999886432 233457899999999999999999999986554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998865332 35788999999999999999999987 99999999999999999999999999986643221
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
......|++.|+|||++.++.++.++|+|||||++++|+||+.||...... .....++.......+..
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 224 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGSYPPVSSH 224 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcCCCCCCccc
Confidence 112346889999999998888999999999999999999999998643211 11222222222333455
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+..+.+++.+||+.+|.+||++.+++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 678899999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.88 Aligned_cols=245 Identities=29% Similarity=0.382 Sum_probs=195.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
+|.....||.|+||.||++.+. +..+++|.+.... ......+.+|++++++++||||+++++++.... ++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666778999999999999986 5689999887653 234567899999999999999999999986554 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++++|.+++.... ..++......++.|++.||.|||+ .+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999887543 458889999999999999999999 77 99999999999999999999999999876542211
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
....|+..|+|||++.+..++.++||||||+++|+|+||+.||......... ....+..++.......+..
T Consensus 157 --------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd06605 157 --------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFELLQYIVNEPPPRLPSG 227 (265)
T ss_pred --------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHHHHHHHhcCCCCCCChh
Confidence 1257889999999998889999999999999999999999999643211000 0011122222222222332
Q ss_pred -HHHHHHHHHHHHhhccCCCCCccch
Q 004388 638 -ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 638 -~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+.+++.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (265)
T cd06605 228 KFSPDFQDFVNLCLIKDPRERPSYKE 253 (265)
T ss_pred hcCHHHHHHHHHHcCCCchhCcCHHH
Confidence 5778999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=298.61 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=198.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++|+..+.||.|+||.||+|... +..+++|++.... ......+.+|+.+|+.++|||++++++.+.+.. ++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36888899999999999999874 5589999986543 335567899999999999999999999875544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++++|.+++........+++.....++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999876543346899999999999999999999988 99999999999999999999999999987664332
Q ss_pred CccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC-
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP- 635 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p- 635 (757)
... .......|+..|++||++... .++.++|+|||||++|+|+||+.||....... .+.+.+.......+
T Consensus 158 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 229 (267)
T cd06610 158 RTR--KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDPPSLET 229 (267)
T ss_pred ccc--cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCCCCCcCC
Confidence 110 112344689999999988776 78999999999999999999999996433221 11111111111111
Q ss_pred ----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 ----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHH
Confidence 245678999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=299.81 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=195.1
Q ss_pred CCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 404 SFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~------~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
+|+....||+|+||.||+|.. .+..+|+|++..... .....+.+|+.++++++||||+++++++.+.. ++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477778999999999999986 456899999865431 12456889999999999999999999987654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCcccc
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTML 552 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~ 552 (757)
||||+++++|.+++...+ ++++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999886543 5889999999999999999999988 99999999999998776 6999999999776
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh-hhhc
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQA 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l-d~~~ 631 (757)
....... ........||..|+|||++.+..++.++||||||+++|+|++|..||........ ...+.... ....
T Consensus 155 ~~~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~ 229 (268)
T cd06630 155 AAKGTGA--GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATTA 229 (268)
T ss_pred ccccccC--CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCCC
Confidence 5432110 0111234689999999999888899999999999999999999999963321110 00111111 1112
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...|...+..+.+++.+|+..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 260 (268)
T cd06630 230 PSIPEHLSPGLRDVTLRCLELQPEDRPPSRE 260 (268)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence 3344556788999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.23 Aligned_cols=260 Identities=24% Similarity=0.385 Sum_probs=208.5
Q ss_pred cccCCCHHHHHHhhc-CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceee
Q 004388 389 RYRNLTWEEIESATL-SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLL 462 (757)
Q Consensus 389 ~~~~~~~~ei~~at~-~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~ 462 (757)
+|-...|-|....|. .|+.-+.||+||||.||-+... |.-+|.|.+..... ......++|-.||.+++.|.||.
T Consensus 170 rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVs 249 (591)
T KOG0986|consen 170 RFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVS 249 (591)
T ss_pred HHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEE
Confidence 344445555555554 4888899999999999987664 55788888765432 22334678999999999999999
Q ss_pred eccccc--CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 463 LLGACP--DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 463 l~g~~~--~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
|-.+|. +..||||..|.||+|.-+|.+.++ +.++......++.+|+.||.+||+.. ||+|||||+|||||+.|+
T Consensus 250 laYAfeTkd~LClVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~Gh 325 (591)
T KOG0986|consen 250 LAYAFETKDALCLVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGH 325 (591)
T ss_pred EeeeecCCCceEEEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCC
Confidence 988874 566999999999999988887665 67999999999999999999999988 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
+.|+|+|||..++..... ++.+||.+|||||++.++.|+...|+|||||+||||+.|+.||.... .....
T Consensus 326 vRISDLGLAvei~~g~~~-------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---eKvk~ 395 (591)
T KOG0986|consen 326 VRISDLGLAVEIPEGKPI-------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---EKVKR 395 (591)
T ss_pred eEeeccceEEecCCCCcc-------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---hhhhH
Confidence 999999999988765432 44599999999999999999999999999999999999999995221 11112
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...+-.....+|...++++.+|....|+.||.+|-.-..
T Consensus 396 eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg 437 (591)
T KOG0986|consen 396 EEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRG 437 (591)
T ss_pred HHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCC
Confidence 222222222234566677889999999999999999976553
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.20 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=192.4
Q ss_pred cCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||.|+||.||++.... ..|++|.+..... .....+.+|+.+++.++||||+++++.+.... ++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 367888999999999999998864 5899998875432 23456889999999999999999999986655 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++...+ .+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999986543 4889999999999999999999987 999999999999999999999999998742211
Q ss_pred CC---------CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 556 PS---------FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 556 ~~---------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
.. ............|+..|+|||++....++.++|+|||||++|+|+||..||...... ..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 00 000111122346889999999998888999999999999999999999999633211 111111
Q ss_pred hhhhcCCCCh---hHHHHHHHHHHHHhhccCCCCCccc
Q 004388 627 LDAQAGDWPI---KETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 627 ld~~~~~~p~---~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
... ...+|. ..+..+.+++.+||..+|.+||+..
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 265 (305)
T cd05609 229 ISD-DIEWPEGDEALPADAQDLISRLLRQNPLERLGTG 265 (305)
T ss_pred Hhc-ccCCCCccccCCHHHHHHHHHHhccChhhccCcc
Confidence 111 111221 3567899999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=296.90 Aligned_cols=244 Identities=26% Similarity=0.387 Sum_probs=195.6
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||.|+||.||++... +..+|||.+.... ......+.+|+.+|++++|||++++++.+.+.. ++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999999999998874 5689999986542 234567889999999999999999999875443 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla~~~~~~~ 556 (757)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999987543 235889999999999999999999987 9999999999999854 568999999998765432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .............+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 223 (256)
T cd08220 157 K-------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMSGTFAPISD 223 (256)
T ss_pred c-------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHhcCCCCCCC
Confidence 1 123468999999999988889999999999999999999999996432211 111222222223344
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..+.+++.+||..+|.+||++.+.+
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIM 251 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 4678899999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=300.26 Aligned_cols=240 Identities=25% Similarity=0.273 Sum_probs=197.5
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+|.....||.|+||.||+|.+. +..||+|++..... ...+.+.+|++++++++||||+++++++.+.. ++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778889999999999999986 66899999875432 34567899999999999999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+.+++|.+++... .++++.....|+.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988654 35889999999999999999999987 9999999999999999999999999988765432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... ....+...........|.
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 223 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETADVLYPA 223 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccccccCcc
Confidence 113356889999999998888999999999999999999999999744321 011122222222234455
Q ss_pred hHHHHHHHHHHHHhhccCCCCCcc
Q 004388 637 KETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
..+..+.+++.+||..+|.+||++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCc
Confidence 567899999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.12 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=190.5
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|+..++||.|+||.||+|.+. +..||+|++..... ...+.+.+|+++++.++||||++++++|.+.. ++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5778889999999999999985 56899998764322 23456889999999999999999999996654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++++|..+.... ..+++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 82 VDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred CCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 9999888765432 23899999999999999999999987 99999999999999999999999999987644321
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh--------hHHHHhh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NLAEILD 628 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--------~l~~~ld 628 (757)
......++..|+|||++.+ ..++.++|||||||++|+|+||++||......+...... ......+
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 156 ------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred ------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 1133468999999998765 457889999999999999999999996433221100000 0000000
Q ss_pred ------hh-cCC---------CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 ------AQ-AGD---------WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ------~~-~~~---------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. ... .....+..+.+|+.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 00 000 01234677999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.36 Aligned_cols=240 Identities=20% Similarity=0.295 Sum_probs=190.9
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCCH
Q 004388 408 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSL 483 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gsL 483 (757)
...||.|+||.||++... +..||||.+........+.+.+|+.+++.++||||+++++.+... .++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999874 568999998765555567789999999999999999999987544 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 107 ~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~------ 173 (292)
T cd06658 107 TDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP------ 173 (292)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc------
Confidence 9987432 3788999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 643 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 643 (757)
......|++.|+|||++.+..++.++|||||||++|||++|+.||......... ..+...+... .......+..+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~ 249 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRDNLPPR-VKDSHKVSSVLR 249 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCCCc-cccccccCHHHH
Confidence 112346899999999998888999999999999999999999999643321110 0011111111 111223566899
Q ss_pred HHHHHHhhccCCCCCccchhh
Q 004388 644 ALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 644 ~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+++.+||..+|.+||++.+++
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il 270 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELL 270 (292)
T ss_pred HHHHHHccCChhHCcCHHHHh
Confidence 999999999999999998533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=303.09 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=190.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|+....||.|+||.||+|.+. +..||+|++.... ....+.+.+|+.++++++|||++++++++.+.. ++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5778889999999999999985 5689999876432 223456789999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++++|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 82 CDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred cCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 9998887765432 24899999999999999999999987 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh-hH-------HHHhh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-NL-------AEILD 628 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~l-------~~~ld 628 (757)
......++..|+|||++.+ ..++.++|||||||++|+|+||++||......+...... .+ ..+.+
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 156 ------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred ------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 1123467899999998765 457899999999999999999999996443322111000 00 00000
Q ss_pred hh------cCCC-----C-----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 AQ------AGDW-----P-----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ~~------~~~~-----p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. .... + ...+..+.+|+.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 00 0000 0 123577899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=299.30 Aligned_cols=243 Identities=23% Similarity=0.416 Sum_probs=191.1
Q ss_pred CCccceeeccCCcEEEEEEEECC---eEEEEEEEccCC----------chhhHHHHHHHHHHHh-cCCCceeeecccccC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH---TFAAVKVLQSKG----------NIQNKQFLQELEVLSK-IRHPHLLLLLGACPD 469 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~---~~vAvK~l~~~~----------~~~~~~f~~Ev~il~~-l~Hpniv~l~g~~~~ 469 (757)
+|+....||.|+||.||+|.+.+ ..+|+|.+.... ......+.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46777889999999999999864 589999875321 2233457789998875 799999999999866
Q ss_pred Cc--eEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEee
Q 004388 470 HG--CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGD 545 (757)
Q Consensus 470 ~~--~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~D 545 (757)
.. ++||||++|++|.+++... .....+++..+..++.|++.||.|||+ .+ ++||||+|+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 54 8999999999999987542 223458899999999999999999996 44 99999999999999999999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHH
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
||++....... ......|+..|++||++.++.++.++||||||+++|+|++|++||........ ...
T Consensus 158 fg~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~ 224 (269)
T cd08528 158 FGLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATK 224 (269)
T ss_pred ccceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHH
Confidence 99998755432 12345789999999999888899999999999999999999999964322111 111
Q ss_pred HhhhhcCCCC-hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 626 ILDAQAGDWP-IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 626 ~ld~~~~~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+........+ ...+..+.+++.+||..+|.+||++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 262 (269)
T cd08528 225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQ 262 (269)
T ss_pred HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHH
Confidence 1111111111 134678999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=302.02 Aligned_cols=238 Identities=24% Similarity=0.366 Sum_probs=189.7
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCCH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSL 483 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gsL 483 (757)
||.|+||.||++... +..+|+|++.... ......+..|+.+|++++||||+++++.+... .|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 5689999986532 22344577899999999999999999988543 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------
Confidence 998876543 45899999999999999999999988 99999999999999999999999999876543211
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 643 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 643 (757)
.....++..|++||++.++.++.++|||||||++|+|++|+.||....... ....+...........+...+..+.
T Consensus 151 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd05577 151 -IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV---EKEELKRRTLEMAVEYPDKFSPEAK 226 (277)
T ss_pred -cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc---cHHHHHhccccccccCCccCCHHHH
Confidence 123468889999999988889999999999999999999999996432210 0111111111112233445678899
Q ss_pred HHHHHHhhccCCCCCccch
Q 004388 644 ALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 644 ~Li~~Cl~~~p~~RPs~~~ 662 (757)
+++.+||+.+|.+||++.+
T Consensus 227 ~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 227 DLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHccCChhHccCCCc
Confidence 9999999999999998776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.48 Aligned_cols=232 Identities=24% Similarity=0.404 Sum_probs=185.1
Q ss_pred eeccCCcEEEEEEEECCeEEEEEE--Ec----cCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc----eEEEEecC
Q 004388 410 RIGMGGYGTVYKGTFHHTFAAVKV--LQ----SKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYME 479 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~~~vAvK~--l~----~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~----~LV~Ey~~ 479 (757)
.||+|+|-+||+|.+..+.+.|.. ++ .......++|..|+++|+.|.|||||++|.+|.+.. -+|.|+|.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 599999999999998766554432 11 112334578999999999999999999999996543 57999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCccccCCCCCC
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla~~~~~~~~~ 558 (757)
.|+|..|+.+.+. ++......|+.||+.||.|||++. +||||||||.+||+|+.+ |.+||+|+|||+......
T Consensus 127 SGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 127 SGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred CCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 9999999987654 677889999999999999999998 489999999999999865 999999999999876432
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-CCCCh-
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GDWPI- 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~~p~- 636 (757)
....+|||.|||||... ..|+..+||||||++++||+|+..||.-.... +++..... |..|.
T Consensus 201 ------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~---------AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 201 ------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP---------AQIYKKVTSGIKPAA 264 (632)
T ss_pred ------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH---------HHHHHHHHcCCCHHH
Confidence 24479999999999876 77999999999999999999999999622111 11111111 11121
Q ss_pred ---hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 ---KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ---~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
-..+++.+||.+|+.. ..+||++.+.+
T Consensus 265 l~kV~dPevr~fIekCl~~-~~~R~sa~eLL 294 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLAT-KSERLSAKELL 294 (632)
T ss_pred hhccCCHHHHHHHHHHhcC-chhccCHHHHh
Confidence 1257899999999999 99999998644
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.30 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=196.2
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCC------
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH------ 470 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~------ 470 (757)
..+++|.....||.|+||.||+|... +..+++|++..... ....|.+|+.+++++ .||||++++++|.+.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999985 45899999876543 346789999999999 699999999998432
Q ss_pred --ceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 471 --GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 471 --~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 379999999999999886532 2345889999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhh
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 622 (757)
++........ ......|++.|+|||++.. ..++.++|||||||+||+|+||++||...+... .
T Consensus 159 ~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~ 226 (275)
T cd06608 159 VSAQLDSTLG------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------A 226 (275)
T ss_pred cceecccchh------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------H
Confidence 9876543221 1234578999999998753 346789999999999999999999996432221 1
Q ss_pred HHHHhhhhcCC--CChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 623 LAEILDAQAGD--WPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 623 l~~~ld~~~~~--~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
+..+....... .+...+..+.+|+.+||..+|.+||++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 227 LFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred HHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 12222211111 122356789999999999999999999853
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=293.93 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=193.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|+....||+|.|+.||++... +..+|+|+++.. ...+.+.+.+|+.|-..|+|||||+|...+.+.. |||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 45666667999999999998765 457788876533 2335677889999999999999999999987665 79999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec---CCCceEEeeecCccccC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld---~~~~~KL~DFGla~~~~ 553 (757)
+|.||+|..-+..+. .+++..+-..+.||+.+|.|+|.++ |||||+||+|+||. ..--+||+|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred cccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999976554432 3566777889999999999999999 99999999999994 34568999999999887
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
... ...+.+|||.|||||++....|+..+|||+.|||||-||.|.+||....... +-++......|.....
T Consensus 165 ~g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~~g~yd~~~~~ 235 (355)
T KOG0033|consen 165 DGE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIKAGAYDYPSPE 235 (355)
T ss_pred Ccc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhccccCCCCcc
Confidence 322 2356799999999999999999999999999999999999999996421110 0111111122222334
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|+ ..+++..+|+.+||..||.+|.+..+.+
T Consensus 236 w~-~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 236 WD-TVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cC-cCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 55 3578899999999999999999987643
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=310.42 Aligned_cols=252 Identities=17% Similarity=0.204 Sum_probs=185.0
Q ss_pred ceeeccC--CcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecC
Q 004388 408 NLRIGMG--GYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 479 (757)
Q Consensus 408 ~~~IG~G--~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~ 479 (757)
..+||+| +||+||++... +..||+|.+.... ......+.+|+.+++.++||||++++++|.+. .++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3568999 78999999875 5689999987543 22345577899999999999999999998554 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999886533 234899999999999999999999988 9999999999999999999999998765433211100
Q ss_pred -cccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--hhhHHHHhhh-----
Q 004388 560 -STTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--EDNLAEILDA----- 629 (757)
Q Consensus 560 -~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~~~l~~~ld~----- 629 (757)
..........++..|+|||++.+ ..++.++|||||||++|+|+||+.||........... .+.+...++.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 00001122367888999999875 4589999999999999999999999963221110000 0000000000
Q ss_pred ------------------------hc--------CCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 630 ------------------------QA--------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 630 ------------------------~~--------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.. .......+..+.+|+.+||+.||.+||++.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el 304 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL 304 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence 00 00111245689999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.44 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=194.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||+|+||.||+|... +..+++|++...... ....+.+|+.++++++||||+++++++.+.. ++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3667789999999999999874 568999998765443 5667899999999999999999999986543 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++++|.+++.... .+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999886532 3788899999999999999999988 99999999999999999999999999987654332
Q ss_pred CccccccccCCcccccCCCccccccCC---CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGL---ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.... ......+++.|++||++.... ++.++||||||+++|+|++|+.||........ ....+........
T Consensus 155 ~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~ 227 (264)
T cd06626 155 TMGE--EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHVGAGHKPPI 227 (264)
T ss_pred cccc--cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHHhcCCCCCC
Confidence 1111 012357889999999987766 88999999999999999999999963321110 0011111111222
Q ss_pred Chh--HHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIK--ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~--~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
|.. .+..+.+++.+||+.+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 257 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASE 257 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 322 3778899999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.46 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=189.2
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|+....||.|+||.||+|... +..||||.+.... ......+.+|++++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788889999999999999884 5689999886543 223356889999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+. ++|..++.... ...+++..+..++.|++.||.|||..+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 68988876543 245899999999999999999999987 99999999999999999999999999876543221
Q ss_pred CccccccccCCcccccCCCccccccCC-CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh--------hH----H
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NL----A 624 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--------~l----~ 624 (757)
. .....+++.|+|||++.+.. ++.++|||||||++|+|+||+.||............. .+ .
T Consensus 156 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 T------YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred c------cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 1 12335789999999876544 6889999999999999999999996443221111000 00 0
Q ss_pred HHh--hhhcCCC--------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 625 EIL--DAQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 625 ~~l--d~~~~~~--------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+. ......| ....+..+.+++.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 277 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKA 277 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHH
Confidence 000 0000011 1123567889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.96 Aligned_cols=239 Identities=26% Similarity=0.400 Sum_probs=192.8
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
|....+||.|+||.||+|... +..+|+|++.... ......|.+|+.++.+++||||+++++++.+.. ++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566778999999999999874 5689999876433 233467889999999999999999999986544 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.. ..+++.....++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999998753 24889999999999999999999987 99999999999999999999999999876643221
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
......|+..|++||++.+..++.++|+|||||++|+|+||..||........ ...+........+...+
T Consensus 157 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~ 226 (277)
T cd06641 157 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIPKNNPPTLEGNYS 226 (277)
T ss_pred ----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHhcCCCCCCCcccC
Confidence 12334688999999999888889999999999999999999999964322111 11111111222334567
Q ss_pred HHHHHHHHHHhhccCCCCCccch
Q 004388 640 KELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~ 249 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKE 249 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHH
Confidence 88999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=302.15 Aligned_cols=247 Identities=22% Similarity=0.309 Sum_probs=187.2
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||.|+||.||+|.+. +..+|+|.+.... ......+.+|+.++++++||||+++++++.+.. ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999985 5689999886532 222356788999999999999999999986554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 57888776533 34899999999999999999999988 99999999999999999999999999986543221
Q ss_pred CccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch----------hhH---
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE----------DNL--- 623 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----------~~l--- 623 (757)
......+++.|+|||++.+. .++.++|||||||++|+|+||..|+.........+.. ..+
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 11234678999999987664 4789999999999999999998886432222111100 000
Q ss_pred HHHhhhh-cCCC---------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILDAQ-AGDW---------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld~~-~~~~---------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+.. .... ....+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 0000000 0000 1124578899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.66 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=198.4
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEE
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~ 475 (757)
..+++|.....||.|+||.||+|.+. +..+++|++..... ....+.+|+++++.++|||++++++++... .++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567788889999999999999986 67899999876544 566788999999999999999999988544 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999997654 35899999999999999999999987 999999999999999999999999998765432
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC--
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD-- 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~-- 633 (757)
.. ......+++.|++||++.+..++.++|+|||||++|+|+||+.||......... ..+.......
T Consensus 170 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~ 237 (286)
T cd06614 170 KS------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLITTKGIPPLK 237 (286)
T ss_pred hh------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcCCCCCc
Confidence 21 112346789999999988888999999999999999999999998643322111 1111111111
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+...+..+.+++.+|++.+|..||++.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 266 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEE 266 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHH
Confidence 12225678999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.46 Aligned_cols=242 Identities=26% Similarity=0.421 Sum_probs=196.6
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCC
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~ 480 (757)
|.....||.|++|.||++... +..+++|++..........+.+|++++++++|||++++++++... .++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 667788999999999999986 678999999876555567899999999999999999999988554 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
++|.+++.... ..+++..+..++.+++.||.|||..+ ++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 99999886543 35899999999999999999999977 99999999999999999999999999987654321
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 640 (757)
.....|+..|++||++....++.++||||||+++|+|++|+.||........... .. .........+...+.
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~ 225 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IA-TNGPPGLRNPEKWSD 225 (253)
T ss_pred ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HH-hcCCCCcCcccccCH
Confidence 1345788999999999888899999999999999999999999964322111100 00 011111112222367
Q ss_pred HHHHHHHHHhhccCCCCCccch
Q 004388 641 ELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHH
Confidence 8999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.03 Aligned_cols=235 Identities=25% Similarity=0.320 Sum_probs=191.6
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCCH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSL 483 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gsL 483 (757)
||.|+||.||+|.+. +..+++|++..... .....+.+|+.++++++||||+++++.+.+. .++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999997 67999999875432 2346789999999999999999999998654 4899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99986543 3888999999999999999999987 9999999999999999999999999998765432
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-hhcCCCChhHHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDWPIKETKEL 642 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~~~~l 642 (757)
......|++.|++||++....++.++|+||||+++|+|++|..||....... ...+..+.. ......|...+..+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 223 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGKLEFPNYIDKAA 223 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCCCCCCcccCHHH
Confidence 1123468899999999888889999999999999999999999997543100 111122221 22234455557899
Q ss_pred HHHHHHHhhccCCCCCccch
Q 004388 643 AALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 643 ~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+++.+||..+|.+||++.+
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~ 243 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLK 243 (262)
T ss_pred HHHHHHHccCChhhCcCCcc
Confidence 99999999999999999654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=303.41 Aligned_cols=243 Identities=24% Similarity=0.368 Sum_probs=196.0
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
.+|...+.||.|+||.||+|.. .+..+++|.+........+.+.+|+.++++++||||+++++.|.+. .++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999986 4568999998765555567789999999999999999999998544 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++.+. .+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999988543 3788899999999999999999988 99999999999999999999999999876553321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC--CCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD--WPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~--~p~ 636 (757)
......|++.|++||++..+.++.++|||||||++|+|++|+.||.......... .+....... .+.
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~~~~~ 239 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTPELQNPE 239 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCCCCCCCcc
Confidence 1133468899999999988889999999999999999999999996433221110 010011111 122
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..+.+++.+||..+|.+||++.+.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3456799999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.02 Aligned_cols=241 Identities=26% Similarity=0.408 Sum_probs=192.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcC---CCceeeecccccCCc--eEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~---Hpniv~l~g~~~~~~--~LV~ 475 (757)
.|+....||.|+||.||+|.+. +..+|+|.+.... ......+.+|+.++++++ |||+++++++|.+.. ++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4666778999999999999974 5689999987542 334567889999999997 999999999986554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++++|.+++... .+++.....++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999987542 5889999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.. ......|+..|+|||++.++ .++.++|+|||||++|+|++|.+||.......... .+........
T Consensus 155 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~~~~~~~~~~ 222 (277)
T cd06917 155 SS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------LIPKSKPPRL 222 (277)
T ss_pred cc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------ccccCCCCCC
Confidence 21 12334789999999987654 46899999999999999999999996433221110 0000011122
Q ss_pred Ch-hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 635 PI-KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 635 p~-~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
+. ..+..+.+++.+||..+|.+||++.+.
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~i 252 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEEL 252 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 22 256789999999999999999998853
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=295.50 Aligned_cols=243 Identities=23% Similarity=0.398 Sum_probs=195.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||.|+||.||+|... +..+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.+.. ++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999885 5689999886542 223456889999999999999999999986654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~~~~~ 556 (757)
+++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999998875432 35799999999999999999999988 99999999999998885 56999999998765432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
.. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||....... .............+.
T Consensus 157 ~~------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 224 (257)
T cd08225 157 EL------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQGYFAPISP 224 (257)
T ss_pred cc------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhcccCCCCCC
Confidence 11 123468999999999988889999999999999999999999996432211 112222222222233
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+..+.+++.+||..+|.+||++.+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHH
Confidence 45678999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=303.37 Aligned_cols=244 Identities=24% Similarity=0.321 Sum_probs=189.9
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch-----hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-----QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~-----~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
+|.....||.|+||.||+|.+. ++.||||.+...... ....+..|++++++++||||+++++++.+.. ++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667788999999999999875 569999998755322 2345678999999999999999999997644 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999886543 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh------
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL------ 627 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l------ 627 (757)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......... .....+
T Consensus 155 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~ 225 (298)
T cd07841 155 PNR------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG---KIFEALGTPTEE 225 (298)
T ss_pred CCc------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH---HHHHHcCCCchh
Confidence 321 1123467889999998754 457899999999999999999988886433221100 000000
Q ss_pred ---------hhh----cCC-----CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 ---------DAQ----AGD-----WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 ---------d~~----~~~-----~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.. ... .....+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e 278 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQ 278 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHH
Confidence 000 000 01223578899999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.08 Aligned_cols=239 Identities=20% Similarity=0.311 Sum_probs=192.3
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC--CceEEEEecCC
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~~LV~Ey~~~ 480 (757)
|....+||.|++|.||++... +..+++|++........+.+.+|+.+++.++||||+++++++.. ..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 56899999876555556678899999999999999999998754 44899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 999998865 24888999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh--cCCCChhH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDWPIKE 638 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~~p~~~ 638 (757)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ +..+.... ....+...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 241 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDNLPPKLKNLHKV 241 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHhcCCCCCcccccC
Confidence 11234689999999999888899999999999999999999999864332111 11111111 11112235
Q ss_pred HHHHHHHHHHHhhccCCCCCccch
Q 004388 639 TKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+..+.+++.+||..+|.+||++.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHH
Confidence 678999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=300.87 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=191.6
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||.|+||.||+|.+. ++.||+|++.... ......+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3677788999999999999874 6799999987653 233467899999999999999999999986554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+ +++|.+++.... .++++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 45899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------hhhHHH--
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------EDNLAE-- 625 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------~~~l~~-- 625 (757)
. ......|+..|+|||++.+. .++.++|||||||++|+|+||.+||........... ......
T Consensus 155 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 R-----LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-----ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 0 11234789999999987654 468999999999999999999888854322111000 000000
Q ss_pred -Hhh------hhcC-----CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 626 -ILD------AQAG-----DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 626 -~ld------~~~~-----~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.+ .... ......+..+.+++.+|+..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 000 0000 001134578999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=300.54 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=191.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
+|+...+||.|++|.||+|++. +..||||++..... .....+.+|+.++++++||||+++++++.+. .++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5778899999999999999985 66899999875532 2345678899999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++ +|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 84 88888876554456899999999999999999999987 99999999999999999999999999976543211
Q ss_pred ccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------hhhHHHHhh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------EDNLAEILD 628 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------~~~l~~~ld 628 (757)
......+++.|++||++.+ ..++.++|||||||++|+|+||++||......+.... ...+..+.+
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1123467899999998755 3578999999999999999999999964432211100 000000000
Q ss_pred --hhcCC-----------CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 --AQAGD-----------WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 --~~~~~-----------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..... .....+..+.+++.+|++.+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 00000 11123567889999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=301.41 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=192.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|+....||.|+||.||+|.+. +..||+|++.... ......+.+|++++++++||||+++++++.+.. ++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788889999999999999885 4589999886532 233467899999999999999999999986543 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++++.|..++... ..+++..+..++.+|+.||.|||..+ ++||||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9987776554332 24889999999999999999999988 99999999999999999999999999987654332
Q ss_pred CccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHH--------HHhh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA--------EILD 628 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~--------~~ld 628 (757)
. ......++..|+|||++.+. .++.++||||||+++|+|++|++||................ ....
T Consensus 156 ~-----~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 S-----PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred c-----cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 0 11335788999999998887 78999999999999999999999996443222111000000 0000
Q ss_pred ------------hh-----cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 ------------AQ-----AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ------------~~-----~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. ...++...+..+.+++.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 281 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence 00 00122234788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.78 Aligned_cols=248 Identities=20% Similarity=0.324 Sum_probs=187.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++|.....||.|+||.||+|... ++.||||.+..... .....+.+|++++++++||||+++++++.+.. ++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46888889999999999999874 57899999865432 22345778999999999999999999987554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+. ++|.+++..... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LD-TDLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CC-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 98 489998865432 5889999999999999999999988 99999999999999999999999999875432111
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc----------hhhHHHH
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------EDNLAEI 626 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----------~~~l~~~ 626 (757)
......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.........+. ...+...
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 1122357889999998765 4588999999999999999999999964431111110 0000000
Q ss_pred hhh------hcCC----------CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 LDA------QAGD----------WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 ld~------~~~~----------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... .... ........+.+++.+||+.+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e 284 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence 000 0000 00111267889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.88 Aligned_cols=243 Identities=22% Similarity=0.327 Sum_probs=189.8
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc----------hhhHHHHHHHHHHHhcCCCceeeecccccCC-
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN----------IQNKQFLQELEVLSKIRHPHLLLLLGACPDH- 470 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~----------~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~- 470 (757)
+|.....||.|+||.||+|... +..+|+|.+..... ...+.+.+|+.+++.++|||++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4566778999999999999764 56899998753211 0124578899999999999999999998654
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 38999999999999998654 35888999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
........ ........|+..|+|||++.... ++.++|+||||+++|+|++|..||.......... +..
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~ 225 (272)
T cd06629 156 KKSDDIYD----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF------KLG 225 (272)
T ss_pred cccccccc----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH------Hhh
Confidence 76543211 11123456899999999887654 7899999999999999999999996433222111 111
Q ss_pred hh-hcCCC----ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DA-QAGDW----PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~-~~~~~----p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. ..... ....+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (272)
T cd06629 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265 (272)
T ss_pred ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 00 01111 1234678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=298.70 Aligned_cols=244 Identities=26% Similarity=0.375 Sum_probs=188.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHH-HHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEV-LSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~i-l~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|+....||+|+||.||+|.+. +..||+|.+..... .....+..|+.+ ++.++||||+++++++.+.. ++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999985 56999999875432 233456667776 55678999999999985543 89999
Q ss_pred ecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 477 YMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 477 y~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|++ |+|.+++... .....+++..+..++.||+.||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877642 2335689999999999999999999986 5 99999999999999999999999999986543
Q ss_pred CCCCccccccccCCcccccCCCcccccc----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRT----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
.. ..+...|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...... ...+...+...
T Consensus 157 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 224 (283)
T cd06617 157 SV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVEEP 224 (283)
T ss_pred cc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHhcC
Confidence 21 1123468899999998754 44688999999999999999999999532111 11122222221
Q ss_pred cCCCC-hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 AGDWP-IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 ~~~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....| ...+..+.+++.+||..+|.+||++.+
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 257 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPE 257 (283)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 12222 234678999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.87 Aligned_cols=247 Identities=20% Similarity=0.318 Sum_probs=188.8
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
|+....||.|++|.||+|.+. +..||+|++.... ......+.+|+++++.++|||++++++++.+.. ++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 556778999999999999874 6799999987543 223356889999999999999999999986554 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+ ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689998865442 35899999999999999999999987 99999999999999999999999999976543211
Q ss_pred ccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------h------h
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------D------N 622 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------~------~ 622 (757)
......+++.|+|||++.+. .++.++||||||+++|+|+||++||............ . .
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11233678999999987654 5789999999999999999999999644332111000 0 0
Q ss_pred HHHHhhh-------hcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 623 LAEILDA-------QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 623 l~~~ld~-------~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.+.... .........+..+.+++.+|++.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 0000000 000111234577899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.71 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=189.2
Q ss_pred CccceeeccCCcEEEEEEEEC----CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCC----ceE
Q 004388 405 FSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCL 473 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~L 473 (757)
|....+||.|+||.||+|... +..||+|.+.... ......+.+|+.++.+++||||++++++|.+. .++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 677788999999999999984 4699999988633 33446678899999999999999999998655 389
Q ss_pred EEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC----CCceEEeeec
Q 004388 474 VYEYMENGSLEDRLYRKN--NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDVG 547 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~----~~~~KL~DFG 547 (757)
||||+++ +|.+.+.... ....++...+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 6766664322 2236888999999999999999999988 999999999999999 9999999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhh---hhhchhhH
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVE---TAIDEDNL 623 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~l 623 (757)
++......... ........+|+.|+|||++.+. .++.++|||||||++|+|++|++||....... .......+
T Consensus 158 ~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 158 LARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred cccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 99876543221 1122345789999999987654 57899999999999999999999996332211 00000011
Q ss_pred HHHhh------------------------hh-cCCCC-----------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILD------------------------AQ-AGDWP-----------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld------------------------~~-~~~~p-----------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..++. .. ....+ ...+..+.+++.+||+.+|++||++.+
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e 309 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE 309 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 11100 00 00111 034467899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=299.38 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=188.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++.+|...+.||+|+||.||+|... +..||+|++..... .....+.+|+.+++.++||||+++++++.+.. ++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4568889999999999999999874 67999999865432 22346788999999999999999999986553 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67777665433 34778888999999999999999987 999999999999999999999999999764322
Q ss_pred CCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh---------hHHH
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------NLAE 625 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------~l~~ 625 (757)
.. ......+++.|+|||++.+. .++.++|||||||++|+|+||++||.........+... ....
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 11 11234678999999988653 57889999999999999999999996433221111000 0000
Q ss_pred Hh---hhhcCC-------------C-ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 626 IL---DAQAGD-------------W-PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 626 ~l---d~~~~~-------------~-p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+ ...... | .......+.+++.+|+..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~ 284 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD 284 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHH
Confidence 00 000000 0 0122567899999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.14 Aligned_cols=239 Identities=24% Similarity=0.397 Sum_probs=195.4
Q ss_pred ceeeccCCcEEEEEEEECCe--EEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeeccccc--CCceEEEEecCCCCH
Q 004388 408 NLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMENGSL 483 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~--~~~~LV~Ey~~~gsL 483 (757)
...||.|+||.||++..+.+ ..|-|++........++|+-||+||..+.||+||+|+++|. ....+..|||.||-.
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 34589999999999988765 56888888777778889999999999999999999999763 344788999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
+.++..-+. +|...++..++.|++.||.|||+.+ |||||||..|||++.+|.++|+|||.+.... .+..
T Consensus 117 DaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~------~t~q 185 (1187)
T KOG0579|consen 117 DAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK------STRQ 185 (1187)
T ss_pred hHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch------hHHh
Confidence 888776553 5899999999999999999999998 9999999999999999999999999875432 2334
Q ss_pred cccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh--hhcCCCCh
Q 004388 564 KNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD--AQAGDWPI 636 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld--~~~~~~p~ 636 (757)
+...+.|||+|||||+.. ..+|+.++|||||||+|.||..+.||..-.+.....+ .+-. +...-.|.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll------KiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSEPPTLLQPS 259 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH------HHhhcCCCcccCcc
Confidence 556789999999999754 4579999999999999999999999975333322211 1111 11112355
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
..+..+.+++.+||..+|..||+..+.
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaql 286 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQL 286 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence 678899999999999999999998853
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.37 Aligned_cols=254 Identities=17% Similarity=0.199 Sum_probs=180.9
Q ss_pred cCCccceeeccCCcEEEEEEEECCe-----EEEEEEEccCCchhh-----------HHHHHHHHHHHhcCCCceeeeccc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN-----------KQFLQELEVLSKIRHPHLLLLLGA 466 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~-----~vAvK~l~~~~~~~~-----------~~f~~Ev~il~~l~Hpniv~l~g~ 466 (757)
..|...++||+|+||.||+|...++ .+|+|+......... .....+...+..+.|+|++.++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4688889999999999999987544 567776443322111 112233445566789999999987
Q ss_pred ccCCc------eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 467 CPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 467 ~~~~~------~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
+.... +++++++. .++.+.+... ...++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 64322 56777764 4676665432 23577888999999999999999987 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCcc-ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-
Q 004388 541 SKIGDVGLSTMLNSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI- 618 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~- 618 (757)
+||+|||+|+.+........ .........||+.|+|||++.+..++.++|||||||++|||+||++||.........+
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987653221111 0111233479999999999999999999999999999999999999996442111111
Q ss_pred --chhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhh
Q 004388 619 --DEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP 666 (757)
Q Consensus 619 --~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~ 666 (757)
..+.+..+..... .+...+..+.+++..|+.++|.+||++.+ +.+
T Consensus 245 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~-l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDA-LIK 291 (294)
T ss_pred HhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHH-HHH
Confidence 1111122211111 12234678999999999999999999984 443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.31 Aligned_cols=240 Identities=26% Similarity=0.395 Sum_probs=189.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~ 475 (757)
..|.....||.|+||.||+|... +..||+|++..... .....+.+|+++++.++||||++++++|.+. .++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 34777789999999999999874 67899998864322 2335688999999999999999999998654 38999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 67777665433 25899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCCccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
....|++.|+|||++. .+.++.++||||||+++|+|+||++||......... ..+......
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~~~~~ 232 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNDSP 232 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhcCCCC
Confidence 2346888999999874 456889999999999999999999998644322211 111111111
Q ss_pred C-CChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 633 D-WPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 633 ~-~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
. .+...+..+.+++.+||..+|.+||++.+++
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 1 1223466899999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.35 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=200.6
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~ 475 (757)
+|...+.||+|++|.||+|... +..+++|++..... ...+.+.+|+.++++++||||+++++.+.+. .++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999986 67899999876543 3466789999999999999999999998665 37999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987544 6899999999999999999999987 999999999999999999999999999877654
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-hhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~~ 634 (757)
... .......++..|++||++.+..++.++||||||+++++|++|..||........ .+..+.. ......
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~ 225 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKIGSSGEPPEI 225 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHhccccCCCcCC
Confidence 321 012345789999999999888899999999999999999999999965431111 1111111 112234
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|...+..+.+++.+|+..+|.+||++.+.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 445578999999999999999999998633
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=292.69 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=193.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCceeeecccccCC----c
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~ 471 (757)
.+|...+.||+|+||.||+|.+. +..+|+|.+.... ......|.+|++++++++||||+++++++.+. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888899999999999999874 5689999875431 22345788999999999999999999988543 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++++|.+++...+ .+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999886543 3788899999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-hh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-AQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-~~ 630 (757)
...... .........|+..|+|||++.+..++.++|+|||||++|+|++|++||........ +..... +.
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 226 (264)
T cd06653 156 IQTICM---SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQPT 226 (264)
T ss_pred cccccc---cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcCCC
Confidence 542111 00111335689999999999888889999999999999999999999964322211 111111 11
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....|......+.+++.+||. +|..||+..+
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~ 257 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEF 257 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence 223455677889999999999 5799999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=292.17 Aligned_cols=238 Identities=27% Similarity=0.319 Sum_probs=190.9
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 483 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL 483 (757)
||.|+||.||++.+. +..+++|++..... .....+.+|+.++.+++||||+++++.+.+.. |+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 66999999876543 34566889999999999999999999886544 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC--ccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF--VST 561 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~--~~~ 561 (757)
.+++.+.+ .+++..+..|+.||+.||.|||..+ ++||||+|+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987644 5899999999999999999999988 999999999999999999999999998765432110 000
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhH--H
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE--T 639 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~--~ 639 (757)
........++..|++||+.....++.++||||||+++|+|+||+.||....... .... +......+|... +
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~~~~~~ 227 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQN-ILNGKIEWPEDVEVS 227 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HhcCCcCCCccccCC
Confidence 112234568899999999988889999999999999999999999996443211 1111 111223344444 7
Q ss_pred HHHHHHHHHHhhccCCCCCccc
Q 004388 640 KELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+.+++.+||+.+|.+||++.
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~ 249 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAK 249 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCc
Confidence 8899999999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.87 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=189.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccC----CceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPD----HGCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~~LV 474 (757)
.+|.....||.|+||.||+|.+. ++.+++|.+..... .....+.+|+.++.+++||||+++++++.+ ..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 36778889999999999999986 56899998865432 223456789999999999999999998753 34899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+. ++|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 599998865432 5899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------hhHH
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLA 624 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------~~l~ 624 (757)
... ......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||............ ..+.
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PLK------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Ccc------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 321 11234678999999987654 4689999999999999999999999643221110000 0000
Q ss_pred HH--hhh-------------hcCCCChh-HHHHHHHHHHHHhhccCCCCCccchh
Q 004388 625 EI--LDA-------------QAGDWPIK-ETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 625 ~~--ld~-------------~~~~~p~~-~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.. +.. .....+.. .+..+.+++.+||..+|++||++.++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el 287 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence 00 000 00111111 36778999999999999999998853
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=297.07 Aligned_cols=244 Identities=24% Similarity=0.301 Sum_probs=191.7
Q ss_pred CCccceeeccCCcEEEEEEEE-----CCeEEEEEEEccCC----chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--
Q 004388 404 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~-- 471 (757)
+|+....||.|+||.||++.. ++..||+|++.... ....+.+.+|+.+|.++ +||||+.+++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 46789999987532 22345678899999999 5999999998886554
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++++|.+++.... ++++.....++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 79999999999999986543 4788889999999999999999987 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccC--CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
....... ......|+..|+|||++..+ .++.++||||||+++|+|+||..||....... ....+...+..
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~ 226 (290)
T cd05613 155 FHEDEVE-----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILK 226 (290)
T ss_pred ccccccc-----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhc
Confidence 5432211 11234689999999988653 46789999999999999999999996322110 01111222222
Q ss_pred hcCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 630 QAGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 630 ~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
....+|...+..+.+++.+|+..+|.+||+..
T Consensus 227 ~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~ 258 (290)
T cd05613 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCG 258 (290)
T ss_pred cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCC
Confidence 23345556778899999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.00 Aligned_cols=244 Identities=25% Similarity=0.315 Sum_probs=188.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEcc--CCchhhHHHHHHHHHHHhcC-CCceeeecccccCC--ceEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQS--KGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~--~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~--~~LV~E 476 (757)
..|+..++||+||.+.||++... .+.||+|.... ........|.+|+..|.+|. |.+||.||+|-... .|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 34788889999999999999875 45777775443 34556678999999999995 99999999986443 389999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|-+ .+|..+|.++... ...| .+..+..|++.++.++|.++ |||.||||.|+|+- .|.+||+|||+|..+..+.
T Consensus 441 ~Gd-~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ccc-ccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence 864 6899988765543 2335 56678999999999999988 99999999999995 4689999999999887653
Q ss_pred CCccccccccCCcccccCCCccccccC-----------CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHH
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTG-----------LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
+.......+||+.||+||.+... +.+.++||||||||||+|+.|++||+...... ..+..
T Consensus 514 ----TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~-----aKl~a 584 (677)
T KOG0596|consen 514 ----TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI-----AKLHA 584 (677)
T ss_pred ----cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-----HHHHh
Confidence 23334567999999999976422 26789999999999999999999997433222 23445
Q ss_pred Hhhhhc-CCCChh-HHHHHHHHHHHHhhccCCCCCccch
Q 004388 626 ILDAQA-GDWPIK-ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 626 ~ld~~~-~~~p~~-~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.++.. -++|.- ...++.+++..||..||++||+..+
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~e 623 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPE 623 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHH
Confidence 555532 122221 1233999999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=303.06 Aligned_cols=241 Identities=24% Similarity=0.309 Sum_probs=191.0
Q ss_pred CCccceeeccCCcEEEEEEEECCe--EEEEEEEccCCchhhH---HHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~~~~~---~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
-|...+.||-|+||.|.+++-..| .||+|.|++.....+. ....|-+||..-+.+.||+||..|+|.. |+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 477778899999999999876544 8899998876544333 4577999999999999999999998765 88999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC--
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS-- 554 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~-- 554 (757)
|++||++..+|.+.+- +++.....++.++..|+++.|..| +|||||||+|||||.+|++||+|||||.-+.-
T Consensus 710 YIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999988764 777777888899999999999988 99999999999999999999999999974421
Q ss_pred CCCCc----------------------------------cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHH
Q 004388 555 DPSFV----------------------------------STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 600 (757)
Q Consensus 555 ~~~~~----------------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~e 600 (757)
+..+. .........+||+.|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 00000 00011234589999999999999999999999999999999
Q ss_pred HHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHH-Hhhcc
Q 004388 601 LLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLS-CAELR 653 (757)
Q Consensus 601 lltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~-Cl~~~ 653 (757)
|+.|++||......+......++...|+-. +..+.+.+..+||.+ |+..+
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~---~~~~ls~e~~~li~kLc~sad 914 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIP---YQGNLSKEALDLIQKLCCSAD 914 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhccccc---cccccCHHHHHHHHHHhcChh
Confidence 999999998776666666666666666532 223456666777765 55433
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=288.00 Aligned_cols=241 Identities=29% Similarity=0.456 Sum_probs=198.0
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||.|+||.||++... +..|++|.+..... .....+.+|++++++++|||++++++++.+.. ++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999875 46899999876643 34567899999999999999999999886544 799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999988654 35899999999999999999999987 99999999999999999999999999987664332
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
. .....|+..|+|||+..+..++.++||||||+++|+|++|+.||........ +...........+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQDDHPPLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhccCCCCCCCC
Confidence 1 1334689999999998888889999999999999999999999964332111 112221222334445
Q ss_pred HHHHHHHHHHHHhhccCCCCCccch
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~ 247 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQ 247 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHH
Confidence 6788999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=288.48 Aligned_cols=244 Identities=28% Similarity=0.459 Sum_probs=199.5
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|.....||.|+||.||++.+. +..+++|++..... .....+.+|+++++.++|||++++++.+.+.. ++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677788999999999999986 66999999876533 45567889999999999999999998875544 799999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 2356899999999999999999999987 9999999999999999999999999998765432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. ......|++.|+|||++....++.++|+||||+++++|++|+.||...... ..............|.
T Consensus 158 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~ 225 (258)
T cd08215 158 D------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILKGQYPPIPS 225 (258)
T ss_pred c------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhcCCCCCCCC
Confidence 1 123347899999999988888999999999999999999999998643211 1111222222233444
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ 251 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQ 251 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 56788999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=293.09 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=184.8
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcC-CCceeeecccccCC----ceEEEE
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH----GCLVYE 476 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~----~~LV~E 476 (757)
|....+||.|+||.||+|... +..+|+|.+.... ........+|+.++.++. |||++++++++.+. .++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456778999999999999874 5689999987542 222234557999999985 99999999998654 389999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++ |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++. +.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 58888776533 35899999999999999999999988 999999999999999 999999999998765332
Q ss_pred CCccccccccCCcccccCCCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------hhhHHHHh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------EDNLAEIL 627 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--------~~~l~~~l 627 (757)
.. ....+++.|+|||++. ++.++.++|||||||++|+|++|.+||...+..+.... ...+...+
T Consensus 154 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 PY-------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred Cc-------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 11 2346789999999764 45678999999999999999999999964432221000 00000000
Q ss_pred hhh-c--CCC-----------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQ-A--GDW-----------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~-~--~~~-----------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... . ..+ ....+..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 275 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence 000 0 001 1134688999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.23 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=189.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC-------c
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------G 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-------~ 471 (757)
+.+|....+||+|+||.||+|.+. +..||||++.... ......+.+|+.++++++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467889999999999999999874 5689999986432 23445688899999999999999999886432 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 79999996 588777643 24889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh------h---chh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA------I---DED 621 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~------~---~~~ 621 (757)
......... ......||+.|+|||.+.+ ..++.++|||||||++|+|+||++||...+..... + ..+
T Consensus 156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTG---FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccC---CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 643321111 1234578999999997654 56889999999999999999999999643221110 0 001
Q ss_pred hHHHHhhhhc----------CC--C---ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 622 NLAEILDAQA----------GD--W---PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 622 ~l~~~ld~~~----------~~--~---p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+.+... .. + ....+..+.+++.+||+.+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e 288 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEE 288 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence 1111111000 00 0 0123567899999999999999999985
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=344.86 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=193.7
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..|.....||+|+||.||+|.. .+..||||.+...... ...|++++++++|||||+++|+|.+.. ++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778899999999999986 4679999988643321 235689999999999999999996544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++. .++|..+.+|+.||+.||.|||.....+|+||||||+|||++.++..++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999984 28899999999999999999997655669999999999999999988876 7765443211
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch--------hhhhhchhhHHHHhhhh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK--------VETAIDEDNLAEILDAQ 630 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~--------~~~~~~~~~l~~~ld~~ 630 (757)
....||+.|+|||++.+..++.++|||||||++|||+||+.||..... .............+|+.
T Consensus 836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 223689999999999999999999999999999999999999853211 11111122223333433
Q ss_pred cC---CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 631 AG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 631 ~~---~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.. ..+.....++.+++.+||+.+|.+||++. +|+..|+.+..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN-DVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH-HHHHHHHHhhc
Confidence 21 22345567789999999999999999998 46677766543
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.55 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=188.5
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcC-CCceeeecccccC--C-----
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIR-HPHLLLLLGACPD--H----- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~----- 470 (757)
++|.....||.|+||.||+|.+. +..||||++..... .....+.+|+.+++.+. ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788889999999999999985 56899998765432 23456888999999995 6999999998743 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeec
Q 004388 471 GCLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVG 547 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFG 547 (757)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||..+ |+||||||+|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 3899999985 88888765432 346899999999999999999999987 999999999999998 8999999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|+||.+||........... +...
T Consensus 157 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~ 227 (295)
T cd07837 157 LGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH---IFKL 227 (295)
T ss_pred cceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHH
Confidence 9976543211 1123367889999998754 4578999999999999999999999964433221110 0000
Q ss_pred hh-hh---------------cCC--------CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 LD-AQ---------------AGD--------WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 ld-~~---------------~~~--------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+. +. ... .....+..+.+++.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 00 00 000 01134677899999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=297.25 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=187.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC--------
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-------- 470 (757)
++|....+||.|+||.||+|... +..||||.+.... ......+.+|+.++++++||||++++++|...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999875 5699999886432 22234567899999999999999999987432
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 471 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 471 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
.++||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 289999996 58888775433 35899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH----
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL---- 623 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l---- 623 (757)
+..+....... ........++..|+|||++.+. .++.++||||||+++|+|+||++||..............+
T Consensus 166 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 98765432211 1112345678999999987654 4788999999999999999999998643321110000000
Q ss_pred ----------HHHhhhhc-C----------CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 ----------AEILDAQA-G----------DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ----------~~~ld~~~-~----------~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+... . .++......+.+++.+||..+|.+||++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 00000000 0 011123456789999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=298.46 Aligned_cols=236 Identities=27% Similarity=0.416 Sum_probs=187.4
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEe
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEY 477 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey 477 (757)
|.....||+|+||.||+|... +..+|+|++..... .....+.+|+.++++++|||+++++++|.+. .++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 666778999999999999874 56899999864322 2335688999999999999999999998654 3899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 97 57877775433 35899999999999999999999988 999999999999999999999999998754422
Q ss_pred CccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC-
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD- 633 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~- 633 (757)
....|++.|+|||++. .+.++.++|||||||++|+|++|++||....... .+..+.......
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~ 244 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESPTL 244 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccCCCC
Confidence 2346889999999873 4568899999999999999999999986432111 111222211111
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+...+..+.+++.+||+.+|.+||++.+
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 273 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEE 273 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHH
Confidence 12245677999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=295.19 Aligned_cols=232 Identities=24% Similarity=0.315 Sum_probs=178.4
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHh---cCCCceeeecccccCC--ceEEEEecC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSK---IRHPHLLLLLGACPDH--GCLVYEYME 479 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~---l~Hpniv~l~g~~~~~--~~LV~Ey~~ 479 (757)
.||+|+||.||++... ++.+|+|.+..... .....+.+|..++.. .+||||+.+++++... .++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999874 56999998865422 122334455544443 4799999999988543 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++...+ .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999886543 4899999999999999999999988 9999999999999999999999999987554221
Q ss_pred cccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
.....||+.|+|||.+.+ ..++.++|||||||++|+|+||..||....... ...+...........|...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 222 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTVNVELPDSF 222 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC----HHHHHHHhhcCCcCCcccc
Confidence 123468999999998764 458899999999999999999999996332111 0111111111112334456
Q ss_pred HHHHHHHHHHHhhccCCCCCc
Q 004388 639 TKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs 659 (757)
+..+.+++.+||..+|.+||+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcC
Confidence 788999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=291.24 Aligned_cols=235 Identities=21% Similarity=0.241 Sum_probs=180.9
Q ss_pred hcCCccceee--ccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCC--ceEE
Q 004388 402 TLSFSENLRI--GMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH--GCLV 474 (757)
Q Consensus 402 t~~f~~~~~I--G~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~--~~LV 474 (757)
.++|...+.+ |.|+||.||++... +..+|+|++....... .|+.+...+ +||||+++++.|... .++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3455555555 99999999999875 4589999886532211 133333322 699999999998544 4899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCccccC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLN 553 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~~ 553 (757)
|||+++|+|.+++.... ++++..+..++.||+.||.|||+.+ ++||||||+||+++.++ .++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999886543 6899999999999999999999988 99999999999999998 99999999987654
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.. ....|+..|+|||++.+..++.++|||||||++|+|+||+.||...... .+....+..... ....
T Consensus 162 ~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~-~~~~ 228 (267)
T PHA03390 162 TP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQQ-KKLP 228 (267)
T ss_pred CC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhhc-ccCC
Confidence 32 2236899999999998888999999999999999999999999633211 111111222221 1112
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
.+...+..+.+++.+||+.+|.+||+.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 229 FIKNVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred cccccCHHHHHHHHHHhccChhhCCch
Confidence 233567899999999999999999964
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.06 Aligned_cols=192 Identities=25% Similarity=0.363 Sum_probs=164.8
Q ss_pred CCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcC-C-----Cceeeecccc--cCCceE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-H-----PHLLLLLGAC--PDHGCL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H-----pniv~l~g~~--~~~~~L 473 (757)
.|.+...||+|+||.|.+|.+.+ ..||||+++..... ..+-..|+.||..|+ | -|+|+++++| .++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 67888999999999999999875 49999999876432 344567999999997 3 4899999987 567799
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC--CceEEeeecCccc
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN--LVSKIGDVGLSTM 551 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~--~~~KL~DFGla~~ 551 (757)
|+|.+. .+|.++|..+. ..+++...+..|+.||+.||.+||..+ |||+||||+||||.+. ..+||+|||+|..
T Consensus 266 VfELL~-~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 69999887654 456999999999999999999999988 9999999999999653 4789999999998
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 610 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 610 (757)
..... ...+.+..|.|||++.+.+|+.+.||||||||++||+||.|-|..
T Consensus 341 ~~q~v---------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 341 ESQRV---------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred cCCcc---------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 66432 134778999999999999999999999999999999999888763
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.67 Aligned_cols=245 Identities=27% Similarity=0.337 Sum_probs=186.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcC-CCceeeecccccCC--ceEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH--GCLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~--~~LV~Ey 477 (757)
+|.....||.|+||.||++.+. +..+|+|.+.... ......+.+|+.++.++. ||||+++++++.+. .+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3444567999999999999885 5689999886543 234556889999999996 99999999988544 3789999
Q ss_pred cCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 478 MENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 478 ~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
+. ++|.++... ......+++.....++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++..+..
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 466554321 11224589999999999999999999975 5 99999999999999999999999999976543
Q ss_pred CCCCccccccccCCcccccCCCccccccC---CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||....... ..+........
T Consensus 161 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~ 228 (288)
T cd06616 161 SIA-------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF-----DQLTQVVKGDP 228 (288)
T ss_pred CCc-------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHH-----HHHhhhcCCCC
Confidence 221 1233689999999988766 68999999999999999999999996432111 11111111111
Q ss_pred ----CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 632 ----GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 632 ----~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
...+...+..+.+|+.+||..+|.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 111224677899999999999999999998533
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=298.63 Aligned_cols=251 Identities=19% Similarity=0.203 Sum_probs=188.3
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCH
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 483 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL 483 (757)
.+.+|.|+++.||++...+..||||++... .......+.+|+.+++.++||||+++++++.+.. +++|||+++|+|
T Consensus 7 ~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 7 GKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred hHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 344567777888888878889999998754 2334567899999999999999999999986543 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC-cccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF-VSTT 562 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~-~~~~ 562 (757)
.+++..... ..+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+..+...... ....
T Consensus 87 ~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 87 EDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 998875432 34888899999999999999999988 999999999999999999999999998765432211 0111
Q ss_pred ccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch--hhHHHHhh----------
Q 004388 563 YKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--DNLAEILD---------- 628 (757)
Q Consensus 563 ~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--~~l~~~ld---------- 628 (757)
.......++..|+|||++.. ..++.++|||||||++|+|++|+.||............ +.....++
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCC
Confidence 11234467889999998865 35889999999999999999999999744322211110 00000000
Q ss_pred ----------h-----hcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 ----------A-----QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ----------~-----~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. .....+......+.+++.+||..+|.+||++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 291 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHH
Confidence 0 000112234568899999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=296.37 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=190.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcC-CCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|.....||.|+||.||+|.+. +..||||.+.... ......+..|+.++.++. ||||++++++|.+.. ++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 46778889999999999999997 7799999987543 223455777888777775 999999999986654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|+. ++|.+++.... .++++..+..++.+|+.||.|||+. + |+||||+|+|||++.++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 57877665533 2689999999999999999999974 5 999999999999999999999999998765432
Q ss_pred CCCccccccccCCcccccCCCccccccCC----CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGL----ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
.. .....+++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...+..++....
T Consensus 169 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~ 236 (296)
T cd06618 169 KA-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEEP 236 (296)
T ss_pred Cc-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCCC
Confidence 21 12335788999999886543 788999999999999999999999642111 112222333222
Q ss_pred CCCC--hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 632 GDWP--IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 632 ~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..++ ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 271 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 2222 23577899999999999999999997533
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=296.37 Aligned_cols=238 Identities=26% Similarity=0.321 Sum_probs=197.8
Q ss_pred CCccceeeccCCcEEEEEEEECCe--EEEEEEEccCCchhhHH---HHHHHHHHHhc-CCCceeeeccccc--CCceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKI-RHPHLLLLLGACP--DHGCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~~~~~~---f~~Ev~il~~l-~Hpniv~l~g~~~--~~~~LV~ 475 (757)
+|....+||+|+||.|.++..+++ .+|||+++.+...+.++ -+.|-.+|... +-|.++.|..+|+ +..|+||
T Consensus 350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM 429 (683)
T KOG0696|consen 350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM 429 (683)
T ss_pred ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence 588889999999999999998876 89999998875444333 35677777765 5788899998885 5669999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+.||+|.-.++..+. +.+..+..+|.+||-||-|||+.+ ||+||||.+|||||.+|++||+|||+++.---+
T Consensus 430 EyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 430 EYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999998887665 555677889999999999999988 999999999999999999999999999743221
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
. ......+|||.|+|||++.+.+|+..+|+|||||+|||||.|++||+..+ ++.+...+....-.+|
T Consensus 504 ~------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-------E~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 504 G------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-------EDELFQAIMEHNVSYP 570 (683)
T ss_pred C------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHHccCcCc
Confidence 1 12256799999999999999999999999999999999999999997553 2334444444556788
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 636 IKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
...+.+...+....+...|.+|-..
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccCC
Confidence 8899999999999999999999543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=293.52 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=188.7
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEEE
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYE 476 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~E 476 (757)
|....+||.|+||.||+|... +..+|+|.+.... ......+.+|+.++++++|||++++++++.+. .++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556778999999999999886 4789999998653 33345688999999999999999999998655 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++ ++|.+++.... ..+++..+..++.||+.||.|||..+ ++|+||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMD-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccc-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 997 48888876543 35899999999999999999999987 9999999999999999999999999998765432
Q ss_pred CCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------hhHH--
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLA-- 624 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------~~l~-- 624 (757)
.. ..+...++..|+|||.+.+ ..++.++||||||+++|+|+||++||............ ..+.
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SA-----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cc-----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 10 1133467889999997654 45789999999999999999999999643321110000 0000
Q ss_pred -HH--hhhhcC---------C-CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 625 -EI--LDAQAG---------D-WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 625 -~~--ld~~~~---------~-~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+ ...... . ....++..+.+++.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 280 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 00 000000 0 00012678899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.86 Aligned_cols=241 Identities=22% Similarity=0.362 Sum_probs=200.9
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCC
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~ 480 (757)
|....+||+|+||.||++.++ |..+|||....+. +.+++..|+.||.++..|++|++||.|-.+ ..+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 667778999999999999886 5588999876643 567789999999999999999999987543 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
||+.|++.-+. .+|+..++..|+...+.||.|||... -||||||..||||+-+|++||+|||.|..+.+.
T Consensus 113 GSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT----- 182 (502)
T KOG0574|consen 113 GSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT----- 182 (502)
T ss_pred CcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh-----
Confidence 99999886443 46999999999999999999999988 799999999999999999999999999776542
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 640 (757)
..+.....|||.|||||++..-.|+.++||||||++..||.-|+|||...|.....+-... -.+..-..|...+.
T Consensus 183 -MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT----~PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 183 -MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT----KPPPTFKKPEEWSS 257 (502)
T ss_pred -HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC----CCCCCCCChHhhhh
Confidence 3344667999999999999998999999999999999999999999987776544221100 00111123556788
Q ss_pred HHHHHHHHHhhccCCCCCccch
Q 004388 641 ELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
++.+++.+||-..|++|-++..
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~ 279 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALR 279 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHH
Confidence 9999999999999999988763
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=304.26 Aligned_cols=248 Identities=19% Similarity=0.232 Sum_probs=190.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccC-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------- 469 (757)
....|.....||+|+||.||+|... +..||+|.+... .......+.+|+.++++++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467888999999999999999874 568999998643 22334567889999999999999999998742
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
..|+||||+. ++|.+.+... ++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2389999996 5888877432 778888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------h
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------E 620 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--------~ 620 (757)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....... .
T Consensus 165 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98654321 12334688999999999988999999999999999999999999964332111000 0
Q ss_pred hhHHHHhh--------hhc-----------C--CC-------ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 DNLAEILD--------AQA-----------G--DW-------PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 ~~l~~~ld--------~~~-----------~--~~-------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+...++ ... . .+ +...+..+.+++.+||..+|.+||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00000000 000 0 00 113456789999999999999999998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=302.80 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=192.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC------Cce
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGC 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~~~ 472 (757)
.+|.....||.|+||.||+|... +..||+|++.... ......+.+|+.+|++++||||+++++++.. ..+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 57888889999999999999875 5689999987542 2334567889999999999999999998742 238
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+. |+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 68988875433 4899999999999999999999988 999999999999999999999999999766
Q ss_pred CCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--------------
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-------------- 617 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-------------- 617 (757)
...... .........|+..|+|||++.. ..++.++|||||||++|+|++|++||.........
T Consensus 158 ~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 158 SSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred cccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 533211 1111234578999999998755 45889999999999999999999999643221110
Q ss_pred ---hchhhHHHHhhhhc--CCCC-----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 618 ---IDEDNLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 618 ---~~~~~l~~~ld~~~--~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
...+.+...++... ...+ ...+..+.+++.+||+.+|.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 00111111111111 0111 23467899999999999999999988533
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=315.56 Aligned_cols=194 Identities=29% Similarity=0.485 Sum_probs=168.3
Q ss_pred ccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccC--------CceEE
Q 004388 406 SENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------HGCLV 474 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--------~~~LV 474 (757)
.....||+||||.||+|+++ |..||||.++... ....+...+|+++|++++|||||++++.=.+ ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 34456999999999999976 5699999988754 3345667899999999999999999987432 23799
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec--CCC--ceEEeeecCcc
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNL--VSKIGDVGLST 550 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld--~~~--~~KL~DFGla~ 550 (757)
||||.||||+.+|.+-.+...|+..+.+.++.+++.||.|||.++ |+||||||.||++- .+| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999998778888999999999999999999999988 99999999999993 333 45999999999
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
.++++.. .+..+||+.|.+||... .+.|+.-+|.|||||++|++.||..||-
T Consensus 173 el~d~s~-------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 173 ELDDNSL-------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cCCCCCe-------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9886542 35679999999999887 4889999999999999999999999995
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=291.50 Aligned_cols=246 Identities=29% Similarity=0.373 Sum_probs=198.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcC-CCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~LV 474 (757)
++|.....||.|+||.||+|... +..||+|++.... ......+.+|+.++.+++ ||||+++++++.+.. ++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999884 6799999987532 223456889999999998 999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++++|.+++.... .+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999986543 5999999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCcc--------------ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 555 DPSFVS--------------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 555 ~~~~~~--------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
...... .........|+..|++||++....++.++|+||||+++++|++|+.||.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 229 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----- 229 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence 321100 0112234568899999999888889999999999999999999999997443211
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.+..+. .....+|...+..+.+++.+||..+|.+||++.
T Consensus 230 -~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 268 (280)
T cd05581 230 -TFQKIL-KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268 (280)
T ss_pred -HHHHHH-hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence 111221 222344555678899999999999999999994
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=327.95 Aligned_cols=241 Identities=25% Similarity=0.321 Sum_probs=197.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEECCe--EEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
...+|.+.+.||+|+||.|..++.+++ .||+|++..-. .....-|..|-+||..-+.+.|+.|+.+|+|.. ||
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 345688888999999999999998754 89999987632 234456899999999999999999999998866 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|||||+||+|-.+|.+.+ .+|...+..++.+|..||.-||+.| +|||||||+|||||..|++||+|||.|-.+.
T Consensus 153 VMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999887655 4888888889999999999999998 9999999999999999999999999998777
Q ss_pred CCCCCccccccccCCcccccCCCccccc----c-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQR----T-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
.++.. +....+|||.|++||++. + +.|++.+|+||+||++||||.|..||.....+++ +..+++
T Consensus 227 ~dG~V-----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT------Y~KIm~ 295 (1317)
T KOG0612|consen 227 ADGTV-----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET------YGKIMN 295 (1317)
T ss_pred CCCcE-----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH------HHHHhc
Confidence 55432 335679999999999874 2 6799999999999999999999999986655544 233333
Q ss_pred hh-cCCCC--hhHHHHHHHHHHHHhhccCCCCCc
Q 004388 629 AQ-AGDWP--IKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 629 ~~-~~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
-. .-.+| .+.+.++.+||.+.+. +|..|-.
T Consensus 296 hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 296 HKESLSFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred hhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 21 22344 5678899999988665 4555644
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=294.07 Aligned_cols=245 Identities=25% Similarity=0.317 Sum_probs=191.3
Q ss_pred CCccceeeccCCcEEEEEEEE-----CCeEEEEEEEccCC----chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--
Q 004388 404 SFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~-- 471 (757)
+|.....||.|+||.||++.. ++..+|||++.... ......+.+|+.++.++ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778899999999999875 34689999986432 22345688999999999 5999999998886543
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++|+|.+.+.... .+++.....++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 79999999999999886532 4888999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
+...... ......|++.|++||++.+.. .+.++||||||+++|+|+||..||......... ..+...+..
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~~~ 226 (288)
T cd05583 155 FLAEEEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ---SEISRRILK 226 (288)
T ss_pred ccccccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH---HHHHHHHHc
Confidence 5433211 112346899999999887654 788999999999999999999999633211100 111111112
Q ss_pred hcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 ~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....|...+..+.+++.+||+.+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~ 259 (288)
T cd05583 227 SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259 (288)
T ss_pred cCCCCCcccCHHHHHHHHHHhcCCHhhccCcch
Confidence 223344456778999999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.06 Aligned_cols=242 Identities=28% Similarity=0.444 Sum_probs=196.0
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|....+||.|+||.||++... +..+++|.+.... ......+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999875 4589999886542 233556789999999999999999999886544 899999
Q ss_pred cCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++||||+|.||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886532 2345889999999999999999999988 9999999999999999999999999998765431
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
.....|++.|++||++.+..++.++|+||||+++|+|++|+.||........ ...+........+.
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 223 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL------RYKVQRGKYPPIPP 223 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCCCCCCch
Confidence 1234688999999999888899999999999999999999999964432110 01111112223344
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+.++.+++.+|+..+|.+||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~ 249 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDK 249 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHH
Confidence 56788999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=295.63 Aligned_cols=234 Identities=20% Similarity=0.328 Sum_probs=188.6
Q ss_pred eeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC--CceEEEEecCCCCHH
Q 004388 409 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENGSLE 484 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~~LV~Ey~~~gsL~ 484 (757)
.+||+|+||.||++... +..||||.+..........+.+|+.+++.++|||++++++.+.+ ..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999884 56899998865555556678999999999999999999998854 448999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccccc
Q 004388 485 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564 (757)
Q Consensus 485 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~ 564 (757)
+++... .+++.....++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------~ 172 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------R 172 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc------c
Confidence 877432 4788999999999999999999987 99999999999999999999999999876543211 1
Q ss_pred ccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-CC--CChhHHHH
Q 004388 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GD--WPIKETKE 641 (757)
Q Consensus 565 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~--~p~~~~~~ 641 (757)
.....|++.|++||++.+..++.++|+||||+++|+|++|.+||........ ...+.... .. .....+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPPKLKNLHKVSPS 245 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhhCCcccCCcccCCHH
Confidence 1234689999999999888889999999999999999999999864322211 11111111 11 11234677
Q ss_pred HHHHHHHHhhccCCCCCccch
Q 004388 642 LAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.+++.+||..+|.+||++.+
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAE 266 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHH
Confidence 899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=320.78 Aligned_cols=254 Identities=17% Similarity=0.231 Sum_probs=178.3
Q ss_pred hcCCccceeeccCCcEEEEEEEECCe---EEEEEE--------------Ec---cCCchhhHHHHHHHHHHHhcCCCcee
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHT---FAAVKV--------------LQ---SKGNIQNKQFLQELEVLSKIRHPHLL 461 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~---~vAvK~--------------l~---~~~~~~~~~f~~Ev~il~~l~Hpniv 461 (757)
..+|....+||+|+||.||+|..... .+++|. +. .........|.+|+.+|.+++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 34788889999999999999875422 111110 00 01112345678999999999999999
Q ss_pred eecccccCC--ceEEEEecCCCCHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC
Q 004388 462 LLLGACPDH--GCLVYEYMENGSLEDRLYRKNN--TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 537 (757)
Q Consensus 462 ~l~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~ 537 (757)
++++++.+. .++|++++. ++|.+++..... ...........|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 999998554 488999985 577777654321 112334567789999999999999988 999999999999999
Q ss_pred CCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCC-Cccccch--h
Q 004388 538 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP-AIAITHK--V 614 (757)
Q Consensus 538 ~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~-Pf~~~~~--~ 614 (757)
++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|.. |+..... .
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA-----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCEEEEeCCCceecCccccc-----ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999876543211 1234579999999999998899999999999999999999874 4432110 0
Q ss_pred hhhhc---------------hhhHHHHhhhhc-CCCC---------hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 615 ETAID---------------EDNLAEILDAQA-GDWP---------IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 615 ~~~~~---------------~~~l~~~ld~~~-~~~p---------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..... ...+.+.++... ...+ ...+..+.+++.+||..||.+||++.+.+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 00000 001111111110 0000 01234677889999999999999998643
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.95 Aligned_cols=232 Identities=24% Similarity=0.316 Sum_probs=179.7
Q ss_pred eeccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHH---HHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEV---LSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~i---l~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
.||+|+||.||++... +..||+|.+...... ....+..|..+ ++...||||+.+++++.+.. ++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999874 568999988654221 12234444443 44457999999999886544 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
||+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999888643 35899999999999999999999987 9999999999999999999999999987554321
Q ss_pred cccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||........ .............+|...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 222 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTMAVELPDSF 222 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHhhccCCCCCCcC
Confidence 1234789999999998754 589999999999999999999999964321111 111122222223455556
Q ss_pred HHHHHHHHHHHhhccCCCCCc
Q 004388 639 TKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs 659 (757)
+..+.+++.+|+..+|.+||.
T Consensus 223 s~~~~~li~~~l~~~p~~R~~ 243 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLG 243 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccC
Confidence 789999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=286.38 Aligned_cols=230 Identities=25% Similarity=0.270 Sum_probs=181.3
Q ss_pred eeeccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHHH-HhcCCCceeeecccccCC--ceEEEEecCC
Q 004388 409 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVL-SKIRHPHLLLLLGACPDH--GCLVYEYMEN 480 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~il-~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~ 480 (757)
+.||.|+||.||+|... +..||||++...... ....+..|..++ ...+|||++++++++.+. .++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45899999999999884 569999998654321 222345555544 455899999999998654 4899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
++|.+++.... ++++..+..++.||+.||.|||+.+ ++||||+|+|||++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999886543 4788899999999999999999987 99999999999999999999999999875432
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC----h
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP----I 636 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p----~ 636 (757)
.....|++.|++||.+.+..++.++||||||+++|+|+||.+||....... +...+......++ .
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~ 218 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRINWPEEVKE 218 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccCCCCcccc
Confidence 123468899999999888888999999999999999999999996432211 1111111111222 2
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccc
Q 004388 637 KETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+..+.+++.+||..+|.+||++.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCC
Confidence 3568899999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.19 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=191.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhc-CCCceeeecccccCC----ce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH----GC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~----~~ 472 (757)
.++|.....||.|+||.||+|.+. +..+|+|.+... .......+.+|+.++.++ +||||++++++|... .+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456788889999999999999874 578999987543 223345677899999999 999999999987532 38
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||++ ++|..++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 86 lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 5898877543 5788999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-------------
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------------- 618 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~------------- 618 (757)
....... .........||+.|+|||++.+ ..++.++||||||+++|+|+||++||..........
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 5433211 0111233578999999997754 567899999999999999999999996432221100
Q ss_pred ----chhhHHHHhhhhc-------CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 619 ----DEDNLAEILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 619 ----~~~~l~~~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.......+++... .......+..+.+++.+||+.+|.+||++.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il 293 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh
Confidence 0000011111100 001112467899999999999999999998644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.23 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=190.9
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
|.....||.|++|.||+|... +..+++|.+...... ....+.+|+.+|++++||||+++++++.+.. ++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455678999999999999874 668999988654322 4567889999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++ +|.+.+.... ..+++..+..++.+|+.||.|||+.+ |+|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 8888776543 35899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------hhHHHHhh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLAEILD 628 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------~~l~~~ld 628 (757)
......++..|+|||.+.+. .++.++|+||||+++|+|+||++||...+..+..... ..+..+.+
T Consensus 154 -----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 -----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 11234688899999988766 7899999999999999999999999654432211000 00000000
Q ss_pred ---hh------cCCC-----ChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 629 ---AQ------AGDW-----PIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 629 ---~~------~~~~-----p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.. .... ....+..+.+++.+||..+|.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l 277 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA 277 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence 00 0000 11346789999999999999999999853
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.62 Aligned_cols=248 Identities=23% Similarity=0.277 Sum_probs=190.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------- 469 (757)
..++|.....||.|+||.||+|... +..||+|++.... ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4567888999999999999999985 5689999987543 2233567789999999999999999998854
Q ss_pred -----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEe
Q 004388 470 -----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544 (757)
Q Consensus 470 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~ 544 (757)
..++|+||+++ +|.+.+... ...+++..+..|+.||+.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 24799999975 777776543 235899999999999999999999988 9999999999999999999999
Q ss_pred eecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 545 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 545 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
|||++..+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||........... +
T Consensus 159 dfg~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~---~ 230 (302)
T cd07864 159 DFGLARLYNSEESR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL---I 230 (302)
T ss_pred cccccccccCCccc-----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---H
Confidence 99999876543211 1122356889999997754 4578999999999999999999999975433221100 0
Q ss_pred HHHhhh--------------------hc------CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILDA--------------------QA------GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld~--------------------~~------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...... .. .......+..+.+++.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 000000 00 0001123678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.41 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=188.3
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCceeeecccccCCc--eEEEEec
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
|.....||.|+||.||+|... +..|+||.+..... .......+|+..+.+++ |||++++++++.+.. ++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556778999999999999985 56899998865432 22334567999999999 999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 789999886544 245899999999999999999999988 999999999999999999999999999866543211
Q ss_pred ccccccccCCcccccCCCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh---------------h
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------------N 622 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------------~ 622 (757)
....|+..|+|||++. ...++.++|+||||+++++|+||++||............. .
T Consensus 156 -------~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 156 -------TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -------CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 2346889999999774 4457899999999999999999999996443322111000 0
Q ss_pred HHHHhhhhc--------CCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 623 LAEILDAQA--------GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 623 l~~~ld~~~--------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
+...++... .......+..+.+++.+||..+|.+||++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 277 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence 000000000 00011124679999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.05 Aligned_cols=249 Identities=25% Similarity=0.285 Sum_probs=189.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCceeeecccccCC----ceE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~L 473 (757)
..+|.....||.|+||.||+|.+. +..||+|++...... ....+.+|+.++++++||||+++++++.+. .++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999985 568999998654321 223467899999999999999999987533 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 58888876533 45899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch--------hhHH
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------DNLA 624 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------~~l~ 624 (757)
.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||............ ..+.
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 4321 1123356889999998765 45789999999999999999999999644322211000 0000
Q ss_pred HHhhh-------hcCCCC--------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 625 EILDA-------QAGDWP--------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 625 ~~ld~-------~~~~~p--------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..++. .....+ ...+..+.+++.+|+..||.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~ 286 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 00000 000000 013677889999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.97 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=187.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|.....||.|+||.||+|.+. +..||+|.+..... .....+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788889999999999999875 56899998764322 23456889999999999999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecCccccCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGla~~~~~~ 555 (757)
|++ ++|.+.+.... ...+++.....++.||+.||.|||+.+ |+||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 57888775433 234677888899999999999999987 999999999999985 567999999999765432
Q ss_pred CCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhh-----HHHHh--
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN-----LAEIL-- 627 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-----l~~~l-- 627 (757)
... .....|++.|+|||++.+ ..++.++|||||||++|+|+||++||.............. .....
T Consensus 157 ~~~------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 VRT------FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred ccc------cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 111 123467899999998765 4578999999999999999999999964322211100000 00000
Q ss_pred -----h--hhcCCC--------ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 628 -----D--AQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 628 -----d--~~~~~~--------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+ .....| ....+..+.+++.+|+..+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 0 000011 123456789999999999999999988533
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=285.52 Aligned_cols=200 Identities=26% Similarity=0.429 Sum_probs=164.8
Q ss_pred cCCccceeeccCCcEEEEEEEECC------eEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc---
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--- 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~------~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--- 471 (757)
..|....+||+|.||.||++.-.+ ..+|+|.++... ........+|+.+++.|+||||+.|..++..+.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 357777889999999999996532 268999887542 223345689999999999999999999886632
Q ss_pred eEEEEecCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC----CceEEee
Q 004388 472 CLVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN----LVSKIGD 545 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~----~~~KL~D 545 (757)
+|++||.+. +|..+++- ......++-..+..|++||+.|+.|||++. |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 799999985 78887753 333456888999999999999999999999 9999999999999877 9999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCcc
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
||+++.+.+.-. ..+.....+-|.+|.|||.+.+ ..|+++.|||+.|||+.||||-.|.|.
T Consensus 180 lGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999875432 2223355688999999998766 469999999999999999999988775
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=294.29 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=188.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
.++|....+||.|+||.||+|.+. +..+|||++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999985 56899998864432 2234577899999999999999999886321
Q ss_pred ---ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 471 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 471 ---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
.++||||+. ++|...+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 278999996 46777665432 35899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCcc-----ccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--
Q 004388 548 LSTMLNSDPSFVS-----TTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-- 619 (757)
Q Consensus 548 la~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~-- 619 (757)
++........... .....+...|++.|+|||++.+ ..++.++|||||||++|+|++|++||.........-.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9986653322111 1111234577899999997754 4588999999999999999999999964332211000
Q ss_pred -------hhhH------HHHhh-hhcCCCC-------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 -------EDNL------AEILD-AQAGDWP-------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 -------~~~l------~~~ld-~~~~~~p-------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+ ....+ ......+ ......+.+++.+||..+|.+||++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 0000 00000 0000001 112367889999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=286.24 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=189.7
Q ss_pred CccceeeccCCcEEEEEEEECCe--EEEEEEEccC-----CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSK-----GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~-----~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
|....+||.|+||.||++.+... .+++|+++.. .......+..|+.++++++||||+++++++.+.. ++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 66778899999999999987643 4566665432 1123345778999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++. +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999999988652 22346899999999999999999999987 999999999999975 5699999999977643
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... .............
T Consensus 158 ~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 225 (260)
T cd08222 158 SCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIVEGPTPSL 225 (260)
T ss_pred Ccc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHcCCCCCC
Confidence 321 1123468899999999888888999999999999999999999985332211 1112222222334
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+...+..+.+++.+||..+|.+||++.+
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 253 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAE 253 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHH
Confidence 5566789999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.13 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=194.5
Q ss_pred ccCCCHHHHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecc
Q 004388 390 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLG 465 (757)
Q Consensus 390 ~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g 465 (757)
++.....++...+++|.....||+|+||.||+|... +..||+|++.... ......+.+|+.++.+++||||+++++
T Consensus 4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 344455667778899999999999999999999864 5689999886532 223456888999999999999999999
Q ss_pred cccC--------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC
Q 004388 466 ACPD--------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 537 (757)
Q Consensus 466 ~~~~--------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~ 537 (757)
++.. ..+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~ 155 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE 155 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence 8742 236788876 78998877532 3889999999999999999999988 999999999999999
Q ss_pred CCceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhh
Q 004388 538 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616 (757)
Q Consensus 538 ~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 616 (757)
++.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||........
T Consensus 156 ~~~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~ 226 (345)
T cd07877 156 DCELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 226 (345)
T ss_pred CCCEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999998764321 133478999999998765 5688999999999999999999999964322111
Q ss_pred hh-----------------chhhHHHHhhh--hcC-----CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 617 AI-----------------DEDNLAEILDA--QAG-----DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 617 ~~-----------------~~~~l~~~ld~--~~~-----~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. ........+.. ... ......+..+.+++.+|++.+|.+||+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 00 00000000000 000 001123567899999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.23 Aligned_cols=250 Identities=21% Similarity=0.298 Sum_probs=191.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
...|.....||.|+||.||+|... +..||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888899999999999999875 569999988643 222345677899999999999999999987432
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 489999996 6898887543 34889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhh-------------
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVET------------- 616 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~------------- 616 (757)
....... ......|+..|+|||.+.. ..++.++|||||||++|+|++|++||........
T Consensus 157 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKGD------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCcc------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 7653321 1233468899999997754 4689999999999999999999999964322110
Q ss_pred ----hhchhhHHHHhhhhc-------CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 617 ----AIDEDNLAEILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 617 ----~~~~~~l~~~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+........+.... .......+..+.+++.+||+.+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell 289 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEAL 289 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHH
Confidence 000111111111000 001123567789999999999999999998543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=282.33 Aligned_cols=241 Identities=23% Similarity=0.316 Sum_probs=192.4
Q ss_pred cCCccc-eeeccCCcEEEEEEEECCe--EEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCC----c--e
Q 004388 403 LSFSEN-LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH----G--C 472 (757)
Q Consensus 403 ~~f~~~-~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~----~--~ 472 (757)
.+|... .+||-|-.|.|..+..+.+ .+|+|++.. .....+|+++.-.. .|||||.++++|.+. . .
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 344333 4699999999999988644 899999854 23456788876555 599999999998542 2 4
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec---CCCceEEeeecCc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLS 549 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld---~~~~~KL~DFGla 549 (757)
+|||.|+||.|..++..++. ..+++.++..|+.||+.|+.|||+.+ |.||||||+|+|.. .|-.+||+|||+|
T Consensus 136 iVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccc
Confidence 69999999999999987764 46899999999999999999999998 99999999999995 4678999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
+...... .....+.||+|.|||++...+|+..+|+||+|||+|-||+|.|||...|. .++..+--..+...
T Consensus 212 K~t~~~~-------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~aispgMk~rI~~g 282 (400)
T KOG0604|consen 212 KETQEPG-------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKRRIRTG 282 (400)
T ss_pred cccCCCc-------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccCChhHHhHhhcc
Confidence 8754322 23567899999999999999999999999999999999999999986655 34444433333222
Q ss_pred hcCCCCh----hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 QAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 ~~~~~p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.-.+|. ..+...+++|...|..+|.+|-++.+
T Consensus 283 -qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 283 -QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred -CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 222332 35788899999999999999999875
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.67 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=189.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------ 470 (757)
..++|.....||.|+||.||+|... +..||||.+.... ......+.+|+.+|++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4667888999999999999999875 5689999885432 22345688999999999999999999987532
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 471 --GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 471 --~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
.++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 27999999 7799887753 24889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-------- 619 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~-------- 619 (757)
+...... .....+++.|++||++.+ ..++.++|+|||||++|+|++|++||...........
T Consensus 165 ~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 165 ARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9765432 123467899999998765 4588999999999999999999999964332211000
Q ss_pred hhhHHH---------Hhhhhc-------CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 620 EDNLAE---------ILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 620 ~~~l~~---------~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
...+.. .+.... .......+..+.+++.+|+..+|.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000000 000000 001123456789999999999999999998533
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.40 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=193.3
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------ce
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------GC 472 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-------~~ 472 (757)
+|.....||.|+||.||+|... +..+|||++.... ......+.+|+.+++.++||||+++++++.+. .|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4677889999999999999975 5689999987643 33456789999999999999999999998543 38
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||++ ++|.+++.... ++++..+..++.+|+.||.|||+.+ |+||||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888875433 6899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--------------
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-------------- 617 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-------------- 617 (757)
...... ........+|+.|+|||++.+. .++.++|+||||+++|+|+||++||......+..
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 543211 0112345689999999998877 7899999999999999999999999644321110
Q ss_pred ---hchhhHHHHhhhhcCCC-------ChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 618 ---IDEDNLAEILDAQAGDW-------PIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 618 ---~~~~~l~~~ld~~~~~~-------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.........+....... ....+..+.+++.+||+.+|.+||++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 286 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEA 286 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 00000111111000000 11245778999999999999999998853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=300.26 Aligned_cols=245 Identities=23% Similarity=0.324 Sum_probs=186.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
..+|.....||.|+||.||+|... +..||||++.... ......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888899999999999999874 6689999886432 22345688999999999999999999987532
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++|+||+. ++|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 279999996 47766541 24889999999999999999999988 999999999999999999999999998
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------h
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------E 620 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--------~ 620 (757)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... .
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 764321 134467899999998765 4688999999999999999999999974332111000 0
Q ss_pred hhHHHHhhh--------hcCCC--------ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 DNLAEILDA--------QAGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 ~~l~~~ld~--------~~~~~--------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+.+.+.. ..... ....+..+.+|+.+||+.+|.+||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000000000 00000 012356788999999999999999998643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=295.59 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=190.8
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC---
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--- 469 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--- 469 (757)
++..++++|.....||.|+||.||++... +..||||.+.... ......+.+|+.++..++||||++++++|..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34457889999999999999999999865 5589999875432 2234668899999999999999999998743
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 470 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
..++||||+ +++|.+++.. .++++.....++.|++.||.|||+.+ |+||||+|.|||++.++.+||+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 348999998 5689887743 24778888899999999999999988 999999999999999999999999998
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-----------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA----------- 617 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~----------- 617 (757)
...... .....+++.|+|||++.+ ..++.++|||||||++|+|+||++||.........
T Consensus 156 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 156 RIQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 754321 123467889999998765 56899999999999999999999999643321110
Q ss_pred ------hchhhHHHHhhhhcC--CCC-----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 618 ------IDEDNLAEILDAQAG--DWP-----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 618 ------~~~~~l~~~ld~~~~--~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+..+...+++..... ..| ...+..+.+++.+||..+|.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 000011111111111 111 124578999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=296.31 Aligned_cols=251 Identities=18% Similarity=0.246 Sum_probs=184.4
Q ss_pred eeccC--CcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCC
Q 004388 410 RIGMG--GYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 410 ~IG~G--~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.||.| +||+||++.+ .++.||+|++.... ....+.+.+|+.+++.++||||++++++|.... ++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999988 46799999987543 223467889999999999999999999986544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||.+............
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998876432 35889999999999999999999987 999999999999999999999999876443322111110
Q ss_pred ccc-ccCCcccccCCCccccccC--CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---h--------------
Q 004388 562 TYK-NTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---D-------------- 621 (757)
Q Consensus 562 ~~~-~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---~-------------- 621 (757)
.+. .....++..|++||++.++ .++.++|||||||++|+|++|++||............ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 000 1112456779999998764 4789999999999999999999999643221111000 0
Q ss_pred --------hH---------H-----HHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 622 --------NL---------A-----EILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 622 --------~l---------~-----~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.. . .+.+.. ....+...+..+.+|+.+||..+|.+||++.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00 0 000000 0011223567899999999999999999998644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=291.10 Aligned_cols=237 Identities=27% Similarity=0.393 Sum_probs=185.4
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
|....+||.|+||.||+|... +..|++|++..... .....+.+|+++++.++|||++++++++.+.. ++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555667999999999999874 56899999865322 23356788999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+. |+|.+.+.... .++++..+..++.||+.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 67878775433 35899999999999999999999988 99999999999999999999999999864321
Q ss_pred CccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.....|+..|+|||++. .+.++.++|||||||++|+|++|.+||......... ..+........
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~~~~~ 240 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNDSPTL 240 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcCCCCC
Confidence 12347899999999874 456889999999999999999999998643322111 11111111111
Q ss_pred -ChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 635 -PIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 635 -p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
....+..+.+++.+||+.+|.+||++.++
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~ 270 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAEL 270 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11234678999999999999999998853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=278.93 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=200.8
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCc
Q 004388 395 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG 471 (757)
Q Consensus 395 ~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~ 471 (757)
++|+-..|. ..||+|+||.|--+.. .+..||||++.+.....+.+..+|++++.+.+ |+||+.|+.+|.+..
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 445555544 3599999999998765 46689999999887778889999999999985 999999999997654
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC---ceEEeee
Q 004388 472 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKIGDV 546 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~---~~KL~DF 546 (757)
|||||-|.||+|...+.+... +++.+..++..+|+.||.|||..+ |.||||||+|||-.... -+|||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 999999999999998887654 888899999999999999999988 99999999999996654 4799999
Q ss_pred cCccccCCCCCC-ccccccccCCcccccCCCcccc-----ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 547 GLSTMLNSDPSF-VSTTYKNTGPVGTLCYIDPEYQ-----RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 547 Gla~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
.|..-+.-..+. ...+..-..++|+..|||||+. ....|+.++|.||||||||-||.|.+||.........++.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 998654322211 1222233567999999999954 2346899999999999999999999999755444444443
Q ss_pred h--------hHHHHhhhhcCCCCh----hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 D--------NLAEILDAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ~--------~l~~~ld~~~~~~p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+ .+.+-+...--.+|. ..+.+..+|+...+-.++.+|-++..
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~ 357 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ 357 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence 3 333333333333443 35677889999999999999988764
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=331.61 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=196.0
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccc--cCCc
Q 004388 398 IESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGAC--PDHG 471 (757)
Q Consensus 398 i~~at~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~--~~~~ 471 (757)
+...+-++....+||.|.||.||-|.... ...|+|-+.... ......+.+|+.+|..|+|||+|++||+= .+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34446678888899999999999998754 467888765443 22334577899999999999999999974 4556
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
+|.||||++|+|.+.+...+. .++.....+..|++.||.|||++| ||||||||+||||+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 899999999999998865443 455566678889999999999998 99999999999999999999999999988
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccC---CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG---LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+.+... .....-....||+.|||||++.+. ...-+.|||||||+++||+||+.||.-.+.-+. .+..+-.
T Consensus 1384 i~~~~~--~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-----IMy~V~~ 1456 (1509)
T KOG4645|consen 1384 IKNNAQ--TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-----IMYHVAA 1456 (1509)
T ss_pred ecCchh--cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-----HHhHHhc
Confidence 775421 111223456899999999988643 356789999999999999999999963322111 1222222
Q ss_pred hhcCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 629 AQAGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 629 ~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
...+..|...+.+-.+++.+||+.||++|-++.
T Consensus 1457 gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1457 GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence 334566777888899999999999999995554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=291.74 Aligned_cols=236 Identities=28% Similarity=0.419 Sum_probs=185.5
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccC---CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
|.....||.|+||.||+|... +..+|+|.+... .......+.+|+++++.++|||++++++++.+.. ++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 556678999999999999874 568999987643 2223456889999999999999999999886543 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 97 CL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred cC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 96 68887775433 34889999999999999999999987 999999999999999999999999998765432
Q ss_pred CccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC-
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD- 633 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~- 633 (757)
....|++.|+|||++. .+.++.++|||||||++|+|+||+.||........ +..+.......
T Consensus 169 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 234 (308)
T cd06634 169 --------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPAL 234 (308)
T ss_pred --------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcCCCCc
Confidence 2346889999999874 35678899999999999999999999854321111 11111111111
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+...+..+.+|+.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 263 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHH
Confidence 12245678999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=323.40 Aligned_cols=249 Identities=29% Similarity=0.396 Sum_probs=184.8
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccC----------
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---------- 469 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---------- 469 (757)
.+|.+...||+||||.||+++. +|+.||||++.... ......+.+|+.+|++|+|||||++|.+|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4677888899999999999986 68999999987653 3344568899999999999999999864400
Q ss_pred --------------------------------------------------------------------C-----------
Q 004388 470 --------------------------------------------------------------------H----------- 470 (757)
Q Consensus 470 --------------------------------------------------------------------~----------- 470 (757)
+
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0
Q ss_pred --------------------------------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC
Q 004388 471 --------------------------------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518 (757)
Q Consensus 471 --------------------------------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~ 518 (757)
.||-||||+...|.+++.++.... .....++++.+|+.||.|+|+.
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC
Confidence 045688888777777665443211 2345678999999999999998
Q ss_pred CCCCEEEcCCCCCCeeecCCCceEEeeecCccccC----C--------CCCCccccccccCCcccccCCCccccccC---
Q 004388 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN----S--------DPSFVSTTYKNTGPVGTLCYIDPEYQRTG--- 583 (757)
Q Consensus 519 ~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~----~--------~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--- 583 (757)
+ ||||||||.||+||.++.+||+|||+|+... . ...........|+.+||.-|+|||++.+.
T Consensus 717 g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 G---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred c---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 8 9999999999999999999999999998722 0 00111222245778999999999988665
Q ss_pred CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC---CChhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 584 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD---WPIKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 584 ~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~---~p~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
.|+.|+|+|||||||+||+. ||+.. .+.+. .+..+-+...+. +.....+.-+.+|.++++.||.+||++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~---iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA 865 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTS--MERAS---ILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA 865 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCch--HHHHH---HHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH
Confidence 49999999999999999996 46422 22221 112222222221 233455667899999999999999999
Q ss_pred chhh
Q 004388 661 KNQV 664 (757)
Q Consensus 661 ~~~v 664 (757)
.+.+
T Consensus 866 ~eLL 869 (1351)
T KOG1035|consen 866 TELL 869 (1351)
T ss_pred HHHh
Confidence 8643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=279.80 Aligned_cols=233 Identities=29% Similarity=0.356 Sum_probs=191.3
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCCch---hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSL 483 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL 483 (757)
||.|+||.||++... +..+++|++...... ....+..|+.++++++||||+++++.+.+.. ++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999885 579999998765322 4457889999999999999999999986554 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.+++.... .+++.....++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 99986543 4889999999999999999999987 99999999999999999999999999977654321
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 643 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 643 (757)
......++..|++||...+...+.++|+||||+++|+|++|+.||...... .....+.. .....|...+..+.
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~~~~~l~ 221 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EIYEKILK-DPLRFPEFLSPEAR 221 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHhc-CCCCCCCCCCHHHH
Confidence 123457899999999998888899999999999999999999999643321 11112221 22344555678899
Q ss_pred HHHHHHhhccCCCCCccch
Q 004388 644 ALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 644 ~Li~~Cl~~~p~~RPs~~~ 662 (757)
+++.+||..+|.+||++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999963
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=297.16 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=187.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC----------
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---------- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~---------- 470 (757)
.+|...+.||.|+||.||+|... +..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888899999999999999885 568999998766555567788999999999999999999876432
Q ss_pred ------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceEE
Q 004388 471 ------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKI 543 (757)
Q Consensus 471 ------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~KL 543 (757)
.++||||++ ++|.+.+.. ..+++.....++.||+.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 379999997 588887743 24888999999999999999999988 99999999999997 4668899
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--- 619 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--- 619 (757)
+|||+++.+....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||...+.......
T Consensus 157 ~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 157 GDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred CCcccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999998654321110 01123467899999997644 5688899999999999999999999964432221100
Q ss_pred ---------hhhHH----HHhh--hhcCCCC-----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 ---------EDNLA----EILD--AQAGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 ---------~~~l~----~~ld--~~~~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+. ..+. ......+ ...+..+.+++.+||..+|.+||++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 296 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHH
Confidence 00000 0000 0001111 124567889999999999999999885
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.78 Aligned_cols=243 Identities=22% Similarity=0.299 Sum_probs=200.1
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeeccccc--CCceE
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCL 473 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~--~~~~L 473 (757)
....+|....+||.|.|+.|.++++. ++.||||++....- .....+.+|+++|..|+|||||+++++.. ...|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34567888999999999999999875 67999999876542 23355889999999999999999999975 44599
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||..+|.+.++|.+.+. +.......++.|+.+|++|||+.+ |||||||.+||||+.+..+||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999988765 344677889999999999999988 9999999999999999999999999999887
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh--
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-- 630 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-- 630 (757)
... .....+|++.|+|||++.+..| ++.+|+||+|++||-|+.|..||+.... ..+-+..
T Consensus 207 ~~~-------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----------k~Lr~rvl~ 269 (596)
T KOG0586|consen 207 YGL-------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----------KELRPRVLR 269 (596)
T ss_pred ccc-------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----------ccccchhee
Confidence 432 2245699999999999988765 5899999999999999999999974321 1111111
Q ss_pred -cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhh
Q 004388 631 -AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 665 (757)
Q Consensus 631 -~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl 665 (757)
.-..|.-.+.+..+|+.+++-++|.+|+++.+...
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 11235556778899999999999999999985443
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=284.88 Aligned_cols=240 Identities=26% Similarity=0.368 Sum_probs=187.0
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhc---CCCceeeecccccC--C-----
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACPD--H----- 470 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l---~Hpniv~l~g~~~~--~----- 470 (757)
|.....||.|+||.||+|.+. +..+|+|++..... .....+.+|+.++.++ +|||++++++++.+ .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999985 57999999874322 2234566788887766 59999999999853 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.+++|||+. ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+|||++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 479999997 589888865432 35899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
.+..... .....+++.|+|||++.+..++.++|||||||++|+|+||++||......+. +..+++..
T Consensus 156 ~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~------~~~~~~~~ 222 (287)
T cd07838 156 IYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ------LDKIFDVI 222 (287)
T ss_pred eccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH------HHHHHHHc
Confidence 7653321 1233578999999999888899999999999999999999999964432211 11111100
Q ss_pred ----------------------cCCC----ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 ----------------------AGDW----PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 ----------------------~~~~----p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.... ....+..+.+++.+||..+|.+||++.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 280 (287)
T cd07838 223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280 (287)
T ss_pred CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHH
Confidence 0000 0133577889999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=292.94 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=186.9
Q ss_pred CCccceeeccCCcEEEEEEEECC----eEEEEEEEccCC--chhhHHHHHHHHHHHhc-CCCceeeecccccC------C
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKG--NIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------H 470 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~----~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~------~ 470 (757)
+|.....||.|+||.||++...+ ..||+|.+.... ......+.+|+.++.++ .||||+++++++.. .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46777889999999999999864 489999886432 22345678899999999 59999999986421 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.+++++|+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 367888885 6898888543 35889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh---------ch
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---------DE 620 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---------~~ 620 (757)
.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.......... ..
T Consensus 154 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGE--NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred eccccccc--ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 76543211 1111234578999999998755 468899999999999999999999996433111000 00
Q ss_pred hhHHHHhhh-------hcCCC--------ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 DNLAEILDA-------QAGDW--------PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 ~~l~~~ld~-------~~~~~--------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.+..+... ..... ....+..+.+++.+|++.+|.+||++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000 00000 012356899999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=286.94 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=190.5
Q ss_pred CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEec
Q 004388 405 FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYM 478 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~ 478 (757)
|+....||.|+||.||+|... +..+|+|++.... ......+..|+.++++++|||++++++++.+. .++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999986 5699999987653 33346678899999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+ ++|.+++.... ..+++..+..++.+++.||.|||..+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 58999887643 35899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------hhHHHHh-
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DNLAEIL- 627 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------~~l~~~l- 627 (757)
......++..|+|||++.+. .++.++|||||||++|+|++|++||............ ..+..+.
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 11233567889999988766 7899999999999999999999999654332211000 0000000
Q ss_pred ----hhhcCCCC--------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 ----DAQAGDWP--------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 ----d~~~~~~p--------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.....++ ...+..+.+++.+||..+|.+||++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 00001110 122568999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=273.94 Aligned_cols=236 Identities=27% Similarity=0.415 Sum_probs=188.4
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCceeeecccccCCc--eEEEEecCCCCH
Q 004388 410 RIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGSL 483 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~LV~Ey~~~gsL 483 (757)
.||.|+-|.||++++.. ...|||.+....+ ...++++..+.++.+.+ .|+||+.+|+|.... .+.||.|. ..+
T Consensus 99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ 177 (391)
T KOG0983|consen 99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCA 177 (391)
T ss_pred hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHH
Confidence 49999999999999875 6889999876543 34567888888887765 899999999985443 67889884 456
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
+.+|.+.. .++|+...-++..-+..||.||...+ +|||||+||+|||+|..|.+||||||++-.+.+...
T Consensus 178 ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA------ 247 (391)
T KOG0983|consen 178 EKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA------ 247 (391)
T ss_pred HHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc------
Confidence 66665433 35899888899999999999999865 599999999999999999999999999977765432
Q ss_pred cccCCcccccCCCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC--hhH
Q 004388 564 KNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP--IKE 638 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p--~~~ 638 (757)
.+..+|.+.|||||.+.. ..|+.++|||||||+|+||.||+.||.... .+.+.+..+++...+..| ...
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-----tdFe~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-----TDFEVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-----ccHHHHHHHHhcCCCCCCcccCc
Confidence 244589999999998753 468999999999999999999999997532 233445556654332222 236
Q ss_pred HHHHHHHHHHHhhccCCCCCccch
Q 004388 639 TKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
++.+.+++..||..|+.+||...+
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~ 345 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNK 345 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHH
Confidence 889999999999999999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=297.25 Aligned_cols=239 Identities=23% Similarity=0.297 Sum_probs=200.5
Q ss_pred CccceeeccCCcEEEEEEEECCeE--EEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 405 FSENLRIGMGGYGTVYKGTFHHTF--AAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~~~--vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+.....||-||||.|=++..++.. +|+|++++... .+.+.+..|-.||..++.|.||+||..|.+.. |+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344456999999999999987664 78998876543 34456788999999999999999999998876 788999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|-||.|+..|..++. +...+...++.+++.|+.|||+.+ ||+|||||+|.|||.+|.+||.|||+|+.+.....
T Consensus 502 ClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 502 CLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999977664 666777889999999999999988 99999999999999999999999999998876542
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.-+++|||.|.|||++.+...+.++|.|||||++||||||.|||...+....- ..+..-+|. -.||..
T Consensus 576 -------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY---n~ILkGid~--i~~Pr~ 643 (732)
T KOG0614|consen 576 -------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY---NLILKGIDK--IEFPRR 643 (732)
T ss_pred -------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH---HHHHhhhhh--hhcccc
Confidence 24579999999999998888999999999999999999999999876655431 122222222 467888
Q ss_pred HHHHHHHHHHHHhhccCCCCCccc
Q 004388 638 ETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.+....+|+.+.|..+|.+|-...
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG~~ 667 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLGYQ 667 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhccc
Confidence 899999999999999999997743
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=292.07 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=183.5
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchh--------------hHHHHHHHHHHHhcCCCceeeecccccCC-
Q 004388 408 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ--------------NKQFLQELEVLSKIRHPHLLLLLGACPDH- 470 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~--------------~~~f~~Ev~il~~l~Hpniv~l~g~~~~~- 470 (757)
...||.|+||.||+|.+. +..||||++....... ...+.+|+++++.++||||+++++++...
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 356999999999999875 5689999886432211 12477899999999999999999998644
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++||||+. |+|.+++.... .+++.....++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccce
Confidence 489999997 68998886433 4888999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCCCc--------cccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 550 TMLNSDPSFV--------STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 550 ~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
.......... ..........+++.|+|||++.+. .++.++|||||||++|+|+||++||..........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-- 244 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG-- 244 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 8665211000 001112234678899999988654 47899999999999999999999997543322110
Q ss_pred hhHHHHhh-hhcCCC-----------------------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 DNLAEILD-AQAGDW-----------------------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ~~l~~~ld-~~~~~~-----------------------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+...+. +....| ....+..+.+++.+||..+|.+||++.+
T Consensus 245 -~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 245 -RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred -HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 0000000 000001 0123567899999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=288.75 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=188.7
Q ss_pred CccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHh--cCCCceeeecccccC------CceEEEE
Q 004388 405 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK--IRHPHLLLLLGACPD------HGCLVYE 476 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~--l~Hpniv~l~g~~~~------~~~LV~E 476 (757)
......||+|.||.||+|.+++..||||++... ..+.|.+|-+|.+. +.|+||++|+++-.. ...||++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 334456999999999999999999999999753 45678888888775 579999999998532 2268999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC------CCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP------KPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
|-+.|||.++|.... ++|....+|+.-+++||+|||.--| ++|+|||||..||||..|+.+.|+|||||.
T Consensus 289 fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999997543 8999999999999999999998443 589999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCC-CC-----CcchhhhHHHHHHHHHhCCCCc--cccchhhhhhc---
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL-IS-----PKSDVYAYGMVILQLLTAKPAI--AITHKVETAID--- 619 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-----~ksDvwSlGvil~elltG~~Pf--~~~~~~~~~~~--- 619 (757)
.+........ ..+.+||..|||||++.+.. +. .+.||||+|.|||||++.-..+ +........++
T Consensus 365 ~~~p~~~~~d----~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 365 RLEPGKPQGD----THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred EecCCCCCcc----hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 8875543222 24479999999999886542 22 3689999999999999975443 11111111111
Q ss_pred -----hhhHHHHhh--hhcCCCCh-----hHHHHHHHHHHHHhhccCCCCCccc
Q 004388 620 -----EDNLAEILD--AQAGDWPI-----KETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 620 -----~~~l~~~ld--~~~~~~p~-----~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.+.+.+++- ...+.+|. .....|.+.+..||..|+..|-|+.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 122222221 22344443 3456789999999999999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=303.79 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=204.3
Q ss_pred ccceeeccCCcEEEEEEEEC------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEe
Q 004388 406 SENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEY 477 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey 477 (757)
...++||.|+||+||+|.+- +-+||+|++.... .....+|+.|+-+|.+++|||+++|+|+|.... -||.+|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 34568999999999999873 2389999987654 445678999999999999999999999997654 689999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|++|+|.|++...+. .+..+..+.|..|||+|+.|||.+. +|||||-..||||....++||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999976443 4888899999999999999999877 99999999999999999999999999999887654
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDWP 635 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p 635 (757)
. |...+..-.+.|||-|.+....|+.++|||||||++||++| |..|+.... ...+.+++... ....|
T Consensus 854 e----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-------~~eI~dlle~geRLsqP 922 (1177)
T KOG1025|consen 854 E----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-------AEEIPDLLEKGERLSQP 922 (1177)
T ss_pred c----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-------HHHhhHHHhccccCCCC
Confidence 3 33344455778999999999999999999999999999998 888875321 12223333322 34567
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+.++.++.-++.+||..|+..||.+++ +...+.++
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fke-l~~~fs~~ 957 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKE-LAEEFSRM 957 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHH-HHHHHHHH
Confidence 788999999999999999999999985 44444333
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=275.20 Aligned_cols=219 Identities=20% Similarity=0.172 Sum_probs=175.3
Q ss_pred CCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCHHHHHhh
Q 004388 414 GGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYR 489 (757)
Q Consensus 414 G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL~~~L~~ 489 (757)
|.||.||++.+. +..+|+|.+.... .+.+|...+....||||+++++++.+.. ++||||++||+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999884 5689999987543 2344555566667999999999986543 899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCc
Q 004388 490 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569 (757)
Q Consensus 490 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 569 (757)
.. .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------DGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc---------ccCC
Confidence 43 4899999999999999999999987 9999999999999999999999999886554321 2235
Q ss_pred ccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHH
Q 004388 570 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSC 649 (757)
Q Consensus 570 gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~C 649 (757)
++..|+|||+..++.++.++||||||+++|+|++|+.|+....... . .......|...+..+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---~--------~~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---N--------THTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---c--------cccccCCcccCCHHHHHHHHHH
Confidence 6778999999988889999999999999999999998875321100 0 0001123444567899999999
Q ss_pred hhccCCCCCccchh
Q 004388 650 AELRRKDRPDLKNQ 663 (757)
Q Consensus 650 l~~~p~~RPs~~~~ 663 (757)
++.||.+||++.+.
T Consensus 213 l~~dp~~R~~~~~~ 226 (237)
T cd05576 213 LQFNPTERLGAGVA 226 (237)
T ss_pred ccCCHHHhcCCCcc
Confidence 99999999998643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=292.02 Aligned_cols=246 Identities=22% Similarity=0.271 Sum_probs=189.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-----
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----- 470 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----- 470 (757)
...++|.....||.|+||.||+|... +..||||++.... ......+.+|+.++++++|||++++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34668999999999999999999985 5689999876432 22345678899999999999999999877422
Q ss_pred ---ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 471 ---GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 471 ---~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 47999998 6799998754 34899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh--------
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-------- 618 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-------- 618 (757)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|+||+.||..........
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99865432 133468899999998755 367899999999999999999999996432211100
Q ss_pred ---------chhhHHHHhhhhcC----C---CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 619 ---------DEDNLAEILDAQAG----D---WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 619 ---------~~~~l~~~ld~~~~----~---~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
........+..... . .....+..+.+++.+||..+|.+||++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 00000000000000 0 00123678999999999999999999885
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=281.89 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=192.1
Q ss_pred CCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHh--cCCCceeeecccccC-C-----ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK--IRHPHLLLLLGACPD-H-----GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~--l~Hpniv~l~g~~~~-~-----~~LV~ 475 (757)
.......||+|.||.||+|.|.|..||||++.... ...+.+|.+|... |+|+||+.|+++-.. . .+||.
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 45556789999999999999999999999997654 3456778888764 599999999988532 2 27999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-----CCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-----TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
+|-++|||.|+|.+. .++-...++++.-+|.||++||. ++.+.|.|||||+.|||+..||.+-|+|+|||-
T Consensus 289 dYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred ecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999999763 37888999999999999999996 455679999999999999999999999999997
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCC----C--CCcchhhhHHHHHHHHHhC----------CCCccccchh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----I--SPKSDVYAYGMVILQLLTA----------KPAIAITHKV 614 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~--s~ksDvwSlGvil~elltG----------~~Pf~~~~~~ 614 (757)
..+...+. ........+||-.|||||++.... + -..+||||||.|+||+.-. ++||...-..
T Consensus 365 ~h~~~t~~--idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 365 RHDSDTDT--IDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred EecccCCc--ccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 76654322 222335569999999999875432 1 2358999999999999863 4676532222
Q ss_pred hhhhchhhHHHHh--hhhcCC----CC-hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 615 ETAIDEDNLAEIL--DAQAGD----WP-IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 615 ~~~~~~~~l~~~l--d~~~~~----~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
+.. .+.+.+++ +...+. |. ......+.+|+..||..+|.-|-++- .+-+.|.++.
T Consensus 443 DPs--~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL-riKKtl~~l~ 504 (513)
T KOG2052|consen 443 DPS--FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL-RIKKTLAKLS 504 (513)
T ss_pred CCC--HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH-HHHHHHHHHh
Confidence 211 11222221 111222 22 24567899999999999999998865 3445554443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=313.48 Aligned_cols=143 Identities=30% Similarity=0.366 Sum_probs=125.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~ 475 (757)
++|....+||.|+||.||+|.+. +..||||++..... .....+..|+.++..++||||+++++++... .||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 47888899999999999999987 67999999875432 2345688999999999999999999888544 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
||+.|++|.+++...+ .+++..+..|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999886543 4788899999999999999999987 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=307.50 Aligned_cols=254 Identities=25% Similarity=0.471 Sum_probs=202.8
Q ss_pred CCccceeeccCCcEEEEEEEEC---------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCCc-
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG- 471 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~- 471 (757)
+......||.|.||.|++|... ...||||.++.... ...+.+..|+++|+.+ .||||+.++|+|....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 3344458999999999999753 34799999886543 4567799999999998 5999999999997743
Q ss_pred -eEEEEecCCCCHHHHHhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC
Q 004388 472 -CLVYEYMENGSLEDRLYRKN-----NT--------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 537 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~-----~~--------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~ 537 (757)
++|+||+..|+|.++|.... .. ..++....+.++.|||.|+.||++.+ +|||||-..|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence 88999999999999998765 01 13888999999999999999999987 999999999999999
Q ss_pred CCceEEeeecCccccCCCCCCccccccccCCcc--cccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 004388 538 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG--TLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 614 (757)
Q Consensus 538 ~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~ 614 (757)
+..+||+|||+|+.......+ ......| ...|||||.+....|+.++|||||||+||||+| |..|+.....
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y-----~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYY-----RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred CCEEEEccccceeccCCCCce-----EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 999999999999976554322 2222233 344999999999999999999999999999998 7788854110
Q ss_pred hhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 615 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 615 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+.+..+-+......|..+..++.+++..||+.+|.+||++.+ +...++.+
T Consensus 528 ----~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~-~~~~~~~~ 579 (609)
T KOG0200|consen 528 ----TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE-CVEFFEKH 579 (609)
T ss_pred ----HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH-HHHHHHHH
Confidence 11112223333455678888999999999999999999999994 66666653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=297.61 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=204.1
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccc-------cC
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC-------PD 469 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~-------~~ 469 (757)
.-+.-|.+...||.|.||.||+++. .++.+|+|++...... .+++..|.+||+.+ .|||++.++|++ .|
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 3456688888999999999998865 5679999999876543 45677899999887 699999999997 34
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 470 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
...||||||.|||..|++.... +..+.|..+..|+.+++.||.+||.++ ++|||||=.||||+.++.+||+|||++
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence 4589999999999999887655 566999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHH
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 624 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~ 624 (757)
..+... ..+....+|||+|||||++... .|+..+|+||||++..||--|.||+...|.+...+...
T Consensus 171 aQldsT------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip--- 241 (953)
T KOG0587|consen 171 AQLDST------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--- 241 (953)
T ss_pred eeeecc------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC---
Confidence 877643 3345667999999999987543 47889999999999999999999998888776543211
Q ss_pred HHhhhh--cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 625 EILDAQ--AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 625 ~~ld~~--~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... ....|...+.++.++|..||..|...||++.+
T Consensus 242 ---RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ 278 (953)
T KOG0587|consen 242 ---RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEE 278 (953)
T ss_pred ---CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhh
Confidence 100 01224567889999999999999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=271.28 Aligned_cols=246 Identities=23% Similarity=0.263 Sum_probs=199.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECCe--EEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~L 473 (757)
.++|.....||+|+|+.|..+++..+ .+|+|++++.. ..+.+-.+.|-.+..+. +||.+|.|..+|+... ++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 35688889999999999999998765 89999987543 23344566787777765 7999999999997654 88
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|.||++||+|.-.+.+.. .+|...+..+..+|+.||.|||+.+ ||+||||.+|+|||..|++||+|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999977665544 4888888889999999999999988 9999999999999999999999999997543
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch-hhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK-VETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~~~~l~~~ld~~~~ 632 (757)
.+.+. ....+|||.|+|||++++..|+..+|+|+|||+++||+.|+.||++... ......++.+.+++-...-
T Consensus 403 ~~gd~------tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi 476 (593)
T KOG0695|consen 403 GPGDT------TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI 476 (593)
T ss_pred CCCcc------cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence 33221 2457999999999999999999999999999999999999999985421 1112234556666655555
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCc
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
..|...+-....++..-+..||++|-.
T Consensus 477 riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 567677778888899999999999854
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=285.20 Aligned_cols=238 Identities=23% Similarity=0.344 Sum_probs=188.0
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeeccccc--CCceEEEEecCCC
Q 004388 408 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEYMENG 481 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~--~~~~LV~Ey~~~g 481 (757)
...||.|-||+||-|.++ |+.||||++.+.. ..+..++.+|+.||.+++||.||.|-..|. +..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 457999999999999875 5699999987542 334577899999999999999999998884 5559999999755
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---CceEEeeecCccccCCCCCC
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~---~~~KL~DFGla~~~~~~~~~ 558 (757)
=|+-+|.... ..|+......++.||+.||.|||-.+ |+|+||||+||||... -.+||||||+|+++....
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 5555554433 24888888889999999999999988 9999999999999654 468999999999987532
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
-....+|||.|+|||++++..|+..-|+||.|||+|--|.|..||.-...+...+.+..+ ......| .+.
T Consensus 722 -----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF----MyPp~PW-~ei 791 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF----MYPPNPW-SEI 791 (888)
T ss_pred -----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc----ccCCCch-hhc
Confidence 125579999999999999999999999999999999999999999644443333222111 0001122 145
Q ss_pred HHHHHHHHHHHhhccCCCCCccch
Q 004388 639 TKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+....+||...|+..-++|-+...
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHh
Confidence 678899999999999999987653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=263.25 Aligned_cols=230 Identities=29% Similarity=0.409 Sum_probs=188.4
Q ss_pred CcEEEEEEEECC--eEEEEEEEccCCchh-hHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecCCCCHHHHHhh
Q 004388 415 GYGTVYKGTFHH--TFAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYMENGSLEDRLYR 489 (757)
Q Consensus 415 ~~G~Vyk~~~~~--~~vAvK~l~~~~~~~-~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~~gsL~~~L~~ 489 (757)
+||.||+|...+ ..+++|++....... .+.+.+|+.++++++|||++++++++... .+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 689999999864 789999998765444 67899999999999999999999998653 4899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCc
Q 004388 490 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569 (757)
Q Consensus 490 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~ 569 (757)
... +++..+..++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++....... ......
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 432 888999999999999999999987 9999999999999999999999999998776432 123457
Q ss_pred ccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChh---HHHHHHHHH
Q 004388 570 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK---ETKELAALG 646 (757)
Q Consensus 570 gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~---~~~~l~~Li 646 (757)
++..|++||.+....++.++||||||+++++|++|..||...... ..+.+.+.......... .+..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------LELFKKIGKPKPPFPPPEWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHhccCCCCccccccCCHHHHHHH
Confidence 889999999998888999999999999999999999999642211 12222222222222211 567899999
Q ss_pred HHHhhccCCCCCccchh
Q 004388 647 LSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 647 ~~Cl~~~p~~RPs~~~~ 663 (757)
.+|+..+|.+||++.+.
T Consensus 222 ~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 222 RKLLVKDPEKRLTAEEA 238 (244)
T ss_pred HHHccCCchhccCHHHH
Confidence 99999999999999853
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=290.01 Aligned_cols=234 Identities=23% Similarity=0.297 Sum_probs=187.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+..|.....+|.|+|+.|-.+... +...+||++.... .+-.+|+.++... .||||+++.+.|.+.. ++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 556777778999999999999875 4588999987652 2234678777666 6999999999998765 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee-cCCCceEEeeecCccccCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl-d~~~~~KL~DFGla~~~~~~ 555 (757)
++.||-|.+.+..... +. ..+..|+.+|+.|+.|||.++ +|||||||+|||+ +..|+++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988887765442 22 567789999999999999987 9999999999999 68999999999999987654
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
....+-|..|.|||++....|+.++||||||++||+||||+.||.....- ..+...+ ..+...
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i--~~~~~s 532 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRI--QMPKFS 532 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhh--cCCccc
Confidence 12346789999999999889999999999999999999999999632111 1111111 112233
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+...++|+.+||+.+|.+||++.+.
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i 560 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEI 560 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhh
Confidence 5678899999999999999999999853
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=270.44 Aligned_cols=236 Identities=28% Similarity=0.359 Sum_probs=181.3
Q ss_pred eeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCC-c-eEEEEecCCCC
Q 004388 409 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH-G-CLVYEYMENGS 482 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~-~-~LV~Ey~~~gs 482 (757)
..||.|.||+|+|-.++ +...|||.++.... ....+|+.|.++..+- +-||||++||++-.+ . .+.||+|. .|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 35999999999998886 55889999987654 4566788899876655 689999999997544 3 58899995 67
Q ss_pred HHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 483 LEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 483 L~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+.+... ......+++...-.|......||.||-... .|||||+||+|||||..|.+||||||++-.+.+.-
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---- 222 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---- 222 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH----
Confidence 7654332 111234888888889999999999998754 29999999999999999999999999997765432
Q ss_pred ccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC---
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP--- 635 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p--- 635 (757)
..+..+|...|||||.+.. ..|+.+|||||||++|||+.||+.|+..-..+ .+.+..+ ..++.|
T Consensus 223 ---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~V---v~gdpp~l~ 291 (361)
T KOG1006|consen 223 ---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQV---VIGDPPILL 291 (361)
T ss_pred ---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHH---HcCCCCeec
Confidence 2355689999999997743 34899999999999999999999998522111 1111111 123322
Q ss_pred -----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 -----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 -----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+..++..|+..+..+||.+.+
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~ 323 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDD 323 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhh
Confidence 246788999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=263.76 Aligned_cols=250 Identities=23% Similarity=0.365 Sum_probs=187.4
Q ss_pred CccceeeccCCcEEEEEEEECCe--EEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccC-----C-----
Q 004388 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-----H----- 470 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-----~----- 470 (757)
|....+||+|.||.||+++.+++ .||+|+.-.+ ...-...-++|+.+|..|.|+|++.++..|.. .
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 45566899999999999987654 6777754321 12223345789999999999999999999832 1
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.||||.+|+. +|.-+|.... ..++..++.+++.++..||.|+|..+ |+|||+||+|+||+.+|.+||+|||+++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 3799999974 7888775432 34788899999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccc-----------------
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITH----------------- 612 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~----------------- 612 (757)
.+......... +.+..+-|.+|.+||.+.+ ..|+++.|||..|||+.||+||.+.|....
T Consensus 173 ~fs~~~n~~kp--rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 173 AFSTSKNVVKP--RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ceecccccCCC--CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 77654432222 3466788999999997655 569999999999999999999999886322
Q ss_pred hhhhhhchhhHHHHhhhh-cCC----------CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 613 KVETAIDEDNLAEILDAQ-AGD----------WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 613 ~~~~~~~~~~l~~~ld~~-~~~----------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.++...++-.+.+.+... .+. .|..-.....+|+.+++.+||.+|++..+
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~ 311 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQ 311 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHh
Confidence 222222222222222110 000 11222347889999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=282.00 Aligned_cols=254 Identities=20% Similarity=0.242 Sum_probs=177.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEE------------------CCeEEEEEEEccCCchhhHHH--------------HHH
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTF------------------HHTFAAVKVLQSKGNIQNKQF--------------LQE 448 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~------------------~~~~vAvK~l~~~~~~~~~~f--------------~~E 448 (757)
..++|...++||+|+||.||+|.+ .++.||||.+........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 366899999999999999999964 235799999875543333333 346
Q ss_pred HHHHHhcCCCce-----eeecccccC----------CceEEEEecCCCCHHHHHhhcCC---------------------
Q 004388 449 LEVLSKIRHPHL-----LLLLGACPD----------HGCLVYEYMENGSLEDRLYRKNN--------------------- 492 (757)
Q Consensus 449 v~il~~l~Hpni-----v~l~g~~~~----------~~~LV~Ey~~~gsL~~~L~~~~~--------------------- 492 (757)
+.++.+++|.++ +.++++|.. ..+|||||+++|+|.++|.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 677777642 23899999999999999874321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccc
Q 004388 493 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572 (757)
Q Consensus 493 ~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 572 (757)
...++|..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----CccccCCCc
Confidence 113467788899999999999999987 999999999999999999999999999765432211 112234589
Q ss_pred cCCCccccccCC----------------------CCCcchhhhHHHHHHHHHhCCC-Cccccchhhhhhch--hhH--HH
Q 004388 573 CYIDPEYQRTGL----------------------ISPKSDVYAYGMVILQLLTAKP-AIAITHKVETAIDE--DNL--AE 625 (757)
Q Consensus 573 ~Y~aPE~~~~~~----------------------~s~ksDvwSlGvil~elltG~~-Pf~~~~~~~~~~~~--~~l--~~ 625 (757)
.|+|||.+.... ...+.||||+|||||+|++|.. ||.........+.. ..+ +.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999765322 1234799999999999999975 76532222111110 000 11
Q ss_pred HhhhhcCCCC--hhHHHHHHHHHHHHhhccC---CCCCccch
Q 004388 626 ILDAQAGDWP--IKETKELAALGLSCAELRR---KDRPDLKN 662 (757)
Q Consensus 626 ~ld~~~~~~p--~~~~~~l~~Li~~Cl~~~p---~~RPs~~~ 662 (757)
.......+++ ...+....+|+.+++..+| .+|+++.+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~e 496 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQ 496 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHH
Confidence 1111111111 1246778999999999766 68999885
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=265.45 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=188.8
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCC--Cc----eeeeccccc--CCc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRH--PH----LLLLLGACP--DHG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H--pn----iv~l~g~~~--~~~ 471 (757)
++.|.....+|+|.||.|-.+.+.. ..||||+++.-.. -.+.-+-|+++|.+|.+ |+ +|.+.++|. .+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 6678888899999999999998864 4899999875322 23445679999999942 22 677878775 445
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec---------------
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--------------- 536 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld--------------- 536 (757)
|||+|.+ |.|+.|+|..++ ..+++...+..|+.|++.++.|||..+ ++|-||||+|||+.
T Consensus 167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999998 569999996544 457999999999999999999999999 99999999999993
Q ss_pred -----CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc
Q 004388 537 -----HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 611 (757)
Q Consensus 537 -----~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~ 611 (757)
.+..+||+|||.|+...... ...+.|..|.|||++.+-.++.++||||+||||+||.||...|...
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 13458999999998755432 4458899999999999999999999999999999999999888643
Q ss_pred chhhhh--------------hchhhHHHHhhhhcCCCCh-------------------------hHHHHHHHHHHHHhhc
Q 004388 612 HKVETA--------------IDEDNLAEILDAQAGDWPI-------------------------KETKELAALGLSCAEL 652 (757)
Q Consensus 612 ~~~~~~--------------~~~~~l~~~ld~~~~~~p~-------------------------~~~~~l~~Li~~Cl~~ 652 (757)
...+.. +....-.+.......+||. .+...|.+|+.+||.+
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 322211 0000000111111122321 3456799999999999
Q ss_pred cCCCCCccchhh
Q 004388 653 RRKDRPDLKNQV 664 (757)
Q Consensus 653 ~p~~RPs~~~~v 664 (757)
||.+|+++.+.+
T Consensus 393 DP~~RiTl~EAL 404 (415)
T KOG0671|consen 393 DPARRITLREAL 404 (415)
T ss_pred CccccccHHHHh
Confidence 999999998643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=287.53 Aligned_cols=250 Identities=20% Similarity=0.214 Sum_probs=160.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccc-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC------- 467 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~------- 467 (757)
..++|...++||+|+||.||+|.+. +..||||.+..... .+.+..+ .+....+.++..++..+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 3567899999999999999999985 45899998764321 1111111 12222233333332221
Q ss_pred -cCCceEEEEecCCCCHHHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCC
Q 004388 468 -PDHGCLVYEYMENGSLEDRLYRKNNT-----------------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529 (757)
Q Consensus 468 -~~~~~LV~Ey~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK 529 (757)
.+..+|||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 22348999999999999988653210 00112334578999999999999987 9999999
Q ss_pred CCCeeecC-CCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC----------------------CCC
Q 004388 530 PGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG----------------------LIS 586 (757)
Q Consensus 530 p~NILld~-~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s 586 (757)
|+||||+. ++.+||+|||+|+.+..... +......||+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999986 68999999999986543322 222456889999999954322 234
Q ss_pred CcchhhhHHHHHHHHHhCCCCccccch-hhhhhc-----hhhHHHHhhhhcC-CCC------hhHHHHHHHHHHHHhhcc
Q 004388 587 PKSDVYAYGMVILQLLTAKPAIAITHK-VETAID-----EDNLAEILDAQAG-DWP------IKETKELAALGLSCAELR 653 (757)
Q Consensus 587 ~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~-----~~~l~~~ld~~~~-~~p------~~~~~~l~~Li~~Cl~~~ 653 (757)
.++|||||||+||||+++..++..... ....+. ...+...+..... +.. ........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999998766542100 000000 0011111111100 000 001223458999999999
Q ss_pred CCCCCccch
Q 004388 654 RKDRPDLKN 662 (757)
Q Consensus 654 p~~RPs~~~ 662 (757)
|++||++.+
T Consensus 438 P~kR~ta~e 446 (566)
T PLN03225 438 GRQRISAKA 446 (566)
T ss_pred cccCCCHHH
Confidence 999999885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-30 Score=291.02 Aligned_cols=244 Identities=27% Similarity=0.338 Sum_probs=185.2
Q ss_pred CccceeeccCCcEE-EEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCC
Q 004388 405 FSENLRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~-Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
|.....+|.|+-|+ ||+|.+.++.||||.+-... ..-..+||..|+.- .|||||++||.=.+.. ||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 55556689998875 89999999999999875432 22346899999887 5999999998876554 88999995
Q ss_pred CCHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-----CCceEEeeecCccccCC
Q 004388 481 GSLEDRLYRKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-----NLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 481 gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-----~~~~KL~DFGla~~~~~ 554 (757)
.+|.|++...... ..........++.|++.||++||+.+ ||||||||.||||+. ...++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 7999999763111 11111344678899999999999988 999999999999975 25789999999999887
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhC-CCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
+...... ..+..||-+|+|||++....-+.++|||||||++|+.++| .+||+..-.-+..+-.+...-. .-
T Consensus 664 ~~sS~~r---~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~-----~L 735 (903)
T KOG1027|consen 664 GKSSFSR---LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLV-----HL 735 (903)
T ss_pred Ccchhhc---ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcccee-----ee
Confidence 6643332 4677999999999999988888899999999999999987 8999854333222222211000 00
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.|.... +..+||.+|+.++|..||++.+++
T Consensus 736 ~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 736 EPLPDC-EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ccCchH-HHHHHHHHhcCCCcccCCCHHHHh
Confidence 111111 789999999999999999998644
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=236.06 Aligned_cols=195 Identities=24% Similarity=0.379 Sum_probs=159.8
Q ss_pred CCccceeeccCCcEEEEEEEECCe--EEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+|....+||+|.||+||+|+..++ .||+|..+.+. .......++|+-+|+.+.|.|||++++...... -||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 344556899999999999988654 89999877553 334566789999999999999999999875433 799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|. .+|..+.....+ .++......++.|++.||.|+|+++ +.||||||.|.||+.||.+|++|||+++.+.-...
T Consensus 83 cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 96 578777655433 4777888899999999999999998 99999999999999999999999999997764321
Q ss_pred CccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHh-CCCCccc
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLT-AKPAIAI 610 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~ellt-G~~Pf~~ 610 (757)
.....+-|.+|.+|.++.+. .|+...|+||.|||+.|+.. |+|.|..
T Consensus 157 ------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred ------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 12345789999999988765 48899999999999999986 5555543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=238.82 Aligned_cols=193 Identities=30% Similarity=0.407 Sum_probs=156.4
Q ss_pred cceeeccCCcEEEEEEEE--CCeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCC
Q 004388 407 ENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 407 ~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
....||+|+||.|-+-++ .++..|+|.+...-. +...+.++|+++..+. ..|.+|.|||...+.+ .+.||.|.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 345699999999876655 578999999876543 3445678899987665 6999999999875544 78999995
Q ss_pred CCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 481 GSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 481 gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
.||..+..+ -.....+++...-+|+..+..||.|||+.- .+||||+||+|||++.+|++||||||++-.+.+...
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA-- 204 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA-- 204 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH--
Confidence 688765443 122345889999999999999999999975 499999999999999999999999999988765432
Q ss_pred cccccccCCcccccCCCcccccc----CCCCCcchhhhHHHHHHHHHhCCCCcc
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRT----GLISPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
.+...|.-.|||||.+.. ..|+.++||||||+++.||.+++.||.
T Consensus 205 -----kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 205 -----KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred -----HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 233578889999997643 368999999999999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=248.68 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=161.9
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccC-------Cce
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------HGC 472 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------~~~ 472 (757)
+.+..+.||-|+||.||.+++. ++.||+|++..- .-...+.+.+|+.+|.-++|.|++..++..+. +.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4566788999999999999874 678999987543 22345778999999999999999999887643 236
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
++.|+|. .+|..++..- ..++...+.-++.||++||.|||+.+ |.||||||.|.|++.|..+||||||+++..
T Consensus 134 V~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 7888885 5787776542 24666777888999999999999998 999999999999999999999999999987
Q ss_pred CCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccch
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHK 613 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~ 613 (757)
..+.. ..++..+-|-+|.|||++.+. .|+.+.||||.|||+.|||..+..|.....
T Consensus 207 e~d~~-----~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 207 DQRDR-----LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred chhhh-----hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 65442 234556889999999988764 699999999999999999999887764433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=235.68 Aligned_cols=243 Identities=21% Similarity=0.393 Sum_probs=188.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCc----eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG----CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~----~LV 474 (757)
.++|+..+++|+|.|+.||.|.. ++..++||++++ ...+.+.+|+.||..|+ ||||+.|++...+.. .||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45788899999999999999984 566899999976 34567889999999997 999999999987654 799
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCccccC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLN 553 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla~~~~ 553 (757)
+||+.+.+...+. +.++...+..++.+++.||.|||+.| |+|||+||.|+++|.. ..++|+|+|||.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998876643 23666788889999999999999998 9999999999999864 679999999999887
Q ss_pred CCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-------chhhHHH
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-------DEDNLAE 625 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-------~~~~l~~ 625 (757)
+..... -.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||...+..-..+ ..+.+..
T Consensus 185 p~~eYn-------VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 185 PGKEYN-------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred CCceee-------eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 655432 2356778899997654 568899999999999999999999996433221111 1111222
Q ss_pred Hhhhh----------------cCCCCh--------hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 626 ILDAQ----------------AGDWPI--------KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 626 ~ld~~----------------~~~~p~--------~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.+... ...|.. -..++..+|+.+.|.+|-.+|||+.+.
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH
Confidence 11111 111211 124788899999999999999998863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=231.40 Aligned_cols=203 Identities=37% Similarity=0.569 Sum_probs=176.4
Q ss_pred eccCCcEEEEEEEEC--CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccC--CceEEEEecCCCCHHH
Q 004388 411 IGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYMENGSLED 485 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~~LV~Ey~~~gsL~~ 485 (757)
||.|++|.||++... +..+++|++...... ....+.+|+.++..+.|++++++++++.. ..+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 779999998865432 34678999999999999999999999876 4589999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecCccccCCCCCCcccccc
Q 004388 486 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYK 564 (757)
Q Consensus 486 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGla~~~~~~~~~~~~~~~ 564 (757)
++.... ..+++..+..++.+++.+|.|||..+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 886542 35888999999999999999999987 999999999999999 89999999999987654321 1
Q ss_pred ccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHH
Q 004388 565 NTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELA 643 (757)
Q Consensus 565 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~ 643 (757)
.....+...|++||.+... .++.+.|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2334678899999998877 788999999999999998 5788
Q ss_pred HHHHHHhhccCCCCCccch
Q 004388 644 ALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 644 ~Li~~Cl~~~p~~RPs~~~ 662 (757)
+++..|+..+|.+||++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHhhCCcccCcCHHH
Confidence 9999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-27 Score=249.60 Aligned_cols=129 Identities=27% Similarity=0.444 Sum_probs=107.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-----C---CceeeecccccC--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----H---PHLLLLLGACPD-- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----H---pniv~l~g~~~~-- 469 (757)
...|-..++||.|.|++||++.+. .+.||+|+.+...- -.+..+.||.+|++++ | .+||+|++.|.-
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 356888899999999999999875 56999999876432 3345678999999984 3 469999999842
Q ss_pred ----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 470 ----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 470 ----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
+.|+|+|++ |.+|..++.... ...++...+..|+.||+.||.|||... +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 339999999 678888776544 456999999999999999999999876 59999999999999
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=245.85 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=199.3
Q ss_pred CccceeeccCCcEEEEEEEECC-------eEEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccCC---ceE
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---GCL 473 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~---~~L 473 (757)
++....+-+|.||.||.|.|.. ..|-||.++.. +..+...|++|--.+..+.|||+..+.|.+.+. .+.
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 3444567899999999997642 24555655433 344566789999999999999999999998654 378
Q ss_pred EEEecCCCCHHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 474 VYEYMENGSLEDRLYR-----KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~-----~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
.|.++.-|+|..+|.. ......++-.+...++.|++.|+.|||+++ |||.||-..|.+||+...+||+|=.+
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaL 442 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSAL 442 (563)
T ss_pred EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchh
Confidence 8999999999999972 223334666677889999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
++.+-+.+-. +-..+......||+||.+.+..|+.++|||||||+||||+| |+.|+.-.+..+. ..-+.
T Consensus 443 SRDLFP~DYh----cLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------~~ylk 512 (563)
T KOG1024|consen 443 SRDLFPGDYH----CLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------EHYLK 512 (563)
T ss_pred ccccCccccc----ccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------HHHHh
Confidence 9876543311 11233455778999999999999999999999999999997 8899865444332 12345
Q ss_pred hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 628 d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
|......|.+++.+|..++..||...|++||++.+ +..-|...
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Q-lv~cLseF 555 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQ-LVICLSEF 555 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHH-HHHHHHHH
Confidence 56666789999999999999999999999999984 55555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=256.15 Aligned_cols=197 Identities=23% Similarity=0.291 Sum_probs=166.1
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC------CCceeeecccc--cC
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR------HPHLLLLLGAC--PD 469 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~------Hpniv~l~g~~--~~ 469 (757)
.....|......|+|-|++|.+|.+. +..||||++..... ..+.=+.|++||++|+ --|+++|+..| ..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 34456777777899999999999875 55999999986532 3344568999999994 35788888877 45
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecC
Q 004388 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGL 548 (757)
Q Consensus 470 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGl 548 (757)
+.|||+|-+. .+|.++|.+.+..-.|....+..++.|+..||..|-.++ |+|.||||+|||++.+ ..+||||||.
T Consensus 508 HLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 6799999985 699999999888888999999999999999999999988 9999999999999875 6789999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
|....... . +...-+..|.|||++.+-.|+...|+||+||+||||.||+..|.
T Consensus 584 A~~~~ene---i-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 584 ASFASENE---I-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred cccccccc---c-----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 98776543 1 22345678999999999999999999999999999999998775
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=265.29 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=200.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeeccccc--CCceEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--DHGCLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~--~~~~LV~Ey 477 (757)
..+|....++|.|.||.|||+++. +...|||+++........-+++|+-+++..+|||||.++|.+. +...++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 346778889999999999999986 4589999998887777777889999999999999999999984 556899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
|.||+|.|..+- +.+++..+...+.++.+.||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--- 164 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh---
Confidence 999999997654 346888888899999999999999988 79999999999999999999999999876543
Q ss_pred CccccccccCCcccccCCCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
+..+...+.||++|||||+. ..+.|...+|||++|++..|+---++|....|.....+-- -....++.....
T Consensus 165 ---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~qpp~lkD 239 (829)
T KOG0576|consen 165 ---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQPPTLKD 239 (829)
T ss_pred ---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCCCCcccC
Confidence 33455778999999999954 5678999999999999999999888887655544321100 000011111112
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+......|.+++..|+..+|++||+....+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 234577899999999999999999987543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=231.49 Aligned_cols=196 Identities=31% Similarity=0.487 Sum_probs=167.1
Q ss_pred CccceeeccCCcEEEEEEEECC--eEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccC--CceEEEEecC
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPD--HGCLVYEYME 479 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~~LV~Ey~~ 479 (757)
|.....||.|++|.||+|...+ ..+++|.+...... ....+.+|++.+.+++|+|++++++++.. ..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999864 78999999876544 56788999999999999999999999864 4589999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+++|.+++..... .+++.....++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999998875432 1788999999999999999999987 999999999999999999999999999877643200
Q ss_pred cccccccCCcccccCCCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCccc
Q 004388 560 STTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAIAI 610 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf~~ 610 (757)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11334678899999988 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-27 Score=252.61 Aligned_cols=193 Identities=24% Similarity=0.308 Sum_probs=162.2
Q ss_pred cCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchh--------hHHHHHHHHHHHhcC---CCceeeecccccC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQ--------NKQFLQELEVLSKIR---HPHLLLLLGACPD 469 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~--------~~~f~~Ev~il~~l~---Hpniv~l~g~~~~ 469 (757)
.+|.....+|.|+||.|+++.++. ..|+||.+.+..... ....-.||.||..++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357888899999999999999864 478899876543211 112346999999997 9999999999987
Q ss_pred Cc--eEEEEec-CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 470 HG--CLVYEYM-ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 470 ~~--~LV~Ey~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
.. ||+||-- +|.+|.|++..+. .+++.+..-|+.||+.|+++||+.+ |||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 76 6788763 5568899886554 4889999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCcc
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
|.|.+...++ ...++||..|.|||++.+.+| +..-|||++||+||.++....||.
T Consensus 715 gsaa~~ksgp--------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998766543 245689999999999988765 577899999999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=233.58 Aligned_cols=243 Identities=20% Similarity=0.239 Sum_probs=182.4
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC--------
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-------- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-------- 470 (757)
..|.....+|.|.- .|.-+.+ .+.+||+|.+.... .....+..+|..++..+.|+|++.++.+|...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555667888877 5555543 46799999865431 22345567899999999999999999998432
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.|+|||||. ++|...+.. .++..+...|+.|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 289999996 688887763 2556678899999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch--------hh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------DN 622 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------~~ 622 (757)
..... +.++..+.|..|.|||++.+..|...+||||+|||+.||++|+.-|............ ..
T Consensus 167 ~e~~~-------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 167 TEDTD-------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred ccCcc-------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 64432 4567779999999999988888999999999999999999999877643332221110 00
Q ss_pred HHHHhh-------------------hhcC--CCCh------hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 623 LAEILD-------------------AQAG--DWPI------KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 623 l~~~ld-------------------~~~~--~~p~------~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.+-+. ...+ .|+. .....+.+|+.+||-.+|++|-+..+
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~d 306 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDD 306 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHH
Confidence 000000 0001 1221 23556789999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=269.47 Aligned_cols=197 Identities=16% Similarity=0.175 Sum_probs=136.6
Q ss_pred hcCC-Cceeeeccccc-------C--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCE
Q 004388 454 KIRH-PHLLLLLGACP-------D--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523 (757)
Q Consensus 454 ~l~H-pniv~l~g~~~-------~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 523 (757)
.++| +||+.++++|. + ..++++||+ +++|.++|... ..++++..+..|+.||+.||.|||+.+ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3456 58888888771 1 124678887 56999999643 245899999999999999999999988 9
Q ss_pred EEcCCCCCCeeecCC-------------------CceEEeeecCccccCCCCCC----------ccccccccCCcccccC
Q 004388 524 IHRDMKPGNILLDHN-------------------LVSKIGDVGLSTMLNSDPSF----------VSTTYKNTGPVGTLCY 574 (757)
Q Consensus 524 vHrDLKp~NILld~~-------------------~~~KL~DFGla~~~~~~~~~----------~~~~~~~~~~~gt~~Y 574 (757)
+||||||+||||+.. +.+||+|||+++........ ...........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 45556666665532210000 0000111234689999
Q ss_pred CCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccC
Q 004388 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRR 654 (757)
Q Consensus 575 ~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p 654 (757)
||||++.+..++.++|||||||+||||++|.+|+....... ..+..................++.+||+.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM--------SSLRHRVLPPQILLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH--------HHHHHhhcChhhhhcCHHHHHHHHHhCCCCh
Confidence 99999998999999999999999999999999875221111 1110001111111223456788999999999
Q ss_pred CCCCccchhh
Q 004388 655 KDRPDLKNQV 664 (757)
Q Consensus 655 ~~RPs~~~~v 664 (757)
.+||++.+++
T Consensus 254 ~~Rps~~eil 263 (793)
T PLN00181 254 SCRPSMSELL 263 (793)
T ss_pred hhCcChHHHh
Confidence 9999998643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=223.50 Aligned_cols=233 Identities=21% Similarity=0.298 Sum_probs=171.7
Q ss_pred cCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeeccc-ccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA-CPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~-~~~~~--~LV~E 476 (757)
+.|.+.+.||+|.||.+-++.+++ +.+++|...... ....+|.+|...--.| .|.||+.-|.. |+... ++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 357888899999999999999975 588999876543 3457799998876666 48999988765 44333 57999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee-c-CCCceEEeeecCccccCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-D-HNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl-d-~~~~~KL~DFGla~~~~~ 554 (757)
|++.|+|..-+.. ..+.+....+++.|+++||.|+|+.+ +||||||.+|||| + +...+||||||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999887644 23777788899999999999999988 9999999999999 3 346899999999886553
Q ss_pred CCCCccccccccCCcccccCCCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh--
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-- 627 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l-- 627 (757)
... ...-+..|.+||.+... ...+.+|+|.||||++.+|||++||.... +......+.+
T Consensus 176 tV~---------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-----~~d~~Y~~~~~w 241 (378)
T KOG1345|consen 176 TVK---------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-----IMDKPYWEWEQW 241 (378)
T ss_pred eeh---------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-----ccCchHHHHHHH
Confidence 321 22346779999965432 35788999999999999999999996221 1112122111
Q ss_pred -hhhcCCCCh---hHHHHHHHHHHHHhhccCCCC
Q 004388 628 -DAQAGDWPI---KETKELAALGLSCAELRRKDR 657 (757)
Q Consensus 628 -d~~~~~~p~---~~~~~l~~Li~~Cl~~~p~~R 657 (757)
.......|. ..++.+..+..+-+..++++|
T Consensus 242 ~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 242 LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 111111121 235667777788888888888
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-25 Score=233.28 Aligned_cols=200 Identities=24% Similarity=0.365 Sum_probs=160.0
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeeccccc--CC
Q 004388 399 ESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACP--DH 470 (757)
Q Consensus 399 ~~at~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~--~~ 470 (757)
....+.|....+||.|.|++||++++.. ..||+|.+.... ....+.+|+++|..+. +-||+++.+++. +.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445568888999999999999997643 489999876543 4556889999999995 999999999985 45
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecCc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLS 549 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGla 549 (757)
.++|+||++.....+++.. ++......+++.++.||.++|..| ||||||||+|+|.+. -+.-.|+|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 5899999999999887743 566788899999999999999998 999999999999975 467789999999
Q ss_pred cccCCCC------C-------C---------------ccc----------cccccCCcccccCCCccccc-cCCCCCcch
Q 004388 550 TMLNSDP------S-------F---------------VST----------TYKNTGPVGTLCYIDPEYQR-TGLISPKSD 590 (757)
Q Consensus 550 ~~~~~~~------~-------~---------------~~~----------~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksD 590 (757)
....... . . ... .......+||++|.|||++. .+..++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321100 0 0 000 01112348999999999764 456889999
Q ss_pred hhhHHHHHHHHHhCCCCcc
Q 004388 591 VYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 591 vwSlGvil~elltG~~Pf~ 609 (757)
|||.|||++-+++++.||.
T Consensus 261 iws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred eeeccceeehhhccccccc
Confidence 9999999999999999996
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-24 Score=209.08 Aligned_cols=159 Identities=21% Similarity=0.248 Sum_probs=122.7
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|+|.+++...+ .++++..+..|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 78999987543 35999999999999999999999965 999999999999999 9999875432
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC------C
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD------W 634 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~------~ 634 (757)
...||+.|+|||++.+..++.++|||||||++|||+||++||........ .+..++...... .
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 131 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-----ILEILLNGMPADDPRDRSN 131 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-----HHHHHHHHhccCCcccccc
Confidence 12689999999999999999999999999999999999999964332211 111122111111 1
Q ss_pred ChhHHH--HHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 635 PIKETK--ELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 635 p~~~~~--~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
+..... .+.+++.+||..+|.+||++.+ ++..+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~-ll~~~~ 167 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANH-YLAHCR 167 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHH-HHHHHH
Confidence 122233 6999999999999999999984 544443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=221.83 Aligned_cols=258 Identities=22% Similarity=0.233 Sum_probs=189.9
Q ss_pred CCccceeeccCCcEEEEEEEECCe---EEEEEEEccCCchhhHHHHHHHHHHHhcCC----Cceeeeccccc-CC--ceE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLGACP-DH--GCL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~---~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H----pniv~l~g~~~-~~--~~L 473 (757)
.|....+||+|+||.||+|..... .+|+|+...........+..|+.++..+.. +++..+++... .. .++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999998654 689998776543333367789999998863 57777777763 33 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-----CceEEeeecC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-----LVSKIGDVGL 548 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-----~~~KL~DFGl 548 (757)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.| ++||||||+|++++.. ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 789999775554 456999999999999999999999988 9999999999999865 4689999999
Q ss_pred cc--ccCCCCCCcccccc--ccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHH
Q 004388 549 ST--MLNSDPSFVSTTYK--NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 624 (757)
Q Consensus 549 a~--~~~~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~ 624 (757)
++ .+...........+ .....||..|+++....+...+.+.|+||++.++.+|+.|..||........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 33222211101111 2346799999999999999999999999999999999999999953332111 11111
Q ss_pred HHhhhhcCC-CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 625 EILDAQAGD-WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 625 ~~ld~~~~~-~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
......... .....+..+..+...+-..+..++|+.. .+...|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~-~~~~~l~~ 296 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYE-KLAELLKD 296 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHH-HHHHHHHH
Confidence 111111111 1223456777777777779999999997 34444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=226.95 Aligned_cols=171 Identities=20% Similarity=0.202 Sum_probs=130.4
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCceee-ecccc
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLL-LLGAC 467 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~Hpniv~-l~g~~ 467 (757)
.+.....+|.....||+|+||.||+|.+. ++.+|||++.... ......|.+|+++|.+++|+|++. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34455667999999999999999999874 5678999875331 223456899999999999999985 5442
Q ss_pred cCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCC-CCCCeeecCCCceEEeee
Q 004388 468 PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM-KPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 468 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL-Kp~NILld~~~~~KL~DF 546 (757)
+..+|||||++|++|.. +. . .. ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~--~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-AR--P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hC--c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45699999999999963 21 1 11 1467889999999999988 999999 999999999999999999
Q ss_pred cCccccCCCCCCccc-ccc-ccCCcccccCCCcccccc
Q 004388 547 GLSTMLNSDPSFVST-TYK-NTGPVGTLCYIDPEYQRT 582 (757)
Q Consensus 547 Gla~~~~~~~~~~~~-~~~-~~~~~gt~~Y~aPE~~~~ 582 (757)
|+|+.+......... .+. -+...+++.|++||++..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999987643211110 011 145688999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=207.25 Aligned_cols=255 Identities=30% Similarity=0.435 Sum_probs=193.2
Q ss_pred CccceeeccCCcEEEEEEEECCeEEEEEEEccCCch---hhHHHHHHHHHHHhcCCC-ceeeecccccCCc--eEEEEec
Q 004388 405 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHP-HLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~Hp-niv~l~g~~~~~~--~LV~Ey~ 478 (757)
|.....||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++.+++.+.... +++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 556678999999999999888 77899988765443 367799999999999988 7999999985554 7999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCccccCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~~~~~~ 557 (757)
.+++|.+++........++......++.|++.+|.|+|..+ ++||||||+|||++..+ .++++|||+++.+.....
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966644321125788899999999999999999988 99999999999999988 799999999986554332
Q ss_pred CccccccccCCcccccCCCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC-
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD- 633 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~- 633 (757)
............||..|++||.+.. ..++...|+||+|++++++++|..||...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTPS 234 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCcc
Confidence 1110012356689999999998877 57889999999999999999999997644321 0001111111111111
Q ss_pred --CChh------HHHHHHHHHHHHhhccCCCCCccchhhhh
Q 004388 634 --WPIK------ETKELAALGLSCAELRRKDRPDLKNQVLP 666 (757)
Q Consensus 634 --~p~~------~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~ 666 (757)
.+.. ....+.+++..|+..+|..|.+....+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111 13578999999999999999998754443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-23 Score=205.34 Aligned_cols=262 Identities=21% Similarity=0.397 Sum_probs=205.4
Q ss_pred hccccccccCCCHHHHHHhhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCce
Q 004388 383 LNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHL 460 (757)
Q Consensus 383 ~~~~~~~~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpni 460 (757)
...+..+|..++..++...| +|.+...|..|+|++.+..+++|++..... ....+|..|.-.|+-+.||||
T Consensus 177 rdatlsr~~gid~~~lnl~t-------kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpni 249 (448)
T KOG0195|consen 177 RDATLSRYTGIDVSSLNLIT-------KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNI 249 (448)
T ss_pred cccccccccCcchhhhhhhh-------hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCch
Confidence 44556677777776666555 588999999999999999999999876532 234679999999999999999
Q ss_pred eeecccccC--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC
Q 004388 461 LLLLGACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 538 (757)
Q Consensus 461 v~l~g~~~~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~ 538 (757)
+.++|+|.. +..++..||+.|||...|+.... -.++-.+..+++.+|++|++|||+..| -|..--|....+++|++
T Consensus 250 lpvlgacnsppnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmided 327 (448)
T KOG0195|consen 250 LPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDED 327 (448)
T ss_pred hhhhhhccCCCCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecch
Confidence 999999965 44788999999999999986543 245666888999999999999999984 23444699999999999
Q ss_pred CceEEe--eecCccccCCCCCCccccccccCCcccccCCCccccccCCC---CCcchhhhHHHHHHHHHhCCCCccccch
Q 004388 539 LVSKIG--DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI---SPKSDVYAYGMVILQLLTAKPAIAITHK 613 (757)
Q Consensus 539 ~~~KL~--DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~ksDvwSlGvil~elltG~~Pf~~~~~ 613 (757)
.+++|+ |--++ +...+..-.|.||+||.++..+- -..+|+|||+++||||.|...||..-..
T Consensus 328 ltarismad~kfs-------------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 328 LTARISMADTKFS-------------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred hhhheecccceee-------------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 988874 32222 12233456899999998876543 3579999999999999999999975555
Q ss_pred hhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 614 VETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.+... .-.+.......|+..+..+.+|+.-|+..||.+||.+. .|++.|+++.
T Consensus 395 mecgm-----kialeglrv~ippgis~hm~klm~icmnedpgkrpkfd-mivpilekm~ 447 (448)
T KOG0195|consen 395 MECGM-----KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD-MIVPILEKMI 447 (448)
T ss_pred hhhhh-----hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc-eehhhHHHhc
Confidence 44432 22344445567888899999999999999999999997 7889998864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=191.45 Aligned_cols=249 Identities=20% Similarity=0.216 Sum_probs=189.2
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCC-CceeeecccccC--CceEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH-PHLLLLLGACPD--HGCLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H-pniv~l~g~~~~--~~~LV~E 476 (757)
..+|...++||.|+||.+|.|.. .+..||||+-..... ..++..|..+...|+| +.|..+..+..+ ...|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 34688999999999999999986 467999999765443 3457788888888875 344444444444 3479999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---CceEEeeecCccccC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTMLN 553 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~---~~~KL~DFGla~~~~ 553 (757)
.+ |.||++++.-... .++..+++.++-|++.-++|+|..+ +|||||||+|+|.+-+ ..+.|+|||||+.+-
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 99 7899998764433 3888899999999999999999988 9999999999999755 457899999999877
Q ss_pred CCCCCcccccc-ccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTTYK-NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
+........++ .....||..|.+-..+.+...+.+.|+-|+|.+|.++.-|..||....... .......+......
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t---k~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT---KKQKYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh---HHHHHHHHHHhhcC
Confidence 65544444443 356789999999888877788899999999999999999999996433222 22233333333322
Q ss_pred CCC----hhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 633 DWP----IKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 633 ~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+ ...+.++.-.+.-|-.+.-.+-|+..
T Consensus 243 ~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 243 TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 211 12356788888999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-21 Score=195.46 Aligned_cols=249 Identities=18% Similarity=0.215 Sum_probs=188.9
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccC--CceEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~~~LV~E 476 (757)
..+|...++||+|.||.++.|.. ++.+||||.-...+. .-++.-|....+.|. -++|...|-+-++ +..||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 45799999999999999999975 688999998654432 234566777777774 5777666555444 4579999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-----CceEEeeecCccc
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-----LVSKIGDVGLSTM 551 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-----~~~KL~DFGla~~ 551 (757)
++ |.||+|++.-.+. .++..++..||.|++.-+.|+|.+. +|+|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99 7899997765554 4899999999999999999999988 9999999999999754 4689999999999
Q ss_pred cCCCCCCccccccc-cCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 552 LNSDPSFVSTTYKN-TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
+-+........|+. ....||..||+=.-..+...+.+.|+-|||-++++.|-|..||..... .........+=+..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA---~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA---DTNKEKYEKIGETK 255 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC---cchHHHHHHhcccc
Confidence 88766555555543 457899999999988888899999999999999999999999963211 11112222222221
Q ss_pred cCCC----ChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 631 AGDW----PIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 631 ~~~~----p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.... ....+.+++..+.-.-.++-.+-|+..
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 1111 112456778888777788888999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-20 Score=186.93 Aligned_cols=138 Identities=17% Similarity=0.204 Sum_probs=106.2
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEccCCch--h-------hHHH-----------------HHHHHHHHhcCCCcee
Q 004388 409 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI--Q-------NKQF-----------------LQELEVLSKIRHPHLL 461 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~--~-------~~~f-----------------~~Ev~il~~l~Hpniv 461 (757)
..||+|+||.||+|... +..||||+++..... . ...| ..|+.+|.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 46999999999999874 779999998754211 0 1122 3499999999877663
Q ss_pred eecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL-HNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 462 ~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
..........+|||||++|++|...+... .++++.....++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 32222233448999999988776543322 3588889999999999999999 6877 99999999999998 578
Q ss_pred eEEeeecCccccC
Q 004388 541 SKIGDVGLSTMLN 553 (757)
Q Consensus 541 ~KL~DFGla~~~~ 553 (757)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-20 Score=191.78 Aligned_cols=170 Identities=14% Similarity=0.088 Sum_probs=131.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhH---H------HHHHHHHHHhcCCCceeeeccccc---
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNK---Q------FLQELEVLSKIRHPHLLLLLGACP--- 468 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~---~------f~~Ev~il~~l~Hpniv~l~g~~~--- 468 (757)
..++|...+.||.|+||.||+...++..+|||++......... . |.+|+..+.++.||+|.....++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 3567899999999999999998777779999999765432222 2 578999999999999998877643
Q ss_pred -------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 469 -------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 469 -------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
...+|||||++|.+|.+... ++. ....+++.+|..||..+ ++|||+||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 13489999999999988631 222 34569999999999988 99999999999999988 9
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt 603 (757)
+|+|||........... .-+.....|+.++|+||||++|..+..
T Consensus 174 ~liDfg~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEECCCcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999988755322110 013334456679999999999886654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=184.20 Aligned_cols=188 Identities=16% Similarity=0.088 Sum_probs=140.3
Q ss_pred ccceeeccCCcEEEEEEEECCeEEEEEEEccCCch----hhHHHHHHHHHHHhcC-CCceeeecccccCCceEEEEecCC
Q 004388 406 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI----QNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYMEN 480 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~----~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~~LV~Ey~~~ 480 (757)
.....||+|+||+||.+...+..++.+.+...... ....|.+|+++|.+|. |++++.++++ +..+++|||+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 45668999999999998888888887777654331 1225789999999995 5788888886 446899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCC-CCCCeeecCCCceEEeeecCccccCCCCCC-
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM-KPGNILLDHNLVSKIGDVGLSTMLNSDPSF- 558 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL-Kp~NILld~~~~~KL~DFGla~~~~~~~~~- 558 (757)
.+|...+.. ....++.+++.+|.+||..+ |+|||| ||+|||++.++.++|+|||+|.........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 998654311 11357789999999999988 999999 799999999999999999999865533210
Q ss_pred ---c----cccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCcc
Q 004388 559 ---V----STTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 559 ---~----~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
. ....+ .-...++.|++|+...- ..--...++++-|+-+|.++||..++.
T Consensus 150 r~L~~rDl~~llk-~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLK-HKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHH-HHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00000 11246888999984322 222256799999999999999997764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-20 Score=218.34 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=178.3
Q ss_pred CCccceeeccCCcEEEEEEEECCeEEEEEEEccCC-chhhHHHHHHHHH--HHhcCCCceeeecccccC--CceEEEEec
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG-NIQNKQFLQELEV--LSKIRHPHLLLLLGACPD--HGCLVYEYM 478 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~-~~~~~~f~~Ev~i--l~~l~Hpniv~l~g~~~~--~~~LV~Ey~ 478 (757)
+|.....||.+.|=.|.+|.++...|+||++-... ......|.++++- ..-++|||++++.-+-.. ..|||-+|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 45566779999999999999998889999986654 4445555554443 344589999998766432 348899999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc--cCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM--LNSDP 556 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~--~~~~~ 556 (757)
.+ +|.|+|.-+ +-+...+...|+.|++.||.-+|..+ |+|||||.+||||+.-..+.|+||..-+. ++.++
T Consensus 104 kh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 104 KH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 64 899988532 34667778889999999999999998 99999999999999999999999986543 22222
Q ss_pred CCccccccccCCcccccCCCccccccC-----------CCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhc-hhhH
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTG-----------LISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID-EDNL 623 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~-~~~l 623 (757)
. ....|-..+...-.+|+|||.+..+ .+++++||||+||+++||++ |+|||.+.+....... ....
T Consensus 177 P-adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 177 P-ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP 255 (1431)
T ss_pred c-ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence 1 1222222333456789999966431 27889999999999999997 7999986655443222 1111
Q ss_pred HHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..++.. . +...+.+|++.|++.+|..|-++.+
T Consensus 256 e~~Le~-I------ed~~~Rnlil~Mi~rdPs~RlSAed 287 (1431)
T KOG1240|consen 256 EQLLEK-I------EDVSLRNLILSMIQRDPSKRLSAED 287 (1431)
T ss_pred HHHHHh-C------cCccHHHHHHHHHccCchhccCHHH
Confidence 222211 1 2346899999999999999999875
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=181.65 Aligned_cols=139 Identities=18% Similarity=0.134 Sum_probs=109.3
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEccCCchh--------------------------hHHHHHHHHHHHhcCCCcee
Q 004388 409 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQ--------------------------NKQFLQELEVLSKIRHPHLL 461 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~--------------------------~~~f~~Ev~il~~l~Hpniv 461 (757)
..||+|+||.||+|.+. ++.||||+++...... ...+..|...+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 57999999999999875 7899999988652110 12235789999999998874
Q ss_pred eecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCc
Q 004388 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 462 ~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~ 540 (757)
....+.....+|||||++|+++....... ..++......++.+++.+|.+||+ .+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 83 VPEPILLKKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CceEEEecCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 43333334568999999988654432222 246777889999999999999999 87 99999999999999 899
Q ss_pred eEEeeecCccccCC
Q 004388 541 SKIGDVGLSTMLNS 554 (757)
Q Consensus 541 ~KL~DFGla~~~~~ 554 (757)
++|+|||++...+.
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-20 Score=216.92 Aligned_cols=247 Identities=18% Similarity=0.252 Sum_probs=175.0
Q ss_pred cceeeccCCcEEEEEEEEC--CeEEEEEEEccC--Cchhh----HHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 407 ENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQN----KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 407 ~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~----~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
....+|.|.||.|+..... ...++.|..... ..... ..+..|+-+-..+.|||++..+..+.+.. .-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4567899999977765432 223333332210 11111 11556777778889999988877765433 33599
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
||++ +|..++...+ .+....+..++.|++.||.|||..| |.||||||+|+|+..+|.+||+|||.+..+.-..
T Consensus 402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9998 9999887653 3666788899999999999999998 9999999999999999999999999997765332
Q ss_pred CCccccccccCCcccccCCCccccccCCCCC-cchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISP-KSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
. .......+.+|+-.|+|||.+....|.+ ..||||.||+++.|++|+.||......+..........-.....+.++
T Consensus 475 e--~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 475 E--KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred c--hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 2 1123446789999999999999888876 589999999999999999999755443332100000000000001111
Q ss_pred --hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 --IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 --~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..-..++-++|+++|.+|-++.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~ 581 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQ 581 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHH
Confidence 134566788999999999999999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-20 Score=208.42 Aligned_cols=222 Identities=25% Similarity=0.261 Sum_probs=177.5
Q ss_pred eccCCcEEEEEE-----EECCeEEEEEEEccCCchh--hHHHHHHHHHHHhcC-CCceeeecccccCCc--eEEEEecCC
Q 004388 411 IGMGGYGTVYKG-----TFHHTFAAVKVLQSKGNIQ--NKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 411 IG~G~~G~Vyk~-----~~~~~~vAvK~l~~~~~~~--~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
+|.|.||.|+++ .+.+..+|+|++....... ......|..++..++ ||.+|.+..++.... +++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999974 3456688999887653221 114556888898887 999999998886544 899999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS 560 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 560 (757)
|.|...+..... +.......+..+++-+++++|..+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 999887765443 555566677889999999999998 9999999999999999999999999998765432
Q ss_pred ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHH
Q 004388 561 TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640 (757)
Q Consensus 561 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 640 (757)
..+||..|||||+.+ .....+|+||||++++||+||-.||.. +.+. .|-......|.....
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~-~Il~~~~~~p~~l~~ 212 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMK-RILKAELEMPRELSA 212 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHH-HHhhhccCCchhhhH
Confidence 128999999999988 457899999999999999999999964 1222 222333456777888
Q ss_pred HHHHHHHHHhhccCCCCCccc
Q 004388 641 ELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.+..++..++..+|..|-...
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccC
Confidence 899999999999999997664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=175.07 Aligned_cols=135 Identities=16% Similarity=0.245 Sum_probs=104.7
Q ss_pred CccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhc-----CCCceeeecccccCC---ce---E
Q 004388 405 FSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-----RHPHLLLLLGACPDH---GC---L 473 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-----~Hpniv~l~g~~~~~---~~---L 473 (757)
......||+|+||.||..... ...+||++........+.+.+|+.+++.+ .||||++++|++.+. ++ +
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cCCcceecCCCceEEEECCCC-cCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 345568999999999962222 23479988765444567799999999999 579999999999665 23 6
Q ss_pred EEEe--cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhhCCCCCEEEcCCCCCCeeecC----CCceEEeee
Q 004388 474 VYEY--MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL-AFLHNTKPKPIIHRDMKPGNILLDH----NLVSKIGDV 546 (757)
Q Consensus 474 V~Ey--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~ivHrDLKp~NILld~----~~~~KL~DF 546 (757)
|+|| +.+|+|.+++.+. .++.. ..++.+++.++ .|||+++ |+||||||+|||++. ++.++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999542 24443 35678888888 8999988 999999999999974 348999995
Q ss_pred cCc
Q 004388 547 GLS 549 (757)
Q Consensus 547 Gla 549 (757)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=175.31 Aligned_cols=229 Identities=19% Similarity=0.262 Sum_probs=144.8
Q ss_pred CccceeeccCCcEEEEEEEECC--eEEEEEEEccCCc---hhhHHHHHHHHHHHhcCC-----------Cc-----eeee
Q 004388 405 FSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGN---IQNKQFLQELEVLSKIRH-----------PH-----LLLL 463 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H-----------pn-----iv~l 463 (757)
+.....||.|+|+.||.+++.. ..+|||++..... ...+++.+|.-....+.+ .. ++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3445679999999999999975 6999999765432 234556666544443322 11 1121
Q ss_pred ccc---c---c-------CCceEEEEecCCCCHHHHHh---hcCCC-CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEc
Q 004388 464 LGA---C---P-------DHGCLVYEYMENGSLEDRLY---RKNNT-PPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526 (757)
Q Consensus 464 ~g~---~---~-------~~~~LV~Ey~~~gsL~~~L~---~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHr 526 (757)
-+- + . -+.+++|+-+. ++|.+++. ..... ..+....++.+..|++..+++||..+ +||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 110 0 1 12256787774 78888754 22211 22445566777789999999999998 9999
Q ss_pred CCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc--------CCCCCcchhhhHHHHH
Q 004388 527 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--------GLISPKSDVYAYGMVI 598 (757)
Q Consensus 527 DLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDvwSlGvil 598 (757)
||+|+|+|++.+|.++|+||+......... .....+..|.+||.... -.++.+.|.|+||+++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE---------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee---------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 999999999999999999998876543211 11244577999996533 2478899999999999
Q ss_pred HHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCC
Q 004388 599 LQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDR 657 (757)
Q Consensus 599 ~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~R 657 (757)
|.|++|..||+........ .. ...... +.+..+..||..+|+.+|.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~~---~~-------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEADP---EW-------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGSTS---GG-------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCccccc---cc-------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999865322110 00 112233 678899999999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=6.6e-18 Score=187.82 Aligned_cols=201 Identities=24% Similarity=0.403 Sum_probs=150.6
Q ss_pred HHhcCCCceeeecccccCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCC
Q 004388 452 LSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529 (757)
Q Consensus 452 l~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK 529 (757)
|+.+.|.|+.+|+|.+.+.. +.|.+||..|+|.|.+.... ..++|.-...++.+|+.||.|||... . ..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 45689999999999996654 78999999999999997633 45889999999999999999999865 1 3999999
Q ss_pred CCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC-------CCCCcchhhhHHHHHHHHH
Q 004388 530 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-------LISPKSDVYAYGMVILQLL 602 (757)
Q Consensus 530 p~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDvwSlGvil~ell 602 (757)
+.|.++|..+.+||+|||+........... ......-...|.|||.+... ..+.+.||||||++++|++
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~----~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPE----AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred cccceeeeeEEEEechhhhccccccccccc----ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999988764311000 01122345679999987653 1477899999999999999
Q ss_pred hCCCCccccchhhhhhchhhHHHHhh-hhc---CC-CCh-hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 603 TAKPAIAITHKVETAIDEDNLAEILD-AQA---GD-WPI-KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 603 tG~~Pf~~~~~~~~~~~~~~l~~~ld-~~~---~~-~p~-~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.+.||......... .+.+..+.+ ... +. +.. ...+.+..++..||..+|.+||++..
T Consensus 153 ~r~~~~~~~~~~~~~--~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDP--DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred hccCccccccccCCh--HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHH
Confidence 999999865443332 122222222 111 11 112 33446999999999999999999873
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.9e-18 Score=197.63 Aligned_cols=213 Identities=23% Similarity=0.270 Sum_probs=149.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCceEEEEec
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYM 478 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~~LV~Ey~ 478 (757)
...+|...+.|..|+||.||.++++ .+.+|+|+- .... +.+- ||.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----hhhc--cccccCCccee-----------------
Confidence 3567889999999999999999887 457888442 2111 1110 22223333333
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC--
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP-- 556 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~-- 556 (757)
|+-.+.+..-+ +++.. ++.+++|||+.+ |+|||+||+|.||..-|++|++|||+++...-..
T Consensus 136 --gDc~tllk~~g---~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKNIG---PLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhcccCC---CCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 45555453322 34432 378999999988 9999999999999999999999999987532111
Q ss_pred -------CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 557 -------SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 557 -------~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
...+..+.....+|||.|+|||++....|+..+|+|++|+|+||.+.|..||.....- .|...+-.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-------elfg~vis 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVIS 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-------HHHhhhhh
Confidence 1122334456679999999999998888999999999999999999999999744211 11111111
Q ss_pred hcCCCCh---hHHHHHHHHHHHHhhccCCCCCccc
Q 004388 630 QAGDWPI---KETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 630 ~~~~~p~---~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
....||. ....++++++.+.|+.+|..|--..
T Consensus 273 d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 273 DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 2234443 3568899999999999999995543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=166.43 Aligned_cols=132 Identities=23% Similarity=0.319 Sum_probs=109.7
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCch--------hhHHHHHHHHHHHhcCCCceeeeccc--ccCCceEEEEec
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI--------QNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYM 478 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~--------~~~~f~~Ev~il~~l~Hpniv~l~g~--~~~~~~LV~Ey~ 478 (757)
..||+|++|.||+|.+.+..+++|+....... ....+.+|+.++..+.|+++.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46899999999999999899999987654321 12457889999999999887654444 455668999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
+|++|.+.+.... + .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885421 2 77899999999999999988 99999999999999 88999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.1e-17 Score=165.32 Aligned_cols=127 Identities=26% Similarity=0.387 Sum_probs=105.0
Q ss_pred eccCCcEEEEEEEECCeEEEEEEEccCCc--------hhhHHHHHHHHHHHhcCCCce--eeecccccCCceEEEEecCC
Q 004388 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGN--------IQNKQFLQELEVLSKIRHPHL--LLLLGACPDHGCLVYEYMEN 480 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l~Hpni--v~l~g~~~~~~~LV~Ey~~~ 480 (757)
||+|+||.||+|.+.+..+++|+...... ....++.+|+.++..+.|+++ ..+++...+..++||||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 89999999999999999999998654321 123557789999999988754 45555556666999999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++|.+.+.... ..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 82 ~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 82 KPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99998774321 078999999999999988 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=190.60 Aligned_cols=195 Identities=25% Similarity=0.299 Sum_probs=152.0
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCcee----eeccc--ccC
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL----LLLGA--CPD 469 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv----~l~g~--~~~ 469 (757)
+++.....|.+.+.||+|+||.||+|... +..||+|+-++..... |.-=.+++.+|+ |-+. .+..+ |.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLK-PQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhc-hhhhcchHHHHHHHccCC
Confidence 44555667888899999999999999874 6799999987654321 222234555555 3333 33222 356
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-------CCceE
Q 004388 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------NLVSK 542 (757)
Q Consensus 470 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-------~~~~K 542 (757)
..+||+||.+-|+|.|++. ....++|..+..++.|++..+..||..+ ||||||||+|+||.. +..++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 6789999999999999986 3456999999999999999999999998 999999999999942 45689
Q ss_pred EeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCC
Q 004388 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605 (757)
Q Consensus 543 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~ 605 (757)
|+|||-+.-+.--... .+....++|-.+-.+|...+..++...|.|.|+-+++-||.|+
T Consensus 842 lIDfG~siDm~lfp~~----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDG----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EEecccceeeeEcCCC----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 9999998644322211 1235568899999999999999999999999999999999997
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.3e-17 Score=166.92 Aligned_cols=141 Identities=18% Similarity=0.156 Sum_probs=108.2
Q ss_pred CccceeeccCCcEEEEEEE-E--CCeEEEEEEEccCCch------------------------hhHHHHHHHHHHHhcCC
Q 004388 405 FSENLRIGMGGYGTVYKGT-F--HHTFAAVKVLQSKGNI------------------------QNKQFLQELEVLSKIRH 457 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~-~--~~~~vAvK~l~~~~~~------------------------~~~~f~~Ev~il~~l~H 457 (757)
|.....||.|+||.||+|. . .+..||||+++..... ....+..|+.++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 6677889999999999998 2 5779999998754210 01235689999999975
Q ss_pred C--ceeeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 458 P--HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 458 p--niv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
. .+...+++ ...+|||||++|++|...+... .++.......++.||+.+|.+||..+ .|+||||||+|||+
T Consensus 110 ~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli 182 (237)
T smart00090 110 AGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILV 182 (237)
T ss_pred cCCCCCeeeEe--cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEE
Confidence 3 34444543 2458999999998887654222 23555567789999999999999976 39999999999999
Q ss_pred cCCCceEEeeecCccccC
Q 004388 536 DHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~ 553 (757)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.7e-17 Score=187.48 Aligned_cols=143 Identities=24% Similarity=0.317 Sum_probs=114.0
Q ss_pred CHHHHHHhhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCC--------chhhHHHHHHHHHHHhcCCCceeeecc
Q 004388 394 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--------NIQNKQFLQELEVLSKIRHPHLLLLLG 465 (757)
Q Consensus 394 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~--------~~~~~~f~~Ev~il~~l~Hpniv~l~g 465 (757)
+|.........|...+.||+|+||.||+|.+.+..+++|+..... ......+.+|++++..++|++++....
T Consensus 324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 344444445556678899999999999999887766666543221 112356889999999999999887655
Q ss_pred cc--cCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 466 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 466 ~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
++ .+..++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEE
Confidence 54 345689999999999999874 35678999999999999988 9999999999999 6789999
Q ss_pred eeecCccc
Q 004388 544 GDVGLSTM 551 (757)
Q Consensus 544 ~DFGla~~ 551 (757)
+|||+++.
T Consensus 469 iDFGla~~ 476 (535)
T PRK09605 469 IDFGLGKY 476 (535)
T ss_pred EeCccccc
Confidence 99999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.7e-18 Score=184.40 Aligned_cols=173 Identities=29% Similarity=0.395 Sum_probs=135.9
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.++.|++|.-.+|.++|.+.......+|.....++.|++.|+.| .+ .+|+|+||.||+...+..+||.|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhee
Confidence 47899999999999999877666678899999999999999999 55 8999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhC-CCCccccchhhhhhchhhHHHHhhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
...............+...||..||+||.+.+..|+.++||||||+||+||++- ..+|. ..+.+. |-
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e---------r~~t~~---d~ 472 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE---------RIATLT---DI 472 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH---------HHHhhh---hh
Confidence 776554222223345677999999999999999999999999999999999982 22221 111222 22
Q ss_pred hcCCCChh---HHHHHHHHHHHHhhccCCCCCccc
Q 004388 630 QAGDWPIK---ETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 630 ~~~~~p~~---~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.-+.||+. .-+.-..|+++++.+.|.+||+..
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 23455532 224456899999999999999543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=165.96 Aligned_cols=199 Identities=19% Similarity=0.219 Sum_probs=140.7
Q ss_pred CCCceeeecccccCC-----------------------------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHH
Q 004388 456 RHPHLLLLLGACPDH-----------------------------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 506 (757)
Q Consensus 456 ~Hpniv~l~g~~~~~-----------------------------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 506 (757)
+|||||+++++|.+. .||||.-.+ .+|..+|..+. .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 699999999987321 167887664 58888886544 45567778999
Q ss_pred HHHHHHHHHhhCCCCCEEEcCCCCCCeee--cCCC--ceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc
Q 004388 507 EVASALAFLHNTKPKPIIHRDMKPGNILL--DHNL--VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582 (757)
Q Consensus 507 qia~aL~~LH~~~~~~ivHrDLKp~NILl--d~~~--~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 582 (757)
|+++|+.|||.++ |.|||||.+|||| |+++ .+.|+|||.+---....-...........-|....||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 4444 4688999987533222111111222334567888999998754
Q ss_pred CC------CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCC
Q 004388 583 GL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKD 656 (757)
Q Consensus 583 ~~------~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~ 656 (757)
.+ .-.++|.|+.|-+.||+++...||..... ..++..+ ......+..|...++.+.+|+...++.+|.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe--m~L~~r~---Yqe~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE--MLLDTRT---YQESQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccch--heechhh---hhhhhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 32 23579999999999999999999974211 1111111 1122334456677888999999999999999
Q ss_pred CCccchhhhhHH
Q 004388 657 RPDLKNQVLPVL 668 (757)
Q Consensus 657 RPs~~~~vl~~L 668 (757)
||+.. +...+|
T Consensus 501 Rvsp~-iAANvl 511 (598)
T KOG4158|consen 501 RVSPN-IAANVL 511 (598)
T ss_pred cCCcc-HHHhHH
Confidence 99975 333343
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=159.63 Aligned_cols=137 Identities=18% Similarity=0.101 Sum_probs=107.0
Q ss_pred CCccceeeccCCcEEEEEEEE-CCeEEEEEEEccCCch----------------------hhHHHHHHHHHHHhcCCCc-
Q 004388 404 SFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNI----------------------QNKQFLQELEVLSKIRHPH- 459 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~-~~~~vAvK~l~~~~~~----------------------~~~~f~~Ev~il~~l~Hpn- 459 (757)
.|.....||.|+||.||++.. .++.||||++...... ....+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 366678899999999999988 4779999987643210 1123567899999998874
Q ss_pred -eeeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC
Q 004388 460 -LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN 538 (757)
Q Consensus 460 -iv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~ 538 (757)
++..++. ...++||||++|++|...... .....++.+++.++.++|..+ |+||||||+|||++.+
T Consensus 96 ~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~ 161 (198)
T cd05144 96 PVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCC
Confidence 4444443 344899999999999765321 234578899999999999987 9999999999999999
Q ss_pred CceEEeeecCccccCC
Q 004388 539 LVSKIGDVGLSTMLNS 554 (757)
Q Consensus 539 ~~~KL~DFGla~~~~~ 554 (757)
+.++|+|||++.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.63 E-value=4e-15 Score=142.36 Aligned_cols=117 Identities=44% Similarity=0.682 Sum_probs=100.9
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
++||||.++....+++.+. .+....+....++++++++.++...|...|+.++.+++++++++++|++++.+
T Consensus 30 l~ll~v~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~g~~~~~~I~~~a~~ 101 (146)
T cd01989 30 IVLVHVHPPITSIPSSSGK--------LEVASAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVAD 101 (146)
T ss_pred EEEEEeccCcccCCCCccc--------hHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCeEEEEEEeCCcHHHHHHHHHHH
Confidence 5789998876554444332 12345566777788999999999999999999999999998999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEecC
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 125 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~kg 125 (757)
+++|.||||+++++.+.+.+.+++++..|++.+|.+|+|+||++|
T Consensus 102 ~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 102 HGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred cCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 999999999999999999887678999999999999999999998
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.8e-15 Score=141.25 Aligned_cols=132 Identities=23% Similarity=0.224 Sum_probs=111.4
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCC--CceeeecccccC--CceEEEEecCCCCH
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH--PHLLLLLGACPD--HGCLVYEYMENGSL 483 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H--pniv~l~g~~~~--~~~LV~Ey~~~gsL 483 (757)
...||.|+++.||++...+..+++|....... ...+.+|+.++..++| ++++++++++.. ..+++|||++|+.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 46799999999999999888999999866543 5678899999999976 588888887754 45899999998877
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
..+ +......++.+++.+|.+||.....+++|+||+|.|||++.++.++++|||++..
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4456778899999999999987545699999999999999999999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.1e-15 Score=148.22 Aligned_cols=137 Identities=18% Similarity=0.205 Sum_probs=96.3
Q ss_pred ceeeccCCcEEEEEEEEC-CeEEEEEEEccCCch--hhHHH----------------------HHHHHHHHhcCCCc--e
Q 004388 408 NLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI--QNKQF----------------------LQELEVLSKIRHPH--L 460 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~--~~~~f----------------------~~Ev~il~~l~Hpn--i 460 (757)
.+.||+|+||.||+|... +..||||++...... ....+ ..|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 356999999999999886 779999998754221 11111 34566666664432 3
Q ss_pred eeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCC
Q 004388 461 LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL 539 (757)
Q Consensus 461 v~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~ 539 (757)
...+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+||||||+|||++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 333332 345899999998543221111100 00 4567899999999999999 77 99999999999999 99
Q ss_pred ceEEeeecCccccCC
Q 004388 540 VSKIGDVGLSTMLNS 554 (757)
Q Consensus 540 ~~KL~DFGla~~~~~ 554 (757)
.++|+|||.+.....
T Consensus 152 ~~~liDfg~a~~~~~ 166 (187)
T cd05119 152 KVYIIDVPQAVEIDH 166 (187)
T ss_pred cEEEEECcccccccC
Confidence 999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.8e-16 Score=129.85 Aligned_cols=69 Identities=42% Similarity=0.878 Sum_probs=60.1
Q ss_pred CCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHHhhC
Q 004388 689 PPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757 (757)
Q Consensus 689 ~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~~ 757 (757)
.|..|.|||+.++|.||+++.+|+|||+.+|+.||.. +.+||+|+.++.+.+|+||++||++|++|+.+
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~ 70 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAE 70 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHH
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHH
Confidence 3789999999999999999999999999999999998 99999999999999999999999999999863
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.7e-14 Score=149.88 Aligned_cols=133 Identities=18% Similarity=0.198 Sum_probs=104.5
Q ss_pred ceeec-cCCcEEEEEEEECCeEEEEEEEccCC-------------chhhHHHHHHHHHHHhcCCCce--eeecccccC--
Q 004388 408 NLRIG-MGGYGTVYKGTFHHTFAAVKVLQSKG-------------NIQNKQFLQELEVLSKIRHPHL--LLLLGACPD-- 469 (757)
Q Consensus 408 ~~~IG-~G~~G~Vyk~~~~~~~vAvK~l~~~~-------------~~~~~~f~~Ev~il~~l~Hpni--v~l~g~~~~-- 469 (757)
...|| .||.|+||++...+..++||.+.... ......+.+|++++.+|.|+++ +..++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34688 89999999999988899999875321 1223567889999999998775 566665322
Q ss_pred ----CceEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEe
Q 004388 470 ----HGCLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544 (757)
Q Consensus 470 ----~~~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~ 544 (757)
..++||||++| .+|.+++... +++.. .+.+|+.+|.+||..+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 12599999997 6898887432 24432 3678999999999988 9999999999999999999999
Q ss_pred eecCccc
Q 004388 545 DVGLSTM 551 (757)
Q Consensus 545 DFGla~~ 551 (757)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.8e-15 Score=170.48 Aligned_cols=248 Identities=19% Similarity=0.243 Sum_probs=178.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCC--chhhHHHHHHHHHHHhcC-CCceeeecccccCC--ceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIR-HPHLLLLLGACPDH--GCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~--~~LV 474 (757)
..|.....||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++...+. .+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666777999999999887652 2356666554332 222333455788777777 99999999988554 4789
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCcccc
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH-NTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTML 552 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~ 552 (757)
++|..||++.+.+.. ......+....-.++.|+..+|.|+| ..+ +.||||||+|.+++..+ .+|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999887731 11213445566788999999999999 766 99999999999999999 9999999999887
Q ss_pred CC-CCCCccccccccCCcc-cccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 553 NS-DPSFVSTTYKNTGPVG-TLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 553 ~~-~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
.. .... ......+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+....... +........
T Consensus 176 ~~~~g~~----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~ 246 (601)
T KOG0590|consen 176 RNKNGAE----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSN 246 (601)
T ss_pred cccCCcc----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeeccc
Confidence 76 3221 12234577 999999998876 456788999999999999999999997443222 111111111
Q ss_pred h-c-CC-CChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 630 Q-A-GD-WPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 630 ~-~-~~-~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
. . .. ...........++.+++..+|..|.+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhccccccc
Confidence 1 0 01 112345667888899999999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=147.92 Aligned_cols=137 Identities=19% Similarity=0.193 Sum_probs=98.3
Q ss_pred eeeccCCcEEEEEEEE-CCeEEEEEEEccCCchhh----------------------------------------HHHHH
Q 004388 409 LRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQN----------------------------------------KQFLQ 447 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~-~~~~vAvK~l~~~~~~~~----------------------------------------~~f~~ 447 (757)
..||.|++|.||+|++ +|+.||||+.++...... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 478999999876421100 02455
Q ss_pred HHHHHHhcC-----CCce--eeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHhhCC
Q 004388 448 ELEVLSKIR-----HPHL--LLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS-ALAFLHNTK 519 (757)
Q Consensus 448 Ev~il~~l~-----Hpni--v~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 519 (757)
|...+.+++ +|++ .+.+..+....+|||||++|++|.+.+...... . .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666652 3332 233333344568999999999998876432211 2 23456666666 467889877
Q ss_pred CCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 520 ~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
++|+|++|.||+++.++.++|+|||++..++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.3e-13 Score=128.79 Aligned_cols=130 Identities=20% Similarity=0.156 Sum_probs=100.3
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCce-eeecccccCCceEEEEecCCCCHHHHH
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-LLLLGACPDHGCLVYEYMENGSLEDRL 487 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpni-v~l~g~~~~~~~LV~Ey~~~gsL~~~L 487 (757)
..|+.|.++.||++...+..+++|+...... ....+..|+.++..+.+.++ .+++.+..+..++||||++|.++.+.
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~- 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE- 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc-
Confidence 4689999999999999999999999765432 12346789999998865443 45566656667999999999887643
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 488 YRKNNTPPIPWFERYRIAWEVASALAFLHNTK--PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 488 ~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
. . ....++.+++.+|..||..+ +..++|||++|.||+++ ++.++|+|||.+..
T Consensus 82 ---~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 ---D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ---c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 1 11345679999999999987 34479999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.1e-13 Score=136.19 Aligned_cols=201 Identities=25% Similarity=0.336 Sum_probs=138.6
Q ss_pred HHHHhcCCCceeeecccccCCc-------eEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 004388 450 EVLSKIRHPHLLLLLGACPDHG-------CLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPK 521 (757)
Q Consensus 450 ~il~~l~Hpniv~l~g~~~~~~-------~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~ 521 (757)
.-|-++-|-|||++..||.+.. .++.|||..|+|..+|.+. .....+......+|+.||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455667999999999996543 5889999999999999863 23344666777899999999999999998 5
Q ss_pred CEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcc-ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHH
Q 004388 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 600 (757)
Q Consensus 522 ~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~e 600 (757)
||+|+++...-|++..+|-+||.--.....- ..... .........|-++|.+||+-.....+.++|||+||...++
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h---~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH---PSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccc---hhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 7999999999999999999988532211110 00001 1111122356789999998877788889999999999999
Q ss_pred HHhCCCC-ccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 601 LLTAKPA-IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 601 lltG~~P-f~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|..|..- -.....+ .....+...+-..-. ..=+.++.+|++-.|..||++..++
T Consensus 275 mailEiq~tnseS~~---~~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 275 MAILEIQSTNSESKV---EVEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HHHheeccCCCccee---ehhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhh
Confidence 9887522 1111111 111222222211111 1124577899999999999998644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=8.5e-12 Score=139.41 Aligned_cols=243 Identities=22% Similarity=0.254 Sum_probs=171.5
Q ss_pred CCccceeecc--CCcEEEEEEEE----CCeEEEEEEEccC--CchhhHHHHHHHHHHHhcC-CCceeeecccccCCc--e
Q 004388 404 SFSENLRIGM--GGYGTVYKGTF----HHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--C 472 (757)
Q Consensus 404 ~f~~~~~IG~--G~~G~Vyk~~~----~~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~ 472 (757)
.|.....+|. |.+|.||.+.. ....+|+|.-+.. .......=.+|+....+++ |+|.++.+..+.+.. +
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556677999 99999999876 2347888873322 2223333346777777775 999999888887665 6
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeec
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS----ALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVG 547 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFG 547 (757)
+-.|++ +.+|..+...... -++......+..+... ||.++|+.+ ++|-|+||.||++..+ ..++++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 667777 4788777655443 2566677777788888 999999988 9999999999999999 889999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc-chhhhhhchhhHHHH
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT-HKVETAIDEDNLAEI 626 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~-~~~~~~~~~~~l~~~ 626 (757)
+...+.+..-. ..........|...|++||..+ +.++...|+|+||.++++..+|....... ...+..++...+.
T Consensus 269 ~v~~i~~~~~~-~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip-- 344 (524)
T KOG0601|consen 269 LVSKISDGNFS-SVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP-- 344 (524)
T ss_pred eeEEccCCccc-cceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc--
Confidence 99887765421 1112223447888999999765 56889999999999999999987654321 1222222222111
Q ss_pred hhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 627 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 627 ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.++.......+...+..++..+|..|++.+
T Consensus 345 -----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 345 -----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred -----hhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 011112245566688899999999998876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.4e-11 Score=136.04 Aligned_cols=142 Identities=18% Similarity=0.148 Sum_probs=91.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchh----------------------------------hH--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ----------------------------------NK-- 443 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~----------------------------------~~-- 443 (757)
...|+. ..||.|++|.||+|+++ |+.||||+.++..... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 334655 67999999999999985 6799999997652110 01
Q ss_pred ----HHHHHHHHHHhcC----CCceeeeccc---ccCCceEEEEecCCCCHHHHH--hhcCCC-CCCCHHHHHHHHHHHH
Q 004388 444 ----QFLQELEVLSKIR----HPHLLLLLGA---CPDHGCLVYEYMENGSLEDRL--YRKNNT-PPIPWFERYRIAWEVA 509 (757)
Q Consensus 444 ----~f~~Ev~il~~l~----Hpniv~l~g~---~~~~~~LV~Ey~~~gsL~~~L--~~~~~~-~~l~~~~~~~i~~qia 509 (757)
+|.+|+..+.+++ +.+.+.+-.. +....+|||||+.|+.|.+.- ...+.. ..+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 2445555555552 3333333333 334568999999999998742 222210 01211112222223
Q ss_pred HHHHHHhhCCCCCEEEcCCCCCCeeecCCC----ceEEeeecCccccCC
Q 004388 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVGLSTMLNS 554 (757)
Q Consensus 510 ~aL~~LH~~~~~~ivHrDLKp~NILld~~~----~~KL~DFGla~~~~~ 554 (757)
+...| ++|+|+||.||+++.+| .++++|||++..++.
T Consensus 276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33445 99999999999999888 999999999987764
|
|
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-11 Score=97.50 Aligned_cols=62 Identities=47% Similarity=0.976 Sum_probs=60.3
Q ss_pred ccCccchhcccCCcccCCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHH
Q 004388 693 FICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDW 754 (757)
Q Consensus 693 ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w 754 (757)
++|||.+++|.||++...|++|++..|..|+..+.+||+|+.++...+|+||++||++|++|
T Consensus 2 ~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 2 FLCPISLEVMKDPVILPSGQTYERRAIEKWLLSHGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred cCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHHCCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 68999999999999999999999999999999888999999999999999999999999999
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.2e-10 Score=110.09 Aligned_cols=128 Identities=28% Similarity=0.379 Sum_probs=102.0
Q ss_pred eeccCCcEEEEEEEECCeEEEEEEEccCC--------chhhHHHHHHHHHHHhcC--CCceeeecccccCCceEEEEecC
Q 004388 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKG--------NIQNKQFLQELEVLSKIR--HPHLLLLLGACPDHGCLVYEYME 479 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~--------~~~~~~f~~Ev~il~~l~--Hpniv~l~g~~~~~~~LV~Ey~~ 479 (757)
.+++|+-+.+|.+.+.+..+.+|.=.+.. .....+-.+|..+|.+++ -=+...++.+.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 47899999999998888777777643321 112344678999999885 34556777777888899999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
|..|.+.+... +..++..+-.-+.-||..+ |||+||.++||++..++ +.++||||+..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888543 2467788888899999998 99999999999998765 89999999874
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4e-10 Score=112.78 Aligned_cols=136 Identities=18% Similarity=0.142 Sum_probs=96.5
Q ss_pred eeeccCCcEEEEEEEEC--------CeEEEEEEEccCCc----------------------hhhHHHH----HHHHHHHh
Q 004388 409 LRIGMGGYGTVYKGTFH--------HTFAAVKVLQSKGN----------------------IQNKQFL----QELEVLSK 454 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~--------~~~vAvK~l~~~~~----------------------~~~~~f~----~Ev~il~~ 454 (757)
..||.|--+.||.|... +..+|||+.+.... .....+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 36899999999999764 36899999753210 0112233 79999998
Q ss_pred cCC--CceeeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhCCCCCEEEcCCCCC
Q 004388 455 IRH--PHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL-HNTKPKPIIHRDMKPG 531 (757)
Q Consensus 455 l~H--pniv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivHrDLKp~ 531 (757)
+.. -++...+++ ...+|||||+.++.+.....+. ..++......+..+++.+|..| |..+ ||||||+|.
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 852 345555543 5678999999765442211111 1244445667889999999999 7877 999999999
Q ss_pred CeeecCCCceEEeeecCccccC
Q 004388 532 NILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 532 NILld~~~~~KL~DFGla~~~~ 553 (757)
|||++ ++.+.|+|||.+-...
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4679999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.1e-09 Score=123.82 Aligned_cols=162 Identities=19% Similarity=0.229 Sum_probs=120.4
Q ss_pred CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHH
Q 004388 425 HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY 502 (757)
Q Consensus 425 ~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~ 502 (757)
.+.+|.|.+.............+-+..|+.++||||++++..+.... |||.|-+. .|..++...+ .....
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHHHH
Confidence 35578888776654434455677889999999999999999987666 99999984 6777776543 34667
Q ss_pred HHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc
Q 004388 503 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582 (757)
Q Consensus 503 ~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 582 (757)
-.+.||+.||.|||..+ .++|++|.-+.|+|+..|..||++|-++........ ......---.|..|+....
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCc
Confidence 78899999999999765 399999999999999999999999998865443221 0011111223556654322
Q ss_pred CCCCCcchhhhHHHHHHHHHhC
Q 004388 583 GLISPKSDVYAYGMVILQLLTA 604 (757)
Q Consensus 583 ~~~s~ksDvwSlGvil~elltG 604 (757)
.. -..|.|-|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 21 346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.4e-10 Score=115.30 Aligned_cols=139 Identities=24% Similarity=0.287 Sum_probs=107.2
Q ss_pred eeeccCCcEEEEEEEECC-eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCC--CceeeecccccC-----CceEEEEecC
Q 004388 409 LRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRH--PHLLLLLGACPD-----HGCLVYEYME 479 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H--pniv~l~g~~~~-----~~~LV~Ey~~ 479 (757)
..||.|.++.||++...+ ..+++|+...... .....+.+|++++..+.+ .++.+++.++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998876 7899998765432 134568899999999975 345667777655 3489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC----------------------------------------
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK---------------------------------------- 519 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~---------------------------------------- 519 (757)
|++|.+.+.. ..++...+..++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 23666677788888888888888531
Q ss_pred -------------CCCEEEcCCCCCCeeecC--CCceEEeeecCccc
Q 004388 520 -------------PKPIIHRDMKPGNILLDH--NLVSKIGDVGLSTM 551 (757)
Q Consensus 520 -------------~~~ivHrDLKp~NILld~--~~~~KL~DFGla~~ 551 (757)
+..++|+|+.|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 256899999999999998 67789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.4e-11 Score=141.96 Aligned_cols=248 Identities=19% Similarity=0.225 Sum_probs=169.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEECCe--EEEEEEEccCCch---hhHHHHHHHHHHHhcCCCceeeeccc--ccCCceE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCL 473 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~~~---~~~~f~~Ev~il~~l~Hpniv~l~g~--~~~~~~L 473 (757)
..+.|....-+-.|.++.++...-.++ ..+.|+....... ..+....+-.++-..+||-++..+-. |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 344566666778899999987654332 3344443322111 12223334444444567888877665 4566699
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|++|+.|++|...|+..+ +.+.......+..+..+++|||... ++|+|++|.|+|...+|+.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999887654 2333334456678899999999987 8999999999999999999999999543322
Q ss_pred CCC---CC--------------------cc--ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCc
Q 004388 554 SDP---SF--------------------VS--TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 608 (757)
Q Consensus 554 ~~~---~~--------------------~~--~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 608 (757)
.-. .. .. .........||+.|.+||...+......+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 110 00 00 001234468999999999999999999999999999999999999999
Q ss_pred cccchhhhhhchhhHHHHhhhhcCCCC---hhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 609 AITHKVETAIDEDNLAEILDAQAGDWP---IKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 609 ~~~~~~~~~~~~~~l~~~ld~~~~~~p---~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.....-. ..+-+-.....|| ...+.....++.+.+..+|.+|-.+.
T Consensus 1036 na~tpq~-------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ-------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhh-------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 6432211 1111122223344 45677889999999999999997765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=3e-09 Score=113.87 Aligned_cols=258 Identities=19% Similarity=0.226 Sum_probs=169.6
Q ss_pred ccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceee--------ecccccCC-ceEEE
Q 004388 406 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLL--------LLGACPDH-GCLVY 475 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~--------l~g~~~~~-~~LV~ 475 (757)
...+.||+||-+.+|-.---...|| |+.+........+ -++.|... .||-+-. |+|.-... ..+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhhchhh-eeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 3456799999999995422222333 6665443322222 23334433 4554332 22222222 25677
Q ss_pred EecCCCC-HHHHHh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 476 EYMENGS-LEDRLY---RKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 476 Ey~~~gs-L~~~L~---~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
..+.|.. +.+++. +....+...|.-.++++..++.+.+-||..| .+-||+.++|||+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 7776642 233222 3445566899999999999999999999998 88999999999999999999987543222
Q ss_pred cCCCCCCccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhC-CCCcccc-------chhhhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTA-KPAIAIT-------HKVETAI 618 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG-~~Pf~~~-------~~~~~~~ 618 (757)
..++. .....+|.+.|.+||.+. +..-+...|.|.||+++++||.| ++||... ...+..+
T Consensus 167 ~~ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 167 NANGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred ccCCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 21111 124568999999999765 23456789999999999999987 9999632 2334445
Q ss_pred chhhHHHHhhhhc------CCCChh-HHHHHHHHHHHHhhc--cCCCCCccchhhhhHHHHHHHhhhcc
Q 004388 619 DEDNLAEILDAQA------GDWPIK-ETKELAALGLSCAEL--RRKDRPDLKNQVLPVLERLKEVADRA 678 (757)
Q Consensus 619 ~~~~l~~~ld~~~------~~~p~~-~~~~l~~Li~~Cl~~--~p~~RPs~~~~vl~~L~~l~~~~~~~ 678 (757)
..+.+...-+... ..||.. .++.+..|..+|+.. .+.-||+.+ .-+..|..+...+..+
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~-aW~aAl~al~~~L~~C 307 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK-AWVAALDALRQQLKKC 307 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHHHHhhhhh
Confidence 5555544444332 345543 467889999999985 367899987 6777888777666554
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=9e-10 Score=104.93 Aligned_cols=109 Identities=10% Similarity=0.125 Sum_probs=84.3
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
++||||.++....... . .. ...+.|....++..++.|.++.......+++++..+.+| ++++.|++++.+
T Consensus 34 l~llhv~~~~~~~~~~--~-~~------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~v~~~v~~G-~~~~~I~~~a~~ 103 (142)
T PRK15456 34 IHLLHVLPGSASLSLH--R-FA------ADVRRFEEHLQHEAEERLQTMVSHFTIDPSRIKQHVRFG-SVRDEVNELAEE 103 (142)
T ss_pred EEEEEEecCccccccc--c-cc------cchhhHHHHHHHHHHHHHHHHHHHhCCCCcceEEEEcCC-ChHHHHHHHHhh
Confidence 5799999875322111 1 00 112345666677788888888887776788899888877 999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEe
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVE 123 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~ 123 (757)
+++|.||||+++++ +.+.| .|+++..|+++++ |+|.||.
T Consensus 104 ~~~DLIVmG~~g~~-~~~~l-lGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 104 LGADVVVIGSRNPS-ISTHL-LGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred cCCCEEEEcCCCCC-cccee-cCccHHHHHHcCC--CCEEEeC
Confidence 99999999999976 66655 4999999999999 9999973
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-10 Score=129.60 Aligned_cols=236 Identities=21% Similarity=0.232 Sum_probs=164.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCCchhhHHH--HHHHHHHHhc-CCCceeeeccccc--CCceE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQF--LQELEVLSKI-RHPHLLLLLGACP--DHGCL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~~~~~~~f--~~Ev~il~~l-~Hpniv~l~g~~~--~~~~L 473 (757)
+.+|..+..||.|.|+.||.+..+ +..|++|-+.........+. ..|+-+...+ -|.|++.++..|. ++.++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 446888999999999999987643 55888887765543332222 4566666666 4888888777664 34588
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCcccc
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTML 552 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla~~~ 552 (757)
-.|||.++++...+.... -+....++++..+++.++.++|+.. ++|+|+||+||++..+ +..+++|||....+
T Consensus 344 p~e~~~~~s~~l~~~~~~---~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTSQ---MLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhhHHHH---hcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 889999999887663222 2555677889999999999999877 9999999999999876 88899999998643
Q ss_pred CCCCCCccccccccCCcccccC-CCccccccCCCCCcchhhhHHHHHHHHHhCCCCcc-ccchhhhhhchhhHHHHhhhh
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCY-IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA-ITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~-~~~~~~~~~~~~~l~~~ld~~ 630 (757)
.-.. .....++..| .+|.......+..+.|+||||..+.+.+||.+--. ..++. .+....
T Consensus 418 ~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~----------~i~~~~ 479 (524)
T KOG0601|consen 418 AFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL----------TIRSGD 479 (524)
T ss_pred ceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce----------eeeccc
Confidence 2110 1112233344 36666667778899999999999999999974221 11110 011111
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... .......+..+...+...++..||.+.+
T Consensus 480 ~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~ 510 (524)
T KOG0601|consen 480 TPN-LPGLKLQLQVLLKVMINPDRKRRPSAVE 510 (524)
T ss_pred ccC-CCchHHhhhhhhhhhcCCccccchhhhh
Confidence 111 1223377788888899999999998763
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.5e-09 Score=101.69 Aligned_cols=141 Identities=24% Similarity=0.284 Sum_probs=102.6
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEccC--------CchhhHHHHHHHHHHHhcCCCc--eeeecccccCCceEEEE
Q 004388 407 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSK--------GNIQNKQFLQELEVLSKIRHPH--LLLLLGACPDHGCLVYE 476 (757)
Q Consensus 407 ~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~--------~~~~~~~f~~Ev~il~~l~Hpn--iv~l~g~~~~~~~LV~E 476 (757)
....|-+|+-+.|+++.+.|....||.-... ......+..+|+.+|.+++--. ...++-.-....+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4456889999999999999998888853222 1123456788999999885322 22333333456689999
Q ss_pred ecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---CceEEeeecCccc
Q 004388 477 YMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTM 551 (757)
Q Consensus 477 y~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~---~~~KL~DFGla~~ 551 (757)
|++| .++.+++.........+ .....++..|-..+.-||..+ ||||||..+||+|..+ ..+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9986 47888887654433222 223578889999999999998 9999999999999654 3458999999864
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=8.8e-09 Score=98.05 Aligned_cols=81 Identities=15% Similarity=0.094 Sum_probs=67.2
Q ss_pred HHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCc
Q 004388 38 EKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFC 117 (757)
Q Consensus 38 ~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C 117 (757)
.+++.++.+..+...+...++.+++.+.+| ++++.|++++.++++|.||||++ ++++.+.+. |+++..|++++| |
T Consensus 64 ~~~~~~~~l~~~~~~~~~~~~~~~~~v~~G-~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~ll-GS~a~~vl~~a~--c 138 (144)
T PRK15005 64 LKAEAKSQLEEIIKKFKLPTDRVHVHVEEG-SPKDRILELAKKIPADMIIIASH-RPDITTYLL-GSNAAAVVRHAE--C 138 (144)
T ss_pred HHHHHHHHHHHHHHHhCCCCCceEEEEeCC-CHHHHHHHHHHHcCCCEEEEeCC-CCCchheee-cchHHHHHHhCC--C
Confidence 344556667777766677788888888877 89999999999999999999998 457777664 899999999999 9
Q ss_pred eEEEEe
Q 004388 118 TVYGVE 123 (757)
Q Consensus 118 ~V~vv~ 123 (757)
+|+||.
T Consensus 139 pVlvVr 144 (144)
T PRK15005 139 SVLVVR 144 (144)
T ss_pred CEEEeC
Confidence 999983
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.2e-08 Score=94.52 Aligned_cols=77 Identities=23% Similarity=0.280 Sum_probs=66.7
Q ss_pred HHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhC-CCCceE
Q 004388 41 KTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICV-PSFCTV 119 (757)
Q Consensus 41 ~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~a-p~~C~V 119 (757)
+.++.++.+..++...++. ..++.+.+++++|++++.+++++.||||+++++.+.+.+. ++++..|+.++ + |+|
T Consensus 46 ~~~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~-Gs~~~~v~~~a~~--~~v 120 (124)
T cd01987 46 AERRRLAEALRLAEELGAE--VVTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFR-GSLVDRLLRRAGN--IDV 120 (124)
T ss_pred HHHHHHHHHHHHHHHcCCE--EEEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhc-ccHHHHHHHhCCC--CeE
Confidence 3456788888888887764 4466778999999999999999999999999999999875 89999999999 6 999
Q ss_pred EEE
Q 004388 120 YGV 122 (757)
Q Consensus 120 ~vv 122 (757)
+|+
T Consensus 121 ~v~ 123 (124)
T cd01987 121 HIV 123 (124)
T ss_pred EEe
Confidence 997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.4e-08 Score=93.17 Aligned_cols=81 Identities=16% Similarity=0.216 Sum_probs=73.4
Q ss_pred HHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCce
Q 004388 39 KWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCT 118 (757)
Q Consensus 39 ~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~ 118 (757)
.+..++++..+..++...|+.++.+++.+.+++++|++++.++++|.||||+.+.+.+.+.+. ++++..|++.++ |+
T Consensus 51 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~l-Gs~~~~v~~~~~--~p 127 (132)
T cd01988 51 VQRARKLLRQAERIAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLF-GGVIDQVLESAP--CD 127 (132)
T ss_pred HHHHHHHHHHHHHHhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceec-CchHHHHHhcCC--CC
Confidence 456788999999999999999999888777999999999999999999999999998877664 889999999999 99
Q ss_pred EEEE
Q 004388 119 VYGV 122 (757)
Q Consensus 119 V~vv 122 (757)
|.||
T Consensus 128 vlvv 131 (132)
T cd01988 128 VAVV 131 (132)
T ss_pred EEEe
Confidence 9987
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-07 Score=98.84 Aligned_cols=133 Identities=15% Similarity=0.032 Sum_probs=95.1
Q ss_pred CcEEEEEEEECCeEEEEEEEccCCch-----------hhHHHHHHHHHHHhcC-----CCceeeeccc--c--cCCceEE
Q 004388 415 GYGTVYKGTFHHTFAAVKVLQSKGNI-----------QNKQFLQELEVLSKIR-----HPHLLLLLGA--C--PDHGCLV 474 (757)
Q Consensus 415 ~~G~Vyk~~~~~~~vAvK~l~~~~~~-----------~~~~f~~Ev~il~~l~-----Hpniv~l~g~--~--~~~~~LV 474 (757)
....|+++.+.+..+.||........ ....+.+|...+.+|. -|.+|-+... . ....+||
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 33447788888899999976433211 1114778998888774 3433333211 1 1234899
Q ss_pred EEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-------CCceEEeee
Q 004388 475 YEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------NLVSKIGDV 546 (757)
Q Consensus 475 ~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-------~~~~KL~DF 546 (757)
+|++++. +|.+++..... .+.+...+..++.+++..+.-||..| |+|+||++.|||++. ++.+.|+||
T Consensus 114 te~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl 189 (268)
T PRK15123 114 TEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL 189 (268)
T ss_pred EeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence 9999986 89998753221 23455667789999999999999998 999999999999975 478999999
Q ss_pred cCccc
Q 004388 547 GLSTM 551 (757)
Q Consensus 547 Gla~~ 551 (757)
+.+..
T Consensus 190 ~r~~~ 194 (268)
T PRK15123 190 HRAQI 194 (268)
T ss_pred Ccccc
Confidence 98863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.1e-07 Score=102.45 Aligned_cols=163 Identities=20% Similarity=0.276 Sum_probs=124.5
Q ss_pred EEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC------CceEEEEecCC-CCHHHHH
Q 004388 417 GTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGCLVYEYMEN-GSLEDRL 487 (757)
Q Consensus 417 G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~~~LV~Ey~~~-gsL~~~L 487 (757)
.+.|++.. +|..|++|.++.+..........=++.++++.|+|+|+|..++.. ..+|||+|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56788875 577899999965544443334456889999999999999988752 12799999886 5787766
Q ss_pred hhcC------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 488 YRKN------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 488 ~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
+... .....++...+.++.|+..||.++|+.| +..+-|.|.+||++.+.+++|+.-|+.-.+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 5321 1234677888999999999999999998 888999999999999999999988887766543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~ 605 (757)
.. +-+. --.+-|.=.||.+++.|.||.
T Consensus 447 ~~--------------------~~le---~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 447 PT--------------------EPLE---SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CC--------------------cchh---HHhhhhHHHHHHHHHHHhhcc
Confidence 21 1011 123678999999999999995
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.1e-08 Score=96.24 Aligned_cols=125 Identities=20% Similarity=0.199 Sum_probs=79.5
Q ss_pred EEEEEEE-CCeEEEEEEEccCCch--------------------------hhHHHHHHHHHHHhcCCC--ceeeeccccc
Q 004388 418 TVYKGTF-HHTFAAVKVLQSKGNI--------------------------QNKQFLQELEVLSKIRHP--HLLLLLGACP 468 (757)
Q Consensus 418 ~Vyk~~~-~~~~vAvK~l~~~~~~--------------------------~~~~f~~Ev~il~~l~Hp--niv~l~g~~~ 468 (757)
.||.|.. ++..+|||+.+..... ......+|...|.++..- ++...+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899887 5779999997542110 012356899999999754 44555543
Q ss_pred CCceEEEEecC--CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhhCCCCCEEEcCCCCCCeeecCCCceEEee
Q 004388 469 DHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF-LHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545 (757)
Q Consensus 469 ~~~~LV~Ey~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~ivHrDLKp~NILld~~~~~KL~D 545 (757)
...+|||||++ |..+..+. ... ++......++.+++..+.. +|..+ |+||||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35689999998 65554432 211 1122445677788885555 57877 9999999999999988 899999
Q ss_pred ecCccccC
Q 004388 546 VGLSTMLN 553 (757)
Q Consensus 546 FGla~~~~ 553 (757)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99986544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.9e-08 Score=91.67 Aligned_cols=106 Identities=11% Similarity=0.098 Sum_probs=75.0
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
|+||||.++..... +. ..++ . .+.+.+..++..++.+.++...+.. ..++..+..| +|++.|+++|.+
T Consensus 34 l~llhV~~~~~~~~-~~-~~~~----~---~~~~~~~~~~~~~~~l~~~~~~~~~--~~~~~~v~~G-~p~~~I~~~A~~ 101 (142)
T PRK09982 34 LTLIHIDDGLSELY-PG-IYFP----A---TEDILQLLKNKSDNKLYKLTKNIQW--PKTKLRIERG-EMPETLLEIMQK 101 (142)
T ss_pred EEEEEEccCcchhc-hh-hhcc----c---hHHHHHHHHHHHHHHHHHHHHhcCC--CcceEEEEec-CHHHHHHHHHHH
Confidence 57999987643211 10 0000 0 1223444555667777777766543 3456666665 999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEec
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEK 124 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~k 124 (757)
.++|.||||++ ++++.+.+ + ++..|+++++ |+|+||..
T Consensus 102 ~~aDLIVmG~~-~~~~~~~~--~-va~~V~~~s~--~pVLvv~~ 139 (142)
T PRK09982 102 EQCDLLVCGHH-HSFINRLM--P-AYRGMINKMS--ADLLIVPF 139 (142)
T ss_pred cCCCEEEEeCC-hhHHHHHH--H-HHHHHHhcCC--CCEEEecC
Confidence 99999999986 88888887 4 9999999999 99999863
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=8.7e-08 Score=91.01 Aligned_cols=105 Identities=12% Similarity=0.140 Sum_probs=77.1
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
+.+|||.++..+.. . ......+.+.+..+++.++.|..+ +.+.|+..+.+++...+++++|++++.+
T Consensus 34 l~ll~v~~~~~~~~----~------~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~G~~~~~I~~~a~~ 100 (142)
T PRK10116 34 ISLITLASDPEMYN----Q------FAAPMLEDLRSVMQEETQSFLDKL---IQDADYPIEKTFIAYGELSEHILEVCRK 100 (142)
T ss_pred EEEEEEccCcccch----h------hhHHHHHHHHHHHHHHHHHHHHHH---HHhcCCCeEEEEEecCCHHHHHHHHHHH
Confidence 46889976543211 1 112223455555555666665554 4567887766666667999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEe
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVE 123 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~ 123 (757)
.++|.||||+++++++.+.+ +++..|++.++ |+|+||.
T Consensus 101 ~~~DLiV~g~~~~~~~~~~~---s~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 101 HHFDLVICGNHNHSFFSRAS---CSAKRVIASSE--VDVLLVP 138 (142)
T ss_pred hCCCEEEEcCCcchHHHHHH---HHHHHHHhcCC--CCEEEEe
Confidence 99999999999998888874 57999999999 9999985
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.1e-07 Score=88.74 Aligned_cols=80 Identities=13% Similarity=0.194 Sum_probs=59.9
Q ss_pred HHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCC
Q 004388 35 KQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP 114 (757)
Q Consensus 35 ~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap 114 (757)
.+...++.++.+.. ++.+.|+.+...++...++++.|+++|.++++|.||||+++ +.+ +.+ ++++..|+++|+
T Consensus 59 ~~~~~~~~~~~l~~---~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~-~~l--gSva~~v~~~a~ 131 (144)
T PRK15118 59 QKRISEETHHALTE---LSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-DFW-SKL--MSSARQLINTVH 131 (144)
T ss_pred HHHHHHHHHHHHHH---HHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-cHH-HHH--HHHHHHHHhhCC
Confidence 33333344444433 44667888766666555999999999999999999999996 333 444 599999999999
Q ss_pred CCceEEEEe
Q 004388 115 SFCTVYGVE 123 (757)
Q Consensus 115 ~~C~V~vv~ 123 (757)
|+|+||.
T Consensus 132 --~pVLvv~ 138 (144)
T PRK15118 132 --VDMLIVP 138 (144)
T ss_pred --CCEEEec
Confidence 9999986
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.5e-07 Score=84.30 Aligned_cols=70 Identities=24% Similarity=0.285 Sum_probs=62.5
Q ss_pred HHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEe
Q 004388 51 NMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVE 123 (757)
Q Consensus 51 ~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~ 123 (757)
..+...+......++...+++++|++++.++++|.||||+++++.+.+.+ .++++..+++++| |+|+||.
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~-~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 71 EEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLL-FGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp HHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSS-SHHHHHHHHHHTS--SEEEEEE
T ss_pred HHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCC-cCCHHHHHHHcCC--CCEEEeC
Confidence 66777777777788888899999999999999999999999998988866 5899999999999 9999973
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=98.51 E-value=6.5e-07 Score=82.29 Aligned_cols=84 Identities=24% Similarity=0.330 Sum_probs=72.2
Q ss_pred HHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCC
Q 004388 35 KQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP 114 (757)
Q Consensus 35 ~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap 114 (757)
......+.++.|.+|...|...|+.+...+..++ ++++|++++.++++|.||||+.+.+.+.+.+ .++.+..+++.++
T Consensus 47 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~-~~~~~~~ll~~~~ 124 (130)
T cd00293 47 AELLEEEARALLEALREALAEAGVKVETVVLEGD-PAEAILEAAEELGADLIVMGSRGRSGLRRLL-LGSVAERVLRHAP 124 (130)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCCCceEEEEecCC-CHHHHHHHHHHcCCCEEEEcCCCCCccceee-eccHHHHHHhCCC
Confidence 3445567789999999999889999998888774 5999999999999999999999998887765 4888999999988
Q ss_pred CCceEEEE
Q 004388 115 SFCTVYGV 122 (757)
Q Consensus 115 ~~C~V~vv 122 (757)
|+|++|
T Consensus 125 --~pvliv 130 (130)
T cd00293 125 --CPVLVV 130 (130)
T ss_pred --CCEEeC
Confidence 999875
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.8e-08 Score=111.08 Aligned_cols=150 Identities=23% Similarity=0.323 Sum_probs=104.4
Q ss_pred HHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccc---cCCcccccCCCcccccc
Q 004388 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN---TGPVGTLCYIDPEYQRT 582 (757)
Q Consensus 506 ~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~---~~~~gt~~Y~aPE~~~~ 582 (757)
.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+++-.......+.-..|.. ........|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34559999999865 49999999999999999999999999986655422221111111 11245678999999998
Q ss_pred CCCCCcchhhhHHHHHHHHH-hCCCCccccchh-hhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 583 GLISPKSDVYAYGMVILQLL-TAKPAIAITHKV-ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 583 ~~~s~ksDvwSlGvil~ell-tG~~Pf~~~~~~-~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
...++++|+|||||++|.+. .|++-+...... ...... ...+..........+.++.+=+.+.+..++.-||++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~----~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR----NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh----cccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 88999999999999999999 566554322111 111110 011112223345667888999999999999999965
Q ss_pred c
Q 004388 661 K 661 (757)
Q Consensus 661 ~ 661 (757)
.
T Consensus 260 ~ 260 (700)
T KOG2137|consen 260 D 260 (700)
T ss_pred h
Confidence 4
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.6e-07 Score=95.52 Aligned_cols=90 Identities=16% Similarity=0.111 Sum_probs=75.6
Q ss_pred HHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhh
Q 004388 33 AYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISIC 112 (757)
Q Consensus 33 ~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ 112 (757)
..++...++.++.+..+...+.+.|++++..++...+++++|++++.++++|.||||+.+.+.+.+.+. ++++..+++.
T Consensus 58 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~-gs~~~~l~~~ 136 (305)
T PRK11175 58 AMRQGVISQRTAWIREQAKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIF-TPTDWHLLRK 136 (305)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhcc-ChhHHHHHhc
Confidence 333444445667788888888888999999888666999999999999999999999999988888774 7899999999
Q ss_pred CCCCceEEEEecC
Q 004388 113 VPSFCTVYGVEKG 125 (757)
Q Consensus 113 ap~~C~V~vv~kg 125 (757)
+| |+|+||..+
T Consensus 137 ~~--~pvlvv~~~ 147 (305)
T PRK11175 137 CP--CPVLMVKDQ 147 (305)
T ss_pred CC--CCEEEeccc
Confidence 99 999999764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.4e-07 Score=89.87 Aligned_cols=105 Identities=21% Similarity=0.220 Sum_probs=78.4
Q ss_pred hHHHHHHHHHHHhcCCCc--eeeeccccc------CCceEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 004388 442 NKQFLQELEVLSKIRHPH--LLLLLGACP------DHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512 (757)
Q Consensus 442 ~~~f~~Ev~il~~l~Hpn--iv~l~g~~~------~~~~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL 512 (757)
.....+|...+.+|..-. +...+++.. ...+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 445778888887774222 222333322 1237999999984 79998865332 44456778999999999
Q ss_pred HHHhhCCCCCEEEcCCCCCCeeecCCC---ceEEeeecCcccc
Q 004388 513 AFLHNTKPKPIIHRDMKPGNILLDHNL---VSKIGDVGLSTML 552 (757)
Q Consensus 513 ~~LH~~~~~~ivHrDLKp~NILld~~~---~~KL~DFGla~~~ 552 (757)
.-||..+ |+|+|++|.|||++.++ .+.|+||+.++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999998887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.3e-06 Score=83.63 Aligned_cols=106 Identities=23% Similarity=0.238 Sum_probs=85.3
Q ss_pred HHHHHHHHhcCC-CceeeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEE
Q 004388 446 LQELEVLSKIRH-PHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524 (757)
Q Consensus 446 ~~Ev~il~~l~H-pniv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iv 524 (757)
..|.-+|..+.+ +++++++|+|.. ++|.||+..+++......-......+|..|.+||.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 358888888876 699999999944 78999998777653210001112368999999999999999999997766799
Q ss_pred EcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 525 HrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
-.|++|+|+-++++|.+|++|...+....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 99999999999999999999999876554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.3e-06 Score=94.24 Aligned_cols=84 Identities=12% Similarity=0.199 Sum_probs=64.9
Q ss_pred HHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhC
Q 004388 34 YKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICV 113 (757)
Q Consensus 34 ~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~a 113 (757)
|....+.+..+.+..+. ...|+..+..++...+++++|++++.++++|.||||+.+++.+.+.|. |+++..|+..+
T Consensus 216 ~~~~~~~~~~~~l~~~~---~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~ll-GS~a~~v~~~~ 291 (305)
T PRK11175 216 YNDAIRGQHLLAMKALR---QKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFL-GNTAEHVIDHL 291 (305)
T ss_pred HHHHHHHHHHHHHHHHH---HHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceee-cchHHHHHhcC
Confidence 44443444444444443 444676654455555899999999999999999999999999998775 89999999999
Q ss_pred CCCceEEEEe
Q 004388 114 PSFCTVYGVE 123 (757)
Q Consensus 114 p~~C~V~vv~ 123 (757)
| |+|+||.
T Consensus 292 ~--~pVLvv~ 299 (305)
T PRK11175 292 N--CDLLAIK 299 (305)
T ss_pred C--CCEEEEc
Confidence 9 9999985
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.5e-06 Score=83.48 Aligned_cols=136 Identities=16% Similarity=0.058 Sum_probs=102.0
Q ss_pred eccCCcEEEEEEEECCeEEEEEEEccC------CchhhHHHHHHHHHHHhcCCC--ceeeeccccc---CC----ceEEE
Q 004388 411 IGMGGYGTVYKGTFHHTFAAVKVLQSK------GNIQNKQFLQELEVLSKIRHP--HLLLLLGACP---DH----GCLVY 475 (757)
Q Consensus 411 IG~G~~G~Vyk~~~~~~~vAvK~l~~~------~~~~~~~f~~Ev~il~~l~Hp--niv~l~g~~~---~~----~~LV~ 475 (757)
-|+||.+.|++..+.+..+=+|.-... .......|.+|...|.+|..- ++...+ ++. .. .+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 478999999999888877878865421 133567799999999998532 233433 332 11 37999
Q ss_pred EecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc--eEEeeecCccc
Q 004388 476 EYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--SKIGDVGLSTM 551 (757)
Q Consensus 476 Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~--~KL~DFGla~~ 551 (757)
|-++| -+|.+++.... ..+.+...+..++.+|+..+.-||..+ +.|+|+.+.|||++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98864 48888875433 234566777899999999999999998 999999999999986666 89999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.7e-06 Score=98.73 Aligned_cols=138 Identities=20% Similarity=0.225 Sum_probs=91.4
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhh------------------------------H----------HHHH
Q 004388 409 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQN------------------------------K----------QFLQ 447 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~------------------------------~----------~f~~ 447 (757)
..|+.++-|.||+|++. |..||||+.++.-.... + +|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 46999999999999998 78999999876532111 0 1345
Q ss_pred HHHHHHhcC-----CCcee--eecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhhCC
Q 004388 448 ELEVLSKIR-----HPHLL--LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL-AFLHNTK 519 (757)
Q Consensus 448 Ev~il~~l~-----Hpniv--~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~ 519 (757)
|..-+.+++ .|++. ..+--+.....|+|||++|..+.+....... .++ +..|+..++.+. .-+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d---~k~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GID---RKELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCC---HHHHHHHHHHHHHHHHHhcC
Confidence 555555552 23321 2222233455899999999999887433222 233 233444444332 2222234
Q ss_pred CCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 520 ~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
++|+|..|.||+++.+|.+-+.|||+...+++
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=4e-06 Score=86.51 Aligned_cols=134 Identities=18% Similarity=0.097 Sum_probs=90.3
Q ss_pred CccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCch----------------------hhHHHHHHHHHHHhcCCC--c
Q 004388 405 FSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI----------------------QNKQFLQELEVLSKIRHP--H 459 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~----------------------~~~~f~~Ev~il~~l~Hp--n 459 (757)
.....+||-|--+.||.|... +..+|||.-+..... .+....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345578999999999999986 789999986532111 112346799999888533 3
Q ss_pred eeeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC
Q 004388 460 LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 539 (757)
Q Consensus 460 iv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~ 539 (757)
+..-+++ +..++||||++|-.|...-. .-...-.|+..|+.-+.-+-..| |||||+.+-|||++.+|
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc--ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 3333322 33479999999866654211 11222334445555444444555 99999999999999999
Q ss_pred ceEEeeecCccc
Q 004388 540 VSKIGDVGLSTM 551 (757)
Q Consensus 540 ~~KL~DFGla~~ 551 (757)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.2e-06 Score=85.53 Aligned_cols=141 Identities=22% Similarity=0.232 Sum_probs=84.6
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC--ceeeeccccc---C--CceEEEEecCCC
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGACP---D--HGCLVYEYMENG 481 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp--niv~l~g~~~---~--~~~LV~Ey~~~g 481 (757)
..|+.|..+.||+....+..+++|+.... .....+.+|+.++..+... .+..++.++. . ..+++|+|++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 56899999999999998889999997654 4456678899998888522 3445555331 1 137899999998
Q ss_pred CHHH----------------HH---hhc-CCCCCCCHHHHH---------HH------------HHHHHH-HHHHHhh--
Q 004388 482 SLED----------------RL---YRK-NNTPPIPWFERY---------RI------------AWEVAS-ALAFLHN-- 517 (757)
Q Consensus 482 sL~~----------------~L---~~~-~~~~~l~~~~~~---------~i------------~~qia~-aL~~LH~-- 517 (757)
.+.. .| +.. ....++.+.... .. ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 11 111 111122221110 00 011222 3334443
Q ss_pred --CCCCCEEEcCCCCCCeeec-CCCceEEeeecCccc
Q 004388 518 --TKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTM 551 (757)
Q Consensus 518 --~~~~~ivHrDLKp~NILld-~~~~~KL~DFGla~~ 551 (757)
..+..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 667668999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.2e-06 Score=84.19 Aligned_cols=136 Identities=17% Similarity=0.179 Sum_probs=78.7
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc--eeeecccccC--CceEEEEecCCCC-H
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--LLLLLGACPD--HGCLVYEYMENGS-L 483 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--iv~l~g~~~~--~~~LV~Ey~~~gs-L 483 (757)
..||.|..+.||+.. +..+++|...... ......+|.+++..+..-. +.+.++++.+ ...+|||+++|.. +
T Consensus 7 ~~i~~G~t~~~y~~~--~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTHK--TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEec--CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 469999999999842 4456788876533 3345688999998875322 2344544432 3368999999863 2
Q ss_pred HHH---------------------HhhcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhhC-CCCCEEEcCCC
Q 004388 484 EDR---------------------LYRKNNTPPIPWFERYR-IAW----------EVAS-ALAFLHNT-KPKPIIHRDMK 529 (757)
Q Consensus 484 ~~~---------------------L~~~~~~~~l~~~~~~~-i~~----------qia~-aL~~LH~~-~~~~ivHrDLK 529 (757)
... |+... ....+...... +.. .+.. ...+|... .+..++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 111 11100 01111111100 000 0111 12222221 12457999999
Q ss_pred CCCeeecCCCceEEeeecCcc
Q 004388 530 PGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 530 p~NILld~~~~~KL~DFGla~ 550 (757)
|.||+++.++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.2e-05 Score=76.59 Aligned_cols=87 Identities=18% Similarity=0.318 Sum_probs=75.7
Q ss_pred HHHHHHHHhHhhHHHHHHhhhcCcee-eEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhC
Q 004388 35 KQEEKWKTDRLLLPFRNMCAQRRVEV-EVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICV 113 (757)
Q Consensus 35 ~~~~~~~~~~ll~~~~~~c~~~~v~~-~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~a 113 (757)
.........+.+........+.|+.. +..+.+++.....|++++.++++|.||||+.+++.+.+.+ .++++..|+.++
T Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~l-lGsvs~~v~~~~ 143 (154)
T COG0589 65 EEELEEEAEELLAEAKALAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLL-LGSVAEKVLRHA 143 (154)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCcccccee-eehhHHHHHhcC
Confidence 34456677889999999999999984 8888888666999999999999999999999999998844 589999999999
Q ss_pred CCCceEEEEec
Q 004388 114 PSFCTVYGVEK 124 (757)
Q Consensus 114 p~~C~V~vv~k 124 (757)
+ |+|++|..
T Consensus 144 ~--~pVlvv~~ 152 (154)
T COG0589 144 P--CPVLVVRS 152 (154)
T ss_pred C--CCEEEEcc
Confidence 9 99998763
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.17 E-value=9.1e-06 Score=82.25 Aligned_cols=135 Identities=21% Similarity=0.148 Sum_probs=90.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHH---------HHHHHHHHhcCCC---ceeeecccc--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF---------LQELEVLSKIRHP---HLLLLLGAC-- 467 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f---------~~Ev~il~~l~Hp---niv~l~g~~-- 467 (757)
.++|...+.+-......|.+-..++..+.+|..+.........| .+.+..+.+++.. ....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 44566667777777788888888999999999877654333322 2344444444321 112212111
Q ss_pred -----cCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceE
Q 004388 468 -----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 542 (757)
Q Consensus 468 -----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~K 542 (757)
....+|+|||++|..|.+... ++. .++..|..++.-||..| ++|+|..|.|++++.++ ++
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EE
Confidence 122358999999988866431 221 34567788899999998 99999999999999665 88
Q ss_pred EeeecCccc
Q 004388 543 IGDVGLSTM 551 (757)
Q Consensus 543 L~DFGla~~ 551 (757)
++||+..+.
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.2e-05 Score=91.67 Aligned_cols=139 Identities=18% Similarity=0.144 Sum_probs=91.1
Q ss_pred eeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhh-------------------------------------HHHHHHHH
Q 004388 409 LRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQN-------------------------------------KQFLQELE 450 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~-------------------------------------~~f~~Ev~ 450 (757)
..||.-+.|.||+++.+ |..||||+-++.-.... -+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 45899999999999986 56899999776532110 02455555
Q ss_pred HHHhc----CCCc------eeeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC
Q 004388 451 VLSKI----RHPH------LLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520 (757)
Q Consensus 451 il~~l----~Hpn------iv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 520 (757)
-..++ .|-+ |.++|-.+.....|+||||+|..+.|.-.-... .++-.....-+.++..-.-+.|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHhc----
Confidence 44443 3555 445555556667999999999887775432222 1443433333333322222322
Q ss_pred CCEEEcCCCCCCeeec----CCCceEEeeecCccccCC
Q 004388 521 KPIIHRDMKPGNILLD----HNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 521 ~~ivHrDLKp~NILld----~~~~~KL~DFGla~~~~~ 554 (757)
+++|+|=.|.||++. .++.+.+-|||+...+..
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 399999999999998 367899999999887654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.2e-05 Score=81.75 Aligned_cols=137 Identities=18% Similarity=0.075 Sum_probs=82.2
Q ss_pred eccCCc-EEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccC--CceEEEEecCCCCHHHH
Q 004388 411 IGMGGY-GTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCLVYEYMENGSLEDR 486 (757)
Q Consensus 411 IG~G~~-G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~~~LV~Ey~~~gsL~~~ 486 (757)
|-.|.+ ..||+....+..+.||+..... ...+.+|+.++..+. +--+.++++++.. ..++||||++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 445555 7899998777778888876543 334678999988874 3334566666544 35899999999877643
Q ss_pred H-------------------hhcCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHhh----CCC
Q 004388 487 L-------------------YRKNN-TPPIPW--FERYRIAW--------------------EVASALAFLHN----TKP 520 (757)
Q Consensus 487 L-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qia~aL~~LH~----~~~ 520 (757)
. +.... ..++.. ........ .+...+..|-. ..+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 11100 001110 00010000 01111222211 122
Q ss_pred CCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 521 ~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 459999999999999998888999998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.2e-06 Score=84.70 Aligned_cols=71 Identities=35% Similarity=0.559 Sum_probs=66.3
Q ss_pred CCCCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 686 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 686 ~~~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
....|...-|-|..++|++|++..-|.||++..|+..|+. +..+|+|+.+|..-.++||++|+.+|..++.
T Consensus 205 ~rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~ 276 (284)
T KOG4642|consen 205 KREVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLK 276 (284)
T ss_pred cccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHH
Confidence 3477888889999999999999999999999999999998 9999999999999999999999999988764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.7e-05 Score=79.70 Aligned_cols=138 Identities=20% Similarity=0.215 Sum_probs=75.6
Q ss_pred eeeccCCcE-EEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC---ceeeecccccC-----CceEEEEecC
Q 004388 409 LRIGMGGYG-TVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---HLLLLLGACPD-----HGCLVYEYME 479 (757)
Q Consensus 409 ~~IG~G~~G-~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp---niv~l~g~~~~-----~~~LV~Ey~~ 479 (757)
..|+.||.. .||+. +..+.+|+.... .....+.+|.++|..+... .+...++.+.. ..+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457877776 49975 235677775442 2345688899999877521 23333433322 2378999999
Q ss_pred CCCHHHH------------------HhhcCCC-CCC-------------CHHHHH--HHH-------HHHHHH-HH-HHh
Q 004388 480 NGSLEDR------------------LYRKNNT-PPI-------------PWFERY--RIA-------WEVASA-LA-FLH 516 (757)
Q Consensus 480 ~gsL~~~------------------L~~~~~~-~~l-------------~~~~~~--~i~-------~qia~a-L~-~LH 516 (757)
|.++.+. |+..... .+. .|.... .+. .+.+.. +. +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 8766321 1111100 000 011110 000 011111 11 111
Q ss_pred h--CCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 517 N--TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 517 ~--~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
. ..+..++|+|+.|.|||++.++..-|+||+.+..
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 1 1334599999999999999877778999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.95 E-value=8.1e-05 Score=91.14 Aligned_cols=146 Identities=19% Similarity=0.223 Sum_probs=91.3
Q ss_pred ceeeccCCcEEEEEEEECC----eEEEEEEEccCCc-hhhHHHHHHHHHHHhcC-CCce--eeecccccCC-----ceEE
Q 004388 408 NLRIGMGGYGTVYKGTFHH----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIR-HPHL--LLLLGACPDH-----GCLV 474 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~----~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~-Hpni--v~l~g~~~~~-----~~LV 474 (757)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|+.+. |+++ .+.+++|.+. .|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568999999999987754 3567776544321 23356889999999995 6665 7778887653 4899
Q ss_pred EEecCCCCHHH--------------------H---HhhcCC--------CCCCCHHH--HHHHH---------------H
Q 004388 475 YEYMENGSLED--------------------R---LYRKNN--------TPPIPWFE--RYRIA---------------W 506 (757)
Q Consensus 475 ~Ey~~~gsL~~--------------------~---L~~~~~--------~~~l~~~~--~~~i~---------------~ 506 (757)
|||++|..+.+ . |+.... ..+..+.. ...+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999864321 1 111110 01111111 11111 1
Q ss_pred HHHHHHHHHhhCCCC--------CEEEcCCCCCCeeecC--CCceEEeeecCccccC
Q 004388 507 EVASALAFLHNTKPK--------PIIHRDMKPGNILLDH--NLVSKIGDVGLSTMLN 553 (757)
Q Consensus 507 qia~aL~~LH~~~~~--------~ivHrDLKp~NILld~--~~~~KL~DFGla~~~~ 553 (757)
.+...+.+|..+-|. .+||+|++|.|||++. +..+-|.||+++..-+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 233446677554442 4999999999999975 2346799999987644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.85 E-value=5.5e-05 Score=79.45 Aligned_cols=139 Identities=12% Similarity=0.035 Sum_probs=80.5
Q ss_pred eeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCce-eeecccccCCceEEEEecCCCCHHH---
Q 004388 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-LLLLGACPDHGCLVYEYMENGSLED--- 485 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpni-v~l~g~~~~~~~LV~Ey~~~gsL~~--- 485 (757)
.+..|-.+.+|+....+..+++|+.........-...+|..+++.+..-.+ ..+++.+ ..++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~~~v~e~i~G~~~~~~~~ 80 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EHWLLVEWLEGEVITLDQF 80 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CCEEEEEeccCcccccccc
Confidence 356788889999987777888887654322211135679999988853222 2333333 3579999999866531
Q ss_pred -----------H---HhhcC-CCCCCCHHHHH-HHHHH---------HHHHHHHHhhC-----CCCCEEEcCCCCCCeee
Q 004388 486 -----------R---LYRKN-NTPPIPWFERY-RIAWE---------VASALAFLHNT-----KPKPIIHRDMKPGNILL 535 (757)
Q Consensus 486 -----------~---L~~~~-~~~~l~~~~~~-~i~~q---------ia~aL~~LH~~-----~~~~ivHrDLKp~NILl 535 (757)
. |+... ...+++..... .+..+ +...+..+-.. .+..++|+|+.|.|||+
T Consensus 81 ~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~ 160 (256)
T TIGR02721 81 VALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVV 160 (256)
T ss_pred cCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEE
Confidence 1 11111 11122222211 11111 11112222211 12358999999999999
Q ss_pred cCCCceEEeeecCccc
Q 004388 536 DHNLVSKIGDVGLSTM 551 (757)
Q Consensus 536 d~~~~~KL~DFGla~~ 551 (757)
+.++ +.|+||+.|..
T Consensus 161 ~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 161 TPQG-LKLIDWEYASD 175 (256)
T ss_pred eCCC-CEEEeccccCc
Confidence 9887 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00013 Score=74.81 Aligned_cols=134 Identities=20% Similarity=0.241 Sum_probs=83.9
Q ss_pred eeccCCcEEEEEEEE-CCeEEEEEEEccCCchhh---------HH---------------HHHHHHHHHhcCCCc--eee
Q 004388 410 RIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQN---------KQ---------------FLQELEVLSKIRHPH--LLL 462 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~-~~~~vAvK~l~~~~~~~~---------~~---------------f~~Ev~il~~l~Hpn--iv~ 462 (757)
.|+.|--+.||+|.. ++..+|||+......... .. ...|+.-|.++..-+ +.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 466777889999876 477999999865422111 01 134555555542111 111
Q ss_pred ecccccCCceEEEEecCCCCH-HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCc
Q 004388 463 LLGACPDHGCLVYEYMENGSL-EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 463 l~g~~~~~~~LV~Ey~~~gsL-~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~ 540 (757)
=++ .....|||||+....+ .-.|.. .++.......+..+++..+.-|-. .+ +||+||..-|||+. ++.
T Consensus 135 Pi~--~~~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 135 PIA--FRNNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGE 204 (268)
T ss_pred cee--ecCCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCe
Confidence 111 1234799999964311 011111 112222456677788888887777 55 99999999999999 889
Q ss_pred eEEeeecCccccC
Q 004388 541 SKIGDVGLSTMLN 553 (757)
Q Consensus 541 ~KL~DFGla~~~~ 553 (757)
+.|+|||-|-...
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999886554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0001 Score=71.65 Aligned_cols=128 Identities=16% Similarity=0.153 Sum_probs=88.6
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceee-ecccccCCceEEEEecCCCCHHH
Q 004388 407 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL-LLGACPDHGCLVYEYMENGSLED 485 (757)
Q Consensus 407 ~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~-l~g~~~~~~~LV~Ey~~~gsL~~ 485 (757)
....||+|++|.||+|.+.+..+|+|+-+.++ ....+..|+++|..+.--++-+ +|.+ +..++.|||+.|-.|.+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y--g~~~i~me~i~G~~L~~ 101 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY--GEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe--chhhhhhhhhcCcchhh
Confidence 34569999999999999999999999977654 3566889999999887555432 2222 23356699999888877
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCC-CCCeeecCCCceEEeeecCccc
Q 004388 486 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK-PGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 486 ~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK-p~NILld~~~~~KL~DFGla~~ 551 (757)
.-... . .+-+..++..-.-|...+ |-|+.|. |..++|-.++.+.|+||..|+.
T Consensus 102 ~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 54211 1 122334445444455555 8888875 5555555555999999998874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0003 Score=78.30 Aligned_cols=74 Identities=15% Similarity=0.029 Sum_probs=55.6
Q ss_pred eeeccCCcEEEEEEEECCe--EEEEEEEccCC-------chhhHHHHHHHHHHHhcC---CCceeeecccccCCceEEEE
Q 004388 409 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKG-------NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYE 476 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~--~vAvK~l~~~~-------~~~~~~f~~Ev~il~~l~---Hpniv~l~g~~~~~~~LV~E 476 (757)
..||.|.+..||++...+. .+.||.-.+.. ....+++..|.+.|..+. ..++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 4689999999999988653 89999744221 224566778888888763 35677888887777899999
Q ss_pred ecCCCC
Q 004388 477 YMENGS 482 (757)
Q Consensus 477 y~~~gs 482 (757)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00015 Score=74.84 Aligned_cols=139 Identities=20% Similarity=0.218 Sum_probs=80.5
Q ss_pred eeeccCCcEEEEEEEEC---CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC-ceeeecccccCCceEEEEecCCCCHH
Q 004388 409 LRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP-HLLLLLGACPDHGCLVYEYMENGSLE 484 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp-niv~l~g~~~~~~~LV~Ey~~~gsL~ 484 (757)
..|..|-...+|+.... +..|.+|+........ -...+|+.++..+... -.+++++.+. ..+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 45788888999998876 4678889765432211 1234688888888532 2334444433 35899999987652
Q ss_pred HH-----------------HhhcCCC--------CCCC-HHHHHHHHH----------------------HHH---HHH-
Q 004388 485 DR-----------------LYRKNNT--------PPIP-WFERYRIAW----------------------EVA---SAL- 512 (757)
Q Consensus 485 ~~-----------------L~~~~~~--------~~l~-~~~~~~i~~----------------------qia---~aL- 512 (757)
.. ++..... .... |.....+.. .+. ..|
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 11 1111111 1111 222112111 111 111
Q ss_pred HHHhhC-CCCCEEEcCCCCCCeeecC-CCceEEeeecCcc
Q 004388 513 AFLHNT-KPKPIIHRDMKPGNILLDH-NLVSKIGDVGLST 550 (757)
Q Consensus 513 ~~LH~~-~~~~ivHrDLKp~NILld~-~~~~KL~DFGla~ 550 (757)
..+-.. .+..++|+|+.|.|||++. ++.+.|+||..|.
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 112221 2346999999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=6.3e-06 Score=93.13 Aligned_cols=178 Identities=17% Similarity=0.161 Sum_probs=123.4
Q ss_pred eeccCCcEEEEEEEECCe-EEEEEEEccCCchhhHHHHHHHHHHHhcCCCc-eeeecccccCCc--eEEEEecCCC-CHH
Q 004388 410 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHG--CLVYEYMENG-SLE 484 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn-iv~l~g~~~~~~--~LV~Ey~~~g-sL~ 484 (757)
-+++|+++.+||.+...+ ....++... .....-++++|.+++||| .+..++-+..+. .++++|+.+| +-.
T Consensus 249 ~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 378999999999765433 122333322 234456899999999999 666666665444 5789998776 221
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCcccccc
Q 004388 485 DRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564 (757)
Q Consensus 485 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~ 564 (757)
+.... ....+.......+...-+.+|++||+.. =+|+| |||... +..|..|||....+.... .
T Consensus 324 ~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-------~ 386 (829)
T KOG0576|consen 324 LEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-------K 386 (829)
T ss_pred ccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-------c
Confidence 11100 0001222233456667788999999854 48998 777765 678999999987766432 3
Q ss_pred ccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 004388 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 565 ~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
.....+|+.+++||+...+.+....|+|++|+--.+|--|-+|-.
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 356789999999999999999999999999987778877877654
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00034 Score=75.29 Aligned_cols=73 Identities=15% Similarity=0.029 Sum_probs=53.1
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCC---Cceeeeccccc-----CCceEEEEecCC
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH---PHLLLLLGACP-----DHGCLVYEYMEN 480 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H---pniv~l~g~~~-----~~~~LV~Ey~~~ 480 (757)
..||.|..+.||+....+..+.+|..+.. .....|..|...|+.|.- -.+.+.+++|. +..+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 45999999999998765556777775431 123568899999988853 35677777664 235999999998
Q ss_pred CCH
Q 004388 481 GSL 483 (757)
Q Consensus 481 gsL 483 (757)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00092 Score=72.53 Aligned_cols=158 Identities=16% Similarity=0.235 Sum_probs=84.9
Q ss_pred ccCCCHHHHHHhhcCCcc-----ceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-----CCc
Q 004388 390 YRNLTWEEIESATLSFSE-----NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HPH 459 (757)
Q Consensus 390 ~~~~~~~ei~~at~~f~~-----~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----Hpn 459 (757)
|..++.+++...-..|.. ...|+.|....+|+....+..+++|+.. .. .......|+.++..|. -|.
T Consensus 4 yt~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~--~~~~l~~~~~~l~~L~~~glpvP~ 80 (319)
T PRK05231 4 YTDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFE-RL--TAEDLPFFLGLMQHLAARGVPVPA 80 (319)
T ss_pred cccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEec-cC--ChHHhHHHHHHHHHHHHCCCCCCc
Confidence 344455555444344433 2346677778999988776688999876 21 2233444556555552 333
Q ss_pred eeee-----cccccCCceEEEEecCCCCHH-----------HH---HhhcCC--------CCCCCHH-HHHH--------
Q 004388 460 LLLL-----LGACPDHGCLVYEYMENGSLE-----------DR---LYRKNN--------TPPIPWF-ERYR-------- 503 (757)
Q Consensus 460 iv~l-----~g~~~~~~~LV~Ey~~~gsL~-----------~~---L~~~~~--------~~~l~~~-~~~~-------- 503 (757)
++.- +....+..+++++|++|..+. .. |+.... ...+.|. ....
T Consensus 81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (319)
T PRK05231 81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD 160 (319)
T ss_pred ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence 3321 111123347899999986431 11 111111 0112221 1111
Q ss_pred ----HH-HHHHHHHHHHhhC----CCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 504 ----IA-WEVASALAFLHNT----KPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 504 ----i~-~qia~aL~~LH~~----~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.+ ..+...+..+... -|.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 1111222333311 35679999999999999977667899999875
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00096 Score=67.25 Aligned_cols=127 Identities=22% Similarity=0.282 Sum_probs=85.8
Q ss_pred cceeeccCCcEEEEEEEECCeEEEEEEEccCC----------------chhhHHHHHHHHHHHhcC------CCceeeec
Q 004388 407 ENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG----------------NIQNKQFLQELEVLSKIR------HPHLLLLL 464 (757)
Q Consensus 407 ~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~----------------~~~~~~f~~Ev~il~~l~------Hpniv~l~ 464 (757)
....||.|+.-.||.--. +...+||+..... .....++.+|+.-...+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 345699999999997432 3467889987665 123455677777666655 88999999
Q ss_pred ccccCCc--eEEEEecCC------CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 465 GACPDHG--CLVYEYMEN------GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 465 g~~~~~~--~LV~Ey~~~------gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
|+..... .+|+|.+.+ -+|.+++.... ++. . +...+-.-..||-..+ |+.+||+|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 9986544 688888643 36888774432 433 2 2333334445666666 99999999999995
Q ss_pred CC--C--ceEEee
Q 004388 537 HN--L--VSKIGD 545 (757)
Q Consensus 537 ~~--~--~~KL~D 545 (757)
.+ + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 43 2 466766
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00085 Score=67.34 Aligned_cols=123 Identities=21% Similarity=0.266 Sum_probs=89.6
Q ss_pred cCCccceeeccCCc-EEEEEEEECCeEEEEEEEcc---CCc------------------hhhHHHHHHHHHHHhcC---C
Q 004388 403 LSFSENLRIGMGGY-GTVYKGTFHHTFAAVKVLQS---KGN------------------IQNKQFLQELEVLSKIR---H 457 (757)
Q Consensus 403 ~~f~~~~~IG~G~~-G~Vyk~~~~~~~vAvK~l~~---~~~------------------~~~~~f~~Ev~il~~l~---H 457 (757)
.+++....||.|.- |.||++...+..+|+|++.. ... ....-|..|.....+|. +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67888889999999 99999999999999999331 110 11134778888877774 5
Q ss_pred Cce--eeeccccc-C---------------C----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 004388 458 PHL--LLLLGACP-D---------------H----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 515 (757)
Q Consensus 458 pni--v~l~g~~~-~---------------~----~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~L 515 (757)
.++ |+.+||.. + . ..||.||++... .+ ...-+.+|.+-|..+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKIL 180 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHHH
Confidence 566 88888861 0 0 157888887543 11 123456788888999
Q ss_pred hhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 516 H~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9988 999999999975 2489999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=5.5e-05 Score=92.56 Aligned_cols=159 Identities=14% Similarity=0.073 Sum_probs=116.8
Q ss_pred HHHHHHHHHhcCCCceeeecccccCC----ceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 004388 445 FLQELEVLSKIRHPHLLLLLGACPDH----GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTK 519 (757)
Q Consensus 445 f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~ 519 (757)
...|..-++...|+++...+.-.++. .+.+++|+.+|.+.+.|.+.. ..+++...-+.....+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 34566666677899988776655433 378999999999999887543 3334443333333334356666655432
Q ss_pred --CCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHH
Q 004388 520 --PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597 (757)
Q Consensus 520 --~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvi 597 (757)
..--+|++||+.|.+|..+..+|++++|+.+...+..++ .....+++.|+.|++.+.-.++.++|+|..|+-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf------~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF------FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLS 1429 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhh------hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHH
Confidence 234799999999999999999999999999955443322 133478889999999988889999999999999
Q ss_pred HHHHHhCCCCcc
Q 004388 598 ILQLLTAKPAIA 609 (757)
Q Consensus 598 l~elltG~~Pf~ 609 (757)
+|.+--|.++|-
T Consensus 1430 ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHhcccHHHH
Confidence 999998888773
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.001 Score=71.59 Aligned_cols=139 Identities=22% Similarity=0.223 Sum_probs=82.3
Q ss_pred eeeccCCcEEEEEEEECC--------eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc-eeeecccccCCceEEEEecC
Q 004388 409 LRIGMGGYGTVYKGTFHH--------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHGCLVYEYME 479 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~--------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn-iv~l~g~~~~~~~LV~Ey~~ 479 (757)
..|..|-...+|+....+ ..+++|+...... ......+|..++..+..-. ..++++++. ..+|+||++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP--NGRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC--CCchhheeC
Confidence 356677778999988653 5788998765432 2234567888888875322 234555554 346899998
Q ss_pred CCCHHHH-----------------HhhcCCCC------CCC--HHHHHH--------------------------HHHHH
Q 004388 480 NGSLEDR-----------------LYRKNNTP------PIP--WFERYR--------------------------IAWEV 508 (757)
Q Consensus 480 ~gsL~~~-----------------L~~~~~~~------~l~--~~~~~~--------------------------i~~qi 508 (757)
|..+... |+...... ..+ |..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8765421 11111110 111 111111 11122
Q ss_pred HHHHHHHhh------CCCCCEEEcCCCCCCeeecCC----CceEEeeecCcc
Q 004388 509 ASALAFLHN------TKPKPIIHRDMKPGNILLDHN----LVSKIGDVGLST 550 (757)
Q Consensus 509 a~aL~~LH~------~~~~~ivHrDLKp~NILld~~----~~~KL~DFGla~ 550 (757)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 223344432 234579999999999999874 889999998875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0017 Score=69.62 Aligned_cols=140 Identities=17% Similarity=0.189 Sum_probs=85.5
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC--ceeeecccc--------cCCceEEEEe
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGAC--------PDHGCLVYEY 477 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp--niv~l~g~~--------~~~~~LV~Ey 477 (757)
...|..|....+|+....+..+++|+... .....+..|+.++..+.+- .+.+.+... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 34577787889999887777899998765 2334566788888877432 244444322 2233689999
Q ss_pred cCCCCHHH--------------HHhhcCC--C------CCCCHHHHHH----------HHHHHHHHHHHHhh----CCCC
Q 004388 478 MENGSLED--------------RLYRKNN--T------PPIPWFERYR----------IAWEVASALAFLHN----TKPK 521 (757)
Q Consensus 478 ~~~gsL~~--------------~L~~~~~--~------~~l~~~~~~~----------i~~qia~aL~~LH~----~~~~ 521 (757)
++|..+.. .|+.... . ....|..... ....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99866421 1111100 0 1112222110 11123344555553 2345
Q ss_pred CEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 522 PIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 522 ~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 69999999999999998888999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0041 Score=67.22 Aligned_cols=140 Identities=15% Similarity=0.188 Sum_probs=81.1
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC--ceeeecccc--------cCCceEEEEec
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HLLLLLGAC--------PDHGCLVYEYM 478 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp--niv~l~g~~--------~~~~~LV~Ey~ 478 (757)
..++.|....+|+....+..+.+|+..... .......|++++..|..- .+.+.+... .+..+++++|+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 346667678999987766678888875532 233455677777776421 233443322 12237899999
Q ss_pred CCCCHH-----------H---HHhhcCCC--C-------CCCHHHHHH------------HHHHHHHHHHHHhh----CC
Q 004388 479 ENGSLE-----------D---RLYRKNNT--P-------PIPWFERYR------------IAWEVASALAFLHN----TK 519 (757)
Q Consensus 479 ~~gsL~-----------~---~L~~~~~~--~-------~l~~~~~~~------------i~~qia~aL~~LH~----~~ 519 (757)
+|..+. . .++..... . .-.|..... ....+...+.+|.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 985431 1 11211110 0 011211110 01123334555543 23
Q ss_pred CCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 520 ~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
+.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4679999999999999998878999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0023 Score=71.05 Aligned_cols=73 Identities=14% Similarity=0.052 Sum_probs=53.7
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccCCc-------hhhHHHHHHHHHHHhcC---CCceeeecccccCCceEEEEe
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN-------IQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYEY 477 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~-------~~~~~f~~Ev~il~~l~---Hpniv~l~g~~~~~~~LV~Ey 477 (757)
...||.|....||+....+..+.||.-..... ....+-..|.+.|..+. ..++.+++.+|.+..+++|||
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~ 116 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY 116 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence 45689999999999988777889997542111 12333445677776653 357889999999999999999
Q ss_pred cCC
Q 004388 478 MEN 480 (757)
Q Consensus 478 ~~~ 480 (757)
+++
T Consensus 117 L~~ 119 (418)
T PLN02756 117 LEP 119 (418)
T ss_pred cCC
Confidence 976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0038 Score=68.70 Aligned_cols=139 Identities=15% Similarity=0.180 Sum_probs=80.3
Q ss_pred eeeccCCcEEEEEEEEC------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCce-eeecccccCCceEEEEecCCC
Q 004388 409 LRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-LLLLGACPDHGCLVYEYMENG 481 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpni-v~l~g~~~~~~~LV~Ey~~~g 481 (757)
..|-.|-...+|+.... +..+.+|+.........+ ..+|..++..+..-++ .++++.+... .|++|+++.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~ 118 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHAR 118 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCC
Confidence 35656888899998753 247888887654332222 2578888888753222 3445555433 789999876
Q ss_pred CHHHH-----------------HhhcCC--CC-CCCHHHHHHHHHHH-----------------HHHHHH----Hhh-CC
Q 004388 482 SLEDR-----------------LYRKNN--TP-PIPWFERYRIAWEV-----------------ASALAF----LHN-TK 519 (757)
Q Consensus 482 sL~~~-----------------L~~~~~--~~-~l~~~~~~~i~~qi-----------------a~aL~~----LH~-~~ 519 (757)
+|... ++.... .. +..|.....+..++ ...+.. +.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66321 111110 01 12233222332111 111212 222 22
Q ss_pred CCCEEEcCCCCCCeeecC-CCceEEeeecCcc
Q 004388 520 PKPIIHRDMKPGNILLDH-NLVSKIGDVGLST 550 (757)
Q Consensus 520 ~~~ivHrDLKp~NILld~-~~~~KL~DFGla~ 550 (757)
+..++|+|+++.|||+++ ++.+.|+||..|.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 346999999999999986 5789999998875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0058 Score=65.92 Aligned_cols=139 Identities=18% Similarity=0.265 Sum_probs=79.6
Q ss_pred CCcEEEEEEEECCeEEEEEEEcc--CCchhhHHHHHHHHHHHhcCC--CceeeecccccCCc----eEEEEecCCCCHHH
Q 004388 414 GGYGTVYKGTFHHTFAAVKVLQS--KGNIQNKQFLQELEVLSKIRH--PHLLLLLGACPDHG----CLVYEYMENGSLED 485 (757)
Q Consensus 414 G~~G~Vyk~~~~~~~vAvK~l~~--~~~~~~~~f~~Ev~il~~l~H--pniv~l~g~~~~~~----~LV~Ey~~~gsL~~ 485 (757)
|..-.+|.....+..+++. ... ..........+|+.+|+.+.- --+...++.|.+.. +.||+|++|..+.+
T Consensus 36 G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 3334455555556677777 332 122233455678888887742 33456677886665 89999999832221
Q ss_pred ------------------HHhh---cC--CCC-----------C-CCHHHHHHHHH--------HHHHHHHHHhhCCC--
Q 004388 486 ------------------RLYR---KN--NTP-----------P-IPWFERYRIAW--------EVASALAFLHNTKP-- 520 (757)
Q Consensus 486 ------------------~L~~---~~--~~~-----------~-l~~~~~~~i~~--------qia~aL~~LH~~~~-- 520 (757)
.|.. -. ..+ + -.|...++.+. ....-..||+.+-|
T Consensus 115 ~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~ 194 (321)
T COG3173 115 ALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPW 194 (321)
T ss_pred cCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCc
Confidence 1110 00 000 0 01111111110 12223445554433
Q ss_pred ---CCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 521 ---KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 521 ---~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
..++|||+.+.||+++.++-+=|.||+++.+-+
T Consensus 195 ~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 195 AGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 579999999999999998889999999987543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0019 Score=78.26 Aligned_cols=188 Identities=20% Similarity=0.162 Sum_probs=129.2
Q ss_pred HHHHHHHHhcCCCceeeecccccCCc------eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Q 004388 446 LQELEVLSKIRHPHLLLLLGACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519 (757)
Q Consensus 446 ~~Ev~il~~l~Hpniv~l~g~~~~~~------~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~ 519 (757)
.-|...+.++.|+|++.+++|..+.. .+..+|+..-++...+...+ .++..+...+..++..||.|+|...
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 34677788889999999998865433 23457888888888776544 3777788888999999999999975
Q ss_pred CCCEEEcCCCCC---CeeecCCCceEEe--eecCccccCCCCCCccccccccCCcccccCCCccccccCCCCC--cchhh
Q 004388 520 PKPIIHRDMKPG---NILLDHNLVSKIG--DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISP--KSDVY 592 (757)
Q Consensus 520 ~~~ivHrDLKp~---NILld~~~~~KL~--DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--ksDvw 592 (757)
..|.-|..+ +...+..+...++ ||+.+..+++.... .....+..|.+||......+.. ..|+|
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-------FSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc-------hhhcCccccccccccccccchhhhhhHHH
Confidence 555555444 4455666777777 99988776654321 2234566678888665554444 47999
Q ss_pred hHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 593 AYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 593 SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+|..+..+..|..+-..... ...+++.. ....+.....+|+.-+++.|++..+
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~---------~~~~l~~~-------~~~~~~d~~~~~~~~~~~~Rl~~~~ 430 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAV---------PVSLLDVL-------STSELLDALPKCLDEDSEERLSALE 430 (1351)
T ss_pred HHHHHHhhhhhcCcccccccc---------hhhhhccc-------cchhhhhhhhhhcchhhhhccchhh
Confidence 999999999998755322111 11112111 1115677788899999999998875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.011 Score=64.78 Aligned_cols=72 Identities=15% Similarity=0.070 Sum_probs=50.1
Q ss_pred eeccCCcEEEEEEEECC--eEEEEEEEccC-------CchhhHHHHHHHHHHHhcC--CC-ceeeecccccCCceEEEEe
Q 004388 410 RIGMGGYGTVYKGTFHH--TFAAVKVLQSK-------GNIQNKQFLQELEVLSKIR--HP-HLLLLLGACPDHGCLVYEY 477 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~-------~~~~~~~f~~Ev~il~~l~--Hp-niv~l~g~~~~~~~LV~Ey 477 (757)
.||.|...-||++...+ +.+.||.-.+. .....++..-|.+.|.... -| ++.++|.+-++...+|||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 37999999999998865 47899864321 1333455566888887653 34 4566777767777899999
Q ss_pred cCCC
Q 004388 478 MENG 481 (757)
Q Consensus 478 ~~~g 481 (757)
++..
T Consensus 82 L~~~ 85 (370)
T TIGR01767 82 LSHH 85 (370)
T ss_pred Cccc
Confidence 9653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0058 Score=67.04 Aligned_cols=52 Identities=15% Similarity=0.280 Sum_probs=42.5
Q ss_pred HHHhHhhHHHHHHhhh------cCceeeEEEeec-------ccHHHHHHHHHHhcCCcEEEeecc
Q 004388 40 WKTDRLLLPFRNMCAQ------RRVEVEVKVIES-------DDVAKAIADEVASCNINKLVIGAQ 91 (757)
Q Consensus 40 ~~~~~ll~~~~~~c~~------~~v~~~~~v~e~-------~~va~~I~~~i~~~~i~~LVmG~~ 91 (757)
...++++......+.+ .||++++.++++ .++++.|++||+++++|.||||-.
T Consensus 58 ~~~eelle~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 58 AAAEELLERVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred HHHHHHHHHHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 3445666666666655 599999999874 599999999999999999999975
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0051 Score=76.15 Aligned_cols=75 Identities=16% Similarity=0.286 Sum_probs=62.7
Q ss_pred HhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEe
Q 004388 44 RLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVE 123 (757)
Q Consensus 44 ~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~ 123 (757)
+-+..++.+|.+-|.+ ++.+.++||+++|++||..++|+.||||.+.++.+ |..+++...+++.+|+ =+|+||.
T Consensus 300 ~~l~~~~~lA~~lGa~--~~~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~---~~~~s~~~~l~r~~~~-idi~iv~ 373 (895)
T PRK10490 300 RAILSALRLAQELGAE--TATLSDPAEEKAVLRYAREHNLGKIIIGRRASRRW---WRRESFADRLARLGPD-LDLVIVA 373 (895)
T ss_pred HHHHHHHHHHHHcCCE--EEEEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCC---ccCCCHHHHHHHhCCC-CCEEEEe
Confidence 3455666799998876 66788999999999999999999999999998765 4458999999999974 5899986
Q ss_pred c
Q 004388 124 K 124 (757)
Q Consensus 124 k 124 (757)
.
T Consensus 374 ~ 374 (895)
T PRK10490 374 L 374 (895)
T ss_pred C
Confidence 3
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 757 | ||||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-35 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-35 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-32 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-11 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-11 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-11 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-11 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-11 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-04 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-04 |
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 8e-83
Identities = 102/294 (34%), Positives = 149/294 (50%), Gaps = 24/294 (8%)
Query: 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQEL 449
+ ++E AT +F IG G +G VYKG A+K + + ++F E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 450 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAW 506
E LS RHPHL+ L+G C + L+Y+YMENG+L+ LY + T + W +R I
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKN 565
A L +LH + IIHRD+K NILLD N V KI D G+S D + +ST K
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK- 202
Query: 566 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE---------T 616
GTL YIDPEY G ++ KSDVY++G+V+ ++L A+ AI + E
Sbjct: 203 ----GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 617 AIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669
+ + L +I+D A + ++ + C L +DRP + VL LE
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-GDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 2e-80
Identities = 101/312 (32%), Positives = 167/312 (53%), Gaps = 29/312 (9%)
Query: 380 ERALNGTFQRYRNLTWEEIESATLSFSENL------RIGMGGYGTVYKGTFHHTFAAVKV 433
++L + R+ + ++ E+++ T +F E ++G GG+G VYKG ++T AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK 61
Query: 434 LQSKGNIQ----NKQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL 487
L + +I +QF QE++V++K +H +L+ LLG D CLVY YM NGSL DRL
Sbjct: 62 LAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL 121
Query: 488 YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547
+ TPP+ W R +IA A+ + FLH IHRD+K NILLD +KI D G
Sbjct: 122 SCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFG 178
Query: 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 607
L+ + T + VGT Y+ PE G I+PKSD+Y++G+V+L+++T PA
Sbjct: 179 LARASEKF----AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPA 233
Query: 608 IAITHK----VETA----IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPD 659
+ + ++ +E + + +D + D + + ++ C ++ RPD
Sbjct: 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD 293
Query: 660 LKNQVLPVLERL 671
+K +V +L+ +
Sbjct: 294 IK-KVQQLLQEM 304
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-74
Identities = 100/296 (33%), Positives = 158/296 (53%), Gaps = 23/296 (7%)
Query: 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNK-QFLQE 448
+ + E++ A+ +FS +G GG+G VYKG T AVK L+ + + QF E
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 449 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIA 505
+E++S H +LL L G C P LVY YM NGS+ L R + PP+ W +R RIA
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565
A LA+LH+ IIHRD+K NILLD + +GD GL+ +++ + V+T +
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR- 196
Query: 566 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI-----------AITHKV 614
GT+ +I PEY TG S K+DV+ YG+++L+L+T + A + V
Sbjct: 197 ----GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 615 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669
+ + E L ++D G++ +E ++L + L C + +RP + +V+ +LE
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLE 307
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-62
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 394 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLS 453
+ I+ + E +G G +G V K + A+K ++S+ K F+ EL LS
Sbjct: 1 SLHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELRQLS 56
Query: 454 KIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 513
++ HP+++ L GAC + CLV EY E GSL + L+ P + + +A
Sbjct: 57 RVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 514 FLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
+LH+ +PK +IHRD+KP N+LL V KI D G + + + T G+
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---------HMTNNKGSA 167
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
++ PE S K DV+++G+++ +++T +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-61
Identities = 69/302 (22%), Positives = 120/302 (39%), Gaps = 44/302 (14%)
Query: 396 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 455
E + ++ G +G V+K + + AVK+ + Q+ Q E+ L +
Sbjct: 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF-PIQDKQSWQNEYEVYSLPGM 75
Query: 456 RHPHLLLLLGAC--PDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 509
+H ++L +GA L+ + E GSL D L + W E IA +A
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMA 131
Query: 510 SALAFLHNTKPK-------PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562
LA+LH P I HRD+K N+LL +NL + I D GL+ + S T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 563 YKNTGPVGTLCYIDPEYQRTGLI-----SPKSDVYAYGMVILQLLTAKPAIAITHKVETA 617
+ VGT Y+ PE + + D+YA G+V+ +L + A
Sbjct: 192 GQ----VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV----- 242
Query: 618 IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLP--VLERLKEVA 675
++ + + +++ +E+ + +K RP L++ + L E
Sbjct: 243 --DEYMLPFEEEIGQHPSLEDMQEVV--------VHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 676 DR 677
+
Sbjct: 293 EE 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-61
Identities = 71/240 (29%), Positives = 123/240 (51%), Gaps = 13/240 (5%)
Query: 370 KHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA 429
H + N FQ + +I L+ E +IG G +GTV++ +H +
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDV 63
Query: 430 AVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLED 485
AVK+L + +FL+E+ ++ ++RHP+++L +GA P + +V EY+ GSL
Sbjct: 64 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 486 RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545
L++ + R +A++VA + +LHN P PI+HR++K N+L+D K+ D
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
GLS + ST + GT ++ PE R + KSDVY++G+++ +L T +
Sbjct: 183 FGLSRLKA------STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 73/316 (23%), Positives = 132/316 (41%), Gaps = 50/316 (15%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSK 454
+I L E IG G +G VY G +H A++++ + + ++ K F +E+ +
Sbjct: 29 DIPFEQLEIGE--LIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQ 85
Query: 455 IRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
RH +++L +GAC P H ++ + +L + + + +IA E+ +
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGM 143
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
+LH K I+H+D+K N+ D+ V I D GL ++ + K G L
Sbjct: 144 GYLHA---KGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRRED-KLRIQNGWL 198
Query: 573 CYIDPEYQRTGLI---------SPKSDVYAYGMVILQLLTAK------PAIAITHKVETA 617
C++ PE R S SDV+A G + +L + PA AI ++
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-- 256
Query: 618 IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADR 677
+ G KE++ + L C +++RP +++ +LE+L + R
Sbjct: 257 --TGMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFT-KLMDMLEKLPKRNRR 306
Query: 678 ARDTVPSVHPAPPNHF 693
+ P HF
Sbjct: 307 ---------LSHPGHF 313
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-54
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 35/290 (12%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL--QSKGNIQNKQFLQELEVL 452
WE I ++ + RIG G +GTVYKG +H AVK+L + Q + F E+ VL
Sbjct: 19 WE-IPDGQITVGQ--RIGSGSFGTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 453 SKIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
K RH ++LL +G +V ++ E SL L + + IA + A
Sbjct: 75 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARG 132
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+ +LH K IIHRD+K NI L + KIGD GL+T + S +++ G+
Sbjct: 133 MDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW----SGSHQFEQLSGS 185
Query: 572 LCYIDPE---YQRTGLISPKSDVYAYGMVILQLLTAK-------PAIAITHKVETAIDED 621
+ ++ PE Q + S +SDVYA+G+V+ +L+T + I V
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG----RG 241
Query: 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
+L+ L + P K + L C + +R +RP ++L +E L
Sbjct: 242 SLSPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFP-RILAEIEEL 286
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-54
Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN----KQFLQELEVL 452
EI+ A L+ E IG+GG+G VY+ + AVK + + + QE ++
Sbjct: 3 EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 453 SKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 510
+ ++HP+++ L G C + CLV E+ G L L K IP A ++A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIAR 116
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLD--------HNLVSKIGDVGLSTMLNSDPSFVSTT 562
+ +LH+ PIIHRD+K NIL+ N + KI D GL+ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----- 171
Query: 563 YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK 605
G ++ PE R + S SDV++YG+++ +LLT +
Sbjct: 172 ---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-53
Identities = 44/218 (20%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVLSK 454
I+ L+F ++ G ++KG + VKVL+ + + F +E L
Sbjct: 6 GIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63
Query: 455 IRHPHLLLLLGAC----PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 510
HP++L +LGAC H L+ +M GSL + L + + + + A ++A
Sbjct: 64 FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMAR 122
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 570
+AFLH +P I + ++++D ++ ++I + S G +
Sbjct: 123 GMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----------PGRMY 170
Query: 571 TLCYIDPE---YQRTGLISPKSDVYAYGMVILQLLTAK 605
++ PE + +D++++ +++ +L+T +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 7e-53
Identities = 55/227 (24%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVL-------QSKGNIQNKQF 445
+ + + + +IG GG+G V+KG + A+K L +++ + ++F
Sbjct: 13 LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 446 LQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 505
+E+ ++S + HP+++ L G + +V E++ G L RL K + PI W + R+
Sbjct: 71 QREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLM 128
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLD-----HNLVSKIGDVGLSTMLNSDPSFVS 560
++A + ++ N P PI+HRD++ NI L + +K+ D GLS
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------- 178
Query: 561 TTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQLLTAK 605
+ + +G +G ++ PE + K+D Y++ M++ +LT +
Sbjct: 179 SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-51
Identities = 66/320 (20%), Positives = 122/320 (38%), Gaps = 46/320 (14%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSK 454
+ L E +G G +G K T T +K L + FL+E++V+
Sbjct: 6 IFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 455 IRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
+ HP++L +G + EY++ G+L + K+ PW +R A ++AS +
Sbjct: 64 LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGM 121
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP---- 568
A+LH+ IIHRD+ N L+ N + D GL+ ++ + + P
Sbjct: 122 AYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 569 ----VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--- 621
VG ++ PE K DV+++G+V+ +++ A D D
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----------DPDYLP 227
Query: 622 -NLAEILDAQAG-------DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
+ L+ + + P + + C +L + RP ++ LE L+
Sbjct: 228 RTMDFGLNVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFV-KLEHWLETLRM 282
Query: 674 VADRARDTVPSVHPAPPNHF 693
P + +
Sbjct: 283 HLAGHLPLGPQLEQLDRGFW 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 59/243 (24%), Positives = 89/243 (36%), Gaps = 33/243 (13%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LSK 454
++ L E IG G YG VYKG+ AVKV + F+ E + +
Sbjct: 9 SLDLDNLKLLE--LIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPL 63
Query: 455 IRHPHLLLLLGAC-------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 507
+ H ++ + LV EY NGSL L W R+A
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHS 119
Query: 508 VASALAFLHNTKPK------PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV-- 559
V LA+LH P+ I HRD+ N+L+ ++ I D GLS L +
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 560 STTYKNTGPVGTLCYIDPEY-------QRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612
VGT+ Y+ PE + + D+YA G++ ++ +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 613 KVE 615
V
Sbjct: 240 SVP 242
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-50
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LSKIRHPHLLLLLGAC 467
+G G YG V++G++ AVK+ S+ K + +E E+ +RH ++L + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 468 ------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN---- 517
L+ Y E GSL D L + RI +AS LA LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 518 TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
T+ KP I HRD+K NIL+ N I D+GL+ M S N VGT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH--SQSTNQLDVGNNPRVGTKRYMA 185
Query: 577 PE------YQRTGLISPKSDVYAYGMVILQLLT 603
PE + D++A+G+V+ ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 30/227 (13%)
Query: 396 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV--LS 453
+ + + + +IG G YG V+ G + AVKV + + + +E E+
Sbjct: 32 QRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTV 86
Query: 454 KIRHPHLLLLLGAC------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 507
+RH ++L + A L+ +Y ENGSL D L + ++A+
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYS 142
Query: 508 VASALAFLHN----TKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562
S L LH T+ KP I HRD+K NIL+ N I D+GL+ SD +
Sbjct: 143 SVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN--EVD 200
Query: 563 YKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLT 603
VGT Y+ PE + +D+Y++G+++ ++
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-48
Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 31/231 (13%)
Query: 392 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEV 451
L I + T+ E IG G +G V++G + AVK+ S+ + + + +E E+
Sbjct: 34 LLVQRTI-ARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEI 87
Query: 452 --LSKIRHPHLLLLLGACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 503
+RH ++L + A LV +Y E+GSL D L R + +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIK 143
Query: 504 IAWEVASALAFLH----NTKPKP-IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558
+A AS LA LH T+ KP I HRD+K NIL+ N I D+GL+ +S
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD- 202
Query: 559 VSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLT 603
+ VGT Y+ PE + ++D+YA G+V ++
Sbjct: 203 -TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 37/288 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G GG+G V++ +A ++ + ++ ++E++ L+K+ HP ++ A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 467 CPDHG--------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
+ + + +L+D + + I ++A A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN------T 566
FLH+ ++HRD+KP NI + V K+GD GL T ++ D + T
Sbjct: 132 EFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 567 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626
G VGT Y+ PE S K D+++ G+++ +LL P +V T L ++
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQMERVRT------LTDV 240
Query: 627 LDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL--PVLERLK 672
+ + ++ + +RP+ ++ V E L
Sbjct: 241 RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA-INIIENAVFEDLD 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 48/291 (16%)
Query: 361 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 420
Q + + + E E + + + +G F ++ IG G + TVY
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIE-----------------IGRGSFKTVY 43
Query: 421 KGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGACPDHG----- 471
KG T A LQ + ++ ++F +E E+L ++HP+++ +
Sbjct: 44 KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103
Query: 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKP 530
LV E M +G+L+ ++ I + ++ L FLH P PIIHRD+K
Sbjct: 104 IVLVTELMTSGTLKT-YLKRFKVMKIKVLRSW--CRQILKGLQFLHTRTP-PIIHRDLKC 159
Query: 531 GNILLDHNL-VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS 589
NI + KIGD+GL+T+ + +GT ++ PE
Sbjct: 160 DNIFITGPTGSVKIGDLGLATLKRAS--------FAKAVIGTPEFMAPEMYEEKY-DESV 210
Query: 590 DVYAYGMVILQLLTAKP-------AIAITHKVETAIDEDNLAEILDAQAGD 633
DVYA+GM +L++ T++ A I +V + + + ++ + +
Sbjct: 211 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 50/291 (17%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
IG GG+G V+K +K + N++ +E++ L+K+ H +++ G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 468 PDHG------------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 509
+ E+ + G+LE + ++ + + ++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK-LDKVLALELFEQIT 132
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569
+ ++H+ K +I+RD+KP NI L KIGD GL T L +D +
Sbjct: 133 KGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-------K 182
Query: 570 GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629
GTL Y+ PE + + D+YA G+++ +LL TA + D
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---------TAFETSKF--FTDL 231
Query: 630 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL---PVLERLKEVADR 677
+ G K+ L + +DRP+ +++L V ++ E +R
Sbjct: 232 RDGIISDIFDKKEKTLLQKLLSKKPEDRPNT-SEILRTLTVWKKSPEKNER 281
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-32
Identities = 68/275 (24%), Positives = 111/275 (40%), Gaps = 40/275 (14%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLL 464
IG G YG K K L G++ + E+ +L +++HP+++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 465 GACPDHG----CLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTK 519
D +V EY E G L + + + R+ ++ AL H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 520 PKP--IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
++HRD+KP N+ LD K+GD GL+ +LN D SF T VGT Y+ P
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF------VGTPYYMSP 185
Query: 578 E------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-ILDAQ 630
E Y + KSD+++ G ++ +L P TA + LA I + +
Sbjct: 186 EQMNRMSY------NEKSDIWSLGCLLYELCALMPPF-------TAFSQKELAGKIREGK 232
Query: 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 665
P + + EL + L+ RP + ++L
Sbjct: 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSV-EEIL 266
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 33/216 (15%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G V K + A+K + + L E+ +L+ + H +++ A
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 468 PDHG---------------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
+ + EY ENG+L D ++ +N E +R+ ++ AL
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD--EYWRLFRQILEAL 129
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN------- 565
+++H+ IIHRD+KP NI +D + KIGD GL+ ++ + +N
Sbjct: 130 SYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 566 -TGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVIL 599
T +GT Y+ E TG + K D+Y+ G +I
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG-IIF 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 39/269 (14%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 465
IG G +G +K + + + +K + +E+ VL+ ++HP+++
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
+ ++G L V +Y E G L R+ + + ++ AL +H+ K I
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHDRK---I 146
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 578
+HRD+K NI L + ++GD G++ +LNS +GT Y+ PE
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC------IGTPYYLSPEICENK 200
Query: 579 -YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE-ILDAQAGDWPI 636
Y + KSD++A G V+ +L T K A A NL I+ +
Sbjct: 201 PY------NNKSDIWALGCVLYELCTLKHAF-------EAGSMKNLVLKIISGSFPPVSL 247
Query: 637 KETKELAALGLSCAELRRKDRPDLKNQVL 665
+ +L +L + +DRP + N +L
Sbjct: 248 HYSYDLRSLVSQLFKRNPRDRPSV-NSIL 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-32
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 23/216 (10%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVL 452
WE +E ++ ++G G YG VY+G + + AVK L+ ++ ++FL+E V+
Sbjct: 215 WE-MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVM 270
Query: 453 SKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 510
+I+HP+L+ LLG C ++ E+M G+L D L R+ N + +A +++S
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 329
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 570
A+ +L IHR++ N L+ N + K+ D GLS ++ D TY G
Sbjct: 330 AMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHA--G 378
Query: 571 TLCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 603
I PE S KSDV+A+G+++ ++ T
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 29/216 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLL-- 464
+G G V++G T A+KV + ++ ++E EVL K+ H +++ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 465 --GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
H L+ E+ GSL L +N +P E + +V + L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 523 IIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I+HR++KPGNI+ D V K+ D G + L D + Y GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY------GTEEYLHPD 185
Query: 579 -YQRTGLI-------SPKSDVYAYGMVILQLLTAKP 606
Y+R L D+++ G+ T
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 70/319 (21%), Positives = 125/319 (39%), Gaps = 38/319 (11%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 450
E L + ++G G +G+V + AVK LQ G Q + F +E++
Sbjct: 19 IFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 451 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 506
+L + ++ G G LV EY+ +G L D L + + + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSS 134
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566
++ + +L + + +HRD+ NIL++ KI D GL+ +L D Y
Sbjct: 135 QICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD----YYVVR 187
Query: 567 G----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-----AKPAIAITHKVETA 617
P+ + PE + S +SDV+++G+V+ +L T P+ +
Sbjct: 188 EPGQSPI---FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244
Query: 618 IDEDNLAEILDA-QAG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
D L+ +L+ + G P E+ L C +DRP + P L+ L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS-ALGPQLDMLWS 303
Query: 674 VADRARDTVPSVHPAPPNH 692
+ + HP +H
Sbjct: 304 GSRGCETHAFTAHPEGKHH 322
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 14/209 (6%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 455
EI +L ++G G +G V+ GT+ T A+K L+ G + + FLQE +V+ K+
Sbjct: 180 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 236
Query: 456 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
RH L+ L + +V EYM GSL D L + + + +A ++AS +A+
Sbjct: 237 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
+ +HRD++ NIL+ NLV K+ D GL+ ++ + K P+ +
Sbjct: 296 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIK---W 347
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PE G + KSDV+++G+++ +L T
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVL-QSKGNIQNKQFLQELEV 451
W + L E +IG G +G V+ G +T AVK ++ +FLQE +
Sbjct: 109 WV-LNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165
Query: 452 LSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 509
L + HP+++ L+G C +V E ++ G L + + ++ + A
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAA 223
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569
+ + +L + K IHRD+ N L+ V KI D G+S Y +G +
Sbjct: 224 AGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG------VYAASGGL 274
Query: 570 GTLCY--IDPEYQRTGLISPKSDVYAYGMVI 598
+ PE G S +SDV+++G+++
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 59/300 (19%), Positives = 104/300 (34%), Gaps = 40/300 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
++G GG+ V H F A+K + ++ +E ++ HP++L L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 468 PDHG------CLVYEYMENGSLEDRLY-RKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L+ + + G+L + + K+ + + + + L +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK---NTGPVGTLCYIDP 577
K HRD+KP NILL + D+G T+ Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 578 E---YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634
E Q +I ++DV++ G V+ ++ + D++A + Q
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQNQL-SI 266
Query: 635 PIKET--KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNH 692
P L L S + RP + +L LE L+ PAP H
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEALQ-------------PPAPGQH 312
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 70/340 (20%), Positives = 137/340 (40%), Gaps = 41/340 (12%)
Query: 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVL-QSKGNIQNK 443
+ L + L + +G G +GTV+KG + +KV+ G +
Sbjct: 4 KVLARI-FKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 444 QFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERY 502
+ + + H H++ LLG CP LV +Y+ GSL D + + + +
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLL 118
Query: 503 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTT 562
++A + +L ++HR++ N+LL ++ D G++ +L D
Sbjct: 119 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----DKQ 171
Query: 563 YKNTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVET 616
+ P+ ++ E G + +SDV++YG+ + +L+T A+P + +V
Sbjct: 172 LLYSEAKTPIK---WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228
Query: 617 AIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRP---DLKNQVLPVLERLKE 673
+++ E L P T ++ + + C + RP +L N+ +
Sbjct: 229 LLEKG---ERLAQ-----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280
Query: 674 VADRARDTVPSVHPAP-PNHFICPILKEVMNEPCVAADGY 712
R++ P + P P P+ L+EV EP + D
Sbjct: 281 YLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLD 320
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-31
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI 455
EI +L ++G G +G V+ GT+ T A+K L+ G + + FLQE +V+ K+
Sbjct: 263 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKL 319
Query: 456 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
RH L+ L + +V EYM GSL D L + + + +A ++AS +A+
Sbjct: 320 RHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
+ +HRD++ NIL+ NLV K+ D GL+ ++ + K P+
Sbjct: 379 VER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTA- 432
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PE G + KSDV+++G+++ +L T
Sbjct: 433 --PEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHPHLLLLLG 465
IG G + VY+ A+K +Q + K ++E+++L ++ HP+++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 466 ACPDHGCL--VYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAW--EVASALAFLHNTKP 520
+ + L V E + G L + + K IP ER + ++ SAL +H+ +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP--ERTVWKYFVQLCSALEHMHSRR- 156
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 578
++HRD+KP N+ + V K+GD+GL +S + + VGT Y+ PE
Sbjct: 157 --VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYYMSPERI 208
Query: 579 ----YQRTGLISPKSDVYAYGMVILQLLTAKPA 607
Y + KSD+++ G ++ ++ +
Sbjct: 209 HENGY------NFKSDIWSLGCLLYEMAALQSP 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 53/215 (24%), Positives = 86/215 (40%), Gaps = 29/215 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLL--- 464
+G G V++G T A+KV + ++ +E EVL K+ H +++ L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 465 -GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
H L+ E+ GSL L +N +P E + +V + L I
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 524 IHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 578
+HR++KPGNI+ D V K+ D G + L D + Y GT Y+ P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY------GTEEYLHPDM 186
Query: 579 YQRTGLI-------SPKSDVYAYGMVILQLLTAKP 606
Y+R L D+++ G+ T
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR 456
+ L + IG G +G V G + AVK + K + + FL E V++++R
Sbjct: 189 ALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLR 244
Query: 457 HPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 513
H +L+ LLG + +Y EYM GSL D L R + + + +V A+
Sbjct: 245 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAME 303
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
+L +HRD+ N+L+ + V+K+ D GL+ +S K T
Sbjct: 304 YLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA------ 354
Query: 574 YIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PE R S KSDV+++G+++ ++ +
Sbjct: 355 ---PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 464
+G GG+ ++ + T A K++ K + ++ E+ + + H H++
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 465 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G D +V E SL + R+ + E ++ +LH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR--- 135
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+IHRD+K GN+ L+ +L KIGD GL+T + D GT YI PE
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL------CGTPNYIAPEVLSK 189
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
S + DV++ G ++ LL KP
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKP 213
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 26/73 (35%), Positives = 38/73 (52%), Gaps = 1/73 (1%)
Query: 686 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPN 744
P P +F CPI E+M +P + + G TY+R +I++WL + P + L + L PN
Sbjct: 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPN 61
Query: 745 YTLLSAILDWKSK 757
Y L S I W
Sbjct: 62 YVLKSLIALWCES 74
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQ-SKGNIQNKQFLQ 447
++ + +G G +GTVYKG + A+K L+ + NK+ L
Sbjct: 9 LRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 448 ELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 506
E V++ + +PH+ LLG C L+ + M G L D + + + I
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCV 124
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566
++A + +L + + ++HRD+ N+L+ KI D GL+ +L ++ Y
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAE 177
Query: 567 G---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
G P+ ++ E + + +SDV++YG+ + +L+T
Sbjct: 178 GGKVPIK---WMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 20/217 (9%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 450
+ E L F + ++G G +G+V + AVK LQ + F +E+E
Sbjct: 6 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 451 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 506
+L ++H +++ G C G L+ EY+ GSL D L + + I + +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 121
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566
++ + +L K IHRD+ NIL+++ KIGD GL+ +L D F
Sbjct: 122 QICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 567 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
P+ + PE S SDV+++G+V+ +L T
Sbjct: 179 SPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 25/217 (11%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVL 452
WE +E ++ ++G G YG VY+G + + AVK L+ + ++ ++FL+E V+
Sbjct: 8 WE-MERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVM 63
Query: 453 SKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 510
+I+HP+L+ LLG C ++ E+M G+L D L R+ N + +A +++S
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISS 122
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG--- 567
A+ +L IHRD+ N L+ N + K+ D GLS ++ D TY
Sbjct: 123 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAK 173
Query: 568 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
P+ + PE S KSDV+A+G+++ ++ T
Sbjct: 174 FPIK---WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK 454
W + L + IG G +G V G + AVK + K + + FL E V+++
Sbjct: 16 WA-LNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQ 70
Query: 455 IRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
+RH +L+ LLG + +Y EYM GSL D L R + + + +V A
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEA 129
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG---P 568
+ +L +HRD+ N+L+ + V+K+ D GL+ + P
Sbjct: 130 MEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTGKLP 177
Query: 569 VGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
V + PE R S KSDV+++G+++ ++ +
Sbjct: 178 V---KWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 464
+G GG+ ++ + T A K++ K + ++ E+ + + H H++
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 465 G--ACPDHGCLVYEYMENGSLEDRL-YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
G D +V E SL + RK T P E ++ +LH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLRQIVLGCQYLHR---N 160
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
+IHRD+K GN+ L+ +L KIGD GL+T + D GT YI PE
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL------CGTPNYIAPEVLS 214
Query: 582 TGLISPKSDVYAYGMVILQLLTAKP 606
S + DV++ G ++ LL KP
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKP 239
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK---QFLQELEVLSKIRHP--HLLLL 463
IG GG V++ + A+K + + N+ + E+ L+K++ ++ L
Sbjct: 36 IGSGGSSKVFQV-LNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 464 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
+V E N L L +K I +ER + A+ +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG-- 147
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--- 578
I+H D+KP N L+ ++ K+ D G++ + D +T+ VGT+ Y+ PE
Sbjct: 148 -IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGTVNYMPPEAIK 201
Query: 579 --------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
+ ISPKSDV++ G ++ + K
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 26/222 (11%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 448
S + F+E IG G +G VY GT AVK L +I FL E
Sbjct: 19 VIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76
Query: 449 LEVLSKIRHPHLLLLLGACPDHG---CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 505
++ HP++L LLG C +V YM++G L + + +N T +
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFG 134
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYK 564
+VA + +L + K +HRD+ N +LD K+ D GL+ M + + Y
Sbjct: 135 LQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY------YS 185
Query: 565 NTGPVGTLCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 603
G + E +T + KSDV+++G+++ +L+T
Sbjct: 186 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 51/218 (23%), Positives = 95/218 (43%), Gaps = 21/218 (9%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQS-KGNIQNKQFLQEL 449
E L +G G +G V + AVK L+ G +E+
Sbjct: 17 HFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI 74
Query: 450 EVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 505
E+L + H +++ G C + G L+ E++ +GSL++ L N I ++ + A
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYA 132
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565
++ + +L + + +HRD+ N+L++ KIGD GL+ + +D + +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDR 189
Query: 566 TGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PV + PE SDV+++G+ + +LLT
Sbjct: 190 DSPV---FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 464
+G G + VY+ HT A+K++ K + ++ E+++ +++HP +L L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMI-DKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 465 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
D LV E NG + L + P E ++ + + +LH+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHS---HG 132
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
I+HRD+ N+LL N+ KI D GL+T L T GT YI PE
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL------CGTPNYISPEIATR 186
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
+SDV++ G + LL +P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRP 210
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSKGNIQNKQFLQELE 450
+ E L F + ++G G +G+V + AVK LQ + F +E+E
Sbjct: 37 QFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 451 VLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 506
+L ++H +++ G C G L+ EY+ GSL D L + + I + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTS 152
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566
++ + +L K IHRD+ NIL+++ KIGD GL+ +L D + YK
Sbjct: 153 QICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVK 205
Query: 567 G----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
P+ + PE S SDV+++G+V+ +L T
Sbjct: 206 EPGESPI---FWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 51/204 (25%), Positives = 77/204 (37%), Gaps = 21/204 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKI-RHPHLLLLL 464
R+G G YG V+K AVK S G + L E+ K+ +HP + L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 465 GA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
A L E SL+ +P + + + ALA LH+
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG--- 177
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
++H D+KP NI L K+GD GL L + G Y+ PE +
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-AGAGEVQ------EGDPRYMAPELLQG 230
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
+DV++ G+ IL++
Sbjct: 231 SY-GTAADVFSLGLTILEVACNME 253
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHP--HLLLLL 464
IG GG V++ + A+K L+ N + E+ L+K++ ++ L
Sbjct: 17 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 465 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+V E N L L +K I +ER + A+ +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 578
I+H D+KP N L+ ++ K+ D G++ + D +T+ VGT+ Y+ PE
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGTVNYMPPEAIKD 183
Query: 579 -------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
+ ISPKSDV++ G ++ + K
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 21/214 (9%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLS 453
WE + TL E R+G G +G V+ G + HT AVK L+ G++ FL E ++
Sbjct: 8 WE-VPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMK 63
Query: 454 KIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
+++H L+ L ++ EYMENGSL D L + + + + +A ++A +
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGM 122
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
AF+ IHRD++ NIL+ L KI D GL+ ++ + Y T G
Sbjct: 123 AFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN------EY--TAREGAK 171
Query: 573 CYID---PEYQRTGLISPKSDVYAYGMVILQLLT 603
I PE G + KSDV+++G+++ +++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-AVKVLQSKGNIQNKQFLQELEVLS 453
W I+ + L+F + IG G +G V+ G + + A+K ++ +G + + F++E EV+
Sbjct: 3 WV-IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMM 58
Query: 454 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
K+ HP L+ L G C + CLV E+ME+G L D Y + + +V
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG 116
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+A+L +IHRD+ N L+ N V K+ D G++ + D Y ++ GT
Sbjct: 117 MAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD------QYTSST--GT 165
Query: 572 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 603
+ PE S KSDV+++G+++ ++ +
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 70/336 (20%), Positives = 139/336 (41%), Gaps = 41/336 (12%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH------HTFAAVKVLQSK-GNIQNKQFLQ 447
++ + +G G +GTVYKG + A+K L+ NK+ L
Sbjct: 9 LRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 66
Query: 448 ELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 506
E V++ + +PH+ LLG C L+ + M G L D + + + I
Sbjct: 67 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCV 124
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566
++A + +L + + ++HRD+ N+L+ KI D GL+ +L ++ Y
Sbjct: 125 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAE 177
Query: 567 G---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDE 620
G P+ ++ E + + +SDV++YG+ + +L+T +KP I ++ + +++
Sbjct: 178 GGKVPIK---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
Query: 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARD 680
E L P T ++ + + C + RP + +++ ++ R
Sbjct: 235 G---ERLPQ-----PPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQRYLV 285
Query: 681 TVPSVHPAPPN----HFICPILKEVMNEPCVAADGY 712
P+ +F ++ E + V AD Y
Sbjct: 286 IQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY 321
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 448
S + F+E IG G +G VY GT AVK L +I FL E
Sbjct: 83 VIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140
Query: 449 LEVLSKIRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIA 505
++ HP++L LLG C YM++G L + + +N T +
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFG 198
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYK 564
+VA + FL + K +HRD+ N +LD K+ D GL+ M + + + +
Sbjct: 199 LQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF---DSVHN 252
Query: 565 NTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
TG PV ++ E +T + KSDV+++G+++ +L+T
Sbjct: 253 KTGAKLPV---KWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 20/212 (9%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKI 455
EI +L + ++G G +G V+ T++ HT AVK ++ G++ + FL E V+ +
Sbjct: 184 EIPRESLKLEK--KLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 240
Query: 456 RHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
+H L+ L ++ E+M GSL D L + + P + + ++A +AF
Sbjct: 241 QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
+ + IHRD++ NIL+ +LV KI D GL+ ++ + Y T G
Sbjct: 300 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDN------EY--TAREGAKFP 348
Query: 575 ID---PEYQRTGLISPKSDVYAYGMVILQLLT 603
I PE G + KSDV+++G+++++++T
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 59/244 (24%), Positives = 109/244 (44%), Gaps = 22/244 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRHPHLLLLLGA 466
+G G G V+K + + A K++ + Q ++EL+VL + P+++ GA
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 467 CPDHGCLVY--EYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 522
G + E+M+ GSL+ + +K IP E+ +++ V L +L
Sbjct: 100 FYSDGEISICMEHMDGGSLDQ-VLKKAG--RIP--EQILGKVSIAVIKGLTYLREKHK-- 152
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
I+HRD+KP NIL++ K+ D G+S L ++ ++ VGT Y+ PE +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSF-----VGTRSYMSPERLQG 204
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642
S +SD+++ G+ ++++ + I E + E A+ P + L
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 643 AALG 646
G
Sbjct: 265 NKFG 268
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 18/217 (8%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGNIQNKQ-FLQELE 450
I + + IG G +G VY G + + A+K L +Q + FL+E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGL 74
Query: 451 VLSKIRHPHLLLLLGACPDHGCLVY---EYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 507
++ + HP++L L+G L + YM +G L + ++ + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQ 132
Query: 508 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSFVSTTYKNT 566
VA + +L K +HRD+ N +LD + K+ D GL+ +L+ + V
Sbjct: 133 VARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 567 GPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PV + E +T + KSDV+++G+++ +LLT
Sbjct: 190 LPVK---WTALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 54/215 (25%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLS 453
E ++ ++ + +G G +G V G + AVK+++ +G++ +F QE + +
Sbjct: 3 ME-LKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMM 58
Query: 454 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
K+ HP L+ G C +V EY+ NG L + Y +++ + + + ++V
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+AFL + IHRD+ N L+D +L K+ D G++ + D Y ++ GT
Sbjct: 117 MAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD------QYVSSV--GT 165
Query: 572 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 603
+ PE S KSDV+A+G+++ ++ +
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLS 453
WE I+ L+F + +G G +G V G + A+K+++ +G++ +F++E +V+
Sbjct: 19 WE-IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMM 74
Query: 454 KIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
+ H L+ L G C ++ EYM NG L + Y + + + +V A
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEA 132
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+ +L + + +HRD+ N L++ V K+ D GLS + D Y T VG+
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD------EY--TSSVGS 181
Query: 572 LCYID---PEYQRTGLISPKSDVYAYGMVILQLLT 603
+ PE S KSD++A+G+++ ++ +
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-28
Identities = 34/162 (20%), Positives = 59/162 (36%), Gaps = 11/162 (6%)
Query: 600 QLLTAKPAI---AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKD 656
L AK ++ + L + + + + + + ++ +
Sbjct: 18 ALRIAKKKRWNSIEEKRISQENELHAYLSKLILAEKERELDDRVKQSDDSQNGGDISKMK 77
Query: 657 RPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDR 716
++ L ++ L D R P++ I E+M EPC+ G TYDR
Sbjct: 78 --SKHDKYLMDMDELFSQVDEKRKKRE-----IPDYLCGKISFELMREPCITPSGITYDR 130
Query: 717 KAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
K IEE LQ P+T PL L+PN + I + +
Sbjct: 131 KDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQE 172
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 32/215 (14%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHP--HLLLLL 464
IG GG V++ + A+K L+ N + E+ L+K++ ++ L
Sbjct: 64 IGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 465 GACPDHGCLVYEYME--NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ Y ME N L L +K I +ER + A+ +H
Sbjct: 123 DYEITDQYI-YMVMECGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG--- 175
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 578
I+H D+KP N L+ ++ K+ D G++ + D +T+ VG + Y+ PE
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPD----TTSVVKDSQVGAVNYMPPEAIKD 230
Query: 579 -------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
+ ISPKSDV++ G ++ + K
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 71/299 (23%), Positives = 118/299 (39%), Gaps = 31/299 (10%)
Query: 393 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQS---KGNIQNKQ 444
LT I L E ++G G +G V +G + AVK L+
Sbjct: 11 LTCL-IGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 445 FLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 503
F++E+ + + H +L+ L G +V E GSL DRL + + R
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSR 125
Query: 504 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563
A +VA + +L + K IHRD+ N+LL + KIGD GL L +
Sbjct: 126 YAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT--AKPAIAIT-HKVETAIDE 620
P + PE +T S SD + +G+ + ++ T +P I + ++ ID+
Sbjct: 183 HRKVPFA---WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239
Query: 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 679
+ E L P +++ + + C + +DRP + L + RA
Sbjct: 240 EG--ERLPR-----PEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEAQPTDMRAE 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 58/288 (20%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGAC 467
+ GG+ VY+ + A+K L S +N+ +QE+ + K+ HP+++ A
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 468 ---------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
L+ + G L + L + + P+ +I ++ A+ +H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP------VGTL 572
KP PIIHRD+K N+LL + K+ D G +T ++ P + + + T
Sbjct: 156 KP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 573 CYIDPE----YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628
Y PE Y I K D++A G ++ L + ++ I++
Sbjct: 215 MYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQ----------HPFEDGAKLRIVN 263
Query: 629 AQAGDWPIKET--KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674
+ P +T +L + ++ ++R + +V+ L+ +
Sbjct: 264 GK-YSIPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAA 309
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQN--KQFLQEL 449
I + +G G +G+V + AVK+L++ + ++FL+E
Sbjct: 19 LIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 450 EVLSKIRHPHLLLLLGACPDHG--------CLVYEYMENGSLED--RLYRKNNTPPIPWF 499
+ + HPH+ L+G ++ +M++G L R P
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 500 ER-YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPS 557
+ R ++A + +L + IHRD+ N +L ++ + D GLS + + D
Sbjct: 137 QTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-- 191
Query: 558 FVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
Y+ PV ++ E L + SDV+A+G+ + +++T
Sbjct: 192 ----YYRQGCASKLPV---KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 28/224 (12%)
Query: 388 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA------AVKVL-QSKGNI 440
Q T E I + ++ + IG G +G VYKG + A+K L
Sbjct: 32 QAVLKFTTE-IHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK 88
Query: 441 QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPW 498
Q FL E ++ + H +++ L G + ++ EYMENG+L+ + +
Sbjct: 89 QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSV 146
Query: 499 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558
+ + +A+ + +L N +HRD+ NIL++ NLV K+ D GLS +L DP
Sbjct: 147 LQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-- 201
Query: 559 VSTTYKNTG---PVG-TLCYIDPEYQRTGLISPKSDVYAYGMVI 598
TY +G P+ T PE + SDV+++G+V+
Sbjct: 202 -EATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVM 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 48/219 (21%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQNKQ-FLQE 448
+ I + + +G G +G VY+G + + AVK + + NK+ F+ E
Sbjct: 7 YG-IAREDVVLNR--ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSE 63
Query: 449 LEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 507
++ + HPH++ L+G + ++ E G L L + N + + +
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQ 121
Query: 508 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 567
+ A+A+L + +HRD+ NIL+ K+GD GLS + + YK +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----DYYKASV 173
Query: 568 ---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
P+ ++ PE + SDV+ + + + ++L+
Sbjct: 174 TRLPIK---WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 31/222 (13%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA------AVKVLQSKGNIQNKQ-FLQEL 449
L +G G +G V + T AVK L++ Q++ + QE+
Sbjct: 27 VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI 84
Query: 450 EVLSKIRHPHLLLLLGACPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIA 505
++L + H H++ G C D G LV EY+ GSL D L +++ I + A
Sbjct: 85 DILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHS---IGLAQLLLFA 140
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565
++ +A+LH IHRD+ N+LLD++ + KIGD GL+ + + Y+
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRV 193
Query: 566 TG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PV + PE + SDV+++G+ + +LLT
Sbjct: 194 REDGDSPV---FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 50/217 (23%), Positives = 99/217 (45%), Gaps = 25/217 (11%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQNKQ-FLQELE 450
EI+ + IG G +G V++G + A+K ++ + ++ FLQE
Sbjct: 11 EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 451 VLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVA 509
+ + HPH++ L+G ++ ++ E G L + + + A++++
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLS 126
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG-- 567
+ALA+L + + +HRD+ N+L+ N K+GD GLS + T YK +
Sbjct: 127 TALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGK 178
Query: 568 -PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
P+ ++ PE + SDV+ +G+ + ++L
Sbjct: 179 LPIK---WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 60/252 (23%), Positives = 110/252 (43%), Gaps = 48/252 (19%)
Query: 378 MLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQ 435
M+ + +N RY +I ++G GG TVY + A+K +
Sbjct: 4 MIGKIINE---RY------KIVD---------KLGGGGMSTVYLAEDTILNIKVAIKAIF 45
Query: 436 SKGNIQNKQFL----QELEVLSKIRHPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYR 489
+ ++ L +E+ S++ H +++ ++ + C LV EY+E +L + +
Sbjct: 46 IPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES 104
Query: 490 KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
P+ ++ + H+ + I+HRD+KP NIL+D N KI D G++
Sbjct: 105 HG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA 158
Query: 550 TMLNSDPSFVSTTYKNTGPV-GTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP-- 606
L+ T+ T V GT+ Y PE + +D+Y+ G+V+ ++L +P
Sbjct: 159 KALS------ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 607 ------AIAITH 612
+IAI H
Sbjct: 213 NGETAVSIAIKH 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 388 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVL-QSKGNIQ 441
+ R+ T E IE++ + + IG G G V G A+K L Q
Sbjct: 37 RAGRSFTRE-IEASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ 93
Query: 442 NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF 499
+ FL E ++ + HP+++ L G +V EYMENGSL+ + + +
Sbjct: 94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIM 151
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559
+ + V + + +L + +HRD+ N+L+D NLV K+ D GLS +L DP
Sbjct: 152 QLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP--- 205
Query: 560 STTYKNTG---PVG-TLCYIDPEYQRTGLISPKSDVYAYGMVI 598
Y TG P+ T PE S SDV+++G+V+
Sbjct: 206 DAAYTTTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVM 244
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 34/223 (15%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 448
E+ ++ S +G G +G VY+G T A+K + +++ + FL E
Sbjct: 21 EVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 449 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED-------RLYRKNNTPPIPWF 499
V+ + H++ LLG ++ E M G L+ + P
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559
+ ++A E+A +A+L+ +HRD+ N ++ + KIGD G++ +
Sbjct: 139 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET---- 191
Query: 560 STTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
Y+ G PV ++ PE + G+ + SDV+++G+V+
Sbjct: 192 -DYYRKGGKGLLPV---RWMSPESLKDGVFTTYSDVWSFGVVL 230
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQ-FLQELEV 451
++ L ++ + +G G +G+V +G + A+KVL+ + + ++E ++
Sbjct: 5 FLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 452 LSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVAS 510
+ ++ +P+++ L+G C LV E G L L IP + +V+
Sbjct: 64 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSM 121
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 570
+ +L K +HRD+ N+LL + +KI D GLS L +D S+ + P+
Sbjct: 122 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 571 TLCYIDPEYQRTGLISPKSDVYAYGMVI 598
+ PE S +SDV++YG+ +
Sbjct: 179 ---WYAPECINFRKFSSRSDVWSYGVTM 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 45/247 (18%), Positives = 91/247 (36%), Gaps = 22/247 (8%)
Query: 435 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNN 492
++ + + + L L + +L+D + R+ +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 493 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552
I ++A A+ FLH+ ++HRD+KP NI + V K+GD GL T +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 553 NSDPSFVST------TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
+ D + +TG VGT Y+ PE S K D+++ G+++ +LL +
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 607 AIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL- 665
++ T + + ++ + + +RP+ ++
Sbjct: 275 TQMERVRIITDVRNLKFPLL--------FTQKYPQEHMMVQDMLSPSPTERPEA-TDIIE 325
Query: 666 -PVLERL 671
+ E L
Sbjct: 326 NAIFENL 332
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-27
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLL-- 464
R+G GG+G V + T A+K + + + +N++ E++++ K+ HP+++
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 465 ------GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
A D L EY E G L L + N + + +++SAL +LH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 519 KPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
+ IIHRD+KP NI+L L+ KI D+G + L+ + VGTL Y+
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEF------VGTLQYL 190
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE + D +++G + + +T
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-27
Identities = 55/297 (18%), Positives = 104/297 (35%), Gaps = 50/297 (16%)
Query: 410 RIGMGGYGTVYKGTFHHTFA---AVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLL- 464
I GG G +Y + +K L G+ + + + E + L+++ HP ++ +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 465 -GACPDHGC-----LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
D +V EY+ SL+ + +P E E+ AL++LH+
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS- 200
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDP 577
+++ D+KP NI+L + K+ D+G + +NS G + GT + P
Sbjct: 201 --IGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINS-----------FGYLYGTPGFQAP 246
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637
E + +D+Y G + L P + D+ +K
Sbjct: 247 E-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDP-------------VLK 292
Query: 638 ETKELAALGLSCAELRRKDRP----DLKNQVLPVLERLKEVADRARDTVPSVHPAPP 690
L + + R ++ Q+ VL + S +P
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPS 349
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 36/229 (15%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGNIQN--KQFLQEL 449
I+ L + +G G +G+V +G AVK ++ + Q ++FL E
Sbjct: 30 VIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87
Query: 450 EVLSKIRHPHLLLLLGACPDHGC-------LVYEYMENGSLED--RLYR-KNNTPPIPWF 499
+ HP+++ LLG C + ++ +M+ G L R + IP
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNSDPSF 558
+ ++A + +L N +HRD+ N +L ++ + D GLS + + D
Sbjct: 148 TLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD--- 201
Query: 559 VSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
Y+ PV +I E + + KSDV+A+G+ + ++ T
Sbjct: 202 ---YYRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 19/219 (8%)
Query: 388 QRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVL-QSKGNIQ 441
Q E +++ +S + +G G +G V G A+K L Q
Sbjct: 33 QTVHEFAKE-LDATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 442 NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWF 499
+ FL E ++ + HP+++ L G +V EYMENGSL+ + + +
Sbjct: 90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVI 147
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559
+ + +AS + +L + +HRD+ NIL++ NLV K+ D GL +L DP
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
TT P+ + PE + SDV++YG+V+
Sbjct: 205 YTTRGGKIPIR---WTSPEAIAYRKFTSASDVWSYGIVL 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQEL 449
I+ + +G G +G V+ + AVK L+ K F +E
Sbjct: 11 HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 68
Query: 450 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERYR-- 503
E+L+ ++H H++ G C D +V+EYM++G L R + + + R
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 504 ---------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554
IA ++AS + +L + +HRD+ N L+ NL+ KIGD G+S + S
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 555 DPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
Y+ G P+ ++ PE + +SDV+++G++
Sbjct: 186 TD-----YYRVGGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVI 224
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEV-LSKIRHPHLLLLLG 465
+G G YG V K + AVK +++ N Q K+ L +L++ + + P + G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 521
A G + E M + SL D+ Y++ E +IA + AL LH+ K
Sbjct: 74 ALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLS 130
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 576
+IHRD+KP N+L++ K+ D G+S L V K+ G Y I+
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDID-AGCKPYMAPERIN 182
Query: 577 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE + G S KSD+++ G+ +++L +
Sbjct: 183 PELNQKGY-SVKSDIWSLGITMIELAILRF 211
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 44/233 (18%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 446
WE LSF + +G G +G V + T + AVK+L+ ++ ++ +
Sbjct: 18 WE-FPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 447 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER 501
EL+VLS + H +++ LLGAC G ++ EY G L + R R +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 502 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
+++VA +AFL + IHRD+ NILL H ++KI D GL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191
Query: 549 STMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
+ + +D Y G PV ++ PE + + +SDV++YG+
Sbjct: 192 ARDIKNDS-----NYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGIF 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 51/229 (22%), Positives = 102/229 (44%), Gaps = 26/229 (11%)
Query: 385 GTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKGN 439
T+ +E I+ + IG G +G V++G + A+K ++ +
Sbjct: 375 DTYTMPSTRDYE-IQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS 431
Query: 440 IQNKQ-FLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYMENGSLEDRLYRKNNTPPIP 497
++ FLQE + + HPH++ L+G ++ ++ E G L + + +
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRS--FLQVRKFSLD 489
Query: 498 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557
A+++++ALA+L + + +HRD+ N+L+ N K+GD GLS +
Sbjct: 490 LASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-- 544
Query: 558 FVSTTYKNTG---PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
T YK + P+ ++ PE + SDV+ +G+ + ++L
Sbjct: 545 ---TYYKASKGKLPIK---WMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 18/220 (8%)
Query: 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQ-- 444
R ++ L+ E+ +G G +GTV KG + AVK+L+++ N +
Sbjct: 7 RPKEVY-LDRKLLTL-EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 445 FLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR 503
L E V+ ++ +P+++ ++G C LV E E G L L ++N
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL-QQNRHVKDKNI--IE 121
Query: 504 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563
+ +V+ + +L +HRD+ N+LL +KI D GLS L +D ++
Sbjct: 122 LVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 178
Query: 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT 603
PV + PE S KSDV+++G+++ + +
Sbjct: 179 HGKWPVK---WYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 464
+G G +G VY + A+KVL K ++ Q +E+E+ S +RHP++L L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 465 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G D L+ EY G++ L + + E+A+AL++ H+ K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ---RTATYITELANALSYCHS---KR 129
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+IHRD+KP N+LL KI D G S S S + GTL Y+ PE
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDL------CGTLDYLPPEMIEG 181
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
+ K D+++ G++ + L KP
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 52/269 (19%), Positives = 96/269 (35%), Gaps = 30/269 (11%)
Query: 353 ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-- 410
S + Q AK + L+R T L E+++ + E +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 411 -----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G +G V++ T AVK ++ + +EL + + P ++ L
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV-----EELVACAGLSSPRIVPL 115
Query: 464 LGACPDHGCL--VYEYMENGSLEDRL--YRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
GA + + E +E GSL + ++ + L +LH +
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-----QALEGLEYLHTRR 170
Query: 520 PKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I+H D+K N+LL + + D G + L D S + GT ++ PE
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY-IPGTETHMAPE 226
Query: 579 -YQRTGLISPKSDVYAYGMVILQLLTAKP 606
K D+++ ++L +L
Sbjct: 227 VVMGKP-CDAKVDIWSSCCMMLHMLNGCH 254
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQFLQEL 449
I+ + +G G +G V+ H+ AVK L+ + F +E
Sbjct: 37 HIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 450 EVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRL------------YRKNNTPP 495
E+L+ ++H H++ G C + +V+EYM +G L L P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 496 IPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS-TMLNS 554
+ + +A +VA+ + +L +HRD+ N L+ LV KIGD G+S + ++
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 555 DPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
D Y+ G P+ ++ PE + +SDV+++G+V
Sbjct: 212 D------YYRVGGRTMLPI---RWMPPESILYRKFTTESDVWSFGVV 249
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEVLSK-IRHPHLLLLLG 465
+G G G V+K F T AVK ++ GN + NK+ L +L+V+ K P+++ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 521
+ + E M E R PIP ER ++ + AL +L
Sbjct: 92 TFITNTDVFIAMELM-GTCAEKLKKRMQG--PIP--ERILGKMTVAIVKALYYLKEKHG- 145
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 576
+IHRD+KP NILLD K+ D G+S L V K+ G Y ID
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRL------VDDKAKDRS-AGCAAYMAPERID 197
Query: 577 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
P ++DV++ G+ +++L T +
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQF 227
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 43/233 (18%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 446
WE L + +G G +G V + AVK+L+ + +
Sbjct: 22 WE-FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 447 QELEVLSKI-RHPHLLLLLGACPDHG---CLVYEYMENGSLED--RLYRKNNTPPIPWFE 500
EL++L I H +++ LLGAC G ++ E+ + G+L R R P E
Sbjct: 79 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 501 RYR-----------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
+++VA + FL + K IHRD+ NILL V KI D GL+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 550 TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
+ DP Y G P+ ++ PE + + +SDV+++G+++
Sbjct: 196 RDIYKDP-----DYVRKGDARLPL---KWMAPETIFDRVYTIQSDVWSFGVLL 240
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
+G G YG VY G A+K + + + ++ +E+ + ++H +++ LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 469 DHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 524
++G + E + GSL L ++ P+ E+ ++ L +LH+ + I+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 525 HRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQR 581
HRD+K N+L++ ++ V KI D G S L T GTL Y+ PE +
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF------TGTLQYMAPEIIDKG 198
Query: 582 TGLISPKSDVYAYGMVILQLLTAKP 606
+D+++ G I+++ T KP
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKP 223
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 62/228 (27%), Positives = 97/228 (42%), Gaps = 41/228 (17%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQ-FLQEL 449
+ ++ + F + IG G +G V K AA+K ++ + + + F EL
Sbjct: 19 YPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 76
Query: 450 EVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY---- 502
EVL K+ HP+++ LLGAC G L EY +G+L D L + P F
Sbjct: 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 503 ---------RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553
A +VA + +L + IHRD+ NIL+ N V+KI D GLS
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR--G 191
Query: 554 SDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
+ Y PV ++ E + + SDV++YG++
Sbjct: 192 QE------VYVKKTMGRLPV---RWMAIESLNYSVYTTNSDVWSYGVL 230
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 15/208 (7%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
IG G V A+K + K + L+E++ +S+ HP+++ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 467 --CPDHGCLVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTK 519
D LV + + GS+ D + + IA EV L +LH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 578
IHRD+K GNILL + +I D G+S L + + T VGT C++ PE
Sbjct: 142 ---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF-VGTPCWMAPEV 197
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKP 606
++ K+D++++G+ ++L T
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAA 225
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 38/223 (17%)
Query: 411 IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN------------------KQFLQELEVL 452
+ G + + + F A+K K ++ F EL+++
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKY-EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 453 SKIRHPHLLLLLG--ACPDHGCLVYEYMENGSLEDRL-----YRKNNTPPIPWFERYRIA 505
+ I++ + L G D ++YEYMEN S+ KN T IP I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565
V ++ +++HN K I HRD+KP NIL+D N K+ D G S + + +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD--KKIKGS--- 210
Query: 566 TGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVILQLLTAKP 606
GT ++ PE + K D+++ G+ + +
Sbjct: 211 ---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 49/238 (20%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 446
WE L + +G G +G V K T H T AVK+L+ + + L
Sbjct: 18 WE-FPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL 74
Query: 447 QELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFERY 502
E VL ++ HPH++ L GAC G L+ EY + GSL R RK +
Sbjct: 75 SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 503 -------------------RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543
AW+++ + +L K ++HRD+ NIL+ KI
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKI 191
Query: 544 GDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
D GLS + + +Y PV ++ E + + +SDV+++G++
Sbjct: 192 SDFGLSRDVYEED-----SYVKRSQGRIPV---KWMAIESLFDHIYTTQSDVWSFGVL 241
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 51/241 (21%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELE 450
+ E+E +IG G +G+V+K A+K G++ + L+E+
Sbjct: 13 FHELE----------KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 451 VLSKI-RHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTP-PIPWFERYRIAW 506
+ + +H H++ A + + EY GSL D + E +
Sbjct: 63 AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHN-------------------LVSKIGDVG 547
+V L ++H+ ++H D+KP NI + ++ KIGD+G
Sbjct: 123 QVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTGLISPKSDVYAYGMVILQLLTAKP 606
T ++S G ++ E Q PK+D++A + ++ A+P
Sbjct: 180 HVTRISSPQVE----------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229
Query: 607 A 607
Sbjct: 230 L 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQ- 444
WE L+ + +G G +G V AVK+L+ ++
Sbjct: 30 WE-FPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 86
Query: 445 FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 501
+ E+E++ I +H +++ LLGAC G ++ EY G+L + L + ++
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 502 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
R +++A + +L + K IHRD+ N+L+ N V KI D GL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 203
Query: 549 S-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
+ + N D YK T PV ++ PE + + +SDV+++G+++
Sbjct: 204 ARDINNID------YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLM 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 51/234 (21%), Positives = 95/234 (40%), Gaps = 35/234 (14%)
Query: 386 TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG 438
+ E + ++ +G G +G VY+G AVK L
Sbjct: 16 GKTSSISDLKE-VPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC 72
Query: 439 NIQNKQ-FLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNT 493
+ Q++ FL E ++SK H +++ +G ++ E M G L+ R R +
Sbjct: 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS 132
Query: 494 --PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGL 548
+ + +A ++A +L IHRD+ N LL V+KIGD G+
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 549 STMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
+ + + Y+ G PV ++ PE G+ + K+D +++G+++
Sbjct: 190 ARDIYRA-----SYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLL 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-26
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 24/213 (11%)
Query: 403 LSFSENLRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHL 460
+SF +G G GT VY+G F + AVK + + +E+++L + HP++
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNV 80
Query: 461 LLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
+ D + E +L++ + +K+ E + + S LA LH+
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL--EPITLLQQTTSGLAHLHSL 137
Query: 519 KPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
I+HRD+KP NIL+ + + I D GL L + + +G GT
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR---HSFSRRSGVPGTEG 191
Query: 574 YIDPEY---QRTGLISPKSDVYAYGMVILQLLT 603
+I PE + D+++ G V +++
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 51/228 (22%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 393 LTWEEIESATLSFSENLRIGMGGYGTVYKGTF---------HHTFAAVKVLQSKGNIQNK 443
+ + I + L F+E +G G + ++KG H T +KVL ++
Sbjct: 1 VFHK-IRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE 57
Query: 444 QFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 501
F + ++SK+ H HL+L G C LV E+++ GSL+ L + N I W
Sbjct: 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK-- 115
Query: 502 YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--------HNLVSKIGDVGLSTMLN 553
+A ++A+A+ FL +IH ++ NILL + K+ D G+S +
Sbjct: 116 LEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 554 SDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVI 598
+ + ++ PE + ++ +D +++G +
Sbjct: 173 PK-----DILQ--ERIP---WVPPECIENPKN--LNLATDKWSFGTTL 208
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 40/230 (17%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQ-FL 446
WE L F + L G G +G V + T AVK+L+S + K+ +
Sbjct: 41 WE-FPRNNLQFGKTL--GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 447 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNT---------- 493
EL+++S + +H +++ LLGAC G ++ EY G L + L RK+
Sbjct: 98 SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 494 -PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552
+ + +VA +AFL + IHRD+ N+LL + V+KIGD GL+ +
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 553 NSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
+D Y G PV ++ PE + + +SDV++YG+++
Sbjct: 215 MNDS-----NYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILL 256
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-26
Identities = 38/233 (16%), Positives = 73/233 (31%), Gaps = 29/233 (12%)
Query: 396 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQFLQE 448
E + + + +G G + VY+ T +KV + + Q
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 449 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRL--YRKNNTPPIPWFERYRI 504
+E L + A + LV E G+L + + Y+ +P
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS-----------KIGDVGLSTMLN 553
A + + +H+ + IIH D+KP N +L + + + D+G S +
Sbjct: 178 AMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
P T T + E + + D + + +L
Sbjct: 235 LFPKGTIF----TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 59/210 (28%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ-NKQFLQELEV-LSKIRHPHLLLLLG 465
IG G YG+V K + AVK ++S + + KQ L +L+V + P+++ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 521
A G E M + S + + E +I AL L
Sbjct: 89 ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY-----ID 576
IIHRD+KP NILLD + K+ D G+S L + T G Y ID
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQL-------VDSIAKTRDAGCRPYMAPERID 198
Query: 577 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
P R G +SDV++ G+ + +L T +
Sbjct: 199 PSASRQGY-DVRSDVWSLGITLYELATGRF 227
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 40/228 (17%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVLQSKGNIQNKQ-FLQE 448
EI + + F E +G +G VYKG A+K L+ K ++ F E
Sbjct: 5 EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 449 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYR--- 503
+ ++++HP+++ LLG +++ Y +G L + L ++ + + R
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 504 ----------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553
+ ++A+ + +L + ++H+D+ N+L+ L KI D+GL +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 554 SDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
+ + YK G P+ ++ PE G S SD+++YG+V
Sbjct: 180 A-----ADYYKLLGNSLLPI---RWMAPEAIMYGKFSIDSDIWSYGVV 219
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 410 RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 462
+G GG V+ H AVKVL + ++ F +E + + + HP ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL--RADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 463 LLGACPDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
+ +V EY++ +L D ++ + P+ + + AL F H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH 133
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYI 575
IIHRD+KP NI++ K+ D G++ + + T V GT Y+
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADS----GNSVTQTAAVIGTAQYL 186
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKP--------AIAITH 612
PE R + +SDVY+ G V+ ++LT +P ++A H
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 231
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 63/239 (26%), Positives = 107/239 (44%), Gaps = 49/239 (20%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FL 446
WE L F + +G G +G V T + AVK+L+ K + ++ +
Sbjct: 40 WE-FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM 96
Query: 447 QELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER 501
EL++++++ H +++ LLGAC G L++EY G L + R R+ + +E
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 502 YR------------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543
+ A++VA + FL +HRD+ N+L+ H V KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKI 213
Query: 544 GDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
D GL+ + SD Y G PV ++ PE G+ + KSDV++YG+++
Sbjct: 214 CDFGLARDIMSDS-----NYVVRGNARLPV---KWMAPESLFEGIYTIKSDVWSYGILL 264
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 30/296 (10%), Positives = 76/296 (25%), Gaps = 61/296 (20%)
Query: 356 EKEAAQRQEAEMKAKHEAKEK--EMLERALNGTFQRYRNLTWEEIESATLSFSENLR--- 410
+ +E + EA ++ M+E + + T ++S L+
Sbjct: 12 RDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETT---VDSLLSQGERKLKLVE 68
Query: 411 -IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 464
+ +G V+ A+KV ++ + +++
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 465 GACP----------------------------DHGCLVYEYMENGSLEDRL----YRKNN 492
+ L+ LE +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVF 187
Query: 493 TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552
+ + ++ A L + K ++H P N+ + + +GDV +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 553 NSDPSFVSTTYKNTGPVGTLCYIDPEY--QRTGLISPKSDVYAYGMVILQLLTAKP 606
+ + + Y E+ T + + + G+ I ++
Sbjct: 245 GT---------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 50/237 (21%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 448
E + + IG G +G V++ T AVK+L+ + + + F +E
Sbjct: 43 EYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 100
Query: 449 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRL------------------- 487
++++ +P+++ LLG C CL++EYM G L + L
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 488 --YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545
PP+ E+ IA +VA+ +A+L K +HRD+ N L+ N+V KI D
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIAD 217
Query: 546 VGLS-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMV 597
GLS + ++D YK G P+ ++ PE + +SDV+AYG+V
Sbjct: 218 FGLSRNIYSAD------YYKADGNDAIPI---RWMPPESIFYNRYTTESDVWAYGVV 265
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/243 (23%), Positives = 104/243 (42%), Gaps = 44/243 (18%)
Query: 386 TFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQS 436
++ + WE + L + +G G +G V T AVK+L+S
Sbjct: 55 EYELPEDPRWE-LPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS 111
Query: 437 KGNIQNKQ-FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNN 492
++ + E+E++ I +H +++ LLGAC G ++ EY G+L + L +
Sbjct: 112 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 171
Query: 493 TPPIPWFERYR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 539
+ A++VA + +L + K IHRD+ N+L+ +
Sbjct: 172 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDN 228
Query: 540 VSKIGDVGLSTMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYG 595
V KI D GL+ ++ YK T PV ++ PE + + +SDV+++G
Sbjct: 229 VMKIADFGLARDIHHID-----YYKKTTNGRLPV---KWMAPEALFDRIYTHQSDVWSFG 280
Query: 596 MVI 598
+++
Sbjct: 281 VLL 283
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 448
E+ ++ +G G +G VY+G AVK L + Q++ FL E
Sbjct: 67 EVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLME 124
Query: 449 LEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLED--RLYRKNNTPPIPWFER--Y 502
++SK H +++ +G ++ E M G L+ R R + P
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 503 RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNSDPSFV 559
+A ++A +L IHRD+ N LL V+KIGD G++ +
Sbjct: 185 HVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA---- 237
Query: 560 STTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
Y+ G PV ++ PE G+ + K+D +++G+++
Sbjct: 238 -GYYRKGGCAMLPV---KWMPPEAFMEGIFTSKTDTWSFGVLL 276
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-25
Identities = 48/202 (23%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 408 NLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLL 462
++ +G G +G+V +G + A+KVL+ + + ++E +++ ++ +P+++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 463 LLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
L+G C LV E G L + IP + +V+ + +L K
Sbjct: 401 LIGVCQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYLEE---K 455
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
+HR++ N+LL + +KI D GLS L +D S+ + P+ + PE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK---WYAPECIN 512
Query: 582 TGLISPKSDVYAYGMVILQLLT 603
S +SDV++YG+ + + L+
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 56/235 (23%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQ- 444
WE L+ + +G G +G V AVK+L+ ++
Sbjct: 76 WE-FPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD 132
Query: 445 FLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFER 501
+ E+E++ I +H +++ LLGAC G ++ EY G+L + L + ++
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 502 YR-------------IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
R +++A + +L + K IHRD+ N+L+ N V KI D GL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 249
Query: 549 S-TMLNSDPSFVSTTYKNTG----PVGTLCYIDPEYQRTGLISPKSDVYAYGMVI 598
+ + N D YK T PV ++ PE + + +SDV+++G+++
Sbjct: 250 ARDINNID------YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLM 295
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 23/204 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLLLL 464
+G G +G VY A+KVL K ++ Q +E+E+ S +RHP++L +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 465 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
D L+ E+ G L L + E+A AL + H +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ---RSATFMEELADALHYCHE---RK 134
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+IHRD+KP N+L+ + KI D G S + T GTL Y+ PE
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTM------CGTLDYLPPEMIEG 186
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
K D++ G++ + L P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMP 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 35/222 (15%)
Query: 410 RIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN-----KQFLQELEVLSKIRHPHL 460
+G GG G VY+ T A+K++ + + + +E +++ PH+
Sbjct: 41 LVGRGGMGDVYEA--EDTVRERIVALKLM--SETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 461 LLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
+ + G + + L L R+ P+ I ++ SAL H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA 153
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV-GTLCYIDP 577
HRD+KP NIL+ + + + D G+++ G GTL Y+ P
Sbjct: 154 G---ATHRDVKPENILVSADDFAYLVDFGIASATT------DEKLTQLGNTVGTLYYMAP 204
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKP-------AIAITH 612
E + ++D+YA V+ + LT P ++ H
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 6e-25
Identities = 33/314 (10%), Positives = 79/314 (25%), Gaps = 53/314 (16%)
Query: 337 EKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWE 396
+ Y R + E+ + +A ++ E + + + E
Sbjct: 11 RENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVE 70
Query: 397 -EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ--------- 444
E+ + +G + T T V V +
Sbjct: 71 SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 130
Query: 445 -------------------FLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYMENG 481
F+ +++ + ++ + D +Y M+
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-S 189
Query: 482 SLEDRL----YRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH 537
+L+ + + R ++ +V LA LH+ ++H ++P +I+LD
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQ 246
Query: 538 NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-----YQRTGLISPKSDVY 592
+ + L++ D +
Sbjct: 247 RGGVFLTGFEHLVRDGASAVSPIGR-----GFAPPETTAERMLPFGQHHPTLMTFAFDTW 301
Query: 593 AYGMVILQLLTAKP 606
G+ I + A
Sbjct: 302 TLGLAIYWIWCADL 315
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 411 IGMGGYGTV-YKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC- 467
+G G GTV ++G+F AVK + L E+++L++ HP+++ +
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 468 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEV----ASALAFLHNTKPKP 522
+ E +L+D + KN + ++ + AS +A LH+ K
Sbjct: 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--- 135
Query: 523 IIHRDMKPGNILLDH-------------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPV 569
IIHRD+KP NIL+ NL I D GL L+S S T P
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN--NPS 193
Query: 570 GTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLT 603
GT + PE Q ++ D+++ G V +L+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 19/207 (9%)
Query: 412 GMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA- 466
G TV + T + V+ L++ N EL V HP+++
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 467 -CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 522
+ +V +M GS +D L + + E IA+ V AL ++H+
Sbjct: 96 IADNELWVVTSFMAYGSAKD-LICTHFMDGMN--ELA-IAYILQGVLKALDYIHHMG--- 148
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP-VGTLCYIDPE--Y 579
+HR +K +IL+ + + + + + S + V L ++ PE
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
Q KSD+Y+ G+ +L
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHV 235
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-23
Identities = 20/90 (22%), Positives = 29/90 (32%), Gaps = 4/90 (4%)
Query: 668 LERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEND 727
+E + RA P+ F P++ +M +P G DR I L +
Sbjct: 9 VEEIVAKNARAEIDYSDA----PDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP 64
Query: 728 KSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
P L L P L I W +
Sbjct: 65 TDPFNRQTLTESMLEPVPELKEQIQAWMRE 94
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNK----QFLQELEVLSKIRHPHLLLLL 464
+G G +G V T AVKV+ SK ++ K L+E+++L ++ HP+++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 465 GACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKP 520
D G LV E G L D + + E RI +V S + ++H K
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-----EVDAARIIRQVLSGITYMHKNK- 146
Query: 521 KPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
I+HRD+KP N+LL + +I D GLST + +GT YI P
Sbjct: 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-------KDKIGTAYYIAP 197
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKP 606
E G K DV++ G+++ LL+ P
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCP 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
+IG G +G V+KG + T A+K++ +++ I++ Q QE+ VLS+ P++
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYY 86
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTK 519
G+ L + EY+ GS D L P E IA E+ L +LH+ K
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALD-LLEPG-----PLDETQ-IATILREILKGLDYLHSEK 139
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
IHRD+K N+LL + K+ D G++ L T K VGT ++ PE
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT------DTQIKRNTFVGTPFWMAPEV 190
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
+ K+D+++ G+ ++L +P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEP 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G G YG V T A+K+++ N + L+E+ VL + HP+++ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 467 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 522
D LV E + G L D + + E I +V S + +LH
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKFN-----EVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 523 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
I+HRD+KP N+LL + + + KI D GLS + + +GT YI PE
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM-------KERLGTAYYIAPEV 209
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKP 606
R K DV++ G+++ LL P
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYP 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 27/199 (13%)
Query: 411 IGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLL 463
IG G + V H A+K++ K + ++ +E+ ++ + HP+++ L
Sbjct: 23 IGKGNFAKVKLAR--HILTGREVAIKII-DKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 464 LG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
L+ EY G + D L + E ++ SA+ + H K
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQ---K 133
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 580
I+HRD+K N+LLD ++ KI D G S + + G Y PE +Q
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAF------CGAPPYAAPELFQ 186
Query: 581 RTGLISPKSDVYAYGMVIL 599
P+ DV++ G VIL
Sbjct: 187 GKKYDGPEVDVWSLG-VIL 204
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 465
+G G + TV T A+K+L+ + I+ + +E +V+S++ HP + L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 466 ACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKP 522
D L Y +NG L + + + R E+ SAL +LH K
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE----TCTRFYTAEIVSALEYLHG---KG 150
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
IIHRD+KP NILL+ ++ +I D G + +L+ + N+ VGT Y+ PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA---NSF-VGTAQYVSPE---- 202
Query: 583 GLISPK-----SDVYAYGMVILQLLTAKP 606
L++ K SD++A G +I QL+ P
Sbjct: 203 -LLTEKSACKSSDLWALGCIIYQLVAGLP 230
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-22
Identities = 17/68 (25%), Positives = 24/68 (35%)
Query: 690 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLS 749
P+ F P++ +M +P G DR I L + P L L P L
Sbjct: 12 PDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSPTDPFNRQMLTESMLEPVPELKE 71
Query: 750 AILDWKSK 757
I W +
Sbjct: 72 QIQAWMRE 79
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG- 465
+G G YG V T AVK++ + + +E+ + + H +++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 466 -ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
+ L EY G L DR+ +P + R ++ + + +LH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTM--LNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 581
HRD+KP N+LLD KI D GL+T+ N+ ++ GTL Y+ PE +R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------CGTLPYVAPELLKR 181
Query: 582 TGLISPKSDVYAYGMVIL 599
+ DV++ G ++L
Sbjct: 182 REFHAEPVDVWSCG-IVL 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 3e-22
Identities = 37/306 (12%), Positives = 82/306 (26%), Gaps = 66/306 (21%)
Query: 352 RASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEI---ESATLSFSEN 408
E+ + +A ++ E + + + E TL
Sbjct: 21 DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGT- 79
Query: 409 LRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ------------------------- 441
+G + T T V V
Sbjct: 80 -VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 442 ---NKQFLQELEVLSKIRHPHLLLLLGACPDHG----CLVYEYME--NGSLEDRLY-RKN 491
+ +F+ +++ + ++ + D +Y M+ + + L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 492 NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551
+ R ++ +V LA LH+ ++H ++P +I+LD +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEY-----------QRTGLISPKSDVYAYGMVILQ 600
+ + + PE R L++ D +A G+VI
Sbjct: 256 DGARVVS----------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 601 LLTAKP 606
+ A
Sbjct: 306 IWCADL 311
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 465
+G G +G V K T AVKV+ +K + +NK L+E+E+L K+ HP+++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 466 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 521
D +V E G L D + ++ E RI +V S + ++H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFS-----EHDAARIIKQVFSGITYMHKHN-- 141
Query: 522 PIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I+HRD+KP NILL + + KI D GLST + +GT YI PE
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE 193
Query: 579 YQRTGLISPKSDVYAYGMVIL-QLLTAKP 606
R G K DV++ G VIL LL+ P
Sbjct: 194 VLR-GTYDEKCDVWSAG-VILYILLSGTP 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 24/198 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 464
+G+G +G V G T AVK+L ++ I++ + E++ L RHPH++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKIL-NRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 465 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ P +V EY+ G L D + + + E R+ ++ SA+ + H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHR---HM 131
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 581
++HRD+KP N+LLD ++ +KI D GLS M++ F+ T+ G+ Y PE
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS------CGSPNYAAPEVISG 184
Query: 582 TGLISPKSDVYAYGMVIL 599
P+ D+++ G VIL
Sbjct: 185 RLYAGPEVDIWSCG-VIL 201
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 26/209 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G VYK T AA KV+++K + + ++ E+E+L+ HP+++ LLGA
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 468 PDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHNTKPKP 522
G L + E+ G+++ + + + +I ++ AL FLH+ +
Sbjct: 86 YHDGKLWIMIEFCPGGAVDA-IMLELDRG----LTEPQIQVVCRQMLEALNFLHSKR--- 137
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---- 578
IIHRD+K GN+L+ ++ D G+S T K +GT ++ PE
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL------KTLQKRDSFIGTPYWMAPEVVMC 191
Query: 579 -YQRTGLISPKSDVYAYGMVILQLLTAKP 606
+ K+D+++ G+ ++++ +P
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEP 220
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 53/226 (23%)
Query: 411 IGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFL--------------------- 446
IG G YG V + +T+ A+KVL SK + +
Sbjct: 21 IGKGSYGVVKLAY-NENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 447 ------QELEVLSKIRHPHLLLLL----GACPDHGCLVYEYMENGSLEDRLYRKNNTPPI 496
QE+ +L K+ HP+++ L+ DH +V+E + G + + K P+
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PL 134
Query: 497 PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556
+ ++ + +LH K IIHRD+KP N+L+ + KI D G+S
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 557 SFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVIL 599
+ +S T VGT ++ PE R DV+A G V L
Sbjct: 192 ALLSNT------VGTPAFMAPESLSETRKIFSGKALDVWAMG-VTL 230
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 47/203 (23%), Positives = 89/203 (43%), Gaps = 31/203 (15%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQ-SKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G V+ + +K + + + +Q E+EVL + HP+++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 468 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY------RIAWEVASALAFLHNTK 519
D+ +V E E G L +R+ + + ++ +ALA+ H+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARG-----KALSEGYVAELMKQMMNALAYFHSQH 144
Query: 520 PKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
++H+D+KP NIL + KI D GL+ + SD T GT Y+
Sbjct: 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------TNAAGTALYMA 194
Query: 577 PEYQRTGLISPKSDVYAYGMVIL 599
PE + ++ K D+++ G V++
Sbjct: 195 PEVFK-RDVTFKCDIWSAG-VVM 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-22
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKV-----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
IG G + V + T AVK+ S + + +E + ++HPH++ L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 464 LGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTK 519
L G +V+E+M+ L + ++ + + E ++ AL + H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF-VYSEAVASHYMRQILEALRYCHDNN 150
Query: 520 PKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
IIHRD+KP +LL +++ K+G G++ L VGT ++
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR------VGTPHFMA 201
Query: 577 PEYQRTGLISPKSDVYAYGMVIL 599
PE + DV+ G VIL
Sbjct: 202 PEVVKREPYGKPVDVWGCG-VIL 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 51/208 (24%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
++ +IG G GTVY T A++ + + + + + E+ V+ + ++P+++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 463 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 518
L + L V EY+ GSL D + + E + E AL FLH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTD-VVTET-----CMDEGQIAAVCRECLQALEFLHSN 135
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
+ +IHRD+K NILL + K+ D G + K + VGT ++ PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 186
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PK D+++ G++ ++++ +P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG- 465
+G G YG V T AVK++ + + +E+ + + H +++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 466 -ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
+ L EY G L DR+ +P + R ++ + + +LH I
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---IT 127
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTM--LNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 581
HRD+KP N+LLD KI D GL+T+ N+ ++ GTL Y+ PE +R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM------CGTLPYVAPELLKR 181
Query: 582 TGLISPKSDVYAYGMVIL 599
+ DV++ G ++L
Sbjct: 182 REFHAEPVDVWSCG-IVL 198
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 38/204 (18%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-FLQELEVLSKIRHPHLLLLLGAC 467
IG G +G V T A K + K +++ F QE+E++ + HP+++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 468 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 523
D+ LV E G L +R+ K + E RI +V SA+A+ H +
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRV-----FRESDAARIMKDVLSAVAYCHKLN---V 127
Query: 524 IHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 578
HRD+KP N L + K+ D GL+ VGT Y+ P+
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------RTKVGTPYYVSPQVL 180
Query: 579 ---YQRTGLISPKSDVYAYGMVIL 599
Y P+ D ++ G V++
Sbjct: 181 EGLY------GPECDEWSAG-VMM 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 40/206 (19%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLG 465
+G G +G V K T AVKV+ +K + +NK L+E+E+L K+ HP+++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVI-NKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 466 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPK 521
D +V E G L D + ++ + E RI +V S + ++H
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKR-----FSEHDAARIIKQVFSGITYMHKHN-- 141
Query: 522 PIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I+HRD+KP NILL + + KI D GLST + +GT YI PE
Sbjct: 142 -IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE 193
Query: 579 -----YQRTGLISPKSDVYAYGMVIL 599
Y K DV++ G VIL
Sbjct: 194 VLRGTY------DEKCDVWSAG-VIL 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
F ++G G YG+VYK T A+K + + ++Q +E+ ++ + PH++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII--KEISIMQQCDSPHVVK 88
Query: 463 LLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFLHN 517
G+ + L V EY GS+ D + R N IA L +LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKT----LTEDEIATILQSTLKGLEYLHF 143
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+ IHRD+K GNILL+ +K+ D G++ L T K +GT ++ P
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLT------DTMAKRNTVIGTPFWMAP 194
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKP 606
E + + +D+++ G+ +++ KP
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKP 223
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 28/212 (13%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 463
IG G + V K T A+K++ ++ + F +E +VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
A ++ LV EY G L L + P R+ +A E+ A+ +H
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVHR---L 181
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 580
+HRD+KP NILLD ++ D G L +D + S VGT Y+ PE Q
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-----AVGTPDYLSPEILQ 236
Query: 581 RTGLISPKS------DVYAYGMVILQLLTAKP 606
G D +A G+ ++ +
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 49/252 (19%), Positives = 105/252 (41%), Gaps = 31/252 (12%)
Query: 371 HEAKEKEMLERALNGTFQRYRNLTWEEIESA----------TLSFSENLRIGMGGYGTVY 420
H ++ + + +T E+ ++A L ++IG G G V
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVC 62
Query: 421 KGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCL--VYE 476
H+ AVK++ + + + E+ ++ +H +++ + + L + E
Sbjct: 63 LAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122
Query: 477 YMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 534
+++ G+L D + + E + V ALA+LH +IHRD+K +IL
Sbjct: 123 FLQGGALTD-IVSQV-----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSIL 173
Query: 535 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAY 594
L + K+ D G ++ K VGT ++ PE L + + D+++
Sbjct: 174 LTLDGRVKLSDFGFCAQIS------KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSL 227
Query: 595 GMVILQLLTAKP 606
G+++++++ +P
Sbjct: 228 GIMVIEMVDGEP 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 38/305 (12%)
Query: 325 LLEEKAIELAKQEKKKYETARREAECARASAEKEAAQR--------QEAEMKAKHEAKEK 376
+ + A+ + Y + + C+ AE A R Q +
Sbjct: 98 ADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQA 157
Query: 377 EMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKGTFHHT--FAAVKV 433
E + F R+ W E + + + R +G GG+G V+ T A K
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKK 217
Query: 434 LQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLY 488
L K + K + + E ++L+K+ ++ L A CLV M G + +Y
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 489 RKNNTPPIPWFERYRI---AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545
+ P F+ R ++ S L LH II+RD+KP N+LLD + +I D
Sbjct: 278 NVDEDNPG--FQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISD 332
Query: 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKS-DVYAYGMVILQL 601
+GL+ L + + GT ++ PE + S D +A G+ + ++
Sbjct: 333 LGLAVELKAGQTKTKGY------AGTPGFMAPELLLGEEYD----FSVDYFALGVTLYEM 382
Query: 602 LTAKP 606
+ A+
Sbjct: 383 IAARG 387
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGA 466
+G G YG VYKG T AA+KV+ G+ + ++ QE+ +L K H ++ GA
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 89
Query: 467 --------CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW---EVASALAFL 515
D LV E+ GS+ D L + + E + IA+ E+ L+ L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK--EEW-IAYICREILRGLSHL 145
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H K +IHRD+K N+LL N K+ D G+S L+ T + +GT ++
Sbjct: 146 HQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLD------RTVGRRNTFIGTPYWM 196
Query: 576 DPE-----YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE KSD+++ G+ +++ P
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 40/219 (18%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVL-------------QSKGNIQNKQFLQELEVLSKI 455
+G G YG V + + A+KV+ +++ E+ +L +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 456 RHPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASA 511
HP+++ L D LV E+ E G L +++ ++ E I ++ S
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD-----ECDAANIMKQILSG 158
Query: 512 LAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
+ +LH I+HRD+KP NILL + L KI D GLS+ + D
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-------RDR 208
Query: 569 VGTLCYIDPEYQRTGLISPKSDVYAYGMVIL-QLLTAKP 606
+GT YI PE + + K DV++ G VI+ LL P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCG-VIMYILLCGYP 245
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-21
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 689 PPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTL 747
+ F+ PI+ +M +P V T DR I L + P PL + PN L
Sbjct: 19 ACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTEL 78
Query: 748 LSAILDWKSK 757
I W ++
Sbjct: 79 KEKIQRWLAE 88
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 401 ATLSFSENLR---------IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQEL 449
+T SFS +G G + V T AVK+++ + + +E+
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 450 EVLSKIR-HPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--R 503
E+L + + H ++L L+ + LV+E M GS+ ++++ + F E
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASV 115
Query: 504 IAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVS 560
+ +VASAL FLHN K I HRD+KP NIL + KI D L + + +
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 561 TTYKN-TGPVGTLCYIDPEYQRTGLISPKS-----DVYAYGMVIL 599
+ P G+ Y+ PE D+++ G VIL
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VIL 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 22/196 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL--LGA 466
IG G +G T AVK + +G ++ +E+ +RHP+++ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 467 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526
P H ++ EY G L +R+ E ++ S +++ H+ + I HR
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLSGVSYCHSMQ---ICHR 140
Query: 527 DMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 583
D+K N LLD + KI D G S S +T VGT YI PE R
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST------VGTPAYIAPEVLLRQE 193
Query: 584 LISPKSDVYAYGMVIL 599
+DV++ G V L
Sbjct: 194 YDGKIADVWSCG-VTL 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 55/235 (23%), Positives = 95/235 (40%), Gaps = 41/235 (17%)
Query: 389 RYRNLTWEEIESATLSFSENLRI----GMGGYGTVYKGTFHHTFA--AVKVL-------- 434
+ +LT ++ + + + G G G V T A++++
Sbjct: 117 VFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIG 176
Query: 435 QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNN 492
++ E+E+L K+ HP ++ + D+ +V E ME G L D++
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR 235
Query: 493 TPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVG 547
E +++ A+ +LH IIHRD+KP N+LL + + + KI D G
Sbjct: 236 LK-----EATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQRTGLISPKSDVYAYGMVIL 599
S +L + S + T GT Y+ PE T + D ++ G VIL
Sbjct: 288 HSKILG-ETSLMRTL------CGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VIL 334
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 21/177 (11%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 463
IG G +G V K A+K+L ++ + F +E +VL + L
Sbjct: 82 IGRGAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
A ++ LV +Y G L L + + P R+ +A E+ A+ +H
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVHQ---L 194
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
+HRD+KP NIL+D N ++ D G L D + S+ VGT YI PE
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-----AVGTPDYISPE 246
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA-- 466
+G G + V+ T A+K ++ ++ E+ VL KI+H +++ L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 467 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 524
H LV + + G L DR+ + + E+ + +V SA+ +LH I+
Sbjct: 77 STTHYYLVMQLVSGGELFDRILERGV-----YTEKDASLVIQQVLSAVKYLHENG---IV 128
Query: 525 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
HRD+KP N+L + N I D GLS M +ST GT Y+ PE
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTA------CGTPGYVAPEVLA 180
Query: 582 TGLISPKSDVYAYGMVIL 599
S D ++ G VI
Sbjct: 181 QKPYSKAVDCWSIG-VIT 197
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 3e-20
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 24/198 (12%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 464
+G+G +G V G T AVK+L ++ I++ + E++ L RHPH++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKIL-NRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 465 G--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+ P +V EY+ G L D + + E R+ ++ S + + H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK---ESRRLFQQILSGVDYCHRHM--- 136
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQR 581
++HRD+KP N+LLD ++ +KI D GLS M++ F+ T+ G+ Y PE
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTS------CGSPNYAAPEVISG 189
Query: 582 TGLISPKSDVYAYGMVIL 599
P+ D+++ G VIL
Sbjct: 190 RLYAGPEVDIWSSG-VIL 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 45/206 (21%), Positives = 78/206 (37%), Gaps = 34/206 (16%)
Query: 411 IGMGGYGTVYKGTFHHTFA----AVKVLQSKGNIQNKQFL---------QELEVLSKIRH 457
+G G +G V+ VK + K + ++ E+ +LS++ H
Sbjct: 32 LGSGAFGFVWTAV--DKEKNKEVVVKFI-KKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 458 PHLLLLLG--ACPDHGCLVYEYMENGS-LEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
+++ +L LV E +G L + R I ++ SA+ +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE---PLASYIFRQLVSAVGY 145
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
L K IIHRD+K NI++ + K+ D G + L T GT+ Y
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTF------CGTIEY 195
Query: 575 IDPE-YQRTGLISPKSDVYAYGMVIL 599
PE P+ ++++ G V L
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLG-VTL 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-20
Identities = 51/258 (19%), Positives = 102/258 (39%), Gaps = 27/258 (10%)
Query: 354 SAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRI-- 411
E++ + + + + K + + N F ++ + +E ++ I
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163
Query: 412 --GMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
G G +G V++ T T A K + + + +E++ +S +RHP L+ L A
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 468 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPI 523
+ ++YE+M G L +++ ++N E +V L +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHE---NNY 276
Query: 524 IHRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
+H D+KP NI+ + K+ D GL+ L+ S GT + PE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV-------KVTTGTAEFAAPEVAE 329
Query: 582 TGLISPKSDVYAYGMVIL 599
+ +D+++ G V+
Sbjct: 330 GKPVGYYTDMWSVG-VLS 346
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 55/247 (22%), Positives = 82/247 (33%), Gaps = 57/247 (23%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKV-----LQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
IG G YG V + T A+K+ ++ ++ E+ ++ K+ HP++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 464 LGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE-------------- 507
D LV E G L D+L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 508 -----------------------VASALAFLHNTKPKPIIHRDMKPGNILL--DHNLVSK 542
+ SAL +LHN + I HRD+KP N L + + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE--YQRTGLISPKSDVYAYGMVIL- 599
+ D GLS Y T GT ++ PE PK D ++ G V+L
Sbjct: 211 LVDFGLSKEF--YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLH 267
Query: 600 QLLTAKP 606
LL
Sbjct: 268 LLLMGAV 274
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 23/197 (11%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
+G G +G V++ T K + + + E+ +++++ HP L+ L A
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 469 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 524
D L+ E++ G L DR+ ++ E + L +H I+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMHE---HSIV 171
Query: 525 HRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
H D+KP NI+ + S KI D GL+T LN D T + PE
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV-------KVTTATAEFAAPEIVDR 224
Query: 583 GLISPKSDVYAYGMVIL 599
+ +D++A G V+
Sbjct: 225 EPVGFYTDMWAIG-VLG 240
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 38/211 (18%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKV-------LQSKGNIQNKQ--FLQELEVLSKI-RHP 458
+G G V + T AVK+ S +Q + L+E+++L K+ HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 459 HLLLLLGACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAF 514
+++ L + LV++ M+ G L D L K E+ +I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVICA 139
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH I+HRD+KP NILLD ++ K+ D G S L+ GT Y
Sbjct: 140 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-------REVCGTPSY 189
Query: 575 IDPE------YQRTGLISPKSDVYAYGMVIL 599
+ PE + D+++ G VI+
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTG-VIM 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 42/216 (19%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-----ELEVLSKIRHPHLLLL 463
+G G YG V + T AVK+L K ++ + E+++L ++RH +++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKIL-KKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 464 ----LGACPDHGCLVYEYMENGSLE--DRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
+V EY G E D + K P + + ++ L +LH+
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHS 127
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN--SDPSFVSTTYKNTGPVGTLCYI 575
+ I+H+D+KPGN+LL KI +G++ L+ + T+ G+ +
Sbjct: 128 ---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS------QGSPAFQ 178
Query: 576 DPEYQRTGLIS-------PKSDVYAYGMVILQLLTA 604
PE + + K D+++ G V L +T
Sbjct: 179 PPE-----IANGLDTFSGFKVDIWSAG-VTLYNITT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-20
Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 26/200 (13%)
Query: 411 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFL-QELEVLSKIRHPHLLLLLGA 466
+G G + V + +AA+ + K + ++ Q L +E + ++HP+++ L +
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 467 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 522
+ G L+++ + G L + + + + E ++ A+ H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREY-----YSEADASHCIQQILEAVLHCHQMG--- 130
Query: 523 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
++HR++KP N+LL K+ D GL+ + + GT Y+ PE
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF------AGTPGYLSPEV 184
Query: 580 QRTGLISPKSDVYAYGMVIL 599
R D++A G VIL
Sbjct: 185 LRKDPYGKPVDLWACG-VIL 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 42/300 (14%), Positives = 89/300 (29%), Gaps = 73/300 (24%)
Query: 410 RIGMGGYGTVYKG--TFHHTFAAVKVLQSKGNI---QNKQFLQELEVLSKIRHPHLLLLL 464
G ++ T A+ + +G + ++ L LS+I P + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 465 --GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G +V E++ GSL++ +T P P R +A+A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPV-GAIRAMQSLAAAADAAHRA---G 149
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+ P + + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA--------------------------TMPDA---- 179
Query: 583 GLISPKSDVYAYGMVILQLLTAKP-----------AIAITHKVETAIDEDNLAEILDAQA 631
+P+ D+ G + LL + A A I+ ++ +
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF-- 234
Query: 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPN 691
+++A+ + R + +L ++++ VADR P + AP +
Sbjct: 235 ---------QISAVAARSVQGDGGIRSA--STLLNLMQQATAVADRTEVLGP-IDEAPVS 282
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 35/286 (12%)
Query: 322 EIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEAKEKEMLER 381
Q ++ + ++ + + A+ K A A +
Sbjct: 20 YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVT 79
Query: 382 ALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN 439
A G + ++ EI +G G +G V+K T A K+++++G
Sbjct: 80 AKQGAVNSFYTVSKTEI------------LGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 440 IQNKQFLQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIP 497
++ E+ V++++ H +L+ L A + LV EY++ G L DR+ ++
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-- 185
Query: 498 WFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLN 553
E ++ + +H I+H D+KP NIL + KI D GL+
Sbjct: 186 --ELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVIL 599
GT ++ PE +S +D+++ G VI
Sbjct: 241 PREKL-------KVNFGTPEFLAPEVVNYDFVSFPTDMWSVG-VIA 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 49/164 (29%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
IG G +G VY A+K + + N + + ++E+ L K+RHP+ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIA---WEVASALAFLHNTK 519
G V EY GS D L + P + IA LA+LH+
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASD-LLEVHKKP----LQEVEIAAVTHGALQGLAYLHSHN 174
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563
+IHRD+K GNILL + K+GD G ++++ SFV T Y
Sbjct: 175 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY 215
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 46/205 (22%), Positives = 87/205 (42%), Gaps = 32/205 (15%)
Query: 411 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
+G G + V K T +AA ++ S+ + ++ +E+ +L +IRHP+++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 463 LLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 518
L L+ E + G L D L K + E + ++ + +LH+
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLT-----EDEATQFLKQILDGVHYLHSK 127
Query: 519 KPKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
+ I H D+KP NI+L V K+ D G++ + + F GT +
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-------KNIFGTPEF 177
Query: 575 IDPEYQRTGLISPKSDVYAYGMVIL 599
+ PE + ++D+++ G VI
Sbjct: 178 VAPEIVNYEPLGLEADMWSIG-VIT 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 44/205 (21%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 411 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
+G G + V K T +AA + S+ + ++ +E+ +L ++ H +++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 518
L L+ E + G L D L +K + E ++ + +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLHTK 134
Query: 519 KPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
K I H D+KP NI+L K+ D GL+ + F GT +
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-------KNIFGTPEF 184
Query: 575 IDPEYQRTGLISPKSDVYAYGMVIL 599
+ PE + ++D+++ G VI
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG-VIT 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 37/239 (15%)
Query: 385 GTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQ 441
F R+ W E + T + R +G GG+G V T A K L+ K +
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK 224
Query: 442 NKQF---LQELEVLSKIRHPHLLLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPI 496
K L E ++L K+ ++ L A D CLV M G L+ +Y
Sbjct: 225 RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ---- 280
Query: 497 PWFERYRI---AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553
F R A E+ L LH + I++RD+KP NILLD + +I D+GL+ +
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 554 SDPSFVSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
T G VGT+ Y+ PE Y + D +A G ++ +++ +
Sbjct: 338 EG----QTI---KGRVGTVGYMAPEVVKNERYTFS------PDWWALGCLLYEMIAGQS 383
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G G + V + T A K++ +K ++ +E + K++HP+++ L +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 467 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 522
+ LV++ + G L + + + + E ++ ++A+ H+
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNG--- 125
Query: 523 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
I+HR++KP N+LL K+ D GL+ +N ++ G GT Y+ PE
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-------HGFAGTPGYLSPEV 178
Query: 580 QRTGLISPKSDVYAYGMVIL 599
+ S D++A G VIL
Sbjct: 179 LKKDPYSKPVDIWACG-VIL 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 51/200 (25%), Positives = 84/200 (42%), Gaps = 30/200 (15%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGAC 467
+G G + K + AVK++ + +E+ L HP+++ L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 468 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNTKPKP 522
D LV E + G L +R+ +K + F E I ++ SA++ +H+
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHD---VG 126
Query: 523 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
++HRD+KP N+L + NL KI D G + + D + T P TL Y PE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT------PCFTLHYAAPEL 180
Query: 580 QRTGLISPKSDVYAYGMVIL 599
D+++ G VIL
Sbjct: 181 LNQNGYDESCDLWSLG-VIL 199
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 411 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
+G G + V K T +AA + S+ + ++ +E+ +L ++ HP+++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 518
L L+ E + G L D L +K + E ++ + +LH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLS-----EEEATSFIKQILDGVNYLHT- 133
Query: 519 KPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
K I H D+KP NI+L K+ D GL+ + F GT +
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-------KNIFGTPEF 184
Query: 575 IDPEYQRTGLISPKSDVYAYGMVIL 599
+ PE + ++D+++ G VI
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG-VIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 38/199 (19%), Positives = 78/199 (39%), Gaps = 28/199 (14%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 467
+G G +G V++ + K + +E+ +L+ RH ++L L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 468 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFER--YRIAWEVASALAFLHNTKPKPII 524
+ +++E++ + +R+ ER +V AL FLH+ I
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELN----EREIVSYVHQVCEALQFLHS---HNIG 124
Query: 525 HRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
H D++P NI+ + KI + G + L +F Y PE
Sbjct: 125 HFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNF-------RLLFTAPEYYAPEVH 175
Query: 581 RTGLISPKSDVYAYGMVIL 599
+ ++S +D+++ G ++
Sbjct: 176 QHDVVSTATDMWSLG-TLV 193
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 45/200 (22%), Positives = 88/200 (44%), Gaps = 27/200 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G G + V + T A K++ +K ++ +E + K++HP+++ L +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 467 CPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKP 522
+ LV++ + G L + + + + E ++ ++A+ H+
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREF-----YSEADASHCIQQILESIAYCHSNG--- 148
Query: 523 IIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
I+HR++KP N+LL K+ D GL+ +N ++ G GT Y+ PE
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-------HGFAGTPGYLSPEV 201
Query: 580 QRTGLISPKSDVYAYGMVIL 599
+ S D++A G VIL
Sbjct: 202 LKKDPYSKPVDIWACG-VIL 220
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-19
Identities = 66/318 (20%), Positives = 122/318 (38%), Gaps = 32/318 (10%)
Query: 305 KVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQE 364
++ K + EEE + ++ + ++ + + E ++ +
Sbjct: 88 EIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQ 147
Query: 365 AEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIES---ATLSFSENLR-IGMGGYGTVY 420
++ + ++ ++ + R W+ +E T++ R IG GG+G VY
Sbjct: 148 PYIEEICQNLRGDVFQKFIESDKFT-RFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVY 206
Query: 421 KGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKI---RHPHLLLLLGA--CPDH 470
T A+K L K + L E +LS + P ++ + A PD
Sbjct: 207 GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266
Query: 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMK 529
+ + M G L L + R A E+ L +HN +++RD+K
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEHMHNRF---VVYRDLK 319
Query: 530 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKS 589
P NILLD + +I D+GL+ + K VGT Y+ PE + G+ S
Sbjct: 320 PANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPEVLQKGVAYDSS 371
Query: 590 -DVYAYGMVILQLLTAKP 606
D ++ G ++ +LL
Sbjct: 372 ADWFSLGCMLFKLLRGHS 389
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 53/194 (27%), Positives = 80/194 (41%), Gaps = 28/194 (14%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLL 463
IG G +G V K T A+K+L I+ F +E ++++ P ++ L
Sbjct: 77 IGRGAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
A + +V EYM G L + + + F Y EV AL +H+
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF--Y--TAEVVLALDAIHS---M 187
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
IHRD+KP N+LLD + K+ D G +N + T VGT YI PE
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPE--- 239
Query: 582 TGLISPKSDVYAYG 595
++ + YG
Sbjct: 240 --VLKSQGGDGYYG 251
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 37/209 (17%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVL--------QSKGNIQNKQFLQELEVLSKIRHPHL 460
+G G G V T A+K++ ++ E+E+L K+ HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 461 LLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLH 516
+ + D+ +V E ME G L D++ E +++ A+ +LH
Sbjct: 78 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK-----EATCKLYFYQMLLAVQYLH 131
Query: 517 NTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
IIHRD+KP N+LL + + + KI D G S +L + S + T GT
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL------CGTPT 181
Query: 574 YIDPE---YQRTGLISPKSDVYAYGMVIL 599
Y+ PE T + D ++ G VIL
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLG-VIL 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 9e-19
Identities = 67/298 (22%), Positives = 109/298 (36%), Gaps = 46/298 (15%)
Query: 332 ELAKQEKKKYETARREAECAR-ASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRY 390
+ K+ ++ R R + R + A A+ K++ + GT Y
Sbjct: 14 KFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLY 73
Query: 391 RNLTWEEIESATLSFSENLR--------IGMGGYGTVYKGTFHHT--FAAVKVL------ 434
E E + ++ IG G V + T AVK++
Sbjct: 74 FQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAER 133
Query: 435 --QSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGC--LVYEYMENGSLEDRLYR 489
+ + +E +L ++ HPH++ L+ + LV++ M G L D L
Sbjct: 134 LSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE 193
Query: 490 KNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547
K E+ I + A++FLH I+HRD+KP NILLD N+ ++ D G
Sbjct: 194 KVA-----LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFG 245
Query: 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVIL 599
S L GT Y+ PE + + D++A G VIL
Sbjct: 246 FSCHLEPGEKL-------RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VIL 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 36/207 (17%)
Query: 411 IGMGGYGTVYKGTFHHT---FAA-----VKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
+G G + V K T +AA + S+ + + +E+ +L +I+HP+++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNT 518
L L+ E + G L D L K + E ++ + + +LH+
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLT-----EEEATEFLKQILNGVYYLHSL 133
Query: 519 KPKPIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
+ I H D+KP NI+L + KI D GL+ ++ F GT
Sbjct: 134 Q---IAHFDLKPENIMLLDRNVPKPRI--KIIDFGLAHKIDFGNEF-------KNIFGTP 181
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVIL 599
++ PE + ++D+++ G VI
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIG-VIT 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 29/200 (14%)
Query: 411 IGMGGYGTVYKGTFHHTF----AAVKVLQSKGNIQN----KQFLQELEVLSKIRHPHLLL 462
+G G +G V T H A+K + S+ ++ + +E+ L +RHPH++
Sbjct: 17 LGEGSFGKVKLAT--HYKTQQKVALKFI-SRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 463 LLG--ACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L P +V EY G L D + K E R ++ A+ + H K
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED---EGRRFFQQIICAIEYCHRHK- 128
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-Y 579
I+HRD+KP N+LLD NL KI D GLS ++ +F+ T+ G+ Y PE
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTS------CGSPNYAAPEVI 179
Query: 580 QRTGLISPKSDVYAYGMVIL 599
P+ DV++ G ++L
Sbjct: 180 NGKLYAGPEVDVWSCG-IVL 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 34/202 (16%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSK-IRHPHLLLLLGAC 467
IG+G Y + T AVK++ K + E+E+L + +HP+++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTE---EIEILLRYGQHPNIITLKDVY 85
Query: 468 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNTKPKP 522
D +V E M+ G L D++ R+ F ER + + + + +LH +
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQKF------FSEREASAVLFTITKTVEYLHA---QG 136
Query: 523 IIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
++HRD+KP NIL + +I D G + L ++ + T P T ++ PE
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT------PCYTANFVAPE 190
Query: 579 -YQRTGLISPKSDVYAYGMVIL 599
+R G D+++ G V+L
Sbjct: 191 VLERQGY-DAACDIWSLG-VLL 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 54/198 (27%), Positives = 84/198 (42%), Gaps = 27/198 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 467
+G G VY+ T A+KVL+ + + E+ VL ++ HP+++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 468 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY--RIAWEVASALAFLHNTKPKPII 524
P LV E + G L DR+ K + ER ++ A+A+LH I+
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAYLHE---NGIV 170
Query: 525 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
HRD+KP N+L + KI D GLS ++ GT Y PE R
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM-------KTVCGTPGYCAPEILR 223
Query: 582 TGLISPKSDVYAYGMVIL 599
P+ D+++ G +I
Sbjct: 224 GCAYGPEVDMWSVG-IIT 240
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 46/261 (17%)
Query: 364 EAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKG 422
A K + KE L +A +++ +A L + ++ +G G +G V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWET---PSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 423 TFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLGACPDHGCL--VY 475
+ A+K+L + ++ KQ L E +L + P L+ L + D+ L V
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 476 EYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKPKPIIHRDMKPGNIL 534
EY+ G + L R R A ++ +LH+ +I+RD+KP N+L
Sbjct: 121 EYVAGGEMFSHLRRIGRFSE----PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLL 173
Query: 535 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YIDPEYQRTGLISPKS- 589
+D ++ D G + + T+ TLC + PE +I K
Sbjct: 174 IDQQGYIQVTDFGFAKRVK------GRTW-------TLCGTPEALAPE-----IILSKGY 215
Query: 590 ----DVYAYGMVILQLLTAKP 606
D +A G++I ++ P
Sbjct: 216 NKAVDWWALGVLIYEMAAGYP 236
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 36/204 (17%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 467
+G+G G V + T A+K+L + QE++ + PH++ +L
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 468 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 518
+ ++ E ME G L R+ + + F ER I ++ +A+ FLH+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FTEREAAEIMRDIGTAIQFLHS- 146
Query: 519 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
I HRD+KP N+L + + V K+ D G + + + T P T Y+
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT------PCYTPYYV 196
Query: 576 DPEYQRTGLISPKSDVYAYGMVIL 599
PE D+++ G VI+
Sbjct: 197 APEVLGPEKYDKSCDMWSLG-VIM 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 50/205 (24%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-------ELEVLSKIRH--PH 459
+G GG+G+VY G A+K + K I + L E+ +L K+
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 460 LLLLLG--ACPDHGCLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
++ LL PD L+ E E L D + + W+V A+ H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE---LARSFFWQVLEAVRHCH 166
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
N ++HRD+K NIL+D N K+ D G +L + + GT Y
Sbjct: 167 NCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF------DGTRVYS 215
Query: 576 DPEY-QRTGLISPKSDVYAYGMVIL 599
PE+ + + V++ G ++L
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLG-ILL 239
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 87.1 bits (215), Expect = 1e-17
Identities = 23/97 (23%), Positives = 44/97 (45%), Gaps = 7/97 (7%)
Query: 668 LERLKEVADRARDTVPSVHP------APPNHFICPILKEVMNEPCV-AADGYTYDRKAIE 720
+E+L A++A + + P+ F+ P++ +M +P + A DR I+
Sbjct: 861 IEKLLNFANKAEEQRKADEEEDLEYGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIK 920
Query: 721 EWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757
L + P +PL +++ PN L IL +K +
Sbjct: 921 AHLLSDSTDPFNRMPLKLEDVTPNEELRQKILCFKKQ 957
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 34/207 (16%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ-------ELEVLSKIR----H 457
+G GG+GTV+ G A+KV+ + + L E+ +L K+ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVI-PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 458 PHLLLLLG--ACPDHGCLVYEYMENGS-LEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
P ++ LL + LV E L D + K + +V +A+
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQH 154
Query: 515 LHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
H+ + ++HRD+K NIL+D +K+ D G +L+ +P Y + GT
Sbjct: 155 CHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP------YTDF--DGTRV 203
Query: 574 YIDPEY-QRTGLISPKSDVYAYGMVIL 599
Y PE+ R + + V++ G ++L
Sbjct: 204 YSPPEWISRHQYHALPATVWSLG-ILL 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 56/182 (30%), Positives = 83/182 (45%), Gaps = 36/182 (19%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V+ + + A+KVL+ + ++ KQ E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 464 LGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 520
G D + + +Y+E G L L + P + A EV AL +LH+
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPN----PVAKFYAAEVCLALEYLHS--- 124
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC----YID 576
K II+RD+KP NILLD N KI D G + + TY TLC YI
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------DVTY-------TLCGTPDYIA 171
Query: 577 PE 578
PE
Sbjct: 172 PE 173
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 35/204 (17%)
Query: 411 IGMGGYGTVYKGTFHHTFA--AVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 467
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 124
Query: 468 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 518
+ +V E ++ G L R+ + + F ER I + A+ +LH+
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHS- 179
Query: 519 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
I HRD+KP N+L N + K+ D G + S S T P T Y+
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-------TTPCYTPYYV 230
Query: 576 DPEYQRTGLISPKSDVYAYGMVIL 599
PE D+++ G VI+
Sbjct: 231 APEVLGPEKYDKSCDMWSLG-VIM 253
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLLLG 465
IG G +G V + T A+K + + ++ + +EL+++ + HP L+ L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 466 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHNTKP 520
+ + +V + + G L L + + F E ++ E+ AL +L N
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVH------FKEETVKLFICELVMALDYLQN--- 133
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-Y 579
+ IIHRDMKP NILLD + I D ++ ML + TT GT Y+ PE +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTM-----AGTKPYMAPEMF 186
Query: 580 QRTGLI--SPKSDVYAYGMVILQLLTAKP 606
S D ++ G+ +LL +
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 49/218 (22%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V K T + A+K+L+ + I + + E VL RHP L L
Sbjct: 13 LGKGTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 520
A D C V EY G L L R+ ER R E+ SAL +LH+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYLHS--- 123
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC----Y 574
+ +++RD+K N++LD + KI D GL + + T T C Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-----TMK-------TFCGTPEY 171
Query: 575 IDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
+ PE Y R D + G+V+ +++ +
Sbjct: 172 LAPEVLEDNDYGRA------VDWWGLGVVMYEMMCGRL 203
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-17
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V K T + A+K+L+ + + + L E VL RHP L L
Sbjct: 156 LGKGTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTKP 520
+ D C V EY G L L R+ +R R E+ SAL +LH+
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHS--E 267
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-- 578
K +++RD+K N++LD + KI D GL D + + T GT Y+ PE
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGTPEYLAPEVL 321
Query: 579 ----YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y R D + G+V+ +++ +
Sbjct: 322 EDNDYGRA------VDWWGLGVVMYEMMCGRL 347
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 45/207 (21%), Positives = 76/207 (36%), Gaps = 38/207 (18%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRH-PHLLLLLG 465
+G G + V + T A K L + +G + L E+ VL + P ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 466 A--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERY------RIAWEVASALAFLHN 517
L+ EY G + + E R+ ++ + +LH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPEL-------AEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 518 TKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
I+H D+KP NILL ++ KI D G+S + +GT
Sbjct: 150 NN---IVHLDLKPQNILLSSIYPLGDI--KIVDFGMSRKIGHACEL-------REIMGTP 197
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVIL 599
Y+ PE I+ +D++ G +I
Sbjct: 198 EYLAPEILNYDPITTATDMWNIG-IIA 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 49/224 (21%), Positives = 93/224 (41%), Gaps = 52/224 (23%)
Query: 411 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 463
G G +GTV G T +V KV+Q + +F LQ ++ L+ + HP+++ L
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 464 LGACPDHG---------CLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVA 509
G +V EY+ + R Y + P P + + +++
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFL-FQLI 139
Query: 510 SALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
++ LH + HRD+KP N+L++ + K+ D G + L+ V+ Y
Sbjct: 140 RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA--Y----- 191
Query: 569 VGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 606
+ + Y PE LI + D+++ G + +++ +P
Sbjct: 192 ICSRYYRAPE-----LIFGNQHYTTAVDIWSVGCIFAEMMLGEP 230
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 48/228 (21%)
Query: 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQFLQELEVLSKIRHP 458
+S+++ IG G +G VY+ + V KVLQ K + +EL+++ K+ H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHC 107
Query: 459 HLLLLLGACPDHG--------CLVYEYMENGSLED-----RLYRKNNTPPIPWFERYRIA 505
+++ L G LV +Y+ E R Y + + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM- 162
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYK 564
+++ +LA++H+ I HRD+KP N+LLD + K+ D G + L VS Y
Sbjct: 163 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--Y- 216
Query: 565 NTGPVGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 606
+ + Y PE LI + DV++ G V+ +LL +P
Sbjct: 217 ----ICSRYYRAPE-----LIFGATDYTSSIDVWSAGCVLAELLLGQP 255
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 53/221 (23%)
Query: 411 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLL 462
+G G +G V+ K + A+KVL K ++ + E ++L ++ HP ++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 517
L A L+ +++ G L RL ++ F E + E+A AL LH+
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLHS 144
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 573
II+RD+KP NILLD K+ D GLS ++ + Y + C
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-----KAY-------SFCGT 189
Query: 574 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y+ PE + ++ +D +++G+++ ++LT
Sbjct: 190 VEYMAPEVVNRRGHTQS------ADWWSFGVLMFEMLTGTL 224
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 55/223 (24%)
Query: 411 IGMGGYGTVY---KGTFHHT--FAAVKVLQSKGNIQNKQF-----LQELEVLSKIRHPHL 460
+G GGYG V+ K T +T A+KVL+ K I E +L +++HP +
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLK-KAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 461 LLLLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFL 515
+ L+ A L+ EY+ G L +L R+ F + E++ AL L
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI------FMEDTACFYLAEISMALGHL 137
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC 573
H II+RD+KP NI+L+H K+ D GL ++ + T+ T C
Sbjct: 138 HQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-----VTH-------TFC 182
Query: 574 ----YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y+ PE + R D ++ G ++ +LT P
Sbjct: 183 GTIEYMAPEILMRSGHNRA------VDWWSLGALMYDMLTGAP 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 57/234 (24%), Positives = 104/234 (44%), Gaps = 47/234 (20%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVL 452
+ E ++++ IG G +G V++ + A KVLQ K + +EL+++
Sbjct: 32 GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIM 86
Query: 453 SKIRHPHLLLLLGACPDHGC--------LVYEYMENGSLED-----RLYRKNNTPPIPWF 499
++HP+++ L +G LV EY+ E R Y K
Sbjct: 87 RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLL 142
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSF 558
+ + +++ +LA++H+ I HRD+KP N+LLD + V K+ D G + +L +
Sbjct: 143 IKLYM-YQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 559 VSTTYKNTGPVGTLCYIDPEYQRTGLI------SPKSDVYAYGMVILQLLTAKP 606
VS Y + + Y PE LI + D+++ G V+ +L+ +P
Sbjct: 199 VS--Y-----ICSRYYRAPE-----LIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 66/266 (24%), Positives = 107/266 (40%), Gaps = 36/266 (13%)
Query: 361 QRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTV 419
+ + A A + E+ L + E + E L+ +G G YG V
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKV 70
Query: 420 Y---KGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLGAC--- 467
+ K + H T A+KVL+ +Q + E +VL IR L+ L
Sbjct: 71 FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130
Query: 468 PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHNTKPKPII 524
L+ +Y+ G L L ++ F +I E+ AL LH II
Sbjct: 131 ETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHK---LGII 181
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE---YQR 581
+RD+K NILLD N + D GLS +D + + + GT+ Y+ P+
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-----CGTIEYMAPDIVRGGD 236
Query: 582 TGLISPKS-DVYAYGMVILQLLTAKP 606
+G K+ D ++ G+++ +LLT
Sbjct: 237 SG--HDKAVDWWSLGVLMYELLTGAS 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.5 bits (195), Expect = 4e-16
Identities = 40/254 (15%), Positives = 78/254 (30%), Gaps = 58/254 (22%)
Query: 393 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVL--------QSKGNIQNKQ 444
+ + T +IG G +G V++ HT A+K++ ++
Sbjct: 11 VPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 445 FLQELEVLSKI---------RHPHLLLLL------GACPDHGCLVYEYM--ENGSLEDRL 487
L E+ + ++ R + L G+ P +++ GS DR
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 488 -YRKNNTPPIP-------------------WFERYRIAWEVASALAFLHNTKPKPIIHRD 527
+ K++ I I ++ ++LA HRD
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRD 187
Query: 528 MKPGNILLDHNLVSKIGDVGLSTMLNSDPS---------FVSTTYKNTGPVGTLCYIDPE 578
+ GN+LL + K+ +S ++ V +D +
Sbjct: 188 LHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDED 247
Query: 579 YQRTGLISPKSDVY 592
TG + D+Y
Sbjct: 248 L-FTGDGDYQFDIY 260
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 31/210 (14%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG V+K T A+K + + K L+E+ +L +++HP+L+ LL
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 466 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
LV+EY ++ ++ +P I W+ A+ F H
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLH--ELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---C 123
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 578
IHRD+KP NIL+ + V K+ D G + +L PS V T Y PE
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDE-----VATRWYRSPELLVGD 177
Query: 579 --YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y P DV+A G V +LL+ P
Sbjct: 178 TQY------GPPVDVWAIGCVFAELLSGVP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 31/210 (14%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVK--VLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+G G YG V K T A+K + + K ++E+++L ++RH +L+ LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 466 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
C LV+E++++ ++ D + + + + +++ + + F H+ I
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILD--DLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---I 145
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE----- 578
IHRD+KP NIL+ + V K+ D G + L + P V V T Y PE
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDE-----VATRWYRAPELLVGD 199
Query: 579 --YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y DV+A G ++ ++ +P
Sbjct: 200 VKY------GKAVDVWAIGCLVTEMFMGEP 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 53/225 (23%), Positives = 96/225 (42%), Gaps = 40/225 (17%)
Query: 407 ENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLL 462
E ++G G YG VYK A+K ++ G + +E+ +L +++HP+++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVIS 82
Query: 463 LLGACPDHG----CLVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRI---AWEVASAL 512
L H L+++Y E+ ++ K N P+ R + +++ +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ-LPRGMVKSLLYQILDGI 141
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGP 568
+LH ++HRD+KP NIL+ KI D+G + + NS +
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP---LKPLADLDPV 195
Query: 569 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
V T Y PE Y + D++A G + +LLT++P
Sbjct: 196 VVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSEP 234
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 50/219 (22%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSK-IRHPHLLL 462
+G G +G V +K T + F A+K L+ + + + E VLS HP L
Sbjct: 25 LGKGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 519
+ ++ V EY+ G L + + R A E+ L FLH+
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL----SRATFYAAEIILGLQFLHSKG 138
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 573
I++RD+K NILLD + KI D G+ ML T T C
Sbjct: 139 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-----KTN-------TFCGTPD 183
Query: 574 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
YI PE Y + D +++G+++ ++L +
Sbjct: 184 YIAPEILLGQKYNHSV------DWWSFGVLLYEMLIGQS 216
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 54/236 (22%), Positives = 88/236 (37%), Gaps = 54/236 (22%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
IG G Y V K T A+KV++ + ++ E V + + L+
Sbjct: 17 IGRGSYAKVLLVRLKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 517
L +C V EY+ G L + R+ E R + E++ AL +LH
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE 128
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 573
+ II+RD+K N+LLD K+ D G+ + D TT T C
Sbjct: 129 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTS-------TFCGT 173
Query: 574 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621
YI PE Y + D +A G+++ +++ + I +
Sbjct: 174 PNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V KGT AVK+L+ IQ+ + E VL+ P L
Sbjct: 28 LGKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 519
L +C D V EY+ G L + + A E+A L FL +
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQS-- 139
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 573
K II+RD+K N++LD KI D G+ + + TT T C
Sbjct: 140 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-----TTK-------TFCGTPD 186
Query: 574 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
YI PE Y ++ D +A+G+++ ++L +
Sbjct: 187 YIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQA 219
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 69/221 (31%), Positives = 96/221 (43%), Gaps = 54/221 (24%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSK-IRHPHLLL 462
IG G +G V K F AVKVLQ K ++ K+ + E VL K ++HP L+
Sbjct: 46 IGKGSFGKVLLARHKAE--EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 517
L + D V +Y+ G L L R+ F R R A E+ASAL +LH+
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHS 157
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 573
I++RD+KP NILLD + D GL + ++ TT T C
Sbjct: 158 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS-----TTS-------TFCGT 202
Query: 574 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y+ PE Y RT D + G V+ ++L P
Sbjct: 203 PEYLAPEVLHKQPYDRT------VDWWCLGAVLYEMLYGLP 237
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 54/236 (22%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
IG G Y V K T A++V++ + ++ E V + + L+
Sbjct: 60 IGRGSYAKVLLVRLKKT--DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWF--ERYRI-AWEVASALAFLHN 517
L +C V EY+ G L + R+ E R + E++ AL +LH
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE 171
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC-- 573
+ II+RD+K N+LLD K+ D G+ + D TT T C
Sbjct: 172 ---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTS-------TFCGT 216
Query: 574 --YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621
YI PE Y + D +A G+++ +++ + I +
Sbjct: 217 PNYIAPEILRGEDYGFS------VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 63/219 (28%), Positives = 89/219 (40%), Gaps = 50/219 (22%)
Query: 411 IGMGGYGTVY----KGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V K T AVKVL+ +Q+ + E +LS R+ L
Sbjct: 31 LGKGSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 519
L C PD V E++ G L + + R R A E+ SAL FLH+
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEIISALMFLHD-- 142
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 573
K II+RD+K N+LLDH K+ D G+ + N TT T C
Sbjct: 143 -KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-----TTA-------TFCGTPD 189
Query: 574 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
YI PE Y D +A G+++ ++L
Sbjct: 190 YIAPEILQEMLYGPA------VDWWAMGVLLYEMLCGHA 222
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 4e-15
Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 50/219 (22%)
Query: 411 IGMGGYGTV----YKGTFHHTFAAVKVLQSKGNIQNKQF---LQELEVLSKIRHPHLLLL 463
+G G +G V KGT AVK+L+ IQ+ + E VL+ P L
Sbjct: 349 LGKGSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 464 LGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRI-AWEVASALAFLHNTK 519
L +C D V EY+ G L + + A E+A L FL +
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIAIGLFFLQS-- 460
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLS--TMLNSDPSFVSTTYKNTGPVGTLC---- 573
K II+RD+K N++LD KI D G+ + + TT T C
Sbjct: 461 -KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-----TTK-------TFCGTPD 507
Query: 574 YIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
YI PE Y ++ D +A+G+++ ++L +
Sbjct: 508 YIAPEIIAYQPYGKS------VDWWAFGVLLYEMLAGQA 540
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 49/249 (19%), Positives = 97/249 (38%), Gaps = 51/249 (20%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-----------H 457
+G G + TV+ A+K+++ + E+++L ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 458 PHLLLLL------GACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
H+L LL G H +V+E + +L L +K IP +I+ ++
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA-LIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVS------KIGDVGLSTMLNSDPSFVSTTYKN 565
L ++H + IIH D+KP N+L++ KI D+G + + T
Sbjct: 144 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNS-- 195
Query: 566 TGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 619
+ T Y PE + +D+++ +I +L+T D
Sbjct: 196 ---IQTREYRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 620 EDNLAEILD 628
+D++A+I++
Sbjct: 247 DDHIAQIIE 255
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 40/182 (21%), Positives = 69/182 (37%), Gaps = 5/182 (2%)
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
QR ++ + + + L AK + + E L L +E
Sbjct: 95 LQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLTRLIAAERERE 154
Query: 639 TKEL--AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICP 696
+E G R + ++ + + + E+ + + P++
Sbjct: 155 LEECQRNHEGHEDDGHIRAQQACIEAKHDKYMADMDELFSQVDEKR--KKRDIPDYLCGK 212
Query: 697 ILKEVMNEPCVAADGYTYDRKAIEEWLQENDK-SPITDLPLPNKNLLPNYTLLSAILDWK 755
I E+M EPC+ G TYDRK IEE LQ +P+T PL + L+PN + I +
Sbjct: 213 ISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFI 272
Query: 756 SK 757
S+
Sbjct: 273 SE 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 40/151 (26%), Positives = 73/151 (48%), Gaps = 18/151 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 462
++G G Y TVYKG T + A+K + + +++ ++E+ ++ +++H +++
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALK----EVKLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 463 LLGACPDHGC--LVYEYMEN--GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
L LV+E+M+N D N + W++ LAF H
Sbjct: 68 LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549
K I+HRD+KP N+L++ K+GD GL+
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 11/146 (7%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG VYK T A+K L ++ ++E+ +L ++ HP+++ LL
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 466 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
LV+E++ L+ + + IP +++ LAF H+ + +
Sbjct: 70 VIHTENKLYLVFEFLHQ-DLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 124
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLS 549
+HRD+KP N+L++ K+ D GL+
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 2e-13
Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 14/147 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YGTV+K T A+K L L+E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 466 ACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
LV+E+ + D + Y + + +++ L F H+
Sbjct: 69 VLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLS 549
++HRD+KP N+L++ N K+ + GL+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 40/214 (18%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 462
++G G Y TVYKG T A+K + +++++ ++E+ +L ++H +++
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 463 LLGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
L LV+EY++ D + Y + I +++ LA+ H K
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE- 578
++HRD+KP N+L++ K+ D GL+ S P + TY V TL Y P+
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAK-SIP---TKTY--DNEVVTLWYRPPDI 171
Query: 579 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y S + D++ G + ++ T +P
Sbjct: 172 LLGSTDY------STQIDMWGVGCIFYEMATGRP 199
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-13
Identities = 11/57 (19%), Positives = 29/57 (50%), Gaps = 1/57 (1%)
Query: 691 NHFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYT 746
+H +C I +V P ++ +++ +E+++++ PIT+ PL + ++
Sbjct: 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVP 58
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 56/222 (25%), Positives = 86/222 (38%), Gaps = 45/222 (20%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF----LQE---LEVLSKIRHPH 459
IG+G YGTVYK H+ V V G ++E L L HP+
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 460 LLLLLGACPDHGC-------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEVAS 510
++ L+ C LV+E+++ D K P +P + +
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVG 570
L FLH I+HRD+KP NIL+ K+ D GL+ + + + T V
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-------TPVVV 181
Query: 571 TLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
TL Y PE Y + D+++ G + ++ KP
Sbjct: 182 TLWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRKP 217
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 49/225 (21%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ--F----LQELEVLSKIRHPHLL 461
+IG G +G V+K T A+K K ++N++ F L+E+++L ++H +++
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALK----KVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 462 LLLGACPDHGC----------LVYEYMEN---GSLEDRLYRKNNTPPIPWFERYRIAWEV 508
L+ C LV+++ E+ G L N E R+ +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQML 133
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
+ L ++H K I+HRDMK N+L+ + V K+ D GL+ + + Y T
Sbjct: 134 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY--TNR 188
Query: 569 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
V TL Y PE Y P D++ G ++ ++ T P
Sbjct: 189 VVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRSP 227
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 8e-13
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 17/149 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ-----FLQELEVLSKIRHPHLLL 462
+G G + TVYK +T A+K ++ + K L+E+++L ++ HP+++
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 463 LLGACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
LL A LV+++ME D + K+N+ + L +LH
Sbjct: 77 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGL 548
I+HRD+KP N+LLD N V K+ D GL
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 56/275 (20%), Positives = 94/275 (34%), Gaps = 63/275 (22%)
Query: 411 IGMGGYGTVY--KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HP---HL 460
+G G + TV+ F A+KV++S + + L E+ +L +R P +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH-YTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 461 LLLL------GACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALA 513
+ LL G H C+V+E + G L K+N +P +I +V L
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 514 FLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTY------- 563
+LH IIH D+KP NILL + + + + P S
Sbjct: 161 YLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 564 ------------------------------KNTGPVGTLCYIDPEYQRTGLISPKSDVYA 593
T + T Y E + +D+++
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWS 278
Query: 594 YGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628
+ +L T E DED++A I++
Sbjct: 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 37/147 (25%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
++G G YG VYK A+K L ++ ++E+ +L ++ HP+++ L+
Sbjct: 28 KVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 466 ACPDHGC--LVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
C LV+E+ME D + N + + +++ +A H +
Sbjct: 87 VIHSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--- 139
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLS 549
I+HRD+KP N+L++ + K+ D GL+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 33/147 (22%), Positives = 69/147 (46%), Gaps = 15/147 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG VYK ++ A+K L+ + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 466 ACPDHG--CLVYEYMENGSLED-RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
LV+E+++ D + + ++ + +A+ H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLS 549
++HRD+KP N+L++ KI D GL+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLA 147
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 27/153 (17%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 467
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 468 PDHGC------LVYEYMENGSLEDRLYRKNNTPPIPWF-ERY--RIAWEVASALAFLHNT 518
+ +V E ++ G L R+ + + F ER I + A+ +LH+
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----FTEREASEIMKSIGEAIQYLHS- 135
Query: 519 KPKPIIHRDMKPGNILL---DHNLVSKIGDVGL 548
I HRD+KP N+L N + K+ D G
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 37/203 (18%), Positives = 64/203 (31%), Gaps = 25/203 (12%)
Query: 390 YRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQ- 441
Y WE L + +G G +G V + AVK+L+
Sbjct: 12 YDASKWE-FPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 68
Query: 442 NKQFLQELEVLSKI-RHPHLLLLLGACPDHG---CLVYEYMENGSLEDRLYRKNNTPPIP 497
++ + EL++L I H +++ LLGAC G ++ E+ + G+L L K N
Sbjct: 69 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
Query: 498 WFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557
+ R I D+K + + S L+
Sbjct: 129 KTKGARFR----------QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178
Query: 558 FVSTTYKNTGPVGTLCYIDPEYQ 580
+ + I +Q
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQ 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKV--LQSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
++G G YG VYK T A+K L+ + ++E+ +L +++H +++ L
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 466 ACPDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
+ L++EY EN L+ + + P + +++ + + F H+ +
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCHSRR---C 153
Query: 524 IHRDMKPGNILLDHNLVS-----KIGDVGL 548
+HRD+KP N+LL + S KIGD GL
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.7 bits (167), Expect = 6e-12
Identities = 77/556 (13%), Positives = 158/556 (28%), Gaps = 175/556 (31%)
Query: 161 SSQTDLGSAVASYTHSSSPSLP---TQRLQALSAVNKTLLHLKPSSTEINH--------- 208
S T + ++ + RLQ + + LL L+P+ +
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW 165
Query: 209 ---SRCQSFDVEEQKD-----ASSSCLSGPEVRQTVSRSSSYRSMETENQDWSDQASTTD 260
C S+ V+ + D + + PE + + Y+ +W+ ++ +
Sbjct: 166 VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQID----PNWTSRSDHSS 221
Query: 261 VLPYDSSSESQVDVNFELEK-----LRIELRHVRGMYAIAQNEANDASRKVNDLN-KCKL 314
+ S K L + L +V+ +A + N N CK+
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYENCLLV-LLNVQ-----------NA-KAWNAFNLSCKI 268
Query: 315 EEETRLSEI--QLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAK-- 370
TR ++ L ++ T E ++ + + + +
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLT----------PDEVKSLLLKYLDCRPQDL 318
Query: 371 -HEAKE---------KEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVY 420
E E + L T+ ++++ +++ + S L Y
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLA-TWDNWKHVNCDKLTTIIESSLNVL------EPAEY 371
Query: 421 KGTFHHTFAAVKVLQSKGNIQNK---------------QFLQELEVLSKI-RHP------ 458
+ F + V +I + +L S + + P
Sbjct: 372 RKMF-DRLS---VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427
Query: 459 -HLLLLLGACPD------HGCLVYEYMENGSLEDRLYRK--NNTPPIPWFERYRIAWEVA 509
+ L H +V Y + + ++ P+ ++Y
Sbjct: 428 IPSIYLELKVKLENEYALHRSIVDHY--------NIPKTFDSDDLIPPYLDQY-FYS--- 475
Query: 510 SALAFL--HNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVST----- 561
+ H + + + LD L KI + N+ S ++T
Sbjct: 476 ----HIGHHLKNIEHPERMTLFR-MVFLDFRFLEQKIRHDSTA--WNASGSILNTLQQLK 528
Query: 562 TYKNTGPVGTLCYI---DPEYQR-------------TGLI-SPKSDVYAYGMVILQLLTA 604
YK YI DP+Y+R LI S +D +L+
Sbjct: 529 FYKP--------YICDNDPKYERLVNAILDFLPKIEENLICSKYTD-------LLR---- 569
Query: 605 KPAIAITHKVETAIDE 620
IA+ + E +E
Sbjct: 570 ---IALMAEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 4e-08
Identities = 75/509 (14%), Positives = 157/509 (30%), Gaps = 157/509 (30%)
Query: 306 VNDLNKCK-LEEETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQRQE 364
V++ + CK +++ + +L ++ I+ K R +
Sbjct: 30 VDNFD-CKDVQDMPK----SILSKEEIDHIIMSKDAVSGTLRLFWTLLS----------- 73
Query: 365 AEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF 424
K++EM+++ + + I++ S R+ Y
Sbjct: 74 ---------KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQR 116
Query: 425 HHTFAAVKVLQSKGNIQNKQFLQEL-EVLSKIRHPHLLLLLGACPDHG-------CLVYE 476
+ +V +K N+ Q +L + L ++R P +L+ G + +
Sbjct: 117 DRLYNDNQVF-AKYNVSRLQPYLKLRQALLELR-PAKNVLI-----DGVLGSGKTWVALD 169
Query: 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII-------HRDMK 529
+ ++ ++ ++I W L + P+ ++ ++
Sbjct: 170 VCLSYKVQCKMD-------------FKIFW-----LNLKNCNSPETVLEMLQKLLYQIDP 211
Query: 530 PGNILLDH--NLVSKIGDV--GLSTMLNSDPSFVSTTYKNTGPVGTLCYI------DPEY 579
DH N+ +I + L +L S P Y+N C + + +
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKP------YEN-------CLLVLLNVQNAK- 257
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKPAIA--ITHKVETAIDEDNLAEILDAQAGDWPIK 637
+ + IL L T + ++ T I D+ + L
Sbjct: 258 ----AW----NAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSMTLTP-------D 301
Query: 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPN---HFI 694
E K L + R +D P P L +A+ RD A + H
Sbjct: 302 EVKSLLL---KYLDCRPQDLPREVLTTNPRR--LSIIAESIRD-----GLATWDNWKHVN 351
Query: 695 CPILKEVMNEPCVAA---DGY--TYDRKAI-EE------------WLQ--ENDKSPITDL 734
C L ++ E + Y +DR ++ W ++D + +
Sbjct: 352 CDKLTTII-ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNK 410
Query: 735 PLPNKNLL---PN---YTLLSAILDWKSK 757
L +L+ P ++ S L+ K K
Sbjct: 411 -LHKYSLVEKQPKESTISIPSIYLELKVK 438
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 4e-07
Identities = 96/642 (14%), Positives = 189/642 (29%), Gaps = 185/642 (28%)
Query: 198 HLKPSSTEINHSR-----------CQSFDVEEQKDASSSCLSGPEVRQTVSRSS----SY 242
H+ + E + +FD ++ +D S LS E+ + +
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTL 65
Query: 243 RSMET--ENQDWSDQASTTDVLPYDSSSESQVDVNFELEKLRIELRH---VRGMYAIAQN 297
R T Q+ Q +VL +++ F + ++ E R + MY ++
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVL--------RINYKFLMSPIKTEQRQPSMMTRMYIEQRD 117
Query: 298 EANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQEKK----------KYETARRE 347
+ ++ N +RL L + +EL + K K A
Sbjct: 118 RLYNDNQVFAKYNV------SRLQPYLKLRQALLEL-RPAKNVLIDGVLGSGKTWVA--- 167
Query: 348 AECARASAEKEAAQRQEAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSE 407
+ + + + + K+ + +LE +Q N T + S
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT------SRSDHSS 221
Query: 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
N+++ H A ++ L +++K + L VL +++
Sbjct: 222 NIKL-----------RIHSIQAELRRL-----LKSKPYENCLLVLLNVQNAKAWNAF--- 262
Query: 468 PDHGC--LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH---NTKPK- 521
+ C L+ + D L T + + + + L + +P+
Sbjct: 263 -NLSCKILLTT--RFKQVTDFL--SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 522 ---------P----IIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNS-DPSFVSTTYK 564
P II ++ G D H K+ + + + LN +P+ +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI-IESSLNVLEPAEYRKMFD 376
Query: 565 NTG--------PVGTLC-------YIDPE-----YQRTGLI--SPKSDVYAYGMVILQLL 602
P L D + L+ PK + + L+L
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK 436
Query: 603 TAKPAIAITHKVETAIDEDNLAEILD-----AQAGD--W------------PIKETKELA 643
H+ + +D N+ + D D + +
Sbjct: 437 VKLENEYALHR--SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR 494
Query: 644 ALGLSCAELRRKDRPD-----LKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPIL 698
+ L L +K R D +L L++LK +IC
Sbjct: 495 MVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP----------------YICD-- 536
Query: 699 KEVMNEPCVAADGYTYDR--KAIEEWLQEND----KSPITDL 734
N+P Y+R AI ++L + + S TDL
Sbjct: 537 ----NDP-------KYERLVNAILDFLPKIEENLICSKYTDL 567
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 39/214 (18%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH------PHLLL 462
IG G +G V K H A+K+++++ +Q +E+ +L +R +++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH-RQAAEEIRILEHLRKQDKDNTMNVIH 163
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
+L +H C+ +E + +L + L +KN + A + L LH +
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYE-LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR- 220
Query: 521 KPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
IIH D+KP NILL S K+ D G S + TY + + Y PE
Sbjct: 221 --IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY----TY-----IQSRFYRAPE 269
Query: 579 ------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y D+++ G ++ +LLT P
Sbjct: 270 VILGARY------GMPIDMWSLGCILAELLTGYP 297
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 27/177 (15%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGA 466
++G G Y V++ VK+L+ ++ K+ +E+++L +R P+++ L
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 99
Query: 467 CPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
D LV+E++ N + +LY+ I R+ + +E+ AL + H+
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDI----RFYM-YEILKALDYCHS---MG 150
Query: 523 IIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I+HRD+KP N+++DH + ++ D GL+ F + V + + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLA-------EFYHPGQEYNVRVASRYFKGPE 200
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 57/273 (20%), Positives = 104/273 (38%), Gaps = 36/273 (13%)
Query: 350 CARASAEKEAAQRQ--EAEMKAKHEAKEKEMLERALNGTFQRY--RNLTWEEIESATLSF 405
C+ + + + A Q + ++ + AK M + ++ F + T+ +
Sbjct: 9 CSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFT----VLKRY 64
Query: 406 SENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLL 461
IG G G V V K+ + N + K+ +EL ++ + H +++
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 462 LLLGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 513
LL P LV E M+ L + Y + +++ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLL-YQMLCGIK 178
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
LH+ IIHRD+KP NI++ + KI D GL+ SF+ T Y V T
Sbjct: 179 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-----VVTRY 228
Query: 574 YIDPEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
Y PE D+++ G ++ +++ K
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-11
Identities = 20/76 (26%), Positives = 30/76 (39%), Gaps = 10/76 (13%)
Query: 692 HFICPILKEVMNEPCVAAD-GYTYDRKAIEEWLQENDKS------PIT---DLPLPNKNL 741
F CPI KE M +P G+TY+ AI ++ K P + +L
Sbjct: 7 GFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDL 66
Query: 742 LPNYTLLSAILDWKSK 757
+ + L AI + K
Sbjct: 67 IQDEALRRAIENHNKK 82
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 45/264 (17%), Positives = 98/264 (37%), Gaps = 82/264 (31%)
Query: 399 ESATLSFSENLRIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQNKQF-LQELEVLSK 454
E+++ +S +G G +G V + + KVLQ + ++ +EL+++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKV 56
Query: 455 IRHPHLLLLL----------------------------------GACPDHGC------LV 474
+ H +++ L+ + + ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 475 YEYMENGSLED-----RLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529
EY+ + + + ++ I +++ A+ F+H+ I HRD+K
Sbjct: 117 MEYVP----DTLHKVLKSFIRSGRSIPMNLISIYI-YQLFRAVGFIHSLG---ICHRDIK 168
Query: 530 PGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI--- 585
P N+L++ + K+ D G + L V+ Y + + Y PE L+
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA--Y-----ICSRFYRAPE-----LMLGA 216
Query: 586 ---SPKSDVYAYGMVILQLLTAKP 606
+P D+++ G V +L+ KP
Sbjct: 217 TEYTPSIDLWSIGCVFGELILGKP 240
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLG 465
IG G G V V K+ + N + K+ +EL ++ + H +++ LL
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 91
Query: 466 A-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLH 516
P +V E M+ +L ++ + ER + +++ + LH
Sbjct: 92 VFTPQKSLEEFQDVYIVMELMDA-NLC-QVIQMELDH-----ERMSYLLYQMLCGIKHLH 144
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ IIHRD+KP NI++ + KI D GL+ SF+ T Y V T Y
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPY-----VVTRYYRA 194
Query: 577 PEYQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE D+++ G ++ +++
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 16/155 (10%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHP------HLLL 462
IG G +G V K + A+K++++K Q E+ +L + +++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 463 LLGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L +H CLV+E + +L D L R N + + A ++ +AL FL +
Sbjct: 121 LKRHFMFRNHLCLVFEMLSY-NLYD-LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 521 KPIIHRDMKPGNILLDHNLVS--KIGDVGLSTMLN 553
IIH D+KP NILL + S KI D G S L
Sbjct: 179 S-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 57/227 (25%)
Query: 410 RIGMGGYGTVYKGT-FHHT--FAAVKVLQSKGNIQNKQ------------FLQELEVLSK 454
IG G YG V+K + F A+K + +Q + L+ L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALK----RVRVQTGEEGMPLSTIREVAVLRHL---ET 70
Query: 455 IRHPHLLLLLGACPDHGC-------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIA 505
HP+++ L C LV+E+++ D K P +P +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMM 126
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN 565
+++ L FLH+ + ++HRD+KP NIL+ + K+ D GL+ + + +
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL------- 176
Query: 566 TGPVGTLCYIDPE------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
T V TL Y PE Y + D+++ G + ++ KP
Sbjct: 177 TSVVVTLWYRAPEVLLQSSY------ATPVDLWSVGCIFAEMFRRKP 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 50/225 (22%), Positives = 80/225 (35%), Gaps = 51/225 (22%)
Query: 411 IGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN----------KQFLQELEVLSKIRH 457
I G YG V G V +V + + + K+ L+E+ +L+ H
Sbjct: 30 ISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 458 PHLLLLLGA-CPDHGC------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIAWEV 508
P++L L LV E M D ++ P +Y + +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQHIQY-FMYHI 143
Query: 509 ASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
L LH ++HRD+ PGNILL N I D L+ +D + T Y
Sbjct: 144 LLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHY----- 193
Query: 569 VGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
V Y PE + + D+++ G V+ ++ K
Sbjct: 194 VTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRKA 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 47/217 (21%)
Query: 411 IGMGGYGTVYKGTFHHTFAAV------KVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
+G G YG+V + V + QS+ I K+ +EL +L ++H +++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE--IFAKRAYRELLLLKHMQHENVIGLL 89
Query: 465 GA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
P LV +M+ D L + +Y + +++ L ++H
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKIQY-LVYQMLKGLKYIH 143
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ ++HRD+KPGN+ ++ + KI D GL+ +++ T Y V T Y
Sbjct: 144 SAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGY-----VVTRWYRA 191
Query: 577 PE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE Y + D+++ G ++ ++LT K
Sbjct: 192 PEVILSWMHY------NQTVDIWSVGCIMAEMLTGKT 222
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 35/137 (25%), Positives = 60/137 (43%), Gaps = 15/137 (10%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH-----PHLLLL 463
+G G +G V + AVKV+++ + E ++L KI++ +++
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIVKY 101
Query: 464 LGA--CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
G DH CL++E + SL + + +NN + E+ AL +L
Sbjct: 102 HGKFMYYDHMCLIFEPLGP-SLYE-IITRNNYNGFHIEDIKLYCIEILKALNYLRKMS-- 157
Query: 522 PIIHRDMKPGNILLDHN 538
+ H D+KP NILLD
Sbjct: 158 -LTHTDLKPENILLDDP 173
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 32/141 (22%), Positives = 62/141 (43%), Gaps = 21/141 (14%)
Query: 411 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQN--KQFLQELEVLSKIR-----HPHL 460
+G G +G V + H AVK+++ N+ + E++VL +
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 461 LLLLGACPD---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
+ + + H C+V+E + S D ++N P ++A+++ ++ FLH+
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGL-STYD-FIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 518 TKPKPIIHRDMKPGNILLDHN 538
K + H D+KP NIL +
Sbjct: 137 NK---LTHTDLKPENILFVQS 154
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 40/268 (14%), Positives = 88/268 (32%), Gaps = 69/268 (25%)
Query: 343 TARREAECARASA---EKEAAQRQEAEMKAKHEAKEKEMLERALNGTF---QRYRNLTWE 396
++ A + ++ + +QE + + +H + + + + RY
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH-- 59
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--------KQFL 446
IG G YG V + A+K I K+ L
Sbjct: 60 -------------LIGTGSYGHVCEAYDKLEKRVVAIK------KILRVFEDLIDCKRIL 100
Query: 447 QELEVLSKIRHPHLLLLLGACPDHGC-------LVYEYME---------NGSLEDRLYRK 490
+E+ +L+++ H H++ +L +V E + L + +
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK- 159
Query: 491 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550
+ + + + ++H+ I+HRD+KP N L++ + K+ D GL+
Sbjct: 160 ------------TLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204
Query: 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
++ + S + P
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 39/173 (22%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 411 IGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQNKQFLQELEVLSKIRHP-----HLLL 462
+G G +G V + H A+K++++ + E+ VL KI+ L +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCV 85
Query: 463 LLGACPD---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
L+ + H C+ +E + + + ++NN P P +A+++ AL FLH +
Sbjct: 86 LMSDWFNFHGHMCIAFELLGK-NTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS-------FVSTTYKN 565
+ H D+KP NIL ++ + + S S + F S T+ +
Sbjct: 144 ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 19/175 (10%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 465
+IG G +G +Y GT V + ++ Q E ++ ++ P + G
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT-IRWCG 74
Query: 466 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
A D+ +V E + G SLED + + +A ++ S + ++H+ K I
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS---KNFI 127
Query: 525 HRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 574
HRD+KP N L+ NLV I D GL+ + Y+ N GT Y
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 49/229 (21%), Positives = 95/229 (41%), Gaps = 55/229 (24%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLL 463
+G GG G V+ + A+K K + + Q L+E++++ ++ H +++ +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIK----KIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 464 LGA-CPDHGC---------------LVYEYMENGSLED--RLYRKNNTPPIPWFERYRIA 505
P +V EYME D + + R
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMET----DLANVLEQGPLLEE--HARL-FM 126
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVS--TT 562
+++ L ++H+ ++HRD+KP N+ ++ +LV KIGD GL+ +++ S +
Sbjct: 127 YQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 563 YKNTGPVGTLCYIDPEYQRTGLISPKS-----DVYAYGMVILQLLTAKP 606
+ T Y P L+SP + D++A G + ++LT K
Sbjct: 184 G-----LVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 38/180 (21%), Positives = 65/180 (36%), Gaps = 27/180 (15%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 465
RIG G +G +++GT V + Q E + P++ G
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF-G 75
Query: 466 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERY---RIAWEVASALAFLHNTKPK 521
H LV + + G SLED L F A ++ + + +H K
Sbjct: 76 QEGLHNVLVIDLL--GPSLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHE---K 125
Query: 522 PIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 574
+++RD+KP N L+ + N++ + D G+ + Y+ GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 42/189 (22%), Positives = 74/189 (39%), Gaps = 26/189 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
IG G YG VY +T A+K + + I K+ L+E+ +L++++ +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDL--IDCKRILREITILNRLKSDYIIRL 90
Query: 464 LGACPDHGC-------LVYEYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAF 514
+V E + D L + K + I + + F
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLTEEHIKT-ILYNLLLGENF 144
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
+H + IIHRD+KP N LL+ + K+ D GL+ +NS+
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 575 IDPEYQRTG 583
+ + Q T
Sbjct: 202 KNLKKQLTS 210
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 47/231 (20%), Positives = 83/231 (35%), Gaps = 61/231 (26%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNI-QNKQFLQ----ELEVLSKIRHPHLLL 462
+G G YG V T T A+K K F E+++L +H +++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIK----KIEPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 463 LLGACPDHGC-------LVYEYME--------NGSLEDRLYRKNNTPPIPWFERYR-IAW 506
+ ++ E M+ L D + + +
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD--------------DHIQYFIY 119
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKN- 565
+ A+ LH + +IHRD+KP N+L++ N K+ D GL+ +++ + S
Sbjct: 120 QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 566 ---TGPVGTLCYIDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
V T Y PE Y S DV++ G ++ +L +P
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRRP 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 44/217 (20%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQF----LQELEVLSKIRHPHLLLLLG 465
+G G YG+V T V V + Q+ +EL +L ++H +++ LL
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 466 A-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAFLH 516
P LV M L + + + T + + + +++ L ++H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTD-----DHVQFLIYQILRGLKYIH 149
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ IIHRD+KP N+ ++ + KI D GL+ + T Y V T Y
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGY-----VATRWYRA 197
Query: 577 PE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE Y + D+++ G ++ +LLT +
Sbjct: 198 PEIMLNWMHY------NQTVDIWSVGCIMAELLTGRT 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 44/184 (23%), Positives = 76/184 (41%), Gaps = 33/184 (17%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQ----ELEVLSKIRHPHLLLLL 464
IG G YG V + A+K + +++ + Q E+++L + RH +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 465 GACPDHGC-------LVYEYMENGSLEDRLYRKNNTPPI-PWFERYRIAWEVASALAFLH 516
+V + ME D LY+ T + Y +++ L ++H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSNDHICY-FLYQILRGLKYIH 145
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL--STMLNSDPSFVSTTYKNTGPVGTLCY 574
+ ++HRD+KP N+LL+ KI D GL + D + T Y V T Y
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-----VATRWY 197
Query: 575 IDPE 578
PE
Sbjct: 198 RAPE 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 48/219 (21%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVK----VLQSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G YG V T A+K QS+ + K+ +EL +L +RH +++ L
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE--LFAKRAYRELRLLKHMRHENVIGL 89
Query: 464 LGA-CPDHGC-------LVYEYMENGSLEDRLYRKNNTPPIPWFERYR-IAWEVASALAF 514
L PD LV +M L + + +R + + +++ L +
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGE-----DRIQFLVYQMLKGLRY 143
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
+H IIHRD+KPGN+ ++ + KI D GL+ +S+ T Y V T Y
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGY-----VVTRWY 191
Query: 575 IDPE-------YQRTGLISPKSDVYAYGMVILQLLTAKP 606
PE Y + D+++ G ++ +++T K
Sbjct: 192 RAPEVILNWMRY------TQTVDIWSVGCIMAEMITGKT 224
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 25/178 (14%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLLLG 465
+IG G +G +Y GT T V + ++ Q L E ++ ++ P+ + G
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPN-VRWFG 72
Query: 466 ACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERY---RIAWEVASALAFLHNTKPK 521
D+ LV + + G SLED L+ + +A ++ + + F+H+ K
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFNFCSRK----LSLKTVLMLADQMINRVEFVHS---K 122
Query: 522 PIIHRDMKPGNILL----DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGPVGTLCY 574
+HRD+KP N L+ N V I D GL+ + Y+ N GT Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAV---KVLQSKGNIQN-KQFLQELEVLSKIR-HPHLLLLL 464
++G G YG V+K T V K+ + N + ++ +E+ +L+++ H +++ LL
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 465 GAC-PDHGC---LVYEYME--------NGSLEDRLYRKNNTPPIPWFERYR-IAWEVASA 511
D+ LV++YME LE + + +++
Sbjct: 76 NVLRADNDRDVYLVFDYMETDLHAVIRANILEP--------------VHKQYVVYQLIKV 121
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGP 568
+ +LH+ ++HRDMKP NILL+ K+ D GLS + + +
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 32/166 (19%)
Query: 410 RIGMGGYGTVYKGTFHHTFA----------AVKVLQSKGNIQNKQ-FLQELEVLSKIRHP 458
G +Y+ T ++K+ G + N+Q F Q ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 459 HLLLLLGA------------CPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIA 505
L + LV + G SL+ + + ++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQVA 165
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 549
+ AL FLH +H ++ NI +D S++ G +
Sbjct: 166 CRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 41/186 (22%), Positives = 73/186 (39%), Gaps = 39/186 (20%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRH----PHLLLL 463
+IG G +G + G +T + A+K+ + Q E ++ P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLE--PMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 464 LGACPDHGCLVYEYMENG-SLEDRLYRKNNTPPIPWFER-------YRIAWEVASALAFL 515
G C + +V E + G SLED L+ + R IA ++ S + ++
Sbjct: 74 -GPCGKYNAMVLELL--GPSLED-LFDLCD--------RTFSLKTVLMIAIQLISRMEYV 121
Query: 516 HNTKPKPIIHRDMKPGNILL------DHNLVSKIGDVGLSTMLNSDPSFVSTTYK-NTGP 568
H+ K +I+RD+KP N L+ ++ I D L+ + Y+ +
Sbjct: 122 HS---KNLIYRDVKPENFLIGRPGNKTQQVIHII-DFALAKEYIDPETKKHIPYREHKSL 177
Query: 569 VGTLCY 574
GT Y
Sbjct: 178 TGTARY 183
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 31/166 (18%), Positives = 58/166 (34%), Gaps = 35/166 (21%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHP---------H 459
+IG GG+G +Y + K +N EL+ ++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 460 LLLLLGACPDHGCLVYEYMENG-----------SLEDRLYRKNNTPPIPWFER---YRIA 505
L LG +G + E+ L+ + +N T F++ ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGT-----FKKSTVLQLG 157
Query: 506 WEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 549
+ L ++H +H D+K N+LL + ++ D GLS
Sbjct: 158 IRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 34/172 (19%), Positives = 58/172 (33%), Gaps = 44/172 (25%)
Query: 410 RIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---- 458
IG GG+G +Y + VKV S N EL+ + P
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD----NGPLFTELKFYQRAAKPEQIQ 97
Query: 459 -----HLLLLLGACPDHGCLVYEYMENG-----------SLEDRLYRKNNTPPIPWFER- 501
L LG G +++ L+ +Y N F R
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKR----FSRK 152
Query: 502 --YRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI--GDVGLS 549
+++ + L ++H +H D+K N+LL++ ++ D GL+
Sbjct: 153 TVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 5e-05
Identities = 12/70 (17%), Positives = 25/70 (35%), Gaps = 5/70 (7%)
Query: 693 FICPILKEVMNEPCVAAD-GYTYDRKAIEEWLQENDKS--PIT--DLPLPNKNLLPNYTL 747
CPI + P ++ + +DR I+ +LQ P + ++ + + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 748 LSAILDWKSK 757
K K
Sbjct: 242 ELRCKIAKMK 251
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 6e-05
Identities = 27/144 (18%), Positives = 49/144 (34%), Gaps = 9/144 (6%)
Query: 268 SESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVND---LNKCKLEEETRLSEIQ 324
+++ F L + V+ + + Q + R V + E + +
Sbjct: 620 PKARDQAVFPQNGLVVSSVDVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQR 679
Query: 325 LLEEKAIELAKQ---EKKKYETARR---EAECARASAEKEAAQRQEAEMKAKHEAKEKEM 378
L +E L +Q ++ + E AR+ E E + E + EAE +A+ E E
Sbjct: 680 LEQEARGRLERQKILDQSEAEKARKELLELEAMSMAVESTGNAKAEAESRAEAARIEGEG 739
Query: 379 LERALNGTFQRYRNLTWEEIESAT 402
Q T E+E
Sbjct: 740 SVLQAKLKAQALAIETEAELERVK 763
|
| >2zuo_A MVP, major vault protein; repeat domains, protein-protein complex, cytoplasm, ribonucleoprotein, structural protein; 3.50A {Rattus norvegicus} PDB: 2zv4_N 2zv5_a 2qzv_A Length = 861 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 30/147 (20%), Positives = 47/147 (31%), Gaps = 6/147 (4%)
Query: 260 DVLPYDSSSESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKL----E 315
DV + + D +L IE+ A L + K+ E
Sbjct: 639 DVQSVEPVDQRTRDALQRSVQLAIEITTNSQEAAAKHEAQRLEQEARGRLERQKILDQSE 698
Query: 316 EETRLSEIQLLEEKAIELAKQEKKKYETARREAECARASAEKEAAQ-RQEAEMKAKHEAK 374
E E+ LE ++ + K E A AE AR E Q + +A+ A
Sbjct: 699 AEKARKELLELEAMSMAVESTGNAKAE-AESRAEAARIEGEGSVLQAKLKAQALAIETEA 757
Query: 375 EKEMLERALNGTFQRYRNLTWEEIESA 401
E E +++ R E+ A
Sbjct: 758 ELERVKKVREMELIYARAQLELEVSKA 784
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 8/58 (13%), Positives = 22/58 (37%), Gaps = 6/58 (10%)
Query: 327 EEKAIELAKQEKKKYETARREAECARASAEKEAAQRQEAEMKAKHEA----KEKEMLE 380
EE+ L + + + +A + E ++++E K++ +K +
Sbjct: 92 EEQRKRLQELDAA--SKVMEQEWREKAKKDLEEWNQRQSEQVEKNKINNRIADKAFYQ 147
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 7e-04
Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 20/96 (20%)
Query: 270 SQVD-VNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE 328
+Q D + E E +R + R + + + DA+ K +E+E R E+
Sbjct: 75 AQADRLTQEPESIR-KWREEQR----KRLQELDAASK-------VMEQEWR-------EK 115
Query: 329 KAIELAKQEKKKYETARREAECARASAEKEAAQRQE 364
+L + +++ E + R + + Q
Sbjct: 116 AKKDLEEWNQRQSEQVEKNKINNRIADKAFYQQPDA 151
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 28/114 (24%), Positives = 50/114 (43%), Gaps = 8/114 (7%)
Query: 269 ESQVDVNFELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEE 328
+ + E L+ +L+ +YA A+ + K +L + E E R+ E EE
Sbjct: 885 QKHTQLCEEKNLLQEKLQAETELYAEAEEMRVRLAAKKQELEEILHEMEARIEE----EE 940
Query: 329 KAIELAKQEKKKYETARREAECARASAEKEAAQRQEAE-MKAKHEAKEKEMLER 381
+ + + EKKK + + E E+E A RQ+ + K + K K+M +
Sbjct: 941 ERSQQLQAEKKKMQQQMLDLE---EQLEEEEAARQKLQLEKVTADGKIKKMEDD 991
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 24/104 (23%), Positives = 48/104 (46%), Gaps = 6/104 (5%)
Query: 277 ELEKLRIELRHVRGMYAIAQNEANDASRKVNDLNKCKLEEETRLSEIQLLEEKAIELAKQ 336
+ KL E + + + + K +L K K + E+ +SE+ E ++ ++
Sbjct: 998 QNNKLTKERKLLEERVSDLTTNLAEEEEKAKNLTKLKNKHESMISEL----EVRLKKEEK 1053
Query: 337 EKKKYETARR--EAECARASAEKEAAQRQEAEMKAKHEAKEKEM 378
+++ E +R E E + + Q Q AE+KA+ KE+E+
Sbjct: 1054 SRQELEKIKRKLEGESSDLHEQIAELQAQIAELKAQLAKKEEEL 1097
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 757 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2kr4_A | 85 | Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ri | 99.4 | |
| 1wgm_A | 98 | Ubiquitin conjugation factor E4A; ubiquitinating e | 99.38 | |
| 2kre_A | 100 | Ubiquitin conjugation factor E4 B; U-box domain, E | 99.38 | |
| 3m62_A | 968 | Ubiquitin conjugation factor E4; armadillo-like re | 99.32 | |
| 2f42_A | 179 | STIP1 homology and U-box containing protein 1; cha | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 2bay_A | 61 | PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin l | 99.18 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.12 | |
| 2yu4_A | 94 | E3 SUMO-protein ligase NSE2; SP-ring domain, struc | 99.11 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.07 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 98.96 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 98.95 | |
| 2c2l_A | 281 | CHIP, carboxy terminus of HSP70-interacting protei | 98.91 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 98.9 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 98.84 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 98.84 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 98.83 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 98.79 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 1t1h_A | 78 | Gspef-atpub14, armadillo repeat containing protein | 98.63 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 98.57 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 98.54 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 98.5 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 98.49 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 98.48 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.36 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.3 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 98.3 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 98.12 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.89 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 3htk_C | 267 | E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL- | 97.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.62 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 3ztg_A | 92 | E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mR | 97.32 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.05 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.38 | |
| 3fl2_A | 124 | E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA | 96.09 | |
| 2y43_A | 99 | E3 ubiquitin-protein ligase RAD18; DNA repair, met | 95.92 | |
| 1z6u_A | 150 | NP95-like ring finger protein isoform B; structura | 95.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.74 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.68 | |
| 2ckl_A | 108 | Polycomb group ring finger protein 4; BMI1, RING1B | 94.52 | |
| 3hct_A | 118 | TNF receptor-associated factor 6; cross-brace, bet | 93.78 | |
| 1jm7_B | 117 | BARD1, BRCA1-associated ring domain protein 1; rin | 93.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.97 | |
| 2csy_A | 81 | Zinc finger protein 183-like 1; ring finger protei | 92.71 | |
| 3hcs_A | 170 | TNF receptor-associated factor 6; cross-brace, bet | 91.78 | |
| 1jm7_A | 112 | BRCA1, breast cancer type 1 susceptibility protein | 91.62 | |
| 2ckl_B | 165 | Ubiquitin ligase protein RING2; BMI1, RING1B, poly | 91.37 | |
| 2ecv_A | 85 | Tripartite motif-containing protein 5; metal bindi | 90.6 | |
| 2ecw_A | 85 | Tripartite motif-containing protein 30; metal bind | 90.51 | |
| 4ayc_A | 138 | E3 ubiquitin-protein ligase RNF8; DNA damage, K63 | 88.64 | |
| 1rmd_A | 116 | RAG1; V(D)J recombination, antibody, MAD, ring fin | 87.99 | |
| 3lrq_A | 100 | E3 ubiquitin-protein ligase TRIM37; structural gen | 87.52 | |
| 2egp_A | 79 | Tripartite motif-containing protein 34; ZF-C3HC4 d | 87.36 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.01 | |
| 3ng2_A | 71 | RNF4, snurf, ring finger protein 4; ring domain, E | 85.91 | |
| 2djb_A | 72 | Polycomb group ring finger protein 6; PCGF6, ring | 85.28 | |
| 2yur_A | 74 | Retinoblastoma-binding protein 6; P53-associated c | 84.58 | |
| 3l11_A | 115 | E3 ubiquitin-protein ligase RNF168; E3 ligase, rin | 81.22 | |
| 2ecy_A | 66 | TNF receptor-associated factor 3; metal binding pr | 81.02 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=449.80 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=213.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
++|...++||+|+||.||+|++. +..||||+++.......+.|.+|+++|++++|||||+++|+|.+.. +|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778889999999999999874 4689999998776667788999999999999999999999997644 89
Q ss_pred EEEecCCCCHHHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 474 VYEYMENGSLEDRLYRKN----------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
|||||+||+|.++|...+ ....++|..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 2346999999999999999999999987 999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 622 (757)
+|||+|+........ .......||+.|||||++.++.|+.++|||||||+||||+| |++||...... ..
T Consensus 170 ~DFGla~~~~~~~~~----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~ 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EV 239 (299)
T ss_dssp CCCSCHHHHTGGGCE----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HH
T ss_pred CCcccceecCCCCce----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence 999999876543211 11234579999999999999999999999999999999999 89999643321 12
Q ss_pred HHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 623 l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+..+........|...+.++.+|+.+||+.+|.+||++. +|.+.|+.+..
T Consensus 240 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~-~i~~~L~~~~~ 289 (299)
T 4asz_A 240 IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIK-GIHTLLQNLAK 289 (299)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHHHh
Confidence 233334444566777889999999999999999999998 46777777654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=450.93 Aligned_cols=257 Identities=25% Similarity=0.425 Sum_probs=208.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
.+|...++||+|+||.||+|++. ++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.. ||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35677789999999999999874 4689999998777667788999999999999999999999997654 89
Q ss_pred EEEecCCCCHHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 474 VYEYMENGSLEDRLYRKNN------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
|||||+||+|.++|..... ..+++|..++.|+.|||.||.|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 246999999999999999999999987 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 620 (757)
||+|||+|+.+...... ...+...||+.|||||++.+..|+.++|||||||+||||+| |+.||......+
T Consensus 198 Ki~DFGla~~~~~~~~~----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~----- 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYY----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE----- 268 (329)
T ss_dssp EECCCC--------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-----
T ss_pred EEcccccceeccCCCcc----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 99999999876543221 11234689999999999999999999999999999999999 899996443221
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+..+........|..++..+.+|+.+||+.||.+||++. +|+..|+.+..
T Consensus 269 -~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~-ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 -AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIK-DVHARLQALAQ 319 (329)
T ss_dssp -HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHH-HHHHHHHHHHH
T ss_pred -HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHH-HHHHHHHHHhh
Confidence 2223333334556777889999999999999999999998 57777777654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=447.22 Aligned_cols=253 Identities=31% Similarity=0.487 Sum_probs=202.3
Q ss_pred cCCccceeeccCCcEEEEEEEECCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~~ 479 (757)
++|...++||+|+||.||+|++++ .||||+++... ....+.|.+|+.+|++++|||||+++|+|.+. .+||||||+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~ 114 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCE 114 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCC
Confidence 467778899999999999999876 59999987543 33456799999999999999999999998654 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
||+|.++|.... .+++|..+..|+.|||.||.|||+.+ ||||||||+||||+.++.+||+|||+|+........
T Consensus 115 gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~- 188 (307)
T 3omv_A 115 GSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS- 188 (307)
T ss_dssp SCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc-
Confidence 999999997543 35999999999999999999999987 999999999999999999999999999876543211
Q ss_pred cccccccCCcccccCCCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh-----hhc
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-----AQA 631 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-----~~~ 631 (757)
......+||+.|||||++.+ +.|+.++|||||||+||||+||++||........ +...+. +..
T Consensus 189 ---~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 189 ---QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYASPDL 259 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCCCCCS
T ss_pred ---eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCCCc
Confidence 12345689999999998853 4689999999999999999999999964332111 111111 112
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
...+..++..+.+|+.+||+.+|.+||++. +|+..|+.|+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-ei~~~Le~l~ 299 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFP-QILSSIELLQ 299 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHH-HHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHh
Confidence 234456778999999999999999999998 5777777665
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-52 Score=445.17 Aligned_cols=253 Identities=21% Similarity=0.352 Sum_probs=206.8
Q ss_pred CCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~L 473 (757)
++...++||+|+||.||+|.+. ++.||||+++... ....+.|.+|+.+|++++|||||+|+|+|.+. .+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455678999999999999873 4689999997543 33457899999999999999999999999654 489
Q ss_pred EEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc
Q 004388 474 VYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~ 540 (757)
|||||++|+|.++|..... ...++|..+.+|+.|||.||.|||+.+ ||||||||+||||+.++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999975421 235899999999999999999999988 999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhc
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAID 619 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 619 (757)
+||+|||+|+.+...... ...+...||+.|||||++.++.|+.++|||||||+||||+| |++||......
T Consensus 184 ~Ki~DFGlar~~~~~~~~----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~----- 254 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYY----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----- 254 (308)
T ss_dssp EEECCSCCBCGGGGGGCB----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----
T ss_pred EEECCcccceeccCCCce----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999876543211 12245689999999999999999999999999999999999 89999643321
Q ss_pred hhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 620 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 620 ~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
..+..+........|..++..+.+|+.+||+.+|.+||++.+ |+..|+.
T Consensus 255 -~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~e-i~~~L~a 303 (308)
T 4gt4_A 255 -DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKD-IHSRLRA 303 (308)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHT
T ss_pred -HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHH-HHHHHHh
Confidence 122223333344567778899999999999999999999984 6555543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=440.50 Aligned_cols=245 Identities=23% Similarity=0.344 Sum_probs=200.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|...++||+|+||.||+|++. +..||||++.... ....+.|.+|+.+|++|+|||||++++++.+.. |||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 47889999999999999999985 6799999997553 334567999999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
||+||+|.++|...+ ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999997544 335788899999999999999999988 9999999999999999999999999998764321
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
...+..+||+.|||||++.+..|+.++||||||||||||+||++||...... ..+..++.......+.
T Consensus 180 ------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~~~~~~~~ 247 (350)
T 4b9d_A 180 ------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIISGSFPPVSL 247 (350)
T ss_dssp ------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCCCCCT
T ss_pred ------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcCCCCCCCc
Confidence 1123458999999999999999999999999999999999999999654322 2233444443344555
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
..+.++.+|+.+||+.||.+||++.+.
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 678899999999999999999999853
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=434.74 Aligned_cols=241 Identities=20% Similarity=0.317 Sum_probs=203.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..|....+||+|+||.||+|++. +..||||++........+.+.+|+.+|++++|||||+++++|.+.. |||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 35788889999999999999986 5699999997665556677899999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+||+|.+++.+. .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999988653 3899999999999999999999988 99999999999999999999999999988764332
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC--CCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--DWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~--~~p~ 636 (757)
..+..+||+.|||||++.+..|+.++||||||||||||+||++||......+ .+..+.+.... ..+.
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~~~~~~~~~ 294 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNLPPRLKNLH 294 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSSCCCCSCGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCCCCCCCccc
Confidence 2245689999999999999999999999999999999999999996443222 12222222111 2234
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+.++.+|+.+||+.||.+||++.+
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e 320 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAE 320 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 56789999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=428.56 Aligned_cols=243 Identities=26% Similarity=0.333 Sum_probs=206.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.+|...+.||+|+||.||+|++. +..||||++.... ....+.+.+|+++|++++|||||++++++.+.. ||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999985 5699999997532 234567899999999999999999999997655 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|||+||+|.++|.+.+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999997654 4899999999999999999999988 999999999999999999999999999987643
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
... ......+||+.|||||++.+..|+.++|||||||+||+|+||++||...+..+ .+..++. ....+|
T Consensus 186 ~~~----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~-~~~~~p 254 (311)
T 4aw0_A 186 SKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------IFAKIIK-LEYDFP 254 (311)
T ss_dssp TTC----CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-TCCCCC
T ss_pred CCc----ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHc-CCCCCC
Confidence 221 12345689999999999999999999999999999999999999996443211 1222222 234566
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+.++.+|+.+||+.||.+||++.+
T Consensus 255 ~~~s~~~~dli~~lL~~dp~~R~t~~e 281 (311)
T 4aw0_A 255 EKFFPKARDLVEKLLVLDATKRLGCEE 281 (311)
T ss_dssp TTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred cccCHHHHHHHHHHccCCHhHCcChHH
Confidence 677889999999999999999999985
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=429.49 Aligned_cols=252 Identities=18% Similarity=0.181 Sum_probs=200.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
...|....+||+|+||.||+|++. +..||||+++.... +.+|+.+|++++|||||+++++|.+.. ||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 345777889999999999999986 56999999976432 246999999999999999999996654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCccccCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~~~~~ 556 (757)
|+||+|.++|...+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999997654 4999999999999999999999988 99999999999999987 69999999999876433
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh--cCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ--AGDW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~~ 634 (757)
.. .........+||+.|||||++.+..|+.++|||||||+||||+||++||....... .+..+.... ....
T Consensus 206 ~~-~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~~~~~~~ 278 (336)
T 4g3f_A 206 LG-KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP------LCLKIASEPPPIREI 278 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC------CHHHHHHSCCGGGGS
T ss_pred cc-cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHHcCCCCchhc
Confidence 21 11122344689999999999999999999999999999999999999996432211 122222211 1234
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
|...+..+.+|+.+||+.||.+||++.+ +++.|....
T Consensus 279 ~~~~s~~~~~li~~~L~~dP~~R~sa~e-l~~~l~~~l 315 (336)
T 4g3f_A 279 PPSCAPLTAQAIQEGLRKEPVHRASAME-LRRKVGKAL 315 (336)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHH
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHH-HHHHHHHHH
Confidence 5567889999999999999999999984 555555443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=421.90 Aligned_cols=238 Identities=26% Similarity=0.395 Sum_probs=192.2
Q ss_pred ccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC------CceEEE
Q 004388 406 SENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGCLVY 475 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~~~LV~ 475 (757)
....+||+|+||.||+|.+. +..||||++.... ....+.|.+|+.+|++|+|||||+++++|.+ ..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999986 4589999986542 3345679999999999999999999999843 238999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGla~~~~~ 554 (757)
|||+||+|.++|.+.+ .+++..+..|+.||+.||.|||+.+ .+||||||||+||||+. +|.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999997654 4899999999999999999999987 36999999999999974 89999999999986433
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--C
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--G 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~ 632 (757)
. .....+||+.|||||++. +.|+.++|||||||+||||+||++||........ +...+.... .
T Consensus 185 ~--------~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~~~ 249 (290)
T 3fpq_A 185 S--------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA 249 (290)
T ss_dssp T--------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG
T ss_pred C--------ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCCCC
Confidence 2 123468999999999886 4699999999999999999999999964322211 111111111 1
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.++...++++.+|+.+||+.||.+||++.+
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 279 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 122334578999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=434.99 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=213.5
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCC-CceeeecccccC
Q 004388 399 ESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRH-PHLLLLLGACPD 469 (757)
Q Consensus 399 ~~at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~H-pniv~l~g~~~~ 469 (757)
+-..++|...++||+|+||.||+|.+.+ +.||||++..... ...+.|.+|+.+|.+++| ||||+++|+|.+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 3345678889999999999999998754 4799999976543 345679999999999965 999999999854
Q ss_pred C---ceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCe
Q 004388 470 H---GCLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 533 (757)
Q Consensus 470 ~---~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NI 533 (757)
. .+||||||++|+|.++|..... ...++|..+..|+.|||.||.|||+.+ ||||||||+||
T Consensus 140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NI 216 (353)
T 4ase_A 140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 216 (353)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccce
Confidence 2 4899999999999999975321 345899999999999999999999988 99999999999
Q ss_pred eecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccc
Q 004388 534 LLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITH 612 (757)
Q Consensus 534 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~ 612 (757)
||+.++.+||+|||+|+.+....... .....+||+.|||||++.++.|+.++|||||||+||||+| |++||....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~----~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSE----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred eeCCCCCEEECcchhhhhcccCCCce----eeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999776543221 2245689999999999999999999999999999999998 999996432
Q ss_pred hhhhhhchhhHHH-HhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 613 KVETAIDEDNLAE-ILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 613 ~~~~~~~~~~l~~-~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
..+ .+.. +.+......|...++++.+|+.+||+.||.+||++. +|+..|+.+..
T Consensus 293 ~~~------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~-eil~~L~~llq 347 (353)
T 4ase_A 293 IDE------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 347 (353)
T ss_dssp CSH------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHH------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHH-HHHHHHHHHHH
Confidence 211 1222 223334456667788999999999999999999998 57777776643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=426.03 Aligned_cols=262 Identities=24% Similarity=0.330 Sum_probs=197.0
Q ss_pred CCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC------ceEEEEe
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------GCLVYEY 477 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------~~LV~Ey 477 (757)
+|...++||+|+||.||+|+++++.||||++..... ....+..|+.++.+++|||||+++|+|.+. .||||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey 82 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecC
Confidence 456678899999999999999999999999975432 122233456666789999999999999643 3899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-----PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
|+||+|.++|... +++|..+.+|+.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|+..
T Consensus 83 ~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 83 HEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999754 4899999999999999999999861 235999999999999999999999999999877
Q ss_pred CCCCCCccccccccCCcccccCCCccccccC------CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-------
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG------LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID------- 619 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~------- 619 (757)
....... .......+||+.|||||++.+. .++.++|||||||+||||+||++||+..........
T Consensus 159 ~~~~~~~--~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 159 DSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp ETTTTEE--SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cCCCCce--eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 6543211 1122346899999999988654 467899999999999999999988864322211110
Q ss_pred -hhhHHHHh-hhh-cCCCC-----hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 620 -EDNLAEIL-DAQ-AGDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 620 -~~~l~~~l-d~~-~~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
...+...+ ... .+..| ......+.+|+.+||+.||.+|||+. +|++.|+.|..
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHH-HHHHHHHHHHH
Confidence 11111111 111 12222 24567899999999999999999998 57777877654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=436.35 Aligned_cols=241 Identities=20% Similarity=0.315 Sum_probs=203.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..|....+||+|+||.||+|.+. +..||||++........+.+.+|+.+|++++|||||+++++|.+.. |||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 45888899999999999999986 5699999998766666677999999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+||+|.+++... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~- 302 (423)
T 4fie_A 231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 302 (423)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-
T ss_pred CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-
Confidence 999999988643 3899999999999999999999988 99999999999999999999999999988764332
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--CCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~ 636 (757)
..+..+||+.|||||++.+..|+.++||||||||||||+||++||......+. +..+..... ...+.
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~------~~~i~~~~~~~~~~~~ 371 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDNLPPRLKNLH 371 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCCCCSCTT
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHcCCCCCCcccc
Confidence 22456899999999999999999999999999999999999999964432221 122222211 12233
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+..+.+|+.+||..||.+||++.+
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~e 397 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAE 397 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 56789999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=424.43 Aligned_cols=240 Identities=25% Similarity=0.298 Sum_probs=195.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
++|...+.||+|+||.||+|+.. +..||||++.... ......+.+|+.+|++++|||||++++++.+.. ||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 47999999999999999999862 4589999987542 223346889999999999999999999996554 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|||||+||+|.++|.+.+ .+++..+..|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999997654 4899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....+||+.|||||++.+..|+.++|||||||+||||+||++||...+..+ .+..++. ....
T Consensus 178 ~~~~------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~-~~~~ 244 (304)
T 3ubd_A 178 DHEK------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILK-AKLG 244 (304)
T ss_dssp ---C------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCCC
T ss_pred CCCc------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHc-CCCC
Confidence 3321 2245689999999999999999999999999999999999999996543221 1222222 2345
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.|...++++.+|+.+||+.||.+||+..
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~ 272 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGAG 272 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCS
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCCC
Confidence 5667789999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=411.57 Aligned_cols=239 Identities=24% Similarity=0.343 Sum_probs=187.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|.+. ++.||||++.... ......|.+|+.+|++++|||||++++++.+.. ||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 47999999999999999999875 6799999987543 233567899999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+ +|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999987654 4999999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
. .....+||+.|||||++.+..| +.++|||||||+||+|+||++||...... .+...+......+
T Consensus 166 ~-------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~-------~~~~~i~~~~~~~ 231 (275)
T 3hyh_A 166 N-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP-------VLFKNISNGVYTL 231 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCC
T ss_pred C-------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHcCCCCC
Confidence 2 1244689999999999987765 58999999999999999999999643221 1122222333445
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
|...+.++.+|+.+||+.||.+|||+.+
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~e 259 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHE 259 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 6667889999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=413.76 Aligned_cols=245 Identities=23% Similarity=0.399 Sum_probs=186.3
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC----------
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH---------- 470 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~---------- 470 (757)
+|...+.||+|+||.||+|++. +..||||++.... ....+.|.+|+.+|++|+|||||+++++|.+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888999999999999999986 6799999987543 33456799999999999999999999988421
Q ss_pred ----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 471 ----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 471 ----~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
.|||||||+||+|.+++.........++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 3799999999999999987665556777888999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCCcc------ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 547 GLSTMLNSDPSFVS------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 547 Gla~~~~~~~~~~~------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
|+|+.+........ .....+..+||+.|||||++.+..|+.++|||||||+||||++ ||.....
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~------- 232 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME------- 232 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-------
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-------
Confidence 99998765432111 1123355689999999999999999999999999999999997 6642211
Q ss_pred hhHHHHhhhhcCCCCh---hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 DNLAEILDAQAGDWPI---KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~---~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+.......+|. ...+.+.+|+.+||+.||.+||++.+
T Consensus 233 -~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 276 (299)
T 4g31_A 233 -RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAIN 276 (299)
T ss_dssp -HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -HHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 011111112233343 34466789999999999999999885
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=405.14 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=194.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC--------C
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------H 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--------~ 470 (757)
++|...++||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.|+|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46899999999999999999986 6699999997543 2344678899999999999999999998742 3
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.|||||||+ |+|.+++...+ ++++..+..|+.||+.||.|||+.+ ||||||||+|||++.+|.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 389999996 68999886543 5999999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc----------
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------- 619 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------- 619 (757)
.+..... ......+..+||+.|||||++.+. .++.++||||||||||||+||++||...+..+....
T Consensus 207 ~~~~~~~--~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 207 GLCTSPA--EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CC---------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred ecccCcc--ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 7654321 112233567999999999987764 579999999999999999999999975433221100
Q ss_pred -------hhhHHHHhhhhcCCC--C-----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 -------EDNLAEILDAQAGDW--P-----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 -------~~~l~~~ld~~~~~~--p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.......+....... + ...+.++.+|+.+||..||.+|||+.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 000011111100000 1 123578899999999999999999885
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=390.70 Aligned_cols=199 Identities=22% Similarity=0.284 Sum_probs=165.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--e
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~ 472 (757)
..+.|...++||+|+||.||+|+.+ +..||||++.... ...++.+|+++|..+ +|||||++++++.+.. |
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4567999999999999999999863 4589999986543 345688999999998 6999999999986544 8
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTM 551 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla~~ 551 (757)
|||||++||+|.+++. .+++..+..++.||+.||.|||+.+ ||||||||+||||+.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999883 3889999999999999999999988 9999999999999877 8999999999987
Q ss_pred cCCCCCCc----------------------cccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCc
Q 004388 552 LNSDPSFV----------------------STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAI 608 (757)
Q Consensus 552 ~~~~~~~~----------------------~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf 608 (757)
........ ......+..+||+.|+|||++.+. .|+.++||||+|||+|||+||++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 65432110 001122446899999999988765 5899999999999999999999999
Q ss_pred cc
Q 004388 609 AI 610 (757)
Q Consensus 609 ~~ 610 (757)
..
T Consensus 248 ~~ 249 (361)
T 4f9c_A 248 YK 249 (361)
T ss_dssp SC
T ss_pred CC
Confidence 53
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=412.60 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=196.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHH---HHHHHHhcCCCceeeecccccCCc--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQ---ELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~---Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
.++|...+.||+|+||.||+|+.. +..||||++.... ......+.+ ++.+++.++|||||+++++|.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 357999999999999999999986 5699999996432 112223333 466777789999999999997655
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
|||||||+||+|.++|.+.+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 89999999999999998754 4899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
+.... ....+||+.|||||++.. ..|+.++||||||||||||+||++||....... ...+...+...
T Consensus 342 ~~~~~--------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~~~i~~~i~~~ 409 (689)
T 3v5w_A 342 FSKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTM 409 (689)
T ss_dssp CSSCC--------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----HHHHHHHHHHC
T ss_pred cCCCC--------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhcCC
Confidence 65432 234689999999999865 579999999999999999999999996432111 11122222223
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
...+|...+.++.+|+.+||+.||.+|++.
T Consensus 410 ~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 410 AVELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 345667788999999999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.37 Aligned_cols=275 Identities=36% Similarity=0.616 Sum_probs=228.0
Q ss_pred cccCCCHHHHHHhhcCCccc------eeeccCCcEEEEEEEECCeEEEEEEEccCC----chhhHHHHHHHHHHHhcCCC
Q 004388 389 RYRNLTWEEIESATLSFSEN------LRIGMGGYGTVYKGTFHHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHP 458 (757)
Q Consensus 389 ~~~~~~~~ei~~at~~f~~~------~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~Hp 458 (757)
.+..|++.++..++.+|... .+||+|+||.||+|.+.++.||||++.... ....+.|.+|+.++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 56789999999999999988 899999999999999999999999987532 23456789999999999999
Q ss_pred ceeeecccccCC--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 459 HLLLLLGACPDH--GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 459 niv~l~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
||+++++++.+. .++||||+++|+|.+++.......++++..+..|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999654 4899999999999999986555567999999999999999999999988 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 616 (757)
.++.+||+|||++......... .......||+.|+|||.+.+ .++.++||||||+++|+|+||++||........
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQT----VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSC----EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred CCCcEEEeeccccccccccccc----ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999999999999876543211 11234579999999998764 589999999999999999999999974332111
Q ss_pred h--------hchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 617 A--------IDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 617 ~--------~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
. .....+...++......+...+..+.+++.+||+.+|.+||++. +++..|+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~l~~~L~~l~ 305 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQEMT 305 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHC
T ss_pred HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHh
Confidence 0 01123344455555566778889999999999999999999998 5777777653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=408.29 Aligned_cols=241 Identities=20% Similarity=0.291 Sum_probs=202.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
++|...+.||+|+||.||+|... +..||||++........+.+.+|+.+|+.|+|||||+|+++|.+.. |||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57889999999999999999986 5699999998776666778999999999999999999999997655 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC--CceEEeeecCccccCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN--LVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~--~~~KL~DFGla~~~~~~~ 556 (757)
+||+|.++|.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 9999999986543 35899999999999999999999988 9999999999999854 899999999999876432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC-
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP- 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p- 635 (757)
. ....+||+.|||||++.+..|+.++|||||||+||+|++|++||......+. +..+... ....+
T Consensus 312 ~-------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~-~~~~~~ 377 (573)
T 3uto_A 312 S-------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSC-DWNMDD 377 (573)
T ss_dssp E-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTT-CCCCCS
T ss_pred c-------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhC-CCCCCc
Confidence 1 2345899999999999999999999999999999999999999975433221 2222211 11111
Q ss_pred ---hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 ---IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ---~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+|+.+||+.||.+||++.+
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e 407 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQ 407 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 235788999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=377.28 Aligned_cols=294 Identities=23% Similarity=0.367 Sum_probs=219.8
Q ss_pred cCCccceeeccCCcEEEEEEEECCe------EEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~------~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV 474 (757)
.+|...++||+|+||.||+|.+..+ .||+|.+.... ......|.+|+.++++++||||++++++|.+.. ++|
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 4688899999999999999987432 46888875432 345577999999999999999999999997655 799
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+.+|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 99999999999997654 35899999999999999999999988 99999999999999999999999999987764
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~ 632 (757)
.... .......||+.|+|||++.+..++.++|||||||++|+|+| |+.||..... ..+...+... ..
T Consensus 170 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~~~~~~~~ 238 (327)
T 3poz_A 170 EEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEKGERL 238 (327)
T ss_dssp TCC-----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHHHTTCCC
T ss_pred Cccc----ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-------HHHHHHHHcCCCC
Confidence 4321 12234567899999999999999999999999999999999 9999964322 2223333322 23
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhhccc----cCCCCCCCCCCCCccCccchhcccCCccc
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR----DTVPSVHPAPPNHFICPILKEVMNEPCVA 708 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~~~~----~~~~~~~~~~p~~ficPi~~evM~dp~ia 708 (757)
..+...+..+.+++.+||+.+|.+||++. +++..|+.+........ .......+..++.|.+++..+.+.|+++.
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~-ell~~l~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 317 (327)
T 3poz_A 239 PQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD 317 (327)
T ss_dssp CCCTTBCHHHHHHHHHHTCSCGGGSCCHH-HHHHHHHHHHTSHHHHBCCTTGGGCCCCCTTTCHHHHHHHC------CCC
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHHhhhhhhhhhcCCCccCCCCCCchHHHHhcccccccccccC
Confidence 45566788999999999999999999998 57777776654322111 11111222334456678888888888888
Q ss_pred CCCcc
Q 004388 709 ADGYT 713 (757)
Q Consensus 709 adG~t 713 (757)
+|++-
T Consensus 318 ~d~~~ 322 (327)
T 3poz_A 318 ADEYL 322 (327)
T ss_dssp HHHHC
T ss_pred HHHcc
Confidence 77753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.97 Aligned_cols=263 Identities=27% Similarity=0.475 Sum_probs=205.0
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 396 EEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 396 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
.++.....+|....+||+|+||.||+|.+.++.||||++.... ......|.+|+.+|++++||||+++++++.+..
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3334446688999999999999999999999999999987653 233467899999999999999999999996544
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++|+|.+++........+++..+..|+.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999999999999976543345899999999999999999999976 3599999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh-hhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l-d~~ 630 (757)
..... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+. ...
T Consensus 189 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~ 256 (309)
T 3p86_A 189 KASTF------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGFKCK 256 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHHSCC
T ss_pred ccccc------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCC
Confidence 54321 112345899999999999999999999999999999999999999964432211 11111 112
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
....|...+..+.+|+.+||+.+|.+||++. +++..|+.+.
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~ll~~L~~~~ 297 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFA-TIMDLLRPLI 297 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 2345666788999999999999999999998 5767766654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=373.71 Aligned_cols=275 Identities=36% Similarity=0.569 Sum_probs=220.9
Q ss_pred CCCHHHHHHhhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC
Q 004388 392 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH 470 (757)
Q Consensus 392 ~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~ 470 (757)
.+.+.++..++++|.....||+|+||.||+|.+. +..||||++........+.|.+|+.+|++++||||++++++|.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3455567778999999999999999999999975 679999998877666678899999999999999999999999654
Q ss_pred c--eEEEEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 471 G--CLVYEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 471 ~--~LV~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
. ++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 4 899999999999998865432 235899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh---------hh
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET---------AI 618 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~---------~~ 618 (757)
+++........ .......||+.|+|||++.++.++.++|||||||++|+|+||+.||........ ..
T Consensus 185 ~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 185 ISKKGTELDQT----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp TCEECSSSSCC----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred ccccccccccc----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 99865432211 112345799999999999989999999999999999999999999963321110 01
Q ss_pred chhhHHHHhhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 619 DEDNLAEILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 619 ~~~~l~~~ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+.+..++++.. ...+...+..+.+++.+||+.+|.+||++. +++..|+.+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG-DVLWKLEYALRL 316 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHhhc
Confidence 1111222222221 234567889999999999999999999998 577777766543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.88 Aligned_cols=278 Identities=35% Similarity=0.603 Sum_probs=221.5
Q ss_pred cccccCCCHHHHHHhhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeec
Q 004388 387 FQRYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLL 464 (757)
Q Consensus 387 ~~~~~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~ 464 (757)
......+++.++..++++|.....||+|+||.||+|.+. ++.||||++...... ....|.+|+.++++++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345677899999999999999999999999999999874 678999998765322 233689999999999999999999
Q ss_pred ccccCC--ceEEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 465 GACPDH--GCLVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 465 g~~~~~--~~LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
++|.+. .++||||+++|+|.+++.... ...++++..+..|+.|++.||.|||+....+|+||||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 998654 489999999999999997644 34469999999999999999999999822239999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchh-------
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV------- 614 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~------- 614 (757)
||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|+|+||++||......
T Consensus 174 kl~Dfg~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTH-----VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp EECCCSSCEECCSSSSC-----EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred EeccCccccccCccccc-----ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 99999999876543221 123456999999999998889999999999999999999999999632111
Q ss_pred ----hhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 615 ----ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 615 ----~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
........+..+++.. ....+...+..+.+++.+||+.+|.+||++. +|+..|+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~~L~~ 308 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLEG 308 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHH-HHHHHHHT
T ss_pred HHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHH-HHHHHhcC
Confidence 1111112222222222 1345667789999999999999999999998 46666653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=364.63 Aligned_cols=256 Identities=25% Similarity=0.427 Sum_probs=205.0
Q ss_pred cCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCceEEEEecCCCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHGCLVYEYMENGS 482 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~~LV~Ey~~~gs 482 (757)
.+|.....||+|+||.||+|.+.+..||||++... ...+.|.+|+.+|++++||||+++++++.+..++||||+++|+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~ 85 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGS 85 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCB
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCC
Confidence 46788889999999999999999999999998653 3456799999999999999999999999988999999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc-eEEeeecCccccCCCCCCccc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV-SKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~-~KL~DFGla~~~~~~~~~~~~ 561 (757)
|.+++........+++..+..++.||+.||.|||+.++.+|+||||||+|||++.++. +||+|||++......
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------ 159 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------ 159 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------
Confidence 9999986655556889999999999999999999954445999999999999998886 799999999765432
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~ 641 (757)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ..............+...+..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 232 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHNGTRPPLIKNLPKP 232 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHTTCCCCCBTTCCHH
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhcCCCCCcccccCHH
Confidence 1234699999999999988999999999999999999999999963321111 011112222223344456788
Q ss_pred HHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 642 LAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 642 l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
+.+|+.+||+.+|.+||++. +++..|+.+...
T Consensus 233 l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~~ 264 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSME-EIVKIMTHLMRY 264 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHH-HHHHHHHHHGGG
T ss_pred HHHHHHHHhcCChhhCcCHH-HHHHHHHHHHHh
Confidence 99999999999999999998 577777776544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=372.74 Aligned_cols=260 Identities=23% Similarity=0.396 Sum_probs=211.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC---------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCC
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~ 470 (757)
..+|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+|+++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357888899999999999999863 24799999976533 3456789999999999 899999999999654
Q ss_pred c--eEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 471 G--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 471 ~--~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
. |+||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 4 899999999999999976432 235899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 004388 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 614 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~ 614 (757)
+.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYK----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTC----TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCCEEEccccCCcccCccccee----cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999998765433211 1234567899999999999999999999999999999999 99999643211
Q ss_pred hhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhh
Q 004388 615 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 675 (757)
Q Consensus 615 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~ 675 (757)
..+..+........|...+..+.+|+.+||+.+|.+||++. +++..|+++....
T Consensus 313 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILTLT 366 (370)
T ss_dssp ------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHHH
T ss_pred ------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHHHh
Confidence 11122222223445667788999999999999999999998 5888888776543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=368.54 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=208.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~L 473 (757)
...|...+.||+|+||.||+|.+. +..||||++.... ......|.+|+.+|++++||||++++++|.+. .++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 346888899999999999999984 3469999997653 33456799999999999999999999999654 489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 999999999999986543 35899999999999999999999988 9999999999999999999999999998776
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
..... ........+|+.|+|||++.+..++.++|||||||++|+|+| |..||...... ..+..+......
T Consensus 203 ~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~~ 273 (325)
T 3kul_A 203 DDPDA---AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISSVEEGYRL 273 (325)
T ss_dssp ----C---CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTTCCC
T ss_pred cCccc---eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcCCCC
Confidence 44321 122234567889999999998999999999999999999999 99999643221 112222222233
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+...+..+.+|+.+||..+|.+||++. +++..|+.+...
T Consensus 274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~-eil~~L~~l~~~ 314 (325)
T 3kul_A 274 PAPMGCPHALHQLMLDCWHKDRAQRPRFS-QIVSVLDALIRS 314 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHS
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHhC
Confidence 45566788999999999999999999998 587888777654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=362.90 Aligned_cols=265 Identities=23% Similarity=0.381 Sum_probs=211.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
..+|....+||+|+||.||+|.+. +..||+|++..........|.+|+.+|.+++||||++++++|.+.. ++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356888899999999999999986 6699999987766667788999999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999997643 35899999999999999999999988 99999999999999999999999999987654332
Q ss_pred Ccc--------ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 558 FVS--------TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 558 ~~~--------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
... .........||+.|+|||++.+..++.++|||||||++|+|+||..||.......... .......++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~ 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-GLNVRGFLDR 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-SBCHHHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-hhhhhccccc
Confidence 110 0011124589999999999999999999999999999999999999986322111111 1111222222
Q ss_pred hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 630 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 630 ~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
..|...+..+.+|+.+||+.+|.+||++. +++..|+.+.....
T Consensus 243 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 243 ---YCPPNCPPSFFPITVRCCDLDPEKRPSFV-KLEHWLETLRMHLA 285 (310)
T ss_dssp ---TCCTTCCTTHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHHHH
T ss_pred ---cCCCCCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHHhcc
Confidence 12344566799999999999999999998 57888888876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=360.60 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=203.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey 477 (757)
...|....+||+|+||.||+|.+. +..||||++........+.+.+|+.++++++||||++++++|.+. .++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 457888999999999999999864 669999999876666677899999999999999999999998644 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999998654 3889999999999999999999988 99999999999999999999999999987654332
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--CCCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWP 635 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p 635 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ +..+..... ...|
T Consensus 172 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~ 239 (297)
T 3fxz_A 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNP 239 (297)
T ss_dssp ------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSCCCSCG
T ss_pred ------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCCCCc
Confidence 12445899999999999999999999999999999999999999964432221 111111111 2234
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+..+.+|+.+||+.||.+||++.+.
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~el 267 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKEL 267 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 5667889999999999999999999853
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=360.77 Aligned_cols=263 Identities=23% Similarity=0.374 Sum_probs=207.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE------CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC----Cc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~------~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~ 471 (757)
..+|...++||+|+||.||+|++ .+..||||++..........|.+|+.+|.+++||||++++++|.. ..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35688889999999999999985 467999999987766666789999999999999999999998843 35
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++|+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 899999999999999976432 4899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh-hhhc--------hhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE-TAID--------EDN 622 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~-~~~~--------~~~ 622 (757)
........ .......||+.|+|||++.+..++.++|||||||++|+|+||..|+....... .... ...
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 164 LPQDKEFF---KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccCCccee---eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 75433211 11234467888999999999999999999999999999999999986332110 0000 001
Q ss_pred HHHHh-hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 623 LAEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 623 l~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+...+ .......|...+..+.+|+.+||+.+|.+||++. +++..|+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-el~~~L~~l~~ 291 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR-DLALRVDQIRD 291 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHHH
Confidence 11122 2223344566788999999999999999999998 57777777754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=366.47 Aligned_cols=242 Identities=21% Similarity=0.307 Sum_probs=203.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
...+|...+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|+.++||||+++++++.+.. ++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356799999999999999999997 46799999987542 334567889999999999999999999996654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997654 4889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCC-CcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|+||++||...... .+...+......
T Consensus 167 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~i~~~~~~ 232 (328)
T 3fe3_A 167 GG-------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-------ELRERVLRGKYR 232 (328)
T ss_dssp SC-------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC
T ss_pred CC-------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCCC
Confidence 32 12456899999999999887765 7999999999999999999999644321 122222223344
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.|...+..+.+|+.+||..||.+||++.+
T Consensus 233 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e 261 (328)
T 3fe3_A 233 IPFYMSTDCENLLKRFLVLNPIKRGTLEQ 261 (328)
T ss_dssp CCTTSCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 56667889999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=367.24 Aligned_cols=260 Identities=25% Similarity=0.320 Sum_probs=204.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC------ceEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------GCLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------~~LV~ 475 (757)
..+|....+||+|+||.||+|.+.+..||||++.... .....+.+|+.+|.+++||||+++++++.+. .++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 4578899999999999999999999999999997543 2344566799999999999999999998643 28999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC----------CCCCEEEcCCCCCCeeecCCCceEEee
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT----------KPKPIIHRDMKPGNILLDHNLVSKIGD 545 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----------~~~~ivHrDLKp~NILld~~~~~KL~D 545 (757)
||+++|+|.+++... .+++..+..|+.||+.||.|||+. + |+||||||+|||++.++.+||+|
T Consensus 102 e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred ecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 999999999999653 389999999999999999999997 6 99999999999999999999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCccccccC-----CCCCcchhhhHHHHHHHHHhCCCCccccchhh-----
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----LISPKSDVYAYGMVILQLLTAKPAIAITHKVE----- 615 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~----- 615 (757)
||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|+|+||++||.......
T Consensus 175 Fg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 175 FGLALKFEAGKSA----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp CTTCEEECTTSCC----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CCcccccccccCc----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 9999877644321 112346899999999988763 46678899999999999999999996432110
Q ss_pred hh-h---chhhHHHHhhhhc--CCC-----ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 616 TA-I---DEDNLAEILDAQA--GDW-----PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 616 ~~-~---~~~~l~~~ld~~~--~~~-----p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.. . ....+...+.... ... +...+..+.+|+.+||+.||.+||++. +++..|+.+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG-CVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHHH
Confidence 00 0 0111111111111 111 123466799999999999999999998 688888887764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=360.84 Aligned_cols=253 Identities=20% Similarity=0.311 Sum_probs=209.0
Q ss_pred cCCCHHHHHHhhcC----------CccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC
Q 004388 391 RNLTWEEIESATLS----------FSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP 458 (757)
Q Consensus 391 ~~~~~~ei~~at~~----------f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp 458 (757)
..++.+++..++.. |....+||+|+||.||+|... +..||||++........+.+.+|+.+|++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888887764 667779999999999999985 679999999877666677899999999999999
Q ss_pred ceeeecccccCC--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 459 HLLLLLGACPDH--GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 459 niv~l~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
||++++++|... .++||||+++|+|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 999999998644 4899999999999998854 24899999999999999999999988 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 616 (757)
.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|+||++||........
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCCcEEEeeeeeeeecccCcc------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999987654321 12345899999999999999999999999999999999999999964432211
Q ss_pred hhchhhHHHHhhhhcCC--CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 617 AIDEDNLAEILDAQAGD--WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 617 ~~~~~~l~~~ld~~~~~--~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+..+....... .+...+..+.+++.+||..+|.+||++.+
T Consensus 250 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 250 ------MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp ------HHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ------HHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 11222221111 22345678999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=358.56 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=198.4
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHh--cCCCceeeecccccCC------ceE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK--IRHPHLLLLLGACPDH------GCL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~--l~Hpniv~l~g~~~~~------~~L 473 (757)
.++|.....||+|+||.||+|.+.+..||||++... ....+..|.+++.. ++||||+++++++.+. .++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 457889999999999999999999999999998653 34556777887776 7999999999986432 379
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCEEEcCCCCCCeeecCCCceEEee
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH--------NTKPKPIIHRDMKPGNILLDHNLVSKIGD 545 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivHrDLKp~NILld~~~~~KL~D 545 (757)
||||+++|+|.+++.. ..+++..+..|+.||+.||.||| +.+ |+||||||+|||++.++.+||+|
T Consensus 84 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred ehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 9999999999999943 25899999999999999999999 655 99999999999999999999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCccccccC------CCCCcchhhhHHHHHHHHHhC----------CCCcc
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG------LISPKSDVYAYGMVILQLLTA----------KPAIA 609 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltG----------~~Pf~ 609 (757)
||+++......... ........||+.|+|||++.+. .++.++|||||||++|||+|| ++||.
T Consensus 157 fg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 157 LGLAVMHSQSTNQL--DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CTTCEEEETTTTEE--ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred CCCeeecccccccc--cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 99998765443211 1122345899999999998776 455799999999999999999 77774
Q ss_pred ccchhhhhhchhhHHHHh--hhhcCCCC-----hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 610 ITHKVETAIDEDNLAEIL--DAQAGDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 610 ~~~~~~~~~~~~~l~~~l--d~~~~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
........ ...+...+ +......| ...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS--FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL-RIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH-HHHHHHHHH
T ss_pred ccCCCCcc--hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH-HHHHHHhcc
Confidence 32111110 11111111 11112222 23678899999999999999999998 577777654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=367.58 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=215.0
Q ss_pred CCHHHHHHhhcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeee
Q 004388 393 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLL 463 (757)
Q Consensus 393 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l 463 (757)
+.....+...++|.....||+|+||.||+|.+. +..||||++..... .....|.+|+.+|.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445556666788999999999999999999853 25899999976533 3446799999999999 79999999
Q ss_pred cccccCC---ceEEEEecCCCCHHHHHhhcCC------------------------------------------------
Q 004388 464 LGACPDH---GCLVYEYMENGSLEDRLYRKNN------------------------------------------------ 492 (757)
Q Consensus 464 ~g~~~~~---~~LV~Ey~~~gsL~~~L~~~~~------------------------------------------------ 492 (757)
+++|.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 9998653 4899999999999999976432
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 493 ---------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 493 ---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999988 99999999999999999999999999987654332
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. .......||+.|+|||++.+..++.++|||||||++|+|+| |++||........ ....+........|.
T Consensus 249 ~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~ 319 (359)
T 3vhe_A 249 Y----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRAPD 319 (359)
T ss_dssp C----EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----HHHHHHHTCCCCCCT
T ss_pred c----hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-----HHHHHHcCCCCCCCC
Confidence 1 12245678999999999999999999999999999999998 9999964332111 111222222344556
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
..+..+.+++.+||+.+|.+||++. +++..|+.+..
T Consensus 320 ~~~~~l~~li~~~l~~dP~~Rps~~-ell~~L~~~~~ 355 (359)
T 3vhe_A 320 YTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 355 (359)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHHHH
Confidence 6778999999999999999999998 57777776654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=362.64 Aligned_cols=237 Identities=25% Similarity=0.297 Sum_probs=199.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|..++||||+++++++.+.. |+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999985 6699999997542 234567889999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999987654 4889999999999999999999988 999999999999999999999999999864332
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. .....+||+.|+|||++.+..++.++|||||||++|||+||++||...... .+...+......+|
T Consensus 159 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~p 225 (337)
T 1o6l_A 159 GA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIRFP 225 (337)
T ss_dssp TC------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCC
T ss_pred CC------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 21 124568999999999999999999999999999999999999999643221 11222222234466
Q ss_pred hhHHHHHHHHHHHHhhccCCCCC
Q 004388 636 IKETKELAALGLSCAELRRKDRP 658 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RP 658 (757)
...+..+.+|+.+||+.+|.+||
T Consensus 226 ~~~s~~~~~li~~lL~~dP~~R~ 248 (337)
T 1o6l_A 226 RTLSPEAKSLLAGLLKKDPKQRL 248 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCCCHHHHHHHHHHhhcCHHHhc
Confidence 67788999999999999999999
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.84 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=208.7
Q ss_pred cCCccceeeccCCcEEEEEEEE-CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~-~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
.+|.....||+|+||.||+|.+ .+..||+|++..... ..+.+.+|+.++++++||||+++++++.+.. ++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4688889999999999999998 466899999976543 3467999999999999999999999997654 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 160 (269)
T 4hcu_A 89 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 160 (269)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc---
Confidence 999999986543 35899999999999999999999988 9999999999999999999999999998764321
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
........||+.|+|||++.+..++.++||||||+++|+|+| |++||...... ..+..+........|...
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~ 232 (269)
T 4hcu_A 161 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFRLYKPRLA 232 (269)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCCCCCTTS
T ss_pred --cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcCccCCCCCcC
Confidence 112234567889999999998999999999999999999999 99999643221 112222222233345556
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+..+.+++.+||+.+|.+||++. +++..|+.+.+
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~-~ll~~l~~l~~ 266 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFS-RLLRQLAEIAE 266 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHH-HHHHHHHHHHH
Confidence 78899999999999999999998 57777776654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=370.24 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=197.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......|.+|+.+|.+++||||++++++|.+.. ++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 347888999999999999999874 4579999987653 334567999999999999999999999997644 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999997543 35899999999999999999999988 9999999999999999999999999998776
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh-hhc
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQA 631 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld-~~~ 631 (757)
...... +......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...+. ...
T Consensus 199 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-------~~~~~i~~~~~ 268 (373)
T 2qol_A 199 DDPEAA---YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------DVIKAVDEGYR 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------HHHHHHHTTEE
T ss_pred cCCccc---eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC
Confidence 432211 11223456789999999999999999999999999999998 99999643221 1222222 222
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
...+...+..+.+|+.+||+.+|.+||++. +|+..|+.+...
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFE-QIVSILDKLIRN 310 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHC
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCHH-HHHHHHHHHHhC
Confidence 344556778999999999999999999998 578888877654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=374.62 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=207.2
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC---CceEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~LV~Ey~ 478 (757)
..+|....+||+|+||.||+|.+.++.||||+++... ..+.|.+|+.+|++++||||++++++|.+ ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 3467888899999999999999999999999998654 45779999999999999999999999744 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 343 (450)
T ss_dssp TTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence 99999999986543 34789999999999999999999988 9999999999999999999999999998543211
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
....+|+.|+|||++.+..++.++|||||||+||||+| |+.||...... ..+..+........|..
T Consensus 344 -------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~~~~p~~ 410 (450)
T 1k9a_A 344 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDG 410 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------THHHHHHTTCCCCCCTT
T ss_pred -------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCCCCCc
Confidence 22367889999999999999999999999999999998 99999643221 11122222223445667
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 411 ~~~~l~~li~~cl~~dp~~Rpt~~-~l~~~L~~i~~ 445 (450)
T 1k9a_A 411 CPPAVYDVMKNCWHLDAATRPTFL-QLREQLEHIRT 445 (450)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHHHH
Confidence 788999999999999999999998 57777776653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=362.07 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=210.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH- 470 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~- 470 (757)
...++|...+.||+|+||.||+|.+.+ ..||||++..... .....|.+|+.++++++||||++++++|.+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 346789999999999999999999864 6899999976533 3456789999999999999999999998654
Q ss_pred -ceEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCC
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNN---------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM 528 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL 528 (757)
.++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 4899999999999999976431 146899999999999999999999988 999999
Q ss_pred CCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCC
Q 004388 529 KPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPA 607 (757)
Q Consensus 529 Kp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~P 607 (757)
||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|+| |..|
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccc----cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999876432211 11234578999999999998899999999999999999999 9999
Q ss_pred ccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 608 IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 608 f~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
|...... ..+..+.+......|...+..+.+|+.+||..+|.+||++. +++..|+.+.
T Consensus 277 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~~~~L~~~~ 334 (343)
T 1luf_A 277 YYGMAHE------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMC 334 (343)
T ss_dssp TTTSCHH------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCChH------HHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHH-HHHHHHHHHH
Confidence 9643221 11222333333445566778999999999999999999998 5777776654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=359.17 Aligned_cols=246 Identities=22% Similarity=0.400 Sum_probs=197.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC---------
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--------- 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--------- 470 (757)
.+|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|++++||||++++++|.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888899999999999999985 6799999987543 33557799999999999999999999987321
Q ss_pred --------------------------------------------------ceEEEEecCCCCHHHHHhhcCCCCCCCHHH
Q 004388 471 --------------------------------------------------GCLVYEYMENGSLEDRLYRKNNTPPIPWFE 500 (757)
Q Consensus 471 --------------------------------------------------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~ 500 (757)
.++||||+++|+|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 479999999999999998776666678888
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc------cccccCCcccccC
Q 004388 501 RYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST------TYKNTGPVGTLCY 574 (757)
Q Consensus 501 ~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~------~~~~~~~~gt~~Y 574 (757)
+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++........... ........||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 9999999999999999988 999999999999999999999999999887654321110 1123456899999
Q ss_pred CCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC---hhHHHHHHHHHHHHhh
Q 004388 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---IKETKELAALGLSCAE 651 (757)
Q Consensus 575 ~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p---~~~~~~l~~Li~~Cl~ 651 (757)
+|||++.+..++.++|||||||++|+|+||..|+...... +... .....| ......+.+|+.+||+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI--------ITDV---RNLKFPLLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH--------HHHH---HTTCCCHHHHHHCHHHHHHHHHHHC
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH--------HHHh---hccCCCcccccCChhHHHHHHHHcc
Confidence 9999999999999999999999999999998876322111 1111 112223 2345778999999999
Q ss_pred ccCCCCCccch
Q 004388 652 LRRKDRPDLKN 662 (757)
Q Consensus 652 ~~p~~RPs~~~ 662 (757)
.+|.+||++.+
T Consensus 312 ~~p~~Rps~~~ 322 (332)
T 3qd2_B 312 PSPTERPEATD 322 (332)
T ss_dssp SSGGGSCCHHH
T ss_pred CCCCcCCCHHH
Confidence 99999999885
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.40 Aligned_cols=248 Identities=23% Similarity=0.271 Sum_probs=202.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~L 473 (757)
..+|...++||+|+||.||+|+.. +..||||++..... .....+.+|..+|.++ +|||||+++++|.+.. +|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357889999999999999999986 56899999976432 2334578899999887 8999999999997654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999987654 4899999999999999999999988 9999999999999999999999999998633
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh--hhchhhHHHHhhhhc
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET--AIDEDNLAEILDAQA 631 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~l~~~ld~~~ 631 (757)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||++||........ ......+...+....
T Consensus 205 ~~~~------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 205 RPGD------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp CTTC------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred cCCC------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 2221 22456899999999999999999999999999999999999999964321111 111222333343444
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
..+|...+..+.+|+.+||+.+|.+||+..
T Consensus 279 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 308 (396)
T 4dc2_A 279 IRIPRSLSVKAASVLKSFLNKDPKERLGCH 308 (396)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTSTTCS
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHcCCCC
Confidence 556777888999999999999999999973
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=348.86 Aligned_cols=249 Identities=27% Similarity=0.439 Sum_probs=195.3
Q ss_pred cCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCc----hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN----IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~----~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.+|.....||+|+||.||+|.+.+..||||++..... ...+.+.+|+.+++.++||||++++++|.+.. ++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 5788889999999999999999999999999875432 23467899999999999999999999996654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC--------CCceEEeeecC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH--------NLVSKIGDVGL 548 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~--------~~~~KL~DFGl 548 (757)
|+++|+|.+++.. ..+++..+..|+.|++.||.|||+.+..+|+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 87 FARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp CCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred cCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999998843 35899999999999999999999987545999999999999986 78899999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+........ ....||+.|+|||++.+..++.++||||||+++|+|+||+.||........ ......
T Consensus 163 ~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~ 228 (271)
T 3dtc_A 163 AREWHRTTK--------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAM 228 (271)
T ss_dssp ---------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHT
T ss_pred ccccccccc--------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhc
Confidence 986553321 234799999999999999999999999999999999999999964432211 111111
Q ss_pred -hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 629 -AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 629 -~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
......+...+..+.+++.+||..+|.+||++. +++..|+.
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-e~l~~L~~ 270 (271)
T 3dtc_A 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFT-NILDQLTT 270 (271)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHC
T ss_pred CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHH-HHHHHHhc
Confidence 112234556678899999999999999999998 46666654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=369.51 Aligned_cols=255 Identities=21% Similarity=0.329 Sum_probs=207.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~E 476 (757)
..+|.....||+|+||.||+|.+. ++.||||++..... .....|.+|+.+|++++||||++++++|.+. .++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999985 67999999875432 2345688999999999999999999999654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++...+ ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 999999999997643 24889999999999999999999988 9999999999999999999999999998654321
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhh-hcCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAGDW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~ 634 (757)
. ........+|+.|+|||++.++.++.++|||||||++|||+| |..||...... .....+.. .....
T Consensus 268 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 268 Y----AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLPC 336 (377)
T ss_dssp E----ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCCC
T ss_pred e----eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 0 001122346788999999998999999999999999999998 99999643221 11222222 22344
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
|...+..+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~-~i~~~L~~i~~ 374 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFS-TIYQELQSIRK 374 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHHHHh
Confidence 556678999999999999999999998 57777777653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=367.80 Aligned_cols=261 Identities=21% Similarity=0.353 Sum_probs=208.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
..+|...++||+|+||.||+|.+. +..||||++.... ......+.+|+.+|++++||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999854 3479999986543 334557899999999999999999999996543
Q ss_pred eEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC---ceEEe
Q 004388 472 CLVYEYMENGSLEDRLYRKNN----TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKIG 544 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~---~~KL~ 544 (757)
++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 899999999999999986532 235899999999999999999999988 99999999999998554 59999
Q ss_pred eecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhH
Q 004388 545 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 545 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l 623 (757)
|||+++.+...... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||...... ..+
T Consensus 227 DFG~a~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~ 296 (367)
T 3l9p_A 227 DFGMARDIYRAGYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVL 296 (367)
T ss_dssp CCHHHHHHHHHSSC----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH
T ss_pred CCcccccccccccc----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence 99999865422111 11234578999999999999999999999999999999998 99999644321 112
Q ss_pred HHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 624 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 624 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
..+........+...+..+.+|+.+||+.+|.+||++. +|+..|+.+.....
T Consensus 297 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQDPD 348 (367)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHCHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHhhChh
Confidence 22222223344566778899999999999999999998 57777777765443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=364.03 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=213.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC---------eEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccC
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPD 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~---------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~ 469 (757)
..++|...++||+|+||.||+|.+.+ ..||||++..... .....+.+|+.+++++ +||||++++++|.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34678889999999999999998632 4799999976543 3446789999999999 89999999999976
Q ss_pred Cc--eEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCee
Q 004388 470 HG--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 534 (757)
Q Consensus 470 ~~--~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 534 (757)
.. ++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 54 899999999999999976542 235899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccch
Q 004388 535 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 613 (757)
Q Consensus 535 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~ 613 (757)
|+.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|+| |..||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTC----CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EcCCCcEEEcccCcccccccccccc----cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999998765432211 1234578899999999999999999999999999999999 9999964321
Q ss_pred hhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 614 VETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
. ..+..+........|...+..+.+|+.+||+.+|.+||++. +++..|+++.....
T Consensus 300 ~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 300 E------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVALTS 355 (382)
T ss_dssp H------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHHSC
T ss_pred H------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHHHHh
Confidence 1 11122222223445566788999999999999999999998 58888888776543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.29 Aligned_cols=246 Identities=23% Similarity=0.297 Sum_probs=203.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~-- 471 (757)
....+|...+.||+|+||.||+|++. +..||||++.... ......+..|..+|..+ +||||+++++++.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34568999999999999999999985 6799999997542 22345678899999887 8999999999997654
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
|+||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 89999999999999997654 4899999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
...... .....+||+.|+|||++.+..++.++|||||||++|||+||++||...... .+...+....
T Consensus 168 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~ 234 (345)
T 1xjd_A 168 NMLGDA------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDN 234 (345)
T ss_dssp CCCTTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC
T ss_pred cccCCC------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHhCC
Confidence 432221 124568999999999999889999999999999999999999999644321 1122222233
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+|...+..+.+|+.+||..+|.+||++.+++
T Consensus 235 ~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i 267 (345)
T 1xjd_A 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 267 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHH
Confidence 455666788999999999999999999997334
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.41 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=197.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV 474 (757)
..+|.....||+|+||.||+|.+.. ..||+|++.... ....+.|.+|+.++++++||||+++++++.+.. ++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 4578889999999999999998743 369999987543 334567899999999999999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 99999999999997543 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
... .......+|+.|+|||++.+..++.++|||||||++|+|+| |.+||...... ..+..+.......
T Consensus 169 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------~~~~~i~~~~~~~ 237 (281)
T 1mp8_A 169 STY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLP 237 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCCC
T ss_pred ccc-----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------HHHHHHHcCCCCC
Confidence 321 11233467889999999998899999999999999999997 99999643221 1122222322334
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+...+..+.+++.+||..+|.+||++. +++..|+.+.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~~l~~~~~ 276 (281)
T 1mp8_A 238 MPPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTILE 276 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHH
Confidence 5566788999999999999999999998 57777776643
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=350.55 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=203.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchh-------hHHHHHHHHHHHhcCCCceeeecccccCCce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQ-------NKQFLQELEVLSKIRHPHLLLLLGACPDHGC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~-------~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~~ 472 (757)
.++|...+.||+|+||.||+|.+. +..||||++....... .+.|.+|+.++++++||||+++++++.+..+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR 97 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence 457888999999999999999984 6799999986543221 1678999999999999999999999999889
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc-----eEEeeec
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV-----SKIGDVG 547 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~-----~KL~DFG 547 (757)
+||||+++|+|.+.+.... ..+++..+..++.|++.||.|||+.+ .+|+||||||+|||++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 9999999999999886543 35999999999999999999999976 45999999999999988776 9999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCcccc--ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHH
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ--RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~--~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
+++..... .....||+.|+|||++ ....++.++|||||||++|+|+||+.||......... ....
T Consensus 175 ~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~ 241 (287)
T 4f0f_A 175 LSQQSVHS---------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINM 241 (287)
T ss_dssp TCBCCSSC---------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHH
T ss_pred cccccccc---------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHH
Confidence 99754321 2345799999999988 4456789999999999999999999999643221110 0111
Q ss_pred Hhhh-hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 626 ILDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 626 ~ld~-~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
+... .....+...+..+.+|+.+||+.+|.+||++. +++..|+.
T Consensus 242 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~L~~ 286 (287)
T 4f0f_A 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFS-YIVKELSE 286 (287)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHT
T ss_pred HhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHH-HHHHHHHh
Confidence 1111 12345566788999999999999999999998 46666654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=359.58 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=201.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV 474 (757)
.+|...+.||+|+||.||+|++. +..||||++.... ......+.+|+.+|.++ +||||+++++++.+.. |+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888999999999999999986 5699999997643 22345678999999988 8999999999997654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999987654 4899999999999999999999988 99999999999999999999999999986432
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh--hchhhHHHHhhhhcC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA--IDEDNLAEILDAQAG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~l~~~ld~~~~ 632 (757)
... .....+||+.|+|||++.+..++.++|||||||++|||+||++||......... .....+...+.....
T Consensus 163 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 236 (345)
T 3a8x_A 163 PGD------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236 (345)
T ss_dssp TTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC
T ss_pred CCC------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC
Confidence 221 124568999999999999889999999999999999999999999642111110 111222333333344
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
.+|...+..+.+|+.+||..+|.+||+..
T Consensus 237 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 265 (345)
T 3a8x_A 237 RIPRSLSVKAASVLKSFLNKDPKERLGCH 265 (345)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSTTCC
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhHCCCCC
Confidence 56667788999999999999999999973
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=358.15 Aligned_cols=259 Identities=21% Similarity=0.365 Sum_probs=196.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEECCe-----EEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~~-----~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
...+|.....||+|+||.||+|.+..+ .||||++... .....+.|.+|+.++++++||||+++++++.+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 356789999999999999999987543 7999998765 3345677999999999999999999999985432
Q ss_pred ------eEEEEecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceE
Q 004388 472 ------CLVYEYMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSK 542 (757)
Q Consensus 472 ------~LV~Ey~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~K 542 (757)
++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 79999999999999986532 2225899999999999999999999988 99999999999999999999
Q ss_pred EeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchh
Q 004388 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDED 621 (757)
Q Consensus 543 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 621 (757)
|+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|+|+| |++||...... .
T Consensus 178 l~Dfg~a~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~ 247 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYR----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------E 247 (323)
T ss_dssp ECCCCC---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------G
T ss_pred Eeecccccccccccccc----ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH------H
Confidence 99999998765432211 1234467889999999999999999999999999999999 99999643321 1
Q ss_pred hHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 622 ~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+..+........+...+..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~l~~~l~~~l~ 298 (323)
T 3qup_A 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFT-CLRMELENILG 298 (323)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHH
Confidence 2222333333445666778999999999999999999998 56676666654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=361.11 Aligned_cols=242 Identities=20% Similarity=0.273 Sum_probs=200.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch------hhHHHHHHHHHHHhcCCCceeeecccccCCc-
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI------QNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~- 471 (757)
..+.|.....||+|+||.||+|... +..||+|++...... ..+.+.+|+.+|.+++||||++++++|.+..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3457889999999999999999986 669999998765322 3467899999999999999999999997654
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC----ceEEeee
Q 004388 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDV 546 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~----~~KL~DF 546 (757)
++||||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 8999999999999998653 35899999999999999999999988 99999999999998876 7999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
|++..+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||......+ .+..+
T Consensus 164 G~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i 230 (361)
T 2yab_A 164 GLAHEIEDGVE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANI 230 (361)
T ss_dssp SSCEECCTTCC-------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHH
T ss_pred CCceEcCCCCc-------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 99987654321 234579999999999998899999999999999999999999996443211 11222
Q ss_pred hhhhcCCCCh----hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 LDAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 ld~~~~~~p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. ....++. ..+..+.+|+.+||..||.+||++.+
T Consensus 231 ~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 269 (361)
T 2yab_A 231 TA-VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269 (361)
T ss_dssp HT-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred Hh-cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 21 1122222 34678999999999999999999985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=345.43 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=208.0
Q ss_pred hcCCccceeeccCCcEEEEEEEECCe-EEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..+|.....||+|+||.||+|.+.+. .||||++..... ....+.+|+.++.+++||||++++++|.+.. ++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 45788899999999999999998754 899999976543 3467999999999999999999999997654 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY- 159 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-
Confidence 9999999997653 24899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.......||+.|+|||++.+..++.++||||||+++|+|+| |+.||....... ....+........|..
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 229 (268)
T 3sxs_A 160 ----VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLKVSQGHRLYRPHL 229 (268)
T ss_dssp ----EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCCCCCCTT
T ss_pred ----hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHHHHcCCCCCCCCc
Confidence 12234567889999999998889999999999999999999 999996443221 1122222222334455
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.+..+.+++.+||+.+|.+||++. +++..|+.+.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~-~ll~~L~~l~ 263 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQ-QLLSSIEPLR 263 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHGGGC
T ss_pred ChHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHhh
Confidence 678899999999999999999998 5777776653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=351.57 Aligned_cols=248 Identities=20% Similarity=0.278 Sum_probs=201.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~ 475 (757)
..|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|++++||||+++++++.+. .+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888899999999999999987 6799999997543 23456788999999999999999999988543 38999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee----cCCCceEEeeecCccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTM 551 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl----d~~~~~KL~DFGla~~ 551 (757)
||+++|+|.+++........+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999987655556999999999999999999999988 9999999999999 8888999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccc--------cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQR--------TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
...... .....||+.|+|||++. +..++.++|||||||++|+|+||+.||........ ....+
T Consensus 166 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~ 236 (319)
T 4euu_A 166 LEDDEQ-------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVM 236 (319)
T ss_dssp CCTTCC-------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHH
T ss_pred cCCCCc-------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHH
Confidence 764432 13457999999999876 57789999999999999999999999963221111 11122
Q ss_pred HHHhhhhc------------------------CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILDAQA------------------------GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld~~~------------------------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..++.... ...+...+..+.+|+.+||+.||.+||++.+
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 22222111 1223467788999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=355.54 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=199.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
.++|.....||+|+||.||+|.+. +..||+|++.... ....+.|.+|+.++.+++||||+++++++.+.. ++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 346888999999999999999875 5699999986433 233467899999999999999999999997655 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||++||+|.+++...+ ++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999997654 4899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc---
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--- 631 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--- 631 (757)
... .......||+.|+|||++.+..++.++|||||||++|+|+||++||......... ...+....
T Consensus 164 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~~ 232 (294)
T 4eqm_A 164 TSL-----TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDSVPNV 232 (294)
T ss_dssp ----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSCCCCH
T ss_pred ccc-----cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhccCCCc
Confidence 321 1123457999999999999999999999999999999999999999754332211 11111111
Q ss_pred -CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 632 -GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 632 -~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
...+...+..+.+++.+||+.+|.+||+..+++...|+.+
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 1122345678999999999999999997666676666543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=365.43 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=202.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|... +..||+|++.... ......+.+|+.+|..++|||||+++++|.+.. |+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888999999999999999986 4589999986532 223467889999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+.||+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999987543 4899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
. .....+||+.|+|||++.. ..++.++|||||||++|+|+||++||....... ...+...+.....
T Consensus 169 ~-------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 169 T-------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETTVV 237 (384)
T ss_dssp C-------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHCCC
T ss_pred C-------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhccc
Confidence 2 1245689999999998863 458999999999999999999999996432211 1122233333445
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+|...+..+.+|+.+||+.+|.+||+..+.+
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l 269 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV 269 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence 56777788999999999999999999954333
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=352.25 Aligned_cols=257 Identities=25% Similarity=0.433 Sum_probs=209.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~- 471 (757)
...+|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 4567888999999999999999862 3689999987643 334567899999999999999999999986544
Q ss_pred -eEEEEecCCCCHHHHHhhcCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCC
Q 004388 472 -CLVYEYMENGSLEDRLYRKNN---------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK 529 (757)
++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 899999999999999976543 134889999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCc
Q 004388 530 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAI 608 (757)
Q Consensus 530 p~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf 608 (757)
|+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|+| |..||
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCE----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred hheEEEcCCCCEEEccccccccccccccc----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999876543321 12234567899999999998899999999999999999999 99999
Q ss_pred cccchhhhhhchhhHHHHhh-hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 609 AITHKVETAIDEDNLAEILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 609 ~~~~~~~~~~~~~~l~~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
..... ..+...+. ......+...+..+.+|+.+||+.+|.+||++. +++..|+.+.
T Consensus 254 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-~l~~~l~~~~ 310 (314)
T 2ivs_A 254 PGIPP-------ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA-DISKDLEKMM 310 (314)
T ss_dssp TTCCG-------GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCH-------HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 64322 11222222 223345566788999999999999999999998 5777776654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=344.88 Aligned_cols=249 Identities=20% Similarity=0.355 Sum_probs=204.7
Q ss_pred cCCccceeeccCCcEEEEEEEECCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~E 476 (757)
.+|.....||+|+||.||+|.+.++.||||++.... ....+.|.+|+.++++++||||++++++|.+. .++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 468888999999999999999999999999997653 33456799999999999999999999998654 389999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp CCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred ccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 999999999997643 235899999999999999999999976 4599999999999999999999999998764322
Q ss_pred CCccccccccCCcccccCCCccccccCCCCC---cchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh-hhhcC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISP---KSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL-DAQAG 632 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~---ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~ 632 (757)
....||+.|+|||++.+..++. ++|||||||++|+|+||+.||........ ...+. .....
T Consensus 166 ---------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 230 (271)
T 3kmu_A 166 ---------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEGLRP 230 (271)
T ss_dssp ---------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSCCCC
T ss_pred ---------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcCCCC
Confidence 2347899999999988765544 79999999999999999999964332211 11122 12233
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..|...+..+.+++.+||+.+|.+||++. +++..|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~L~~l 268 (271)
T 3kmu_A 231 TIPPGISPHVSKLMKICMNEDPAKRPKFD-MIVPILEKM 268 (271)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHh
Confidence 45566788999999999999999999998 577777665
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.83 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=210.5
Q ss_pred cCCccceeeccCCcEEEEEEEE------CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC--C--ce
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--H--GC 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~--~~ 472 (757)
.+|.....||+|+||.||+|.+ .+..||||++........+.|.+|+.++++++||||+++++++.. . .+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999985 356899999987766667789999999999999999999998742 2 37
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+++|+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976432 4899999999999999999999988 999999999999999999999999999877
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-----hc---hhhHH
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-----ID---EDNLA 624 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-----~~---~~~l~ 624 (757)
...... ........||+.|+|||++.+..++.++|||||||++|+|+||+.||......... .. ...+.
T Consensus 178 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 178 PLDKDY---YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp CTTCSE---EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred ccCCcc---ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 544321 11224457899999999999888999999999999999999999999643221100 00 01112
Q ss_pred HHhh-hhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 625 EILD-AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 625 ~~ld-~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+. ......+...+..+.+|+.+||+.+|.+||++. +++..|+.+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~L~~~~~~ 304 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFS-ALGPQLDMLWSG 304 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHC---
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHhh
Confidence 2222 222345566788999999999999999999998 577777766543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=357.77 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=206.7
Q ss_pred HhhcCCccceeeccCCcEEEEEEEE-------CCeEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCC
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTF-------HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDH 470 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~-------~~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~ 470 (757)
....+|.....||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|.++ +||||++++++|.+.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3456788899999999999999997 23479999997543 33456799999999999 899999999998654
Q ss_pred --ceEEEEecCCCCHHHHHhhcCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCC
Q 004388 471 --GCLVYEYMENGSLEDRLYRKNNT--------------------PPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDM 528 (757)
Q Consensus 471 --~~LV~Ey~~~gsL~~~L~~~~~~--------------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDL 528 (757)
.++||||+++|+|.+++...... ..+++..+..|+.||+.||.|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 48999999999999999765421 34899999999999999999999988 999999
Q ss_pred CCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCC
Q 004388 529 KPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPA 607 (757)
Q Consensus 529 Kp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~P 607 (757)
||+|||++.++.+||+|||++.......... ......||+.|+|||++.++.++.++|||||||++|+|+| |..|
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSE----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccce----eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999998765433211 1234567899999999998999999999999999999998 9999
Q ss_pred ccccchhhhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 608 IAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 608 f~~~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
|....... .+...+... ....|...+..+.+|+.+||..+|.+||++. +++..|+.+.
T Consensus 275 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~l~~~l~~~~ 333 (344)
T 1rjb_A 275 YPGIPVDA------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLGCQL 333 (344)
T ss_dssp STTCCCSH------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHC
T ss_pred cccCCcHH------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHHHH
Confidence 96433211 122222222 2344556788999999999999999999998 5666666553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.83 Aligned_cols=240 Identities=25% Similarity=0.301 Sum_probs=197.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~L 473 (757)
.++|...+.||+|+||.||+|++. +..||||++.... ......+.+|+.+|..+ +||||+++++++.+.. ||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 457999999999999999999986 5699999997542 22345678999999988 6999999999997654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+|+...
T Consensus 102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999997654 4899999999999999999999988 9999999999999999999999999998543
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||++||...... ..+..++ .....
T Consensus 176 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~-~~~~~ 242 (353)
T 3txo_A 176 CNGV------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAIL-NDEVV 242 (353)
T ss_dssp C---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCCC
T ss_pred cCCc------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHH-cCCCC
Confidence 2221 224468999999999999888999999999999999999999999644321 1122222 23344
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
+|...+..+.+|+.+||..+|.+||++
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 566678899999999999999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.78 Aligned_cols=254 Identities=21% Similarity=0.356 Sum_probs=202.6
Q ss_pred cCCccceeeccCCcEEEEEEEECC--e----EEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--T----FAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~----~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV 474 (757)
.+|...+.||+|+||.||+|.+.. . .||+|++.... ......+.+|+.++.+++||||++++++|.+.. ++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 468888999999999999999753 2 38888875443 233456788999999999999999999996544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999987542 35888899999999999999999988 99999999999999999999999999998764
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhh-hcC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDA-QAG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~ 632 (757)
.... .......||+.|+|||++.++.++.++|||||||++|+|+| |+.||...... .+...+.. ...
T Consensus 168 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~ 236 (325)
T 3kex_A 168 DDKQ----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------EVPDLLEKGERL 236 (325)
T ss_dssp CTTC----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-------HHHHHHHTTCBC
T ss_pred cccc----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCC
Confidence 4321 12244578889999999999999999999999999999999 99999643221 12222222 223
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
..|...+..+.+|+.+||..+|.+||++. +++..|+++..
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~-el~~~l~~~~~ 276 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRPTFK-ELANEFTRMAR 276 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSCCHH-HHHHHHHHHTT
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHh
Confidence 34555677899999999999999999998 57777776643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=375.37 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=208.0
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEe
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEY 477 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey 477 (757)
....+|...++||+|+||.||+|.+. +..||||++.... ...+.|.+|+.+|++++|||||++++++.+. .++||||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~ 263 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEF 263 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEee
Confidence 34567888899999999999999986 5689999998654 3567899999999999999999999998654 4899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.++|..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 264 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~- 338 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 338 (454)
T ss_dssp CTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence 999999999975321 24788899999999999999999988 9999999999999999999999999998765321
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
........+|+.|+|||++..+.++.++|||||||+||||+| |+.||......+ .+..+........|.
T Consensus 339 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~ 408 (454)
T 1qcf_A 339 ----YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMPRPE 408 (454)
T ss_dssp ----HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHHHHHTCCCCCCT
T ss_pred ----eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCC
Confidence 111234467889999999998999999999999999999999 999996432211 112222222334455
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+..+.+|+.+||..+|.+||++. +|+..|+.+
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~-~i~~~L~~~ 442 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFE-YIQSVLDDF 442 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHHH
Confidence 6788999999999999999999998 466666544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=353.92 Aligned_cols=235 Identities=27% Similarity=0.338 Sum_probs=198.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.+|...+.||+|+||.||+|... +..||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.. ++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999985 6799999987542 223466889999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999997643 4889999999999999999999988 999999999999999999999999999875432
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
....+||+.|+|||++.+..++.++|||||||++|+|+||++||...... ..+..++.. ...+|
T Consensus 160 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-~~~~p 223 (318)
T 1fot_A 160 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA-ELRFP 223 (318)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC-CCCCC
T ss_pred ---------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CCCCC
Confidence 13458999999999999999999999999999999999999999644321 112223322 23456
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCc
Q 004388 636 IKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
...+..+.+|+.+||..+|.+||+
T Consensus 224 ~~~~~~~~~li~~lL~~dp~~R~~ 247 (318)
T 1fot_A 224 PFFNEDVKDLLSRLITRDLSQRLG 247 (318)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCHHHHHHHHHHhccCHHHcCC
Confidence 667889999999999999999994
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=359.80 Aligned_cols=241 Identities=23% Similarity=0.263 Sum_probs=201.1
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~L 473 (757)
..+|.....||+|+||.||+|.... ..||||++.... ......+..|..+|..+ +||||+++++++.+.. ||
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 4578999999999999999999975 489999987542 23446688999999988 7999999999987654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 999999999999997654 4899999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|++||...... ..+..++ .....
T Consensus 173 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~-~~~~~ 239 (353)
T 2i0e_A 173 WDGV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM-EHNVA 239 (353)
T ss_dssp CTTC------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCCC
T ss_pred cCCc------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hCCCC
Confidence 2221 124568999999999999899999999999999999999999999643321 1122222 22345
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
+|...+..+.+|+.+||..+|.+||+..
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~ 267 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCG 267 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 6667788999999999999999999763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=349.13 Aligned_cols=260 Identities=21% Similarity=0.355 Sum_probs=205.7
Q ss_pred cCCccceeeccCCcEEEEEEEE------CCeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC----c
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----G 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~------~~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~ 471 (757)
..|...++||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|.+++||||+++++++.+. .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3578889999999999999985 46799999987543 33457789999999999999999999998654 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 79999999999999996544 34899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh--------hhhchhhH
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE--------TAIDEDNL 623 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--------~~~~~~~l 623 (757)
....... ........||+.|+|||++.+..++.++|||||||++|+|+||..|+....... .......+
T Consensus 176 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 176 IETDKEY---YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CCTTCCE---EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred ccCCCcc---eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 7654321 112244578999999999998999999999999999999999999875321110 00111111
Q ss_pred HHHh-hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 624 AEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 624 ~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
...+ .......|...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~L~~l 300 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQ-NLIEGFEAL 300 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHH
Confidence 2222 1222344566788999999999999999999998 577777665
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.23 Aligned_cols=241 Identities=21% Similarity=0.284 Sum_probs=198.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~------~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
.+.|.....||+|+||.||+|... +..||+|++..... ...+.+.+|+.+|++++||||++++++|.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999986 56999999875432 23577999999999999999999999997654
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC----ceEEeeec
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVG 547 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~----~~KL~DFG 547 (757)
++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 8999999999999998653 35899999999999999999999988 99999999999998887 89999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||.+||......+. +..+.
T Consensus 164 ~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~ 230 (326)
T 2y0a_A 164 LAHKIDFGNE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVS 230 (326)
T ss_dssp TCEECCTTSC-------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHH
T ss_pred CCeECCCCCc-------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHH
Confidence 9987654321 1345799999999999988999999999999999999999999964332111 11111
Q ss_pred hhhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....++ ...+..+.+|+.+||..+|.+||++.+
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 268 (326)
T 2y0a_A 231 -AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268 (326)
T ss_dssp -HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred -hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 1111222 134678999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=357.99 Aligned_cols=236 Identities=21% Similarity=0.288 Sum_probs=200.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|..++||||+++++++.+.. |+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 357889999999999999999985 6699999986542 224467889999999999999999999997654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999997654 4899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
. ....+||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..+. .....+
T Consensus 194 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~-~~~~~~ 257 (350)
T 1rdq_E 194 R---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIV-SGKVRF 257 (350)
T ss_dssp C---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCCCC
T ss_pred C---------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHH-cCCCCC
Confidence 2 134589999999999998899999999999999999999999996443211 122222 223445
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCc
Q 004388 635 PIKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
|...+..+.+|+.+||+.+|.+||+
T Consensus 258 p~~~~~~~~~li~~lL~~dp~~R~~ 282 (350)
T 1rdq_E 258 PSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred CCCCCHHHHHHHHHHhhcCHHhccC
Confidence 6677889999999999999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.02 Aligned_cols=253 Identities=30% Similarity=0.460 Sum_probs=193.6
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~ 478 (757)
..+|....+||+|+||.||+|.+.+ .||||++.... ....+.|.+|+.+|++++||||+++++++.+. .++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEec
Confidence 4578889999999999999998766 49999987553 33456789999999999999999999987654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++++|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 102 EGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred CCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999999986543 35899999999999999999999988 999999999999999999999999999865532211
Q ss_pred ccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-----
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ----- 630 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~----- 630 (757)
.......||+.|+|||++. +..++.++|||||||++|+|+||+.||....... .+...+...
T Consensus 177 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 177 ----HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPD 246 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCC
T ss_pred ----ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcc
Confidence 1123457999999999886 5678889999999999999999999996433221 112222211
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
....+...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell~~L~~l 286 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFP-RILAEIEEL 286 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHT
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHH
Confidence 1222345678999999999999999999998 466666654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=360.26 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=203.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCchh-----------hHHHHHHHHHHHhcCCCceee
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQ-----------NKQFLQELEVLSKIRHPHLLL 462 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~~~-----------~~~f~~Ev~il~~l~Hpniv~ 462 (757)
...+|....+||+|+||.||+|.+.. ..||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34579999999999999999998853 579999987654211 122445666777889999999
Q ss_pred ecccccCC------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 463 LLGACPDH------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 463 l~g~~~~~------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
+++++... .+|||||+ ||+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998543 48999999 999999987643 35999999999999999999999988 99999999999999
Q ss_pred --CCCceEEeeecCccccCCCCCCcc-ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch
Q 004388 537 --HNLVSKIGDVGLSTMLNSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK 613 (757)
Q Consensus 537 --~~~~~KL~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~ 613 (757)
.++.+||+|||+++.+........ .........||+.|+|||++.+..++.++|||||||+||+|+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 889999999999987654322111 11112445699999999999998999999999999999999999999974221
Q ss_pred hhhhh------chhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 614 VETAI------DEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 614 ~~~~~------~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..... ....+..+++.... +...+..+.+++..||..+|.+||++. .|+..|+.+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~-~l~~~l~~~~~~ 330 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYE-NLRDILLQGLKA 330 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHH-HHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHH
Confidence 11110 11233344444321 123467899999999999999999998 577777766544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=355.97 Aligned_cols=260 Identities=19% Similarity=0.218 Sum_probs=203.6
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~E 476 (757)
..+|.....||+|+||.||+|.. .+..||||++..... ...+.+|+.+++++ +||||+++++++.+.. ++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788899999999999999996 467999999875533 34588999999999 9999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc-----eEEeeecCccc
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV-----SKIGDVGLSTM 551 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~-----~KL~DFGla~~ 551 (757)
|+ +|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 999999987643 35999999999999999999999988 999999999999998887 99999999987
Q ss_pred cCCCCCCcccc-ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 552 LNSDPSFVSTT-YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
+.......... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---KERYQKIGDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---HHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---HHHHHHHHhhh
Confidence 65443221111 112456899999999999999999999999999999999999999974321110 00111111111
Q ss_pred cCCCCh-----hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhh
Q 004388 631 AGDWPI-----KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 675 (757)
Q Consensus 631 ~~~~p~-----~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~ 675 (757)
.. .+. ..+ .+.+|+..||..+|.+||++. .|...|+.+....
T Consensus 237 ~~-~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~-~l~~~l~~~~~~~ 283 (330)
T 2izr_A 237 RA-TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYD-YLRKLFTDLFDRK 283 (330)
T ss_dssp HH-SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHHHHT
T ss_pred cc-CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHH-HHHHHHHHHHHHc
Confidence 10 111 123 899999999999999999998 5777777665443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=346.27 Aligned_cols=257 Identities=21% Similarity=0.354 Sum_probs=206.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CL 473 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~L 473 (757)
...+|.....||+|+||.||+|.+.+ ..||||++.... ....+.|.+|+.++++++||||+++++++.+.. ++
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence 35678889999999999999998642 259999987653 334577999999999999999999999987554 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 999999999999997654 34889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
.... .......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||....... ....+......
T Consensus 165 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------~~~~~~~~~~~ 233 (281)
T 3cc6_A 165 DEDY-----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKGDRL 233 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------HHHHHHHTCCC
T ss_pred cccc-----cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------HHHHHhcCCCC
Confidence 4321 11234567899999999998899999999999999999998 999996332211 11112222223
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+...+..+.+++.+||..+|.+||++. +++..|+.+...
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 PKPDLCPPVLYTLMTRCWDYDPSDRPRFT-ELVCSLSDVYQM 274 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCCchhCcCHH-HHHHHHHHHHHh
Confidence 34455678899999999999999999998 577777776554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.84 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=209.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEE-------CCeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTF-------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~-------~~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
..++|...+.||+|+||.||+|.+ .+..||||++..... ...+.+.+|+.+|.++ +||||++++++|.+..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346788899999999999999986 235899999976543 3456789999999999 9999999999986544
Q ss_pred --eEEEEecCCCCHHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCee
Q 004388 472 --CLVYEYMENGSLEDRLYRKNN---------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 534 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 534 (757)
++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 899999999999999976542 125899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccch
Q 004388 535 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 613 (757)
Q Consensus 535 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~ 613 (757)
++.++.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|+| |+.||.....
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSE----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EcCCCCEEEccccccccccccccce----eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999998766543211 1234567899999999999999999999999999999999 9999964332
Q ss_pred hhhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 614 VETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.. .+...+... ....+...+..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 254 ~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~ 307 (313)
T 1t46_A 254 DS------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQIS 307 (313)
T ss_dssp SH------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred hh------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHHHHH
Confidence 11 122222222 2233455678899999999999999999998 57777766544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=345.12 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=204.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
..++|...+.||+|+||.||+|.+.+ ..||||++..... ..+.+.+|+.++.+++||||++++++|.+.. ++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 34578888999999999999999875 4899999976543 3467999999999999999999999997654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 99999999997533 24899999999999999999999988 9999999999999999999999999998765321
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
........||+.|+|||++.+..++.++||||||+++|+|+| |+.||....... ....+........|.
T Consensus 175 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 244 (283)
T 3gen_A 175 ----YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYRPH 244 (283)
T ss_dssp ----HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHHHHTTCCCCCCT
T ss_pred ----cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------HHHHHhcccCCCCCC
Confidence 112234567889999999998899999999999999999998 999996433221 112222222333455
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
..+..+.+|+.+||+.+|.+||++. +++..|..+.
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~-~ll~~L~~~~ 279 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFK-ILLSNILDVM 279 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHHHh
Confidence 5678899999999999999999998 4666666554
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=354.44 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=197.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--c---
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--G--- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~--- 471 (757)
.++|.....||+|+||.||+|.+. +..||||++..... .....|.+|+.++.+++||||+++++++... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 457888999999999999999974 67999999976532 2345688999999999999999999987543 2
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
|+||||++||+|.+++...+ ++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 89999999999999997654 4899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
.+....... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||......... ...+...
T Consensus 165 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~ 235 (311)
T 3ork_A 165 AIADSGNSV---TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVRED 235 (311)
T ss_dssp --------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCC
T ss_pred ccccccccc---ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCC
Confidence 765432211 1223457999999999999999999999999999999999999999654322211 1111111
Q ss_pred cCC---CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 631 AGD---WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 631 ~~~---~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
... .+...+..+.+|+.+||+.+|.+||+..+++...+.++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 000 01235678999999999999999999988777766554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.11 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=199.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
...+|.....||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+|++++||||++++++|.+.. ++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999986 5699999997543 234467889999999999999999999997655 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---CceEEeeecCccc
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTM 551 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~---~~~KL~DFGla~~ 551 (757)
|||++||+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999886543 4899999999999999999999988 9999999999999764 4699999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
...... .....||+.|+|||++.+..++.++|||||||++|+|+||++||....... +...+....
T Consensus 181 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~ 246 (362)
T 2bdw_A 181 VNDSEA-------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGA 246 (362)
T ss_dssp CTTCCS-------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTC
T ss_pred ecCCcc-------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCC
Confidence 654321 234589999999999998899999999999999999999999996433211 111111111
Q ss_pred CCCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 632 GDWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 632 ~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+| ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 247 YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 2222 23578899999999999999999998644
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.85 Aligned_cols=261 Identities=26% Similarity=0.397 Sum_probs=209.0
Q ss_pred CccceeeccCCcEEEEEEEE------CCeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC----ceE
Q 004388 405 FSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCL 473 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~------~~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~L 473 (757)
|...++||+|+||.||++.+ .+..||||++..... .....|.+|+.+|++++||||+++++++.+. .++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999999876 456899999986543 3456789999999999999999999998653 279
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999998654 3899999999999999999999988 9999999999999999999999999998876
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh--------hhhchhhHHH
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE--------TAIDEDNLAE 625 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~--------~~~~~~~l~~ 625 (757)
...... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .......+..
T Consensus 186 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 186 EGHEYY---RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp TTCSEE---EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccc---ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 543211 12234578899999999998899999999999999999999999996432110 0111112233
Q ss_pred Hhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 626 ILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 626 ~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
.+... ....+...+..+.+|+.+||+.+|.+||++. +++..|+.+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE-NLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHHHhhc
Confidence 33322 2344566788999999999999999999998 57788887765543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.65 Aligned_cols=269 Identities=25% Similarity=0.354 Sum_probs=201.2
Q ss_pred CHHHHHHhhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhc--CCCceeeecccccCC-
Q 004388 394 TWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI--RHPHLLLLLGACPDH- 470 (757)
Q Consensus 394 ~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l--~Hpniv~l~g~~~~~- 470 (757)
....-....++|...++||+|+||.||+|.+.+..||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 33333445578999999999999999999999999999998643 234456667776655 899999999998543
Q ss_pred -----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCEEEcCCCCCCeeecCCCc
Q 004388 471 -----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-----PKPIIHRDMKPGNILLDHNLV 540 (757)
Q Consensus 471 -----~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~ivHrDLKp~NILld~~~~ 540 (757)
.++||||+++|+|.+++... .+++..+..|+.|++.||.|||+.. ..+|+||||||+|||++.++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence 38999999999999999653 4899999999999999999999871 113999999999999999999
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCc------chhhhHHHHHHHHHhCC---------
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPK------SDVYAYGMVILQLLTAK--------- 605 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k------sDvwSlGvil~elltG~--------- 605 (757)
+||+|||++..+....... ........||+.|+|||++.+..++.. +|||||||++|||+||.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV--DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp EEECCCTTCEECC-----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEEEeCCCceeeccccccc--cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 9999999998765433211 111234589999999999987776665 99999999999999994
Q ss_pred -CCccccchhhhhhchhhHHHHhhhh--cCCCCh-----hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 606 -PAIAITHKVETAIDEDNLAEILDAQ--AGDWPI-----KETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 606 -~Pf~~~~~~~~~~~~~~l~~~ld~~--~~~~p~-----~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.||........ ....+...+... ....|. ..+..+.+|+.+||+.+|.+||++. +++..|+.+.+.
T Consensus 259 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~-ell~~L~~l~~~ 332 (337)
T 3mdy_A 259 QLPYHDLVPSDP--SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL-RVKKTLAKMSES 332 (337)
T ss_dssp CCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHH-HHHHHHHHHHHT
T ss_pred cccHhhhcCCCC--chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHH-HHHHHHHHHHhh
Confidence 44432111100 011111111111 122332 5678899999999999999999998 587888777654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.85 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=208.3
Q ss_pred cCCccce-eeccCCcEEEEEEEE----CCeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEE
Q 004388 403 LSFSENL-RIGMGGYGTVYKGTF----HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 475 (757)
Q Consensus 403 ~~f~~~~-~IG~G~~G~Vyk~~~----~~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~ 475 (757)
.+|.... .||+|+||.||+|.+ .+..||||++.... ....+.+.+|+.++.+++||||+++++++.+.. ++||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 3455555 899999999999986 35689999998653 334567899999999999999999999995544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 89 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999986433 35899999999999999999999988 999999999999999999999999999877543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.... .......||+.|+|||++.+..++.++|||||||++|+|+| |+.||....... ....+........
T Consensus 164 ~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~~~~~ 234 (287)
T 1u59_A 164 DSYY---TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMEC 234 (287)
T ss_dssp SCEE---CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCC
T ss_pred ccee---eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCCcCCC
Confidence 3211 11234467899999999988889999999999999999998 999996432211 1122222223445
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 675 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~ 675 (757)
|...+..+.+++.+||..+|.+||++. +++..|+.+....
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~~l~~~~~~~ 274 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFL-TVEQRMRACYYSL 274 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHHhc
Confidence 667788999999999999999999998 5777777765443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=353.65 Aligned_cols=243 Identities=19% Similarity=0.257 Sum_probs=199.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.++|.....||+|+||.||+|.+. +..||+|++.... .....+.+|+.+|+.++||||+++++++.+.. ++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 457888999999999999999986 5689999987543 34566889999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC--CCceEEeeecCccccCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH--NLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~--~~~~KL~DFGla~~~~~~ 555 (757)
++||+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999986533 35899999999999999999999988 999999999999987 799999999999877543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||.+||...... ..+..+... ...++
T Consensus 158 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~-~~~~~ 223 (321)
T 1tki_A 158 DN-------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNA-EYTFD 223 (321)
T ss_dssp CE-------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-CCCCC
T ss_pred Cc-------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcC-CCCCC
Confidence 21 13457999999999999888999999999999999999999999643321 112222221 12222
Q ss_pred h----hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 636 I----KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 636 ~----~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
. ..+..+.+|+.+||..+|.+||++.+.+
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 256 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 2 3467899999999999999999998633
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=343.44 Aligned_cols=261 Identities=16% Similarity=0.181 Sum_probs=205.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~E 476 (757)
..+|.....||+|+||.||+|.+ .+..||||++.... ....+.+|+.++..+ +|||++.+++++.+.. ++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688899999999999999995 57799999986543 234578899999999 7999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc-----eEEeeecCccc
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV-----SKIGDVGLSTM 551 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~-----~KL~DFGla~~ 551 (757)
|+ +|+|.+++...+ .++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 999999997653 35899999999999999999999988 999999999999987766 99999999987
Q ss_pred cCCCCCCcccc-ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 552 LNSDPSFVSTT-YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 552 ~~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
........... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||......... ..+..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~ 237 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---QKYERIGEKK 237 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH---HHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH---HHHHHHHhhc
Confidence 76543221111 1234568999999999999989999999999999999999999999753221111 1111111111
Q ss_pred c----CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 631 A----GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 631 ~----~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
. .......+..+.+|+.+||+.+|.+||++. +|+..|+.+...
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~-~l~~~l~~~~~~ 284 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVLER 284 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHH-HHHHHHHHHHHh
Confidence 0 011123467899999999999999999997 577777776554
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.08 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=207.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~ 479 (757)
.+|.....||+|+||.||+|.+. +..||+|++..... ..+.+.+|+.++++++||||+++++++.+. .++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46888899999999999999984 56899999976543 346799999999999999999999998654 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 158 (267)
T 3t9t_A 87 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 158 (267)
T ss_dssp TCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc---
Confidence 999999997643 35889999999999999999999988 9999999999999999999999999998764321
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
........||+.|+|||++.+..++.++||||||+++|+|+| |++||....... ....+........|...
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~~ 230 (267)
T 3t9t_A 159 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDISTGFRLYKPRLA 230 (267)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTTCCCCCCTTS
T ss_pred --ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHHhcCCcCCCCccC
Confidence 112234567889999999998899999999999999999999 899996432211 11222222223345556
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+..+.+++.+||..+|.+||++. +++..|+.+.+
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~-~ll~~L~~l~~ 264 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFS-RLLRQLAEIAE 264 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHh
Confidence 78899999999999999999998 57777776654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.75 Aligned_cols=258 Identities=27% Similarity=0.464 Sum_probs=200.5
Q ss_pred CCccceeeccCCcEEEEEEEECCe------EEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~------~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
.|...+.||+|+||.||+|.+..+ .||||++..... .....|.+|+.++.+++||||+++++++.+.. ++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 466678999999999999987532 599999976533 34557899999999999999999999997544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 125 TEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999987643 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... ........+|+.|+|||++.+..++.++|||||||++|+|+| |+.||...... ..+..+.+.....
T Consensus 200 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~~~~~~~ 270 (333)
T 1mqb_A 200 DPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFRLP 270 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCCC
T ss_pred cccc---ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHCCCcCC
Confidence 3221 112233467889999999998899999999999999999999 99999643221 1122222222233
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
.+...+..+.+|+.+||+.+|.+||++. +++..|+.+.....
T Consensus 271 ~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 271 TPMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAPD 312 (333)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHSGG
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHhcch
Confidence 4556778899999999999999999998 57788877765433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=366.19 Aligned_cols=245 Identities=20% Similarity=0.307 Sum_probs=199.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..++|.....||+|+||.||+|... +..+|+|++..... .....+.+|+.+|++++||||+++++++.+.. ++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3457889999999999999999874 67999999876542 23456899999999999999999999997665 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec---CCCceEEeeecCccc
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTM 551 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld---~~~~~KL~DFGla~~ 551 (757)
|||++||+|.+.+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999987654 4899999999999999999999988 99999999999998 468899999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|++||....... +...+....
T Consensus 163 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~ 229 (444)
T 3soa_A 163 VEGEQQ------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGA 229 (444)
T ss_dssp CCTTCC------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTC
T ss_pred ecCCCc------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCC
Confidence 654322 1234689999999999998899999999999999999999999996432211 111122211
Q ss_pred CCCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 632 GDWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 632 ~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..++ ...+..+.+|+.+||+.||.+||++.+.+
T Consensus 230 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L 266 (444)
T 3soa_A 230 YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266 (444)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 1112 24578899999999999999999998644
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.25 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=203.5
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccC---Cce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~ 472 (757)
...|....+||+|+||.||+|.+.. ..+|+|.+..... .....|.+|+.++++++||||++++++|.+ ..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 4567888999999999999998643 2589998876433 345678999999999999999999998643 338
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999996533 35889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
...... .........||+.|+|||.+.+..++.++||||||+++|+|+| |.+||....... ....+.....
T Consensus 179 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~~~~~~~~ 250 (298)
T 3f66_A 179 YDKEYY--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRR 250 (298)
T ss_dssp SCGGGC--BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HHHHHHTTCC
T ss_pred cccchh--ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhcCCC
Confidence 543211 1122345678899999999999999999999999999999999 667775332211 1122222223
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
...|...+..+.+++.+||..+|.+||++. +++..|+.+..
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-ell~~L~~~~~ 291 (298)
T 3f66_A 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 291 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHH
Confidence 334555678899999999999999999998 57777776654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.75 Aligned_cols=241 Identities=26% Similarity=0.319 Sum_probs=190.7
Q ss_pred hcCCccceeeccCCcEEEEEEEE-----CCeEEEEEEEccCC----chhhHHHHHHHHHHHhcCCCceeeecccccCCc-
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~- 471 (757)
..+|.....||+|+||.||++.. .+..||+|++.... ......+.+|+.+|+.++||||+++++++.+..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788999999999999999987 46799999997643 223456788999999999999999999996544
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
++||||++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 89999999999999997654 4888999999999999999999988 9999999999999999999999999997
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
....... ......||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..++. .
T Consensus 170 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~ 236 (327)
T 3a62_A 170 ESIHDGT------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILK-C 236 (327)
T ss_dssp ---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHH-T
T ss_pred ccccCCc------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHh-C
Confidence 6443221 1234579999999999988889999999999999999999999996443211 1222222 2
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
....|...+..+.+|+.+||..+|.+||++.
T Consensus 237 ~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~ 267 (327)
T 3a62_A 237 KLNLPPYLTQEARDLLKKLLKRNAASRLGAG 267 (327)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSS
T ss_pred CCCCCCCCCHHHHHHHHHHHhcCHhhccCCC
Confidence 3345666788999999999999999999654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=373.76 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=208.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~E 476 (757)
...+|....+||+|+||.||+|.+. +..||||++..... ..+.|.+|+.+|++++|||||+++++|.+. .+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3456888899999999999999987 56999999976543 467899999999999999999999999654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.++|.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999997643 245899999999999999999999988 9999999999999999999999999998765322
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~ 634 (757)
. .......+|+.|+|||++.++.++.++|||||||+||||+| |..||...... .+...+... ....
T Consensus 373 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 440 (495)
T 1opk_A 373 Y-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKDYRMER 440 (495)
T ss_dssp E-----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHHHHHHTTCCCCC
T ss_pred e-----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC
Confidence 1 11234467889999999999999999999999999999999 99999643221 122222222 2344
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
|...+..+.+|+.+||+.+|.+||++. +|+..|+.+
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~-el~~~L~~~ 476 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETM 476 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHH-HHHHHHHHH
Confidence 566788999999999999999999998 466666543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=350.42 Aligned_cols=241 Identities=20% Similarity=0.311 Sum_probs=175.0
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCc--eEEEEecCCCC
Q 004388 408 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGS 482 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~LV~Ey~~~gs 482 (757)
.+.||+|+||.||+|.+. +..||||++... ....+.+|+.++..+. ||||++++++|.+.. ++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 367999999999999986 569999998653 3456789999999997 999999999997654 89999999999
Q ss_pred HHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC---ceEEeeecCccccCCCCCCc
Q 004388 483 LEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---VSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 483 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~---~~KL~DFGla~~~~~~~~~~ 559 (757)
|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 999997643 5899999999999999999999988 99999999999997665 899999999987654322
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC----
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP---- 635 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p---- 635 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||++||..............+...+......++
T Consensus 165 ----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (325)
T 3kn6_A 165 ----PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHH
T ss_pred ----cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccc
Confidence 123457899999999999999999999999999999999999999744322111111111222222112222
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+..+.+|+.+||..+|.+||++.++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 1356789999999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=358.38 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=197.9
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|.+ .+..||||++.... ......+.+|+.+|+.++||||+++++++.+.. ++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5788899999999999999998 46699999986432 223457889999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+ +|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 789999887654 4899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.. ....+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||....... +...+.......
T Consensus 162 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~~~~i~~~~~~~ 227 (336)
T 3h4j_B 162 NF-------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-------LFKKVNSCVYVM 227 (336)
T ss_dssp BT-------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-------CBCCCCSSCCCC
T ss_pred cc-------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHcCCCCC
Confidence 21 234579999999999987765 789999999999999999999996432111 011111122234
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|...+..+.+|+.+||..||.+||++.+.+
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil 257 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIR 257 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 555678899999999999999999998533
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=354.67 Aligned_cols=267 Identities=23% Similarity=0.373 Sum_probs=213.9
Q ss_pred cCCCHHHHHHhhcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceee
Q 004388 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLL 462 (757)
Q Consensus 391 ~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~ 462 (757)
..+..++++....+|.....||+|+||.||+|.+. +..||||++..... .....|.+|+.++++++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34455566667788999999999999999999865 45899999875433 34456899999999999999999
Q ss_pred ecccccCC--ceEEEEecCCCCHHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCe
Q 004388 463 LLGACPDH--GCLVYEYMENGSLEDRLYRKN-------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNI 533 (757)
Q Consensus 463 l~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NI 533 (757)
+++++.+. .++||||+++|+|.+++.... ...++++..+..|+.||+.||.|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 99999654 489999999999999987532 1245789999999999999999999988 99999999999
Q ss_pred eecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccc
Q 004388 534 LLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITH 612 (757)
Q Consensus 534 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~ 612 (757)
|++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|+| |..||....
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred EEcCCCeEEECcCcccccccccccc----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 9999999999999999865432211 11234467899999999998999999999999999999999 899996432
Q ss_pred hhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 613 KVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 613 ~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.. .....+........+...+..+.+|+.+||..+|.+||++. +++..|+.+
T Consensus 246 ~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-e~l~~L~~~ 297 (322)
T 1p4o_A 246 NE------QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEE 297 (322)
T ss_dssp HH------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHGGG
T ss_pred HH------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHh
Confidence 21 11222223333445566778899999999999999999998 466666544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.52 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=198.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-----chhhHHHHHHHHHHHhcCCCceeeecccccCCc--e
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~ 472 (757)
.+.|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|+.++||||++++++|.+.. +
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 346888999999999999999885 5699999986421 224577999999999999999999999986544 8
Q ss_pred EEEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc---eEEeeecC
Q 004388 473 LVYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV---SKIGDVGL 548 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~---~KL~DFGl 548 (757)
+||||++||+|.+.+.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998876532 2345899999999999999999999988 999999999999976554 99999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+........ ......||+.|+|||++.+..++.++|||||||++|+|+||++||..... ..+..++.
T Consensus 180 a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~ 246 (351)
T 3c0i_A 180 AIQLGESGL------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIK 246 (351)
T ss_dssp CEECCTTSC------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHH
T ss_pred eeEecCCCe------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHc
Confidence 987654321 12345899999999999988999999999999999999999999964321 11122222
Q ss_pred hhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 629 AQAGDWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 629 ~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.. ...+ ...+..+.+|+.+||..||.+||++.+.+
T Consensus 247 ~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l 285 (351)
T 3c0i_A 247 GK-YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL 285 (351)
T ss_dssp TC-CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CC-CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 11 1111 13467899999999999999999998644
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=350.97 Aligned_cols=262 Identities=24% Similarity=0.397 Sum_probs=211.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC---------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccC
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPD 469 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~ 469 (757)
..++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++.++ +||||++++++|.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3467889999999999999999874 34799999876532 3456789999999999 89999999999965
Q ss_pred Cc--eEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCee
Q 004388 470 HG--CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 534 (757)
Q Consensus 470 ~~--~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 534 (757)
.. ++||||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 44 899999999999999976432 234899999999999999999999988 999999999999
Q ss_pred ecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccch
Q 004388 535 LDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHK 613 (757)
Q Consensus 535 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~ 613 (757)
++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|+| |..||.....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSE----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred EcCCCCEEEccccccccccccccc----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 999999999999999876543221 11234567899999999988889999999999999999999 9999964321
Q ss_pred hhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 614 VETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
.+ ....+........+...+..+.+++.+||..+|.+||++. +++..|+++.....
T Consensus 266 ~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 EE------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILTLTT 321 (334)
T ss_dssp HH------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHHHC
T ss_pred HH------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHhccc
Confidence 11 1112222223344556778999999999999999999998 58888888766543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=368.87 Aligned_cols=250 Identities=23% Similarity=0.283 Sum_probs=201.4
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG 471 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~ 471 (757)
++...+++|...++||+|+||.||+|.+. +..||||++..... .....+.+|+.+|..++||||++++++|.+..
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34445678999999999999999999986 46899999875321 12234889999999999999999999997665
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 472 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
||||||++||+|.++|.... ..+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence 89999999999999997633 34899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHH
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 624 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~ 624 (757)
+....... ......+||+.|+|||++. .+.++.++|||||||++|||+||++||......+ .+.
T Consensus 223 ~~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~ 291 (437)
T 4aw2_A 223 LKLMEDGT-----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYG 291 (437)
T ss_dssp EECCTTSC-----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH
T ss_pred hhcccCCC-----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHH
Confidence 87654322 1224468999999999886 5678999999999999999999999997543222 122
Q ss_pred HHhhhh----cCCCChhHHHHHHHHHHHHhhccCCC--CCccch
Q 004388 625 EILDAQ----AGDWPIKETKELAALGLSCAELRRKD--RPDLKN 662 (757)
Q Consensus 625 ~~ld~~----~~~~p~~~~~~l~~Li~~Cl~~~p~~--RPs~~~ 662 (757)
.++... .+..+...+..+.+|+.+||..+|.. ||++.+
T Consensus 292 ~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e 335 (437)
T 4aw2_A 292 KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIED 335 (437)
T ss_dssp HHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred hhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence 222211 12222346789999999999888877 999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=346.31 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=192.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
..++|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++.+.. ++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 3467889999999999999999984 67999999875432 23467889999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++ |+|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFME-KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCS-EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCC-CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9998 58888876543 35899999999999999999999988 999999999999999999999999999876533
Q ss_pred CCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGD 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~ 633 (757)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......... ..+...+... ...
T Consensus 173 ~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~ 243 (311)
T 3niz_A 173 VR------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPRE 243 (311)
T ss_dssp CC---------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTT
T ss_pred cc------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHH
Confidence 21 1234578999999998865 56899999999999999999999999643322110 0001100000 000
Q ss_pred C-------------------------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 W-------------------------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~-------------------------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
| ....+.++.+|+.+||+.||.+||++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 0 1123568899999999999999999985
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.49 Aligned_cols=241 Identities=25% Similarity=0.354 Sum_probs=190.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--------------------------hhHHHHHHHHHHH
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--------------------------QNKQFLQELEVLS 453 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--------------------------~~~~f~~Ev~il~ 453 (757)
.++|.....||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357888999999999999999874 679999998754311 1246889999999
Q ss_pred hcCCCceeeecccccC----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCC
Q 004388 454 KIRHPHLLLLLGACPD----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529 (757)
Q Consensus 454 ~l~Hpniv~l~g~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK 529 (757)
+++||||+++++++.+ ..++||||+++|+|.+++. ..++++..+..++.||+.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999864 2389999999999987542 235999999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCC---CCCcchhhhHHHHHHHHHhCCC
Q 004388 530 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL---ISPKSDVYAYGMVILQLLTAKP 606 (757)
Q Consensus 530 p~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~ 606 (757)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|+||+.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999987654321 123458999999999987654 4788999999999999999999
Q ss_pred CccccchhhhhhchhhHHHHhhhhcCCCC--hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 607 AIAITHKVETAIDEDNLAEILDAQAGDWP--IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 607 Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
||....... +...+......+| ...+..+.+|+.+||..+|.+||++.+
T Consensus 239 pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 239 PFMDERIMC-------LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp SSCCSSHHH-------HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred CCCCccHHH-------HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence 996432211 1111111112222 345788999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=343.29 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=208.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEec
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYM 478 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~ 478 (757)
...+|.....||+|+||.||+|.+.+ ..||||++.... ...+.|.+|+.+|++++||||+++++++.+. .++||||+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~ 89 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYM 89 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecC
Confidence 34578889999999999999999864 589999987653 3456799999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY- 164 (279)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc-
Confidence 9999999986432 124899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.......+|+.|+|||++.++.++.++||||||+++|+|+| |+.||......+ .+..+........+..
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~ 234 (279)
T 1qpc_A 165 ----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVRPDN 234 (279)
T ss_dssp ----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTT
T ss_pred ----ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HHHHHhcccCCCCccc
Confidence 11234467889999999998899999999999999999999 999996432211 1122222222334556
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.+..+.+|+.+||..+|.+||++. +++..|+.+...
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~-~l~~~l~~~~~~ 270 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFD-YLRSVLEDFFTA 270 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHH-HHHHHHHHHHHh
Confidence 678999999999999999999998 577777766543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=338.74 Aligned_cols=242 Identities=24% Similarity=0.332 Sum_probs=200.8
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.+.|....+||+|+||.||+|.+.+ ..+|+|++........+.+.+|+.++++++||||++++++|.+.. ++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 4568889999999999999999865 489999988765566788999999999999999999999997665 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---cCCCceEEeeecCccccCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl---d~~~~~KL~DFGla~~~~~ 554 (757)
+++++|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999887654 4899999999999999999999988 9999999999999 7889999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... .....||+.|+|||++.+ .++.++||||||+++|+|+||+.||....... .+.. +.......
T Consensus 162 ~~~-------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~ 226 (277)
T 3f3z_A 162 GKM-------MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLK-IREGTFTF 226 (277)
T ss_dssp TSC-------BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHH-HHHCCCCC
T ss_pred ccc-------hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHH-HHhCCCCC
Confidence 321 234579999999998865 48999999999999999999999996443211 1111 12222223
Q ss_pred Ch----hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 PI----KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|. ..+..+.+|+.+||+.+|.+||++.+.+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 32 3467899999999999999999998644
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=349.20 Aligned_cols=245 Identities=22% Similarity=0.371 Sum_probs=198.7
Q ss_pred cCCccceeeccCCcEEEEEEEECC---------eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--c
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--G 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~---------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~ 471 (757)
++|.....||+|+||.||+|.+.. ..||+|++........+.|.+|+.++++++||||++++++|.+. .
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 468888999999999999998754 46999999876666678899999999999999999999998654 4
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc--------eEE
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--------SKI 543 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~--------~KL 543 (757)
++||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 89999999999999997643 24889999999999999999999988 999999999999998887 999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCC-CCccccchhhhhhchh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDED 621 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~ 621 (757)
+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|+||. +||......
T Consensus 163 ~Dfg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------- 225 (289)
T 4fvq_A 163 SDPGISITVLPK----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------- 225 (289)
T ss_dssp CCCCSCTTTSCH----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------
T ss_pred ccCcccccccCc----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-------
Confidence 999998755321 22368899999999887 67899999999999999999954 555322211
Q ss_pred hHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 622 ~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
....... .....|...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~l~~l 273 (289)
T 4fvq_A 226 RKLQFYE-DRHQLPAPKAAELANLINNCMDYEPDHRPSFR-AIIRDLNSL 273 (289)
T ss_dssp HHHHHHH-TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHH-HHHHHHHTC
T ss_pred HHHHHhh-ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHh
Confidence 1111111 12233444567799999999999999999998 466666554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.78 Aligned_cols=255 Identities=23% Similarity=0.385 Sum_probs=200.9
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--e----EEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccCCc-eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--T----FAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~----~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~L 473 (757)
..+|...++||+|+||.||+|.+.. . .||+|.+... .......+.+|+.+|.+++||||++++++|.+.. ++
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 93 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL 93 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence 3568889999999999999999743 3 4677777543 3345678999999999999999999999986654 79
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|++|+.+|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 999999999999997654 34899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-c
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-A 631 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~ 631 (757)
..... .......||+.|+|||++.+..++.++|||||||++|+|+| |++||..... ..+...+... .
T Consensus 169 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~~~~~~ 237 (327)
T 3lzb_A 169 AEEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEKGER 237 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-------GGHHHHHHTTCC
T ss_pred Ccccc----ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHcCCC
Confidence 43221 12234567889999999999999999999999999999999 9999964322 1222333222 2
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
...+...+..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFR-ELIIEFSKMAR 278 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHHHh
Confidence 344556778899999999999999999998 57777777654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.07 Aligned_cols=242 Identities=28% Similarity=0.326 Sum_probs=192.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHH-HHhcCCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEV-LSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~i-l~~l~Hpniv~l~g~~~~~~--~L 473 (757)
..+|...+.||+|+||.||+|+.. +..||||++..... .....+.+|..+ ++.++||||++++++|.+.. ||
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 457999999999999999999986 45899999976532 233456677777 56789999999999997654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||++||+|.+++.+.+ .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999997654 4888899999999999999999988 9999999999999999999999999998643
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||++||...... ..+..++.. ...
T Consensus 191 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-~~~ 257 (373)
T 2r5t_A 191 EHNS------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNK-PLQ 257 (373)
T ss_dssp CCCC------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHS-CCC
T ss_pred cCCC------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc-ccC
Confidence 3221 224568999999999999999999999999999999999999999644321 112223322 234
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
++...+..+.+|+.+||+.+|.+||++.+
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 55567789999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.90 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=213.8
Q ss_pred CCHHHHHHhhcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeee
Q 004388 393 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLL 463 (757)
Q Consensus 393 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l 463 (757)
+..........+|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 444555566778999999999999999999852 36899999976543 3446789999999999 79999999
Q ss_pred cccccCC---ceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcC
Q 004388 464 LGACPDH---GCLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRD 527 (757)
Q Consensus 464 ~g~~~~~---~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrD 527 (757)
+++|.+. .++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 9998643 4899999999999999976543 123789999999999999999999988 99999
Q ss_pred CCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCC
Q 004388 528 MKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKP 606 (757)
Q Consensus 528 LKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~ 606 (757)
|||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|+| |..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CccceEEECCCCCEEECCCccccccccCccc----eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999876543321 12234578999999999999999999999999999999998 999
Q ss_pred CccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 607 AIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 607 Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
||........ ....+........+...+..+.+++.+||..+|.+||++. +++..|+.+..
T Consensus 250 p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~ 310 (316)
T 2xir_A 250 PYPGVKIDEE-----FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 310 (316)
T ss_dssp SSTTCCCSHH-----HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCcccchhHH-----HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHh
Confidence 9964322111 1111222222334555678899999999999999999998 57777776654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.60 Aligned_cols=264 Identities=23% Similarity=0.370 Sum_probs=211.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE------CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC----Cc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF------HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~------~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~ 471 (757)
..+|.....||+|+||.||+|.+ .+..||||++..........|.+|+.+|++++||||+++++++.. ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34588889999999999999985 467999999987766667789999999999999999999998754 34
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 89999999999999997653 34899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccch-hhhhhc--------hhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHK-VETAID--------EDN 622 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~-~~~~~~--------~~~ 622 (757)
........ .......+|+.|+|||++.+..++.++|||||||++|+|+||..||..... ...... ...
T Consensus 195 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 195 LPQDKEYY---KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CCSSCSEE---ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccccc---ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 76443211 112334678889999999888899999999999999999999999863211 100000 111
Q ss_pred HHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 623 LAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 623 l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
+...+... ....+...+..+.+|+.+||..+|.+||++. +++..|+.+.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFR-DLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHHH
Confidence 22222221 2334556778999999999999999999998 577888777653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=347.13 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=200.2
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC---CceEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~LV~Ey~ 478 (757)
..+|.....||+|+||.||+|.+.+..||||++.... ..+.|.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4578889999999999999999999999999987643 45678999999999999999999998643 348999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999875432 23788899999999999999999988 9999999999999999999999999997654321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
....+|+.|+|||++.+..++.++||||||+++|+|+| |++||...... .....+........+..
T Consensus 172 -------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~ 238 (278)
T 1byg_A 172 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDG 238 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHTTTCCCCCCTT
T ss_pred -------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhcCCCCCCccc
Confidence 22367899999999998999999999999999999998 99999643211 11112222222344556
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+..+.+++.+||+.+|.+||++. +++..|+.+..
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rps~~-~l~~~L~~i~~ 273 (278)
T 1byg_A 239 CPPAVYEVMKNCWHLDAAMRPSFL-QLREQLEHIKT 273 (278)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCChhhCCCHH-HHHHHHHHHHh
Confidence 778999999999999999999998 57777777654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=353.01 Aligned_cols=246 Identities=22% Similarity=0.281 Sum_probs=195.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.++|.....||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++++++.+.. ++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 357889999999999999999885 66999999865432 23456889999999999999999999997655 79999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999988543 34899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC-CC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG-DW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~-~~ 634 (757)
. ........||+.|+|||++.+..+ +.++|||||||++|+|+||+.||........ .+......... ..
T Consensus 160 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~ 230 (323)
T 3tki_A 160 R----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDWKEKKTYLNP 230 (323)
T ss_dssp E----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-----HHHHHHTTCTTSTT
T ss_pred c----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHHHhcccccCCc
Confidence 1 111235689999999999877765 7789999999999999999999964432211 11111111111 11
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+..+.+|+.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~e 258 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPD 258 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1345778899999999999999999885
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.77 Aligned_cols=206 Identities=24% Similarity=0.314 Sum_probs=176.9
Q ss_pred cCCCHHHHHHhhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-----CCceeee
Q 004388 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HPHLLLL 463 (757)
Q Consensus 391 ~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----Hpniv~l 463 (757)
..+++.+.....++|...++||+|+||.||+|.+ .+..||||++... ......+..|+.++..+. ||||+++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 4456666666788999999999999999999998 4668999998743 234456788999999996 9999999
Q ss_pred cccccCC--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC----
Q 004388 464 LGACPDH--GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---- 537 (757)
Q Consensus 464 ~g~~~~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---- 537 (757)
++++... .+|||||+ +++|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 9998644 48999999 8999999876543 35899999999999999999999988 999999999999975
Q ss_pred ---------------------CCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHH
Q 004388 538 ---------------------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGM 596 (757)
Q Consensus 538 ---------------------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGv 596 (757)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---------GSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC---------cCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 8899999999998654321 3457999999999999999999999999999
Q ss_pred HHHHHHhCCCCcccc
Q 004388 597 VILQLLTAKPAIAIT 611 (757)
Q Consensus 597 il~elltG~~Pf~~~ 611 (757)
++|+|+||++||...
T Consensus 248 il~ell~g~~pf~~~ 262 (360)
T 3llt_A 248 VLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHSSCSCCCS
T ss_pred HHHHHHHCCCCCCCC
Confidence 999999999999643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.33 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=204.8
Q ss_pred hcCCccce-eeccCCcEEEEEEEEC----CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eE
Q 004388 402 TLSFSENL-RIGMGGYGTVYKGTFH----HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CL 473 (757)
Q Consensus 402 t~~f~~~~-~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~L 473 (757)
...|.... .||+|+||.||+|.+. +..||||++.... ....+.|.+|+.+++.++||||+++++++.+.. ++
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l 94 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML 94 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEE
Confidence 34677766 8999999999999652 4589999987653 223567999999999999999999999995444 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 999999999999997643 4899999999999999999999988 9999999999999999999999999998776
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh-hhc
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQA 631 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld-~~~ 631 (757)
....... ......||+.|+|||++.+..++.++||||||+++|+|+| |+.||...... .+...+. ...
T Consensus 169 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~ 238 (291)
T 1xbb_A 169 ADENYYK---AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGER 238 (291)
T ss_dssp TTCSEEE---C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCC
T ss_pred cCCCccc---ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCC
Confidence 4432211 1233457899999999988889999999999999999999 99999643321 1122222 222
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhh
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 675 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~ 675 (757)
...|...+..+.+++.+||..+|.+||++. +++..|+.+-...
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 239 MGCPAGCPREMYDLMNLCWTYDVENRPGFA-AVELRLRNYYYDV 281 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHHHH
Confidence 345566788999999999999999999998 5777777765443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=364.65 Aligned_cols=247 Identities=23% Similarity=0.319 Sum_probs=200.3
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc-
Q 004388 398 IESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG- 471 (757)
Q Consensus 398 i~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~- 471 (757)
+.....+|...++||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|..++|||||+++++|.+..
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 3445678999999999999999999986 5589999986532 122345789999999999999999999997765
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
||||||++||+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+|+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 8999999999999988653 3889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCC----CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL----ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
....... ......+||+.|+|||++.+.. ++.++|||||||+||||+||++||....... .+..+
T Consensus 217 ~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i 285 (410)
T 3v8s_A 217 KMNKEGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKI 285 (410)
T ss_dssp ECCTTSE-----EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH
T ss_pred eeccCCc-----ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHH
Confidence 7654321 1224568999999999887654 8899999999999999999999997443221 22223
Q ss_pred hhhh-cCCCC--hhHHHHHHHHHHHHhhccCCC--CCccch
Q 004388 627 LDAQ-AGDWP--IKETKELAALGLSCAELRRKD--RPDLKN 662 (757)
Q Consensus 627 ld~~-~~~~p--~~~~~~l~~Li~~Cl~~~p~~--RPs~~~ 662 (757)
+... ...+| ...+..+.+|+.+||..+|.+ ||++.+
T Consensus 286 ~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~e 326 (410)
T 3v8s_A 286 MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEE 326 (410)
T ss_dssp HTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred HhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHH
Confidence 3221 12223 246788999999999999988 999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=370.18 Aligned_cols=238 Identities=25% Similarity=0.291 Sum_probs=189.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC---CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK---GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
.++|...++||+|+||.||+|... +..||||++... .......+.+|+.+|+.++||||++++++|.+.. +||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357889999999999999999975 569999998753 2233456788999999999999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|||+++|+|.+++.... .+++..+..|+.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999987654 48999999999999999999998 77 9999999999999999999999999998644
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....+||+.|+|||++.+..++.++|||||||+||+|+||+.||...... .+...+......
T Consensus 301 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~ 367 (446)
T 4ejn_A 301 KDGA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------KLFELILMEEIR 367 (446)
T ss_dssp C-----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC
T ss_pred CCCc------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCC
Confidence 3221 124568999999999999999999999999999999999999999643221 122222223344
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCC
Q 004388 634 WPIKETKELAALGLSCAELRRKDRP 658 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RP 658 (757)
.|...+..+.+|+.+||..||.+||
T Consensus 368 ~p~~~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 368 FPRTLGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTST
T ss_pred CCccCCHHHHHHHHHHcccCHHHhC
Confidence 5666788999999999999999999
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.46 Aligned_cols=261 Identities=24% Similarity=0.386 Sum_probs=209.4
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccC
Q 004388 399 ESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPD 469 (757)
Q Consensus 399 ~~at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~ 469 (757)
+....+|.....||+|+||.||+|.+.+ ..||+|++..... .....+.+|+.+|.++ +||||++++++|.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3445678889999999999999999753 3799999976543 3456789999999999 89999999999965
Q ss_pred C--ceEEEEecCCCCHHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 470 H--GCLVYEYMENGSLEDRLYRKNN-----------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 470 ~--~~LV~Ey~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
. .++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 4 4899999999999999875421 235899999999999999999999987 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 615 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~ 615 (757)
.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|+| |.+||......
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~- 273 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN- 273 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-
T ss_pred CCCeEEECccccccccccccce----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-
Confidence 9999999999999876543221 11234567899999999998999999999999999999999 99999643221
Q ss_pred hhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 616 TAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
..+...+... ....|...+..+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 274 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~~L~~~~~ 326 (333)
T 2i1m_A 274 -----SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ-QICSFLQEQAQ 326 (333)
T ss_dssp -----HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred -----HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHH-HHHHHHHHHHH
Confidence 1122222222 2234555678899999999999999999998 57777766543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.77 Aligned_cols=260 Identities=22% Similarity=0.360 Sum_probs=199.8
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
...+|.....||+|+||.||+|.+.. ..||||++.... ....+.|.+|+.++++++||||++++++|.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45678889999999999999998742 379999987543 334467899999999999999999999986532
Q ss_pred -----eEEEEecCCCCHHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 472 -----CLVYEYMENGSLEDRLYRK---NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 472 -----~LV~Ey~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
++||||+++|+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 8999999999999998542 23356999999999999999999999988 999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 622 (757)
+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|+| |.+||...... ..
T Consensus 189 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~ 258 (313)
T 3brb_A 189 ADFGLSKKIYSGDYY----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------EM 258 (313)
T ss_dssp CSCSCC--------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GH
T ss_pred eecCcceeccccccc----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH------HH
Confidence 999999876543211 11234467889999999999999999999999999999999 89999643221 11
Q ss_pred HHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 623 LAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 623 l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
...+........+...+..+.+|+.+||..+|.+||++. +++..|+.+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~l~~~L~~l~~~ 309 (313)
T 3brb_A 259 YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS-VLRLQLEKLLES 309 (313)
T ss_dssp HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHHh
Confidence 222233333445566778999999999999999999998 577777776543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=359.17 Aligned_cols=243 Identities=21% Similarity=0.281 Sum_probs=200.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
...|.....||+|+||.||+|... +..||+|++..........+.+|+.+|.+++||||++++++|.+.. ++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 457899999999999999999985 5689999998766556677899999999999999999999997654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC--CCceEEeeecCccccCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH--NLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~--~~~~KL~DFGla~~~~~~ 555 (757)
+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999886543 35899999999999999999999988 999999999999974 578999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc---C
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA---G 632 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~---~ 632 (757)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||++||........ +..+..... .
T Consensus 205 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~i~~~~~~~~~ 271 (387)
T 1kob_A 205 EI-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWEFDE 271 (387)
T ss_dssp SC-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCCCCCS
T ss_pred cc-------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCCc
Confidence 21 1234799999999999988999999999999999999999999975432211 111111110 1
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
......+..+.+|+.+||..+|.+||++.+
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 301 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 112345788999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.70 Aligned_cols=260 Identities=17% Similarity=0.201 Sum_probs=198.7
Q ss_pred hhcCCccceeeccC--CcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--e
Q 004388 401 ATLSFSENLRIGMG--GYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 401 at~~f~~~~~IG~G--~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~ 472 (757)
...+|....+||+| +||.||+|.+. +..||||++.... ......+.+|+.+|++++|||||+++++|.+.. +
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35679999999999 99999999986 6799999997543 334466888999999999999999999986554 8
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999987643 235899999999999999999999988 999999999999999999999999998755
Q ss_pred CCCCCC-ccccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--hhhHHHHh
Q 004388 553 NSDPSF-VSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--EDNLAEIL 627 (757)
Q Consensus 553 ~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--~~~l~~~l 627 (757)
...... ...........||+.|+|||++.+ ..++.++|||||||++|+|+||++||........... .+.+..++
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 432211 011111234589999999999877 5799999999999999999999999964332221110 00000000
Q ss_pred hhh-------------------------------------cCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 628 DAQ-------------------------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 628 d~~-------------------------------------~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
+.. ...++...+..+.+|+.+||+.||.+||++.+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000 0012234567899999999999999999998633
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=368.64 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=201.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEec
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYM 478 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~ 478 (757)
...+|....+||+|+||.||+|.+.+ ..||||++.... ...+.|.+|+.+|++++||||+++++++.+. .++||||+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~ 260 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 260 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhh
Confidence 34568888999999999999999975 579999997654 3456799999999999999999999998764 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.++|.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 261 ~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 261 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-
Confidence 9999999996532 134889999999999999999999988 99999999999999999999999999987653221
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
.......+|+.|+|||++.++.++.++|||||||+||||+| |+.||......+ .+..+........|..
T Consensus 336 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~~~~~ 405 (452)
T 1fmk_A 336 ----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPCPPE 405 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTT
T ss_pred ----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCC
Confidence 11233467889999999999999999999999999999999 999996432211 1122222223344566
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.+..+.+|+.+||..+|.+||++. +++..|+.+
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~-~l~~~L~~~ 438 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 438 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTT
T ss_pred CCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHH
Confidence 788999999999999999999998 465655544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=341.94 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=211.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
...+|....+||+|+||.||+|.+. +..||+|++.... ...+.|.+|+.++++++||||+++++++.+.. ++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4667899999999999999999987 5689999987543 34577999999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999987643 346899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-cCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-AGDW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~ 634 (757)
. .......+|+.|+|||++.+..++.++||||||+++|+|+| |.+||...... .+...+... ....
T Consensus 166 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-------~~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 166 Y-----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKDYRMER 233 (288)
T ss_dssp S-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GHHHHHHTTCCCCC
T ss_pred c-----ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhccCCCCC
Confidence 1 12234567889999999999999999999999999999999 99999643221 122222222 2344
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
|...+..+.+|+.+||..+|.+||++. ++++.|+.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~-~~~~~l~~~~~ 271 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETMFQ 271 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHH-HHHHHHHHHHH
Confidence 556778999999999999999999998 57777776654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=359.45 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=195.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC---C--eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccC---CceE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH---H--TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~---~--~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~L 473 (757)
..|.....||+|+||.||+|.+. + ..||||.+.... ......|.+|+.+|++++||||++++++|.+ ..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 34667789999999999999863 2 368999886543 3455779999999999999999999998743 3489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999996543 35889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
..... .........+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+ ....+......
T Consensus 244 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~------~~~~~~~~~~~ 315 (373)
T 3c1x_A 244 DKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITVYLLQGRRL 315 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC------HHHHHHTTCCC
T ss_pred ccccc--cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH------HHHHHHcCCCC
Confidence 33211 1112244578899999999999999999999999999999999 778886432211 11222222233
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..|...+..+.+++.+||..+|.+||++. +++..|+.+...
T Consensus 316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~-ell~~L~~i~~~ 356 (373)
T 3c1x_A 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFST 356 (373)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHHh
Confidence 34556778899999999999999999998 577777766543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=372.33 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=205.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
.++|...+.||+|+||.||+|++. +..||||++.... ......+.+|+.+|.+++||||++++++|.+.. |||
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 357888899999999999999985 6799999986542 223467889999999999999999999987654 899
Q ss_pred EEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 475 YEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|||++||+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876432 346999999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....+||+.|+|||++.+..++.++|||||||++|||+||++||....... ....+...+......
T Consensus 341 ~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~---~~~~~~~~i~~~~~~ 411 (543)
T 3c4z_A 341 AGQT------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV---ENKELKQRVLEQAVT 411 (543)
T ss_dssp TTCC------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC---CHHHHHHHHHHCCCC
T ss_pred CCCc------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch---hHHHHHHHHhhcccC
Confidence 4321 1234589999999999999899999999999999999999999996432110 111122222223345
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+|...+..+.+|+.+||..+|.+||++.+
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 440 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRD 440 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBT
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcc
Confidence 66777899999999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=379.52 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=199.6
Q ss_pred eeccCCcEEEEEEEEC----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecCCCCH
Q 004388 410 RIGMGGYGTVYKGTFH----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENGSL 483 (757)
Q Consensus 410 ~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~~gsL 483 (757)
+||+|+||.||+|.+. +..||||+++... ....+.|.+|+.+|++++|||||+++++|.+.. +|||||+++|+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999873 3479999997653 335678999999999999999999999996544 899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccc
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~ 563 (757)
.++|.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+........
T Consensus 423 ~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~--- 494 (613)
T 2ozo_A 423 HKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT--- 494 (613)
T ss_dssp HHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee---
Confidence 99986543 45899999999999999999999988 99999999999999999999999999987654332111
Q ss_pred cccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHH
Q 004388 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642 (757)
Q Consensus 564 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l 642 (757)
......+|+.|+|||++.++.++.++|||||||+||||+| |+.||......+ .+..+........|...+..+
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~~~~l 568 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECPPECPPEL 568 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHHHTTCCCCCCTTCCHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCCCCCcCCHHH
Confidence 1123356789999999999999999999999999999998 999996433211 112222222345566778999
Q ss_pred HHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 643 AALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 643 ~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.+|+.+||..+|.+||++. +|+..|+.+...
T Consensus 569 ~~li~~cl~~dP~~RPs~~-~l~~~L~~~~~~ 599 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFL-TVEQRMRACYYS 599 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHH-HHHHHHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHH-HHHHHHHHHHHH
Confidence 9999999999999999998 577777666443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.33 Aligned_cols=243 Identities=28% Similarity=0.368 Sum_probs=199.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
+..+|.....||+|+||.||+|.+.. ..||||++.... ......+.+|+.++++++||||++++++|.+.. ++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45678999999999999999999864 489999986532 223456889999999999999999999997655 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999987654 4889999999999999999999987 9999999999999999999999999986544
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+......
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~ 225 (279)
T 3fdn_A 161 SSR--------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFT 225 (279)
T ss_dssp ---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHHTCCC
T ss_pred ccc--------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHHHhCCCC
Confidence 321 134579999999999998899999999999999999999999996433211 11222223344
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.|...+..+.+|+.+||..+|.+||++.+++
T Consensus 226 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 256 (279)
T 3fdn_A 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVL 256 (279)
T ss_dssp CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCcCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 5666778899999999999999999998533
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=348.91 Aligned_cols=268 Identities=24% Similarity=0.369 Sum_probs=196.1
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHH--HhcCCCceeeeccccc-----CC--ce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVL--SKIRHPHLLLLLGACP-----DH--GC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il--~~l~Hpniv~l~g~~~-----~~--~~ 472 (757)
.++|.....||+|+||.||+|.+.+..||||++.... ...+..|.+++ ..++||||+++++++. +. .+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 3578889999999999999999999999999987542 34455555554 4589999999997542 21 27
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC------CCEEEcCCCCCCeeecCCCceEEeee
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP------KPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
+||||+++|+|.+++.... +++..+..|+.||+.||.|||+..+ .+|+||||||+||||+.++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 9999999999999996543 5888999999999999999999810 13999999999999999999999999
Q ss_pred cCccccCCCCCCc--cccccccCCcccccCCCcccccc-------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhh-
Q 004388 547 GLSTMLNSDPSFV--STTYKNTGPVGTLCYIDPEYQRT-------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVET- 616 (757)
Q Consensus 547 Gla~~~~~~~~~~--~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~- 616 (757)
|+++.+....... ..........||+.|+|||++.+ ..++.++|||||||++|||+||..||........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9998775432111 11122234579999999998876 4567789999999999999999777642211100
Q ss_pred --h----h----chhhHHHHhhhh--cCCCC------hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhhc
Q 004388 617 --A----I----DEDNLAEILDAQ--AGDWP------IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADR 677 (757)
Q Consensus 617 --~----~----~~~~l~~~ld~~--~~~~p------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~~ 677 (757)
. . ....+...+... ....| ...+..+.+|+.+||+.+|.+||++. +++..|+.+.....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~-e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQ-XAEERMAELMMIWER 322 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHH-HHHHHHHHHHHCCCC
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchH-HHHHHHHHHHHHHHh
Confidence 0 0 000111111111 11111 23667899999999999999999998 577777777655443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=357.07 Aligned_cols=241 Identities=22% Similarity=0.292 Sum_probs=193.6
Q ss_pred ccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecCCC
Q 004388 406 SENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENG 481 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~~g 481 (757)
.....||+|+||.||+|... +..||+|++........+.|.+|+.+|.+++||||++++++|.+.. +|||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33567999999999999875 6699999998776666778999999999999999999999997654 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee--cCCCceEEeeecCccccCCCCCCc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL--DHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl--d~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 9999887543 34899999999999999999999988 9999999999999 5678999999999987654321
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC---CCh
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD---WPI 636 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~---~p~ 636 (757)
.....||+.|+|||++.++.++.++|||||||++|+|+||+.||....... .+..++...... ...
T Consensus 245 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~ 313 (373)
T 2x4f_A 245 -----LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILACRWDLEDEEFQ 313 (373)
T ss_dssp -----CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCSCSGGGT
T ss_pred -----cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCCCChhhhc
Confidence 133479999999999998899999999999999999999999996543221 222222221111 012
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..+.+|+.+||..+|.+||++.+.+
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 3568899999999999999999998644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.55 Aligned_cols=237 Identities=24% Similarity=0.290 Sum_probs=187.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|....+||+|+||.||+|.+. +..||||++..... .....+..|+..+.++ +||||++++++|.+.. +|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999985 67999999865432 2334556677666665 8999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+ +|+|.+++...+ ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 679999887654 35999999999999999999999988 999999999999999999999999999876533
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-CCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~~ 634 (757)
.. .....||+.|+|||++.+ .++.++|||||||++|||+||..|+....... .+..... ..+
T Consensus 211 ~~-------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---------~~~~~~~~~~~ 273 (311)
T 3p1a_A 211 GA-------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---------QLRQGYLPPEF 273 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---------HHTTTCCCHHH
T ss_pred CC-------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------HHhccCCCccc
Confidence 21 234579999999998875 78999999999999999999976654322111 1111100 011
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+...+..+.+|+.+||+.+|.+||++.+
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e 301 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEA 301 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 2234678999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.03 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=197.2
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC-----CchhhHHHHHHHHHHHhcCCCceeeecccccC
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK-----GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 469 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~-----~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~ 469 (757)
++....++|.....||+|+||.||+|.+. +..||+|++... .....+.+.+|+.+|++++||||++++++|.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35566778999999999999999999885 458999998643 23345679999999999999999999999976
Q ss_pred Cc--eEEEEecCCCCHHHHHhhcC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 004388 470 HG--CLVYEYMENGSLEDRLYRKN-------------------------------------NTPPIPWFERYRIAWEVAS 510 (757)
Q Consensus 470 ~~--~LV~Ey~~~gsL~~~L~~~~-------------------------------------~~~~l~~~~~~~i~~qia~ 510 (757)
.. ++||||++||+|.+++.... ....+++..+..|+.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 65 89999999999999885210 0112356677889999999
Q ss_pred HHHHHhhCCCCCEEEcCCCCCCeeecCCC--ceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc--CCCC
Q 004388 511 ALAFLHNTKPKPIIHRDMKPGNILLDHNL--VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLIS 586 (757)
Q Consensus 511 aL~~LH~~~~~~ivHrDLKp~NILld~~~--~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s 586 (757)
||.|||+.+ |+||||||+||||+.++ .+||+|||+++.+...... ..+......||+.|+|||++.+ ..++
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG--EYYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC----------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCcc--ccccccccCCCccccCchhhccCCCCCC
Confidence 999999988 99999999999998776 8999999999876432211 1112345689999999998865 6789
Q ss_pred CcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC-CCC--hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 587 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG-DWP--IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 587 ~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~-~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.++|||||||++|+|+||+.||....... .+..++..... ..+ ...+..+.+|+.+||+.+|.+||++.++
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 99999999999999999999996443221 22223322211 111 1356889999999999999999999853
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=339.62 Aligned_cols=256 Identities=22% Similarity=0.324 Sum_probs=203.0
Q ss_pred CCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC--c-eEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--G-CLV 474 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~-~LV 474 (757)
.|...++||+|+||.||+|.+.. ..+|+|++..... ...+.|.+|+.++++++||||+++++++.+. . ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45666889999999999998632 2799999875433 3457789999999999999999999998543 2 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+.+|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999986533 45899999999999999999999988 99999999999999999999999999986643
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCC-CCccccchhhhhhchhhHHHHhh-hhcC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNLAEILD-AQAG 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~l~~~ld-~~~~ 632 (757)
... ..........||+.|+|||.+.+..++.++|||||||++|+|+||. +||..... ..+...+. ....
T Consensus 177 ~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-------~~~~~~~~~~~~~ 247 (298)
T 3pls_A 177 REY--YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-------FDLTHFLAQGRRL 247 (298)
T ss_dssp GGG--GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-------GGHHHHHHTTCCC
T ss_pred Ccc--cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-------HHHHHHhhcCCCC
Confidence 221 1111234457899999999999999999999999999999999954 55542221 11122222 2223
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+...+..+.+++.+||..+|.+||++. +++..|+.+...
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFR-VLVGEVEQIVSA 288 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHHH
Confidence 34555678899999999999999999998 577777776554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.16 Aligned_cols=249 Identities=23% Similarity=0.241 Sum_probs=198.9
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG 471 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~ 471 (757)
++....++|...+.||+|+||.||+|+.. +..||||++..... .....+.+|+.+|..++||||++++++|.+..
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 34445678999999999999999999985 67999999975321 12344789999999999999999999997655
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 472 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
||||||++||+|.+++.+.+. .+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|++||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 899999999999999976542 4899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccc-------cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-------TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 622 (757)
+....... ......+||+.|+|||++. .+.++.++|||||||++|||+||++||......+ .
T Consensus 210 ~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~ 278 (412)
T 2vd5_A 210 LKLRADGT-----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------T 278 (412)
T ss_dssp EECCTTSC-----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H
T ss_pred eeccCCCc-----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------H
Confidence 87654322 1223468999999999886 4568999999999999999999999996543222 1
Q ss_pred HHHHhhhh----cCCCChhHHHHHHHHHHHHhhccCCCCC---ccch
Q 004388 623 LAEILDAQ----AGDWPIKETKELAALGLSCAELRRKDRP---DLKN 662 (757)
Q Consensus 623 l~~~ld~~----~~~~p~~~~~~l~~Li~~Cl~~~p~~RP---s~~~ 662 (757)
+..++... ....+...+..+.+|+.+||. +|.+|+ ++.+
T Consensus 279 ~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~e 324 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324 (412)
T ss_dssp HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHH
T ss_pred HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 22222211 111223567899999999999 999985 5553
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=379.67 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=198.6
Q ss_pred eeeccCCcEEEEEEEEC----CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecCCC
Q 004388 409 LRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 481 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~~g 481 (757)
++||+|+||.||+|.+. +..||||+++.... ...+.|.+|+.+|.+++|||||+++++|.+.. +|||||+++|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999662 35899999976432 33578999999999999999999999996554 7999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+........
T Consensus 455 ~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 527 (635)
T 4fl3_A 455 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK- 527 (635)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc-
Confidence 9999996543 4899999999999999999999988 99999999999999999999999999987764432111
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~ 640 (757)
......||+.|+|||++.+..++.++|||||||+||||+| |+.||......+ ....+........|...+.
T Consensus 528 --~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~~~ 599 (635)
T 4fl3_A 528 --AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGCPAGCPR 599 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCCCTTCCH
T ss_pred --cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCCCCCCH
Confidence 1234467899999999999999999999999999999998 999996443211 1122222223455667789
Q ss_pred HHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 641 ELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 641 ~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.+.+|+.+||..+|.+||++. .|+..|+.+.
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~-~l~~~L~~~~ 630 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFA-AVELRLRNYY 630 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHH
Confidence 999999999999999999998 4666666553
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=363.12 Aligned_cols=247 Identities=19% Similarity=0.235 Sum_probs=188.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
..+|...++||+|+||.||+|.+. +..||||++... .......+.+|+.+|+.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467889999999999999999875 679999998754 233456788999999999999999999998543
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.||||||+++ +|.+.+.. .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 2899999975 46666632 3889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------- 620 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------- 620 (757)
+...... ..+..+||+.|+|||++.+..|+.++|||||||+||+|++|++||...+........
T Consensus 212 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 212 RTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp -----CC-------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred eecCCCc-------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 8765322 224568999999999999999999999999999999999999999754332211000
Q ss_pred -------hhHHHHhhhhc--CCC------C-----------hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 -------DNLAEILDAQA--GDW------P-----------IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 -------~~l~~~ld~~~--~~~------p-----------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
......+.... ... | ...+..+.+|+.+||..||.+||++.+.+
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00011111000 000 0 01267899999999999999999998533
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=339.10 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=198.1
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
.|.....||+|+||.||+|.+. +..||||++........+.+.+|+.+++.++||||+++++++.+.. ++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 3455568999999999999984 5689999998766666678999999999999999999999996554 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecCccccCCCCCC
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGla~~~~~~~~~ 558 (757)
+|+|.+++........+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~- 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP- 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence 9999999987655556788899999999999999999988 999999999999987 89999999999987653221
Q ss_pred ccccccccCCcccccCCCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
......||+.|+|||++.++. ++.++||||||+++|+|+||+.||.......... ............|.
T Consensus 179 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 179 -----CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM----FKVGMFKVHPEIPE 249 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH----HHHHHHCCCCCCCT
T ss_pred -----cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH----Hhhccccccccccc
Confidence 113457999999999887653 7899999999999999999999996432211111 11111122234556
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..+.+|+.+||..+|.+||++.+++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 6788999999999999999999998533
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.25 Aligned_cols=245 Identities=20% Similarity=0.308 Sum_probs=190.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.+|....+||+|+||.||+|... +..||+|++..... .....+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 36888899999999999999985 67999999875432 23467889999999999999999999996544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 9999886543 35899999999999999999999988 99999999999999999999999999987653221
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh--------
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD-------- 628 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld-------- 628 (757)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||.......... .+...+.
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWP 226 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTST
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhch
Confidence 1234578999999998865 458999999999999999999999997543222110 0000000
Q ss_pred ---------hhcC--------CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 ---------AQAG--------DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ---------~~~~--------~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+... ......+..+.+|+.+||+.||.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 277 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 0000 001235678899999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.04 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=199.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.++|.....||+|+||.||+|.+. +..||+|++.... ......+.+|+.++++++||||+++++++.+.. ++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999886 5699999987543 234467889999999999999999999997655 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc---eEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV---SKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~---~KL~DFGla~~~ 552 (757)
||+++|+|.+.+.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999887654 4899999999999999999999988 999999999999976654 999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... +...+.....
T Consensus 159 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~ 224 (284)
T 3kk8_A 159 NDSEA-------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAY 224 (284)
T ss_dssp CSSCB-------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCC
T ss_pred ccCcc-------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccc
Confidence 54321 234579999999999999999999999999999999999999996432211 1111111111
Q ss_pred CCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 633 DWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 633 ~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+| ...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (284)
T 3kk8_A 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260 (284)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 222 24568899999999999999999998633
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.26 Aligned_cols=243 Identities=25% Similarity=0.315 Sum_probs=184.4
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
...+.|.....||+|+||.||+|.+. +..||||++.... ..+.+.+|+.+|.+++||||++++++|.+.. ++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34567999999999999999999986 4589999997643 3456889999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~DFGla~~~ 552 (757)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999986543 4899999999999999999999988 999999999999975 899999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA- 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~- 631 (757)
.... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ .+..++....
T Consensus 202 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~~ 269 (349)
T 2w4o_A 202 EHQV-------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEYY 269 (349)
T ss_dssp ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCCC
T ss_pred Cccc-------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCCc
Confidence 5322 12345799999999999988999999999999999999999999964322111 1122222111
Q ss_pred --CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 --GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 --~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+....+..+.+|+.+||..||.+||++.+
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQ 302 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1222356788999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=344.83 Aligned_cols=245 Identities=24% Similarity=0.381 Sum_probs=182.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
..+|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++.+.. ++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356888899999999999999875 66999999875532 34467889999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 477 YMENGSLEDRLYRKN---NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 477 y~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|++ |+|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886532 2235899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh--
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-- 630 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-- 630 (757)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||........ +..+++..
T Consensus 160 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~~~~ 227 (317)
T 2pmi_A 160 IPVN------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ------LKLIFDIMGT 227 (317)
T ss_dssp SCCC------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHHHCS
T ss_pred CCcc------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHHHhCC
Confidence 3321 1234578999999998876 4689999999999999999999999974432211 11111000
Q ss_pred -------------------------------cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 -------------------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 -------------------------------~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+...+..+.+|+.+||+.||.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 290 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHH
Confidence 00001134568999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=347.99 Aligned_cols=264 Identities=22% Similarity=0.306 Sum_probs=191.1
Q ss_pred HHHhhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeeccccc------
Q 004388 398 IESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACP------ 468 (757)
Q Consensus 398 i~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~------ 468 (757)
+.....+|...++||+|+||.||+|.+ .+..||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 334456799999999999999999998 46799999987766666778999999999996 999999999882
Q ss_pred --CC--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEe
Q 004388 469 --DH--GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544 (757)
Q Consensus 469 --~~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~ 544 (757)
+. .++||||+. |+|.+++.......++++..+..|+.||+.||.|||+.+ .+|+||||||+||||+.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence 22 279999996 799998876444456999999999999999999999976 359999999999999999999999
Q ss_pred eecCccccCCCCCCccc------cccccCCcccccCCCcccc---ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 004388 545 DVGLSTMLNSDPSFVST------TYKNTGPVGTLCYIDPEYQ---RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615 (757)
Q Consensus 545 DFGla~~~~~~~~~~~~------~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 615 (757)
|||++............ ........||+.|+|||++ .+..++.++|||||||++|+|+||+.||......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~- 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL- 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence 99999877654321110 0111245699999999988 5667899999999999999999999999633211
Q ss_pred hhhchhhHHHHhhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 616 TAIDEDNLAEILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.++.... ...+...+..+.+|+.+||+.+|.+||++. +++..|+.+...
T Consensus 260 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-e~l~~l~~~~~~ 309 (337)
T 3ll6_A 260 ---------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA-EVVHQLQEIAAA 309 (337)
T ss_dssp ---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred ---------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHhc
Confidence 1111111 111223345689999999999999999998 577777776553
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.25 Aligned_cols=261 Identities=19% Similarity=0.253 Sum_probs=192.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCCch-----------hhHHHHHHHHHHHhcCCCceeeecc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKGNI-----------QNKQFLQELEVLSKIRHPHLLLLLG 465 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~~~-----------~~~~f~~Ev~il~~l~Hpniv~l~g 465 (757)
..+|.....||+|+||.||+|.+. +..+|||++...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356889999999999999999985 358999998765322 1234678899999999999999999
Q ss_pred cccC----C--ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC
Q 004388 466 ACPD----H--GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 539 (757)
Q Consensus 466 ~~~~----~--~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~ 539 (757)
++.+ . .++||||+ +++|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9854 2 38999999 999999987654 5899999999999999999999988 99999999999999887
Q ss_pred --ceEEeeecCccccCCCCCCc-cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhh
Q 004388 540 --VSKIGDVGLSTMLNSDPSFV-STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616 (757)
Q Consensus 540 --~~KL~DFGla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~ 616 (757)
.+||+|||+++.+....... ..........||+.|+|||++.+..++.++|||||||++|+|+||+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 99999999998765332111 111122456899999999999988999999999999999999999999953211111
Q ss_pred hh--chhhHHHHhhhhcCCC--ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 617 AI--DEDNLAEILDAQAGDW--PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 617 ~~--~~~~l~~~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
.. ....+...+......+ +...+..+.+++.+||..+|.+||++. +|+..|+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~l~~~L~~ 325 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQ-ALKKILNP 325 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHH-HHHHHHCT
T ss_pred HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHH-HHHHHHhc
Confidence 00 0000000000000000 114567899999999999999999998 46666654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=358.02 Aligned_cols=257 Identities=19% Similarity=0.270 Sum_probs=204.5
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV~ 475 (757)
..|....+||+|+||.||+|.+. +..||||++.... ....+.+.+|+++|++++||||+++++++.+. .++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888999999999999999986 6799999997543 23456788999999999999999999998543 38999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee----cCCCceEEeeecCccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGDVGLSTM 551 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl----d~~~~~KL~DFGla~~ 551 (757)
||+++|+|.+++........+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976655555999999999999999999999988 9999999999999 7888899999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCcccccc--------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
..... ......||+.|+|||++.. ..++.++|||||||++|+|+||+.||........ ....+
T Consensus 166 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~ 236 (396)
T 4eut_A 166 LEDDE-------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVM 236 (396)
T ss_dssp CCCGG-------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHH
T ss_pred ccCCC-------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHH
Confidence 65432 1234579999999998764 5678899999999999999999999963221111 11112
Q ss_pred HHHhhhhc------------------------CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 624 AEILDAQA------------------------GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 624 ~~~ld~~~------------------------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
..++.... ...+......+.+++.+||+.||.+||++.+ ++..++.+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e-~l~~l~~il 308 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ-FFAETSDIL 308 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH-HHHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH-HHHHHHHHh
Confidence 22222110 1123467788999999999999999999984 555555443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=371.68 Aligned_cols=245 Identities=23% Similarity=0.359 Sum_probs=204.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
.++|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|.+++|||||++++++.+.. |||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 457899999999999999999985 6699999986532 223456889999999999999999999997654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||++||+|.+++...+ ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999887644 235899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ....+||+.|+|||++.+..++.++|||||||++|||+||++||...... .....+...+......+
T Consensus 339 ~~~-------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~---~~~~~i~~~i~~~~~~~ 408 (576)
T 2acx_A 339 GQT-------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK---IKREEVERLVKEVPEEY 408 (576)
T ss_dssp TCC-------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC---CCHHHHHHHHHHCCCCC
T ss_pred Ccc-------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc---hhHHHHHHHhhcccccC
Confidence 321 13458999999999999889999999999999999999999999743221 11122333333444556
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
|...+..+.+|+.+||..||.+||+.
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCC
Confidence 67778999999999999999999943
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.85 Aligned_cols=244 Identities=24% Similarity=0.331 Sum_probs=202.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|...+.||+|+||.||+|.+. +..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.. ++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356888899999999999999986 5689999987542 234567889999999999999999999997654 799
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999886643 4899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ......||+.|+|||++.+..++.++||||||+++|+|+||+.||......+. +..+ .......
T Consensus 168 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~~ 234 (294)
T 2rku_A 168 DGE------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRI-KKNEYSI 234 (294)
T ss_dssp TTC------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH-HTTCCCC
T ss_pred Ccc------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-hhccCCC
Confidence 221 12345799999999999888899999999999999999999999964432211 1111 1122334
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 264 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELL 264 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 556678899999999999999999998643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=338.83 Aligned_cols=239 Identities=23% Similarity=0.340 Sum_probs=196.7
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.++..+ +||||+++++++.+.. ++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457889999999999999999985 6799999987542 33456788999999999 8999999999986544 899
Q ss_pred EEecCCCCHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---------------
Q 004388 475 YEYMENGSLEDRLYRKNN-TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN--------------- 538 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~-~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~--------------- 538 (757)
|||+++|+|.+++..... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999976421 245899999999999999999999988 9999999999999844
Q ss_pred ----CceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccch
Q 004388 539 ----LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHK 613 (757)
Q Consensus 539 ----~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~ 613 (757)
+.+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-
T ss_pred cCCceEEEEcccccccccCCc----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-
Confidence 47999999999876542 223699999999988765 56689999999999999999998774322
Q ss_pred hhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 614 VETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+........|...+..+.+|+.+||+.+|.+||++.+
T Consensus 236 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 276 (289)
T 1x8b_A 236 --------QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMA 276 (289)
T ss_dssp --------HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred --------HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHH
Confidence 12223333344556667889999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=364.06 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=200.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||+++++++.+.. ++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46888899999999999999985 6799999987542 123467899999999999999999999986554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 96 E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 999999999998653 34899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.. ....+||+.|+|||++.+..+ +.++|||||||++|+|+||+.||...+... .+..+.+ .....
T Consensus 170 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~-~~~~~ 235 (476)
T 2y94_A 170 EF-------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICD-GIFYT 235 (476)
T ss_dssp CC-------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHHT-TCCCC
T ss_pred cc-------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhc-CCcCC
Confidence 21 234589999999999887765 689999999999999999999997443211 1122222 22334
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|...+..+.+|+.+||..||.+||++.+.+
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil 265 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIR 265 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 555678899999999999999999998533
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.29 Aligned_cols=243 Identities=21% Similarity=0.290 Sum_probs=191.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|...++||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999985 56899999875432 33467889999999999999999999986554 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++ +|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 6666665433 35899999999999999999999988 9999999999999999999999999998765332
Q ss_pred CCccccccccCCcccccCCCccccccCC-CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh----c
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ----A 631 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~----~ 631 (757)
. ......||+.|+|||++.+.. ++.++|||||||++|+|+||..||......... +..+.... .
T Consensus 156 ~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-----~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-----LKRIFRLLGTPTE 224 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-----HHHHHHHHCCCCT
T ss_pred c------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-----HHHHHHHhCCCCh
Confidence 1 124458899999999887665 899999999999999999988776422221111 11111100 0
Q ss_pred C------------------------CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 G------------------------DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~------------------------~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ......+..+.+|+.+||+.||.+||++.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 279 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHH
Confidence 0 111235678999999999999999999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.62 Aligned_cols=241 Identities=20% Similarity=0.265 Sum_probs=199.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch------hhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI------QNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
.+.|.....||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+|.+++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888999999999999999985 569999998754322 3567999999999999999999999997654
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC----ceEEeeec
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVG 547 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~----~~KL~DFG 547 (757)
++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 8999999999999998653 35899999999999999999999988 99999999999999887 79999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
++........ .....||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .+..+.
T Consensus 165 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~ 231 (321)
T 2a2a_A 165 LAHEIEDGVE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANIT 231 (321)
T ss_dssp TCEECCTTCC-------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH
T ss_pred cceecCcccc-------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH
Confidence 9987654321 134579999999999998999999999999999999999999996433211 111111
Q ss_pred hhhcCCCCh----hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~~~~~p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....++. ..+..+.+|+.+||..+|.+||++.+
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 269 (321)
T 2a2a_A 232 -SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269 (321)
T ss_dssp -TTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHH
T ss_pred -hcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 11122222 34678999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=353.52 Aligned_cols=254 Identities=21% Similarity=0.309 Sum_probs=185.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcC-CCceeeecccccC----Cc
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD----HG 471 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~----~~ 471 (757)
...+|....+||+|+||.||+|.+. +..||||++... .......+.+|+.+|..+. ||||+++++++.. ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 3567899999999999999999875 669999998643 2334566889999999997 9999999999853 23
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
|+||||++ |+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 89999997 6899988653 4889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCc---------------cccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 004388 552 LNSDPSFV---------------STTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615 (757)
Q Consensus 552 ~~~~~~~~---------------~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 615 (757)
+....... ......+..+||+.|+|||++.+ ..++.++||||||||||||+||++||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 64321100 01112345689999999998876 678999999999999999999999997543322
Q ss_pred hhhch-----------------h---hHHHHhhhhc----C----------------CCChhHHHHHHHHHHHHhhccCC
Q 004388 616 TAIDE-----------------D---NLAEILDAQA----G----------------DWPIKETKELAALGLSCAELRRK 655 (757)
Q Consensus 616 ~~~~~-----------------~---~l~~~ld~~~----~----------------~~p~~~~~~l~~Li~~Cl~~~p~ 655 (757)
..... . .+...+.... . ..+...+..+.+|+.+||..||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 11000 0 0000000000 0 00113456899999999999999
Q ss_pred CCCccch
Q 004388 656 DRPDLKN 662 (757)
Q Consensus 656 ~RPs~~~ 662 (757)
+||++.+
T Consensus 319 ~R~t~~e 325 (388)
T 3oz6_A 319 KRISAND 325 (388)
T ss_dssp GSCCHHH
T ss_pred cCCCHHH
Confidence 9999885
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=337.69 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=178.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|.....||+|+||.||+|.. .+..||||++.... ......+.+|+.++.+++||||+++++++.+.. ++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999997 46799999986532 122467899999999999999999999997655 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++++|.+++.... .++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999986543 45899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ......||+.|+|||++.+..++.++||||||+++|+|+||++||........ +..+.. .....
T Consensus 165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~~~ 231 (278)
T 3cok_A 165 PHE------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVVL-ADYEM 231 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-SCCCC
T ss_pred CCC------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHhh-cccCC
Confidence 221 11235789999999999988899999999999999999999999964322111 111111 11234
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
|...+..+.+|+.+||..+|.+||++.+
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ 259 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSS 259 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHH
Confidence 5556788999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.94 Aligned_cols=252 Identities=14% Similarity=0.107 Sum_probs=200.3
Q ss_pred HhhcCCccceeeccCCcEEEEEEE-------ECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC---CCceeeecccccC
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGT-------FHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR---HPHLLLLLGACPD 469 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~-------~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~---Hpniv~l~g~~~~ 469 (757)
....+|....+||+|+||.||+|. ..+..||||++... ....+..|+.++.+++ ||||+.+++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345678889999999999999994 24668999999764 3456888888888887 9999999999854
Q ss_pred --CceEEEEecCCCCHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC--------
Q 004388 470 --HGCLVYEYMENGSLEDRLYRKN--NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-------- 537 (757)
Q Consensus 470 --~~~LV~Ey~~~gsL~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-------- 537 (757)
..+|||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ ||||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 4489999999999999997532 2346999999999999999999999988 999999999999998
Q ss_pred ---CCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchh
Q 004388 538 ---NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKV 614 (757)
Q Consensus 538 ---~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~ 614 (757)
++.+||+|||+|+.+..... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPK----GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCT----TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccCCEEEeeCchhhhhhccCC----CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999976542211 11234568999999999999999999999999999999999999999643221
Q ss_pred hhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 615 ETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 615 ~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
... +....... .....+.+++..|+..+|.+||+..+.+...|+.+.
T Consensus 292 ~~~---------~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 292 ECK---------PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp EEE---------ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred cee---------echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 110 11111111 236678899999999999999776656666665543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=351.47 Aligned_cols=246 Identities=21% Similarity=0.265 Sum_probs=188.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.++|...++||+|+||.||++... +..||||++..... ....+.+|+.+++.++||||+++++++.+.. ++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457899999999999999999985 56999999975433 3466889999999999999999999986554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc--eEEeeecCccccCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--SKIGDVGLSTMLNSD 555 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~--~KL~DFGla~~~~~~ 555 (757)
+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999987654 4899999999999999999999988 999999999999987765 999999999753322
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCc-chhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPK-SDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~k-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
. ......||+.|+|||++.+..++.+ +|||||||++|+|+||++||......... ...+..++... ...
T Consensus 172 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~-~~~ 241 (361)
T 3uc3_A 172 S-------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVK-YSI 241 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTC-CCC
T ss_pred C-------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCC-CCC
Confidence 1 1234579999999999988777655 89999999999999999999643321110 11112222211 122
Q ss_pred C--hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 P--IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
| ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 242 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell 273 (361)
T 3uc3_A 242 PDDIRISPECCHLISRIFVADPATRISIPEIK 273 (361)
T ss_dssp CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCcCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 2 23578899999999999999999998533
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=338.77 Aligned_cols=263 Identities=20% Similarity=0.238 Sum_probs=200.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeeccccc---CCceEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP---DHGCLVY 475 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~---~~~~LV~ 475 (757)
..++|.....||+|+||.||+|.+ .+..||||++..... ...+.+|+.++..++|++++..+++|. +..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346799999999999999999996 467999998765432 235788999999999998888877763 2338999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---cCCCceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl---d~~~~~KL~DFGla~~~ 552 (757)
||+ +|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 999999987543 34899999999999999999999988 9999999999999 78999999999999877
Q ss_pred CCCCCCcccc-ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 553 NSDPSFVSTT-YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 553 ~~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
.......... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~ 235 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK---RQKYERISEKKM 235 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS---SSHHHHHHHHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhh---hhhhhhhhcccc
Confidence 6543221111 123456899999999999999999999999999999999999999974322111 011111111110
Q ss_pred CC----CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhh
Q 004388 632 GD----WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 675 (757)
Q Consensus 632 ~~----~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~ 675 (757)
.. .....+..+.+|+.+||+.+|.+||++. +++..|+.+....
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLFHRQ 282 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH-HHHHHHHHHHHHH
T ss_pred cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHH-HHHHHHHHHHHHh
Confidence 00 1122357899999999999999999998 5777777765543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=341.70 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=193.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC-----chhhHHHHHHHHHHHhcC---CCceeeecccccCC
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-----NIQNKQFLQELEVLSKIR---HPHLLLLLGACPDH 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~-----~~~~~~f~~Ev~il~~l~---Hpniv~l~g~~~~~ 470 (757)
.+.+|....+||+|+||.||+|.+ .+..||||++.... ......+.+|+.+++++. ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 456899999999999999999996 46799999986432 112346778888887775 99999999998542
Q ss_pred -------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEE
Q 004388 471 -------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKI 543 (757)
Q Consensus 471 -------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL 543 (757)
.++||||+. |+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 379999997 699998876443 34899999999999999999999988 999999999999999999999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||++||........ +
T Consensus 162 ~Dfg~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~------~ 228 (308)
T 3g33_A 162 ADFGLARIYSYQMA-------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ------L 228 (308)
T ss_dssp CSCSCTTTSTTCCC-------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH------H
T ss_pred eeCccccccCCCcc-------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------H
Confidence 99999987653321 2345799999999999999999999999999999999999999965433221 1
Q ss_pred HHHhhhh----cCCCC----------------------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILDAQ----AGDWP----------------------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld~~----~~~~p----------------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..++... ...|+ ...+..+.+|+.+||+.||.+||++.+
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 293 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHH
Confidence 1111110 01111 134678999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=344.37 Aligned_cols=266 Identities=24% Similarity=0.373 Sum_probs=205.5
Q ss_pred CCHHHHHHhhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHh--cCCCceeeecccccCC
Q 004388 393 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSK--IRHPHLLLLLGACPDH 470 (757)
Q Consensus 393 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~--l~Hpniv~l~g~~~~~ 470 (757)
..+.--.....+|.....||+|+||.||+|.+.+..||||++... ....+.+|++++.. ++||||+++++++.+.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 344444455678999999999999999999999999999998653 34567889999987 7899999999998543
Q ss_pred ------ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh--------hCCCCCEEEcCCCCCCeeec
Q 004388 471 ------GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH--------NTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 471 ------~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivHrDLKp~NILld 536 (757)
.++||||+++|+|.+++... .+++..+..++.||+.||.||| +.+ |+||||||+||||+
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 48999999999999999653 4899999999999999999999 655 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCC------CCCcchhhhHHHHHHHHHhC------
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTA------ 604 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~------~s~ksDvwSlGvil~elltG------ 604 (757)
.++.+||+|||++.......... ........||+.|+|||++.+.. ++.++|||||||++|+|+||
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEE--EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred CCCCEEEEECCCceecccccccc--ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 99999999999998766443211 11224558999999999887652 34689999999999999999
Q ss_pred ----CCCccccchhhhhhchhhHHHHh-hhh-cCCCC-----hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 605 ----KPAIAITHKVETAIDEDNLAEIL-DAQ-AGDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 605 ----~~Pf~~~~~~~~~~~~~~l~~~l-d~~-~~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
..||........ ....+...+ ... ....| ......+.+|+.+||..+|.+||++. +|+..|+.+..
T Consensus 260 ~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-~i~~~L~~i~~ 336 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQ 336 (342)
T ss_dssp CCCCCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred ccccccCccccCcCcc--cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH-HHHHHHHHHHH
Confidence 667643211110 011111111 111 11222 25667899999999999999999998 57777777654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=350.37 Aligned_cols=238 Identities=28% Similarity=0.415 Sum_probs=194.0
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
..|.....||+|+||.||+|.. .+..||||++..... .....|.+|+.+|++++||||++++++|.+.. +|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999996 467999999875432 23456889999999999999999999986543 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+. |+|.+++.... .++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 68888876443 35899999999999999999999988 999999999999999999999999999865432
Q ss_pred CCCccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
....||+.|+|||++. .+.++.++|||||||++|||+||++||........ +..+......
T Consensus 208 ----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~ 271 (348)
T 1u5q_A 208 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESP 271 (348)
T ss_dssp ----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCC
T ss_pred ----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCC
Confidence 2357999999999874 56789999999999999999999999964432211 1222221111
Q ss_pred -CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 -DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 -~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...+..+.+|+.+||+.+|.+||++.+
T Consensus 272 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 302 (348)
T 1u5q_A 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 302 (348)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 123345678999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=336.91 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=201.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC----------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---------- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---------- 469 (757)
..+|.....||+|+||.||+|.+. +..||+|++.... ..+.+|+.++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888999999999999999986 6799999987643 356789999999999999999998742
Q ss_pred --------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 470 --------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 470 --------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
..++||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 1379999999999999997543 235899999999999999999999988 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 621 (757)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|+||..|+......
T Consensus 162 kl~Dfg~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------- 227 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK-------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------- 227 (284)
T ss_dssp EECCCTTCEESSCCSC-------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-------
T ss_pred EECcchhheecccccc-------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-------
Confidence 9999999987654321 23457999999999999889999999999999999999999988532211
Q ss_pred hHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 622 ~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
...+. ....+...+..+.+++.+||..+|.+||++. +++..|..+.
T Consensus 228 -~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~-e~l~~l~~~~ 273 (284)
T 2a19_B 228 -FTDLR---DGIISDIFDKKEKTLLQKLLSKKPEDRPNTS-EILRTLTVWK 273 (284)
T ss_dssp -HHHHH---TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHT
T ss_pred -HHHhh---cccccccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHh
Confidence 11111 1223444567899999999999999999998 5666666554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.73 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=203.4
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC---CceEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~LV~E 476 (757)
.++|.....||+|+||.||+|.+ .+..||||++..... ...+.+|+.++..++|++++..++++.. ..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 45789999999999999999996 477999999876543 3458899999999999988777776632 3389999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---cCCCceEEeeecCccccC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl---d~~~~~KL~DFGla~~~~ 553 (757)
|+ +|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 899999986433 35899999999999999999999988 9999999999999 588999999999998776
Q ss_pred CCCCCcccc-ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTT-YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
......... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...+..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK---RQKYERISEKKMS 236 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS---SSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh---hhhhhhhcccccC
Confidence 543221111 123456899999999999999999999999999999999999999974322111 0111111111100
Q ss_pred ----CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 633 ----DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 633 ----~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+...+..+.+|+.+||+.+|.+||++. +++..|+.+...
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~l~~~l~~~~~~ 281 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLFHR 281 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHH-HHHHHHHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHH-HHHHHHHHHHHh
Confidence 01123457899999999999999999998 577777776544
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=343.98 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=202.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|...+.||+|+||.||++.+. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.. ++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888999999999999999986 4589999987542 234567899999999999999999999997654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999887643 4899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||......+. +.. +.......
T Consensus 194 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-~~~~~~~~ 260 (335)
T 2owb_A 194 DGE------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNEYSI 260 (335)
T ss_dssp TTC------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHHTCCCC
T ss_pred Ccc------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHH-HhcCCCCC
Confidence 321 12345799999999999988899999999999999999999999964432111 111 11222334
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell 290 (335)
T 2owb_A 261 PKHINPVAASLIQKMLQTDPTARPTINELL 290 (335)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 556678899999999999999999998643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=345.49 Aligned_cols=259 Identities=21% Similarity=0.360 Sum_probs=203.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--c
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--G 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~ 471 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......|.+|+.++++++||||+++++++.+. .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 457999999999999999999843 3479999987543 34456789999999999999999999999664 4
Q ss_pred eEEEEecCCCCHHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEe
Q 004388 472 CLVYEYMENGSLEDRLYRKNN----TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIG 544 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~ 544 (757)
++||||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 899999999999999986542 135899999999999999999999988 999999999999984 5569999
Q ss_pred eecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhH
Q 004388 545 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 545 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l 623 (757)
|||++......... .......||+.|+|||++.++.++.++|||||||++|+|+| |+.||...... ..+
T Consensus 186 Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~ 255 (327)
T 2yfx_A 186 DFGMARDIYRASYY----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVL 255 (327)
T ss_dssp CCHHHHHHHC----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHH
T ss_pred cccccccccccccc----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHH
Confidence 99999865433211 11234578999999999988999999999999999999998 99999643221 111
Q ss_pred HHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 624 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 624 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+........+...+..+.+|+.+||..+|.+||++. +++..|+.+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~l~~~~~~ 305 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQD 305 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHC
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHH-HHHHHHHHHhcC
Confidence 22222223344556778999999999999999999998 577777766543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.20 Aligned_cols=240 Identities=26% Similarity=0.331 Sum_probs=200.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|.....||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++.+.. ++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999986 5689999986532 223467899999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999987654 4889999999999999999999988 999999999999999999999999999765432
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
. .....||+.|+|||++.+..++.++||||||+++|+|+||+.||........ ...+ ......+|
T Consensus 168 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~-~~~~~~~~ 232 (284)
T 2vgo_A 168 R--------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRI-VNVDLKFP 232 (284)
T ss_dssp C--------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH-HTTCCCCC
T ss_pred c--------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHH-hccccCCC
Confidence 1 1345799999999999988999999999999999999999999965432211 1112 22223455
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+..+.+++.+||..+|.+||++.+.
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~l 260 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGV 260 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHH
Confidence 6677899999999999999999999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=350.46 Aligned_cols=243 Identities=20% Similarity=0.322 Sum_probs=194.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.++|.....||+|+||.||+|.+. +..||||++..... .+.+|+++|.++ +||||+++++++.+.. |+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457888999999999999999986 56999999976533 245789999888 7999999999997655 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC----CceEEeeecCcccc
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN----LVSKIGDVGLSTML 552 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~----~~~KL~DFGla~~~ 552 (757)
|++||+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999999987543 4899999999999999999999988 9999999999998432 35999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA- 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~- 631 (757)
..... .....+||+.|+|||++.+..++.++|||||||++|+|+||++||...... ....+...+....
T Consensus 171 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 171 RAENG------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGSGKF 240 (342)
T ss_dssp BCTTC------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHHCCC
T ss_pred cCCCC------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHccCCc
Confidence 54322 123458999999999998888999999999999999999999999642110 0111111121111
Q ss_pred ---CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 632 ---GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 632 ---~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
...+...+..+.+|+.+||..||.+||++.+++
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il 276 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 112234678899999999999999999998533
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=342.96 Aligned_cols=254 Identities=24% Similarity=0.312 Sum_probs=192.2
Q ss_pred cCCccc-eeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSEN-LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~-~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~E 476 (757)
..|... ..||+|+||.||+|... +..||||++..........+.+|+.+|.++ +||||+++++++.+.. ++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 346653 67999999999999874 679999999876656677899999999985 7999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc---eEEeeecCccccC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV---SKIGDVGLSTMLN 553 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~---~KL~DFGla~~~~ 553 (757)
|+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 92 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999997653 4889999999999999999999988 999999999999988765 9999999998664
Q ss_pred CCCCCc-cccccccCCcccccCCCcccccc-----CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--------
Q 004388 554 SDPSFV-STTYKNTGPVGTLCYIDPEYQRT-----GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-------- 619 (757)
Q Consensus 554 ~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~-------- 619 (757)
...... ..........||+.|+|||++.. ..++.++|||||||++|+|+||++||.........+.
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 322110 11111234579999999998865 5688999999999999999999999974432111000
Q ss_pred hhhHHHHhhhhcCCCCh----hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 EDNLAEILDAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 ~~~l~~~ld~~~~~~p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+...+......+|. ..+..+.+|+.+||..||.+||++.+
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 292 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 01122222222233332 24678999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.36 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=190.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||+++++++.+.. ++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46888899999999999999986 66999999865433 23466889999999999999999999986554 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++++|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999998775433 4899999999999999999999988 9999999999999999999999999998765332
Q ss_pred CCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhh--------HHHHh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN--------LAEIL 627 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------l~~~l 627 (757)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||.............. .....
T Consensus 157 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 157 DY------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cc------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 21 234578999999998875 5689999999999999999999999975433221110000 00000
Q ss_pred h------hhcCCC-----C-----hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 628 D------AQAGDW-----P-----IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 628 d------~~~~~~-----p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
. ...... + ...+..+.+|+.+||+.+|.+||++.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 282 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence 0 000000 0 1346679999999999999999999853
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=371.83 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=206.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEec
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYM 478 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~ 478 (757)
...+|....+||+|+||.||+|.+.+ ..||||++.... ...+.|.+|+.+|++++||||++++++|.+. .+|||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehh
Confidence 45568888999999999999999975 579999998654 3456799999999999999999999998764 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.++|.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 344 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 417 (535)
T 2h8h_A 344 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-- 417 (535)
T ss_dssp TTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH--
T ss_pred cCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc--
Confidence 9999999997532 134889999999999999999999988 9999999999999999999999999998764321
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIK 637 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~ 637 (757)
........+|..|+|||++.++.++.++|||||||+||||+| |+.||...... ..+..+........+..
T Consensus 418 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~~~~~~~ 488 (535)
T 2h8h_A 418 ---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYRMPCPPE 488 (535)
T ss_dssp ---HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHHHTTCCCCCCTT
T ss_pred ---eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCCCCCC
Confidence 111234467889999999999999999999999999999999 99999643221 11122222222334556
Q ss_pred HHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 638 ETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 638 ~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
.+..+.+|+.+||+.+|.+||++. +|+..|+.+
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~-~l~~~L~~~ 521 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 521 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHH
Confidence 778999999999999999999998 465555543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=349.81 Aligned_cols=235 Identities=22% Similarity=0.305 Sum_probs=195.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--------hhHHHHHHHHHHHhcCCCceeeecccccCCc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--------QNKQFLQELEVLSKIRHPHLLLLLGACPDHG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--------~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~ 471 (757)
.++|.....||+|+||.||+|.+. +..||||++...... ....+.+|+.+|++++||||++++++|.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 457899999999999999999874 679999998765321 2335778999999999999999999997665
Q ss_pred --eEEEEecCCC-CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 472 --CLVYEYMENG-SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 472 --~LV~Ey~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
++||||+.+| +|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 7999999777 9999886543 4899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
+........ .....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||...... +
T Consensus 177 a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~ 237 (335)
T 3dls_A 177 AAYLERGKL-------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------V 237 (335)
T ss_dssp CEECCTTCC-------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------T
T ss_pred ceECCCCCc-------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------H
Confidence 987654332 133579999999999887776 78999999999999999999999632211 1
Q ss_pred hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. .....|...+..+.+|+.+||..+|.+||++.+
T Consensus 238 ~-~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 271 (335)
T 3dls_A 238 E-AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEK 271 (335)
T ss_dssp T-TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred h-hccCCCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 1 112234446788999999999999999999885
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=346.01 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=200.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--Ce--EEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HT--FAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~--~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV 474 (757)
++|.....||+|+||.||+|.+. +. .+|||.+.... ......+.+|+.+|.++ +||||+++++++.+.. ++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 47888899999999999999874 44 45899886532 33445689999999999 8999999999986554 899
Q ss_pred EEecCCCCHHHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 475 YEYMENGSLEDRLYRKN-------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
|||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999987543 2346899999999999999999999988 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 620 (757)
||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|+|+| |+.||.......
T Consensus 182 kL~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----- 249 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 249 (327)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----
T ss_pred EEcccCcCccccccc-------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----
Confidence 999999997433211 1233467899999999988889999999999999999998 999996443211
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
....+........+...+..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 250 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-ell~~L~~~~~ 300 (327)
T 1fvr_A 250 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRMLE 300 (327)
T ss_dssp -HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred -HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHHH
Confidence 1112222222344556778999999999999999999998 57777766654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=355.06 Aligned_cols=242 Identities=21% Similarity=0.309 Sum_probs=185.8
Q ss_pred cCCccc-eeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHh-cCCCceeeecccccC------Cce
Q 004388 403 LSFSEN-LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSK-IRHPHLLLLLGACPD------HGC 472 (757)
Q Consensus 403 ~~f~~~-~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~-l~Hpniv~l~g~~~~------~~~ 472 (757)
.+|... ..||.|+||.||+|.+. +..||||++.. ...+.+|+.++.+ .+||||++++++|.. ..|
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456555 67999999999999986 56899999863 2457789998754 589999999998743 238
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEeeecCc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGLS 549 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~DFGla 549 (757)
|||||++||+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999997643 245899999999999999999999988 999999999999987 789999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
+...... .....+||+.|+|||++.+..++.++|||||||+||+|+||++||...+.... ..+....+. .
T Consensus 212 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~i~-~ 281 (400)
T 1nxk_A 212 KETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTRIR-M 281 (400)
T ss_dssp EECC------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSS--CCSHHHHHH-H
T ss_pred cccCCCC-------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccc--cHHHHHHHH-c
Confidence 8755322 12345899999999999999999999999999999999999999975432211 111111111 1
Q ss_pred hcCCCC----hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 630 QAGDWP----IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 630 ~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.....+ ...+..+.+|+.+||..||.+||++.++
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei 319 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111111 2457889999999999999999999853
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=338.79 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=199.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC----CceE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD----HGCL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~~~L 473 (757)
.++|.....||+|+||.||+|... +..||+|++.... ....+.+.+|+.++++++||||+++++++.+ ..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888999999999999999985 5689999987543 3345678999999999999999999998732 3489
Q ss_pred EEEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCC--CCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 474 VYEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTK--PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987532 2345899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
....... ......||+.|+|||++.+..++.++||||||+++|+|+||++||...... .....+....
T Consensus 165 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~~ 232 (279)
T 2w5a_A 165 ILNHDTS------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREGK 232 (279)
T ss_dssp HC---CH------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC
T ss_pred eeccccc------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHhhcc
Confidence 7654321 112347899999999999888999999999999999999999999754321 1112222333
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....|...+..+.+++.+||..+|.+||++.+
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 264 (279)
T 2w5a_A 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEE 264 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cccCCcccCHHHHHHHHHHcCCCcccCCCHHH
Confidence 33455667889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=375.05 Aligned_cols=241 Identities=23% Similarity=0.263 Sum_probs=202.3
Q ss_pred hcCCccceeeccCCcEEEEEEEECC--eEEEEEEEccCC---chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKG---NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~L 473 (757)
..+|.....||+|+||.||+|.+.+ ..||||++.... ......+..|..+|..+ +||||+.+++++.+.. ||
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 4578889999999999999999864 579999987532 23456688999999988 7999999999997654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||++||+|.+++...+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+++...
T Consensus 420 V~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999998654 4899999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....+||+.|+|||++.+..|+.++|||||||+||||+||++||...... ..+..++ .....
T Consensus 494 ~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~-~~~~~ 560 (674)
T 3pfq_A 494 WDGV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM-EHNVA 560 (674)
T ss_dssp CTTC------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-SSCCC
T ss_pred cCCc------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hCCCC
Confidence 3221 124568999999999999999999999999999999999999999654321 1122222 23345
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
+|...+.++.+|+.+||+.+|.+||++.
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~ 588 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCG 588 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCC
Confidence 6777889999999999999999999983
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.73 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=201.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
...|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.++.+++||||+++++++.+.. ++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 345888899999999999999875 5699999987553 334577999999999999999999999986543 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++++|.+++.. .++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998853 35899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCCh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPI 636 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~ 636 (757)
. ......||+.|+|||++.+..++.++||||||+++|+|+||++||........ +..+........+.
T Consensus 174 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~ 241 (303)
T 3a7i_A 174 I------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LFLIPKNNPPTLEG 241 (303)
T ss_dssp C------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCCCCCS
T ss_pred c------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HHHhhcCCCCCCcc
Confidence 1 12345799999999999999999999999999999999999999964432211 11122222233445
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+..+.+|+.+||..+|.+||++.+
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ 267 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKE 267 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 66788999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=346.38 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=192.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCC--CceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRH--PHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~H--pniv~l~g~~~~~~--~LV 474 (757)
...|...+.||+|+||.||++.+. +..||||++.... ....+.|.+|+.+|.+++| |||+++++++.+.. +||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456888999999999999999875 5689999987543 2344678999999999986 99999999987655 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||| .+|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+..
T Consensus 88 ~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp ECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 994 5789999997643 4899999999999999999999988 99999999999997 67899999999987654
Q ss_pred CCCCccccccccCCcccccCCCcccccc-----------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRT-----------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
.... .......||+.|+|||++.+ +.++.++|||||||++|+|+||+.||...... ...+
T Consensus 160 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~ 230 (343)
T 3dbq_A 160 DTTS----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKL 230 (343)
T ss_dssp --------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHH
T ss_pred cccc----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHH
Confidence 3211 11234589999999998864 67899999999999999999999999632111 1122
Q ss_pred HHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 624 AEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 624 ~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+++.. ...+|...+..+.+|+.+||+.+|.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l 272 (343)
T 3dbq_A 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272 (343)
T ss_dssp HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHH
Confidence 3333332 2345555677899999999999999999998644
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=347.24 Aligned_cols=244 Identities=21% Similarity=0.292 Sum_probs=189.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
...|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 457899999999999999999985 6699999986432 23456788999999999999999999998543
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.|+||||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 28999999 78999988652 4889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------- 619 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--------- 619 (757)
+..... .+...||+.|+|||++.+ ..++.++|||||||++|+|+||++||...........
T Consensus 176 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 176 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccc---------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 875432 244589999999998876 6799999999999999999999999975433221100
Q ss_pred --------hhhHHHHhhhhc-------CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 --------EDNLAEILDAQA-------GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 --------~~~l~~~ld~~~-------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.......+.... .......+..+.+|+.+||..||.+||++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence 000011111100 0112244678999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=346.03 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=199.8
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--------hhhHHHHHHHHHHHhc-CCCceeee
Q 004388 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--------IQNKQFLQELEVLSKI-RHPHLLLL 463 (757)
Q Consensus 395 ~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l-~Hpniv~l 463 (757)
+........+|.....||.|+||.||+|.+. +..||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344555677999999999999999999985 67999999876532 1235678999999999 79999999
Q ss_pred cccccCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 464 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 464 ~g~~~~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
+++|.... +|||||++||+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+|.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 99986544 89999999999999987543 4899999999999999999999988 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCcccccc------CCCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 615 (757)
||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||.......
T Consensus 240 kl~DfG~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 312 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK-------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312 (365)
T ss_dssp EECCCTTCEECCTTCC-------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEEecCcccccCCCcc-------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 9999999987664321 234589999999998863 358899999999999999999999996432211
Q ss_pred hhhchhhHHHHhhhhcCCCCh----hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 616 TAIDEDNLAEILDAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~~~~~p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+...+......++. ..+..+.+|+.+||..+|.+||++.+
T Consensus 313 -------~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 313 -------MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp -------HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred -------HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 11111111112221 24567999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=342.62 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=201.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC------CceE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGCL 473 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~~~L 473 (757)
.++|.....||+|+||.||++.. .+..||||++..........+.+|+.++++++||||+++++++.. ..++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45799999999999999999997 467999999877666667789999999999999999999999852 2379
Q ss_pred EEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 474 VYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
||||+++|+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998753 22346999999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCCcc---ccccccCCcccccCCCccccccCC---CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 553 NSDPSFVS---TTYKNTGPVGTLCYIDPEYQRTGL---ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 553 ~~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
........ .........||+.|+|||++.... ++.++|||||||++|+|+||+.||....... ..+...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~ 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-----DSVALA 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-----SCHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-----chhhHH
Confidence 42110000 000112346799999999886543 7899999999999999999999995321111 111111
Q ss_pred hhh-hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 627 LDA-QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 627 ld~-~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+.. .....+...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~L~~~ 304 (317)
T 2buj_A 260 VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP-LLLSQLEAL 304 (317)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHT
T ss_pred hhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHH-HHHHHhhhc
Confidence 111 11222345678899999999999999999998 466666544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.16 Aligned_cols=260 Identities=22% Similarity=0.364 Sum_probs=196.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|.....||+|+||.||+|... +..||||++.... ......+.+|+.++++++||||+++++++.+.. ++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357899999999999999999974 6799999987532 334567899999999999999999999986543 899
Q ss_pred EEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 475 YEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
|||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988642 22345899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh-hcC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAG 632 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~ 632 (757)
.... ......||+.|+|||++.+..++.++||||||+++|+|+||+.||....... ..+...+.. ...
T Consensus 188 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 188 SKTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YSLCKKIEQCDYP 256 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-----HHHHHHHHTTCSC
T ss_pred CCCc------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-----HHHHHHhhcccCC
Confidence 3321 1234578999999999998899999999999999999999999996432110 111111111 111
Q ss_pred C-CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhhh
Q 004388 633 D-WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676 (757)
Q Consensus 633 ~-~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~~ 676 (757)
. .+...+..+.+|+.+||..+|.+||++. +++..|+++.....
T Consensus 257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVT-YVYDVAKRMHACTA 300 (310)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHHHC
T ss_pred CCcccccCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHHHhhh
Confidence 1 1234577899999999999999999998 58888888876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=349.80 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=197.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.++|....+||+|+||.||+|.+. +..||+|++.... ......+.+|+.+|.+++||||+++++++.+.. ++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 347888999999999999999997 6699999987653 334567899999999999999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|+++|+|.+++...+ .+++..+..|+.+++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999997654 488999999999999999999985 6 999999999999999999999999999765321
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc----------------
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------------- 619 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------------- 619 (757)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||...........
T Consensus 186 --------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 186 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp --------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred --------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 12345799999999999999999999999999999999999999964322111000
Q ss_pred ----------------hhhHHHHhh----hhcCCCC-hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 620 ----------------EDNLAEILD----AQAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 620 ----------------~~~l~~~ld----~~~~~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.....+.++ ......+ ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 323 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 000111111 1111111 23467899999999999999999998633
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=351.38 Aligned_cols=244 Identities=24% Similarity=0.299 Sum_probs=195.5
Q ss_pred hcCCccceeeccCCcEEEEEEEE-----CCeEEEEEEEccCC----chhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
..+|...+.||+|+||.||+|.. .+..||||++.... ......+.+|+.+|.++ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999988 56799999987532 22345577899999999 6999999999986543
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 472 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
+|||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 89999999999999997654 4889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
+.+..... .......||+.|+|||++.+ ..++.++|||||||+||+|+||+.||........ ...+...+
T Consensus 207 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~ 278 (355)
T 1vzo_A 207 KEFVADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---QAEISRRI 278 (355)
T ss_dssp EECCGGGG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---HHHHHHHH
T ss_pred eecccCCC-----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch---HHHHHHHH
Confidence 86543211 12234579999999999875 3478999999999999999999999964321111 11122222
Q ss_pred hhhcCCCChhHHHHHHHHHHHHhhccCCCCCc
Q 004388 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 628 d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
.......|...+..+.+|+.+||..+|.+||+
T Consensus 279 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~ 310 (355)
T 1vzo_A 279 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 310 (355)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred hccCCCCCcccCHHHHHHHHHHhhhCHHHhcC
Confidence 22334556677888999999999999999994
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.17 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=196.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
..+|.....||+|+||.||+|... +..||+|++..........+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999985 6799999998665555567899999999999999999999987654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---cCCCceEEeeecCccccCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl---d~~~~~KL~DFGla~~~~~ 554 (757)
+++|+|.+++...+ .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999987654 4889999999999999999999988 9999999999999 7889999999999976442
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc---
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--- 631 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--- 631 (757)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||++||....... .+..+.....
T Consensus 162 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~ 227 (304)
T 2jam_A 162 GI--------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIKEGYYEFE 227 (304)
T ss_dssp BT--------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHCCCCCC
T ss_pred Cc--------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCCCCC
Confidence 21 123468999999999999999999999999999999999999996432211 1111211111
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+...+..+.+|+.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 258 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEK 258 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 1122345788999999999999999999985
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=336.34 Aligned_cols=242 Identities=24% Similarity=0.325 Sum_probs=191.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
+.|...++||+|+||.||++... +..+|+|++.... ....+.+.+|+.+|++++||||++++++|.+.. ++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46888999999999999999985 5689999987653 334577999999999999999999999997654 899999
Q ss_pred cCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---cCCCceEEeeecCccccC
Q 004388 478 MENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 478 ~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl---d~~~~~KL~DFGla~~~~ 553 (757)
+++|+|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 22345899999999999999999999988 9999999999999 456889999999998765
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
.... .....||+.|+|||++. +.++.++|||||||++|+|+||+.||........ ..........
T Consensus 179 ~~~~-------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~ 243 (285)
T 3is5_A 179 SDEH-------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-------QQKATYKEPN 243 (285)
T ss_dssp ---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC
T ss_pred Cccc-------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-------HhhhccCCcc
Confidence 4321 23457999999999875 5689999999999999999999999964332111 1111111111
Q ss_pred CC---hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WP---IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p---~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+ ...+..+.+|+.+||+.+|.+||++.+
T Consensus 244 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 275 (285)
T 3is5_A 244 YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQ 275 (285)
T ss_dssp CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cccccCcCCHHHHHHHHHHccCChhhCcCHHH
Confidence 11 124678999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.39 Aligned_cols=242 Identities=21% Similarity=0.297 Sum_probs=196.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc------hhhHHHHHHHHHHHhcCCCceeeecccccCCc--e
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN------IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~------~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~ 472 (757)
++|.....||+|+||.||+|.+. +..||+|++..... ...+.|.+|+.++++++||||+++++++.+.. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888899999999999999986 66999999875432 13577999999999999999999999997654 8
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC----ceEEeeecC
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVGL 548 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~----~~KL~DFGl 548 (757)
+||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999997643 4899999999999999999999988 99999999999998877 899999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+........ .....||+.|+|||++.+..++.++||||||+++|+|+||+.||....... .+..+ .
T Consensus 159 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~ 224 (283)
T 3bhy_A 159 AHKIEAGNE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTNI-S 224 (283)
T ss_dssp CEECC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-H
T ss_pred ceeccCCCc-------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHHh-H
Confidence 987654321 133479999999999998899999999999999999999999996433211 11111 1
Q ss_pred hhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 629 AQAGDWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 629 ~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
......+ ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 264 (283)
T 3bhy_A 225 AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264 (283)
T ss_dssp TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 1111222 23457799999999999999999998644
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=360.26 Aligned_cols=248 Identities=17% Similarity=0.136 Sum_probs=189.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC---CchhhHHHHHHH---HHHHhcCCCceeeecccc-----
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK---GNIQNKQFLQEL---EVLSKIRHPHLLLLLGAC----- 467 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~---~~~~~~~f~~Ev---~il~~l~Hpniv~l~g~~----- 467 (757)
...+|.....||+|+||.||+|.+. +..||||++... .....+.|.+|+ .+|++++|||||++++.|
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3567888999999999999999964 679999998743 333457789999 455566899999998544
Q ss_pred --cCC-------------------ceEEEEecCCCCHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 004388 468 --PDH-------------------GCLVYEYMENGSLEDRLYRKNNT----PPIPWFERYRIAWEVASALAFLHNTKPKP 522 (757)
Q Consensus 468 --~~~-------------------~~LV~Ey~~~gsL~~~L~~~~~~----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 522 (757)
.+. .||||||+ +|+|.+++...+.. ..+++..+..|+.||+.||.|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 222 57999999 68999999764321 12446888899999999999999988
Q ss_pred EEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC-----------CCCCcchh
Q 004388 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-----------LISPKSDV 591 (757)
Q Consensus 523 ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDv 591 (757)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC---------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC---------cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 99999999999999999999999999986332 1234567 999999999877 89999999
Q ss_pred hhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhh-hHHHH
Q 004388 592 YAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL-PVLER 670 (757)
Q Consensus 592 wSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl-~~L~~ 670 (757)
|||||+||+|+||+.||........ +..+.. .+...+..+.+|+.+||..+|.+||++.+++. +.+..
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~------~~~~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGG------SEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CC------SGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcccccccc------hhhhhh-----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 9999999999999999964322111 111111 11234578999999999999999999986442 34444
Q ss_pred HHH
Q 004388 671 LKE 673 (757)
Q Consensus 671 l~~ 673 (757)
+..
T Consensus 366 ~~~ 368 (377)
T 3byv_A 366 LRT 368 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=356.88 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=151.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccC-------C
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------H 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------~ 470 (757)
.++|...+.||+|+||.||+|.+. +..||||++... .......+.+|+.+|++++|||||+++++|.. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 457999999999999999999875 568999998653 23345678999999999999999999999832 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.|+||||+ +|+|.+++... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 38999998 47999988653 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCcc---------------------ccccccCCcccccCCCcccc-ccCCCCCcchhhhHHHHHHHHHh
Q 004388 551 MLNSDPSFVS---------------------TTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLT 603 (757)
Q Consensus 551 ~~~~~~~~~~---------------------~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~ellt 603 (757)
.+........ .....+..+||+.|+|||++ ....++.++||||||||||||+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 7653321100 00123556899999999975 56679999999999999999999
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.93 Aligned_cols=260 Identities=16% Similarity=0.169 Sum_probs=200.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC----------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeee---------
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH----------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLL--------- 463 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~----------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l--------- 463 (757)
++|.....||+|+||.||+|.+. +..||||++... ..+.+|+.++.+++||||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 57899999999999999999885 468999998754 357899999999999999984
Q ss_pred ------ccccc---CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCee
Q 004388 464 ------LGACP---DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNIL 534 (757)
Q Consensus 464 ------~g~~~---~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NIL 534 (757)
++++. ...++||||+ +|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 44443 2238999999 999999997642 235999999999999999999999988 999999999999
Q ss_pred ecCCC--ceEEeeecCccccCCCCCCcc-ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc
Q 004388 535 LDHNL--VSKIGDVGLSTMLNSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 611 (757)
Q Consensus 535 ld~~~--~~KL~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~ 611 (757)
++.++ .+||+|||+++.+........ .........||+.|+|||++.+..++.++|||||||+||+|+||+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 999999999987654322111 111224458999999999999889999999999999999999999999754
Q ss_pred chhhhhhchhhHHHHhhhhcCCCC------hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHhh
Q 004388 612 HKVETAIDEDNLAEILDAQAGDWP------IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVA 675 (757)
Q Consensus 612 ~~~~~~~~~~~l~~~ld~~~~~~p------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~~ 675 (757)
......+.. ....+.......+ ...+..+.+|+.+||..+|.+||++. +++..|+.+....
T Consensus 272 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~l~~~L~~~~~~~ 338 (352)
T 2jii_A 272 LPNTEDIMK--QKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYA-MLRNNLEALLQDL 338 (352)
T ss_dssp TTCHHHHHH--HHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHH-HHHHHHHHHHHHT
T ss_pred CcCHHHHHH--HHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHH-HHHHHHHHHHHhc
Confidence 311111110 0011111111111 13468899999999999999999988 5777777765543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.67 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=195.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC---Ce--EEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCC-ce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH---HT--FAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~---~~--~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~ 472 (757)
..+|.....||+|+||.||+|.+. +. .||||++.... ....+.|.+|+.++.+++||||+++++++.+. .+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK 96 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence 357888999999999999999863 22 68999887542 33456789999999999999999999998654 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 9999999999999987643 24889999999999999999999988 999999999999999999999999999877
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ- 630 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~- 630 (757)
....... .......+|+.|+|||++.+..++.++||||||+++|+|+| |+.||....... .+..+....
T Consensus 172 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~ 242 (291)
T 1u46_A 172 PQNDDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGE 242 (291)
T ss_dssp CC-CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCC
T ss_pred cccccch---hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCC
Confidence 6443211 11234567889999999988889999999999999999999 999996443211 111111111
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
....+...+..+.+++.+||..+|.+||++. +++..|+.+
T Consensus 243 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~l~~~l~~~ 282 (291)
T 1u46_A 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 282 (291)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred CCCCCcCcCHHHHHHHHHHccCCcccCcCHH-HHHHHHHHh
Confidence 1223445678899999999999999999998 466666554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=356.31 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=187.3
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--------hhhHHHHHHHHHHHhcCCCceeeecccccCC
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--------IQNKQFLQELEVLSKIRHPHLLLLLGACPDH 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~ 470 (757)
..++|...++||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++...
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 212 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 212 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3567888999999999999999986 45999999875321 1122478999999999999999999998654
Q ss_pred c-eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---CceEEeee
Q 004388 471 G-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDV 546 (757)
Q Consensus 471 ~-~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~---~~~KL~DF 546 (757)
. ++||||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred ceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 4 8999999999999887643 35899999999999999999999988 9999999999999654 45999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
|+++...... .....+||+.|+|||++. ...++.++|||||||++|+|+||++||...... ..+
T Consensus 287 G~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~------~~~ 353 (419)
T 3i6u_A 287 GHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSL 353 (419)
T ss_dssp STTTSCC------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS------CCH
T ss_pred ccceecCCCc-------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch------HHH
Confidence 9998765322 123458999999999875 366888999999999999999999999643211 112
Q ss_pred HHHhhhhcCCCCh----hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 624 AEILDAQAGDWPI----KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 624 ~~~ld~~~~~~p~----~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+......++. ..+..+.+|+.+||+.+|.+||++.+
T Consensus 354 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 396 (419)
T 3i6u_A 354 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396 (419)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHH
Confidence 2222222222222 34678999999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.76 Aligned_cols=252 Identities=19% Similarity=0.252 Sum_probs=192.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|.....||+|+||.||+|.+. +..||||++..... .....+.+|+.++.+++||||+++++++.+.. ++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 457899999999999999999975 67999999875432 23467899999999999999999999986543 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++++|.+++.... ++++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999997653 4899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc---
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--- 631 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--- 631 (757)
... .......||+.|+|||++.+..++.++||||||+++|+|+||+.||...... .+...+....
T Consensus 187 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~ 254 (309)
T 2h34_A 187 EKL-----TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPRP 254 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCCG
T ss_pred ccc-----ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCCc
Confidence 321 1123457999999999999889999999999999999999999999644321 1111111111
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
...+...+..+.+++.+||..+|.+||+..++++..|+.+
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 1223445678999999999999999994444676666544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.84 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=189.0
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch-----hhHHHHHHHHHHHhcCCCceeeecccccCC-
Q 004388 399 ESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-----QNKQFLQELEVLSKIRHPHLLLLLGACPDH- 470 (757)
Q Consensus 399 ~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~-----~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~- 470 (757)
.....+|.....||+|+||.||+|.+. +..||||++...... ....+.+|+.++.+++||||++++++|.+.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344567899999999999999999985 568999998753221 134678999999999999999999998654
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 4899999985 8988886533 35888899999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+.+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||........ +..++.
T Consensus 160 ~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~------~~~i~~ 227 (346)
T 1ua2_A 160 KSFGSPNR------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ------LTRIFE 227 (346)
T ss_dssp STTTSCCC------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH
T ss_pred eeccCCcc------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHH
Confidence 87653321 12345799999999988654 588999999999999999999999975433221 111111
Q ss_pred hh----cCCCC-----------------------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 AQ----AGDWP-----------------------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ~~----~~~~p-----------------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. ...|+ ...+..+.+|+.+||..+|.+||++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 288 (346)
T 1ua2_A 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288 (346)
T ss_dssp HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHH
Confidence 10 01111 233578999999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=350.55 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=192.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCC--chhhHHHHHHHHHHHhcC--CCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIR--HPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~--Hpniv~l~g~~~~~~--~LV~ 475 (757)
..|...+.||+|+||.||+|... +..||||++.... ......|.+|+.+|.+++ ||||+++++++.... +|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45889999999999999999875 5689999987543 334567899999999996 599999999886544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
| +.+|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999987654 5888899999999999999999988 99999999999995 589999999999876543
Q ss_pred CCCccccccccCCcccccCCCcccccc-----------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHH
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRT-----------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 624 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~ 624 (757)
... ......+||+.|+|||++.+ ..++.++||||||||||+|+||++||...... ...+.
T Consensus 208 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~ 278 (390)
T 2zmd_A 208 TTS----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLH 278 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHH
T ss_pred Ccc----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHH
Confidence 211 11234589999999998864 46899999999999999999999999632211 12233
Q ss_pred HHhhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 625 EILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 625 ~~ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+++... ..+|...+..+.+|+.+||..+|.+||++.+++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 319 (390)
T 2zmd_A 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319 (390)
T ss_dssp HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHh
Confidence 3444332 234444567899999999999999999998643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.49 Aligned_cols=241 Identities=25% Similarity=0.390 Sum_probs=192.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||+++++++.+.. ++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 356888899999999999999985 6799999986532 223457889999999999999999999986654 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997654 4889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
... .....||+.|+|||++.+..+ +.++||||||+++|+|+||+.||...... .+...+......
T Consensus 164 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~ 229 (276)
T 2h6d_A 164 GEF-------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-------TLFKKIRGGVFY 229 (276)
T ss_dssp --------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCC
T ss_pred Ccc-------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHHHhhcCccc
Confidence 321 133478999999999887665 68999999999999999999999643221 122222233334
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.|...+..+.+++.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2h6d_A 230 IPEYLNRSVATLLMHMLQVDPLKRATIKD 258 (276)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CchhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 55566788999999999999999999985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=337.05 Aligned_cols=245 Identities=23% Similarity=0.380 Sum_probs=194.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
....|.....||+|+||.||+|.+. +..||+|++..........|.+|+.++..++||||+++++++.+.. ++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3457889999999999999999986 5689999998766666788999999999999999999999986543 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999887643 24899999999999999999999988 999999999999999999999999997643211
Q ss_pred CCccccccccCCcccccCCCcccc-----ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQ-----RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
........||+.|+|||++ ....++.++||||||+++|+|+||++||........ +..+.....
T Consensus 171 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~ 239 (302)
T 2j7t_A 171 -----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSDP 239 (302)
T ss_dssp -----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCC
T ss_pred -----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccCC
Confidence 0112345799999999987 366789999999999999999999999975432211 111211111
Q ss_pred C--CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 G--DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~--~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
. ..+...+..+.+|+.+||..+|.+||++.+
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 272 (302)
T 2j7t_A 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ 272 (302)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred cccCCccccCHHHHHHHHHHcccChhhCCCHHH
Confidence 1 123455778999999999999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=357.87 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=196.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-------------hhhHHHHHHHHHHHhcCCCceeeecc
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-------------IQNKQFLQELEVLSKIRHPHLLLLLG 465 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-------------~~~~~f~~Ev~il~~l~Hpniv~l~g 465 (757)
....|...++||+|+||.||+|... +..||||++..... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4567999999999999999999986 46899999875431 23467899999999999999999999
Q ss_pred cccCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC---c
Q 004388 466 ACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL---V 540 (757)
Q Consensus 466 ~~~~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~---~ 540 (757)
+|.+.. ++||||++||+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 997665 89999999999999987654 4899999999999999999999988 99999999999998776 6
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
+||+|||++..+.... ......||+.|+|||++. +.++.++|||||||++|+|++|++||.......
T Consensus 188 ~kl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----- 254 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY-------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD----- 254 (504)
T ss_dssp EEECCCTTCEECCTTS-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred EEEEECCCCEEcCCCC-------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence 9999999998765432 123457999999999886 568999999999999999999999997543211
Q ss_pred hhHHHHhhhhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 DNLAEILDAQAGDWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+..+ ......++ ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 255 -~~~~i-~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l 300 (504)
T 3q5i_A 255 -IIKKV-EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300 (504)
T ss_dssp -HHHHH-HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred -HHHHH-HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 11111 11111222 13467899999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=353.90 Aligned_cols=247 Identities=10% Similarity=0.034 Sum_probs=178.1
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhc--CCCceeeeccccc------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKI--RHPHLLLLLGACP------ 468 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l--~Hpniv~l~g~~~------ 468 (757)
..+|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.++..| +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999999999999975 67999999987543 2345677885555544 6999887553331
Q ss_pred --------------------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHhhCCCCC
Q 004388 469 --------------------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFER------YRIAWEVASALAFLHNTKPKP 522 (757)
Q Consensus 469 --------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~------~~i~~qia~aL~~LH~~~~~~ 522 (757)
...||||||++ |+|.+++...+. .+++..+ ..|+.||+.||.|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 22489999998 899999976432 2455566 788899999999999988
Q ss_pred EEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHH
Q 004388 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQ 600 (757)
Q Consensus 523 ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~e 600 (757)
|+||||||+||||+.++.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG---------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE---------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc---------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 9999999999999999999999999998654211 13467799999999977 679999999999999999
Q ss_pred HHhCCCCccccchhhhh-hchhhHHHHhhhhcCCC--ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 601 LLTAKPAIAITHKVETA-IDEDNLAEILDAQAGDW--PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 601 lltG~~Pf~~~~~~~~~-~~~~~l~~~ld~~~~~~--p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
|+||+.||......... +........ ......+ +...+..+.+|+.+||+.+|.+||++.+++
T Consensus 286 lltg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSWKRPSLRVP-GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCCCBCCTTSC-CCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred HHhCCCCCCCcCcccccchhhhhhhhc-cccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999999754221110 000000000 0000111 125578899999999999999999998644
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=341.57 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=191.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.++|.....||+|+||.||+|.+. +..||||++..... .....+.+|+.++++++||||++++++|.+.. ++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 346888899999999999999986 66999999865432 23456789999999999999999999996554 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988765433 4899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh--------hHHHH
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------NLAEI 626 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--------~l~~~ 626 (757)
.. ......||+.|+|||++.+. .++.++|||||||++|+|+||++||............. .....
T Consensus 178 ~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 178 GE------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 21 12345799999999988765 78999999999999999999999997543322111000 00000
Q ss_pred hhhh-------cC----CC-----ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 627 LDAQ-------AG----DW-----PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 627 ld~~-------~~----~~-----p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.... .. .. ....+..+.+|+.+||+.||.+||++.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 305 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHh
Confidence 0000 00 00 013467899999999999999999998644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=347.70 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=194.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC--------CCceeeeccccc---
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR--------HPHLLLLLGACP--- 468 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~--------Hpniv~l~g~~~--- 468 (757)
..+|....+||+|+||.||+|.+. +..||||++... ......+.+|+.+|+.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 467999999999999999999875 679999999754 334567889999999985 788999999875
Q ss_pred -C--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCC-----
Q 004388 469 -D--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNL----- 539 (757)
Q Consensus 469 -~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~----- 539 (757)
+ ..||||||+ +|+|.+.+.... ...+++..+..|+.||+.||.|||+. + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 2 338999999 567777665543 24589999999999999999999997 7 99999999999998775
Q ss_pred --------------------------------------------ceEEeeecCccccCCCCCCccccccccCCcccccCC
Q 004388 540 --------------------------------------------VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575 (757)
Q Consensus 540 --------------------------------------------~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~ 575 (757)
.+||+|||++...... .....||+.|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---------~~~~~gt~~y~ 260 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---------FTEDIQTRQYR 260 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---------SCSCCSCGGGC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---------CccCCCCCccc
Confidence 7999999999876432 13457999999
Q ss_pred CccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh---------------------------
Q 004388 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD--------------------------- 628 (757)
Q Consensus 576 aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld--------------------------- 628 (757)
|||++.+..++.++|||||||+||+|+||++||..............+..+..
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 340 (397)
T 1wak_A 261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK 340 (397)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence 99999998999999999999999999999999964321111000111111100
Q ss_pred --------------hhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 --------------AQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 --------------~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....++...+..+.+|+.+||+.||.+||++.+
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 388 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH
Confidence 0012356677889999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=335.31 Aligned_cols=243 Identities=23% Similarity=0.357 Sum_probs=195.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
...|.....||.|+||.||+|.+. +..||||++.... ....+.+|+.++.+++||||+++++++.+.. ++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 456888999999999999999986 6799999987643 3567899999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.+++.... ..+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999986433 35899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC--CCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--DWP 635 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~--~~p 635 (757)
......||+.|+|||++.+..++.++||||||+++|+|+||+.||......... ..+...... ..+
T Consensus 181 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~ 248 (314)
T 3com_A 181 ------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTNPPPTFRKP 248 (314)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCCCCCSSG
T ss_pred ------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCcccCCc
Confidence 123457999999999999889999999999999999999999999644332211 111111111 123
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+..+.+|+.+||..+|.+||++.+.
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQL 276 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 4456789999999999999999999853
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=332.52 Aligned_cols=241 Identities=25% Similarity=0.390 Sum_probs=191.7
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC----C--ceE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD----H--GCL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~----~--~~L 473 (757)
.|.....||+|+||.||+|.+. +..||+|++.... ......|.+|+.+|++++||||++++++|.+ . .++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3667778999999999999986 4589999887542 3345678999999999999999999998743 1 389
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceEEeeecCcccc
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTML 552 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~KL~DFGla~~~ 552 (757)
||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999997643 4889999999999999999999976 3599999999999997 7899999999999765
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA- 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~- 631 (757)
.... .....||+.|+|||++. +.++.++|||||||++|+|+||+.||......... ...+.....
T Consensus 183 ~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~ 248 (290)
T 1t4h_A 183 RASF--------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKP 248 (290)
T ss_dssp CTTS--------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHTTTCCC
T ss_pred cccc--------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHHHhccCCc
Confidence 4321 13357999999999876 55899999999999999999999999643322111 111111100
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+...+..+.+|+.+||+.+|.+||++.+
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 279 (290)
T 1t4h_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cccCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 1122234578999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=358.06 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=193.5
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
...|....+||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||++++++|.+.. ++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 446889999999999999999985 5689999987543 334567899999999999999999999997654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~DFGla~~~ 552 (757)
||+++|+|.+.+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++..+
T Consensus 116 e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999999887654 4889999999999999999999988 999999999999976 456999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
.... .....+||+.|+|||++. +.++.++|||||||++|+|+||++||......+ .+..+.. ...
T Consensus 190 ~~~~-------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~-~~~ 254 (494)
T 3lij_A 190 ENQK-------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVEK-GKY 254 (494)
T ss_dssp BTTB-------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-TCC
T ss_pred CCCc-------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC
Confidence 5432 123457999999999876 569999999999999999999999997443211 1112221 111
Q ss_pred CCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 633 DWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 633 ~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.++ ...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 255 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 290 (494)
T 3lij_A 255 TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290 (494)
T ss_dssp CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHh
Confidence 111 23567899999999999999999998644
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=342.94 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=193.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccC--------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPD-------- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------- 469 (757)
..+|....+||+|+||.||+|.+. +..||||++..... .....+.+|+.+|+.++||||++++++|.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 357889999999999999999984 56999999865432 234578899999999999999999998854
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 470 --HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 470 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
..++||||+++ +|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 23799999974 7877775443 34899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
+++.+...... .........||+.|+|||++.+ ..++.++|||||||++|+|+||++||.......... .+...
T Consensus 170 ~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---LISQL 244 (351)
T ss_dssp TCEECCCCSSS--SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHH
T ss_pred hcccccccccc--cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHH
Confidence 99876533221 1122345689999999998865 458999999999999999999999997543221110 00000
Q ss_pred hhhhc-CCCCh---------------------------hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 LDAQA-GDWPI---------------------------KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 ld~~~-~~~p~---------------------------~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..... ..|+. ..+..+.+|+.+||..||.+||++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 308 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHH
Confidence 00000 00110 01466899999999999999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.47 Aligned_cols=242 Identities=19% Similarity=0.312 Sum_probs=192.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccC--C--ceEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--H--GCLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~--~~LV 474 (757)
.++|...++||+|+||.||+|.+. +..||||++... ....+.+|+.+|.+++ ||||+++++++.+ . .++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 356888999999999999999874 669999998753 3467899999999997 9999999999865 2 3899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCccccC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTMLN 553 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~~ 553 (757)
|||+.+++|.+++.. +++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999998742 788899999999999999999988 99999999999999776 89999999998765
Q ss_pred CCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh-------hchhhHHH
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-------IDEDNLAE 625 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~-------~~~~~l~~ 625 (757)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||......... .....+..
T Consensus 183 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 183 PGQE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTCC-------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCCc-------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 4332 134578999999998876 67899999999999999999999999532211110 11111112
Q ss_pred HhhhhcCC------------------------CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 626 ILDAQAGD------------------------WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 626 ~ld~~~~~------------------------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.++..... .+...+..+.+|+.+||+.||.+||++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e 316 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHH
Confidence 22211111 11225788999999999999999999885
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.04 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=186.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++|....+||+|+||.||+|.+. +..||||++...... ....+.+|+.+|++++||||+++++++.+.. ++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999985 568999998754322 1223567999999999999999999986554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++ |+|.+++...+ ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 58999887654 35899999999999999999999988 99999999999999999999999999986543221
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh-hcCCCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWP 635 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-~~~~~p 635 (757)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......+... .+...+.. ....|+
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 156 ------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH---FIFRILGTPTEETWP 226 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTST
T ss_pred ------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHhch
Confidence 1234578999999998876 568999999999999999999999997543221110 00000000 000111
Q ss_pred -------------------------hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 -------------------------IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 -------------------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...+..+.+|+.+||+.||.+||++.++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 279 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence 1245778999999999999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=351.22 Aligned_cols=200 Identities=24% Similarity=0.308 Sum_probs=162.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
..+|...+.||+|+||.||+|.+. +..||||++... .......+.+|+.+|++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 467999999999999999999885 568999999754 233456789999999999999999999998543
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.|+||||+. |+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 489999996 6999988653 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCcc----------------ccccccCCcccccCCCcccc-ccCCCCCcchhhhHHHHHHHHHhCCCCc
Q 004388 551 MLNSDPSFVS----------------TTYKNTGPVGTLCYIDPEYQ-RTGLISPKSDVYAYGMVILQLLTAKPAI 608 (757)
Q Consensus 551 ~~~~~~~~~~----------------~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDvwSlGvil~elltG~~Pf 608 (757)
.......... .....+..+||+.|+|||++ ....++.++||||||||||||+||..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7754321100 00123567899999999975 5667999999999999999999855444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.36 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=185.8
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch--hhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI--QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~--~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
...++|....+||+|+||.||+|.+. +..||||++...... ....+.+|+.+|++++||||+++++++.+.. +|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34567999999999999999999874 679999998754322 2456789999999999999999999986554 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee-----cCCCceEEeeecC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL-----DHNLVSKIGDVGL 548 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl-----d~~~~~KL~DFGl 548 (757)
||||++ |+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+
T Consensus 111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999997 59999887654 4899999999999999999999988 9999999999999 4556699999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
++.+..... ......||+.|+|||++.+. .++.++|||||||++|+|+||++||......... ..++
T Consensus 184 a~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~ 251 (329)
T 3gbz_A 184 ARAFGIPIR------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL------FKIF 251 (329)
T ss_dssp HHHHC-----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH
T ss_pred ccccCCccc------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH------HHHH
Confidence 987653321 12345789999999988764 4899999999999999999999999754332221 1111
Q ss_pred hhh----cCCCC-------------------------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQ----AGDWP-------------------------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~----~~~~p-------------------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... ...|+ ...+..+.+|+.+||+.||.+||++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 315 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 110 00010 114578899999999999999999885
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.88 Aligned_cols=243 Identities=22% Similarity=0.302 Sum_probs=198.2
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchh-----------------hHHHHHHHHHHHhcCCCceeeec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQ-----------------NKQFLQELEVLSKIRHPHLLLLL 464 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~-----------------~~~f~~Ev~il~~l~Hpniv~l~ 464 (757)
..+|.....||+|+||.||+|.+.+..||||++....... ...|.+|+.++.+++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4578999999999999999999989999999987542211 17899999999999999999999
Q ss_pred ccccCCc--eEEEEecCCCCHHHH------HhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeee
Q 004388 465 GACPDHG--CLVYEYMENGSLEDR------LYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 465 g~~~~~~--~LV~Ey~~~gsL~~~------L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILl 535 (757)
+++.+.. ++||||+++|+|.++ +... ....+++..+..|+.||+.||.|||+ .+ |+||||||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9987654 899999999999997 4332 24569999999999999999999999 77 9999999999999
Q ss_pred cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC-CCCC-cchhhhHHHHHHHHHhCCCCccccch
Q 004388 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISP-KSDVYAYGMVILQLLTAKPAIAITHK 613 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~-ksDvwSlGvil~elltG~~Pf~~~~~ 613 (757)
+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|+||+.||.....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK--------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT--------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred cCCCcEEEeccccccccccc--------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999876432 12445799999999998877 5666 99999999999999999999975432
Q ss_pred hhhhhchhhHHHHhhhhcCCCC-------------------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 614 VETAIDEDNLAEILDAQAGDWP-------------------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 614 ~~~~~~~~~l~~~ld~~~~~~p-------------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... +...+......+| ...+..+.+|+.+||+.+|.+||++.+
T Consensus 258 ~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e 319 (348)
T 2pml_X 258 LVE------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319 (348)
T ss_dssp SHH------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHH------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHH
Confidence 111 1111111112222 346788999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=340.20 Aligned_cols=250 Identities=20% Similarity=0.250 Sum_probs=197.9
Q ss_pred HHHHHhhcCCccc-eeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcC-CCceeeecccccC
Q 004388 396 EEIESATLSFSEN-LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIR-HPHLLLLLGACPD 469 (757)
Q Consensus 396 ~ei~~at~~f~~~-~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~ 469 (757)
...+...+.|... +.||+|+||.||+|... +..||||++.... ......+.+|+.++..+. ||||++++++|.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3444555567766 78999999999999986 6799999987543 233567899999999995 6999999999976
Q ss_pred Cc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEe
Q 004388 470 HG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIG 544 (757)
Q Consensus 470 ~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~ 544 (757)
.. ++||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 55 89999999999999875432 345899999999999999999999988 999999999999987 7899999
Q ss_pred eecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHH
Q 004388 545 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 624 (757)
Q Consensus 545 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~ 624 (757)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ +.
T Consensus 177 Dfg~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~ 243 (327)
T 3lm5_A 177 DFGMSRKIGHACE-------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YL 243 (327)
T ss_dssp CGGGCEEC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred eCccccccCCccc-------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HH
Confidence 9999987654321 1345799999999999999999999999999999999999999964432221 11
Q ss_pred HHhhhh---cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 625 EILDAQ---AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 625 ~~ld~~---~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+.... ....+...+..+.+|+.+||..+|.+||++.+
T Consensus 244 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 244 NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 111111 11222346788999999999999999999885
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.15 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=197.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+++.++||||+++++++.+.. ++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357888899999999999999985 6799999987543 334567899999999999999999999986544 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999988543 35899999999999999999999988 9999999999999999999999999998654322
Q ss_pred CCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-CCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-GDW 634 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-~~~ 634 (757)
. ........||+.|+|||++.+..+ +.++||||||+++|+|+||+.||......... +........ ...
T Consensus 160 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~ 230 (276)
T 2yex_A 160 R----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKEKKTYLNP 230 (276)
T ss_dssp E----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-----HHHHHTTCTTSTT
T ss_pred c----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHHhhhcccccCc
Confidence 1 111234579999999999877665 77899999999999999999999654321111 111111111 111
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+..+.+|+.+||..+|.+||++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPD 258 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence 2345678999999999999999999875
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.69 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=195.6
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC------
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 470 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------ 470 (757)
....+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|.+++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 34567999999999999999999875 5689999987543 33346789999999999999999999988532
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++||||+. |+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 389999997 5999988653 4899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch--------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 620 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-------- 620 (757)
......... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||............
T Consensus 176 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 176 RVADPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp EECCGGGCB---CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred EecCCCCCc---cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 876543211 111244589999999997654 45899999999999999999999999754322211000
Q ss_pred -h--------hHHHHhhhhc--CCCC-----hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 621 -D--------NLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 621 -~--------~l~~~ld~~~--~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
. .......... ...+ ...+..+.+|+.+||..||.+||++.++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 311 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 311 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0 0000000000 0011 2345789999999999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=341.36 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=196.2
Q ss_pred cCCCHHHHHHhhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccc
Q 004388 391 RNLTWEEIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 467 (757)
Q Consensus 391 ~~~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~ 467 (757)
..+++.++.....+|.....||+|+||.||+|.+ .+..||||++.... .....+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3344455566778899999999999999999998 56799999987543 3456789999999999 799999999998
Q ss_pred cC--------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC
Q 004388 468 PD--------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 539 (757)
Q Consensus 468 ~~--------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~ 539 (757)
.. ..++||||+++|+|.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 43 3489999999999999987643 235889999999999999999999988 99999999999999999
Q ss_pred ceEEeeecCccccCCCCCCccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchh
Q 004388 540 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKV 614 (757)
Q Consensus 540 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~ 614 (757)
.+||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|+||++||......
T Consensus 167 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp CEEECCCTTTC-------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CEEEeeCcCceecCcCcc------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 999999999987653211 123457999999999886 567899999999999999999999999644322
Q ss_pred hhhhchhhHHHHhhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 615 ETAIDEDNLAEILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 615 ~~~~~~~~l~~~ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.. +..+..... ...+...+..+.+|+.+||..+|.+||++.++
T Consensus 241 ~~------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 241 RA------LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp HH------HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HH------HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 21 111111111 11223456789999999999999999999853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=356.30 Aligned_cols=243 Identities=27% Similarity=0.404 Sum_probs=196.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
...|....+||+|+||.||+|.+. +..||||++... .......+.+|+.+|++++||||+++++++.+.. ++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456889999999999999999985 669999998643 2234567899999999999999999999997655 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec---CCCceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld---~~~~~KL~DFGla~~~ 552 (757)
||+.+|+|.+.+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.+
T Consensus 101 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999887654 4899999999999999999999988 99999999999995 5678999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
..... .....||+.|+|||++.+ .++.++|||||||++|+|+||++||......+ .+..+......
T Consensus 175 ~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~ 240 (486)
T 3mwu_A 175 QQNTK-------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKYA 240 (486)
T ss_dssp CCC-----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTCCC
T ss_pred CCCCc-------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC
Confidence 54321 234579999999999875 58999999999999999999999996443211 11222211111
Q ss_pred -CCC--hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 633 -DWP--IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 633 -~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..| ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 241 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 275 (486)
T 3mwu_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275 (486)
T ss_dssp SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 111 24568899999999999999999998533
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=328.62 Aligned_cols=242 Identities=23% Similarity=0.343 Sum_probs=197.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---------hhhHHHHHHHHHHHhcC-CCceeeeccccc
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---------IQNKQFLQELEVLSKIR-HPHLLLLLGACP 468 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---------~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~ 468 (757)
...+|.....||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+|.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3467888999999999999999985 57999999875431 22456889999999996 999999999997
Q ss_pred CCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 469 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 469 ~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
+.. ++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 654 89999999999999997643 4899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccc------cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR------TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~ 620 (757)
|++........ .....||+.|+|||++. ...++.++||||||+++|+|+||+.||.......
T Consensus 169 g~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----- 236 (298)
T 1phk_A 169 GFSCQLDPGEK-------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----- 236 (298)
T ss_dssp TTCEECCTTCC-------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred cchhhcCCCcc-------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-----
Confidence 99987654321 23457999999999874 4568899999999999999999999996433211
Q ss_pred hhHHHHhhhhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 621 DNLAEILDAQAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..+.... ..++ ...+..+.+|+.+||..+|.+||++.+
T Consensus 237 -~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 280 (298)
T 1phk_A 237 -MLRMIMSGN-YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280 (298)
T ss_dssp -HHHHHHHTC-CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred -HHHHHhcCC-cccCcccccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 111122111 1111 245788999999999999999999885
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=368.65 Aligned_cols=256 Identities=22% Similarity=0.355 Sum_probs=205.8
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC-----CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC-ce
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH-----HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GC 472 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~-----~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~ 472 (757)
....+|.....||+|+||.||+|.+. +..||||.+.... ....+.|.+|+.+|++++||||++++|++.+. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 466 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 466 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceE
Confidence 34567888899999999999999884 2479999887543 33456799999999999999999999998654 48
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
+||||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999997543 34899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...... ..+..+.....
T Consensus 542 ~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~~~~~ 610 (656)
T 2j0j_A 542 EDSTY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGER 610 (656)
T ss_dssp CC---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHHTCC
T ss_pred CCCcc-----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCC
Confidence 54321 12234567889999999998999999999999999999997 99999643321 11222333333
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
...|...+..+.+|+.+||..+|.+||++. +++..|+.+.
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs~~-el~~~L~~il 650 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTIL 650 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHHH
Confidence 445666788999999999999999999998 5777777664
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.08 Aligned_cols=247 Identities=18% Similarity=0.223 Sum_probs=185.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
..+|.....||+|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357889999999999999999875 6799999987542 23446788999999999999999999998543
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++||||++ |+|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 389999997 578887742 3889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE--------- 620 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~--------- 620 (757)
+...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||............
T Consensus 175 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 175 RTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ----------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred ccccccc-------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 8654321 123458999999999999889999999999999999999999999754332111000
Q ss_pred -------hhHHHHhhhhc--CC-----------C------ChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 -------DNLAEILDAQA--GD-----------W------PIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 -------~~l~~~ld~~~--~~-----------~------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+...+.... .. + +...+..+.+|+.+||..||.+||++.+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 317 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHh
Confidence 00000000000 00 0 112367899999999999999999998643
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=358.03 Aligned_cols=243 Identities=25% Similarity=0.403 Sum_probs=198.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV 474 (757)
...|...+.||+|+||.||+|... +..||||++.... ......+.+|+.+|++++||||++++++|.+.. ++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999985 5699999986542 334677999999999999999999999997655 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---cCCCceEEeeecCccc
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTM 551 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl---d~~~~~KL~DFGla~~ 551 (757)
|||+.+|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999887543 4899999999999999999999988 9999999999999 5678999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
+..... .....||+.|+|||++.+ .++.++|||||||++|+|+||++||......+ .+..+.....
T Consensus 179 ~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~ 244 (484)
T 3nyv_A 179 FEASKK-------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVEKGKY 244 (484)
T ss_dssp BCCCCS-------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC
T ss_pred cccccc-------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHcCCC
Confidence 654321 133479999999998865 68999999999999999999999997543221 1122221111
Q ss_pred C-CCC--hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 632 G-DWP--IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 632 ~-~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
. ..| ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 245 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l 280 (484)
T 3nyv_A 245 TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDAL 280 (484)
T ss_dssp CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1 111 24578899999999999999999998644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=330.80 Aligned_cols=246 Identities=21% Similarity=0.257 Sum_probs=197.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC----chhhHHHHHHHHHHHhcCCCceeeeccccc--C--Cc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRHPHLLLLLGACP--D--HG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~--~--~~ 471 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.++++++||||+++++++. + ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 357889999999999999999985 5689999987542 234567899999999999999999999983 2 33
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
++||||+++| |.+++.... ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 8999999876 777776543 346899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCC--CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL--ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
....... .......||+.|+|||++.+.. ++.++||||||+++|+|+||+.||...... .+...+..
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~i~~ 227 (305)
T 2wtk_C 159 LHPFAAD----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------KLFENIGK 227 (305)
T ss_dssp CCTTCSS----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHH
T ss_pred cCccccc----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------HHHHHHhc
Confidence 6533211 1123457999999999887543 477999999999999999999999643321 11222222
Q ss_pred hcCCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 630 QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 630 ~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.....+...+..+.+|+.+||..+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 261 (305)
T 2wtk_C 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQI 261 (305)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 2334555677899999999999999999999853
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=331.39 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=183.1
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCch-h-hHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNI-Q-NKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~-~-~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.++|....+||+|+||.||+|.+ .+..||||++...... . ...+.++...++.++||||+++++++.+.. ++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999998 5779999998765322 2 233445555578889999999999986544 8999
Q ss_pred EecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 476 EYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||++ |+|.+++... .....+++..+..|+.||+.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5888877542 2234699999999999999999999997 7 9999999999999999999999999998765
Q ss_pred CCCCCccccccccCCcccccCCCcccc----ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQ----RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
.... .....||+.|+|||++ .+..++.++|||||||++|+|+||+.||...... ...+...+..
T Consensus 162 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~ 229 (290)
T 3fme_A 162 DDVA-------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEE 229 (290)
T ss_dssp ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHS
T ss_pred cccc-------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhcc
Confidence 4321 1334799999999985 5667899999999999999999999999642211 1122233333
Q ss_pred hcCCCC-hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 630 QAGDWP-IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 630 ~~~~~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.....+ ...+..+.+|+.+||+.+|.+||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l 265 (290)
T 3fme_A 230 PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM 265 (290)
T ss_dssp CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHH
Confidence 222222 34678899999999999999999998633
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=343.67 Aligned_cols=260 Identities=19% Similarity=0.274 Sum_probs=194.9
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC-------
Q 004388 399 ESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------- 469 (757)
Q Consensus 399 ~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------- 469 (757)
+....+|...+.||+|+||.||+|.+. +..||||++...... +.+|+.+|+.++||||++++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 445678999999999999999999884 579999998754322 3479999999999999999998721
Q ss_pred -------------------------------C--ceEEEEecCCCCHHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 004388 470 -------------------------------H--GCLVYEYMENGSLEDRLYRK-NNTPPIPWFERYRIAWEVASALAFL 515 (757)
Q Consensus 470 -------------------------------~--~~LV~Ey~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~~L 515 (757)
. .++||||++ |+|.+.+... .....+++..+..|+.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 1 368999998 5888777641 2234699999999999999999999
Q ss_pred hhCCCCCEEEcCCCCCCeeec-CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhh
Q 004388 516 HNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYA 593 (757)
Q Consensus 516 H~~~~~~ivHrDLKp~NILld-~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwS 593 (757)
|+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++||||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------SVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-------CcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 9988 99999999999998 689999999999987654322 2345789999999987764 4899999999
Q ss_pred HHHHHHHHHhCCCCccccchhhhhhch------hhHHHHhh--hh----------cCC----CChhHHHHHHHHHHHHhh
Q 004388 594 YGMVILQLLTAKPAIAITHKVETAIDE------DNLAEILD--AQ----------AGD----WPIKETKELAALGLSCAE 651 (757)
Q Consensus 594 lGvil~elltG~~Pf~~~~~~~~~~~~------~~l~~~ld--~~----------~~~----~p~~~~~~l~~Li~~Cl~ 651 (757)
|||++|+|++|++||......+..... .....+.. +. ... .|...+..+.+|+.+||.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999999754433221100 00000000 00 000 123356789999999999
Q ss_pred ccCCCCCccchhhh-hHHHHHHH
Q 004388 652 LRRKDRPDLKNQVL-PVLERLKE 673 (757)
Q Consensus 652 ~~p~~RPs~~~~vl-~~L~~l~~ 673 (757)
.+|.+||++.+.+. +.++.+..
T Consensus 308 ~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGHHHHH
T ss_pred CChhhCCCHHHHhcCHHHHHHHh
Confidence 99999999986442 34555443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=349.50 Aligned_cols=247 Identities=22% Similarity=0.322 Sum_probs=188.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC------C--c
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------H--G 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~--~ 471 (757)
...|...+.||+|+||.||+|.+. +..||||++..... .+.+|+++|++++|||||+++++|.. . .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346888999999999999999985 67999999865432 23479999999999999999998732 1 2
Q ss_pred eEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCc
Q 004388 472 CLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLS 549 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla 549 (757)
++||||+++ +|.+.+.. ......+++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 689999985 66665543 122346999999999999999999999988 9999999999999955 67899999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch--------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE-------- 620 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-------- 620 (757)
+.+..... .....||+.|+|||++.+. .++.++||||||||||||+||++||......+.....
T Consensus 205 ~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 205 KQLVRGEP-------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 277 (420)
T ss_dssp EECCTTCC-------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred hhcccCCC-------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 87654321 1345789999999988664 7999999999999999999999999754432221110
Q ss_pred -hhHHHHhhhhcCC--------------CChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 621 -DNLAEILDAQAGD--------------WPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 621 -~~l~~~ld~~~~~--------------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+..+ .+.... .+...+..+.+|+.+||..||.+||++.+.+
T Consensus 278 ~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 278 REQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp HHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 000000 000000 1123467899999999999999999998643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.74 Aligned_cols=255 Identities=21% Similarity=0.227 Sum_probs=191.2
Q ss_pred HHHHHHhhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCch-----------hhHHHHHHHHHHHhcCCCceee
Q 004388 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNI-----------QNKQFLQELEVLSKIRHPHLLL 462 (757)
Q Consensus 395 ~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~-----------~~~~f~~Ev~il~~l~Hpniv~ 462 (757)
+.++.....+|...+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.+|++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 3466777889999999999999999999874 679999998643221 1367899999999999999999
Q ss_pred eccccc-----C--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 463 LLGACP-----D--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 463 l~g~~~-----~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
+++++. . ..++||||+. |+|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999982 2 2389999997 68888886433 35899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchh
Q 004388 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKV 614 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~ 614 (757)
+.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+||++||......
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA-------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp CTTCCEEECCTTC----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cCCCCEEEEecCccccccccc-------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999997544322 1234578999999998876 67899999999999999999999999754322
Q ss_pred hhhhc-----------------hhhHHHHhhhhcCCC--------ChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 615 ETAID-----------------EDNLAEILDAQAGDW--------PIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 615 ~~~~~-----------------~~~l~~~ld~~~~~~--------p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..... .......+....... +...+..+.+|+.+||+.+|.+||++.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 11100 000111111111111 1133577999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.60 Aligned_cols=245 Identities=21% Similarity=0.280 Sum_probs=192.1
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--------hhhHHHHHHHHHHHhcCCCceeeecccccCC
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--------IQNKQFLQELEVLSKIRHPHLLLLLGACPDH 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~ 470 (757)
..++|.....||+|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3457889999999999999999985 56999999865421 1223578999999999999999999998654
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc---eEEeee
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV---SKIGDV 546 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~---~KL~DF 546 (757)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred ceEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 48999999999999988643 35899999999999999999999988 999999999999987654 999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l 623 (757)
|++....... ......||+.|+|||++. ...++.++|||||||++|+|+||.+||....... .+
T Consensus 162 g~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~ 228 (322)
T 2ycf_A 162 GHSKILGETS-------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV------SL 228 (322)
T ss_dssp TTCEECCCCH-------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS------CH
T ss_pred ccceeccccc-------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH------HH
Confidence 9998765321 112347899999999863 5678999999999999999999999996432111 11
Q ss_pred HHHhhhhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 624 AEILDAQAGDWP----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 624 ~~~ld~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
...+......+. ...+..+.+|+.+||..+|.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 122221111111 13467899999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.87 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=193.8
Q ss_pred hcCCccceeeccCCcEEEEEEEE---CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc------eeeecccccCCc-
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF---HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH------LLLLLGACPDHG- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~---~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn------iv~l~g~~~~~~- 471 (757)
..+|.....||+|+||.||+|.+ .+..||||++... ......+.+|+.++..++|+| ++++++++.+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35788999999999999999987 4679999998753 234567889999999987654 999999886544
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-------------
Q 004388 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH------------- 537 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~------------- 537 (757)
++||||+ +++|.+++..... .++++..+..|+.||+.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 8999999 8999999876543 45889999999999999999999988 999999999999987
Q ss_pred ------CCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc
Q 004388 538 ------NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 611 (757)
Q Consensus 538 ------~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~ 611 (757)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+||++||...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH---------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC---------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCceEeeCcccccCcccc---------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 6789999999998654321 3457999999999999889999999999999999999999999744
Q ss_pred chhhhhhchhhH-------------------------------HHHhhhh------cCCCChhHHHHHHHHHHHHhhccC
Q 004388 612 HKVETAIDEDNL-------------------------------AEILDAQ------AGDWPIKETKELAALGLSCAELRR 654 (757)
Q Consensus 612 ~~~~~~~~~~~l-------------------------------~~~ld~~------~~~~p~~~~~~l~~Li~~Cl~~~p 654 (757)
...+.......+ ...+... ....+...+..+.+|+.+||..||
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 322110000000 0000000 011123457889999999999999
Q ss_pred CCCCccch
Q 004388 655 KDRPDLKN 662 (757)
Q Consensus 655 ~~RPs~~~ 662 (757)
.+||++.+
T Consensus 318 ~~Rpt~~e 325 (339)
T 1z57_A 318 AKRITLRE 325 (339)
T ss_dssp TTSCCHHH
T ss_pred ccccCHHH
Confidence 99999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.05 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=180.2
Q ss_pred hhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~ 475 (757)
...+|.....||+|+||.||+|.+ .+..||||++.... ......+.+|+.++.+++||||+++++++... .++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 356789999999999999999987 46799999886543 23456788999999999999999999998644 48999
Q ss_pred EecCCCCHHHHHhhc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 476 EYMENGSLEDRLYRK-----NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
||+++|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988641 12345899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
.......... ........||+.|+|||++.+ ..++.++|||||||++|+|+||+.||......... ...+..
T Consensus 170 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~ 242 (303)
T 2vwi_A 170 FLATGGDITR-NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQN 242 (303)
T ss_dssp HCC----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHTS
T ss_pred eeccCCCccc-hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhcc
Confidence 7654322111 111234579999999998865 56899999999999999999999999644322111 111111
Q ss_pred hc---------CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 QA---------GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 ~~---------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. .......+..+.+|+.+||+.+|.+||++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 284 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHH
Confidence 00 1112234678999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.11 Aligned_cols=261 Identities=21% Similarity=0.239 Sum_probs=199.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCcee-eecccc--cCCceEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLL-LLLGAC--PDHGCLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv-~l~g~~--~~~~~LV~E 476 (757)
.++|...++||+|+||.||+|.+. +..||||++..... ...+.+|+.++..+.|++.+ .+..++ .+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 357889999999999999999975 67999999876543 23488999999999875544 333333 344489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---cCCCceEEeeecCccccC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL---DHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl---d~~~~~KL~DFGla~~~~ 553 (757)
|+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+ ||||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 999999987543 35999999999999999999999988 9999999999999 688999999999998876
Q ss_pred CCCCCcccc-ccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 554 SDPSFVSTT-YKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 554 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
......... .......||+.|+|||++.+..++.++||||||||||+|+||+.||........ ...+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~---~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQKYEKISEKKVA 234 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH---HHHHHHHHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH---HHHHHHHhhcccc
Confidence 543221111 122356899999999999999999999999999999999999999974322111 0111111111100
Q ss_pred ----CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 633 ----DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 633 ----~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+...+.++.+|+.+||..+|.+||++. .|+..|+.+...
T Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~-el~~~L~~l~~~ 279 (483)
T 3sv0_A 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYS-YLKRLFRDLFIR 279 (483)
T ss_dssp SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHH-HHHHHHHHHHHH
T ss_pred ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHH-HHHHHHHHHHHH
Confidence 01123356899999999999999999998 577777777543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.28 Aligned_cols=257 Identities=19% Similarity=0.250 Sum_probs=185.4
Q ss_pred HHHHHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC--C-
Q 004388 396 EEIESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--H- 470 (757)
Q Consensus 396 ~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~- 470 (757)
.......++|.....||+|+||.||+|.+. +..||||++..... ....+.+++..+..++||||++++++|.. .
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345566778999999999999999999986 66999998865432 33456788999999999999999999832 1
Q ss_pred ------ceEEEEecCCCCHHHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHh--hCCCCCEEEcCCCCCCeeecC-CCc
Q 004388 471 ------GCLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLH--NTKPKPIIHRDMKPGNILLDH-NLV 540 (757)
Q Consensus 471 ------~~LV~Ey~~~gsL~~~L~~-~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~~~~ivHrDLKp~NILld~-~~~ 540 (757)
.++||||+++ +|.+.+.. ......+++..+..++.||+.||.||| +.+ |+||||||+||||+. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 3789999986 55544432 233456889999999999999999999 766 999999999999997 899
Q ss_pred eEEeeecCccccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc
Q 004388 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 619 (757)
Q Consensus 541 ~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 619 (757)
+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||++|+|+||++||...........
T Consensus 171 ~kl~Dfg~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP-------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EEECCCTTCBCCCTTSC-------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEeeCCCceecCCCCC-------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 99999999987654322 2345789999999988654 489999999999999999999999975432211100
Q ss_pred h--------hhHHHHhhh-----------------hcCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 620 E--------DNLAEILDA-----------------QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 620 ~--------~~l~~~ld~-----------------~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
. ..+...+++ .....+...+..+.+|+.+||+.||.+||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 0 000000000 01112223578899999999999999999998533
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=344.20 Aligned_cols=248 Identities=19% Similarity=0.296 Sum_probs=188.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC------C--ce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------H--GC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~--~~ 472 (757)
..+|...+.||+|+||.||+|.+. +..+|+|++...... ..+|+.+|+.++||||++++++|.. . .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 346889999999999999999985 446888887654322 2369999999999999999999832 1 36
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceEEeeecCccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTM 551 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~KL~DFGla~~ 551 (757)
+||||++++.+............+++..+..|+.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987544443332233346999999999999999999999988 99999999999999 799999999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh---------
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED--------- 621 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~--------- 621 (757)
+..... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||............-
T Consensus 192 ~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 192 LIAGEP-------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CCTTCC-------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCCC-------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 654322 2345789999999988654 58999999999999999999999997544322211100
Q ss_pred hHHHHhhhh-----c---CC------CChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 622 NLAEILDAQ-----A---GD------WPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 622 ~l~~~ld~~-----~---~~------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.+.. ..+. . .. ++...+..+.+|+.+||..+|.+||++.+.+
T Consensus 265 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 265 QIKT-MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp HHHH-HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHh-hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 0000 0000 0 00 1223567899999999999999999988533
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=335.80 Aligned_cols=255 Identities=19% Similarity=0.268 Sum_probs=194.4
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
...+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3567899999999999999999986 6799999987543 33456788999999999999999999987542
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.++||||+. |+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 389999997 6899988652 4899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCcc----ccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-------
Q 004388 551 MLNSDPSFVS----TTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------- 618 (757)
Q Consensus 551 ~~~~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~------- 618 (757)
.......... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 7654321111 0111234579999999997654 678999999999999999999999997543221100
Q ss_pred -----------chhhHHHHhhhhc--CC-----CChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 619 -----------DEDNLAEILDAQA--GD-----WPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 619 -----------~~~~l~~~ld~~~--~~-----~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
......+.+.... .. .+...+..+.+|+.+||..||.+||++.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 0011111111100 00 012356789999999999999999999853
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=342.13 Aligned_cols=246 Identities=22% Similarity=0.283 Sum_probs=177.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC--------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------- 469 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 467899999999999999999874 6799999986532 3345678899999999999999999999853
Q ss_pred CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 470 HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 470 ~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 248999999 6899988754 34899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh----------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---------- 618 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---------- 618 (757)
+..... .+...||+.|+|||++.+ ..++.++|||||||++|+|+||++||..........
T Consensus 180 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 180 RHTADE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cccccc---------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 865432 234589999999998876 678999999999999999999999997543322110
Q ss_pred -------chhhHHHHhhhhc--CCCC-----hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 619 -------DEDNLAEILDAQA--GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 619 -------~~~~l~~~ld~~~--~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
........+.... ...+ ...+..+.+|+.+||..||.+||++.+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 0001111111100 0111 12356789999999999999999998533
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=345.54 Aligned_cols=196 Identities=22% Similarity=0.320 Sum_probs=167.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc------CCCceeeecccccCC--c
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI------RHPHLLLLLGACPDH--G 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l------~Hpniv~l~g~~~~~--~ 471 (757)
..+|....+||+|+||.||+|.+. +..||||++.... .....+.+|+.++..+ +||||+.++++|... .
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 446888999999999999999886 5699999997542 3345678899998887 577999999998644 4
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc--eEEeeecCc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV--SKIGDVGLS 549 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~--~KL~DFGla 549 (757)
|+||||+. |+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 89999996 699998876442 35899999999999999999999988 999999999999999987 999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccc
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~ 612 (757)
...... .....||+.|+|||++.+..++.++|||||||+||||+||++||....
T Consensus 250 ~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR---------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC---------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc---------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 134589999999999998899999999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.00 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=194.0
Q ss_pred hcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-----------CCceeeeccccc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----------HPHLLLLLGACP 468 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----------Hpniv~l~g~~~ 468 (757)
..+|.....||+|+||.||+|.+ .+..||||++... ......+.+|+.++.++. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35789999999999999999997 4679999998753 234566889999999886 899999999985
Q ss_pred C------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeec-----
Q 004388 469 D------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLD----- 536 (757)
Q Consensus 469 ~------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld----- 536 (757)
. ..++||||+ +++|.+++..... ..+++..+..|+.||+.||.|||+. + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 4 347999999 8999999876432 3589999999999999999999997 7 99999999999994
Q ss_pred -CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 004388 537 -HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615 (757)
Q Consensus 537 -~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 615 (757)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||.......
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCcceEEEcccccccccCCC---------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 4458999999999876432 134579999999999999999999999999999999999999997433211
Q ss_pred hhhchhhHHHHhh-----------------------------------------hhcCCCChhHHHHHHHHHHHHhhccC
Q 004388 616 TAIDEDNLAEILD-----------------------------------------AQAGDWPIKETKELAALGLSCAELRR 654 (757)
Q Consensus 616 ~~~~~~~l~~~ld-----------------------------------------~~~~~~p~~~~~~l~~Li~~Cl~~~p 654 (757)
.......+..+++ ......+...+..+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 1111111111111 11123456678899999999999999
Q ss_pred CCCCccchh
Q 004388 655 KDRPDLKNQ 663 (757)
Q Consensus 655 ~~RPs~~~~ 663 (757)
.+||++.++
T Consensus 323 ~~Rpt~~el 331 (373)
T 1q8y_A 323 RKRADAGGL 331 (373)
T ss_dssp TTCBCHHHH
T ss_pred cccCCHHHH
Confidence 999999853
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.78 Aligned_cols=251 Identities=21% Similarity=0.328 Sum_probs=188.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC----------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---------- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---------- 469 (757)
..+|...+.||+|+||.||+|.+. +..||||++........+.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 356888899999999999999986 67999999987666667789999999999999999999988632
Q ss_pred ------CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceE
Q 004388 470 ------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSK 542 (757)
Q Consensus 470 ------~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~K 542 (757)
..++||||++ |+|.+++.. .++++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 2379999997 699998853 35889999999999999999999988 99999999999997 577999
Q ss_pred EeeecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc--
Q 004388 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID-- 619 (757)
Q Consensus 543 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~-- 619 (757)
|+|||+++........ ........||+.|+|||++.. ..++.++|||||||++|+|+||+.||...........
T Consensus 162 l~Dfg~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSH---KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp ECCCTTCBCC-----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EccCccccccCCCccc---ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999876532211 111234568999999998765 6789999999999999999999999975443221100
Q ss_pred -------hhhHHHH-------hhhhc--CCC-----ChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 620 -------EDNLAEI-------LDAQA--GDW-----PIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 620 -------~~~l~~~-------ld~~~--~~~-----p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.....++ +.... ... +...+..+.+|+.+||+.+|.+||++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence 0000000 00000 011 12356789999999999999999999853
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=337.02 Aligned_cols=244 Identities=21% Similarity=0.301 Sum_probs=189.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG------ 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~------ 471 (757)
.++|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||++++++|....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 457888999999999999999875 6799999997643 233567889999999999999999999985432
Q ss_pred --eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 472 --CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
++||||+. |+|.+.+. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 89999997 68888762 23899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------- 619 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--------- 619 (757)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||......+....
T Consensus 192 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 192 RHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccC---------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 865432 234578999999998876 6789999999999999999999999975432211100
Q ss_pred --------hhhHHHHhhhhcCC-------CChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 620 --------EDNLAEILDAQAGD-------WPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 620 --------~~~l~~~ld~~~~~-------~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.......+...... .+...+..+.+|+.+||+.+|.+||++.++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 321 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 321 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence 00000111110000 012346789999999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=346.69 Aligned_cols=249 Identities=23% Similarity=0.360 Sum_probs=174.3
Q ss_pred Ccc-ceeeccCCcEEEEEEEEC----CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeeccccc--C--CceEEE
Q 004388 405 FSE-NLRIGMGGYGTVYKGTFH----HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP--D--HGCLVY 475 (757)
Q Consensus 405 f~~-~~~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~--~--~~~LV~ 475 (757)
|.. .++||+|+||.||+|.+. +..||||++.... ....+.+|+.+|++++||||++++++|. . ..+|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 444 457999999999999965 4589999987543 2356889999999999999999999983 2 338999
Q ss_pred EecCCCCHHHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee----cCCCceEEee
Q 004388 476 EYMENGSLEDRLYRKN------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL----DHNLVSKIGD 545 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl----d~~~~~KL~D 545 (757)
||+. |+|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9997 58888775321 2234899999999999999999999988 9999999999999 7789999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhh---hhhchh
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVE---TAIDED 621 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~---~~~~~~ 621 (757)
||+++.+...... .......+||+.|+|||++.+ ..++.++||||||||||+|+||++||....... ......
T Consensus 176 fg~a~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 176 MGFARLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp TTCCC-------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred CCCceecCCCCcc---cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 9999876543211 112244689999999998876 458999999999999999999999996332110 000011
Q ss_pred hHHHHhhhhc----CCCC---------------------------------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 622 NLAEILDAQA----GDWP---------------------------------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 622 ~l~~~ld~~~----~~~p---------------------------------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+..++.... ..|+ ...+..+.+|+.+||..||.+||++.+
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 1111111100 0010 011467889999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=337.37 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=195.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
...+|.....||+|+||.||+|.+.+ .+|+|++.... ....+.|.+|+.++++++||||+++++++.+.. ++|||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 45678899999999999999999876 49999987542 223355788999999999999999999996654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+++++|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999986543 35889999999999999999999988 99999999999998 6899999999987654221
Q ss_pred CCccccccccCCcccccCCCcccccc---------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRT---------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
.. ..........||+.|+|||++.. ..++.++|||||||++|+|+||+.||....... ....+.
T Consensus 184 ~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~ 256 (319)
T 2y4i_B 184 AG-RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------IIWQMG 256 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HHHHHH
T ss_pred cc-ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHhc
Confidence 11 11112234579999999998764 457889999999999999999999996433211 111111
Q ss_pred hhhcCC-CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 628 DAQAGD-WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 628 d~~~~~-~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
...... .+...+..+.+|+.+||..+|.+||++. +++..|+.+...
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~l~~~l~~l~~~ 303 (319)
T 2y4i_B 257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFT-KLMDMLEKLPKR 303 (319)
T ss_dssp TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHH-HHHHHHTTC---
T ss_pred cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHH-HHHHHHHHHHHh
Confidence 111111 1223566799999999999999999998 577777666543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.91 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=194.9
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCCc--hhhHHHHHHHHHHHhc---CCCceeeeccccc----
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACP---- 468 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l---~Hpniv~l~g~~~---- 468 (757)
+..+|.....||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.+ +||||++++++|.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4568999999999999999999973 57899999865432 2233567888888776 8999999999985
Q ss_pred -C--CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEee
Q 004388 469 -D--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545 (757)
Q Consensus 469 -~--~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~D 545 (757)
. ..++||||+. |+|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 2 2389999998 699998876442 35899999999999999999999988 99999999999999999999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHH
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAE 625 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~ 625 (757)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||++||........ +..
T Consensus 164 fg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~ 230 (326)
T 1blx_A 164 FGLARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ------LGK 230 (326)
T ss_dssp CCSCCCCCGGG-------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH
T ss_pred CcccccccCCC-------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHH
Confidence 99998654221 22446799999999999988999999999999999999999999975432211 111
Q ss_pred Hhhhh--------------------------cCCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 626 ILDAQ--------------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 626 ~ld~~--------------------------~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
+++.. ....+...+..+.+|+.+||..+|.+||++.+.
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 294 (326)
T 1blx_A 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294 (326)
T ss_dssp HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 11100 001122456789999999999999999999853
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.11 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=186.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC----------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---------- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---------- 469 (757)
..+|.....||+|+||.||+|... +..||||++... ......+.+|+.++++++||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999974 679999998643 2345678999999999999999999998732
Q ss_pred -----CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEe
Q 004388 470 -----HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544 (757)
Q Consensus 470 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~ 544 (757)
..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 2379999999999999997643 34788899999999999999999988 9999999999999999999999
Q ss_pred eecCccccCCCCCCc--------cccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhh
Q 004388 545 DVGLSTMLNSDPSFV--------STTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVE 615 (757)
Q Consensus 545 DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~ 615 (757)
|||++.......... ..........||+.|+|||++.+. .++.++|||||||++|+|+| ||......
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~- 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER- 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-
Confidence 999998765321100 001122445799999999988754 68999999999999999999 44311111
Q ss_pred hhhchhhHHHHhhhh----cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 616 TAIDEDNLAEILDAQ----AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~----~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+...+... ...++...+..+.+|+.+||..||.+||++.+
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 280 (303)
T 1zy4_A 235 -----VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGART 280 (303)
T ss_dssp -----HHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----HHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHH
Confidence 1111111111 12234456678999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=334.54 Aligned_cols=244 Identities=21% Similarity=0.292 Sum_probs=190.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 457888999999999999999885 6799999987543 23356788999999999999999999998653
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.++||||+. |+|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 289999997 68877663 24899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh----------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI---------- 618 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~---------- 618 (757)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|+||++||..........
T Consensus 174 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 174 RHADAE---------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp TC-----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred cCCCCC---------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 865432 134578999999998876 678999999999999999999999997543221100
Q ss_pred -------chhhHHHHhhhh-------cCCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 619 -------DEDNLAEILDAQ-------AGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 619 -------~~~~l~~~ld~~-------~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
........+... ....+...+..+.+|+.+||..||.+||++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 303 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA 303 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 000000111100 011223457889999999999999999999853
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.36 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=191.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc------eeeecccccCC--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH------LLLLLGACPDH-- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn------iv~l~g~~~~~-- 470 (757)
..+|.....||+|+||.||+|.+. +..||||++... ......+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 457899999999999999999874 368999999753 234567889999999997766 88888887543
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee---------------
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL--------------- 535 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl--------------- 535 (757)
.+|||||+ +++|.+.+.... ..++++..+..|+.||+.||.|||+.+ |+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 48999999 677777776543 245899999999999999999999988 9999999999999
Q ss_pred ----cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcccc
Q 004388 536 ----DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAIT 611 (757)
Q Consensus 536 ----d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~ 611 (757)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+||++||...
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH---------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC---------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccCCCcEEEeecCccccccccc---------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 678999999999998644321 3457999999999999889999999999999999999999999744
Q ss_pred chhhhhhchhhH-------------------------------HHHhhhhc------CCCChhHHHHHHHHHHHHhhccC
Q 004388 612 HKVETAIDEDNL-------------------------------AEILDAQA------GDWPIKETKELAALGLSCAELRR 654 (757)
Q Consensus 612 ~~~~~~~~~~~l-------------------------------~~~ld~~~------~~~p~~~~~~l~~Li~~Cl~~~p 654 (757)
...........+ ...+.... .......+..+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 322111000000 00000000 01122346789999999999999
Q ss_pred CCCCccchh
Q 004388 655 KDRPDLKNQ 663 (757)
Q Consensus 655 ~~RPs~~~~ 663 (757)
.+||++.++
T Consensus 323 ~~Rpt~~e~ 331 (355)
T 2eu9_A 323 AQRITLAEA 331 (355)
T ss_dssp TTSCCHHHH
T ss_pred hhCcCHHHH
Confidence 999999853
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=322.59 Aligned_cols=243 Identities=27% Similarity=0.403 Sum_probs=195.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
..+|.....||+|+||.||+|.+. +..||||++.... ......+.+|+.++++++||||+++++++.+.. ++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 356888899999999999999985 6799999986542 234577899999999999999999999987654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC---CceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN---LVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~---~~~KL~DFGla~~~ 552 (757)
||+++++|.+.+.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++...
T Consensus 101 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999999999887654 4899999999999999999999988 9999999999999754 47999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~ 632 (757)
..... .....||+.|+|||++.+ .++.++||||||+++|+|+||++||....... .+..+......
T Consensus 175 ~~~~~-------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~~ 240 (287)
T 2wei_A 175 QQNTK-------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVETGKYA 240 (287)
T ss_dssp CCCSS-------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCC
T ss_pred cCCCc-------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCC
Confidence 54321 123468999999998865 48999999999999999999999996543221 11111111111
Q ss_pred -CCC--hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 633 -DWP--IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 633 -~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+ ...+..+.+++.+||..+|.+||++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell 275 (287)
T 2wei_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275 (287)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 111 23567899999999999999999998533
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=328.86 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=190.8
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch------hhHHHHHHHHHHHhc----CCCceeeeccc
Q 004388 399 ESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI------QNKQFLQELEVLSKI----RHPHLLLLLGA 466 (757)
Q Consensus 399 ~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l----~Hpniv~l~g~ 466 (757)
....++|.....||+|+||.||+|.+. +..||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 444668999999999999999999874 568999998754321 223356799999999 89999999999
Q ss_pred ccCC--ceEEEEe-cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceE
Q 004388 467 CPDH--GCLVYEY-MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSK 542 (757)
Q Consensus 467 ~~~~--~~LV~Ey-~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~K 542 (757)
+.+. .++|||| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 8643 4899999 88999999997654 4899999999999999999999988 99999999999999 899999
Q ss_pred EeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCC-CcchhhhHHHHHHHHHhCCCCccccchhhhhhchh
Q 004388 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS-PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621 (757)
Q Consensus 543 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 621 (757)
|+|||++....... .....||+.|+|||++.+..+. .++|||||||++|+|+||+.||.....
T Consensus 181 l~dfg~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------- 244 (312)
T 2iwi_A 181 LIDFGSGALLHDEP--------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------- 244 (312)
T ss_dssp ECCCSSCEECCSSC--------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred EEEcchhhhcccCc--------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence 99999998765432 1345799999999988776654 589999999999999999999964321
Q ss_pred hHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 622 ~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
++. .....+...+..+.+|+.+||..+|.+||++.++
T Consensus 245 ----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 245 ----ILE-AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp ----HHH-TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ----Hhh-hccCCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 111 1223455667889999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=329.68 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=173.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHH-HHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELE-VLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~-il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
..+|.....||+|+||.||+|.+. +..||||++..... .....+..|+. +++.++||||+++++++.+.. ++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 357888899999999999999986 77999999976532 33445666666 677789999999999986554 7999
Q ss_pred EecCCCCHHHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYR--KNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~--~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
||+++ +|.+++.. ......+++..+..|+.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 88887753 12234689999999999999999999997 7 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCcccc----ccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQ----RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
..... .....||+.|+|||++ .+..++.++|||||||++|+|+||+.||......... +..++.
T Consensus 177 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~ 244 (327)
T 3aln_A 177 VDSIA-------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQVVK 244 (327)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC
T ss_pred ccccc-------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHHHhc
Confidence 53321 1334799999999998 4567899999999999999999999999643221111 111111
Q ss_pred hhcCCC----ChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 629 AQAGDW----PIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 629 ~~~~~~----p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
...... +...+..+.+|+.+||..+|.+||++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 283 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 111111 12457789999999999999999999853
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=331.55 Aligned_cols=201 Identities=26% Similarity=0.319 Sum_probs=167.5
Q ss_pred HHhhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CC-----ceeeecccccC-
Q 004388 399 ESATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HP-----HLLLLLGACPD- 469 (757)
Q Consensus 399 ~~at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hp-----niv~l~g~~~~- 469 (757)
....++|.....||+|+||.||+|.+. +..||||++... ......+..|+.++..++ |+ +|+.+++++..
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 445678999999999999999999885 568999999753 233466788999998885 55 48999998854
Q ss_pred -CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec--CCCceEEeee
Q 004388 470 -HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDV 546 (757)
Q Consensus 470 -~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld--~~~~~KL~DF 546 (757)
..||||||+. |+|.+++..... ..+++..+..|+.||+.||.|||++. .+|+||||||+||||+ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 4489999996 599998876542 35899999999999999999999632 3499999999999994 5788999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccc
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITH 612 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~ 612 (757)
|+++..... .....||+.|+|||++.+..++.++|||||||++|+|+||++||....
T Consensus 206 G~a~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 206 GSSCQLGQR---------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TTCEETTCC---------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCceecccc---------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999876432 134589999999999999899999999999999999999999997543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=330.72 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=194.5
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCch------hhHHHHHHHHHHHhcC--CCceeeeccc
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNI------QNKQFLQELEVLSKIR--HPHLLLLLGA 466 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~--Hpniv~l~g~ 466 (757)
+......+|.....||+|+||.||+|.+ .+..||||++...... ....+.+|+.++.+++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3444566799999999999999999987 4679999998754321 2245678999999996 5999999999
Q ss_pred ccCCc--eEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceE
Q 004388 467 CPDHG--CLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSK 542 (757)
Q Consensus 467 ~~~~~--~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~K 542 (757)
+.+.. ++||||+.+ ++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 97654 899999976 89999987643 4889999999999999999999988 99999999999999 789999
Q ss_pred EeeecCccccCCCCCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh
Q 004388 543 IGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED 621 (757)
Q Consensus 543 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 621 (757)
|+|||+++...... .....||+.|+|||++.+..+ +.++|||||||++|+|+||+.||......
T Consensus 191 L~Dfg~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------- 255 (320)
T 3a99_A 191 LIDFGSGALLKDTV--------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------- 255 (320)
T ss_dssp ECCCTTCEECCSSC--------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------
T ss_pred EeeCcccccccccc--------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------
Confidence 99999998765321 134579999999998877665 68899999999999999999999643211
Q ss_pred hHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 622 NLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 622 ~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.. .....+...+..+.+|+.+||..+|.+||++.+
T Consensus 256 -----~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 290 (320)
T 3a99_A 256 -----IR-GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEE 290 (320)
T ss_dssp -----HH-CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -----hc-ccccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 11 112234456678999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=327.46 Aligned_cols=255 Identities=24% Similarity=0.336 Sum_probs=194.3
Q ss_pred CCHHHHHHhhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCC--chhhHHHHHHHHHHHhcC--CCceeeecccc
Q 004388 393 LTWEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIR--HPHLLLLLGAC 467 (757)
Q Consensus 393 ~~~~ei~~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~--Hpniv~l~g~~ 467 (757)
+.+..+.....+|.....||+|+||.||++.+. +..||||++.... ......+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 333344445667999999999999999999875 5689999987543 334567899999999997 59999999998
Q ss_pred cCCc--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEee
Q 004388 468 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGD 545 (757)
Q Consensus 468 ~~~~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~D 545 (757)
.+.. ++||| +.+++|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 6655 78999 56789999997643 5889999999999999999999988 999999999999964 8999999
Q ss_pred ecCccccCCCCCCccccccccCCcccccCCCcccccc-----------CCCCCcchhhhHHHHHHHHHhCCCCccccchh
Q 004388 546 VGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-----------GLISPKSDVYAYGMVILQLLTAKPAIAITHKV 614 (757)
Q Consensus 546 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~ 614 (757)
||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||......
T Consensus 170 fg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (313)
T 3cek_A 170 FGIANQMQPDTTS----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245 (313)
T ss_dssp CSSSCC------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred ccccccccCcccc----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH
Confidence 9999876543211 11234579999999998765 46888999999999999999999999633211
Q ss_pred hhhhchhhHHHHhhhhc-CCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 615 ETAIDEDNLAEILDAQA-GDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 615 ~~~~~~~~l~~~ld~~~-~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
...+..+++... ...+...+..+.+|+.+||..+|.+||++.+++
T Consensus 246 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 291 (313)
T 3cek_A 246 -----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291 (313)
T ss_dssp -----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred -----HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHh
Confidence 112233333322 234445567899999999999999999998533
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=329.54 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=168.1
Q ss_pred hhcCCccce-eeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHH-HHHHhcCCCceeeecccccC----C--
Q 004388 401 ATLSFSENL-RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQEL-EVLSKIRHPHLLLLLGACPD----H-- 470 (757)
Q Consensus 401 at~~f~~~~-~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev-~il~~l~Hpniv~l~g~~~~----~-- 470 (757)
..++|.... .||+|+||.||+|.+. +..||||++.... ...+|+ ..+..+.||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 356788855 5999999999999986 6799999986531 222333 34566799999999999853 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEeeec
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVG 547 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~DFG 547 (757)
.++||||++||+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 3799999999999999976543 46999999999999999999999988 999999999999976 4569999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
+++...... .....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ .......+.
T Consensus 177 ~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~ 246 (336)
T 3fhr_A 177 FAKETTQNA--------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI--SPGMKRRIR 246 (336)
T ss_dssp TCEEC------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred cceeccccc--------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh--hhhHHHhhh
Confidence 998654321 1345789999999999888899999999999999999999999964322111 000000111
Q ss_pred hhhc---CCCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 628 DAQA---GDWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 628 d~~~---~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
.... .......+..+.+|+.+||..+|.+||++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 285 (336)
T 3fhr_A 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0000 01112457889999999999999999999853
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.69 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=179.0
Q ss_pred CccceeeccCCcEEEE-EEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEecCC
Q 004388 405 FSENLRIGMGGYGTVY-KGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vy-k~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey~~~ 480 (757)
|...+.||+|+||+|| .+...+..||||++.... .+.+.+|+.+|.++ +|||||++++++.+.. +|||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456789999999996 455678899999986532 35678999999986 8999999999987655 89999995
Q ss_pred CCHHHHHhhcCCCCC----CCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-------------CceEE
Q 004388 481 GSLEDRLYRKNNTPP----IPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-------------LVSKI 543 (757)
Q Consensus 481 gsL~~~L~~~~~~~~----l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-------------~~~KL 543 (757)
|+|.+++........ .++..+..|+.||+.||.|||+.+ |+||||||+||||+.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 699999976443211 123345789999999999999988 9999999999999754 58999
Q ss_pred eeecCccccCCCCCCccccccccCCcccccCCCcccccc-------CCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 004388 544 GDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-------GLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 615 (757)
Q Consensus 544 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~ 615 (757)
+|||+++.+........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |++||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFR--TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp CCCTTCEECCC----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred cccccceecCCCCccce--eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999988765432111 11234589999999998865 678999999999999999999 999996432221
Q ss_pred hhhchhhHHHHhhhh--cCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 616 TAIDEDNLAEILDAQ--AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~--~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
..+ +....... ....+...+..+.+|+.+||+.+|.+||++.+++
T Consensus 248 ~~i----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 248 SNI----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp HHH----HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHH----hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 111 00000000 0111335678999999999999999999998644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=339.85 Aligned_cols=244 Identities=23% Similarity=0.311 Sum_probs=182.7
Q ss_pred hcCCccceeeccCCcEE-EEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGT-VYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~-Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
..+|.....||+|+||+ ||++...++.||||++...... .+.+|+.+|+.+ +|||||++++++.+.. +|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 45688889999999998 5677778899999998754322 356899999999 7999999999986654 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-----CCceEEeeecCcccc
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-----NLVSKIGDVGLSTML 552 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-----~~~~KL~DFGla~~~ 552 (757)
+. |+|.+++..... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++.+
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 699999875542 2444456789999999999999988 999999999999943 346789999999877
Q ss_pred CCCCCCccccccccCCcccccCCCccccc---cCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQR---TGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
...... ........||+.|+|||++. ...++.++|||||||++|+|+| |.+||+....... ..++.
T Consensus 174 ~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~ 243 (432)
T 3p23_A 174 AVGRHS---FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLG 243 (432)
T ss_dssp ---------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTT
T ss_pred cCCCcc---eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhc
Confidence 643211 11234568999999999887 4567889999999999999999 9999964322111 11111
Q ss_pred hh---cCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 629 AQ---AGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 629 ~~---~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.. ....+......+.+|+.+||+.+|.+||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 11 1112234567789999999999999999998644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=319.95 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=175.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch-hh-HHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-QN-KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~-~~-~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
.++|.....||+|+||.||+|.+. +..||||++...... .. ..+..+..++..++||||+++++++.+.. ++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888899999999999999985 679999999765332 22 23444556788889999999999986654 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-CCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT-KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
||+ ++.+..++.... ..+++..+..++.||+.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 556665554332 3589999999999999999999985 7 99999999999999999999999999976654
Q ss_pred CCCCccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA 629 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~ 629 (757)
... .....||+.|+|||++. ...++.++|||||||++|+|+||+.||...... ...+..++..
T Consensus 178 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~ 245 (318)
T 2dyl_A 178 DKA-------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQE 245 (318)
T ss_dssp ----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHS
T ss_pred Ccc-------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhcc
Confidence 321 13347999999999884 556889999999999999999999999642211 1122223322
Q ss_pred hcCCCC--hhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 630 QAGDWP--IKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 630 ~~~~~p--~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
.....+ ...+..+.+|+.+||..+|.+||++.+++
T Consensus 246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (318)
T 2dyl_A 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282 (318)
T ss_dssp CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 222222 23578899999999999999999998644
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=351.67 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=194.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccC--------Cc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------HG 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--------~~ 471 (757)
.+|....+||.|+||.||+|.+. +..||||++... .......|.+|+.+|.+++||||+++++++.+ ..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57899999999999999999874 679999998764 33345678999999999999999999998643 23
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCc---eEEeeecC
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV---SKIGDVGL 548 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~---~KL~DFGl 548 (757)
++||||++||+|.+++........+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 899999999999999987665557899999999999999999999988 999999999999997664 89999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhh---hch-hh--
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA---IDE-DN-- 622 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~---~~~-~~-- 622 (757)
+........ .....||+.|+|||++.+..++.++|||||||++|+|+||..||......... +.. ..
T Consensus 171 a~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL-------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC-------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccccc-------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 987654321 13458999999999999999999999999999999999999999643111110 000 00
Q ss_pred --HHHHhh---------hhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 623 --LAEILD---------AQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 623 --l~~~ld---------~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+. +.....+...+..+.+|+.+||..||.+||++.+
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 0011233457889999999999999999999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=354.33 Aligned_cols=237 Identities=23% Similarity=0.288 Sum_probs=192.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccC--C-----c
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--H-----G 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~-----~ 471 (757)
++|.....||+|+||.||+|.+. ++.||||++.... ......|.+|+.+|.+++||||++++++|.+ . .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888999999999999999874 6799999986543 3345678999999999999999999999853 2 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
||||||++|++|.+++.. .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 899999999999887643 5899999999999999999999988 9999999999999886 899999999987
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
.... ....||+.|+|||++.++. +.++|||||||+||+|++|.+||...... .+..
T Consensus 231 ~~~~----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--~~~~----------- 286 (681)
T 2pzi_A 231 INSF----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--GLPE----------- 286 (681)
T ss_dssp TTCC----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--SCCT-----------
T ss_pred cccC----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--cccc-----------
Confidence 6532 3357999999999987664 89999999999999999999998532110 0000
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.......+..+.+|+.+||+.+|.+||+..+++...|..+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00011234679999999999999999998888877776553
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=328.20 Aligned_cols=239 Identities=16% Similarity=0.120 Sum_probs=179.5
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCC-Ccee-------------
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRH-PHLL------------- 461 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~H-pniv------------- 461 (757)
.+.+|...+.||+|+||.||+|.+. +..||||++..... ...+.|.+|+.++..+.| +|..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3456778889999999999999986 77999999884432 235779999999999987 3221
Q ss_pred --ee------cccccC-------CceEEEEecCCCCHHHHHhh----cCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 004388 462 --LL------LGACPD-------HGCLVYEYMENGSLEDRLYR----KNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522 (757)
Q Consensus 462 --~l------~g~~~~-------~~~LV~Ey~~~gsL~~~L~~----~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ 522 (757)
.+ +.++.. ..+++|+++ +|+|.+++.. ......+++..++.|+.||+.||.|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 11 111111 125666655 6899998842 122345788899999999999999999988
Q ss_pred EEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCcccc----------ccCCCCCcchhh
Q 004388 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ----------RTGLISPKSDVY 592 (757)
Q Consensus 523 ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~s~ksDvw 592 (757)
||||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE---------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc---------cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 999999999999999999999999999865432 234577 999999988 555688899999
Q ss_pred hHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhh
Q 004388 593 AYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQV 664 (757)
Q Consensus 593 SlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~v 664 (757)
||||++|+|+||+.||........ ...++ ..+ ...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~------~~~~~----~~~-~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGG------SEWIF----RSC-KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSC------SGGGG----SSC-CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHHHHHHCCCCCCCcchhhh------HHHHH----hhc-ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999999999964432111 11111 111 13457899999999999999999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=311.97 Aligned_cols=228 Identities=14% Similarity=0.090 Sum_probs=175.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
+.|.....||+|+||.||+|.+. +..||||++..... .....|.+|+.++.+++||||+++++++.+.. |+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888999999999999999986 67999999976543 23467899999999999999999999986544 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++|++|.+++... .......+|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 999999999998431 344568889999999999999988 9999999999999999999997443
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-chhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-DEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-~~~~l~~~ld~~~~~~ 634 (757)
|++| ++.++|||||||++|+|+||+.||.......... ....+...... ....
T Consensus 175 ------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 228 (286)
T 3uqc_A 175 ------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE-PADI 228 (286)
T ss_dssp ------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCC-HHHH
T ss_pred ------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCC-hhhc
Confidence 3332 6889999999999999999999997543221000 00000000000 0001
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
+...+..+.+|+.+||+.||.+| ++. +++..|+.+...
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~-el~~~L~~~~~~ 266 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SAS-TLLNLMQQATAV 266 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHH-HHHHHHHHHHC-
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHH-HHHHHHHHHhcc
Confidence 12346789999999999999999 877 577777776543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.36 Aligned_cols=228 Identities=17% Similarity=0.148 Sum_probs=175.8
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCc--------hhhHHHHHHHHHHHhcC---------C-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGN--------IQNKQFLQELEVLSKIR---------H------- 457 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~--------~~~~~f~~Ev~il~~l~---------H------- 457 (757)
..+|....+||+|+||.||+|++.+..||||++..... ...+.+.+|+.+|+.++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 45688899999999999999999999999999976532 23377899999999886 5
Q ss_pred ----------Cceeeeccccc---------------CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 004388 458 ----------PHLLLLLGACP---------------DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512 (757)
Q Consensus 458 ----------pniv~l~g~~~---------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL 512 (757)
|||+++++++. +..||||||+++|++.+.+.+ ..+++..+..|+.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 45555555443 334899999999977666633 3489999999999999999
Q ss_pred HHHh-hCCCCCEEEcCCCCCCeeecCCC--------------------ceEEeeecCccccCCCCCCccccccccCCccc
Q 004388 513 AFLH-NTKPKPIIHRDMKPGNILLDHNL--------------------VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571 (757)
Q Consensus 513 ~~LH-~~~~~~ivHrDLKp~NILld~~~--------------------~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt 571 (757)
.||| +.+ |+||||||+||||+.++ .+||+|||+|+..... ..+||
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----------~~~gt 240 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----------IVVFC 240 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------EEECC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------cEEEe
Confidence 9999 888 99999999999999887 9999999999876532 23799
Q ss_pred ccCCCccccccCCCCCcchhhhHHHH-HHHHHhCCCCccccchhhhhhchhhHHHHhhhhc---CCC---ChhHHHHHHH
Q 004388 572 LCYIDPEYQRTGLISPKSDVYAYGMV-ILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA---GDW---PIKETKELAA 644 (757)
Q Consensus 572 ~~Y~aPE~~~~~~~s~ksDvwSlGvi-l~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~---~~~---p~~~~~~l~~ 644 (757)
+.|+|||++.+.. +.++||||||++ .+++++|..||....+... ....++.... ... +...+..+.+
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY-----LTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH-----HHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH-----HHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence 9999999988665 899999998777 7889999999953211111 1111221111 111 2256889999
Q ss_pred HHHHHhhcc
Q 004388 645 LGLSCAELR 653 (757)
Q Consensus 645 Li~~Cl~~~ 653 (757)
|+.+||+.+
T Consensus 315 li~~~L~~d 323 (336)
T 2vuw_A 315 FHRTMLNFS 323 (336)
T ss_dssp HHHHGGGSS
T ss_pred HHHHHhccC
Confidence 999999966
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=303.58 Aligned_cols=222 Identities=20% Similarity=0.311 Sum_probs=172.8
Q ss_pred hcCCccc-eeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHH-HhcCCCceeeecccccC----C--c
Q 004388 402 TLSFSEN-LRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVL-SKIRHPHLLLLLGACPD----H--G 471 (757)
Q Consensus 402 t~~f~~~-~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il-~~l~Hpniv~l~g~~~~----~--~ 471 (757)
..+|... +.||+|+||.||+|.+. +..||||++.. ...+.+|+.++ +.++||||+++++++.. . .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3456666 67999999999999984 56999999864 34577899998 55689999999998854 2 3
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEeeecC
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGL 548 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~DFGl 548 (757)
++||||+++|+|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 899999999999999976542 35899999999999999999999988 999999999999998 78999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
+.... +..++.++|||||||++|+|+||++||.......... . +...+.
T Consensus 167 a~~~~----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~--~-~~~~~~ 215 (299)
T 3m2w_A 167 AKETT----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-MKTRIR 215 (299)
T ss_dssp CEECT----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--C-SCCSSC
T ss_pred ccccc----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--H-HHHHHh
Confidence 87532 1346789999999999999999999996433221100 0 000011
Q ss_pred hhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 629 AQAGDWP----IKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 629 ~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
......+ ...+..+.+|+.+||..+|.+||++.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~ 254 (299)
T 3m2w_A 216 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254 (299)
T ss_dssp TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 1111222 2356789999999999999999999853
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-29 Score=293.61 Aligned_cols=181 Identities=17% Similarity=0.073 Sum_probs=126.3
Q ss_pred ccCCcEEEEEEE--ECCeEEEEEEEccCC----------chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEEEE
Q 004388 412 GMGGYGTVYKGT--FHHTFAAVKVLQSKG----------NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 412 G~G~~G~Vyk~~--~~~~~vAvK~l~~~~----------~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+.|+.|.+..++ +-+..+++|++.... ....++|.+|+++|+++ .||||+++++++.+.. |||||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 445555444332 235679999997652 12345699999999999 6999999999997765 99999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++||+|.++|...+ +++. .+|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+......
T Consensus 323 yv~G~~L~d~i~~~~---~l~~---~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 323 KLPGRLLSDMLAAGE---EIDR---EKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp CCCSEEHHHHHHTTC---CCCH---HHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred cCCCCcHHHHHHhCC---CCCH---HHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 999999999997644 3554 358999999999999998 9999999999999999999999999998765433
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCc
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAI 608 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf 608 (757)
. ..+..+||+.|||||++.+ .+..++|+||+|+++++|++|..++
T Consensus 394 ~------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 S------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C------CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred c------cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 1244689999999998864 5678899999999999888776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.4e-27 Score=270.45 Aligned_cols=187 Identities=16% Similarity=0.181 Sum_probs=145.8
Q ss_pred ccceeeccCCcEEEEEEEECCeEEEEEEEccCCch--------hhHHHHHHHHHHHhcCCCcee--eecccccCCceEEE
Q 004388 406 SENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNI--------QNKQFLQELEVLSKIRHPHLL--LLLGACPDHGCLVY 475 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~--------~~~~f~~Ev~il~~l~Hpniv--~l~g~~~~~~~LV~ 475 (757)
...+.||+|+||.||+|...+..+++|........ ..+.|.+|+.+|++++||||+ .++++..+..||||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 44568999999999999888999999987543211 134589999999999999999 66777677779999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++.. +..|+.||+.||.|||+.+ |+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999998854 4589999999999999988 999999999999998 9999999999987543
Q ss_pred CCCcccc-ccccCCcccccCCCcccccc--CCCCCcchhhhHHHHHHHHHhCCCCc
Q 004388 556 PSFVSTT-YKNTGPVGTLCYIDPEYQRT--GLISPKSDVYAYGMVILQLLTAKPAI 608 (757)
Q Consensus 556 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDvwSlGvil~elltG~~Pf 608 (757)
....... .......||+.|||||++.. ..|+..+|+||.++-.++.+-++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2110000 01134689999999999876 56788899999999999888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-23 Score=216.59 Aligned_cols=146 Identities=14% Similarity=0.047 Sum_probs=116.1
Q ss_pred HhhcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCc------------------hhhHHHHHHHHHHHhcCCCce
Q 004388 400 SATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN------------------IQNKQFLQELEVLSKIRHPHL 460 (757)
Q Consensus 400 ~at~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~------------------~~~~~f~~Ev~il~~l~Hpni 460 (757)
.....|.....||.|+||.||+|.+. +..||||+++.... .....+.+|+.+|++++ |
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred hCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 33445666789999999999999984 67999999864321 13456899999999999 4
Q ss_pred eeeccccc-CCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC
Q 004388 461 LLLLGACP-DHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL 539 (757)
Q Consensus 461 v~l~g~~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~ 539 (757)
+++++++. +..++||||++||+|.+ +.. .....++.||+.||.|||+.+ |+||||||+|||++ ++
T Consensus 164 ~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 164 LAVPKVYAWEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SSSCCEEEEETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TT
T ss_pred CCcCeEEeccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CC
Confidence 66666553 34599999999999988 421 124579999999999999988 99999999999999 99
Q ss_pred ceEEeeecCccccCCCCCCccccccccCCcccccCCCccccc
Q 004388 540 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581 (757)
Q Consensus 540 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 581 (757)
.+||+|||+|+. +..|+|||++.
T Consensus 230 ~vkl~DFG~a~~-------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVE-------------------VGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEE-------------------TTSTTHHHHHH
T ss_pred cEEEEECCCCeE-------------------CCCCCHHHHHH
Confidence 999999999863 34568899764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.5e-20 Score=191.93 Aligned_cols=136 Identities=15% Similarity=0.102 Sum_probs=105.6
Q ss_pred CccceeeccCCcEEEEEEEE--CCeE--EEEEEEccCCch------------------------hhHHHHHHHHHHHhcC
Q 004388 405 FSENLRIGMGGYGTVYKGTF--HHTF--AAVKVLQSKGNI------------------------QNKQFLQELEVLSKIR 456 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~--~~~~--vAvK~l~~~~~~------------------------~~~~f~~Ev~il~~l~ 456 (757)
|.....||+|+||.||+|.+ .+.. ||||+++..... ....+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56678899999999999998 7888 999997543211 1135789999999998
Q ss_pred CCce--eeecccccCCceEEEEecCC-C----CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCEEEcCC
Q 004388 457 HPHL--LLLLGACPDHGCLVYEYMEN-G----SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH-NTKPKPIIHRDM 528 (757)
Q Consensus 457 Hpni--v~l~g~~~~~~~LV~Ey~~~-g----sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivHrDL 528 (757)
|+++ +..++ .+..+|||||+.+ | +|.+.... .++.....++.||+.||.||| ..+ |+||||
T Consensus 129 ~~~i~~p~~~~--~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYT--YMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHADL 197 (258)
T ss_dssp HTTCCCCCEEE--EETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred hCCCCCCeEEE--cCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 8764 33333 2456899999942 4 77776532 123456789999999999999 877 999999
Q ss_pred CCCCeeecCCCceEEeeecCccccC
Q 004388 529 KPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 529 Kp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||+|||++. .++|+|||+|....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETT
T ss_pred CHHHEEEcC--cEEEEECcccccCC
Confidence 999999998 99999999997643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=7.9e-16 Score=168.28 Aligned_cols=136 Identities=13% Similarity=0.146 Sum_probs=95.1
Q ss_pred CccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCc--------------hhhHHHH--------HHHHHHHhcCCCcee
Q 004388 405 FSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN--------------IQNKQFL--------QELEVLSKIRHPHLL 461 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~--------------~~~~~f~--------~Ev~il~~l~Hpniv 461 (757)
|....+||.|+||.||+|... +..||||+++.... ....... .|...|.++.++++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 888999999999999999874 67999999764211 0111122 344455555333321
Q ss_pred eecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC--
Q 004388 462 LLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-- 539 (757)
Q Consensus 462 ~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-- 539 (757)
...-+.....+|||||++|++|..+.. .+ ....++.||+.+|.|||..+ ||||||||.||||+.+|
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~-------~~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSS-------VP--DPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCC-------CS--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECS
T ss_pred CCeeeeccCceEEEEecCCccHhhhcc-------cH--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCc
Confidence 111111223479999999988865321 11 23568899999999999988 99999999999998876
Q ss_pred --------ceEEeeecCcccc
Q 004388 540 --------VSKIGDVGLSTML 552 (757)
Q Consensus 540 --------~~KL~DFGla~~~ 552 (757)
.+.|+||+-+-..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999977543
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.6e-13 Score=117.60 Aligned_cols=70 Identities=24% Similarity=0.410 Sum_probs=66.7
Q ss_pred CCCCCCccCccchhcccCCcccCCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 687 PAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 687 ~~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
...|..|.|||..++|.||++...|++|++..|+.||.++.+||+|+.+|.+.+|+||++||.+|+.|+.
T Consensus 9 ~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~~~~cP~~~~~l~~~~l~pn~~L~~~i~~~~~ 78 (85)
T 2kr4_A 9 SDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSPTDPFNRQMLTESMLEPVPELKEQIQAWMR 78 (85)
T ss_dssp TTCCTTTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHHHHH
T ss_pred hcCchheECcccCchhcCCeECCCCCEECHHHHHHHHhcCCCCCCCcCCCChHhcchHHHHHHHHHHHHH
Confidence 3568899999999999999999999999999999999998999999999999999999999999999985
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 | Back alignment and structure |
|---|
Probab=99.38 E-value=2.9e-13 Score=119.11 Aligned_cols=70 Identities=27% Similarity=0.494 Sum_probs=66.7
Q ss_pred CCCCCCccCccchhcccCCcccCCC-cccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 687 PAPPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 687 ~~~p~~ficPi~~evM~dp~iaadG-~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
...|..|.|||..++|.||++...| ++|++..|+.||..+.+||+|+.+|.+..|+||++||.+|++|+.
T Consensus 17 ~~~p~~~~CpI~~~~m~dPV~~~cG~htf~r~cI~~~l~~~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~ 87 (98)
T 1wgm_A 17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTELKEKIQRWLA 87 (98)
T ss_dssp CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTTSCBCTTTCSBCCTTTSEECHHHHHHHHHHHH
T ss_pred hcCcHhcCCcCccccccCCeECCCCCeEECHHHHHHHHHhCCCCCCCCCCCChhhceEcHHHHHHHHHHHH
Confidence 4568899999999999999999999 999999999999988899999999999999999999999999985
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B | Back alignment and structure |
|---|
Probab=99.38 E-value=2.4e-13 Score=120.06 Aligned_cols=71 Identities=24% Similarity=0.419 Sum_probs=67.3
Q ss_pred CCCCCCccCccchhcccCCcccCCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHhhC
Q 004388 687 PAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757 (757)
Q Consensus 687 ~~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~~ 757 (757)
...|..|.|||..++|.||++...|++|++..|+.||..+.+||+|+.+|.+.+|+||++||.+|+.|+.+
T Consensus 24 ~~~p~~~~CpI~~~~m~dPV~~~cGhtf~r~~I~~~l~~~~~cP~~~~~l~~~~L~pn~~Lk~~I~~~~~~ 94 (100)
T 2kre_A 24 SDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSPTDPFNRQTLTESMLEPVPELKEQIQAWMRE 94 (100)
T ss_dssp SSCSTTTBCTTTCSBCSSEEEETTTEEEEHHHHHHHTTSCSBCSSSCCBCCTTSSEECHHHHHHHHHHHHT
T ss_pred ccCcHhhCCcCccCcccCCeECCCCCEEchHHHHHHHHcCCCCCCCCCCCChhhceECHHHHHHHHHHHHH
Confidence 45688999999999999999999999999999999999889999999999999999999999999999864
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A | Back alignment and structure |
|---|
Probab=99.32 E-value=4.1e-13 Score=158.00 Aligned_cols=70 Identities=26% Similarity=0.526 Sum_probs=67.2
Q ss_pred CCCCCCccCccchhcccCCcccCCC-cccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 687 PAPPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 687 ~~~p~~ficPi~~evM~dp~iaadG-~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
..+|++|+|||+.++|.||++..+| +||||.+|+.||..+++||+|+.+|.+..|+||++||++|++|+.
T Consensus 886 ~~iP~~F~cPIs~~lM~DPVilpsG~~TydR~~I~~wl~~~~tdP~Tr~~L~~~~liPN~~Lk~~I~~w~~ 956 (968)
T 3m62_A 886 GDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIKAHLLSDSTDPFNRMPLKLEDVTPNEELRQKILCFKK 956 (968)
T ss_dssp CCSCGGGBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTTCCBCTTTCCBCCGGGCEECHHHHHHHHHHHH
T ss_pred cCCcHHhCCcchhhHHhCCeEcCCCCEEECHHHHHHHHhcCCCCCCCCCCCCcccccccHHHHHHHHHHHH
Confidence 4789999999999999999999997 899999999999999999999999999999999999999999986
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C | Back alignment and structure |
|---|
Probab=99.31 E-value=8.7e-13 Score=127.99 Aligned_cols=70 Identities=37% Similarity=0.609 Sum_probs=66.0
Q ss_pred CCCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 687 PAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 687 ~~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
...|..|.|||..++|.||++...|++|++..|+.||.. +.+||+|+.+|.+.+|+||++||.+|+.|+.
T Consensus 101 ~~ip~~f~CPI~~elm~DPV~~~~Ghtfer~~I~~~l~~~~~tcP~t~~~l~~~~L~pN~~Lk~~Ie~~~~ 171 (179)
T 2f42_A 101 REIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQDQLIPNLAMKEVIDAFIQ 171 (179)
T ss_dssp CCCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECHHHHHHHHHHHH
T ss_pred cCCcHhhcccCccccCCCCeECCCCCEECHHHHHHHHHhCCCCCCCCcCCCChhhCcchHHHHHHHHHHHH
Confidence 466899999999999999999999999999999999987 5679999999999999999999999999985
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=5.3e-12 Score=130.98 Aligned_cols=142 Identities=15% Similarity=0.050 Sum_probs=109.7
Q ss_pred hhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCc--eEEEEe
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
...+|.....+|.|+.+.||++...+..+++|+...........+.+|+.+|+.+. +.++.++++++.+.. ++||||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred HhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 34467777778888999999998888899999987532223345889999999985 667778888775543 799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-------------------------------------- 519 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------- 519 (757)
++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 92 i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred cCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999999876311 1123578889999999999821
Q ss_pred ------------------CCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 520 ------------------PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 520 ------------------~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
+..++|||++|.|||++.++.+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999887677899998875
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2e-12 Score=103.24 Aligned_cols=56 Identities=20% Similarity=0.510 Sum_probs=52.5
Q ss_pred CccCccchhcccCCccc-CCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHH
Q 004388 692 HFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTL 747 (757)
Q Consensus 692 ~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l 747 (757)
+|+|||..++|.||+++ .+|++||+.+|+.||..+.+||+|+.+|.+.+|+||+.-
T Consensus 3 ~~~CpIs~~~m~dPV~~~~sG~~yer~~I~~~l~~~~~cP~t~~~L~~~~Lip~~~~ 59 (61)
T 2bay_A 3 HMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVPS 59 (61)
T ss_dssp -CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHHHSBCTTTCCBCCGGGCEECCCC
T ss_pred eEEecCCCCCCCCCEEeCCCCcEEcHHHHHHHHHhCCCCcCCcCCCChhhcEECccC
Confidence 68999999999999999 999999999999999988889999999999999999753
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.5e-10 Score=108.67 Aligned_cols=108 Identities=13% Similarity=0.118 Sum_probs=89.7
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCc-eeeEEEeecccHHHHHHH-HH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRV-EVEVKVIESDDVAKAIAD-EV 78 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v-~~~~~v~e~~~va~~I~~-~i 78 (757)
|.+|||.++....+...+ .....+....++.+++.+..+...|...|+ .++..+.++ +++++|++ ++
T Consensus 36 l~ll~v~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~~g-~~~~~I~~~~a 104 (146)
T 3s3t_A 36 LTALYVVDDSAYHTPALD----------PVLSELLDAEAAHAKDAMRQRQQFVATTSAPNLKTEISYG-IPKHTIEDYAK 104 (146)
T ss_dssp EEEEEEEECCCCCCGGGH----------HHHHHHHHHHHHHHHHHHHHHHHHHTTSSCCCCEEEEEEE-CHHHHHHHHHH
T ss_pred EEEEEEecCccccccccc----------cccHHHHHHHHHHHHHHHHHHHHHHHhcCCcceEEEEecC-ChHHHHHHHHH
Confidence 578999887543221110 123455566778889999999999999999 999988888 89999999 99
Q ss_pred HhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 79 ASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 79 ~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
.++++|.||||+++++.+.+.+. ++++..|+.+++ |+|+||
T Consensus 105 ~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvV 145 (146)
T 3s3t_A 105 QHPEIDLIVLGATGTNSPHRVAV-GSTTSYVVDHAP--CNVIVI 145 (146)
T ss_dssp HSTTCCEEEEESCCSSCTTTCSS-CHHHHHHHHHCS--SEEEEE
T ss_pred hhcCCCEEEECCCCCCCcceEEE-cchHHHHhccCC--CCEEEe
Confidence 99999999999999999888764 899999999999 999997
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.7e-11 Score=105.80 Aligned_cols=69 Identities=28% Similarity=0.441 Sum_probs=62.5
Q ss_pred CCCCccCccchhcccCCcccC-CCcccchHHHHHHHHhC------CCCCCCCCC---CCCCCCCchHHHHHHHHHHhhC
Q 004388 689 PPNHFICPILKEVMNEPCVAA-DGYTYDRKAIEEWLQEN------DKSPITDLP---LPNKNLLPNYTLLSAILDWKSK 757 (757)
Q Consensus 689 ~p~~ficPi~~evM~dp~iaa-dG~tye~~aIe~wl~~~------~~sP~t~~~---l~~~~l~pn~~l~~~~~~w~~~ 757 (757)
.+..|.|||..++|.||++.. .|++|++..|+.||..+ .+||+|+-+ +...+|+||++|+.+|+.|+.+
T Consensus 4 ~~~~~~CPI~~~~~~dPV~~~~cGh~f~r~cI~~~l~~~~~~~~~~~CP~tgc~~~~l~~~~L~pn~~L~~~I~~~~~~ 82 (94)
T 2yu4_A 4 GSSGFTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLIQDEALRRAIENHNKK 82 (94)
T ss_dssp CSSCCBCTTTCSBCSSEEEESSSCCEEEHHHHHHHHHHHHTTTCCBCCCSTTCCCCCBCGGGEEECHHHHHHHHHHHTT
T ss_pred CCcEeECcCcCchhcCCEEcCCCCCeecHHHHHHHHHHccCcCCCCCCCcCcCcccccCHhhCcCCHHHHHHHHHHHHH
Confidence 456899999999999999995 99999999999999864 489998887 8899999999999999999864
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.07 E-value=4.6e-10 Score=109.04 Aligned_cols=117 Identities=21% Similarity=0.236 Sum_probs=82.2
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
|+||||.++... +... +......++....+.+..+++.++.|..+...+...|+.++..+.++ +++++|++++.+
T Consensus 48 l~ll~v~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~ 122 (175)
T 2gm3_A 48 ILLLHVQVVDED-GFDD---VDSIYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKR 122 (175)
T ss_dssp EEEEEEEC--------------CCCCSHHHHHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHH
T ss_pred EEEEEEeecccc-cccc---cccccCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCceEEEEecC-CHHHHHHHHHHH
Confidence 478999865321 1110 00111233344445555666778899999999999999999988877 899999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEecC
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 125 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~kg 125 (757)
+++|.||||+++++.+.+.+. ++++..|+++++ |+|+||..+
T Consensus 123 ~~~DLIVmG~~g~~~~~~~~~-Gsva~~vl~~a~--~pVlvv~~~ 164 (175)
T 2gm3_A 123 VRPDFLVVGSRGLGRFQKVFV-GTVSAFCVKHAE--CPVMTIKRN 164 (175)
T ss_dssp HCCSEEEEEECCCC---------CHHHHHHHHCS--SCEEEEECC
T ss_pred hCCCEEEEeCCCCChhhhhhc-CchHHHHHhCCC--CCEEEEcCC
Confidence 999999999999999988764 899999999999 999999754
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.07 E-value=5.5e-10 Score=106.91 Aligned_cols=90 Identities=7% Similarity=0.054 Sum_probs=80.3
Q ss_pred HHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhh
Q 004388 32 AAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISI 111 (757)
Q Consensus 32 ~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~ 111 (757)
..+....++.+++.|..+...|...|++++..+.++ +++++|++++.++++|.||||+++++.+.+.+. ++++..|++
T Consensus 71 ~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~G-~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~-GSv~~~vl~ 148 (162)
T 1mjh_A 71 NELKNKLTEEAKNKMENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILL-GSVTENVIK 148 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSS-CHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHcCCceEEEEcCC-CHHHHHHHHHHHcCCCEEEEcCCCCCCccceEe-cchHHHHHH
Confidence 345566677889999999999999999999988876 899999999999999999999999999988774 899999999
Q ss_pred hCCCCceEEEEecC
Q 004388 112 CVPSFCTVYGVEKG 125 (757)
Q Consensus 112 ~ap~~C~V~vv~kg 125 (757)
+++ |+|+||..+
T Consensus 149 ~~~--~pVlvv~~~ 160 (162)
T 1mjh_A 149 KSN--KPVLVVKRK 160 (162)
T ss_dssp HCC--SCEEEECCC
T ss_pred hCC--CCEEEEeCC
Confidence 999 999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=3e-10 Score=123.60 Aligned_cols=139 Identities=18% Similarity=0.208 Sum_probs=105.8
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEc--cCCc-hhhHHHHHHHHHHHhcC--CCceeeecccccCC-----ceEEEEe
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQ--SKGN-IQNKQFLQELEVLSKIR--HPHLLLLLGACPDH-----GCLVYEY 477 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~--~~~~-~~~~~f~~Ev~il~~l~--Hpniv~l~g~~~~~-----~~LV~Ey 477 (757)
...|+.|.++.||+....+..+++|+.. .... .....+.+|+.+|+.+. +.++.++++++.+. .++||||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 4578999999999999888888999876 3221 12346788999999997 45677888888655 5899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-------------------------------------- 519 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------- 519 (757)
++|..+.+.. ...++...+..++.+++..|..||+..
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9998775421 223677788899999999999999841
Q ss_pred -----------------CCCEEEcCCCCCCeeecCCC--ceEEeeecCccc
Q 004388 520 -----------------PKPIIHRDMKPGNILLDHNL--VSKIGDVGLSTM 551 (757)
Q Consensus 520 -----------------~~~ivHrDLKp~NILld~~~--~~KL~DFGla~~ 551 (757)
+..++|||++|.|||++.++ .+.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 24699999999999998765 368999999875
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.05 E-value=3.6e-10 Score=105.09 Aligned_cols=104 Identities=17% Similarity=0.203 Sum_probs=84.5
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHH-HHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEK-WKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVA 79 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~-~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~ 79 (757)
|.+|||.++....+... .....+....+ +++++.+..+...|...|++++..+.++ +++++|++++.
T Consensus 33 l~ll~v~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~v~~g-~~~~~I~~~a~ 100 (138)
T 3idf_A 33 LTLIHVKPEFMLYGEAV-----------LAAYDEIEMKEEEKAKLLTQKFSTFFTEKGINPFVVIKEG-EPVEMVLEEAK 100 (138)
T ss_dssp EEEEEEECCCCCCHHHH-----------HHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCCCEEEEEES-CHHHHHHHHHT
T ss_pred EEEEEEecCCCcccccc-----------cCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCCeEEEEecC-ChHHHHHHHHh
Confidence 47899988754222110 01122334445 7889999999999999999999988888 89999999999
Q ss_pred hcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 80 SCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 80 ~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
++|.||||+++++.+.+.+ ++++..|+++++ |+|+||
T Consensus 101 --~~dliV~G~~~~~~~~~~~--Gs~~~~vl~~~~--~pVlvv 137 (138)
T 3idf_A 101 --DYNLLIIGSSENSFLNKIF--ASHQDDFIQKAP--IPVLIV 137 (138)
T ss_dssp --TCSEEEEECCTTSTTSSCC--CCTTCHHHHHCS--SCEEEE
T ss_pred --cCCEEEEeCCCcchHHHHh--CcHHHHHHhcCC--CCEEEe
Confidence 9999999999999998876 899999999999 999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.03 E-value=1.9e-10 Score=118.35 Aligned_cols=128 Identities=16% Similarity=0.092 Sum_probs=93.8
Q ss_pred eec-cCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc--eeeecccccCC--ceEEEEecCCCCH
Q 004388 410 RIG-MGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--LLLLLGACPDH--GCLVYEYMENGSL 483 (757)
Q Consensus 410 ~IG-~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--iv~l~g~~~~~--~~LV~Ey~~~gsL 483 (757)
.++ .|..+.||++... +..+++|+.... ....+.+|+.+|..+.+.+ +.++++++.+. .++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 5566999999764 467999997654 2245778999999986544 44577776553 3899999999888
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC--------------------------------------------
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-------------------------------------------- 519 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 519 (757)
. ... . ....++.+++..|..||+..
T Consensus 103 ~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 211 1 12367778888888888753
Q ss_pred -----------CCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 520 -----------PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 520 -----------~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
+..++|||++|.|||++.++.+.|+|||.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998877778999998753
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.02 E-value=1.6e-09 Score=102.97 Aligned_cols=107 Identities=19% Similarity=0.232 Sum_probs=86.7
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCc-eeeEEEeecccHHHHHHHH-H
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRV-EVEVKVIESDDVAKAIADE-V 78 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v-~~~~~v~e~~~va~~I~~~-i 78 (757)
|.+|||.++......+ . +. ..+....++.+++.|..+...+...|+ .++..+.++.+++++|+++ +
T Consensus 48 l~ll~v~~~~~~~~~~--~------~~----~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I~~~~a 115 (156)
T 3fg9_A 48 LGICSVLESEDINIFD--S------LT----PSKIQAKRKHVEDVVAEYVQLAEQRGVNQVEPLVYEGGDVDDVILEQVI 115 (156)
T ss_dssp EEEEEEECCCCTTCCC--S------SH----HHHHHHHHHHHHHHHHHHHHHHHHHTCSSEEEEEEECSCHHHHHHHTHH
T ss_pred EEEEEEEeCCCccccc--c------CC----HHHHHHHHHHHHHHHHHHHHHHHHcCCCceEEEEEeCCCHHHHHHHHHH
Confidence 5799998875432211 1 11 234455677889999999999999999 4898888845999999999 9
Q ss_pred HhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEe
Q 004388 79 ASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVE 123 (757)
Q Consensus 79 ~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~ 123 (757)
.++++|.||||+++++.+.+ + .++++..|+.++| |+|+||.
T Consensus 116 ~~~~~DlIV~G~~g~~~~~~-~-~Gs~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 116 PEFKPDLLVTGADTEFPHSK-I-AGAIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp HHHCCSEEEEETTCCCTTSS-S-CSCHHHHHHHHCS--SEEEEEC
T ss_pred HhcCCCEEEECCCCCCccce-e-ecchHHHHHHhCC--CCEEEeC
Confidence 99999999999999999875 4 4899999999999 9999973
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=6.2e-10 Score=118.23 Aligned_cols=180 Identities=17% Similarity=0.166 Sum_probs=121.1
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCc--eeeecccccC-----CceEEEEecCC
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPH--LLLLLGACPD-----HGCLVYEYMEN 480 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpn--iv~l~g~~~~-----~~~LV~Ey~~~ 480 (757)
..++.|.+..||+.. ..+++|+.... .....+.+|+.+|..+. +.. +...+..+.+ ..++||+|++|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999863 56888886532 34567889999998883 322 3344444322 23789999999
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----------------------------------------
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK----------------------------------------- 519 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~----------------------------------------- 519 (757)
.+|.+.... .++...+..++.+++..|..||+..
T Consensus 101 ~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 101 VPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp EECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred eECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 888764331 2566677888888888888888621
Q ss_pred --------------CCCEEEcCCCCCCeeecC--CCceEEeeecCccccCCCCCCccccccccCCcccccC---CCcccc
Q 004388 520 --------------PKPIIHRDMKPGNILLDH--NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY---IDPEYQ 580 (757)
Q Consensus 520 --------------~~~ivHrDLKp~NILld~--~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y---~aPE~~ 580 (757)
+..++|+|++|.|||++. ++.+.|+||+.+..-+...+. .....+ ..|+..
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl----------~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF----------ISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH----------HTTCCTTTSCCHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH----------HHHHhhccccCHHHH
Confidence 235899999999999998 567899999998764321110 001111 233311
Q ss_pred c-----cCCC---------CCcchhhhHHHHHHHHHhCCCCc
Q 004388 581 R-----TGLI---------SPKSDVYAYGMVILQLLTAKPAI 608 (757)
Q Consensus 581 ~-----~~~~---------s~ksDvwSlGvil~elltG~~Pf 608 (757)
. .+.. ....+.|++|.++|.+.+|.++|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 0111 11268999999999999999887
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=98.96 E-value=3.2e-10 Score=106.46 Aligned_cols=111 Identities=14% Similarity=0.056 Sum_probs=86.2
Q ss_pred CEEEEecCCCC-cccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCcee---eEEEeecccHHHHHHH
Q 004388 1 MVMITDLSASL-AIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEV---EVKVIESDDVAKAIAD 76 (757)
Q Consensus 1 ~~lvHV~~~~~-~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~---~~~v~e~~~va~~I~~ 76 (757)
|.+|||.++.. +...+... +... ...+....++.+++.+..+...|...|+.+ +..+..+ +++++|++
T Consensus 33 l~ll~v~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~~~~g-~~~~~I~~ 104 (147)
T 3hgm_A 33 LYILCVFKHHSLLEASLSMA--RPEQ-----LDIPDDALKDYATEIAVQAKTRATELGVPADKVRAFVKGG-RPSRTIVR 104 (147)
T ss_dssp EEEEEEECCHHHHHHTBSSC--CCGG-----GCCCTTHHHHHHHHHHHHHHHHHHHTTCCGGGEEEEEEES-CHHHHHHH
T ss_pred EEEEEEecCccccccccccc--Chhh-----hhhHHHHHHHHHHHHHHHHHHHHHhcCCCccceEEEEecC-CHHHHHHH
Confidence 57899988754 22222111 1111 112233455678889999999999999998 8877777 99999999
Q ss_pred HHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 77 EVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 77 ~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
++.++++|.||||+++++.+.+.+. ++++..|++++| |+|+||
T Consensus 105 ~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 105 FARKRECDLVVIGAQGTNGDKSLLL-GSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp HHHHTTCSEEEECSSCTTCCSCCCC-CHHHHHHHHHCS--SCEEEC
T ss_pred HHHHhCCCEEEEeCCCCccccceee-ccHHHHHHhhCC--CCEEEC
Confidence 9999999999999999999988764 899999999999 999986
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.95 E-value=8.5e-10 Score=106.27 Aligned_cols=85 Identities=13% Similarity=0.101 Sum_probs=74.6
Q ss_pred HHHHHHHhHhhHHHHHHhhhcCce-eeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCC
Q 004388 36 QEEKWKTDRLLLPFRNMCAQRRVE-VEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP 114 (757)
Q Consensus 36 ~~~~~~~~~ll~~~~~~c~~~~v~-~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap 114 (757)
...++.+++.|..+...+...|+. ++..+.++ +++++|++++.+.++|.||||+++++.+.+.+. ++++..|++.++
T Consensus 73 ~~~~~~~~~~l~~~~~~~~~~gv~~v~~~v~~G-~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l-GSva~~vl~~a~ 150 (163)
T 1tq8_A 73 VTGTAPIYEILHDAKERAHNAGAKNVEERPIVG-APVDALVNLADEEKADLLVVGNVGLSTIAGRLL-GSVPANVSRRAK 150 (163)
T ss_dssp ---CCTHHHHHHHHHHHHHTTTCCEEEEEEECS-SHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT-BBHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCCeEEEEEecC-CHHHHHHHHHHhcCCCEEEECCCCCCcccceee-ccHHHHHHHhCC
Confidence 344556788999999999999998 99988877 899999999999999999999999999988774 899999999999
Q ss_pred CCceEEEEec
Q 004388 115 SFCTVYGVEK 124 (757)
Q Consensus 115 ~~C~V~vv~k 124 (757)
|+|+||..
T Consensus 151 --~PVlvV~~ 158 (163)
T 1tq8_A 151 --VDVLIVHT 158 (163)
T ss_dssp --CEEEEECC
T ss_pred --CCEEEEeC
Confidence 99999864
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 | Back alignment and structure |
|---|
Probab=98.91 E-value=8.7e-10 Score=115.71 Aligned_cols=72 Identities=38% Similarity=0.613 Sum_probs=66.8
Q ss_pred CCCCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHHhhC
Q 004388 686 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757 (757)
Q Consensus 686 ~~~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~~ 757 (757)
...+|..|.|||..++|.||++...|+||++..|+.||.. +.+||+|+.++.+.+|+||++||.+|++|+.+
T Consensus 202 ~~~~~~~~~c~i~~~~~~dPv~~~~gh~f~~~~i~~~~~~~~~~cP~~~~~~~~~~l~~n~~l~~~i~~~~~~ 274 (281)
T 2c2l_A 202 KRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISE 274 (281)
T ss_dssp CCCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTT
T ss_pred CCCCCcccCCcCcCCHhcCCeECCCCCEECHHHHHHHHHHCCCCCcCCCCCCchhcCcccHHHHHHHHHHHHH
Confidence 3567889999999999999999999999999999999987 56699999999999999999999999999864
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=98.90 E-value=3.6e-09 Score=102.06 Aligned_cols=86 Identities=10% Similarity=0.006 Sum_probs=73.8
Q ss_pred HHHHHHHhHhhHHHHHHhhhcCceeeE--EEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhC
Q 004388 36 QEEKWKTDRLLLPFRNMCAQRRVEVEV--KVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICV 113 (757)
Q Consensus 36 ~~~~~~~~~ll~~~~~~c~~~~v~~~~--~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~a 113 (757)
...++++++.|..+...+...|++++. .+..+ +++++|++++.++++|.||||+++++.+.+.+. ++++..|+.++
T Consensus 70 ~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~~~g-~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~-Gsv~~~vl~~~ 147 (170)
T 2dum_A 70 EKLKEEASRKLQEKAEEVKRAFRAKNVRTIIRFG-IPWDEIVKVAEEENVSLIILPSRGKLSLSHEFL-GSTVMRVLRKT 147 (170)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCSEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCCCC--TTCC-CHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHHcCCceeeeeEEecC-ChHHHHHHHHHHcCCCEEEECCCCCCcccccee-chHHHHHHHhC
Confidence 344567788899999999989999987 77776 899999999999999999999999999888764 89999999999
Q ss_pred CCCceEEEEecC
Q 004388 114 PSFCTVYGVEKG 125 (757)
Q Consensus 114 p~~C~V~vv~kg 125 (757)
+ |+|+||..+
T Consensus 148 ~--~PVlvv~~~ 157 (170)
T 2dum_A 148 K--KPVLIIKEV 157 (170)
T ss_dssp S--SCEEEECCC
T ss_pred C--CCEEEEccC
Confidence 9 999998754
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=8.1e-09 Score=96.32 Aligned_cols=106 Identities=9% Similarity=0.038 Sum_probs=74.1
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCc---eeeEEEeecccHHHHHHHH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRV---EVEVKVIESDDVAKAIADE 77 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v---~~~~~v~e~~~va~~I~~~ 77 (757)
|.+|||.++....+..... .+. + ....++..++.+..+..++.+.|+ +++..+.++ +++++|+++
T Consensus 34 l~ll~v~~~~~~~~~~~~~-~~~-----~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~~v~~~~~~g-~~~~~I~~~ 101 (143)
T 3fdx_A 34 VHFLTVIPSLPYYASLGMA-YTA-----E-----LPGMDELREGSETQLKEIAKKFSIPEDRMHFHVAEG-SPKDKILAL 101 (143)
T ss_dssp EEEEEEECC---------------------------CHHHHHHHHHHHHHHHHTTSCCCGGGEEEEEEES-CHHHHHHHH
T ss_pred EEEEEEecCCccccccccc-ccc-----h-----hhhHHHHHHHHHHHHHHHHHHcCCCCCceEEEEEec-ChHHHHHHH
Confidence 5799999875433222111 010 0 112233445666777778888764 568877777 999999999
Q ss_pred HHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 78 VASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 78 i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
+.++++|.||||+++ +.+.+.+ .++++..|+.+++ |+|+||
T Consensus 102 a~~~~~dliV~G~~~-~~~~~~~-~Gs~~~~v~~~~~--~pVlvv 142 (143)
T 3fdx_A 102 AKSLPADLVIIASHR-PDITTYL-LGSNAAAVVRHAE--CSVLVV 142 (143)
T ss_dssp HHHTTCSEEEEESSC-TTCCSCS-SCHHHHHHHHHCS--SEEEEE
T ss_pred HHHhCCCEEEEeCCC-CCCeeee-eccHHHHHHHhCC--CCEEEe
Confidence 999999999999995 7787766 4899999999999 999997
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=98.84 E-value=5.4e-09 Score=97.06 Aligned_cols=80 Identities=21% Similarity=0.297 Sum_probs=67.6
Q ss_pred HHHHHHHhHhhHHHHHHhhhcCc-eeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCC
Q 004388 36 QEEKWKTDRLLLPFRNMCAQRRV-EVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVP 114 (757)
Q Consensus 36 ~~~~~~~~~ll~~~~~~c~~~~v-~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap 114 (757)
...++++++.|..+... .|+ +++..+.++ +++++|++++.++++|.||||+++++.+.+.+. ++++..|+.+++
T Consensus 56 ~~~~~~~~~~l~~~~~~---~g~~~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~-Gs~~~~vl~~~~ 130 (137)
T 2z08_A 56 RRRLERAEGVLEEARAL---TGVPKEDALLLEG-VPAEAILQAARAEKADLIVMGTRGLGALGSLFL-GSQSQRVVAEAP 130 (137)
T ss_dssp CHHHHHHHHHHHHHHHH---HCCCGGGEEEEES-SHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSS-CHHHHHHHHHCS
T ss_pred HHHHHHHHHHHHHHHHH---cCCCccEEEEEec-CHHHHHHHHHHHcCCCEEEECCCCCchhhhhhh-ccHHHHHHhcCC
Confidence 33455667777766544 788 888887776 899999999999999999999999999888764 899999999999
Q ss_pred CCceEEEE
Q 004388 115 SFCTVYGV 122 (757)
Q Consensus 115 ~~C~V~vv 122 (757)
|+|+||
T Consensus 131 --~pVlvv 136 (137)
T 2z08_A 131 --CPVLLV 136 (137)
T ss_dssp --SCEEEE
T ss_pred --CCEEEe
Confidence 999997
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=9.5e-09 Score=98.00 Aligned_cols=83 Identities=11% Similarity=0.087 Sum_probs=72.2
Q ss_pred HHHHHhHhhHHHHHHhhhcCceeeEE-EeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCC
Q 004388 38 EKWKTDRLLLPFRNMCAQRRVEVEVK-VIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSF 116 (757)
Q Consensus 38 ~~~~~~~ll~~~~~~c~~~~v~~~~~-v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~ 116 (757)
.++..++.|..+...+.+.|+.++.. .+...+++++|++++.++++|.||||+.+++.+.+.+. ++++..|+..++
T Consensus 72 ~~~~~~~~l~~~~~~~~~~g~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~l-GSv~~~vl~~a~-- 148 (155)
T 3dlo_A 72 DIIEAKETLSWAVSIIRKEGAEGEEHLLVRGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIF-GSVARDVILKAN-- 148 (155)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCEEEEEEESSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEEC-CHHHHHHHHHCS--
T ss_pred HHHHHHHHHHHHHHHHHhcCCCceEEEEecCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEe-ccHHHHHHHhCC--
Confidence 34567888999999999999988764 35566999999999999999999999999998888764 899999999999
Q ss_pred ceEEEEe
Q 004388 117 CTVYGVE 123 (757)
Q Consensus 117 C~V~vv~ 123 (757)
|+|+||.
T Consensus 149 ~PVLvVr 155 (155)
T 3dlo_A 149 KPVICIK 155 (155)
T ss_dssp SCEEEEC
T ss_pred CCEEEeC
Confidence 9999983
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=1.8e-08 Score=94.92 Aligned_cols=110 Identities=13% Similarity=0.157 Sum_probs=67.4
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCce-eeEEEeecccHHHHHHHHHH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVE-VEVKVIESDDVAKAIADEVA 79 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~-~~~~v~e~~~va~~I~~~i~ 79 (757)
|.+|||.++........+...|...- .+....++++++.|..+ +.+.|+. ++..+.++ +++++|++++.
T Consensus 37 l~ll~v~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~g-~~~~~I~~~a~ 106 (150)
T 3tnj_A 37 LSLIHVLDNIPMPDTPYGTAIPLDTE------TTYDAMLDVEKQKLSQI---GNTLGIDPAHRWLVWG-EPREEIIRIAE 106 (150)
T ss_dssp EEEEEEEC--------CTTCCCSSSC------CCHHHHHHHHHHHHHHH---HHHHTCCGGGEEEEES-CHHHHHHHHHH
T ss_pred EEEEEEEcCccccccccccccCcCHH------HHHHHHHHHHHHHHHHH---HHHcCCCcceEEEecC-CHHHHHHHHHH
Confidence 57999988754321112221232211 12233344555555554 4455777 46666665 99999999999
Q ss_pred hcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEec
Q 004388 80 SCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEK 124 (757)
Q Consensus 80 ~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~k 124 (757)
++++|.||||+++++.+. .+ .++++..|+.+++ |+|+||..
T Consensus 107 ~~~~dliV~G~~~~~~~~-~~-~Gs~~~~vl~~~~--~pVlvv~~ 147 (150)
T 3tnj_A 107 QENVDLIVVGSHGRHGLA-LL-LGSTANSVLHYAK--CDVLAVRL 147 (150)
T ss_dssp HTTCSEEEEEEC----------CCCHHHHHHHHCS--SEEEEEEC
T ss_pred HcCCCEEEEecCCCCCcC-eE-ecchHHHHHHhCC--CCEEEEeC
Confidence 999999999999999888 55 5999999999999 99999864
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 | Back alignment and structure |
|---|
Probab=98.63 E-value=1.5e-08 Score=84.99 Aligned_cols=69 Identities=36% Similarity=0.706 Sum_probs=65.1
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
..|..+.|||-.++|.+|++..-|++|.+..|..|+.. +.+||+++.++...+|+||++|+++|++|+.
T Consensus 4 ~~~~~~~C~IC~~~~~~Pv~~~CgH~fc~~Ci~~~~~~~~~~CP~C~~~~~~~~l~~n~~l~~~i~~~~~ 73 (78)
T 1t1h_A 4 EFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCE 73 (78)
T ss_dssp CCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHH
T ss_pred CCcccCCCCCccccccCCEEcCCCCeecHHHHHHHHHHCcCCCCCCcCCCChhhCccCHHHHHHHHHHHH
Confidence 46778999999999999999999999999999999987 7889999999999999999999999999985
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=98.57 E-value=3e-07 Score=97.81 Aligned_cols=114 Identities=13% Similarity=0.070 Sum_probs=88.9
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
|++|||.++..... + . .+..+....+.....+++++.|..+...|...||.++..+....+++++|++++.+
T Consensus 38 l~ll~v~~~~~~~~-~--~-----~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~v~~~~~~~~~g~~~~~i~~~a~~ 109 (319)
T 3olq_A 38 IKAFLPVYDLSYDM-T--T-----LLSPDERNAMRKGVINQKTAWIKQQARYYLEAGIQIDIKVIWHNRPYEAIIEEVIT 109 (319)
T ss_dssp EEEEEEECCGGGGC-T--T-----TSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEECSCHHHHHHHHHHH
T ss_pred EEEEEEecccchhh-c--c-----ccChhhHHHHHHHHHHHHHHHHHHHHHHHhhcCCeEEEEEEecCChHHHHHHHHHh
Confidence 57899977533211 1 1 12334455555666677888999999999999999999888455999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEecC
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 125 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~kg 125 (757)
+++|.||||+++.+.+.+.+. ++++..|++.++ |+|+||..+
T Consensus 110 ~~~DLiV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 110 DKHDLLIKMAHQHDKLGSLIF-TPLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp HTCSEEEEEEBCC--CCSCBC-CHHHHHHHHHCS--SCEEEEESS
T ss_pred cCCCEEEEecCcCchhhcccc-cccHHHHHhcCC--CCEEEecCc
Confidence 999999999999998888764 888999999999 999998754
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.54 E-value=4.4e-08 Score=91.11 Aligned_cols=76 Identities=14% Similarity=0.222 Sum_probs=60.2
Q ss_pred HHHhHhhHHHHHHhhhcCcee-eEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCce
Q 004388 40 WKTDRLLLPFRNMCAQRRVEV-EVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCT 118 (757)
Q Consensus 40 ~~~~~ll~~~~~~c~~~~v~~-~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~ 118 (757)
+++++.|..+ +.+.|+.+ +..+.. .+++++|++++.++++|.||||++ ++.+.+ + ++++..|+.+++ |+
T Consensus 63 ~~~~~~l~~~---~~~~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-l--gs~~~~vl~~~~--~p 132 (141)
T 1jmv_A 63 TETQKALLDL---AESVDYPISEKLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-L--MSSTRQVMNTIK--ID 132 (141)
T ss_dssp CHHHHHHHHH---HHHSSSCCCCEEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-H--HHHHHHHHTTCC--SE
T ss_pred HHHHHHHHHH---HHHcCCCceEEEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-h--cchHHHHHhcCC--CC
Confidence 3445555544 45568887 444554 589999999999999999999999 888777 4 589999999999 99
Q ss_pred EEEEecC
Q 004388 119 VYGVEKG 125 (757)
Q Consensus 119 V~vv~kg 125 (757)
|+||..+
T Consensus 133 Vlvv~~~ 139 (141)
T 1jmv_A 133 MLVVPLR 139 (141)
T ss_dssp EEEEECC
T ss_pred EEEeeCC
Confidence 9998643
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=98.50 E-value=1.3e-07 Score=99.59 Aligned_cols=110 Identities=16% Similarity=0.118 Sum_probs=84.7
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeE-EEeecccHHHHHHHHHH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEV-KVIESDDVAKAIADEVA 79 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~-~v~e~~~va~~I~~~i~ 79 (757)
|++|||.++........|. .. ..+....++.+++.+..+...|...|++++. .+++..+++++| ++.
T Consensus 53 l~ll~v~~~~~~~~~~~~~------~~----~~~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~v~~~g~~~~~I--~a~ 120 (294)
T 3loq_A 53 IGVLFVINLTKLSTVSGGI------DI----DHYIDEMSEKAEEVLPEVAQKIEAAGIKAEVIKPFPAGDPVVEI--IKA 120 (294)
T ss_dssp EEEECCEECTTC-----CC------CT----THHHHHHHHHHHHHHHHHHHHHHHTTCEEEECSSCCEECHHHHH--HHH
T ss_pred EEEEEEecCcccccccccc------cH----HHHHHHHHHHHHHHHHHHHHHHHHcCCCcceeEeeccCChhHhe--eec
Confidence 5789998765432222211 11 2233445667889999999999999999998 666355999999 999
Q ss_pred hcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEecC
Q 004388 80 SCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 125 (757)
Q Consensus 80 ~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~kg 125 (757)
+.++|.||||+.+.+.+.+.+. ++++..|++.++ |+|+||..+
T Consensus 121 ~~~~DliV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 121 SENYSFIAMGSRGASKFKKILL-GSVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp HTTSSEEEEECCCCCHHHHHHH-CCHHHHHHHHCS--SCEEEECCC
T ss_pred cCCCCEEEEcCCCCccccceee-ccHHHHHHhcCC--CCEEEecCc
Confidence 9999999999999998888764 899999999999 999998654
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=2.9e-07 Score=97.65 Aligned_cols=108 Identities=12% Similarity=0.166 Sum_probs=83.4
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhc-----CceeeEEEeecccHHHHHH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQR-----RVEVEVKVIESDDVAKAIA 75 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~-----~v~~~~~v~e~~~va~~I~ 75 (757)
|++|||.+|.. .+++.+. ++ .+ +....++.+++.|..+...|... |++++..+.++ +++++|+
T Consensus 50 l~ll~v~~~~~-~~~~~~~-~~-----~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~g-~~~~~I~ 117 (309)
T 3cis_A 50 LTLVHAVSPEV-ATWLEVP-LP-----PG----VLRWQQDHGRHLIDDALKVVEQASLRAGPPTVHSEIVPA-AAVPTLV 117 (309)
T ss_dssp EEEEEECCCCC-CCTTCCC-CC-----HH----HHHHHHHHHHHHHHHHHHHHHHHCSSSCCSCEEEEEESS-CHHHHHH
T ss_pred EEEEEEecCcc-cccccCC-CC-----ch----hhHHHHHHHHHHHHHHHHHHHHhcccCCCceEEEEEecC-CHHHHHH
Confidence 57999987532 2223322 12 22 23344566788888888888876 89999988776 8999999
Q ss_pred HHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEecC
Q 004388 76 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 125 (757)
Q Consensus 76 ~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~kg 125 (757)
+++. ++|.||||+.+.+.+.+.+. ++++..|++.++ |+|+||..+
T Consensus 118 ~~a~--~~DliV~G~~g~~~~~~~~~-Gs~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 118 DMSK--DAVLMVVGCLGSGRWPGRLL-GSVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp HHGG--GEEEEEEESSCTTCCTTCCS-CHHHHHHHHHCS--SCEEEECTT
T ss_pred HHhc--CCCEEEECCCCCcccccccc-CcHHHHHHHhCC--CCEEEEcCC
Confidence 9986 89999999999998888764 899999999998 999998754
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.5e-07 Score=97.60 Aligned_cols=85 Identities=16% Similarity=0.119 Sum_probs=75.2
Q ss_pred HHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCC-ceehhhccCCchhhhhhhC
Q 004388 35 KQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQG-IFTWKFKKNNLSSRISICV 113 (757)
Q Consensus 35 ~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~-~~~r~~~~~~~~~~v~~~a 113 (757)
....++.+++.|..+...|...|+.++..+.++ +++++|+++ ++++|.||||+++++ .+.+.+. ++++..|++.+
T Consensus 65 ~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~~g-~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~-Gs~~~~v~~~a 140 (268)
T 3ab8_A 65 ERALALRGEAVLERVRQSALAAGVAVEAVLEEG-VPHEAILRR--ARAADLLVLGRSGEAHGDGFGGL-GSTADRVLRAS 140 (268)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEEE-CHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSC-CHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCCCeEEEEecC-CHHHHHHhh--ccCCCEEEEeccCCCcccccccc-chhHHHHHHhC
Confidence 455667788999999999999999999988876 899999999 999999999999998 8887664 89999999999
Q ss_pred CCCceEEEEecC
Q 004388 114 PSFCTVYGVEKG 125 (757)
Q Consensus 114 p~~C~V~vv~kg 125 (757)
+ |+|+||..+
T Consensus 141 ~--~PVlvv~~~ 150 (268)
T 3ab8_A 141 P--VPVLLAPGE 150 (268)
T ss_dssp S--SCEEEECSS
T ss_pred C--CCEEEECCC
Confidence 9 999998643
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.5e-06 Score=92.23 Aligned_cols=134 Identities=15% Similarity=0.122 Sum_probs=90.5
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC---ceeeeccccc---CCceEEEEecCCC
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP---HLLLLLGACP---DHGCLVYEYMENG 481 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp---niv~l~g~~~---~~~~LV~Ey~~~g 481 (757)
...++.|....||+. +..+++|+... ......+.+|+.+|..|.+. .+...+.++. +..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE---CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 345788999999988 56788888532 23456788999999999642 2344444442 2348999999998
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhC-------------------------------------------
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT------------------------------------------- 518 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------- 518 (757)
+|.+.... .++...+..++.+++..|..||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88763211 133344455555555555555542
Q ss_pred --------------CCCCEEEcCCCCCCeeecC---CCc-eEEeeecCccc
Q 004388 519 --------------KPKPIIHRDMKPGNILLDH---NLV-SKIGDVGLSTM 551 (757)
Q Consensus 519 --------------~~~~ivHrDLKp~NILld~---~~~-~KL~DFGla~~ 551 (757)
.+..++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 344 58999998764
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.37 E-value=5.9e-07 Score=94.38 Aligned_cols=104 Identities=10% Similarity=0.058 Sum_probs=72.5
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCce-eeEEEeecccHHHHHHHHHH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVE-VEVKVIESDDVAKAIADEVA 79 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~-~~~~v~e~~~va~~I~~~i~ 79 (757)
|.||||.++...-. . .|. . .+....+++.++.+.. ++.+.|+. ++..+..+ +++++|++++.
T Consensus 172 l~ll~v~~~~~~~~----~-~~~------~--~~~~~~~~~~~~~l~~---~~~~~g~~~~~~~v~~g-~~~~~I~~~a~ 234 (290)
T 3mt0_A 172 LHVISAHPSPMLSS----A-DPT------F--QLSETIEARYREACRT---FQAEYGFSDEQLHIEEG-PADVLIPRTAQ 234 (290)
T ss_dssp EEEEEEEC--------------C------H--HHHHHHHHHHHHHHHH---HHHHHTCCTTTEEEEES-CHHHHHHHHHH
T ss_pred EEEEEEecCccccc----c-Cch------h--HHHHHHHHHHHHHHHH---HHHHcCCCcceEEEecc-CHHHHHHHHHH
Confidence 47899988643211 0 121 0 2333334445555554 34455785 45556655 99999999999
Q ss_pred hcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEec
Q 004388 80 SCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEK 124 (757)
Q Consensus 80 ~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~k 124 (757)
++++|.||||+++++.+.+.|. ++++..|+.+++ |+|+||..
T Consensus 235 ~~~~dLiVmG~~g~~~~~~~~~-Gsv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 235 KLDAVVTVIGTVARTGLSGALI-GNTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp HHTCSEEEEECCSSCCGGGCCS-CHHHHHHHTTCS--SEEEEECC
T ss_pred hcCCCEEEECCCCCcCCcceec-chHHHHHHhcCC--CCEEEECC
Confidence 9999999999999999988774 899999999999 99999863
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=98.36 E-value=6.1e-07 Score=94.39 Aligned_cols=79 Identities=18% Similarity=0.237 Sum_probs=68.9
Q ss_pred hHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 43 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 43 ~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
++.+..+..++.+.|++++..+.++ +++++|++++.++++|.||||+.+++.+.+.|. ++++..|+..++ |+|+||
T Consensus 213 ~~~l~~~~~~l~~~~~~~~~~~~~g-~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~-Gs~~~~vl~~~~--~pvLvv 288 (294)
T 3loq_A 213 TADLRVMEEVIGAEGIEVHVHIESG-TPHKAILAKREEINATTIFMGSRGAGSVMTMIL-GSTSESVIRRSP--VPVFVC 288 (294)
T ss_dssp HHHHHHHHHHHHHTTCCEEEEEECS-CHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHH-HCHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHHHcCCcEEEEEecC-CHHHHHHHHHHhcCcCEEEEeCCCCCCccceee-CcHHHHHHhcCC--CCEEEE
Confidence 3456667777778899999877776 999999999999999999999999999988774 899999999999 999998
Q ss_pred ecC
Q 004388 123 EKG 125 (757)
Q Consensus 123 ~kg 125 (757)
..+
T Consensus 289 ~~~ 291 (294)
T 3loq_A 289 KRG 291 (294)
T ss_dssp CSC
T ss_pred CCC
Confidence 754
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=98.34 E-value=8.8e-07 Score=94.13 Aligned_cols=109 Identities=11% Similarity=0.126 Sum_probs=77.6
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCce-eeEEEeecccHHHHHHHHHH
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVE-VEVKVIESDDVAKAIADEVA 79 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~-~~~~v~e~~~va~~I~~~i~ 79 (757)
|.||||.++...-. . +. +|.. . ...+....+++.++.|..|. .+.|+. ++..+.++ +++++|++++.
T Consensus 196 l~ll~v~~~~~~~~-~-~~-~~~~--~---~~~~~~~~~~~~~~~l~~~~---~~~~~~~~~~~v~~g-~~~~~I~~~a~ 263 (319)
T 3olq_A 196 VHLLSAYPVAPINI-A-IE-LPDF--D---PNLYNNALRGQHLIAMKELR---QKFSIPEEKTHVKEG-LPEQVIPQVCE 263 (319)
T ss_dssp EEEEEEECCCSCSC-C-TT-CTTC--C---HHHHHHHHHHHHHHHHHHHH---HHTTCCGGGEEEEES-CHHHHHHHHHH
T ss_pred EEEEEeecCcchhh-h-cc-CCcc--c---HHHHHHHHHHHHHHHHHHHH---HHhCCCcccEEEecC-CcHHHHHHHHH
Confidence 47899988643211 1 11 1211 1 23444555556666666554 555664 44555555 89999999999
Q ss_pred hcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEec
Q 004388 80 SCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEK 124 (757)
Q Consensus 80 ~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~k 124 (757)
++++|.||||+.+++.+.+.|. ++++..|+.+++ |+|+||..
T Consensus 264 ~~~~dLiV~G~~g~~~~~~~~~-Gsv~~~vl~~~~--~pVLvv~~ 305 (319)
T 3olq_A 264 ELNAGIVVLGILGRTGLSAAFL-GNTAEQLIDHIK--CDLLAIKP 305 (319)
T ss_dssp HTTEEEEEEECCSCCSTHHHHH-HHHHHHHHTTCC--SEEEEECC
T ss_pred HhCCCEEEEeccCccCCccccc-cHHHHHHHhhCC--CCEEEECC
Confidence 9999999999999999988774 899999999999 99999853
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=7.5e-07 Score=96.33 Aligned_cols=76 Identities=9% Similarity=0.005 Sum_probs=52.7
Q ss_pred eee-ccCCcEEEEEEEEC--------CeEEEEEEEccCC---chhhHHHHHHHHHHHhcC-C--CceeeecccccCC---
Q 004388 409 LRI-GMGGYGTVYKGTFH--------HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIR-H--PHLLLLLGACPDH--- 470 (757)
Q Consensus 409 ~~I-G~G~~G~Vyk~~~~--------~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~-H--pniv~l~g~~~~~--- 470 (757)
..| +.|....+|+.... +..+++|+..... ......+.+|+.+|..|. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88999999998765 5678888765432 111245778999888874 2 3466677776543
Q ss_pred --ceEEEEecCCCCHH
Q 004388 471 --GCLVYEYMENGSLE 484 (757)
Q Consensus 471 --~~LV~Ey~~~gsL~ 484 (757)
.++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 37999999986653
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.7e-06 Score=91.71 Aligned_cols=75 Identities=11% Similarity=0.180 Sum_probs=61.0
Q ss_pred hHhhHHHHHHhhh--cCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEE
Q 004388 43 DRLLLPFRNMCAQ--RRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVY 120 (757)
Q Consensus 43 ~~ll~~~~~~c~~--~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~ 120 (757)
++.+..+...+.. .|+.++..+..+ +++++|++++. ++|.||||+.+++.+.+.|. ++++..|+.+++ |+|+
T Consensus 229 ~~~l~~~~~~~~~~~~~~~~~~~~~~g-~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~-Gsv~~~vl~~~~--~pVl 302 (309)
T 3cis_A 229 EQVLAERLAGWQERYPNVAITRVVVRD-QPARQLVQRSE--EAQLVVVGSRGRGGYAGMLV-GSVGETVAQLAR--TPVI 302 (309)
T ss_dssp HHHHHHHHTTHHHHCTTSCEEEEEESS-CHHHHHHHHHT--TCSEEEEESSCSSCCTTCSS-CHHHHHHHHHCS--SCEE
T ss_pred HHHHHHHHHHHHhhCCCCcEEEEEEcC-CHHHHHHHhhC--CCCEEEECCCCCCCcccccc-CcHHHHHHhcCC--CCEE
Confidence 3444444433332 478898877766 89999999997 99999999999999988774 899999999999 9999
Q ss_pred EEe
Q 004388 121 GVE 123 (757)
Q Consensus 121 vv~ 123 (757)
||.
T Consensus 303 vv~ 305 (309)
T 3cis_A 303 VAR 305 (309)
T ss_dssp EEC
T ss_pred EeC
Confidence 985
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.27 E-value=1.1e-06 Score=92.41 Aligned_cols=79 Identities=10% Similarity=0.057 Sum_probs=68.6
Q ss_pred hHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 43 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 43 ~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
++.|..+...+...|++++..+..+.+++++|++++...++|.||||+.+.+.+.+.+. ++++..+++.++ |+|+||
T Consensus 50 ~~~l~~~~~~~~~~~~~~~~~~~~~g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~-gs~~~~vl~~~~--~PVlvv 126 (290)
T 3mt0_A 50 SAALNDLAQELREEGYSVSTNQAWKDSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAIL-TPDDWKLLRFAP--CPVLMT 126 (290)
T ss_dssp HHHHHHHHHHHHHTTCCEEEEEECSSSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSC-CHHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHhhCCCeEEEEEEeCCCHHHHHHHHHHhcCCCEEEEecccCCchhhccc-CHHHHHHHhcCC--CCEEEe
Confidence 34555666666788999999888777999999999999999999999999998888764 889999999999 999998
Q ss_pred ec
Q 004388 123 EK 124 (757)
Q Consensus 123 ~k 124 (757)
..
T Consensus 127 ~~ 128 (290)
T 3mt0_A 127 KT 128 (290)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.9e-06 Score=86.77 Aligned_cols=132 Identities=17% Similarity=0.095 Sum_probs=90.9
Q ss_pred eeccCCcE-EEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccC--CceEEEEecCCCCH
Q 004388 410 RIGMGGYG-TVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCLVYEYMENGSL 483 (757)
Q Consensus 410 ~IG~G~~G-~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~~~LV~Ey~~~gsL 483 (757)
.+..|..| .||+.... +..+.+|+-... ....+.+|..+|+.+. +-.+.++++++.+ ..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 35555555 68987653 457888886543 3456788999998884 2235566666643 34899999999888
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC-------------------------------------------
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP------------------------------------------- 520 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~------------------------------------------- 520 (757)
.+...... .....++.+++..|.-||...+
T Consensus 108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 77553211 1234566667777777775321
Q ss_pred ------------CCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 521 ------------KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 521 ------------~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 2389999999999999888788999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.6e-06 Score=92.49 Aligned_cols=74 Identities=15% Similarity=0.078 Sum_probs=51.2
Q ss_pred ceeeccCCcEEEEEEEE--CCeEEEEEEEccCCc-------hhhHHHHHHHHHHHhcCC--C-ceeeecccccCCceEEE
Q 004388 408 NLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGN-------IQNKQFLQELEVLSKIRH--P-HLLLLLGACPDHGCLVY 475 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~-------~~~~~f~~Ev~il~~l~H--p-niv~l~g~~~~~~~LV~ 475 (757)
...||.|.++.||++.. .+..++||....... .....+..|.++|..+.. | .+..++.+..+..++||
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm 114 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM 114 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence 45689999999999964 456899998654221 223456789999987742 3 34456666666679999
Q ss_pred EecCCC
Q 004388 476 EYMENG 481 (757)
Q Consensus 476 Ey~~~g 481 (757)
||+++.
T Consensus 115 E~l~g~ 120 (397)
T 2olc_A 115 EDLSHL 120 (397)
T ss_dssp CCCTTS
T ss_pred EeCCCc
Confidence 999864
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=98.12 E-value=5.2e-06 Score=76.60 Aligned_cols=72 Identities=11% Similarity=-0.001 Sum_probs=59.6
Q ss_pred HHHHHHHhHhhHHHHHHh--hhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhC
Q 004388 36 QEEKWKTDRLLLPFRNMC--AQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICV 113 (757)
Q Consensus 36 ~~~~~~~~~ll~~~~~~c--~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~a 113 (757)
...++++++.|..+ ..| ...| +++..+..+ +++++|++++.++++|.||||++++ +++..|+.++
T Consensus 64 ~~~~~~~~~~l~~~-~~~~~~~~~-~~~~~~~~g-~~~~~I~~~a~~~~~dliV~G~~g~----------sv~~~vl~~a 130 (138)
T 1q77_A 64 EESKKRIERRLREV-WEKLTGSTE-IPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPS----------AYLCKVIDGL 130 (138)
T ss_dssp HHHHHHHHHHHHHH-HHHHHSCCC-CCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCG----------GGTHHHHHHS
T ss_pred HHHHHHHHHHHHHH-HHHhhccCC-cceEEEEcC-CHHHHHHHHHHhcCCCEEEEeCCCC----------chHHHHHHhC
Confidence 34455667788888 764 5667 788877665 8999999999999999999999876 7888999999
Q ss_pred CCCceEEEE
Q 004388 114 PSFCTVYGV 122 (757)
Q Consensus 114 p~~C~V~vv 122 (757)
+ |+|+||
T Consensus 131 ~--~PVlvv 137 (138)
T 1q77_A 131 N--LASLIV 137 (138)
T ss_dssp S--SEEEEC
T ss_pred C--CceEee
Confidence 9 999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=1.5e-05 Score=85.05 Aligned_cols=138 Identities=19% Similarity=0.178 Sum_probs=80.0
Q ss_pred eeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-----CCceeeec-c----cccCCceEEEEec
Q 004388 409 LRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----HPHLLLLL-G----ACPDHGCLVYEYM 478 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----Hpniv~l~-g----~~~~~~~LV~Ey~ 478 (757)
..|+.|..+.||+....+..+++|+.... ...+..|+.++..|. .|.++... | ...+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 35666778999999887777999998752 233445666665553 34444311 1 1123347999999
Q ss_pred CCCCHH--------------HHHhhcCC-C--C--------CCCHHHHH-------------------------------
Q 004388 479 ENGSLE--------------DRLYRKNN-T--P--------PIPWFERY------------------------------- 502 (757)
Q Consensus 479 ~~gsL~--------------~~L~~~~~-~--~--------~l~~~~~~------------------------------- 502 (757)
+|..+. ..|+.... . + ...|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11222110 0 0 11333211
Q ss_pred HHHHHHHHHHHHHhh----------CCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 503 RIAWEVASALAFLHN----------TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 503 ~i~~qia~aL~~LH~----------~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.+...+..++.+|+. ..+..++|||++|.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123445667763 134569999999999999888899999999875
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.89 E-value=3.5e-05 Score=85.40 Aligned_cols=73 Identities=10% Similarity=-0.029 Sum_probs=46.1
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccCC-------c--hhhHHHHHHHHHHH-hcCCCceeeecccccCCceEEEEe
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKG-------N--IQNKQFLQELEVLS-KIRHPHLLLLLGACPDHGCLVYEY 477 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~-------~--~~~~~f~~Ev~il~-~l~Hpniv~l~g~~~~~~~LV~Ey 477 (757)
...||.|..+.||++...+..++||...... . .....+..|+..+. ......+.+++.+..+..++||||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~~~~~~lv~e~ 118 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFDRTMALIGMRY 118 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEETTTTEEEECC
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEECCCccEEEEee
Confidence 3568999999999998777789999432211 1 12233434433332 222345666776666677999999
Q ss_pred c-CC
Q 004388 478 M-EN 480 (757)
Q Consensus 478 ~-~~ 480 (757)
+ +|
T Consensus 119 l~~g 122 (420)
T 2pyw_A 119 LEPP 122 (420)
T ss_dssp CCTT
T ss_pred cCCc
Confidence 9 76
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=2.4e-05 Score=80.84 Aligned_cols=70 Identities=16% Similarity=0.114 Sum_probs=58.9
Q ss_pred hHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 43 DRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 43 ~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
++.+..+...+.+.|++++..+..+ +++++|++++.++ |.||||+ .+.+.+ .++++..|+.+++ |+|+||
T Consensus 198 ~~~l~~~~~~l~~~~~~~~~~~~~g-~~~~~i~~~a~~~--dliV~G~----~~~~~~-~Gs~~~~vl~~~~--~pvlvv 267 (268)
T 3ab8_A 198 EAWALEAEAYLRDHGVEASALVLGG-DAADHLLRLQGPG--DLLALGA----PVRRLV-FGSTAERVIRNAQ--GPVLTA 267 (268)
T ss_dssp HHHHHHHHHHHHHTTCCEEEEEECS-CHHHHHHHHCCTT--EEEEEEC----CCSCCS-SCCHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHHHcCCceEEEEeCC-ChHHHHHHHHHhC--CEEEECC----cccccE-eccHHHHHHhcCC--CCEEEe
Confidence 4556667777778899999877765 9999999999999 9999999 555555 4899999999999 999997
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.0001 Score=78.44 Aligned_cols=136 Identities=15% Similarity=0.228 Sum_probs=88.8
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC---CCceeeecccccC--CceEEEEecCCCC
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR---HPHLLLLLGACPD--HGCLVYEYMENGS 482 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~---Hpniv~l~g~~~~--~~~LV~Ey~~~gs 482 (757)
...|+.|.+..+|+....+..+++|+.... ....|..|...|+.|. ...+.+.+.++.. ..++||||++|..
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 456899999999999888888999987643 3556889999998874 3556677766643 3489999999876
Q ss_pred HH--------H---HHhhcCCCC-------------------CCCHHHHH---HHHH----------------HHHHHH-
Q 004388 483 LE--------D---RLYRKNNTP-------------------PIPWFERY---RIAW----------------EVASAL- 512 (757)
Q Consensus 483 L~--------~---~L~~~~~~~-------------------~l~~~~~~---~i~~----------------qia~aL- 512 (757)
+. . .|+...... .-+|...+ ++.. .++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 42 1 233322100 12454332 1111 112122
Q ss_pred HHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 513 AFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 513 ~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
..|.. ..+..+||+|+.+.|||++.++ +-|.||+
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23432 2235799999999999999887 8888973
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=5.1e-05 Score=79.96 Aligned_cols=138 Identities=17% Similarity=0.064 Sum_probs=77.8
Q ss_pred ceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCceEEEEec-CCCCHHH
Q 004388 408 NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYM-ENGSLED 485 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~~LV~Ey~-~~gsL~~ 485 (757)
...|+.|....+|+. ..+++|+........ -...+|+.++..+. +.-..++++++.+.+++|+||+ +|.+|..
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l~~ 97 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTMSP 97 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEECCH
T ss_pred eeEcCCcccccccee----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccCCH
Confidence 567999999999998 568888876532211 11246887777664 2112466677777789999999 6644421
Q ss_pred ------------------HHhhcCCC--CCCCHHHH-HHHHH--------------HHHHHHH----HHhh-CCCCCEEE
Q 004388 486 ------------------RLYRKNNT--PPIPWFER-YRIAW--------------EVASALA----FLHN-TKPKPIIH 525 (757)
Q Consensus 486 ------------------~L~~~~~~--~~l~~~~~-~~i~~--------------qia~aL~----~LH~-~~~~~ivH 525 (757)
.|+..... ........ ..+.. .+...+. .|.. ..+..++|
T Consensus 98 ~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~H 177 (301)
T 3dxq_A 98 EKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAACH 177 (301)
T ss_dssp HHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEEC
T ss_pred hhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceeec
Confidence 01111100 00111111 11100 0111111 1111 23345999
Q ss_pred cCCCCCCeeecCCCceEEeeecCccc
Q 004388 526 RDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 526 rDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
+|+.|.||| ..++.+.|+||..+..
T Consensus 178 gDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 178 CDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp SCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred cCCCcCCEE-ECCCCEEEEecccccC
Confidence 999999999 5666789999988764
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=97.64 E-value=8.7e-06 Score=82.69 Aligned_cols=68 Identities=16% Similarity=0.241 Sum_probs=60.1
Q ss_pred CCCCccCccchhcccCCccc-CCCcccchHHHHHHHHhC--CCCCC--CCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 689 PPNHFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQEN--DKSPI--TDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 689 ~p~~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~--~~sP~--t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
....+.|||..++|.||+.. .=|++|++.+|..|+..+ .+||+ .+.++...+|+||+.|+..|+.|..
T Consensus 178 ~~~el~CPIcl~~f~DPVts~~CGHsFcR~cI~~~~~~~~~~~CPvtGCr~~l~~~dL~pN~~L~~lve~~k~ 250 (267)
T 3htk_C 178 GKIELTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIMELRCKIAKM 250 (267)
T ss_dssp SBCCSBCTTTSSBCSSEEEESSSCCEEEHHHHHHHSTTCSCEECSGGGCSCEECGGGEEECHHHHHHHHHHHH
T ss_pred CceeeECcCccCcccCCeeeCCCCCcccHHHHHHHHHhCCCCCCCcccccCcCchhhCCcCHHHHHHHHHHHH
Confidence 35578999999999999985 779999999999999863 46999 4599999999999999999999975
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00015 Score=75.90 Aligned_cols=77 Identities=17% Similarity=0.118 Sum_probs=55.1
Q ss_pred CccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCC--C-ceeeecccccCCceEEEEecCC
Q 004388 405 FSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH--P-HLLLLLGACPDHGCLVYEYMEN 480 (757)
Q Consensus 405 f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H--p-niv~l~g~~~~~~~LV~Ey~~~ 480 (757)
......+|.|..+.||+.+.. ++.+.||+...........|..|+..|+.|.- + .+.+.+++ +..++||||+++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~lv~e~l~~ 94 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEEEEECCCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceEEEEeecc
Confidence 344567999999999999874 67899998765544444568899999988842 1 23344443 455899999987
Q ss_pred CCH
Q 004388 481 GSL 483 (757)
Q Consensus 481 gsL 483 (757)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00024 Score=75.25 Aligned_cols=159 Identities=13% Similarity=0.162 Sum_probs=90.0
Q ss_pred ccCCCHHHHHHhhcCCcc-----ceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc--eee
Q 004388 390 YRNLTWEEIESATLSFSE-----NLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--LLL 462 (757)
Q Consensus 390 ~~~~~~~ei~~at~~f~~-----~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--iv~ 462 (757)
|..++.+++...-..|.. ...|+.|....+|+....+..+++|+..... ....+..|+.++..|.... +..
T Consensus 4 ~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 4 YTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp -CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCc
Confidence 445666666666555543 2346778889999998776678899887531 2234566888877764212 233
Q ss_pred ecccc--------cCCceEEEEecCCCCHH--------------HHHhhcCCC--CC----C---CHHHHHH--------
Q 004388 463 LLGAC--------PDHGCLVYEYMENGSLE--------------DRLYRKNNT--PP----I---PWFERYR-------- 503 (757)
Q Consensus 463 l~g~~--------~~~~~LV~Ey~~~gsL~--------------~~L~~~~~~--~~----l---~~~~~~~-------- 503 (757)
++... .+..+++|+|++|..+. -.++..... .+ . .|...+.
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 33221 22347899999986531 012221110 01 1 1322111
Q ss_pred ----HHHHHHHHHHHHhhC----CCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 504 ----IAWEVASALAFLHNT----KPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 504 ----i~~qia~aL~~LH~~----~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
+...+...+.+|+.. .+..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 24569999999999999987767899998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00021 Score=79.50 Aligned_cols=71 Identities=14% Similarity=0.151 Sum_probs=49.0
Q ss_pred ceeeccCCcEEEEEEEEC---------CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc-eeeecccccCCceEEEEe
Q 004388 408 NLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHGCLVYEY 477 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn-iv~l~g~~~~~~~LV~Ey 477 (757)
...|+.|....||++... +..+.+|+..... ....+..|..++..|...+ ..++++.+.+ .+||||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~--g~v~e~ 153 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEY 153 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--CEEEEE
Confidence 346888999999999875 3578899874321 1145668999988874322 3566766654 489999
Q ss_pred cCCCC
Q 004388 478 MENGS 482 (757)
Q Consensus 478 ~~~gs 482 (757)
++|.+
T Consensus 154 l~G~~ 158 (429)
T 1nw1_A 154 IPSRP 158 (429)
T ss_dssp CCEEE
T ss_pred eCCcc
Confidence 98643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0008 Score=71.66 Aligned_cols=139 Identities=9% Similarity=-0.005 Sum_probs=73.4
Q ss_pred eeccCCcEE-EEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-C-CceeeecccccCCceEEEEecCCCCHHH
Q 004388 410 RIGMGGYGT-VYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-H-PHLLLLLGACPDHGCLVYEYMENGSLED 485 (757)
Q Consensus 410 ~IG~G~~G~-Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-H-pniv~l~g~~~~~~~LV~Ey~~~gsL~~ 485 (757)
.|+.|+... +|+.... +..+++|....... ..+..|+.++..+. + -.+.+++.+..+.+++|||++.+..+.+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARGLLLIEDLGDALFTE 101 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTTEEEECCCCSCBHHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCCEEEEeeCCCcchHH
Confidence 465555554 6677664 66677776544321 22445677776663 2 2345566666666789999998766654
Q ss_pred HHhhc---------------------CC--CCCCCHHHHH-------H-H------------HHHHHHHHHHHh---hCC
Q 004388 486 RLYRK---------------------NN--TPPIPWFERY-------R-I------------AWEVASALAFLH---NTK 519 (757)
Q Consensus 486 ~L~~~---------------------~~--~~~l~~~~~~-------~-i------------~~qia~aL~~LH---~~~ 519 (757)
.+... .. .+.+...... . + ...+...+..|- ...
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 33211 00 1111111000 0 0 001111222221 123
Q ss_pred CCCEEEcCCCCCCeeecCC----CceEEeeecCccc
Q 004388 520 PKPIIHRDMKPGNILLDHN----LVSKIGDVGLSTM 551 (757)
Q Consensus 520 ~~~ivHrDLKp~NILld~~----~~~KL~DFGla~~ 551 (757)
+..++|||+.|.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999874 6789999998864
|
| >3ztg_A E3 ubiquitin-protein ligase RBBP6; PACT, U-BOX, mRNA processing, mRNA splicing; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00047 Score=59.12 Aligned_cols=69 Identities=25% Similarity=0.402 Sum_probs=61.2
Q ss_pred CCCCCccCccchhcccCCcccCC-CcccchHHHHHHHHh--CCCCCCCCCCC-CCCCCCchHHHHHHHHHHhh
Q 004388 688 APPNHFICPILKEVMNEPCVAAD-GYTYDRKAIEEWLQE--NDKSPITDLPL-PNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaad-G~tye~~aIe~wl~~--~~~sP~t~~~l-~~~~l~pn~~l~~~~~~w~~ 756 (757)
..+..+.|||-.++|.+|.+... |++|-+.-|..|+.. +.+||+.+.++ ....+.||+.|+.+|+.|+.
T Consensus 9 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~~ 81 (92)
T 3ztg_A 9 PIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALIANKFLRQAVNNFKN 81 (92)
T ss_dssp CCCTTTEETTTTEECSSCEECTTTCCEECHHHHHHHHHHCTTCCCTTTCCSSCCTTSCEECHHHHHHHHHHHH
T ss_pred cCCcCCCCCCCChhhcCceECCCCCCHHHHHHHHHHHHhcCCCcCcCCCCcCCCccccCcCHHHHHHHHHHHH
Confidence 45678999999999999999884 999999999999975 36899999998 56689999999999999975
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00053 Score=76.76 Aligned_cols=73 Identities=11% Similarity=-0.014 Sum_probs=48.4
Q ss_pred ceeeccCCcEEEEEEEECC--eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCce-eeecccccCCceEEEEecCCCCH
Q 004388 408 NLRIGMGGYGTVYKGTFHH--TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-LLLLGACPDHGCLVYEYMENGSL 483 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~--~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpni-v~l~g~~~~~~~LV~Ey~~~gsL 483 (757)
...|+.|-...+|++...+ ..+.+|+......... ...+|..+|..|...++ .++++.+. ..+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--NGRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TEEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--CeEEEEeeCCccC
Confidence 3568889999999999876 7888998754322111 12478999988864433 46777764 3479999987443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0054 Score=64.82 Aligned_cols=159 Identities=15% Similarity=0.123 Sum_probs=89.6
Q ss_pred cccCCCHHHHHHhhcCCcc-----ceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCC--ce
Q 004388 389 RYRNLTWEEIESATLSFSE-----NLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHP--HL 460 (757)
Q Consensus 389 ~~~~~~~~ei~~at~~f~~-----~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hp--ni 460 (757)
.|..++.+.+..+-..|.. ...|+ |....||+.... +..+++|+..... .....+..|+.++..+... .+
T Consensus 7 ~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 7 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 4566677777666554432 23566 888899998764 4479999986432 1345677788888877421 23
Q ss_pred eeeccc-------ccCCceEEEEecCCCCHH-----H---------HHhhcCC------CCCCCHHHH----HHH-----
Q 004388 461 LLLLGA-------CPDHGCLVYEYMENGSLE-----D---------RLYRKNN------TPPIPWFER----YRI----- 504 (757)
Q Consensus 461 v~l~g~-------~~~~~~LV~Ey~~~gsL~-----~---------~L~~~~~------~~~l~~~~~----~~i----- 504 (757)
+..+.. ..+..++||+|++|..+. . .++.... .+...+... ..+
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 444443 011225799999875431 1 1121100 111222211 001
Q ss_pred ----------HHHHHHHHHHHhh----CCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 505 ----------AWEVASALAFLHN----TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 505 ----------~~qia~aL~~LH~----~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
...+...+..|.. ..+..++|||++|.|||++ + .+.|+||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 0111122333322 1345689999999999999 4 889999988754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.00056 Score=74.12 Aligned_cols=72 Identities=14% Similarity=0.139 Sum_probs=43.7
Q ss_pred ceeeccCCcEEEEEEEECC----------eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc-eeeecccccCCceEEEE
Q 004388 408 NLRIGMGGYGTVYKGTFHH----------TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH-LLLLLGACPDHGCLVYE 476 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~----------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn-iv~l~g~~~~~~~LV~E 476 (757)
...|+.|....+|+....+ ..+++|+........ .....|..++..+...+ ..++++.. ..++|||
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~~~v~e 114 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--NGGRIEE 114 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--CCcEEEE
Confidence 3467888889999998764 578888865432211 12357888888774222 33555544 3579999
Q ss_pred ecCCCC
Q 004388 477 YMENGS 482 (757)
Q Consensus 477 y~~~gs 482 (757)
|++|..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0008 Score=73.41 Aligned_cols=140 Identities=15% Similarity=0.158 Sum_probs=82.3
Q ss_pred eeeccCCcEEEEEEEEC---------CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCceEEEEec
Q 004388 409 LRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYM 478 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~~LV~Ey~ 478 (757)
..|..|-...+|++... +..+.+|+.... ......+.+|..+++.|. +.-..++++++.+ .+||||+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~--g~v~e~i 132 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE--GRLEQYI 132 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--EEEEECC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--ccEEEEe
Confidence 46777888999998874 357888885332 223455678999998874 3223566777665 3999999
Q ss_pred CCCCHH--------------HH---HhhcC--CCCCC--CHHHHHHHHHHHHH-------------------HHHH----
Q 004388 479 ENGSLE--------------DR---LYRKN--NTPPI--PWFERYRIAWEVAS-------------------ALAF---- 514 (757)
Q Consensus 479 ~~gsL~--------------~~---L~~~~--~~~~l--~~~~~~~i~~qia~-------------------aL~~---- 514 (757)
+|..|. +. |+... ...+. -|....++..++.. .+..
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 985542 11 11111 01112 24444445443321 2233
Q ss_pred HhhC-CCCCEEEcCCCCCCeeecCC----CceEEeeecCccc
Q 004388 515 LHNT-KPKPIIHRDMKPGNILLDHN----LVSKIGDVGLSTM 551 (757)
Q Consensus 515 LH~~-~~~~ivHrDLKp~NILld~~----~~~KL~DFGla~~ 551 (757)
|... .+..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3222 34569999999999999876 7899999988753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0054 Score=65.68 Aligned_cols=32 Identities=22% Similarity=0.277 Sum_probs=28.3
Q ss_pred CCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 520 ~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999988764
|
| >3fl2_A E3 ubiquitin-protein ligase UHRF1; cell cycle, DNA damage, DNA repair, ring finger domain, metal binding, DNA replication; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.0074 Score=54.68 Aligned_cols=65 Identities=12% Similarity=0.133 Sum_probs=58.9
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCC-CCCCchHHHHHHHHHHhh
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPN-KNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~-~~l~pn~~l~~~~~~w~~ 756 (757)
.+.|||-.++|.+|.+..=|++|-+.-|..|+.. ..+||+-+.++.. ..+.||+.|+..|+.|..
T Consensus 52 ~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~n~~l~~~i~~~~p 118 (124)
T 3fl2_A 52 TFQCICCQELVFRPITTVCQHNVCKDCLDRSFRAQVFSCPACRYDLGRSYAMQVNQPLQTVLNQLFP 118 (124)
T ss_dssp HTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCCCHHHHHHHHHHST
T ss_pred CCCCCcCChHHcCcEEeeCCCcccHHHHHHHHhHCcCCCCCCCccCCCCCCCCCCHHHHHHHHHHcc
Confidence 4689999999999999888999999999999986 4589999999988 789999999999999863
|
| >2y43_A E3 ubiquitin-protein ligase RAD18; DNA repair, metal-binding, translesion synthesis, UB conjugation pathway; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.92 E-value=0.0061 Score=52.85 Aligned_cols=65 Identities=17% Similarity=0.180 Sum_probs=59.5
Q ss_pred CccCccchhcccCCccc-CCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 692 HFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 692 ~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
.+.|||=.+.+.+|... .=|++|=..-|..|+..+.+||+-+.++...++.||+.|+..|+.|+.
T Consensus 22 ~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~i~~~~~ 87 (99)
T 2y43_A 22 LLRCGICFEYFNIAMIIPQCSHNYCSLCIRKFLSYKTQCPTCCVTVTEPDLKNNRILDELVKSLNF 87 (99)
T ss_dssp HTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHTTCCBCTTTCCBCCGGGCEECHHHHHHHHHHHH
T ss_pred CCCcccCChhhCCcCEECCCCCHhhHHHHHHHHHCCCCCCCCCCcCChhhCCcCHHHHHHHHHHHH
Confidence 46799999999999877 679999999999999988899999999998899999999999999864
|
| >1z6u_A NP95-like ring finger protein isoform B; structural genomics consortium, ligase, ubiquitin-protein ligase, cell cycle regulation, SGC; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.01 Score=55.72 Aligned_cols=65 Identities=14% Similarity=0.210 Sum_probs=59.3
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHhC-CCCCCCCCCCCCC-CCCchHHHHHHHHHHhh
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN-DKSPITDLPLPNK-NLLPNYTLLSAILDWKS 756 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~-~~sP~t~~~l~~~-~l~pn~~l~~~~~~w~~ 756 (757)
.+.|||-.++|.+|++..=|++|-..-|..|+..+ .+||+.+.++... .|.||..|+.+|..|+.
T Consensus 78 ~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~n~~l~~lv~~~~p 144 (150)
T 1z6u_A 78 SFMCVCCQELVYQPVTTECFHNVCKDCLQRSFKAQVFSCPACRHDLGQNYIMIPNEILQTLLDLFFP 144 (150)
T ss_dssp HTBCTTTSSBCSSEEECTTSCEEEHHHHHHHHHTTCCBCTTTCCBCCTTCCCCBCHHHHHHHHHHST
T ss_pred CCEeecCChhhcCCEEcCCCCchhHHHHHHHHHhCCCcCCCCCccCCCCCCCCCCHHHHHHHHHHhh
Confidence 56899999999999999889999999999999874 4899999999988 89999999999999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.74 E-value=0.027 Score=55.95 Aligned_cols=123 Identities=15% Similarity=0.105 Sum_probs=77.2
Q ss_pred CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 481 GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH-NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 481 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
-||.++|...+ .|++..+++-++.|.+.+|.-+- ...+ ..+=+.|..|+|..+|.+-+.+ +.+.
T Consensus 33 vSL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~~---~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQP---RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCC---CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcccC---CceecCCcceEEecCCceeccc-cccc---------
Confidence 37999997765 47999999999999999987662 1121 1233457899999999887653 1110
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
.....+.+||... ...+.+.=|||||+++|.-+--..| .+.+...+
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------------------e~eE~eLS 143 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------------------ENEERELS 143 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC------------------------TTEEECCC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC------------------------cccchhhC
Confidence 1123456888664 3346788899999999988742221 11233446
Q ss_pred HHHHHHHHHHhhc
Q 004388 640 KELAALGLSCAEL 652 (757)
Q Consensus 640 ~~l~~Li~~Cl~~ 652 (757)
+.|-.|+..|+..
T Consensus 144 ~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 144 PPLEQLIDHMANT 156 (229)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 6777777777655
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.68 E-value=0.028 Score=62.07 Aligned_cols=140 Identities=14% Similarity=0.109 Sum_probs=84.1
Q ss_pred ceeeccCCcEEEEEEEEC---------CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCceEEEEe
Q 004388 408 NLRIGMGGYGTVYKGTFH---------HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEY 477 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~---------~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~~LV~Ey 477 (757)
...|..|-...+|+.... +..+.+++......... ...+|..+++.+. +.-..++++.+ ..++||||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~~~~I~ef 151 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF--PEGRIEEF 151 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--TTEEEEEC
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc--CCCEEEEE
Confidence 346778888999999876 56788888654322111 2346888888774 32234555543 35799999
Q ss_pred cCCCCHHH--------------H---Hhhc-------C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 004388 478 MENGSLED--------------R---LYRK-------N---NTPPIPWFERYRIAWEV-------------------ASA 511 (757)
Q Consensus 478 ~~~gsL~~--------------~---L~~~-------~---~~~~l~~~~~~~i~~qi-------------------a~a 511 (757)
++|..|.. . |+.. . ...+..|....++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 99865311 1 1110 0 11122344444443222 122
Q ss_pred HHHHh---------------------hCCCCCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 512 LAFLH---------------------NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 512 L~~LH---------------------~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
+.+|. ...+..++|+|+.+.||| +.++.+.|+||..|..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 33332 122356999999999999 8888999999988753
|
| >2ckl_A Polycomb group ring finger protein 4; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_B 2h0d_A | Back alignment and structure |
|---|
Probab=94.52 E-value=0.023 Score=49.99 Aligned_cols=66 Identities=15% Similarity=0.288 Sum_probs=59.6
Q ss_pred CCccCccchhcccCCccc-CCCcccchHHHHHHHHhCCCCCCCCCCCCCC----CCCchHHHHHHHHHHhh
Q 004388 691 NHFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNK----NLLPNYTLLSAILDWKS 756 (757)
Q Consensus 691 ~~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~~~sP~t~~~l~~~----~l~pn~~l~~~~~~w~~ 756 (757)
..+.|||-.+++.+|... .=|++|=..-|..|+..+.+||+-+.++... .+.||+.|+..|..|..
T Consensus 14 ~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~CP~Cr~~~~~~~~~~~l~~n~~l~~~i~~~~~ 84 (108)
T 2ckl_A 14 PHLMCVLCGGYFIDATTIIECLHSFCKTCIVRYLETSKYCPICDVQVHKTRPLLNIRSDKTLQDIVYKLVP 84 (108)
T ss_dssp GGTBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHTSCSBCTTTCCBSCSSCGGGGEEECHHHHHHHHHHST
T ss_pred CcCCCccCChHHhCcCEeCCCCChhhHHHHHHHHHhCCcCcCCCccccccCcccccCcCHHHHHHHHHHhh
Confidence 367899999999999986 7899999999999999889999999999876 78999999999998864
|
| >3hct_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.10A {Homo sapiens} PDB: 3hcu_A 2eci_A 2jmd_A | Back alignment and structure |
|---|
Probab=93.78 E-value=0.031 Score=50.00 Aligned_cols=68 Identities=19% Similarity=0.332 Sum_probs=60.9
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHhC-CCCCCCCCCCCCCCCCchHHHHHHHHHHh
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN-DKSPITDLPLPNKNLLPNYTLLSAILDWK 755 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~-~~sP~t~~~l~~~~l~pn~~l~~~~~~w~ 755 (757)
..+..+.|||=.+++.+|....=|++|=..-|..|+... .+||+-+.++....+.||..|+..|.++.
T Consensus 14 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~i~~l~ 82 (118)
T 3hct_A 14 PLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSLM 82 (118)
T ss_dssp CCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHTSE
T ss_pred CCCCCCCCCcCChhhcCeEECCcCChhhHHHHHHHHhhCCCCCCCCCCCcCHHhcccCHHHHHHHccce
Confidence 455678999999999999998889999999999999874 49999999999999999999999998753
|
| >1jm7_B BARD1, BRCA1-associated ring domain protein 1; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=93.63 E-value=0.043 Score=48.99 Aligned_cols=63 Identities=16% Similarity=0.183 Sum_probs=57.4
Q ss_pred CccCccchhcccCCccc-CCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 692 HFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 692 ~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
.+.|||=.+++.+|++. .=|++|=..-|..|+. .+||+-+.++....+.||+.|+..|..|..
T Consensus 22 ~~~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~--~~CP~Cr~~~~~~~~~~n~~l~~l~~~~~~ 85 (117)
T 1jm7_B 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG--TGCPVCYTPAWIQDLKINRQLDSMIQLCSK 85 (117)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT--TBCSSSCCBCSCSSCCCCHHHHHHHHHHHH
T ss_pred CCCCCCCChHhhCccEeCCCCCHHHHHHHHHHhc--CCCcCCCCcCccccccccHHHHHHHHHHHH
Confidence 57899999999999988 7899999999999998 789999999988899999999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.97 E-value=0.19 Score=54.86 Aligned_cols=30 Identities=30% Similarity=0.360 Sum_probs=25.0
Q ss_pred CEEEcCCCCCCeee------cCCCceEEeeecCccc
Q 004388 522 PIIHRDMKPGNILL------DHNLVSKIGDVGLSTM 551 (757)
Q Consensus 522 ~ivHrDLKp~NILl------d~~~~~KL~DFGla~~ 551 (757)
.++|+|+.+.|||+ +.+..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999988753
|
| >2csy_A Zinc finger protein 183-like 1; ring finger protein 161, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.71 E-value=0.13 Score=42.40 Aligned_cols=67 Identities=16% Similarity=0.210 Sum_probs=57.6
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHh
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWK 755 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~ 755 (757)
.....+.|||-.+.+.+|++..=|++|=..-|..|+....+||+-+.++. ..+.||..|...++.+.
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~CP~Cr~~~~-~~~~~~~~l~~~~~~~~ 77 (81)
T 2csy_A 11 EEEIPFRCFICRQAFQNPVVTKCRHYFCESCALEHFRATPRCYICDQPTG-GIFNPAKELMAKLQKSG 77 (81)
T ss_dssp CCCCCSBCSSSCSBCCSEEECTTSCEEEHHHHHHHHHHCSBCSSSCCBCC-SCCEECHHHHHHHSSSC
T ss_pred cCCCCCCCcCCCchhcCeeEccCCCHhHHHHHHHHHHCCCcCCCcCcccc-ccCCcHHHHHHHHHhhC
Confidence 34457889999999999999888999999999999998889999999997 67889988887776543
|
| >3hcs_A TNF receptor-associated factor 6; cross-brace, beta-BETA-alpha, coiled coil, cytoplasm, metal- binding, UBL conjugation, UBL conjugation pathway; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.78 E-value=0.098 Score=49.90 Aligned_cols=67 Identities=19% Similarity=0.347 Sum_probs=60.6
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHH
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDW 754 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w 754 (757)
..+..+.|||=.++|.+|+...=|++|=..-|..|+.. ..++|+-+.++....+.||.+++..|.++
T Consensus 14 ~~~~~~~C~IC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~i~~l 81 (170)
T 3hcs_A 14 PLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSL 81 (170)
T ss_dssp CCCGGGBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHHCSBCTTTCCBCCGGGCEECHHHHHHHHTS
T ss_pred CCCCCCCCCCCChhhcCcEECCCCCHHHHHHHHHHHHhCCCCCCCCccCcchhhhhhhHHHHHHHhhc
Confidence 55678899999999999999989999999999999987 55999999999999999999999998764
|
| >1jm7_A BRCA1, breast cancer type 1 susceptibility protein; ring finger, zinc-binding protein, heterodimer, ubiquitin ligase, antitumor; NMR {Homo sapiens} SCOP: g.44.1.1 | Back alignment and structure |
|---|
Probab=91.62 E-value=0.13 Score=45.15 Aligned_cols=64 Identities=14% Similarity=0.287 Sum_probs=56.7
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHhC---CCCCCCCCCCCCCCCCchHHHHHHHHHHh
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN---DKSPITDLPLPNKNLLPNYTLLSAILDWK 755 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~---~~sP~t~~~l~~~~l~pn~~l~~~~~~w~ 755 (757)
.+.|||-.+.+.+|.+..=|++|=..-|..|+... .+||+-+.++....+.||+.|...++.++
T Consensus 21 ~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~~~~~~~l~~~~~~~~ 87 (112)
T 1jm7_A 21 ILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELL 87 (112)
T ss_dssp HTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHH
T ss_pred CCCCcccChhhcCeEECCCCCHHHHHHHHHHHHhCCCCCCCcCCCCcCCHhhcCccHHHHHHHHHHH
Confidence 45799989999999998889999999999999864 48999999999999999999888888775
|
| >2ckl_B Ubiquitin ligase protein RING2; BMI1, RING1B, polycomb, E3-ligase, nuclear protein, chromosomal protein, transcription regulation; 2.0A {Mus musculus} PDB: 3rpg_C 2h0d_B | Back alignment and structure |
|---|
Probab=91.37 E-value=0.1 Score=49.48 Aligned_cols=65 Identities=17% Similarity=0.261 Sum_probs=57.4
Q ss_pred CCccCccchhcccCCccc-CCCcccchHHHHHHHHh-CCCCCCCCCCCC-CCCCCchHHHHHHHHHHh
Q 004388 691 NHFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQE-NDKSPITDLPLP-NKNLLPNYTLLSAILDWK 755 (757)
Q Consensus 691 ~~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~-~~~sP~t~~~l~-~~~l~pn~~l~~~~~~w~ 755 (757)
..+.|||-.+.+.+|... .=|++|=..-|..|+.. +.+||+-+.++. ...|.||..|+..|..|.
T Consensus 53 ~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~l~~~~~l~~~i~~~~ 120 (165)
T 2ckl_B 53 SELMCPICLDMLKNTMTTKECLHRFCADCIITALRSGNKECPTCRKKLVSKRSLRPDPNFDALISKIY 120 (165)
T ss_dssp HHHBCTTTSSBCSSEEEETTTCCEEEHHHHHHHHHTTCCBCTTTCCBCCSGGGEEECHHHHHHHHHHC
T ss_pred CCCCCcccChHhhCcCEeCCCCChhHHHHHHHHHHhCcCCCCCCCCcCCCcccCCcCHHHHHHHHHHH
Confidence 457899999999999877 77999999999999997 788999999984 456999999999999885
|
| >2ecv_A Tripartite motif-containing protein 5; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.60 E-value=0.095 Score=43.33 Aligned_cols=63 Identities=16% Similarity=0.355 Sum_probs=55.2
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh------CCCCCCCCCCCCCCCCCchHHHHHH
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE------NDKSPITDLPLPNKNLLPNYTLLSA 750 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~------~~~sP~t~~~l~~~~l~pn~~l~~~ 750 (757)
.....+.|||=.+.+.+|....=|++|=..-+..|+.. ..+||+-+.++...++.||+.|+..
T Consensus 15 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~ 83 (85)
T 2ecv_A 15 NVKEEVTCPICLELLTQPLSLDCGHSFCQACLTANHKKSMLDKGESSCPVCRISYQPENIRPNRHVANI 83 (85)
T ss_dssp CCCCCCCCTTTCSCCSSCBCCSSSCCBCTTHHHHHHHHHHHTTSCCCCTTTCCSSCSSSCCCSCCCCCC
T ss_pred HccCCCCCCCCCcccCCceeCCCCCHHHHHHHHHHHHHhhcCCCCCcCCCCCCccCHHhcCccHHHHHh
Confidence 44567889999999999998888999999999999986 7789999999999999999987654
|
| >2ecw_A Tripartite motif-containing protein 30; metal binding protein, structural genomics, NPPSFA; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=90.51 E-value=0.09 Score=43.47 Aligned_cols=63 Identities=25% Similarity=0.436 Sum_probs=55.0
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh------CCCCCCCCCCCCCCCCCchHHHHHH
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE------NDKSPITDLPLPNKNLLPNYTLLSA 750 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~------~~~sP~t~~~l~~~~l~pn~~l~~~ 750 (757)
.....+.|||=.+.+.+|.+..=|++|=..-|..|+.. ..+||+-+.++....+.||+.|+..
T Consensus 15 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~~~~~~CP~Cr~~~~~~~~~~n~~l~~~ 83 (85)
T 2ecw_A 15 MIKEEVTCPICLELLKEPVSADCNHSFCRACITLNYESNRNTDGKGNCPVCRVPYPFGNLKPNLHVANI 83 (85)
T ss_dssp CCCTTTSCTTTCSCCSSCEECTTSCCBCHHHHHHHHHHSBCTTSCBCCTTTCCCCCTTCCEECSCCCSS
T ss_pred hCccCCCCcCCChhhCcceeCCCCCHHHHHHHHHHHHhccCCCCCCCCCCCCCcCCHHhCCcCHHHHHh
Confidence 34567889999999999998888999999999999987 6789999999999999999887654
|
| >4ayc_A E3 ubiquitin-protein ligase RNF8; DNA damage, K63 chains; HET: CPQ; 1.90A {Homo sapiens} PDB: 4epo_C | Back alignment and structure |
|---|
Probab=88.64 E-value=0.33 Score=44.49 Aligned_cols=62 Identities=19% Similarity=0.275 Sum_probs=51.4
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHh
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWK 755 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~ 755 (757)
.+.|||-.+.|.+|++..=|++|=..-|..|+..+.+||+-+.++.... +|..+...|..+.
T Consensus 53 ~~~C~iC~~~~~~~~~~~CgH~fc~~Ci~~~~~~~~~CP~Cr~~~~~~~--~~~~~~~~i~~~~ 114 (138)
T 4ayc_A 53 ELQCIICSEYFIEAVTLNCAHSFCSYCINEWMKRKIECPICRKDIKSKT--YSLVLDNCINKMV 114 (138)
T ss_dssp HSBCTTTCSBCSSEEEETTSCEEEHHHHHHHTTTCSBCTTTCCBCCCEE--ECHHHHHHHHHHH
T ss_pred cCCCcccCcccCCceECCCCCCccHHHHHHHHHcCCcCCCCCCcCCCCC--CccchhHHHHHHH
Confidence 3579999999999999889999999999999999999999999987654 4555555555543
|
| >1rmd_A RAG1; V(D)J recombination, antibody, MAD, ring finger, zinc binuclear cluster, zinc finger, DNA-binding protein; 2.10A {Mus musculus} SCOP: g.37.1.1 g.44.1.1 | Back alignment and structure |
|---|
Probab=87.99 E-value=0.42 Score=42.27 Aligned_cols=63 Identities=17% Similarity=0.270 Sum_probs=54.6
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCC-chHHHHHHHHHH
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLL-PNYTLLSAILDW 754 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~-pn~~l~~~~~~w 754 (757)
.+.|||=.+++.+|.+..=|++|=..-|..|+.. +.++|+-+.++...++. |+..|...|..+
T Consensus 23 ~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~l~~~i~~l 87 (116)
T 1rmd_A 23 SISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNILNSL 87 (116)
T ss_dssp HTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHHHHC
T ss_pred CCCCCCCCcHhcCcEEcCCCCcccHHHHHHHHhHCcCcCCCCCCCCCHhhccccHHHHHHHHHHh
Confidence 5789999999999999888999999999999997 78899999999887765 567777777654
|
| >3lrq_A E3 ubiquitin-protein ligase TRIM37; structural genomics, PSI-2, protein structure initiative, northeast structural genomics consortium, NESG; HET: MSE; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.52 E-value=0.34 Score=41.77 Aligned_cols=63 Identities=19% Similarity=0.225 Sum_probs=55.7
Q ss_pred CccCccchhcccCCcc-cCCCcccchHHHHHHHHhC-CCCCCCCCCCCCCCCCchHHHHHHHHHH
Q 004388 692 HFICPILKEVMNEPCV-AADGYTYDRKAIEEWLQEN-DKSPITDLPLPNKNLLPNYTLLSAILDW 754 (757)
Q Consensus 692 ~ficPi~~evM~dp~i-aadG~tye~~aIe~wl~~~-~~sP~t~~~l~~~~l~pn~~l~~~~~~w 754 (757)
.+.|||=.+++.+|.. ..=|++|=..-|..|+... .+||+-+.++...+|++|+.|...++.-
T Consensus 22 ~~~C~IC~~~~~~p~~~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~~~~~~~l~~~~~~~~i~~~~ 86 (100)
T 3lrq_A 22 VFRCFICMEKLRDARLCPHCSKLCCFSCIRRWLTEQRAQCPHCRAPLQLRELVNCRWAEEVTQQL 86 (100)
T ss_dssp HTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCEECTTHHHHHHHH
T ss_pred CCCCccCCccccCccccCCCCChhhHHHHHHHHHHCcCCCCCCCCcCCHHHhHhhHHHHHHHHHH
Confidence 4679999999999998 7779999999999999986 6999999999999999999888776543
|
| >2egp_A Tripartite motif-containing protein 34; ZF-C3HC4 domain, tripartite motif protein 34, interferon- responsive finger protein 1; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.36 E-value=0.043 Score=45.01 Aligned_cols=63 Identities=22% Similarity=0.325 Sum_probs=54.6
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-------CCCCCCCCCCCCCCCCCchHHHHHH
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-------NDKSPITDLPLPNKNLLPNYTLLSA 750 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-------~~~sP~t~~~l~~~~l~pn~~l~~~ 750 (757)
.....+.|||=.+.+.+|.+..=|++|=..-|..|+.. ..+||+-+.++...++.||+.|+..
T Consensus 8 ~~~~~~~C~IC~~~~~~p~~l~CgH~fC~~Ci~~~~~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~l 77 (79)
T 2egp_A 8 NVQEEVTCPICLELLTEPLSLDCGHSLCRACITVSNKEAVTSMGGKSSCPVCGISYSFEHLQANQHLANI 77 (79)
T ss_dssp CCCCCCEETTTTEECSSCCCCSSSCCCCHHHHSCCCCCCSSSCCCCCCCSSSCCCCCSSGGGTCSSSCCC
T ss_pred hcccCCCCcCCCcccCCeeECCCCCHHHHHHHHHHHHhcccCCCCCCcCCCCCCcCCHhhCCcCHHHHHh
Confidence 34557889999999999998888999999999999976 5679999999999999999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.01 E-value=0.82 Score=45.19 Aligned_cols=116 Identities=9% Similarity=0.078 Sum_probs=76.1
Q ss_pred CCCceeeecccccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 456 RHPHLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 456 ~Hpniv~l~g~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
.||+.+.. ..-.+..-++..|-...+...+-. -..++...+++++..|+....+++. =+|--|.|+||++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 68888755 233333445555544332222111 1236678899999999988866654 4788899999999
Q ss_pred cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCcc
Q 004388 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIA 609 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~ 609 (757)
+.++.++|.-.|+-..+++. .++...=+-.+=+++..+++|+..|.
T Consensus 113 ~~~~~p~i~~RGik~~l~P~----------------------------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVVDPL----------------------------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CTTSCEEESCCEETTTBSCC----------------------------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cCCCCEEEEEccCccCCCCC----------------------------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999888875433221 11122223457889999999998884
|
| >3ng2_A RNF4, snurf, ring finger protein 4; ring domain, E3 ligase, ubiquitylation, sumoylation, zinc-FI metal binding protein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=85.91 E-value=0.47 Score=37.63 Aligned_cols=58 Identities=19% Similarity=0.366 Sum_probs=49.6
Q ss_pred CCCCCccCccchhcccCC-------cccCCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchH
Q 004388 688 APPNHFICPILKEVMNEP-------CVAADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNY 745 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp-------~iaadG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~ 745 (757)
.+...+.|||=.+.+.+| .+..=|++|=..-|..|+..+.++|+-+.++...++.|+|
T Consensus 6 ~~~~~~~C~IC~~~~~~~~~~~~~~~~~~CgH~fc~~Ci~~~~~~~~~CP~Cr~~~~~~~~~~~~ 70 (71)
T 3ng2_A 6 RPSGTVSCPICMDGYSEIVQNGRLIVSTECGHVFCSQCLRDSLKNANTCPTCRKKINHKRYHPIY 70 (71)
T ss_dssp CCTTCCBCTTTCCBHHHHHTTTCCEEECTTSCEEEHHHHHHHHHHCSBCTTTCCBCCCCSCCCCC
T ss_pred CCCCCCCCcccChhhhccccccCCeEeCCCCChHhHHHHHHHHHcCCCCCCCCCccChhheeecc
Confidence 344567899988888887 5666699999999999999989999999999999998875
|
| >2djb_A Polycomb group ring finger protein 6; PCGF6, ring domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.28 E-value=1.7 Score=34.53 Aligned_cols=58 Identities=12% Similarity=0.167 Sum_probs=50.7
Q ss_pred CCCCCccCccchhcccCCccc-CCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchH
Q 004388 688 APPNHFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNY 745 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~ 745 (757)
.....+.|||=.+.+.+|... .=|++|=..-|..|+....++|+-+.++...++++|.
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~CP~Cr~~~~~~~~~~~~ 69 (72)
T 2djb_A 11 ELTPYILCSICKGYLIDATTITECLHTFCKSCIVRHFYYSNRCPKCNIVVHQTQPLSGP 69 (72)
T ss_dssp CCCGGGSCTTTSSCCSSCEECSSSCCEECHHHHHHHHHHCSSCTTTCCCCCSSCSCCCC
T ss_pred hcCCCCCCCCCChHHHCcCEECCCCCHHHHHHHHHHHHcCCcCCCcCcccCcccccccC
Confidence 345578899999999999876 7799999999999999889999999999998888773
|
| >2yur_A Retinoblastoma-binding protein 6; P53-associated cellular protein of testis, proliferation potential-related protein, protein P2P-R; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.58 E-value=1.8 Score=34.80 Aligned_cols=57 Identities=23% Similarity=0.347 Sum_probs=47.0
Q ss_pred CCCCCccCccchhcccCCcccC-CCcccchHHHHHHHHhC--CCCCCCCCCCC-CCCCCch
Q 004388 688 APPNHFICPILKEVMNEPCVAA-DGYTYDRKAIEEWLQEN--DKSPITDLPLP-NKNLLPN 744 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaa-dG~tye~~aIe~wl~~~--~~sP~t~~~l~-~~~l~pn 744 (757)
..+..+.|||=.++|.+|++.. =|++|=..-|..|+... .+||+-+.+.. ...++||
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~~CgH~fC~~Ci~~~~~~~~~~~CP~Cr~~~~~~~~~~~n 71 (74)
T 2yur_A 11 PIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDALSGP 71 (74)
T ss_dssp CSCGGGSCSSSCCCCTTCEECSSSCCEECTTHHHHHHHHSSSSCCSSSCCSSCCTTTTTCT
T ss_pred cCCCCCCCcCCChHHhCCeEcCCCCCHHHHHHHHHHHHhcCCCcCCCCCCcCCCccccccC
Confidence 4556789999999999999987 49999999999999864 68999999854 3446666
|
| >3l11_A E3 ubiquitin-protein ligase RNF168; E3 ligase, ring domain, DNA damage, chromatin regulator, CHR protein, DNA repair, metal-binding, nucleus; 2.12A {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.22 E-value=0.45 Score=41.95 Aligned_cols=66 Identities=18% Similarity=0.209 Sum_probs=58.3
Q ss_pred CCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCC-------CCCCchHHHHHHHHHHh
Q 004388 690 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPN-------KNLLPNYTLLSAILDWK 755 (757)
Q Consensus 690 p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~-------~~l~pn~~l~~~~~~w~ 755 (757)
...+.|||=.+.+.+|.+..=|++|=..-|..|+.. ..+||+-+.++.. .++.+|..|...|+.|.
T Consensus 13 ~~~~~C~iC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~~~~~~~~~~~n~~l~~~i~~~~ 86 (115)
T 3l11_A 13 LSECQCGICMEILVEPVTLPCNHTLCKPCFQSTVEKASLCCPFCRRRVSSWTRYHTRRNSLVNVELWTIIQKHY 86 (115)
T ss_dssp HHHHBCTTTCSBCSSCEECTTSCEECHHHHCCCCCTTTSBCTTTCCBCHHHHHHHHHTTCCBCHHHHHHHHHHS
T ss_pred CCCCCCccCCcccCceeEcCCCCHHhHHHHHHHHhHCcCCCCCCCcccCccccccccccchhhHHHHHHHHHHC
Confidence 346789999999999999888999999999999986 6789999999864 67889999999999985
|
| >2ecy_A TNF receptor-associated factor 3; metal binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.02 E-value=3.4 Score=32.08 Aligned_cols=54 Identities=11% Similarity=0.209 Sum_probs=46.3
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHH-hCCCCCCCCCCCCCCCC
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQ-ENDKSPITDLPLPNKNL 741 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~-~~~~sP~t~~~l~~~~l 741 (757)
..+..+.|||=.+.+.+|....=|++|=..-|..|+. ...++|+-+.++...++
T Consensus 11 ~~~~~~~C~IC~~~~~~p~~~~CgH~fC~~Ci~~~~~~~~~~CP~Cr~~~~~~~i 65 (66)
T 2ecy_A 11 TVEDKYKCEKCHLVLCSPKQTECGHRFCESCMAALLSSSSPKCTACQESIVKDKV 65 (66)
T ss_dssp SCCCCEECTTTCCEESSCCCCSSSCCCCHHHHHHHHTTSSCCCTTTCCCCCTTTC
T ss_pred cCCcCCCCCCCChHhcCeeECCCCCHHHHHHHHHHHHhCcCCCCCCCcCCChhhc
Confidence 4456789999999999999988899999999999995 46789999998876654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 757 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-54 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-52 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-51 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-51 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-48 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-46 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-45 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-45 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-44 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-41 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-28 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 5e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-15 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 1e-09 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 1e-09 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 2e-06 | |
| d2baya1 | 56 | g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 { | 3e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 2e-61
Identities = 83/285 (29%), Positives = 130/285 (45%), Gaps = 21/285 (7%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQN--KQFLQELEVL 452
WE I ++ + RIG G +GTVYKG +H A VK+L + F E+ VL
Sbjct: 3 WE-IPDGQITVGQ--RIGSGSFGTVYKGKWHGDVA-VKMLNVTAPTPQQLQAFKNEVGVL 58
Query: 453 SKIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASA 511
K RH ++LL +G +V ++ E SL L+ + IA + A
Sbjct: 59 RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQG 116
Query: 512 LAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
+ +LH K IIHRD+K NI L +L KIGD GL+T+ + S +++ G+
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW----SGSHQFEQLSGS 169
Query: 572 LCYIDPEY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628
+ ++ PE Q S +SDVYA+G+V+ +L+T + + + + I L
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-RGYLS 228
Query: 629 AQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
K + L C + +R +RP Q+L +E L
Sbjct: 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 73/277 (26%), Positives = 126/277 (45%), Gaps = 21/277 (7%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLS 453
WE + TL E R+G G +G V+ G ++ HT AVK L +G++ FL E ++
Sbjct: 8 WE-VPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMK 63
Query: 454 KIRHPHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
+++H L+ L ++ EYMENGSL D L + + + +A ++A +
Sbjct: 64 QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGM 122
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
AF+ + IHRD++ NIL+ L KI D GL+ ++ + G +
Sbjct: 123 AFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-----EYTAREGAKFPI 174
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632
+ PE G + KSDV+++G+++ +++T + + + +
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLERGYRM 229
Query: 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669
P +EL L C + R +DRP + VLE
Sbjct: 230 VRPDNCPEELYQLMRLCWKERPEDRPTFD-YLRSVLE 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 7e-55
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 37/301 (12%)
Query: 394 TWEEIESATLSFSENL---------RIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGN 439
T+E+ A F++ + IG G +G V G F A+K L+S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 440 IQN-KQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPI 496
+ + FL E ++ + HP+++ L G ++ E+MENGSL+ + + N
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQF 125
Query: 497 PWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556
+ + +A+ + +L + +HRD+ NIL++ NLV K+ D GLS L D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET 616
S + T G + + PE + + SDV++YG+V+ ++++ E
Sbjct: 183 SDPTYT-SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG---------ER 232
Query: 617 AIDEDNLAEILDAQAGDW----PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672
+ ++++A D+ P+ L L L C + R RP Q++ L+++
Sbjct: 233 PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMI 291
Query: 673 E 673
Sbjct: 292 R 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-54
Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 20/267 (7%)
Query: 410 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACP 468
IG G +G V+ G + + A+K + +G + + F++E EV+ K+ HP L+ L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 469 DHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526
+ CLV+E+ME+G L D Y + + +V +A+L +IHR
Sbjct: 71 EQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHR 125
Query: 527 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 586
D+ N L+ N V K+ D G++ + D +TG + + PE S
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 587 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 646
KSDV+++G+++ ++ + ++ +I P + + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----DISTGFRLYKPRLASTHVYQIM 235
Query: 647 LSCAELRRKDRPDLKNQVLPVLERLKE 673
C + R +DRP ++L L + E
Sbjct: 236 NHCWKERPEDRPAFS-RLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-54
Identities = 58/268 (21%), Positives = 114/268 (42%), Gaps = 23/268 (8%)
Query: 410 RIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC- 467
+G G +G V G + A+K++ +G++ +F++E +V+ + H L+ L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 468 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526
++ EYM NG L + L + + + +V A+ +L + K +HR
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFLHR 124
Query: 527 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 586
D+ N L++ V K+ D GLS + D + G + + PE S
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 587 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 646
KSD++A+G+++ ++ + E + + I P ++++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP-----YERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 234
Query: 647 LSCAELRRKDRPDLKNQVLPVLERLKEV 674
SC + +RP K +L + +V
Sbjct: 235 YSCWHEKADERPTFKI----LLSNILDV 258
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 63/266 (23%), Positives = 110/266 (41%), Gaps = 24/266 (9%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-- 467
IG G +G V G + AVK +++ Q FL E V++++RH +L+ LLG
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 468 -PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526
+V EYM GSL D L + + + + +V A+ +L +HR
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 527 DMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLIS 586
D+ N+L+ + V+K+ D GL+ +S + + PE R S
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASST---------QDTGKLPVKWTAPEALREKKFS 178
Query: 587 PKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALG 646
KSDV+++G+++ ++ + +D + + D P + +
Sbjct: 179 TKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 647 LSCAELRRKDRPDLKNQVLPVLERLK 672
+C L RP Q+ LE +K
Sbjct: 234 KNCWHLDAAMRPSFL-QLREQLEHIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-52
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 21/279 (7%)
Query: 395 WEEIESATLSFSENLRIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLS 453
WE I +L ++G G +G V+ GT++ T A+K L G + + FLQE +V+
Sbjct: 12 WE-IPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMK 67
Query: 454 KIRHPHLLLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
K+RH L+ L + +V EYM GSL + + + +A ++AS +
Sbjct: 68 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGM 126
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
A++ +HRD++ NIL+ NLV K+ D GL+ ++ + G +
Sbjct: 127 AYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-----EYTARQGAKFPI 178
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632
+ PE G + KSDV+++G+++ +L T ++ + L ++
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP-----YPGMVNREVLDQVERGYRM 233
Query: 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
P + + L L C ++RP + + LE
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 3e-52
Identities = 68/286 (23%), Positives = 123/286 (43%), Gaps = 23/286 (8%)
Query: 407 ENLRIGMGGYGTVYKGTFHHT----FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLL 461
++ +G G +G+V +G + A+KVL Q ++ ++E +++ ++ +P+++
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 462 LLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L+G C LV E G L L K IP + +V+ + +L
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEE--- 127
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
K +HRD+ N+LL + +KI D GLS L +D S+ + + L + PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECI 184
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETK 640
S +SDV++YG+ + + L+ + + +A I + + P +
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYG-----QKPYKKMKGPEVMAFIEQGKRMECPPECPP 239
Query: 641 ELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 686
EL AL C + +DRPD V +R++ V H
Sbjct: 240 ELYALMSDCWIYKWEDRPDFLT----VEQRMRACYYSLASKVEGHH 281
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 1e-51
Identities = 61/274 (22%), Positives = 112/274 (40%), Gaps = 25/274 (9%)
Query: 407 ENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHL 460
E+ +G G +GTV KG + AVK+L+++ N + L E V+ ++ +P++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 461 LLLLGAC-PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
+ ++G C + LV E E G L L + + + +V+ + +L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
+HRD+ N+LL +KI D GLS L +D ++ T + + PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPVKWYAPEC 181
Query: 580 QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639
S KSDV+++G+++ + + + A + + P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYG-----QKPYRGMKGSEVTAMLEKGERMGCPAGCP 236
Query: 640 KELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
+E+ L C ++RP V RL+
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAA----VELRLRN 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-51
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 23/282 (8%)
Query: 404 SFSENLRIGMGGYGTVYKGTFHHT------FAAVKVL-QSKGNIQNKQFLQELEVLSKIR 456
+ IG G +G VYKG + A+K L Q FL E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 457 HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
H +++ L G + ++ EYMENG+L+ + + + + +A+ + +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
L N +HRD+ NIL++ NLV K+ D GLS +L DP TT +G + +
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT---SGGKIPIRW 179
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634
PE + SDV+++G+V+ +++T + + + I D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVMKAINDGFRLPT 234
Query: 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676
P+ + L + C + R RP ++ +L++L D
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAPD 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 9e-51
Identities = 64/332 (19%), Positives = 128/332 (38%), Gaps = 45/332 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G G G V+K + + A K++ + Q ++EL+VL + P+++ GA
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 467 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
+ E+M+ GSL+ L + IP +++ V L +L I+
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK--IM 127
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 584
HRD+KP NIL++ K+ D G+S L + VGT Y+ PE +
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--------NSFVGTRSYMSPERLQGTH 179
Query: 585 ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAA 644
S +SD+++ G+ ++++ + I D L + Q +
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPI-------PPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 645 LGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFICPILKEVMNE 704
G + RP + + + V P P+ ++ +N+
Sbjct: 233 PGRPLSSYGMDSRPPMA------------IFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 280
Query: 705 PCVAADGYTYDRKAIEE-----WLQENDKSPI 731
C+ + +R +++ +++ +D +
Sbjct: 281 -CLIKN--PAERADLKQLMVHAFIKRSDAEEV 309
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (447), Expect = 1e-50
Identities = 73/285 (25%), Positives = 132/285 (46%), Gaps = 24/285 (8%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSK 454
E+E ++ ++G G YG VY+G + AVK L + ++ ++FL+E V+ +
Sbjct: 13 EMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKE 69
Query: 455 IRHPHLLLLLGACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
I+HP+L+ LLG C + E+M G+L D L N + +A +++SA+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAM 128
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTL 572
+L K IHRD+ N L+ N + K+ D GLS ++ D T + G +
Sbjct: 129 EYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPI 180
Query: 573 CYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QA 631
+ PE S KSDV+A+G+++ ++ T + ID + E+L+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP------YPGIDLSQVYELLEKDYR 234
Query: 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVAD 676
+ P +++ L +C + DRP ++ E + + +
Sbjct: 235 MERPEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETMFQESS 278
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 60/267 (22%), Positives = 106/267 (39%), Gaps = 24/267 (8%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 465
IG G YG K K L + + + E+ +L +++HP+++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 466 ACPDHG----CLVYEYMENGSLEDRLYR-KNNTPPIPWFERYRIAWEVASALAFLH--NT 518
D +V EY E G L + + + R+ ++ AL H +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
++HRD+KP N+ LD K+GD GL+ +LN D SF T Y+ PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG------TPYYMSPE 184
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
+ KSD+++ G ++ +L P + E +I + + P +
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREGKFRRIPYRY 238
Query: 639 TKELAALGLSCAELRRKDRPDLKNQVL 665
+ EL + L+ RP ++ ++L
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVE-EIL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 8e-50
Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 40/296 (13%)
Query: 410 RIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD 469
IG G +G V++G + AVK+ S ++ E+ +RH ++L + A
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 470 HG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-----T 518
LV +Y E+GSL D L R + ++A AS LA LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I HRD+K NIL+ N I D+GL+ +S + VGT Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD--TIDIAPNHRVGTKRYMAPE 182
Query: 579 Y------QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVET-------------AID 619
+ ++D+YA G+V ++ I + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 620 EDNLAEILDAQAGDW--PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
+ + L + + + +A + C R ++ L +L +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQ 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 24/286 (8%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN-KQFLQELE 450
S + F+E IG G +G VY GT AVK L +I QFL E
Sbjct: 23 GPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 451 VLSKIRHPHLLLLLGAC---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWE 507
++ HP++L LLG C +V YM++G L + + +N T + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQ 138
Query: 508 VASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTG 567
VA + FL + K +HRD+ N +LD K+ D GL+ + + + TG
Sbjct: 139 VAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--DSVHNKTG 193
Query: 568 PVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627
+ ++ E +T + KSDV+++G+++ +L+T D +L
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLL 248
Query: 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
+ P L + L C + + RP +++ + +
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 3e-49
Identities = 71/295 (24%), Positives = 121/295 (41%), Gaps = 44/295 (14%)
Query: 410 RIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLL 461
IG G +G V++ T AVK+L+ + + F +E ++++ +P+++
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 462 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKN---------------------NTPPIPW 498
LLG C CL++EYM G L + L + PP+
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 499 FERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558
E+ IA +VA+ +A+L K +HRD+ N L+ N+V KI D GLS + S
Sbjct: 140 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA--- 193
Query: 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI 618
+ + ++ PE + +SDV+AYG+V+ ++ +
Sbjct: 194 -DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG-----LQPYYGMA 247
Query: 619 DEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
E+ + + D P EL L C DRP + +L+R+ E
Sbjct: 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMCE 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 4e-48
Identities = 71/301 (23%), Positives = 134/301 (44%), Gaps = 40/301 (13%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNIQNKQ-FLQE 448
E LSF + +G G +G V + T + AVK+L+ ++ ++ + E
Sbjct: 19 EFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 449 LEVLSKI-RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRK--------------- 490
L+VLS + H +++ LLGAC ++ EY G L + L RK
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 491 NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550
++ + + +++VA +AFL + K IHRD+ NILL H ++KI D GL+
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAI 610
+ +D ++V + ++ PE + + +SDV++YG+ + +L + +
Sbjct: 194 DIKNDSNYVVKGN----ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 611 THKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670
V++ + I + P E+ + +C + RP K Q++ ++E+
Sbjct: 250 GMPVDSKFYK----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEK 304
Query: 671 L 671
Sbjct: 305 Q 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 7e-48
Identities = 57/267 (21%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G VYK T AA KV+ +K + + ++ E+++L+ HP+++ LL A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 468 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
++ E+ G+++ + P+ + + + AL +LH+ IIH
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIH 133
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY-----Q 580
RD+K GNIL + K+ D G+S + +GT ++ PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ------RRDSFIGTPYWMAPEVVMCETS 187
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG--DWPIKE 638
+ K+DV++ G+ ++++ +P + + L +I ++ P +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSEPPTLAQPSRW 241
Query: 639 TKELAALGLSCAELRRKDRPDLKNQVL 665
+ C E R Q+L
Sbjct: 242 SSNFKDFLKKCLEKNVDARWTTS-QLL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-47
Identities = 64/269 (23%), Positives = 111/269 (41%), Gaps = 33/269 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 465
IG G + TVYKG T A LQ + ++ ++F +E E+L ++HP+++
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 466 ACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
+ LV E M +G+L+ L R + ++ L FLH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 520 PKPIIHRDMKPGNILL-DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
P PIIHRD+K NI + KIGD+GL+T+ + + +GT ++ PE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--------KAVIGTPEFMAPE 183
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL--DAQAGDWPI 636
DVYA+GM +L++ T++ + + + + +
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPY------SECQNAAQIYRRVTSGVKPASFDK 236
Query: 637 KETKELAALGLSCAELRRKDRPDLKNQVL 665
E+ + C + +R +K +L
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIK-DLL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 3e-47
Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 29/276 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT-----FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLL 461
++G G +G V +G + AVK L+ Q F++E+ + + H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 462 LLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP 520
L G +V E GSL DRL + R A +VA + +L +
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 521 KPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQ 580
K IHRD+ N+LL + KIGD GL L + + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ---EHRKVPFAWCAPESL 186
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET- 639
+T S SD + +G+ + ++ T + ++ + +D + P E
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYG------QEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 640 -KELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674
+++ + + C + +DRP + + L E
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVA----LRDFLLEA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 9e-47
Identities = 74/306 (24%), Positives = 124/306 (40%), Gaps = 44/306 (14%)
Query: 389 RYRNLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT----FAAVKVLQSKGNIQN-K 443
Y L W +I+ F + IG G +G V K AA+K ++ + + +
Sbjct: 3 IYPVLDWNDIK-----FQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 444 QFLQELEVLSKI-RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTP------ 494
F ELEVL K+ HP+++ LLGAC + L EY +G+L D L +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 495 -------PIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547
+ + A +VA + +L K IHRD+ NIL+ N V+KI D G
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 172
Query: 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPA 607
LS K T + ++ E + + SDV++YG+++ ++++
Sbjct: 173 LS-------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 225
Query: 608 IAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPV 667
+ ++ + P+ E+ L C + +RP Q+L
Sbjct: 226 PYCGMTCAELYE-----KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVS 279
Query: 668 LERLKE 673
L R+ E
Sbjct: 280 LNRMLE 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-46
Identities = 72/313 (23%), Positives = 130/313 (41%), Gaps = 51/313 (16%)
Query: 392 NLTWEEIESATLSFSENLRIGMGGYGTVYKGTFHHT-------FAAVKVLQSKGNIQN-K 443
+L WE L F + +G G +G V T + AVK+L+ K + +
Sbjct: 29 DLKWE-FPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 85
Query: 444 QFLQELEVLSKI-RHPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKN--------- 491
+ EL++++++ H +++ LLGAC G L++EY G L + L K
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145
Query: 492 -----------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLV 540
+ + + + A++VA + FL K +HRD+ N+L+ H V
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKV 202
Query: 541 SKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQ 600
KI D GL+ + SD S + ++ PE G+ + KSDV++YG+++ +
Sbjct: 203 VKICDFGLARDIMSD----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 258
Query: 601 LLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPD 659
+ + + + N +++ D P T+E+ + SC + RP
Sbjct: 259 IFSLG-----VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313
Query: 660 LKNQVLPVLERLK 672
N + L
Sbjct: 314 FPN----LTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-46
Identities = 65/309 (21%), Positives = 129/309 (41%), Gaps = 25/309 (8%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSKGNIQ-NKQFLQELEVLSKIRH 457
F + +G G +GTVYKG + A+K L+ + + NK+ L E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 458 PHLLLLLGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLH 516
PH+ LLG C L+ + M G L D + + I ++A + +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE 128
Query: 517 NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
+ + ++HRD+ N+L+ KI D GL+ +L ++ Y G + ++
Sbjct: 129 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAEGGKVPIKWMA 181
Query: 577 PEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-QAGDWP 635
E + + +SDV++YG+ + +L+T K I ++ IL+ + P
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFG------SKPYDGIPASEISSILEKGERLPQP 235
Query: 636 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVHPAPPNHFIC 695
T ++ + + C + RP + +++ ++ R P+
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294
Query: 696 PILKEVMNE 704
+ +M+E
Sbjct: 295 NFYRALMDE 303
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-45
Identities = 59/262 (22%), Positives = 110/262 (41%), Gaps = 26/262 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+IG G GTVY T A++ + + + + + E+ V+ + ++P+++ L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 468 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
D +V EY+ GSL D + + + + E AL FLH+ +IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 526 RDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI 585
RD+K NILL + K+ D G + + S ST VGT ++ PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------VGTPYWMAPEVVTRKAY 193
Query: 586 SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE--TKELA 643
PK D+++ G++ ++++ +P + + L I + E +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPEKLSAIFR 247
Query: 644 ALGLSCAELRRKDRPDLKNQVL 665
C ++ + R K ++L
Sbjct: 248 DFLNRCLDMDVEKRGSAK-ELL 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 60/277 (21%), Positives = 103/277 (37%), Gaps = 33/277 (11%)
Query: 403 LSFSENLR----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKI 455
+ F E+ +G G YG V T AVK++ K + + +E+ + +
Sbjct: 1 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60
Query: 456 RHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALA 513
H +++ G + L EY G L DR+ +P + R ++ + +
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVV 117
Query: 514 FLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLC 573
+LH I HRD+KP N+LLD KI D GL+T+ + + GTL
Sbjct: 118 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN----NRERLLNKMCGTLP 170
Query: 574 YIDPEY-QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG 632
Y+ PE +R + DV++ G+V+ +L + D+ E D +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW--------DQPSDSCQEYSDWKEK 222
Query: 633 DWPIKE----TKELAALGLSCAELRRKDRPDLKNQVL 665
+ AL R + +
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIP-DIK 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 5e-45
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 405 FSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPH 459
FS+ IG G +G VY A+K + G N + ++E+ L K+RHP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 460 LLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
+ G LV EY + + K P+ E + LA+LH+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS 133
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
+IHRD+K GNILL + K+GD G ++++ SF VGT ++ P
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----------VGTPYWMAP 180
Query: 578 EY---QRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634
E G K DV++ G+ ++L KP + + + ++ + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---------NMNAMSALYHIAQNES 231
Query: 635 PIKE----TKELAALGLSCAELRRKDRPDLKNQVL 665
P + ++ SC + +DRP + +L
Sbjct: 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSE-VLL 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-45
Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 29/263 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL---QSKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
+G G +G VY + A+KVL Q + Q +E+E+ S +RHP++L L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 465 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G D L+ EY G++ L + + E+A+AL++ H+ K
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHS---KR 126
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+IHRD+KP N+LL KI D G S S + T GTL Y+ PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------RRTTLCGTLDYLPPEMIEG 178
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642
+ K D+++ G++ + L KP A + + +P T+
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFE-------ANTYQETYKRISRVEFTFPDFVTEGA 231
Query: 643 AALGLSCAELRRKDRPDLKNQVL 665
L + RP L+ +VL
Sbjct: 232 RDLISRLLKHNPSQRPMLR-EVL 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-44
Identities = 59/294 (20%), Positives = 118/294 (40%), Gaps = 32/294 (10%)
Query: 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFA-------AVKVL-QSKGNIQNKQFLQE 448
E+ ++ S +G G +G VY+G A+K + ++ + +FL E
Sbjct: 16 EVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 449 LEVLSKIRHPHLLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKN-------NTPPIPWF 499
V+ + H++ LLG ++ E M G L+ L P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 500 ERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559
+ ++A E+A +A+L+ +HRD+ N ++ + KIGD G++ +
Sbjct: 134 KMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET---- 186
Query: 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 619
K + + ++ PE + G+ + SDV+++G+V+ ++ T + +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----QPYQGLSN 241
Query: 620 EDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
E L +++ D P L L C + K RP +++ ++ E
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 8e-44
Identities = 59/277 (21%), Positives = 115/277 (41%), Gaps = 24/277 (8%)
Query: 410 RIGMGGYGTVYKGTFHHT-----FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
IG G +G V++G + A+K + ++FLQE + + HPH++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 464 LGACPDHG-CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
+G ++ ++ E G L + + + A+++++ALA+L + K
Sbjct: 74 IGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+HRD+ N+L+ N K+GD GLS + T YK + + ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKWMAPESINF 183
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642
+ SDV+ +G+ + ++L + + D + I + + P L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHG-----VKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 238
Query: 643 AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRAR 679
+L C RP ++ L + E ++A+
Sbjct: 239 YSLMTKCWAYDPSRRPRFT-ELKAQLSTILE-EEKAQ 273
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (395), Expect = 1e-42
Identities = 55/268 (20%), Positives = 107/268 (39%), Gaps = 34/268 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G V++ T T A K + + + +E++ +S +RHP L+ L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 468 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
D ++YE+M G L +++ ++N + E +V L +H +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 526 RDMKPGNILL--DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
D+KP NI+ + K+ D GL+ L+ S TT GT + PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-------GTAEFAAPEVAEGK 200
Query: 584 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE----- 638
+ +D+++ G++ LL+ E++ + + ++ DW + +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFG---------GENDDETLRNVKSCDWNMDDSAFSG 251
Query: 639 -TKELAALGLSCAELRRKDRPDLKNQVL 665
+++ R + Q L
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIH-QAL 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 149 bits (378), Expect = 4e-41
Identities = 61/273 (22%), Positives = 113/273 (41%), Gaps = 23/273 (8%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQ---SKGNIQNKQFLQELEVLSKIRHPHLLLLL 464
+G GG V+ AVKVL+ ++ +F +E + + + HP ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 465 GACPDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
+V EY++ +L D ++ + P+ + + AL F H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQ- 129
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
IIHRD+KP NI++ K+ D G++ + + V+ T +GT Y+ PE
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT---AAVIGTAQYLSPE 184
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
R + +SDVY+ G V+ ++LT +P V A ++ E +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVREDPIPPSARHE-GL 241
Query: 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
+ +L A+ L ++R ++ L R+
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (383), Expect = 5e-41
Identities = 58/268 (21%), Positives = 103/268 (38%), Gaps = 34/268 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G V++ T K + + + E+ +++++ HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 468 PDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
D L+ E++ G L DR+ ++ + E + L +H I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHE---HSIVH 150
Query: 526 RDMKPGNILLDHNLVS--KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
D+KP NI+ + S KI D GL+T LN D T T + PE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-------TATAEFAAPEIVDRE 203
Query: 584 LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE----- 638
+ +D++A G++ LL+ A ED+L + + + DW E
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFA---------GEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 639 -TKELAALGLSCAELRRKDRPDLKNQVL 665
+ E + + + R + L
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVH-DAL 281
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-41
Identities = 65/288 (22%), Positives = 121/288 (42%), Gaps = 39/288 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT---------FAAVKVLQSKGNIQN-KQFLQELEVLSKI-RHP 458
+G G +G V AVK+L+S ++ + E+E++ I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 459 HLLLLLGACPDHG--CLVYEYMENGSLEDRLYRK-------------NNTPPIPWFERYR 503
+++ LLGAC G ++ EY G+L + L + N + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 504 IAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTY 563
A++VA + +L + K IHRD+ N+L+ + V KI D GL+ ++ + TT
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 564 KNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNL 623
+ ++ PE + + +SDV+++G+++ ++ T + VE
Sbjct: 197 GR----LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK---- 248
Query: 624 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671
+ + D P T EL + C RP K Q++ L+R+
Sbjct: 249 -LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 24/259 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 464
+G G + TV T A+K+L+ + I+ +E +V+S++ HP + L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 465 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
D Y +NG L + + E+ SAL +LH K
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KG 128
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
IIHRD+KP NILL+ ++ +I D G + +L+ + S + VGT Y+ PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFVGTAQYVSPELLTE 184
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642
SD++A G +I QL+ P ++ +I+ + D+P K +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLE-YDFPEKFFPKA 237
Query: 643 AALGLSCAELRRKDRPDLK 661
L L R +
Sbjct: 238 RDLVEKLLVLDATKRLGCE 256
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 64/289 (22%), Positives = 117/289 (40%), Gaps = 37/289 (12%)
Query: 410 RIGMGGYGTVYKGTFHHT-------FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLL 461
+G G +G V + AVK+L + + +++ + EL++L I H +
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 462 LLL-GACPDHG---CLVYEYMENGSLEDRLYRKNNTP-------------PIPWFERYRI 504
+ L GAC G ++ E+ + G+L L K N +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 505 AWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYK 564
+++VA + FL + + IHRD+ NILL V KI D GL+ + DP +V
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK--- 193
Query: 565 NTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLA 624
L ++ PE + + +SDV+++G+++ ++ + + IDE+
Sbjct: 194 -GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----SPYPGVKIDEEFCR 248
Query: 625 EILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673
+ + P T E+ L C RP +++ L L +
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 2e-38
Identities = 59/264 (22%), Positives = 99/264 (37%), Gaps = 25/264 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
+G G + V T A+K + + + E+ VL KI+HP+++ L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 467 CPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
G L+ + + G L DR+ K + R+ ++V A+ +LH+ I+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIV 129
Query: 525 HRDMKPGNILL---DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
HRD+KP N+L D + I D GLS M + + GT Y+ PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-------VLSTACGTPGYVAPEVLA 182
Query: 582 TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641
S D ++ G++ LL P + + E L + + W +
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF--EQILKAEYEFDSPYWD-DISDS 239
Query: 642 LAALGLSCAELRRKDRPDLKNQVL 665
E + R + Q L
Sbjct: 240 AKDFIRHLMEKDPEKRFTCE-QAL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 60/264 (22%), Positives = 98/264 (37%), Gaps = 27/264 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSK-IRHPHLLLL 463
+G G +G V+ F T F A+K L+ + + + E VLS HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 464 LGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
V EY+ G L + + A E+ L FLH+ K
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---K 122
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQR 581
I++RD+K NILLD + KI D G+ + K GT YI PE
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK------ENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 582 TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKE 641
+ D +++G+++ ++L + DE+ L + +P KE
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFH-------GQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 642 LAALGLSCAELRRKDRPDLKNQVL 665
L + + R ++ +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 7e-38
Identities = 41/203 (20%), Positives = 85/203 (41%), Gaps = 19/203 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+G G +G V++ + K ++ KG +E+ +L+ RH ++L L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF 70
Query: 468 --PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIH 525
+ +++E++ + +R+ + + E +V AL FLH+ I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 526 RDMKPGNILLDH--NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG 583
D++P NI+ + KI + G + L +F Y PE +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-------TAPEYYAPEVHQHD 178
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
++S +D+++ G ++ LL+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 140 bits (353), Expect = 9e-38
Identities = 61/285 (21%), Positives = 110/285 (38%), Gaps = 41/285 (14%)
Query: 405 FSENLR----IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---------KQFLQEL 449
F EN +G G V + T AVK++ G + L+E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 450 EVLSKIR-HPHLLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAW 506
++L K+ HP+++ L + LV++ M+ G L D L K + E +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMR 117
Query: 507 EVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNT 566
+ + LH I+HRD+KP NILLD ++ K+ D G S L+ K
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-------KLR 167
Query: 567 GPVGTLCYIDPEYQRTGL------ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE 620
GT Y+ PE + + D+++ G+++ LL P ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--R 225
Query: 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVL 665
++ + +W + + L ++ + R + + L
Sbjct: 226 MIMSGNYQFGSPEWD-DYSDTVKDLVSRFLVVQPQKRYTAE-EAL 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 3e-37
Identities = 52/264 (19%), Positives = 93/264 (35%), Gaps = 26/264 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
+IG G +G +Y GT A+K+ K ++ Q E ++ ++ + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 468 ---PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
D+ +V E + + + +A ++ S + ++H+ K I
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 525 HRDMKPGNIL---LDHNLVSKIGDVGLSTMLNSDPSFVSTTY-KNTGPVGTLCYIDPEYQ 580
HRD+KP N L + I D GL+ + Y +N GT Y
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-----IDEDNLAEILDAQAGDWP 635
S + D+ + G V++ I E ++ ++ +P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 636 IKETKELAALGLSCAELRRKDRPD 659
E A C LR D+PD
Sbjct: 246 ----SEFATYLNFCRSLRFDDKPD 265
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 139 bits (350), Expect = 3e-37
Identities = 50/284 (17%), Positives = 90/284 (31%), Gaps = 27/284 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN-KQFLQELEVLSKIRHPHLLLLLGA 466
RIG G +G +++GT A+K + + + + ++L+ + G
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 467 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHR 526
H LV + + + A ++ + + +H K +++R
Sbjct: 72 EGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYR 125
Query: 527 DMKPGNILLD-----HNLVSKIGDVGLSTMLNSDPSFVSTTY-KNTGPVGTLCYIDPEYQ 580
D+KP N L+ + + + D G+ + Y + GT Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETA-----IDEDNLAEILDAQAGDWP 635
S + D+ A G V + L I E + L +P
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFP 245
Query: 636 IKETKELAALGLSCAELRRKDRPD---LKNQVLPVLERLKEVAD 676
+E L PD L+ VLERL D
Sbjct: 246 ----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 5e-36
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 39/299 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT---FAAVKVLQSKGNIQN--KQFLQELEVLSKI---RHPHLL 461
IG G YG V+K F A+K ++ + + ++E+ VL + HP+++
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 462 LLLGACPD-------HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAF 514
L C LV+E+++ K P +P + +++ L F
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 515 LHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCY 574
LH+ ++HRD+KP NIL+ + K+ D GL+ + + + S V TL Y
Sbjct: 132 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-------VVTLWY 181
Query: 575 IDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ---- 630
PE + D+++ G + ++ KP + D D L +ILD
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS------DVDQLGKILDVIGLPG 235
Query: 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSV--HP 687
DWP A A+ K D+ +L + R + S HP
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 294
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (338), Expect = 2e-35
Identities = 66/256 (25%), Positives = 110/256 (42%), Gaps = 29/256 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLL 464
+G G +G V+ H + A+KVL+ + ++ KQ E +LS + HP ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 465 GACPDHGCL--VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
G D + + +Y+E G L L + P A EV AL +LH+ K
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHS---KD 124
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
II+RD+KP NILLD N KI D G + + GT YI PE T
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVST 175
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642
+ D +++G++I ++L ++ ++T +IL+A+ +P +++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAEL-RFPPFFNEDV 228
Query: 643 AALGLSCAELRRKDRP 658
L R
Sbjct: 229 KDLLSRLITRDLSQRL 244
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (339), Expect = 5e-35
Identities = 60/260 (23%), Positives = 100/260 (38%), Gaps = 29/260 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSK------GNIQNKQFLQELEVLSKIRHPHLL 461
IG GG+G VY T A+K L K G L ++S P ++
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 462 LLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
+ A PD + + M G L L + + A E+ L +HN
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHN-- 125
Query: 520 PKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEY 579
+ +++RD+KP NILLD + +I D+GL+ + K VGT Y+ PE
Sbjct: 126 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHGYMAPEV 176
Query: 580 QRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
+ G+ +D ++ G ++ +LL + D+ + + A + P
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP----FRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 639 TKELAALGLSCAELRRKDRP 658
+ EL +L + R
Sbjct: 233 SPELRSLLEGLLQRDVNRRL 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-35
Identities = 53/267 (19%), Positives = 104/267 (38%), Gaps = 35/267 (13%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGAC 467
+G+G G V + T A+K+LQ + +E+E+ + + PH++ ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 468 PDHG------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
+ +V E ++ G L R+ + + E I + A+ +LH+
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 522 PIIHRDMKPGNILLDH---NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE 578
I HRD+KP N+L N + K+ D G + S S + Y T Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183
Query: 579 YQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638
D+++ G+++ LL P H + + + + ++P E
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYEFPNPE 240
Query: 639 ----TKELAALGLSCAELRRKDRPDLK 661
++E+ L + + R +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-35
Identities = 45/203 (22%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL-QSKGNIQNKQFLQELEVLSKIRHPHLLLLLGA 466
IG G YG V + A+K + + ++ L+E+++L + RH +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 467 C--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
P + Y+ + LY+ T + +++ L ++H+ ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGL 584
HRD+KP N+LL+ KI D GL+ + + D T T V T Y PE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 585 I-SPKSDVYAYGMVILQLLTAKP 606
+ D+++ G ++ ++L+ +P
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRP 211
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-34
Identities = 47/204 (23%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 465
+IG G YG VYK T A+K ++ + ++E+ +L ++ HP+++ LL
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 466 AC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
+ LV+E++ + + IP +++ LAF H+ +
Sbjct: 69 VIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRV 123
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 582
+HRD+KP N+L++ K+ D GL+ + V TL Y PE
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE------VVTLWYRAPEILLGC 177
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
S D+++ G + +++T +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-34
Identities = 59/299 (19%), Positives = 109/299 (36%), Gaps = 28/299 (9%)
Query: 403 LSFSENLRIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL 460
+S+++ IG G +G VY+ + A+K + + +EL+++ K+ H ++
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNI 75
Query: 461 LLLLGACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
+ L G LV +Y+ + +P +++ +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
A++H+ I HRD+KP N+LLD + V K+ D G + L VS
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR------ 186
Query: 572 LCYIDP-EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630
Y P + DV++ G V+ +LL +P V+ ++ + +
Sbjct: 187 -YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSV--HP 687
E + + RP + + + RL E AR T H
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-33
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 411 IGMGGYGTVYKGTFHHT--FAAVKVL-----QSKGNIQNKQFLQELEVLSKIRHPHLLLL 463
+G G + TVYK +T A+K + + N+ L+E+++L ++ HP+++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 464 LGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPK 521
L A + LV+++ME + K+N+ + L +LH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLE---VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---H 119
Query: 522 PIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 580
I+HRD+KP N+LLD N V K+ D GL+ S T V T Y PE
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN------RAYTHQVVTRWYRAPELLF 173
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKP 606
+ D++A G ++ +LL P
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVP 199
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 49/212 (23%), Positives = 90/212 (42%), Gaps = 23/212 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 465
+IG G +G V+K T A+K + + + L+E+++L ++H +++ L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 466 ACPDHG----------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFL 515
C LV+++ E+ E R+ + + L ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133
Query: 516 HNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
H K I+HRDMK N+L+ + V K+ D GL+ + + S + T V TL Y
Sbjct: 134 HRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN--SQPNRYTNRVVTLWYR 188
Query: 576 DPEYQRTG-LISPKSDVYAYGMVILQLLTAKP 606
PE P D++ G ++ ++ T P
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 7e-33
Identities = 54/270 (20%), Positives = 102/270 (37%), Gaps = 31/270 (11%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL------QSKGNIQNKQFLQELEVLSKIRHPHLL 461
+G G + V K T A K + S+ + + +E+ +L +I+HP+++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 462 LLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK 519
L + L+ E + G L D L K + E ++ + + +LH+
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 131
Query: 520 PKPIIHRDMKPGNILLDHNLVS----KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYI 575
I H D+KP NI+L V KI D GL+ ++ F GT ++
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-------KNIFGTPEFV 183
Query: 576 DPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635
PE + ++D+++ G++ LL+ K ET N++ + ++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAVNYEFEDEYF 240
Query: 636 IKETKELAALGLSCAELRRKDRPDLKNQVL 665
+ K R ++ L
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQ-DSL 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 2e-32
Identities = 57/270 (21%), Positives = 98/270 (36%), Gaps = 41/270 (15%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN------KQFLQELEVLSKIRHPH-- 459
+G GG+G+VY G A+K ++ + E+ +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 460 LLLLLGAC--PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
++ LL PD L+ E E + + W+V A+ HN
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 518 TKPKPIIHRDMKPGNILLDHNLVS-KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYID 576
++HRD+K NIL+D N K+ D G +L T GT Y
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--------YTDFDGTRVYSP 177
Query: 577 PEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635
PE+ R + V++ G+++ ++ ++ EI+ Q +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF------------EHDEEIIRGQV-FFR 224
Query: 636 IKETKELAALGLSCAELRRKDRPDLKNQVL 665
+ + E L C LR DRP + ++
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFE-EIQ 253
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 124 bits (311), Expect = 4e-32
Identities = 41/203 (20%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 410 RIGMGGYGTVYKGTFHHT-FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLGA 466
+IG G YG VYK ++ A+K ++ + + ++E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 467 CPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPII 524
LV+E+++ + + + ++ + +A+ H+ + ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 525 HRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRTG 583
HRD+KP N+L++ KI D GL+ K T + TL Y P+ +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIP------VRKYTHEIVTLWYRAPDVLMGSK 176
Query: 584 LISPKSDVYAYGMVILQLLTAKP 606
S D+++ G + +++ P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTP 199
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 62/256 (24%), Positives = 99/256 (38%), Gaps = 26/256 (10%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN---KQFLQELEVLSKIRHPHLLLLL 464
+G G +G V T + A+K+L+ + I + E VL RHP L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 465 GACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
A H C V EY G L L R+ E+ SAL +LH+ +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHS---RD 125
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
+++RD+K N++LD + KI D GL SD + GT Y+ PE
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA------TMKTFCGTPEYLAPEVLED 179
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642
D + G+V+ +++ + D + L E++ + +P + E
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF-------YNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 643 AALGLSCAELRRKDRP 658
+L + K R
Sbjct: 233 KSLLAGLLKKDPKQRL 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (307), Expect = 5e-31
Identities = 59/303 (19%), Positives = 115/303 (37%), Gaps = 33/303 (10%)
Query: 364 EAEMKAKHEAKEKEMLERALNGTFQRYRNLTWEEIESATLSFSENLR-IGMGGYGTVYKG 422
A K + KE L +A +++ + +A L + ++ +G G +G V
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQN---TAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 423 TFHHT--FAAVKVLQSKGNIQNKQ---FLQELEVLSKIRHPHLLLLLGACPDHGCL--VY 475
+ A+K+L + ++ KQ L E +L + P L+ L + D+ L V
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535
EY+ G + L R A ++ +LH+ +I+RD+KP N+L+
Sbjct: 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLI 174
Query: 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYG 595
D ++ D G + + + GT + PE + + D +A G
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWTL---------CGTPEALAPEIILSKGYNKAVDWWALG 225
Query: 596 MVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRK 655
++I ++ P A + E + + +P + +L L + ++
Sbjct: 226 VLIYEMAAGYPPF-------FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 656 DRP 658
R
Sbjct: 279 KRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-30
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 465
+G G YG V T A+K L + K+ +EL +L +RH +++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 466 ACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
LV +M G+ +L + + + +++ L ++H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA 139
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
IIHRD+KPGN+ ++ + KI D GL+ +S + TG V T Y P
Sbjct: 140 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---------EMTGYVVTRWYRAP 187
Query: 578 E-YQRTGLISPKSDVYAYGMVILQLLTAKP 606
E + D+++ G ++ +++T K
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-29
Identities = 51/275 (18%), Positives = 105/275 (38%), Gaps = 25/275 (9%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 465
+IG G YGTV+K T A+K ++ + + L+E+ +L +++H +++ L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 466 ACPD--HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPI 523
LV+E+ + + + + +++ L F H+ + +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 524 IHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQRT 582
+HRD+KP N+L++ N K+ + GL+ + V TL Y P+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIP------VRCYSAEVVTLWYRPPDVLFGA 176
Query: 583 GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKETKEL 642
L S D+++ G + +L A + D D+ + + G ++ +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPL------FPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 643 AALGLSCAELRRKDRPDLKNQVLPVLERLKEVADR 677
L L N V + +++
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (283), Expect = 5e-28
Identities = 40/206 (19%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGA 466
++G G Y V++ VK+L+ ++ K+ +E+++L +R P+++ L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 467 CPDHG----CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
D LV+E++ N + + ++ +E+ AL + H+
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHS---MG 149
Query: 523 IIHRDMKPGNILLDH-NLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPE-YQ 580
I+HRD+KP N+++DH + ++ D GL+ + + V + + PE
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-------EYNVRVASRYFKGPELLV 202
Query: 581 RTGLISPKSDVYAYGMVILQLLTAKP 606
+ D+++ G ++ ++ K
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 7e-27
Identities = 45/209 (21%), Positives = 78/209 (37%), Gaps = 28/209 (13%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQN--KQFLQELEVLSKIRHPHLLLLLG 465
IG G G V A+K L Q K+ +EL ++ + H +++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 466 ACPDHG--------CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
LV E M+ + + + +++ + LH+
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQMLCGIKHLHS 137
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
IIHRD+KP NI++ + KI D GL+ T++ T V T Y P
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLA-------RTAGTSFMMTPYVVTRYYRAP 187
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKP 606
E D+++ G ++ +++ K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKI 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 108 bits (270), Expect = 4e-26
Identities = 55/368 (14%), Positives = 124/368 (33%), Gaps = 70/368 (19%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC 467
++G G + TV+ A+K++ + + E+++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 468 ---------------PDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASAL 512
P+ +V + G L +K IP +I+ ++ L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 513 AFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGT 571
++H IIH D+KP N+L++ + + ++ + N+ T + T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSIQT 192
Query: 572 LCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-- 629
Y PE +D+++ +I +L+T D+D++A+I++
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 630 ---QAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEVADRARDTVPSVH 686
K T+ + + L++ + + K+ A D
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD------ 306
Query: 687 PAPPNHFICPIL----------KEVMNEPCVAADGYTYDRKAIEEWLQENDKSPITDLPL 736
F+ P+L ++N P WL++ + ++ +
Sbjct: 307 ------FLSPMLQLDPRKRADAGGLVNHP----------------WLKDT--LGMEEIRV 342
Query: 737 PNKNLLPN 744
P++ L +
Sbjct: 343 PDRELYGS 350
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 7e-26
Identities = 41/204 (20%), Positives = 78/204 (38%), Gaps = 18/204 (8%)
Query: 410 RIGMGGYGTVYKGTFHHT--FAAVKVL--QSKGNIQNKQFLQELEVLSKIRHPHLLLLLG 465
+G G YG+V T AVK L + I K+ +EL +L ++H +++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 466 ACPDHGCLVYE---YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKP 522
L Y+ + L + + +++ L ++H+
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 141
Query: 523 IIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT 582
IIHRD+KP N+ ++ + KI D GL+ + +
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM--------TGYVATRWYRAPEIMLNW 193
Query: 583 GLISPKSDVYAYGMVILQLLTAKP 606
+ D+++ G ++ +LLT +
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRT 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 63/264 (23%), Positives = 100/264 (37%), Gaps = 30/264 (11%)
Query: 410 RIGMGGYGTVYKG---TFHHT--FAAVKVLQSKGNIQN----KQFLQELEVLSKIRH-PH 459
+G G YG V+ + H T A+KVL+ +Q + E +VL IR P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 460 LLLLLGACPDHG--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN 517
L+ L A L+ +Y+ G L L ++ E E+ AL LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK 147
Query: 518 TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDP 577
II+RD+K NILLD N + D GLS +D + Y G + +
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIV 202
Query: 578 EYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG---DW 634
+G D ++ G+++ +LLT + ++++ AEI +
Sbjct: 203 RGGDSG-HDKAVDWWSLGVLMYELLTGASPFTVDG------EKNSQAEISRRILKSEPPY 255
Query: 635 PIKETKELAALGLSCAELRRKDRP 658
P + + L K R
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRL 279
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 71.3 bits (174), Expect = 5e-16
Identities = 27/73 (36%), Positives = 39/73 (53%), Gaps = 1/73 (1%)
Query: 686 HPAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPN 744
P P +F CPI E+M +P + + G TY+R +I++WL K+ P + L + L PN
Sbjct: 2 SPEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPN 61
Query: 745 YTLLSAILDWKSK 757
Y L S I W
Sbjct: 62 YVLKSLIALWCES 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 5e-15
Identities = 24/155 (15%), Positives = 46/155 (29%), Gaps = 19/155 (12%)
Query: 410 RIGMGGYGTVYKGTFH-HTFAAVKVL----------QSKGNIQNKQFLQELEVLSKIRHP 458
+G G V+ VK + K + + F ++
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 459 HLLLLLGACPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNT 518
L L G VY + N L + + K + + +A ++
Sbjct: 67 ALQKLQGLAVPK---VYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKFYH- 121
Query: 519 KPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553
+ I+H D+ N+L+ + I D S +
Sbjct: 122 --RGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVG 153
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 53.3 bits (127), Expect = 1e-09
Identities = 27/69 (39%), Positives = 37/69 (53%), Gaps = 1/69 (1%)
Query: 690 PNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS-PITDLPLPNKNLLPNYTLL 748
P++ I E+M EPC+ G TYDRK IEE LQ P+T PL + L+PN +
Sbjct: 5 PDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMK 64
Query: 749 SAILDWKSK 757
I + S+
Sbjct: 65 EVIDAFISE 73
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.7 bits (128), Expect = 1e-09
Identities = 19/70 (27%), Positives = 28/70 (40%), Gaps = 1/70 (1%)
Query: 689 PPNHFICPILKEVMNEPCVAADGY-TYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTL 747
+ F+ PI+ +M +P V T DR I L + P PL + PN L
Sbjct: 19 ACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTEL 78
Query: 748 LSAILDWKSK 757
I W ++
Sbjct: 79 KEKIQRWLAE 88
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-06
Identities = 9/64 (14%), Positives = 23/64 (35%), Gaps = 3/64 (4%)
Query: 691 NHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQENDKS---PITDLPLPNKNLLPNYTL 747
CPI E++ EP + + + + + L + P+ + ++L +
Sbjct: 20 KILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRF 79
Query: 748 LSAI 751
+
Sbjct: 80 SQLV 83
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 56 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 42.8 bits (100), Expect = 3e-06
Identities = 10/54 (18%), Positives = 27/54 (50%), Gaps = 1/54 (1%)
Query: 694 ICPILKEVMNEPCVAA-DGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYT 746
+C I +V P ++ +++ +E+++++ PIT+ PL + ++
Sbjct: 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVP 55
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 757 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 99.42 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.35 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 99.3 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.28 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 99.27 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 98.96 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 98.88 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 98.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 98.36 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 98.3 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.73 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.68 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.53 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 96.23 | |
| d1jm7a_ | 103 | brca1 RING domain {Human (Homo sapiens) [TaxId: 96 | 95.44 | |
| d1rmda2 | 86 | V(D)J recombination activating protein 1 (RAG1), d | 93.04 | |
| d1fbva4 | 79 | CBL {Human (Homo sapiens) [TaxId: 9606]} | 86.84 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=423.22 Aligned_cols=255 Identities=30% Similarity=0.448 Sum_probs=203.1
Q ss_pred hcCCccceeeccCCcEEEEEEEECCeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEEec
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYEYM 478 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~Ey~ 478 (757)
.++|...++||+|+||.||+|++++ .||||+++.. .....+.|.+|+.+|++++|||||+++|++.+. .+|||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecC
Confidence 3568888999999999999998766 5999998754 234567899999999999999999999998654 48999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+||+|.++|.... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 9999999997543 35999999999999999999999987 999999999999999999999999999876543221
Q ss_pred ccccccccCCcccccCCCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-----
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ----- 630 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~----- 630 (757)
.......||+.|||||++.+ +.|+.++|||||||+||||+||+.||........ +...+...
T Consensus 161 ----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 161 ----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPD 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCCC
T ss_pred ----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCCc
Confidence 12245689999999998864 4589999999999999999999999964332211 11122111
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
....+...+..+.+|+.+||+.+|.+|||+. +|+..|+.|..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHHH
Confidence 1223445678999999999999999999998 57788877764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-49 Score=424.21 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=196.3
Q ss_pred CCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~ 475 (757)
+|...+.||+|+||.||+|.+.. ..||||.+.... ....+.|.+|+.+|++++|||||+++|+|.+. .++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 34556789999999999999853 258899886543 33456799999999999999999999999654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|||++|+|.+++.... ..++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 107 Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 9999999999886543 35999999999999999999999987 999999999999999999999999999887654
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.... +........||+.|||||++.++.++.++|||||||+||||+| |++||...... ..+..+........
T Consensus 182 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 254 (299)
T d1jpaa_ 182 TSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQDYRLPP 254 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCCCC
T ss_pred CCcc-eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCCC
Confidence 3221 1122334578999999999999999999999999999999998 89999643221 11222222333445
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
|...+..+.+|+.+||+.+|.+||++. +|+..|+++..
T Consensus 255 ~~~~~~~l~~li~~cl~~~P~~RPs~~-ei~~~L~~~l~ 292 (299)
T d1jpaa_ 255 PMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMIR 292 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHH
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHhc
Confidence 667788999999999999999999998 57777877643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=411.49 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=199.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~Ey~~ 479 (757)
.+|...++||+|+||.||+|.+. +..||||++.... ...++|.+|+.+|++++|||||+++|+|.+. .++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 46788899999999999999985 5689999987643 3457899999999999999999999999644 489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ..++|..+..|+.|||.||.|||+.+ |+||||||+||||+.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 999999886543 35899999999999999999999988 999999999999999999999999999876543221
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhC-CCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
......||+.|+|||++.++.++.++|||||||+||||+|| ++||...... ..+..+........|...
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~------~~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTGFRLYKPRLA 227 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH------HHHHHHHHTCCCCCCTTS
T ss_pred ----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH------HHHHHHHhcCCCCCcccc
Confidence 12345799999999999999999999999999999999995 6666432211 112222233334456667
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+..+.+|+.+||+.+|.+||++. +|++.|+++.+
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~-~il~~L~~i~e 261 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFS-RLLRQLAEIAE 261 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHH-HHHHHHHHHHh
Confidence 88999999999999999999998 57788887765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-49 Score=411.67 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=206.9
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecC
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 479 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~ 479 (757)
.++|...++||+|+||.||+|.++ ++.||||++.... ...+.|.+|+.+|++++|||||+++|+|.+.. +|||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCC
Confidence 357888899999999999999996 4689999997643 34567999999999999999999999986554 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++..... .+++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-- 164 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--
T ss_pred CCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc--
Confidence 9999998765432 35899999999999999999999987 99999999999999999999999999998764321
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCC-CCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
.......||+.|+|||++.++.++.++|||||||+||||+||. +|+...... ..+..+........|...
T Consensus 165 ---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~~~~~i~~~~~~~~p~~~ 235 (272)
T d1qpca_ 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERGYRMVRPDNC 235 (272)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCCCCTTC
T ss_pred ---ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCCCCcccC
Confidence 1234568999999999999999999999999999999999965 455322211 112222233334455667
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
+..+.+|+.+||+.+|.+|||+. +|+..|+.+
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~-ei~~~L~~~ 267 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFD-YLRSVLEDF 267 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHH-HHHHHhhhh
Confidence 88999999999999999999998 466666654
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=412.40 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred CCccce-eeccCCcEEEEEEEEC----CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEEE
Q 004388 404 SFSENL-RIGMGGYGTVYKGTFH----HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVYE 476 (757)
Q Consensus 404 ~f~~~~-~IG~G~~G~Vyk~~~~----~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~E 476 (757)
+|.... +||+|+||.||+|.+. +..||||+++.... ...+.|.+|+.+|++++|||||+++|+|.+. .+||||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE 88 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 88 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEE
Confidence 455555 5999999999999874 34799999976543 3457799999999999999999999999654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|++||+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 89 ~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp CCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred eCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999999875443 35999999999999999999999988 9999999999999999999999999999876543
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. ........||+.|+|||++.++.++.++|||||||++|||+| |++||......+ .+..+........|
T Consensus 164 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~i~~~~~~~~p 234 (285)
T d1u59a_ 164 SY---YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECP 234 (285)
T ss_dssp CE---ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCCCCC
T ss_pred cc---cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCCC
Confidence 21 122345579999999999999999999999999999999998 999996433211 12223333344566
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
...+.++.+|+.+||+.+|.+||++. +|.+.|+.+.
T Consensus 235 ~~~~~~l~~li~~cl~~~p~~RPs~~-~i~~~L~~~~ 270 (285)
T d1u59a_ 235 PECPPELYALMSDCWIYKWEDRPDFL-TVEQRMRACY 270 (285)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHH
Confidence 77889999999999999999999998 4666665543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=411.03 Aligned_cols=241 Identities=23% Similarity=0.365 Sum_probs=203.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..|....+||+|+||.||+|.+. +..||||++........+.+.+|+.+|++++|||||+++++|.+.. ||||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 35888899999999999999975 6799999998665556778999999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+||+|.+++... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999977543 4899999999999999999999988 99999999999999999999999999987754332
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--CCCCh
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--GDWPI 636 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~~~p~ 636 (757)
.....+||+.|+|||++.++.++.++|||||||++|+|+||++||....... .+..++.... ...|.
T Consensus 172 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~~~~~~~~~ 240 (293)
T d1yhwa1 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPELQNPE 240 (293)
T ss_dssp -----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSCCCSSGG
T ss_pred -----cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCCCCCCCCcc
Confidence 2245589999999999999999999999999999999999999996443222 1222222222 22345
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
..+..+.+|+.+||+.||.+||++.+
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHH
Confidence 56789999999999999999999885
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=408.12 Aligned_cols=239 Identities=28% Similarity=0.369 Sum_probs=202.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|++. +..||||++.... ......+.+|+.+|++++|||||++++++.+.. +|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999986 5689999986432 234567899999999999999999999997765 7999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++...+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999997654 4899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
. .....||+.|+|||++.+..++.++|||||||+||+|+||++||......+ +...+.......|
T Consensus 160 ~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~p 224 (263)
T d2j4za1 160 R--------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFTFP 224 (263)
T ss_dssp C--------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCCCC
T ss_pred c--------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 2 234589999999999999999999999999999999999999996432211 1122222233456
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+.++.+|+.+||+.||.+|||+.+
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~e 251 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLRE 251 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 667889999999999999999999885
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=411.18 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=195.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC----ceEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH----GCLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~----~~LV 474 (757)
++|...+.||+|+||.||+|++. +..||||++.... ....+.|.+|+.+|++++|||||+++++|.+. .+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 46888999999999999999986 5689999987653 23456689999999999999999999998532 3799
Q ss_pred EEecCCCCHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhCCC--CCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 475 YEYMENGSLEDRLYRKN-NTPPIPWFERYRIAWEVASALAFLHNTKP--KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~--~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
|||++||+|.+++.... ....+++..+..|+.||+.||.|||+.++ .+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999886432 23469999999999999999999998652 3599999999999999999999999999998
Q ss_pred cCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 552 LNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 552 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
+..... ......||+.|||||++.+..|+.++|||||||+||||+||++||...... ..+..+.....
T Consensus 164 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~~~ 231 (269)
T d2java1 164 LNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREGKF 231 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC
T ss_pred cccCCC------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcCCC
Confidence 764322 124568999999999999999999999999999999999999999643321 12223333334
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...|...+.++.+|+.+||+.||.+||++.+
T Consensus 232 ~~~~~~~s~~l~~li~~~L~~dp~~Rps~~e 262 (269)
T d2java1 232 RRIPYRYSDELNEIITRMLNLKDYHRPSVEE 262 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence 4556677889999999999999999999885
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=408.48 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=198.7
Q ss_pred eeeccCCcEEEEEEEECC----eEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecCCC
Q 004388 409 LRIGMGGYGTVYKGTFHH----TFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYMENG 481 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~----~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~~g 481 (757)
++||+|+||.||+|.+.. ..||||+++... ....+.|.+|+.+|++++|||||+++|+|.+.. +|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 579999999999998642 479999987543 234567999999999999999999999996544 8999999999
Q ss_pred CHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCccc
Q 004388 482 SLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFVST 561 (757)
Q Consensus 482 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 561 (757)
+|.+++.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+++.+.......
T Consensus 93 ~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 93 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--
T ss_pred cHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc--
Confidence 9999987543 4999999999999999999999988 9999999999999999999999999998776443221
Q ss_pred cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHh-hhhcCCCChhHH
Q 004388 562 TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEIL-DAQAGDWPIKET 639 (757)
Q Consensus 562 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~l-d~~~~~~p~~~~ 639 (757)
.......||+.|+|||++.++.++.++|||||||++|||+| |++||...... .+...+ .......|...+
T Consensus 165 -~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-------~~~~~i~~~~~~~~p~~~~ 236 (277)
T d1xbba_ 165 -KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGCPAGCP 236 (277)
T ss_dssp -EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCCCCTTCC
T ss_pred -ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------HHHHHHHcCCCCCCCcccC
Confidence 12244579999999999999999999999999999999998 89999643221 122222 223345666778
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
..+.+|+.+||+.+|.+||++.+ |...|+.
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~-i~~~L~~ 266 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAA-VELRLRN 266 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHH-HHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHH-HHHHhhC
Confidence 99999999999999999999984 5555543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-48 Score=410.39 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=208.2
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.++|...++||+|+||.||+|.+. ++.||||+++.+. ...++|.+|+.+|++++|||||+++|+|.+.. +|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 357888899999999999999985 6689999987653 34577999999999999999999999997544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+++|+|.++|.... ...+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999987643 346999999999999999999999988 99999999999999999999999999987664322
Q ss_pred CccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-cCCCCh
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ-AGDWPI 636 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~-~~~~p~ 636 (757)
...+...||+.|+|||++.++.|+.++|||||||++|||+||..|+..... ...+.+.+... ....|.
T Consensus 171 -----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------~~~~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 171 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKDYRMERPE 239 (287)
T ss_dssp -----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCCCCCCT
T ss_pred -----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------HHHHHHHHhcCCCCCCCc
Confidence 122445789999999999999999999999999999999997666532211 12223333322 344556
Q ss_pred hHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 637 KETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 637 ~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+..+.+|+.+||+.||.+||++.+ |++.|+.+
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~e-i~~~L~~~ 273 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAE-IHQAFETM 273 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHT
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHH-HHHHHHHH
Confidence 67889999999999999999999984 66666554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=407.58 Aligned_cols=258 Identities=26% Similarity=0.445 Sum_probs=200.9
Q ss_pred cCCccceeeccCCcEEEEEEEECC------eEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH------TFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~L 473 (757)
..|+..+.||+|+||.||+|.+.. ..||||++..... .....|.+|+.+|++++|||||+++|+|.+.. ++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 357788899999999999998753 3699999875543 34457999999999999999999999996544 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+.+|+|.+.+.... ..++|..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999876543 35999999999999999999999988 9999999999999999999999999998876
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
..... ........||+.|+|||++.++.++.++|||||||+||||+||..|+...... ...+..+.+.....
T Consensus 162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 162 DDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGFRLP 233 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCCC
T ss_pred CCCcc---ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHHHHhccCCCC
Confidence 43321 12234557899999999999999999999999999999999965554322111 11122233333455
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
.|...+..+.+|+.+||+.+|.+||++. +|+..|+++...
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRA 273 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHS
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHH-HHHHHHHHHhhC
Confidence 6667788999999999999999999998 577788777653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=408.49 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=196.5
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++|...++||+|+||.||+|++. +..||||++..... ...+.|.+|+.+|++++|||||++++++.+.. ||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 47888999999999999999986 56999999875432 23456899999999999999999999996654 799999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
++||+|.++|... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 9999999988643 35999999999999999999999988 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcC-CCC
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAG-DWP 635 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~-~~p 635 (757)
....+..+||+.|||||++.+..+ +.++|||||||+||||+||++||......... +......... ...
T Consensus 159 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKEKKTYLNPW 229 (271)
T ss_dssp ----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHHHHTTCTTSTTG
T ss_pred ----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----HHHHhcCCCCCCcc
Confidence 112345689999999999987775 57899999999999999999999644322111 1111111111 112
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+.++.+|+.+||+.||.+||++.+
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 345788999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=408.57 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=202.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
+.|+...+||+|+||.||+|++. +..||||++........+.|.+|+++|++++|||||+++++|.+.. +|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35788899999999999999985 5689999998776666778999999999999999999999986544 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
+||+|.+++.+.. .++++..+..|+.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--- 163 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH---
T ss_pred CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC---
Confidence 9999999887544 35999999999999999999999988 999999999999999999999999999765421
Q ss_pred ccccccccCCcccccCCCccccc-----cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQR-----TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA-- 631 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~-- 631 (757)
........||+.|+|||++. ...|+.++|||||||+||||+||++||......+ .+..+.....
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~~~ 234 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPT 234 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCCCC
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence 11224568999999999873 4568999999999999999999999996443222 2222332221
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...|...+.++.+|+.+||+.||.+||++.+
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 2234566789999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-48 Score=407.26 Aligned_cols=243 Identities=25% Similarity=0.331 Sum_probs=201.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|.+. +..||||++.... ....+.+.+|+++|++++|||||++++++.+.. ||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46899999999999999999985 5699999986432 234467899999999999999999999997655 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|.+++...+ .+++..+..++.|++.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999887654 4899999999999999999999988 999999999999999999999999999987643
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
... ......+||+.|+|||++.+..|+.++|||||||+||+|+||++||...+... .+..++ .....+|
T Consensus 162 ~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~-~~~~~~p 230 (288)
T d1uu3a_ 162 SKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKII-KLEYDFP 230 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-TTCCCCC
T ss_pred Ccc----cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHH-cCCCCCC
Confidence 221 12244689999999999999999999999999999999999999996443221 112222 2233456
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+|+.+||+.||.+|||+.+
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e 257 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEE 257 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGG
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 677889999999999999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=411.50 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=203.9
Q ss_pred cCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCC-chhhHHHHHHHHHHHhc-CCCceeeecccccCCc--
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKG-NIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~-- 471 (757)
++|...++||+|+||.||+|++.+ ..||||++.... ......|.+|+.+|.++ +|||||+++|+|.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 568888999999999999998743 268999886543 33456789999999998 8999999999996544
Q ss_pred eEEEEecCCCCHHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCC
Q 004388 472 CLVYEYMENGSLEDRLYRKNN--------------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPG 531 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~ 531 (757)
+|||||++||+|.++|..... ...+++..++.|+.||+.||.|||+.+ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 899999999999999976432 235899999999999999999999988 999999999
Q ss_pred CeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccc
Q 004388 532 NILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAI 610 (757)
Q Consensus 532 NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~ 610 (757)
|||++.++.+||+|||+|+........ .......||+.|||||++.++.++.++|||||||+||||+| |++||..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccccccCCeEEEeeccccccccCCCce----eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999876544321 12234578999999999999999999999999999999998 8999964
Q ss_pred cchhhhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHH
Q 004388 611 THKVETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLE 669 (757)
Q Consensus 611 ~~~~~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~ 669 (757)
.... ..+..++... ....|...+..+.+|+.+||+.+|.+|||+.+ |+..|.
T Consensus 270 ~~~~------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e-i~~~L~ 322 (325)
T d1rjba_ 270 IPVD------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN-LTSFLG 322 (325)
T ss_dssp CCCS------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHH
T ss_pred CCHH------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH-HHHHHh
Confidence 3221 1223333322 34556677889999999999999999999984 666553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=396.91 Aligned_cols=248 Identities=23% Similarity=0.383 Sum_probs=207.3
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~~ 479 (757)
++|...++||+|+||.||+|+++ +..||||+++.... ..+.|.+|+.++++++|||||+++|+|.+.. ++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999996 45899999986543 4568999999999999999999999997544 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.+++.... ..+++..+.+|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 999999876544 35889999999999999999999987 999999999999999999999999999876543221
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ ....+........|...
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCCCCCTTC
T ss_pred ----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHHHHhCCCCCCcccc
Confidence 2345689999999999999999999999999999999998 899997543221 12223333334556677
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVL 668 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L 668 (757)
+..+.+|+.+||+.+|.+||++.+ ++..|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~e-il~~L 255 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKI-LLSNI 255 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHH-HHHHH
T ss_pred cHHHHHHHHHHccCCHhHCcCHHH-HHHHh
Confidence 889999999999999999999974 54444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=406.90 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=205.5
Q ss_pred CCccceeeccCCcEEEEEEEECCe------EEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHT------FAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~------~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~ 475 (757)
+|+..++||+|+||.||+|.+..+ .||+|.+... .....+.|.+|+.+|++++|||||+++|+|.+.. +++|
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~ 89 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT 89 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEE
Confidence 588899999999999999988533 5899988654 3345678999999999999999999999997665 7899
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+.+|+|.+.+.... ..+++..+++|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.+...
T Consensus 90 e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 9999999999887654 35999999999999999999999988 999999999999999999999999999987654
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhh-hhcCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILD-AQAGD 633 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld-~~~~~ 633 (757)
.... ......||+.|+|||++.++.++.++|||||||+||||+| |.+||..... ..+...+. .....
T Consensus 165 ~~~~----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-------~~~~~~i~~~~~~~ 233 (317)
T d1xkka_ 165 EKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEKGERLP 233 (317)
T ss_dssp CC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-------GGHHHHHHHTCCCC
T ss_pred cccc----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-------HHHHHHHHcCCCCC
Confidence 3221 2234578999999999999999999999999999999998 7899864321 11223332 23345
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.|...+..+.+|+.+||..+|.+||++.+ |+..|+.+..
T Consensus 234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~e-il~~l~~~~~ 272 (317)
T d1xkka_ 234 QPPICTIDVYMIMVKCWMIDADSRPKFRE-LIIEFSKMAR 272 (317)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHhCCCChhhCcCHHH-HHHHHHHHHh
Confidence 56677889999999999999999999984 6666776643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=400.27 Aligned_cols=238 Identities=26% Similarity=0.396 Sum_probs=191.3
Q ss_pred ccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC------CceEEE
Q 004388 406 SENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD------HGCLVY 475 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~~~LV~ 475 (757)
....+||+|+||.||+|.+. +..||+|++.... ....+.|.+|+++|++++|||||+++++|.+ ..+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999986 4589999987542 3345678999999999999999999999843 138999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec-CCCceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD-HNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld-~~~~~KL~DFGla~~~~~ 554 (757)
||+++|+|.+++.+.. .+++..+..|+.||+.||.|||+.+ .+|+||||||+||||+ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999997654 4899999999999999999999977 4699999999999996 589999999999986443
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc--C
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA--G 632 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~--~ 632 (757)
.. ....+||+.|||||++.+ .++.++|||||||+||||+||+.||........ +...+.... .
T Consensus 168 ~~--------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 168 SF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA 232 (270)
T ss_dssp TS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG
T ss_pred Cc--------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCCCc
Confidence 21 234589999999998865 599999999999999999999999963322211 111111111 1
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.++...++++.+|+.+||+.+|++|||+.+
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~e 262 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKD 262 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 122335678999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=407.61 Aligned_cols=258 Identities=27% Similarity=0.431 Sum_probs=211.6
Q ss_pred hhcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCch-hhHHHHHHHHHHHhcCCCceeeecccccCC--
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGNI-QNKQFLQELEVLSKIRHPHLLLLLGACPDH-- 470 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~~-~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-- 470 (757)
..++|...++||+|+||.||+|++.+ +.||||+++..... ..++|.+|+.+|++++||||++++++|.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45689999999999999999998753 58999998765443 356799999999999999999999999654
Q ss_pred ceEEEEecCCCCHHHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCC
Q 004388 471 GCLVYEYMENGSLEDRLYRKN---------------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMK 529 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLK 529 (757)
.++||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.+ |||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 489999999999999996532 1235899999999999999999999988 9999999
Q ss_pred CCCeeecCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCC-CCc
Q 004388 530 PGNILLDHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAI 608 (757)
Q Consensus 530 p~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf 608 (757)
|+|||||.++.+||+|||+|+........ ...+...||+.|+|||++.+..|+.++|||||||+||||+||. +||
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred ccceEECCCCcEEEccchhheeccCCccc----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 99999999999999999999876543221 1224567899999999999999999999999999999999995 677
Q ss_pred cccchhhhhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 609 AITHKVETAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 609 ~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
...... ..+..+.+......|...+.++.+|+.+||+.+|.+|||+. +|++.|++|.
T Consensus 244 ~~~~~~------e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~-ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHE------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMC 300 (301)
T ss_dssp TTSCHH------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCHH------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHhc
Confidence 543322 22333444444556667788999999999999999999998 5788887764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=412.33 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=198.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
.++|...++||+|+||.||+|++. +..||+|+++... ......+.+|+.+|++++|||||+++++|.+.. |||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 567999999999999999999985 6799999987653 334567899999999999999999999997655 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|++||+|.+++.+.+ .+++..+..++.||+.||.|||+ ++ |+||||||+||||+.+|.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999997654 48999999999999999999997 46 999999999999999999999999999876432
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc----------------
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------------- 619 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------------- 619 (757)
. .+..+||+.|+|||++.+..|+.++|||||||++|||+||+.||...........
T Consensus 159 ~--------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 159 M--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp T--------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred c--------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 1 2346899999999999999999999999999999999999999964322111000
Q ss_pred ----------------hhhHHHHhhhhcCC----CC-hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 ----------------EDNLAEILDAQAGD----WP-IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 ----------------~~~l~~~ld~~~~~----~p-~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....+.++..... .| ...+.++.+|+.+||..||.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e 294 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 00001111111111 11 124578999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=398.78 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=201.6
Q ss_pred cCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC---CceEEEEecC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCLVYEYME 479 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~LV~Ey~~ 479 (757)
++|...++||+|+||.||+|.++++.||||+++.+. ..+.|.+|+++|++++|||||+++|+|.+ ..+|||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 457778899999999999999999999999997543 45679999999999999999999999853 2489999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|.++|..... ..++|..+++|+.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC---
Confidence 9999999975432 24899999999999999999999987 9999999999999999999999999998654322
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
....+|+.|+|||++.++.++.++|||||||++|||+| |++||...... ..+..+........|...
T Consensus 158 ------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~------~~~~~i~~~~~~~~~~~~ 225 (262)
T d1byga_ 158 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGYKMDAPDGC 225 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHTTTCCCCCCTTC
T ss_pred ------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH------HHHHHHHcCCCCCCCccC
Confidence 23468999999999999999999999999999999998 78888533211 112223333445566677
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
+..+.+|+.+||..||.+||++. ++++.|++++
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~-~l~~~L~~i~ 258 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFL-QLREQLEHIK 258 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHH-HHHHHHHHHH
Confidence 88999999999999999999998 5778887775
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=397.04 Aligned_cols=253 Identities=22% Similarity=0.363 Sum_probs=197.7
Q ss_pred cCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC-ceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH-GCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~-~~LV~ 475 (757)
++|...+.||+|+||.||+|.+.. ..||||.+.... ....+.|.+|+.+|++++|||||+++|+|.+. .++||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 468888999999999999998753 368888876543 33456799999999999999999999999654 48999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+++|+|.+++.... .++++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 87 E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp ECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 9999999999876543 35899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
.. ...+...||+.|+|||++.++.++.++|||||||+||||+| |.+||...... ..+..+........
T Consensus 162 ~~-----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~------~~~~~i~~~~~~~~ 230 (273)
T d1mp8a_ 162 TY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPM 230 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCCCC
T ss_pred cc-----eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCCCC
Confidence 22 12244578999999999999999999999999999999998 89999644322 12223333333455
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
|...+..+.+|+.+||..+|.+||++. +|+..|+.+.
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~-ei~~~L~~i~ 267 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTIL 267 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHH
Confidence 667788999999999999999999998 5777777664
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=401.20 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=200.0
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-eEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc-eEEEEecC
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-TFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CLVYEYME 479 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~LV~Ey~~ 479 (757)
.++|....+||+|+||.||+|++++ ..||||++.... ...+.|.+|+.+|++++|||||+++|+|.+.. ++||||++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~ 94 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecC
Confidence 3578899999999999999999975 489999987553 34578999999999999999999999997654 89999999
Q ss_pred CCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCCc
Q 004388 480 NGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSFV 559 (757)
Q Consensus 480 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~ 559 (757)
+|+|..++..... ..++|..++.|+.||+.||.|||+.+ |+||||||+|||||.++.+||+|||+|+.+.....
T Consensus 95 ~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-- 168 (285)
T d1fmka3 95 KGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-- 168 (285)
T ss_dssp TCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc--
Confidence 9999998875432 34999999999999999999999988 99999999999999999999999999987654321
Q ss_pred cccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhHH
Q 004388 560 STTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKET 639 (757)
Q Consensus 560 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~~ 639 (757)
.......||+.|+|||++..+.++.++|||||||+||||+||..|+....... ..+..+........+...+
T Consensus 169 ---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~~~~i~~~~~~~~~~~~~ 240 (285)
T d1fmka3 169 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGYRMPCPPECP 240 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCCCCCCTTSC
T ss_pred ---eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcCCCCCCcccC
Confidence 12244679999999999999999999999999999999999655543222111 1122222222344566778
Q ss_pred HHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 640 KELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 640 ~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
..+.+|+.+||+.+|.+||++.+ |+..|+.
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~-i~~~L~~ 270 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEY-LQAFLED 270 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHH-HHHHHHT
T ss_pred HHHHHHHHHHcccCHhHCcCHHH-HHHHHhh
Confidence 89999999999999999999984 5555443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-47 Score=407.33 Aligned_cols=243 Identities=23% Similarity=0.318 Sum_probs=185.0
Q ss_pred hhcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc-hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 401 ATLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN-IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 401 at~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
..+.|...+.||+|+||.||+|++. +..||||++..... .....|.+|+.+|++++|||||++++++.+.. ||||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3456889999999999999999986 56899999875432 23456889999999999999999999997665 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec---CCCceEEeeecCcccc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTML 552 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld---~~~~~KL~DFGla~~~ 552 (757)
|||+||+|.++|...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||+. .++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997543 5999999999999999999999988 99999999999994 5789999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc-
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA- 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~- 631 (757)
..... ....+||+.|||||++.+..|+.++|||||||+||+|+||++||....... ....++....
T Consensus 161 ~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~ 227 (307)
T d1a06a_ 161 DPGSV-------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYE 227 (307)
T ss_dssp -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTCCC
T ss_pred cCCCe-------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccCCC
Confidence 54321 234589999999999999999999999999999999999999996433221 1122222211
Q ss_pred --CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 632 --GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 632 --~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+...++.+.+|+.+||+.||.+||++.+
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 1122356788999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=402.49 Aligned_cols=237 Identities=27% Similarity=0.402 Sum_probs=195.3
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC--ceEEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH--GCLVYE 476 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~--~~LV~E 476 (757)
.|+..++||+|+||.||+|++. +..||||++..... ...+.|.+|+.+|++++|||||+++++|.+. .+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999975 56899999876542 2345689999999999999999999998654 489999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
||.+|+|..++... .++++..+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 99999997766543 35999999999999999999999988 999999999999999999999999999865432
Q ss_pred CCccccccccCCcccccCCCcccccc---CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRT---GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGD 633 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~ 633 (757)
....||+.|||||++.+ +.|+.++|||||||++|||+||++||....... .+..+.......
T Consensus 169 ---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 233 (309)
T d1u5ra_ 169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNESPA 233 (309)
T ss_dssp ---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSCCCC
T ss_pred ---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCCCC
Confidence 34579999999998753 468999999999999999999999996433221 122222222211
Q ss_pred -CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 -WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 -~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+...+..+.+|+.+||+.||.+|||+.+
T Consensus 234 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e 263 (309)
T d1u5ra_ 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEV 263 (309)
T ss_dssp CSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 23345788999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=401.12 Aligned_cols=239 Identities=25% Similarity=0.289 Sum_probs=203.4
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|+.. +..||||++.... ......+.+|+.+|++++|||||++++++.+.. |+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 47899999999999999999985 5699999987542 234567899999999999999999999997765 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
|||+||+|.+++...+ .++...+..++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999987755 3888899999999999999999988 999999999999999999999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. .....+||+.|+|||++.+..|+.++|||||||+||||+||++||...... .+...+......+|
T Consensus 159 ~~------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~i~~~~~~~p 225 (337)
T d1o6la_ 159 GA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIRFP 225 (337)
T ss_dssp TC------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCCC
T ss_pred Cc------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH-------HHHHHHhcCCCCCC
Confidence 22 224568999999999999999999999999999999999999999654321 12222333334567
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCcc
Q 004388 636 IKETKELAALGLSCAELRRKDRPDL 660 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs~ 660 (757)
...++++.+|+.+||+.||.+||+.
T Consensus 226 ~~~s~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 226 RTLSPEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ccCCHHHHHHHHhhccCCchhhccc
Confidence 7788999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.2e-46 Score=405.45 Aligned_cols=241 Identities=20% Similarity=0.292 Sum_probs=202.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
++|...+.||+|+||.||+|.+. +..||||++........+.+.+|+.+|++++|||||+++++|.+.. |||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999985 6799999998776666778999999999999999999999986554 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec--CCCceEEeeecCccccCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld--~~~~~KL~DFGla~~~~~~~ 556 (757)
+||+|.+++.... ..+++..+..|+.||+.||.|||+.+ ||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999886543 35999999999999999999999988 99999999999995 46899999999998776433
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC-
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP- 635 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p- 635 (757)
. .....||+.|||||++.+..++.++|||||||++|+|+||++||...+..+ .+..+.... ...+
T Consensus 181 ~-------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~-~~~~~ 246 (350)
T d1koaa2 181 S-------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCD-WNMDD 246 (350)
T ss_dssp C-------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-CCSCC
T ss_pred c-------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-CCCCc
Confidence 2 234589999999999999999999999999999999999999996443211 122222211 1111
Q ss_pred ---hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 636 ---IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 636 ---~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
...+..+.+|+.+||..||.+|||+.+
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 276 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQ 276 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 245678999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.7e-46 Score=403.78 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=202.7
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
+.|...+.||+|+||.||+|.+. +..||||++..........+.+|+.+|++++|||||+++++|.+.. |||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46899999999999999999985 6699999998776666678899999999999999999999997655 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec--CCCceEEeeecCccccCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD--HNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld--~~~~~KL~DFGla~~~~~~~ 556 (757)
+||+|.+.+...+ .++++..+..|+.||+.||.|||+.+ ||||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999998775443 35999999999999999999999988 99999999999997 67899999999999876543
Q ss_pred CCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc---CC
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA---GD 633 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~---~~ 633 (757)
. .....||+.|+|||++.+..++.++|||||||+||+|+||++||....... .+..+..... ..
T Consensus 184 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 184 I-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCDWEFDED 250 (352)
T ss_dssp C-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHCCCCCCSS
T ss_pred c-------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCcc
Confidence 2 234579999999999999999999999999999999999999996443222 1122222111 11
Q ss_pred CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 634 WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 634 ~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.+...+.++.+|+.+||+.||.+||++.+
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 22356789999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=394.95 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=198.7
Q ss_pred hcCCccceeeccCCcEEEEEEEECC-------eEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCC--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFHH-------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH-- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~~-------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~-- 470 (757)
.++|...++||+|+||.||+|.+.+ +.||||+++.... .....|.+|+.++.++ +|||||.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3578889999999999999998742 4799999875433 3456688898888887 689999999997543
Q ss_pred -ceEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
.++|||||++|+|.++|..... ...+++..+..|+.||+.||.|||+.+ ||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 4899999999999999975431 235899999999999999999999988 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhC-CCCccccchhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTA-KPAIAITHKVE 615 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG-~~Pf~~~~~~~ 615 (757)
.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+|| .+||.......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GGGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCcEEEccCcchhhccccccc----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999876543322 123456899999999999999999999999999999999987 56775332211
Q ss_pred hhhchhhHHHHh-hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 616 TAIDEDNLAEIL-DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 616 ~~~~~~~l~~~l-d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+...+ .......|...++.+.+|+.+||+.||.+||++. +++..|+.+.+
T Consensus 245 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-eil~~L~~ilq 296 (299)
T d1ywna1 245 ------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLLQ 296 (299)
T ss_dssp ------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred ------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHHHh
Confidence 122222 2223445566788999999999999999999998 57777877643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=390.81 Aligned_cols=241 Identities=21% Similarity=0.286 Sum_probs=199.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC------chhhHHHHHHHHHHHhcCCCceeeecccccCCc--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG------NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-- 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~------~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-- 471 (757)
.+.|...+.||+|+||.||+|++. +..||||++.... ....+.|.+|+.+|++++|||||+++++|.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356899999999999999999986 6699999986432 123577999999999999999999999997765
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC----ceEEeeec
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL----VSKIGDVG 547 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~----~~KL~DFG 547 (757)
|||||||+||+|.+++...+ .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 89999999999999997654 4999999999999999999999988 99999999999998776 59999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
+|........ .....||+.|+|||++.+..++.++|||||||+||||+||+.||......+. +..+.
T Consensus 163 ~a~~~~~~~~-------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~ 229 (293)
T d1jksa_ 163 LAHKIDFGNE-------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVS 229 (293)
T ss_dssp TCEECTTSCB-------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred hhhhcCCCcc-------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHH
Confidence 9987754321 2345899999999999999999999999999999999999999964432211 11121
Q ss_pred hhhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....++ ...+..+.+|+.+||+.||.+||++.+
T Consensus 230 -~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 230 -AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp -TTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred -hcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 1112222 234678999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-45 Score=395.69 Aligned_cols=235 Identities=26% Similarity=0.335 Sum_probs=199.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|++. +..||||++.... ....+.+.+|+.+|++++|||||++++++.+.. |+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999985 6799999986432 234567899999999999999999999997655 8999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||++||+|..++.... .+++..+..++.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887654 3788888999999999999999988 999999999999999999999999999876542
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
....+||+.|+|||++.+..|+.++|||||||+||+|+||+.||...+..+ .+..++. ....+|
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~-~~~~~p 221 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILN-AELRFP 221 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHH-CCCCCC
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHc-CCCCCC
Confidence 234689999999999999999999999999999999999999996443221 1222222 234556
Q ss_pred hhHHHHHHHHHHHHhhccCCCCCc
Q 004388 636 IKETKELAALGLSCAELRRKDRPD 659 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RPs 659 (757)
...+.++.+++.+||..+|.+||+
T Consensus 222 ~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 222 PFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp TTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCHHHHHHHHHHhhhCHHhccc
Confidence 677889999999999999999973
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=392.74 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=196.3
Q ss_pred cCCccceeeccCCcEEEEEEEECC-----eEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc-eE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG-CL 473 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~-~L 473 (757)
.+|+..+.||+|+||.||+|++++ ..||||++.... ....+.|.+|+.+|++++|||||+++|+|.+.. ++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 468888999999999999998742 378999987542 334567999999999999999999999997654 89
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccC
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLN 553 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~ 553 (757)
||||+++|+|.+++.... .++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 999999999999887644 34999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhhhhhchhhHHHHhhhh-c
Q 004388 554 SDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVETAIDEDNLAEILDAQ-A 631 (757)
Q Consensus 554 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~l~~~ld~~-~ 631 (757)
..... ........||+.|+|||++.+..++.++|||||||++|||+| |++||...+..+ .+..+.... .
T Consensus 163 ~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~~~~i~~~~~~ 233 (273)
T d1u46a_ 163 QNDDH---YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGER 233 (273)
T ss_dssp C-CCE---EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCC
T ss_pred cCCCc---ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------HHHHHHhCCCC
Confidence 54322 112244568899999999999999999999999999999998 899996443222 122222221 2
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
...+...+..+.+|+.+||..+|.+|||+.+ |.+.|+.
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e-i~~~L~~ 271 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA-LRDFLLE 271 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHH-HHHHHHh
Confidence 3345566789999999999999999999984 6666554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=394.31 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=203.4
Q ss_pred ceeeccCCcEEEEEEEECC-----eEEEEEEEccC-CchhhHHHHHHHHHHHhcCCCceeeecccccC---CceEEEEec
Q 004388 408 NLRIGMGGYGTVYKGTFHH-----TFAAVKVLQSK-GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD---HGCLVYEYM 478 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~~-----~~vAvK~l~~~-~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~---~~~LV~Ey~ 478 (757)
..+||+|+||+||+|++.+ ..||||+++.. .....++|.+|+++|++++|||||+++|+|.+ ..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4679999999999999843 26899998743 34455789999999999999999999999743 237999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
++|+|.+++.... ..+++..+++++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999886543 35788899999999999999999988 999999999999999999999999999887654322
Q ss_pred ccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCChhH
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWPIKE 638 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p~~~ 638 (757)
.........||+.|+|||++.++.++.++|||||||+||||+||..||...... ......+........|...
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-----~~~~~~i~~g~~~~~p~~~ 259 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQGRRLLQPEYC 259 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTCCCCCCTTC
T ss_pred --cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCCcccC
Confidence 122234568999999999999999999999999999999999987777532211 1112223333344456667
Q ss_pred HHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 639 TKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 639 ~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
+..+.+|+.+||+.+|.+||++. +|++.|+.+..
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~-ei~~~L~~i~~ 293 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHH-HHHHHHHHHHH
Confidence 78999999999999999999998 57777777754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-45 Score=388.05 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=199.4
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc---hhhHHHHHHHHHHHhcCCCceeeecccccCC------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN---IQNKQFLQELEVLSKIRHPHLLLLLGACPDH------ 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~---~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------ 470 (757)
.+.|...+.||+|+||.||+|.+. ++.||||++..... .....|.+|+.+|+.++|||||++++++...
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 356888999999999999999975 67999999976532 2345789999999999999999999988432
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.||||||++||+|.+++...+ ++++..+..|+.||+.||.|||+.+ ||||||||+||||+.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 379999999999999887654 4899999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ 630 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~ 630 (757)
........ .......+||+.|+|||++.+..++.++|||||||+||+|+||++||......+. +...+...
T Consensus 160 ~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~ 230 (277)
T d1o6ya_ 160 AIADSGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVRED 230 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCC
T ss_pred hhcccccc---ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcC
Confidence 66543221 1223456899999999999999999999999999999999999999975433221 11222111
Q ss_pred cC---CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 631 AG---DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 631 ~~---~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
.. ......+..+.+|+.+||+.||.+||+..++++..|.++.
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 10 1122456889999999999999999965557877777764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=394.91 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=203.1
Q ss_pred cCCccceeeccCCcEEEEEEEECC--e--EEEEEEEccC-CchhhHHHHHHHHHHHhc-CCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH--T--FAAVKVLQSK-GNIQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~--~--~vAvK~l~~~-~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~--~LV 474 (757)
++|...++||+|+||.||+|++.+ . .||||.+... .....+.|.+|+.+|+++ +|||||+++|+|.+.. ++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 467888899999999999999854 3 5778887543 233456799999999999 7999999999997654 899
Q ss_pred EEecCCCCHHHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCce
Q 004388 475 YEYMENGSLEDRLYRK-------------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVS 541 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~ 541 (757)
|||++||+|.++|... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998754 23356999999999999999999999987 9999999999999999999
Q ss_pred EEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCC-CCccccchhhhhhch
Q 004388 542 KIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDE 620 (757)
Q Consensus 542 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~~~~~~~~ 620 (757)
||+|||+|+...... ......||+.|+|||.+.++.++.++|||||||++|||+||. +||......+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~----- 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 234 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----
T ss_pred EEccccccccccccc-------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-----
Confidence 999999998654322 123457899999999999999999999999999999999975 5664322111
Q ss_pred hhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 621 DNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 621 ~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
.+..+........|...+..+.+|+.+||+.+|++||++. +|+..|+++.+
T Consensus 235 -~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~L~~i~~ 285 (309)
T d1fvra_ 235 -LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRMLE 285 (309)
T ss_dssp -HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred -HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHHHh
Confidence 1222233334556667889999999999999999999998 57777877754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-45 Score=396.95 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=199.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~ 475 (757)
++|...+.||+|+||.||+|.+. +..||||++.... ....+.+.+|+.+|+.++|||||++++++.+.. ++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999985 6799999986432 233467899999999999999999999987655 7999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~ 555 (757)
||+.||+|.+++...+ .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997665 4899999999999999999999988 999999999999999999999999999876532
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.....||+.|||||++.+..++.++|||||||+||+|+||++||....... .+..+ .......|
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i-~~~~~~~p 258 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKI-VSGKVRFP 258 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCCCCCC
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHH-hcCCCCCC
Confidence 134689999999999999999999999999999999999999996443221 11222 22233456
Q ss_pred hhHHHHHHHHHHHHhhccCCCCC
Q 004388 636 IKETKELAALGLSCAELRRKDRP 658 (757)
Q Consensus 636 ~~~~~~l~~Li~~Cl~~~p~~RP 658 (757)
...+.++.+|+.+||..||.+|+
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred ccCCHHHHHHHHHHhhhCHHhcc
Confidence 66788999999999999999995
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=389.82 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=207.3
Q ss_pred cCCccceeeccCCcEEEEEEEECC---------eEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCCc
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDHG 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~~---------~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~~ 471 (757)
++|...+.||+|+||.||+|+..+ +.||||+++.+.. .....+.+|+..+.++ +|||||+++|+|.+..
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467888999999999999998643 3799999977654 3457789999999988 8999999999997654
Q ss_pred --eEEEEecCCCCHHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec
Q 004388 472 --CLVYEYMENGSLEDRLYRKNN-------------TPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD 536 (757)
Q Consensus 472 --~LV~Ey~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld 536 (757)
++||||+++|+|.++|..... ...+++..+..++.||+.||.|||+.+ ||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeec
Confidence 899999999999999975432 235899999999999999999999988 99999999999999
Q ss_pred CCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchhh
Q 004388 537 HNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKVE 615 (757)
Q Consensus 537 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~~ 615 (757)
.++.+||+|||+++......... ......||+.|+|||++.++.|+.++|||||||++|||+| |.+||......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYK----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTC----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred CCCCeEeccchhhcccccccccc----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence 99999999999998776543221 2245679999999999999999999999999999999998 78888533221
Q ss_pred hhhchhhHHHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHHh
Q 004388 616 TAIDEDNLAEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKEV 674 (757)
Q Consensus 616 ~~~~~~~l~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~~ 674 (757)
..+..+........|...+..+.+|+.+||+.+|.+|||+. +|++.|+++...
T Consensus 245 -----~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~-eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 -----ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVAL 297 (299)
T ss_dssp -----HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHH-HHHHHHHHHhhc
Confidence 11122223334456667788999999999999999999998 688888887654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=391.81 Aligned_cols=244 Identities=24% Similarity=0.305 Sum_probs=202.6
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHHHHHHHH-hcCCCceeeecccccCCc--eEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQELEVLS-KIRHPHLLLLLGACPDHG--CLV 474 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~Ev~il~-~l~Hpniv~l~g~~~~~~--~LV 474 (757)
++|...+.||+|+||+||+|.+. +..||||++.... ....+.+..|+.++. .++|||||++++++.+.. |||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888999999999999999985 6799999997532 233456777888776 689999999999997665 899
Q ss_pred EEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCC
Q 004388 475 YEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 475 ~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~ 554 (757)
|||++||+|.+++.... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999997654 3888999999999999999999988 99999999999999999999999999986553
Q ss_pred CCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCC
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDW 634 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~ 634 (757)
... ..+...||+.|+|||++.++.++.++|||||||++|+|+||+.||....... +...+......+
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~~ 222 (320)
T d1xjda_ 156 GDA------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFY 222 (320)
T ss_dssp TTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC
T ss_pred ccc------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence 322 2345689999999999999999999999999999999999999996443211 122222233456
Q ss_pred ChhHHHHHHHHHHHHhhccCCCCCccchhhh
Q 004388 635 PIKETKELAALGLSCAELRRKDRPDLKNQVL 665 (757)
Q Consensus 635 p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl 665 (757)
|...+..+.+|+.+||..+|.+||++..+++
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 6667889999999999999999999964453
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.3e-45 Score=396.05 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=194.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC---chhhHHHHH---HHHHHHhcCCCceeeecccccCCc--e
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG---NIQNKQFLQ---ELEVLSKIRHPHLLLLLGACPDHG--C 472 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~---~~~~~~f~~---Ev~il~~l~Hpniv~l~g~~~~~~--~ 472 (757)
++|...+.||+|+||.||+|++. +..||||++.... ......+.+ |+.+++.++|||||+++++|.+.. |
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999985 5699999986432 112233444 466777788999999999997654 8
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
|||||++||+|.++|.... .+++..+..|+.||+.||.|||+.+ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999997654 4788999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhc
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQA 631 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~ 631 (757)
.... ....+||+.|+|||++.. ..|+.++|||||||+||||+||++||........ ..+........
T Consensus 158 ~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~~~~~~~~~ 225 (364)
T d1omwa3 158 SKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLTMA 225 (364)
T ss_dssp SSSC--------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH----HHHHHHSSSCC
T ss_pred CCCc--------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcccCC
Confidence 5432 234589999999998865 4689999999999999999999999964321111 11111111222
Q ss_pred CCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 632 GDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 632 ~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
...|...++.+.+|+.+||..||.+||+..
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 255 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCL 255 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTS
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCc
Confidence 344556788999999999999999999963
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=389.45 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=195.6
Q ss_pred CCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHH--HHHHHHhcCCCceeeecccccCC------ceEEE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQ--ELEVLSKIRHPHLLLLLGACPDH------GCLVY 475 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~--Ev~il~~l~Hpniv~l~g~~~~~------~~LV~ 475 (757)
.|...++||+|+||.||+|++++..||||++.... ...+.+ |+..+.+++|||||+++|+|.+. .+|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 45566789999999999999999999999986543 233444 44455678999999999999542 37999
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCC-----CCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTK-----PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
|||++|+|.++|.+. +++|..+.+++.|++.||.|||+.. .++||||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999764 4899999999999999999999741 2359999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccC------CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh------
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG------LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI------ 618 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~------ 618 (757)
........ .........||+.|+|||++... .++.++|||||||+||||+||.+||..........
T Consensus 157 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 157 RHDSATDT--IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp EEETTTTE--ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccCCCcc--eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 87654321 12233456899999999987654 26778999999999999999998886432111111
Q ss_pred --chhhHHHHh-hhhc-CCCC-----hhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHHH
Q 004388 619 --DEDNLAEIL-DAQA-GDWP-----IKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLKE 673 (757)
Q Consensus 619 --~~~~l~~~l-d~~~-~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~~ 673 (757)
....+...+ +... +..| ......+.+|+.+||..||++||++. +|++.|+.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~ 297 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQ 297 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH-HHHHHHHHHHH
Confidence 011111111 1111 1111 23456799999999999999999998 57777777754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=388.63 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=208.0
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccC--Cc
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--HG 471 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--~~ 471 (757)
.++|...++||+|+||.||+|.+. ++.||||+++... ......|.+|+.++++++|||||+++|+|.. ..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999875 3589999997543 3334568999999999999999999999864 44
Q ss_pred eEEEEecCCCCHHHHHhhc-------CCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEe
Q 004388 472 CLVYEYMENGSLEDRLYRK-------NNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIG 544 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~-------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~ 544 (757)
++||||+++|+|.+++... .....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 8999999999999988643 23345799999999999999999999987 9999999999999999999999
Q ss_pred eecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCC-CCccccchhhhhhchhhH
Q 004388 545 DVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAK-PAIAITHKVETAIDEDNL 623 (757)
Q Consensus 545 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~l 623 (757)
|||+|+.+..... ........||+.|+|||.+.++.++.++|||||||+||||+||. +||..... ...+
T Consensus 176 DFGla~~~~~~~~----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~ 245 (308)
T d1p4oa_ 176 DFGMTRDIYETDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVL 245 (308)
T ss_dssp CTTCCCGGGGGGC----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHH
T ss_pred ecccceeccCCcc----eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence 9999987654322 22234457999999999999999999999999999999999985 77753322 1223
Q ss_pred HHHhhhhcCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHH
Q 004388 624 AEILDAQAGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLER 670 (757)
Q Consensus 624 ~~~ld~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~ 670 (757)
..+.+......|...+..+.+|+.+||+.+|.+||++.+ |+..|+.
T Consensus 246 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~-il~~L~~ 291 (308)
T d1p4oa_ 246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE-IISSIKE 291 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH-HHHHHGG
T ss_pred HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHH-HHHHHHH
Confidence 334444445556677889999999999999999999984 6555544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-44 Score=378.49 Aligned_cols=241 Identities=23% Similarity=0.331 Sum_probs=198.8
Q ss_pred cCCccceeeccCCcEEEEEEEE--CCeEEEEEEEccCCch---------hhHHHHHHHHHHHhcC-CCceeeecccccCC
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF--HHTFAAVKVLQSKGNI---------QNKQFLQELEVLSKIR-HPHLLLLLGACPDH 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~--~~~~vAvK~l~~~~~~---------~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~ 470 (757)
++|...+.||+|+||+||+|+. .++.||||++...... ..+.+.+|+.+|++++ |||||++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 4788899999999999999998 4679999998754321 2346889999999997 99999999999776
Q ss_pred c--eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecC
Q 004388 471 G--CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGL 548 (757)
Q Consensus 471 ~--~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGl 548 (757)
. ||||||++||+|.++|...+ ++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 5 89999999999999997654 4899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCcccccc------CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT------GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN 622 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 622 (757)
++.+..... .+...||+.|+|||++.+ ..++.++|||||||+||+|+||++||....... .
T Consensus 157 a~~~~~~~~-------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~ 223 (277)
T d1phka_ 157 SCQLDPGEK-------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------M 223 (277)
T ss_dssp CEECCTTCC-------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H
T ss_pred eeEccCCCc-------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------H
Confidence 988764321 244689999999998753 347889999999999999999999997543211 1
Q ss_pred HHHHhhhhc---CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 623 LAEILDAQA---GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 623 l~~~ld~~~---~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+..++.... .......++++.+|+.+||+.+|.+||++.+
T Consensus 224 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~e 266 (277)
T d1phka_ 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266 (277)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 222222211 1122356789999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=385.79 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=208.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC-------CeEEEEEEEccCCc-hhhHHHHHHHHHHHhc-CCCceeeecccccCC--
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH-------HTFAAVKVLQSKGN-IQNKQFLQELEVLSKI-RHPHLLLLLGACPDH-- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~-------~~~vAvK~l~~~~~-~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~~-- 470 (757)
.++|...++||+|+||.||+|++. ++.||||+++.... .....|.+|+.+++++ +|||||+++|+|.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 357888899999999999999863 34899999976543 3455789999999999 699999999999764
Q ss_pred ceEEEEecCCCCHHHHHhhcC---------------CCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeee
Q 004388 471 GCLVYEYMENGSLEDRLYRKN---------------NTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILL 535 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILl 535 (757)
.+|||||+++|+|.++|.... ....+++..+..|+.||+.||.|||+.+ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 489999999999999997643 2335899999999999999999999988 9999999999999
Q ss_pred cCCCceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHh-CCCCccccchh
Q 004388 536 DHNLVSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLT-AKPAIAITHKV 614 (757)
Q Consensus 536 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~ellt-G~~Pf~~~~~~ 614 (757)
+.++.+||+|||+++......... ......||+.|+|||++.++.++.++|||||||++|||+| |.+||......
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYV----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSE----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccCcccccccchheeccCCCcce----EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999776543321 2345689999999999999999999999999999999999 56666433221
Q ss_pred hhhhchhhHHHHhhhh-cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 615 ETAIDEDNLAEILDAQ-AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 615 ~~~~~~~~l~~~ld~~-~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
..+..++... ....|...+..+.+|+.+||+.||.+||++. +|+..|+++.
T Consensus 255 ------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-~il~~L~~~i 306 (311)
T d1t46a_ 255 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQI 306 (311)
T ss_dssp ------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred ------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHhh
Confidence 2233333332 2334455678999999999999999999998 5778887653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=387.65 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=192.4
Q ss_pred hcCCccce-eeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhc-CCCceeeecccccC------Cc
Q 004388 402 TLSFSENL-RIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKI-RHPHLLLLLGACPD------HG 471 (757)
Q Consensus 402 t~~f~~~~-~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l-~Hpniv~l~g~~~~------~~ 471 (757)
.++|.... .||+|+||.||+|.+. +..||||++.. ...+.+|+.++.++ +|||||+++++|.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35787765 5999999999999975 56999999864 34577899997665 89999999998853 23
Q ss_pred eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC---CCceEEeeecC
Q 004388 472 CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH---NLVSKIGDVGL 548 (757)
Q Consensus 472 ~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~---~~~~KL~DFGl 548 (757)
|||||||+||+|.++|...+. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 899999999999999976433 46999999999999999999999988 999999999999975 56799999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
|+....... .....||+.|+|||++.+..|+.++|||||||+||+|+||++||...+..... ..+...+.
T Consensus 161 a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~ 230 (335)
T d2ozaa1 161 AKETTSHNS-------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIR 230 (335)
T ss_dssp CEECCCCCC-------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCC
T ss_pred eeeccCCCc-------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHh
Confidence 987664332 23458999999999999999999999999999999999999999644322110 00111111
Q ss_pred hhcCCCC----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 629 AQAGDWP----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 629 ~~~~~~p----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....+| ...+.++.+|+.+||+.||.+||++.+
T Consensus 231 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 268 (335)
T d2ozaa1 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268 (335)
T ss_dssp SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 1111222 245678999999999999999999885
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-44 Score=383.45 Aligned_cols=242 Identities=19% Similarity=0.257 Sum_probs=198.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
.+.|.....||+|+||.||+|.+. +..||||++..... ....+.+|+++|++++|||||++++++.+.. ||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 356888899999999999999985 56999999976543 3456889999999999999999999986544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC--CCceEEeeecCccccCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH--NLVSKIGDVGLSTMLNSD 555 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~--~~~~KL~DFGla~~~~~~ 555 (757)
|+||+|.+++...+ ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999986543 35899999999999999999999988 999999999999985 458999999999876543
Q ss_pred CCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhhcCCCC
Q 004388 556 PSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQAGDWP 635 (757)
Q Consensus 556 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~~~~~p 635 (757)
.. .....||+.|+|||.+.+..|+.++|||||||+||+|+||++||...... ..+..++.. ...++
T Consensus 158 ~~-------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~-~~~~~ 223 (321)
T d1tkia_ 158 DN-------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNA-EYTFD 223 (321)
T ss_dssp CE-------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-CCCCC
T ss_pred Cc-------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CCCCC
Confidence 21 23357899999999999999999999999999999999999999654321 112222221 12223
Q ss_pred h----hHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 636 I----KETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 636 ~----~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
. ..+.++.+|+.+||..||.+||++.+.
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 255 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 2 346789999999999999999999853
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=376.82 Aligned_cols=240 Identities=25% Similarity=0.305 Sum_probs=185.3
Q ss_pred ceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch-----hhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEec
Q 004388 408 NLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI-----QNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEYM 478 (757)
Q Consensus 408 ~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~-----~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey~ 478 (757)
..+||+|+||+||+|++. ++.||||++...... ....+.+|+.+|++++|||||++++++.+.. ||||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 457999999999999975 568999998654322 1346889999999999999999999996654 8999999
Q ss_pred CCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCCC
Q 004388 479 ENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPSF 558 (757)
Q Consensus 479 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~ 558 (757)
.++++..++.. ...+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 98877665532 234888899999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhh--------
Q 004388 559 VSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDA-------- 629 (757)
Q Consensus 559 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~-------- 629 (757)
.....+||+.|+|||++..+ .|+.++|||||||++|||+||++||......+.... +.+.+..
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~---i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR---IFETLGTPTEEQWPD 227 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCTTTSSS
T ss_pred -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH---HHHhcCCCChhhccc
Confidence 12345899999999987654 579999999999999999999999975443322100 0000000
Q ss_pred -----------hcCCCC-----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 630 -----------QAGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 630 -----------~~~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....+ ...+..+.+|+.+||+.||++|||+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 000011 134578999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=374.57 Aligned_cols=233 Identities=23% Similarity=0.326 Sum_probs=191.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCch------hhHHHHHHHHHHHhcC--CCceeeecccccCCc-
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNI------QNKQFLQELEVLSKIR--HPHLLLLLGACPDHG- 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~------~~~~f~~Ev~il~~l~--Hpniv~l~g~~~~~~- 471 (757)
+.|...+.||+|+||.||+|++. +..||||++...... ...++.+|+.+|++++ |||||++++++.+..
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46888999999999999999985 669999998754211 1234678999999996 899999999997654
Q ss_pred -eEEEEecCC-CCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-CCceEEeeecC
Q 004388 472 -CLVYEYMEN-GSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-NLVSKIGDVGL 548 (757)
Q Consensus 472 -~LV~Ey~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-~~~~KL~DFGl 548 (757)
++||||+.+ +++.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 899999976 67878776544 4899999999999999999999988 999999999999985 47999999999
Q ss_pred ccccCCCCCCccccccccCCcccccCCCccccccCCC-CCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHh
Q 004388 549 STMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLI-SPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEIL 627 (757)
Q Consensus 549 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~l 627 (757)
|+...... .+...||+.|+|||++.+..+ +.++|||||||+||+|+||+.||.....+ +
T Consensus 158 a~~~~~~~--------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------~ 217 (273)
T d1xwsa_ 158 GALLKDTV--------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------I 217 (273)
T ss_dssp CEECCSSC--------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------H
T ss_pred ceeccccc--------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------h
Confidence 98754321 245689999999999887665 57799999999999999999999643211 1
Q ss_pred hhhcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 628 DAQAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 628 d~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....++...+.++.+|+.+||..||.+|||+.+
T Consensus 218 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 251 (273)
T d1xwsa_ 218 -RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEE 251 (273)
T ss_dssp -HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -hcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 1123345567789999999999999999999885
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-43 Score=374.04 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=190.8
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
++|...++||+|+||.||+|.+. ++.||||++..... .....+.+|+.+|++++|||||++++++.+.. |+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47889999999999999999985 67999999865432 23567999999999999999999999997654 89999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+.++ +.+++.... ...+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99754 444444332 345999999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCccccccccCCcccccCCCccccccCC-CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh---------hHHHH
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------NLAEI 626 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------~l~~~ 626 (757)
. ......||+.|+|||.+.... ++.++|||||||++|+|+||+.||...+......... .....
T Consensus 157 ~------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 R------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp B------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred c------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 2 224458999999999766554 5889999999999999999999996443222111000 00000
Q ss_pred --hhhhcCCCC-----------hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 --LDAQAGDWP-----------IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 --ld~~~~~~p-----------~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+.......+ ...+..+.+|+.+||..||.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~e 279 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 000000000 123578899999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=374.60 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=191.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC---CeEEEEEEEccCCc--hhhHHHHHHHHHHHhc---CCCceeeecccccC----
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH---HTFAAVKVLQSKGN--IQNKQFLQELEVLSKI---RHPHLLLLLGACPD---- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~---~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l---~Hpniv~l~g~~~~---- 469 (757)
.++|....+||+|+||.||+|++. +..||||++..... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 467999999999999999999984 45799999865422 2234567888887766 79999999999842
Q ss_pred ---CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 470 ---HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 470 ---~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
..+++|||+.+|++...... ....+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 23799999998777554433 2345899999999999999999999988 999999999999999999999999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI 626 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ 626 (757)
|+++..... .......||+.|+|||++.+..|+.++|||||||++|||+||++||......+.... +...
T Consensus 161 g~~~~~~~~-------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~ 230 (305)
T d1blxa_ 161 GLARIYSFQ-------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDV 230 (305)
T ss_dssp CSCCCCCGG-------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHH
T ss_pred hhhhhhccc-------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH---HHHh
Confidence 998765432 123556899999999999999999999999999999999999999975432221100 0000
Q ss_pred hh-------------------hh----cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 LD-------------------AQ----AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 ld-------------------~~----~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
+. .. ...++...+..+.+|+.+||+.||.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e 289 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 289 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 00 00 00112245678999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-42 Score=363.89 Aligned_cols=248 Identities=19% Similarity=0.280 Sum_probs=190.0
Q ss_pred cCCccceeeccCCcEEEEEEEEC-CeEEEEEEEccCCc--hhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH-HTFAAVKVLQSKGN--IQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~-~~~vAvK~l~~~~~--~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~Ey 477 (757)
++|...++||+|+||+||+|++. +..||||++..... ...+.|.+|+.+|++++|||||+++++|.+.. +++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 46888899999999999999986 56999999976532 23578999999999999999999999996554 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDPS 557 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~ 557 (757)
+.++.+..+.... ..++...+..|+.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9877666655333 35999999999999999999999988 99999999999999999999999999987654321
Q ss_pred CccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh---------h---HH
Q 004388 558 FVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------N---LA 624 (757)
Q Consensus 558 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------~---l~ 624 (757)
......||+.|+|||.+.. ..++.++|||||||++|||+||++||...+..+...... . ..
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 2234578999999998765 457999999999999999999999996443222110000 0 00
Q ss_pred HHh--hhhc--------CCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 625 EIL--DAQA--------GDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 625 ~~l--d~~~--------~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
... .... ...+...+..+.+|+.+||+.||++|||+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~e 277 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 000 0000 0011234678999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-41 Score=361.76 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=193.9
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccc-cC--CceEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGAC-PD--HGCLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~-~~--~~~LV~Ey 477 (757)
+.|...+.||+|+||.||+|++. +..||||++..... ...+..|+++++.++|+|++.+++.| .+ ..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 35888999999999999999985 67999999876533 34578999999999988777666555 32 33789999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeec---CCCceEEeeecCccccCC
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLD---HNLVSKIGDVGLSTMLNS 554 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld---~~~~~KL~DFGla~~~~~ 554 (757)
+ +|+|.+.+.... ..+++..+..++.|++.||.|||+.+ ||||||||+|||++ .++.+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 567777665433 35899999999999999999999988 99999999999875 456799999999998765
Q ss_pred CCCCccc-cccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHH-hhhhcC
Q 004388 555 DPSFVST-TYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEI-LDAQAG 632 (757)
Q Consensus 555 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~-ld~~~~ 632 (757)
....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.................. +.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 4432221 12234568999999999999989999999999999999999999999643322211111000000 000000
Q ss_pred CCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHH
Q 004388 633 DWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERL 671 (757)
Q Consensus 633 ~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l 671 (757)
..+...+.++.+|+.+||..+|.+||++. .+.+.|+.+
T Consensus 239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~~ 276 (299)
T d1ckia_ 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNL 276 (299)
T ss_dssp HHTTTSCHHHHHHHHHHHHSCTTCCCCHH-HHHHHHHHH
T ss_pred HhccCCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHHH
Confidence 11123457899999999999999999987 455666554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=370.58 Aligned_cols=251 Identities=19% Similarity=0.259 Sum_probs=191.3
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC-chhhHHHHHHHHHHHhcCCCceeeecccccCC------ce
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG-NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------GC 472 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~-~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------~~ 472 (757)
+.+|....+||+|+||+||+|.+. ++.||||++.... ....+.+.+|+.+|++++||||+++++++... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 346888999999999999999985 6799999997543 33456789999999999999999999998543 25
Q ss_pred EEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcccc
Q 004388 473 LVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTML 552 (757)
Q Consensus 473 LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~ 552 (757)
++++|+.+|+|.+++... .+++..+..++.||+.||.|||+.+ ||||||||+||||+.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666778899999998653 4899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCccccc-cCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh----------
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQR-TGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED---------- 621 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------- 621 (757)
...... .......+||+.|+|||++. ...++.++||||+||++|+|+||++||.............
T Consensus 160 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cCCCcc---ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 543221 11234568999999999874 4567899999999999999999999996433221110000
Q ss_pred -------hHHHHhhhh--cCCCC-----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 622 -------NLAEILDAQ--AGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 622 -------~l~~~ld~~--~~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
......... ....+ ...+..+.+|+.+||+.||.+||++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e 291 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 000000000 01111 123467899999999999999999885
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-41 Score=357.17 Aligned_cols=261 Identities=16% Similarity=0.179 Sum_probs=199.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCC-CceeeecccccCCc--eEEEEe
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRH-PHLLLLLGACPDHG--CLVYEY 477 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H-pniv~l~g~~~~~~--~LV~Ey 477 (757)
++|...++||+|+||.||+|++. ++.||||++..... ...+.+|++++..+.| ||++.+++++.+.. ++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57889999999999999999975 67999999865432 3457789999999975 89999988876544 899999
Q ss_pred cCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecC-----CCceEEeeecCcccc
Q 004388 478 MENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDH-----NLVSKIGDVGLSTML 552 (757)
Q Consensus 478 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~-----~~~~KL~DFGla~~~ 552 (757)
+ +|+|.+++...+. .+++..+..|+.|++.||.|||+.+ ||||||||+|||++. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 6899998865443 5899999999999999999999988 999999999999974 578999999999987
Q ss_pred CCCCCCcc-ccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhhhh-
Q 004388 553 NSDPSFVS-TTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILDAQ- 630 (757)
Q Consensus 553 ~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld~~- 630 (757)
........ ........+||+.|||||++.+..++.++|||||||++|||+||+.||..............+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 65432211 1122345689999999999999999999999999999999999999996332211110000111100000
Q ss_pred cCCCChhHHHHHHHHHHHHhhccCCCCCccchhhhhHHHHHH
Q 004388 631 AGDWPIKETKELAALGLSCAELRRKDRPDLKNQVLPVLERLK 672 (757)
Q Consensus 631 ~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~vl~~L~~l~ 672 (757)
....+...++++.+++..|+..+|.+||++. .+...|+.+.
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~-~l~~~l~~~~ 277 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVL 277 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHH-HHHHHHHHHH
Confidence 0011123457899999999999999999986 4656665543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=369.49 Aligned_cols=246 Identities=22% Similarity=0.293 Sum_probs=188.2
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCceeeecccccC------C--ceE
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHLLLLLGACPD------H--GCL 473 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~------~--~~L 473 (757)
.|...++||+|+||+||+|++. +..||||++...... +.+|+.+|++++|||||+++++|.. . .+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999985 569999999765432 3479999999999999999998832 1 279
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCC-ceEEeeecCcccc
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNL-VSKIGDVGLSTML 552 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~-~~KL~DFGla~~~ 552 (757)
||||+++|.+..+.........+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655544433334456999999999999999999999988 99999999999999775 8999999999876
Q ss_pred CCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhch---------hh
Q 004388 553 NSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDE---------DN 622 (757)
Q Consensus 553 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~---------~~ 622 (757)
..... .....||+.|+|||.+.+ ..++.++|||||||++|||+||++||......+..... ..
T Consensus 174 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGEP-------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTSC-------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCCcc-------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 54322 234589999999997654 57899999999999999999999999644332211000 00
Q ss_pred HHHHhhhh----cC---------CCChhHHHHHHHHHHHHhhccCCCCCccchh
Q 004388 623 LAEILDAQ----AG---------DWPIKETKELAALGLSCAELRRKDRPDLKNQ 663 (757)
Q Consensus 623 l~~~ld~~----~~---------~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~~ 663 (757)
+....... .. ......++++.+|+.+||..||.+|||+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 00000000 00 0112346789999999999999999999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=368.59 Aligned_cols=244 Identities=22% Similarity=0.294 Sum_probs=186.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCC-------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDH------- 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~------- 470 (757)
...|...++||+|+||+||+|.+. +..||||++.... ....+.+.+|+.+|++++|||||+++++|...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467889999999999999999986 6799999987542 23356789999999999999999999998543
Q ss_pred -ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCc
Q 004388 471 -GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLS 549 (757)
Q Consensus 471 -~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla 549 (757)
.||||||+ +++|..++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 38999999 56777766432 4999999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCCCccccccccCCcccccCCCcccccc-CCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc---------
Q 004388 550 TMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRT-GLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID--------- 619 (757)
Q Consensus 550 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~--------- 619 (757)
+..... .+...||+.|+|||.+.+ ..++.++|||||||++|+|+||++||...........
T Consensus 169 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eccCCc---------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 876532 245689999999998765 4578999999999999999999999965432221100
Q ss_pred --------hhhHHHHhhhh--c--CC---CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 --------EDNLAEILDAQ--A--GD---WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 --------~~~l~~~ld~~--~--~~---~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
........... . .. .....++.+.+|+.+||..||.+|||+.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 00000000000 0 00 11234678899999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=362.47 Aligned_cols=253 Identities=22% Similarity=0.281 Sum_probs=188.8
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccC--CchhhHHHHHHHHHHHhcCCCceeeecccccC--------
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSK--GNIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------- 469 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~--~~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------- 469 (757)
.++|....+||+|+||+||+|++. ++.||||++... .......+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 357889999999999999999985 679999997644 23345678999999999999999999998733
Q ss_pred --CceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeec
Q 004388 470 --HGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVG 547 (757)
Q Consensus 470 --~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFG 547 (757)
..++||||+.++.+...... ...++...+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34899999987766544322 335888999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhh----
Q 004388 548 LSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDN---- 622 (757)
Q Consensus 548 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---- 622 (757)
+++.+...... ........+||+.|+|||++.+. .++.++|||||||++|||+||++||...+..........
T Consensus 163 ~~~~~~~~~~~--~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~ 240 (318)
T d3blha1 163 LARAFSLAKNS--QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240 (318)
T ss_dssp TCEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred eeeeccccccc--ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99876643321 11122445899999999988654 689999999999999999999999964332221100000
Q ss_pred -------------HHHHhhhhcC-CCCh-------hHHHHHHHHHHHHhhccCCCCCccch
Q 004388 623 -------------LAEILDAQAG-DWPI-------KETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 623 -------------l~~~ld~~~~-~~p~-------~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
....+..... ..+. ...+.+.+|+.+||+.||++|||+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 0000000000 0000 12456788999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=362.11 Aligned_cols=245 Identities=25% Similarity=0.309 Sum_probs=195.2
Q ss_pred cCCccceeeccCCcEEEEEEEE-----CCeEEEEEEEccCC----chhhHHHHHHHHHHHhcCC-CceeeecccccCCc-
Q 004388 403 LSFSENLRIGMGGYGTVYKGTF-----HHTFAAVKVLQSKG----NIQNKQFLQELEVLSKIRH-PHLLLLLGACPDHG- 471 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~-----~~~~vAvK~l~~~~----~~~~~~f~~Ev~il~~l~H-pniv~l~g~~~~~~- 471 (757)
++|...++||+|+||.||+|.. .++.||||++.... ....+.+.+|+.+|++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999986 25689999986432 2234568899999999976 89999999986544
Q ss_pred -eEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 472 -CLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 472 -~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
++||||+.+|+|.+++...+. ++......++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 899999999999999977653 677888999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccC--CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchhhHHHHhh
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG--LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDEDNLAEILD 628 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~l~~~ld 628 (757)
.+..... .......||+.|++||.+.+. .++.++|||||||+||+|+||+.||......... ..+....-
T Consensus 178 ~~~~~~~-----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~ 249 (322)
T d1vzoa_ 178 EFVADET-----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRIL 249 (322)
T ss_dssp ECCGGGG-----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHH
T ss_pred hhccccc-----ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcc
Confidence 7653321 122445899999999988654 4788999999999999999999999644322110 11111111
Q ss_pred hhcCCCChhHHHHHHHHHHHHhhccCCCCCccc
Q 004388 629 AQAGDWPIKETKELAALGLSCAELRRKDRPDLK 661 (757)
Q Consensus 629 ~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~ 661 (757)
......|...+..+.+|+.+||..+|.+||++.
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~ 282 (322)
T d1vzoa_ 250 KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282 (322)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCC
Confidence 222345567889999999999999999999753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=349.08 Aligned_cols=248 Identities=19% Similarity=0.255 Sum_probs=194.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccCCc--eEEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPDHG--CLVYE 476 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~~~--~LV~E 476 (757)
+.|...++||+|+||+||+|++. ++.||||+++... .....++.+|+.+|+.++||||++++++|.+.. ++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 36888899999999999999985 5689999986543 234577899999999999999999999997655 78999
Q ss_pred ecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCccccCCCC
Q 004388 477 YMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLSTMLNSDP 556 (757)
Q Consensus 477 y~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~~~~~~~ 556 (757)
|+.+++|..++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888775433 4889999999999999999999988 9999999999999999999999999998776433
Q ss_pred CCccccccccCCcccccCCCccccccCC-CCCcchhhhHHHHHHHHHhCCCCccccchhhhhhchh-------------h
Q 004388 557 SFVSTTYKNTGPVGTLCYIDPEYQRTGL-ISPKSDVYAYGMVILQLLTAKPAIAITHKVETAIDED-------------N 622 (757)
Q Consensus 557 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~-------------~ 622 (757)
. ......+++.|+|||++.... ++.++|||||||++|||+||+.||.........+..- .
T Consensus 156 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 2 123446789999999877654 6899999999999999999998874322211111000 0
Q ss_pred HHHHhhh----------hcCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 623 LAEILDA----------QAGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 623 l~~~ld~----------~~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.....+. .....+...+..+.+|+.+||+.||++|||+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e 279 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0000000 001122345678999999999999999999885
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-40 Score=355.45 Aligned_cols=241 Identities=19% Similarity=0.317 Sum_probs=189.1
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccC----CceEEE
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD----HGCLVY 475 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~----~~~LV~ 475 (757)
++|...++||+|+||+||+|++. ++.||||++... ..+++.+|+.+|.++. ||||++++++|.. ..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999985 679999998753 3467889999999995 9999999998853 248899
Q ss_pred EecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCC-CceEEeeecCccccCC
Q 004388 476 EYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHN-LVSKIGDVGLSTMLNS 554 (757)
Q Consensus 476 Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~-~~~KL~DFGla~~~~~ 554 (757)
||+.+|+|.... ..++...+..++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987643 24899999999999999999999988 9999999999999865 4699999999987764
Q ss_pred CCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhh-------chhhHHHH
Q 004388 555 DPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAI-------DEDNLAEI 626 (757)
Q Consensus 555 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~-------~~~~l~~~ 626 (757)
... ....+||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+...... ........
T Consensus 183 ~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TCC-------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CCc-------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 432 2445899999999987654 47999999999999999999999996433211110 00000000
Q ss_pred hhhh------------------------cCCCChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 627 LDAQ------------------------AGDWPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 627 ld~~------------------------~~~~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
.... ........+.++.+|+.+||..||.+|||+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 0000 00011234678999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=359.29 Aligned_cols=244 Identities=19% Similarity=0.218 Sum_probs=182.2
Q ss_pred cCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC--------C
Q 004388 403 LSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD--------H 470 (757)
Q Consensus 403 ~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~--------~ 470 (757)
+.|...++||+|+||+||+|.+. +..||||++.... ......+.+|+.+|++++|||||+++++|.. .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999999999999986 6799999997543 2344568899999999999999999999842 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.|+||||+.++.+ +.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 3899999976544 4442 24889999999999999999999988 9999999999999999999999999988
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc-----------
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID----------- 619 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~----------- 619 (757)
...... ..+...||+.|+|||++.+..+++++||||+||++|+|++|++||...+.......
T Consensus 168 ~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 168 TAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccccc-------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 665432 23455899999999999999999999999999999999999999964432211000
Q ss_pred -----hhhHHHHhhhhc----------------C-C--CChhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 -----EDNLAEILDAQA----------------G-D--WPIKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 -----~~~l~~~ld~~~----------------~-~--~p~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
............ . . .+...+..+.+|+.+||..||++|||+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~e 307 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 001111111100 0 0 01235678999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-40 Score=354.42 Aligned_cols=245 Identities=20% Similarity=0.269 Sum_probs=188.6
Q ss_pred hcCCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCC--chhhHHHHHHHHHHHhcCCCceeeecccccC-------C
Q 004388 402 TLSFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKG--NIQNKQFLQELEVLSKIRHPHLLLLLGACPD-------H 470 (757)
Q Consensus 402 t~~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~--~~~~~~f~~Ev~il~~l~Hpniv~l~g~~~~-------~ 470 (757)
.+.|....+||+|+||+||+|++. +..||||++.... ....+.+.+|+.+|++++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 457999999999999999999875 6799999987543 2344578899999999999999999998742 2
Q ss_pred ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 471 GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 471 ~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
.+++|+|+.+|+|.+++... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.+|.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 26788889999999988542 4999999999999999999999988 9999999999999999999999999997
Q ss_pred ccCCCCCCccccccccCCcccccCCCccccccC-CCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc----------
Q 004388 551 MLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTG-LISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID---------- 619 (757)
Q Consensus 551 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~---------- 619 (757)
.... ......||+.|+|||.+.+. .++.++|||||||++|+|+||++||...+.......
T Consensus 170 ~~~~---------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCTG---------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccCc---------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 6432 22456899999999976554 568999999999999999999999964332211100
Q ss_pred -------hhhHHHHhhhh--cCCCC-----hhHHHHHHHHHHHHhhccCCCCCccch
Q 004388 620 -------EDNLAEILDAQ--AGDWP-----IKETKELAALGLSCAELRRKDRPDLKN 662 (757)
Q Consensus 620 -------~~~l~~~ld~~--~~~~p-----~~~~~~l~~Li~~Cl~~~p~~RPs~~~ 662 (757)
........... ....+ ...+..+.+|+.+||..||.+|||+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 00000000000 00011 134577899999999999999999885
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-36 Score=327.52 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=185.4
Q ss_pred CCccceeeccCCcEEEEEEEEC--CeEEEEEEEccCCchhhHHHHHHHHHHHhcC-----------CCceeeecccccCC
Q 004388 404 SFSENLRIGMGGYGTVYKGTFH--HTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-----------HPHLLLLLGACPDH 470 (757)
Q Consensus 404 ~f~~~~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-----------Hpniv~l~g~~~~~ 470 (757)
.|...++||+|+||+||+|++. +..||||+++.+. ...+.+.+|+.+|+.++ ||||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3888999999999999999984 6799999997653 23466788999998875 57899999887432
Q ss_pred ----ceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCC------
Q 004388 471 ----GCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNL------ 539 (757)
Q Consensus 471 ----~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~------ 539 (757)
.+++|+++.++..............+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 36777777666555544445555678899999999999999999998 66 99999999999998665
Q ss_pred ceEEeeecCccccCCCCCCccccccccCCcccccCCCccccccCCCCCcchhhhHHHHHHHHHhCCCCccccchhhhhhc
Q 004388 540 VSKIGDVGLSTMLNSDPSFVSTTYKNTGPVGTLCYIDPEYQRTGLISPKSDVYAYGMVILQLLTAKPAIAITHKVETAID 619 (757)
Q Consensus 540 ~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 619 (757)
.+||+|||.+...... ....+||+.|+|||++....++.++|||||||++++|+||+.||...........
T Consensus 170 ~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp EEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred eeeEeecccccccccc---------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch
Confidence 3899999999765432 2345899999999999999999999999999999999999999963321110000
Q ss_pred hhhHHHHh---------------------h--------------------hhcCCCChhHHHHHHHHHHHHhhccCCCCC
Q 004388 620 EDNLAEIL---------------------D--------------------AQAGDWPIKETKELAALGLSCAELRRKDRP 658 (757)
Q Consensus 620 ~~~l~~~l---------------------d--------------------~~~~~~p~~~~~~l~~Li~~Cl~~~p~~RP 658 (757)
...+...+ + ......+...+..+.+|+.+||..||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 00000000 0 001122345678899999999999999999
Q ss_pred ccch
Q 004388 659 DLKN 662 (757)
Q Consensus 659 s~~~ 662 (757)
|+.+
T Consensus 321 ta~e 324 (362)
T d1q8ya_ 321 DAGG 324 (362)
T ss_dssp CHHH
T ss_pred CHHH
Confidence 9985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.9e-23 Score=202.71 Aligned_cols=163 Identities=14% Similarity=0.077 Sum_probs=119.4
Q ss_pred ccceeeccCCcEEEEEEEE-CCeEEEEEEEccCCch------------------hhHHHHHHHHHHHhcCCCceeeeccc
Q 004388 406 SENLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNI------------------QNKQFLQELEVLSKIRHPHLLLLLGA 466 (757)
Q Consensus 406 ~~~~~IG~G~~G~Vyk~~~-~~~~vAvK~l~~~~~~------------------~~~~f~~Ev~il~~l~Hpniv~l~g~ 466 (757)
...++||+|+||.||+|.+ ++..||||+++..... ....+..|...|.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4567899999999999987 4789999987642110 11234568899999999999988765
Q ss_pred ccCCceEEEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCCCCEEEcCCCCCCeeecCCCceEEeee
Q 004388 467 CPDHGCLVYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKPKPIIHRDMKPGNILLDHNLVSKIGDV 546 (757)
Q Consensus 467 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivHrDLKp~NILld~~~~~KL~DF 546 (757)
. ..+|||||++++.+.+ ++......++.|++.+|.|||+.+ |+||||||+|||+++++ ++|+||
T Consensus 83 ~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDF 146 (191)
T d1zara2 83 E--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDF 146 (191)
T ss_dssp E--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCC
T ss_pred c--CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEEC
Confidence 3 3589999998865533 233345689999999999999988 99999999999999665 889999
Q ss_pred cCccccCCCCCCccccccccCCcccccCCC------ccccccCCCCCcchhhhHHHHHH
Q 004388 547 GLSTMLNSDPSFVSTTYKNTGPVGTLCYID------PEYQRTGLISPKSDVYAYGMVIL 599 (757)
Q Consensus 547 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~a------PE~~~~~~~s~ksDvwSlGvil~ 599 (757)
|+|......... .|.. .+++ ...|+.++|+||+.--++
T Consensus 147 G~a~~~~~~~~~--------------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR--------------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH--------------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCcccCCCCCcH--------------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 999765432210 1111 1122 355788999999865443
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=4e-14 Score=122.40 Aligned_cols=70 Identities=27% Similarity=0.494 Sum_probs=65.9
Q ss_pred CCCCCCccCccchhcccCCcccCCC-cccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHhh
Q 004388 687 PAPPNHFICPILKEVMNEPCVAADG-YTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWKS 756 (757)
Q Consensus 687 ~~~p~~ficPi~~evM~dp~iaadG-~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~ 756 (757)
...|..|+|||..++|.||++...| ++|++.+|+.||..+.+||+|+.+|...+|+||++||.+|++|+.
T Consensus 17 ~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~ 87 (98)
T d1wgma_ 17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRSPLTMDQIRPNTELKEKIQRWLA 87 (98)
T ss_dssp CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTTSCBCTTTCSBCCTTTSEECHHHHHHHHHHHH
T ss_pred cCCcHHhCCcCchhHHHHHHhcccccchhhHHHHHHHHHhcCCcccccccccchhhcchHHHHHHHHHHHH
Confidence 4678899999999999999999876 599999999999999999999999999999999999999999985
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.35 E-value=1.4e-12 Score=124.63 Aligned_cols=118 Identities=19% Similarity=0.205 Sum_probs=89.9
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
|+++||..+...-.. . .+......+....++...+++++++|..|...|...|+++++++.++ +++++|+++|.+
T Consensus 44 L~~vhv~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~ 118 (171)
T d2gm3a1 44 ILLLHVQVVDEDGFD---D-VDSIYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEVKR 118 (171)
T ss_dssp EEEEEEEC--------------CCCCSHHHHHHHTTSHHHHHHHHHHHHHHHHHHHTCEEEEEEEES-CHHHHHHHHHHH
T ss_pred EEEEEeccccccccc---c-ccccccCHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCceEEEEEeC-ChHHHHHHHHhh
Confidence 467888776432211 1 24455667778888888888999999999999999999999988777 999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEecCc
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKGK 126 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~kg~ 126 (757)
+++|.||||+++.+.+.+.+. |+++..|+++++ |+|+||.++.
T Consensus 119 ~~~dlIV~G~~g~~~~~~~~l-GSv~~~vi~~~~--cpVlvV~~~~ 161 (171)
T d2gm3a1 119 VRPDFLVVGSRGLGRFQKVFV-GTVSAFCVKHAE--CPVMTIKRNA 161 (171)
T ss_dssp HCCSEEEEEECCCC---------CHHHHHHHHCS--SCEEEEECCG
T ss_pred cCCcEEEeccCCccccccCcc-CcHHHHHHhCCC--CCEEEEeCCC
Confidence 999999999999999998774 899999999999 9999998654
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.30 E-value=4.5e-13 Score=110.91 Aligned_cols=71 Identities=37% Similarity=0.722 Sum_probs=66.5
Q ss_pred CCCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHHhhC
Q 004388 687 PAPPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757 (757)
Q Consensus 687 ~~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~~ 757 (757)
|.+|+.|.|||.+++|.||++...|++|.+..|+.|+.. +.++|.++.++....|+||++||++|++|+.+
T Consensus 3 peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~ 74 (78)
T d1t1ha_ 3 PEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCES 74 (78)
T ss_dssp CCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHH
T ss_pred CCCCccCCCcCcCchhhCceEccCCCcchHHHHHHHHHHCCCCCCcccccCCcccccchHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999986 67799999999999999999999999999863
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.28 E-value=6.5e-12 Score=118.18 Aligned_cols=120 Identities=6% Similarity=0.082 Sum_probs=96.2
Q ss_pred CEEEEecCCCCcccCC-----CCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHH
Q 004388 1 MVMITDLSASLAIGHP-----VGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIA 75 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~-----~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~ 75 (757)
|.||||.++....+.+ .+. -......++....+++...+++++.|..+...|...||++++++.+| +|+++|+
T Consensus 34 l~llhV~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~gv~~~~~~~~G-~~~~~I~ 111 (160)
T d1mjha_ 34 VILLHVIDEREIKKRDIFSLLLGV-AGLNKSVEEFENELKNKLTEEAKNKMENIKKELEDVGFKVKDIIVVG-IPHEEIV 111 (160)
T ss_dssp EEEEEEEEGGGTC------------------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEE-CHHHHHH
T ss_pred EEEEEecccccccccccccccccc-cccchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCeEEEEEEec-cHHHHHh
Confidence 5799998764433332 222 12244556666777778888999999999999999999999998887 8999999
Q ss_pred HHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEecC
Q 004388 76 DEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVEKG 125 (757)
Q Consensus 76 ~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~kg 125 (757)
+++.++++|.||||+++++.+.+.|. |+++..|++++| |+|+||.+.
T Consensus 112 ~~a~~~~~dliV~G~~~~~~~~~~~~-GS~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 112 KIAEDEGVDIIIMGSHGKTNLKEILL-GSVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHTTCSEEEEESCCSSCCTTCSS-CHHHHHHHHHCC--SCEEEECCC
T ss_pred hhhhccccceEEeccCCCCccccccc-CcHHHHHHhcCC--CCEEEEcCC
Confidence 99999999999999999999999875 899999999999 999999764
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.27 E-value=1.6e-12 Score=108.02 Aligned_cols=70 Identities=39% Similarity=0.632 Sum_probs=65.9
Q ss_pred CCCCCccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCCchHHHHHHHHHHhhC
Q 004388 688 APPNHFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLLPNYTLLSAILDWKSK 757 (757)
Q Consensus 688 ~~p~~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~~~ 757 (757)
..|++|.|||..++|.||++...|++|++..|..||.. +.+||+++.++...+|+||++||++|++|+.+
T Consensus 3 eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~ 73 (80)
T d2c2la2 3 DIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISE 73 (80)
T ss_dssp CCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTT
T ss_pred CCCccccCcCcCchhhhhcccCCcCeecHHHHHHHHhcCCccCCCccccccccccccHHHHHHHHHHHHHH
Confidence 56899999999999999999999999999999999986 67899999999999999999999999999864
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=98.96 E-value=8.4e-10 Score=100.20 Aligned_cols=104 Identities=17% Similarity=0.207 Sum_probs=77.2
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
|+|+||+++... ..+. .......+...+++++.+.++.. ..|+...+.++.+.++.++|+++|.+
T Consensus 32 l~ll~V~~~~~~---~~~~---------~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~~~~~g~~~~~I~~~a~~ 96 (135)
T d2z3va1 32 LIVVHAYEPVPD---YLGE---------PFFEEALRRRLERAEGVLEEARA---LTGVPKEDALLLEGVPAEAILQAARA 96 (135)
T ss_dssp EEEEEEECCCCT---TCCT---------THHHHHHHHHHHHHHHHHHHHHH---HHCCCGGGEEEEESCHHHHHHHHHHH
T ss_pred EEEEEEecCCcc---cccc---------chhHHHHHHHHHHHHHHHHHHHH---hcCCCeEEEEEEcCChHHHHHHHhhh
Confidence 579999986331 1111 11223333445566666666654 45666666666667999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEE
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGV 122 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv 122 (757)
+++|.||||+++++.+.+.+. |+++..+++++| |+|+||
T Consensus 97 ~~~dliV~G~~~~~~~~~~~~-Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 97 EKADLIVMGTRGLGALGSLFL-GSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp TTCSEEEEESSCSSSCBCSSC-BHHHHHHHHHCS--SCEEEE
T ss_pred hheeeEEeccCCCCccccccc-CcHHHHHHHhCC--CCEEeC
Confidence 999999999999999998774 889999999999 999987
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.88 E-value=1.4e-09 Score=100.17 Aligned_cols=88 Identities=11% Similarity=0.062 Sum_probs=72.8
Q ss_pred HHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccCCchhhhhhh
Q 004388 33 AYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKNNLSSRISIC 112 (757)
Q Consensus 33 ~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ 112 (757)
.+....++.+++++..++..|.+.|+..-...+...++++.|++++.++++|.||||+++++.+.+.+. |+++..|+++
T Consensus 58 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~-Gs~~~~ll~~ 136 (147)
T d1tq8a_ 58 SYKVTGTAPIYEILHDAKERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLL-GSVPANVSRR 136 (147)
T ss_dssp ------CCTHHHHHHHHHHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHT-BBHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHcCCCcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCccccccc-ccHHHHHHHh
Confidence 445556667889999999999999987544455555899999999999999999999999999998774 8899999999
Q ss_pred CCCCceEEEEe
Q 004388 113 VPSFCTVYGVE 123 (757)
Q Consensus 113 ap~~C~V~vv~ 123 (757)
+| |+|+||.
T Consensus 137 ~~--~pVlvV~ 145 (147)
T d1tq8a_ 137 AK--VDVLIVH 145 (147)
T ss_dssp TT--CEEEEEC
T ss_pred CC--CCEEEEe
Confidence 99 9999985
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=98.62 E-value=1.3e-08 Score=92.54 Aligned_cols=105 Identities=9% Similarity=0.082 Sum_probs=76.1
Q ss_pred CEEEEecCCCCcccCCCCCccccccccHHHHHHHHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHh
Q 004388 1 MVMITDLSASLAIGHPVGNFIPIEQVRDDVAAAYKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVAS 80 (757)
Q Consensus 1 ~~lvHV~~~~~~i~~~~g~~~p~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~ 80 (757)
|.++||.++........+. .....++... .+++...+..++.+.+....+.++...+++++|++++.+
T Consensus 33 v~~lhv~~~~~~~~~~~~~---------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~~~a~~ 100 (140)
T d1jmva_ 33 LSIIHVDVNFSDLYTGLID---------VNMSSMQDRI---STETQKALLDLAESVDYPISEKLSGSGDLGQVLSDAIEQ 100 (140)
T ss_dssp EEEEEEEECCGGGCCCCEE---------HHHHHHTTCC---CCHHHHHHHHHHHHSSSCCCCEEEEEECHHHHHHHHHHH
T ss_pred EEEEEEeeecccccccccc---------cchHHHHHHH---HHHHHHHHHHHHHhcCCceEEEEEEecCHHHHHHHhhhh
Confidence 5789998876544433222 1122222222 234455556667777777777788888999999999999
Q ss_pred cCCcEEEeeccCCCceehhhccCCchhhhhhhCCCCceEEEEe
Q 004388 81 CNINKLVIGAQSQGIFTWKFKKNNLSSRISICVPSFCTVYGVE 123 (757)
Q Consensus 81 ~~i~~LVmG~~~~~~~~r~~~~~~~~~~v~~~ap~~C~V~vv~ 123 (757)
+++|.||||++++++.. + ++++..++++++ |+|+||.
T Consensus 101 ~~~dliV~G~~~~~~~~--l--gs~~~~li~~~~--~pVliVp 137 (140)
T d1jmva_ 101 YDVDLLVTGHHQDFWSK--L--MSSTRQVMNTIK--IDMLVVP 137 (140)
T ss_dssp TTCCEEEEEECCCCHHH--H--HHHHHHHHTTCC--SEEEEEE
T ss_pred chhhEEEeccCCCCCCC--c--ccHHHHHHhccC--CCEEEEe
Confidence 99999999999887542 2 688999999999 9999985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=1.5e-07 Score=94.50 Aligned_cols=147 Identities=14% Similarity=0.055 Sum_probs=97.3
Q ss_pred HHHHhhcCCccceeeccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccC--CceE
Q 004388 397 EIESATLSFSENLRIGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPD--HGCL 473 (757)
Q Consensus 397 ei~~at~~f~~~~~IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~--~~~L 473 (757)
++...-.+|+..+..+.|+.+.||+...++..+.||+...........+.+|..++..+. +-.+.+++.++.+ ..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 344444556555544444557899998888888899876554444445778888887764 3224455555433 3489
Q ss_pred EEEecCCCCHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhCCC---------------------------------
Q 004388 474 VYEYMENGSLEDRLYRKNNTPPIPWFERYRIAWEVASALAFLHNTKP--------------------------------- 520 (757)
Q Consensus 474 V~Ey~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~--------------------------------- 520 (757)
||++++|.++.+..... . ....++.+++..|..||+...
T Consensus 88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEeccccccccccccc-----c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999998886644211 1 123345566666666665321
Q ss_pred -----------------------CCEEEcCCCCCCeeecCCCceEEeeecCccc
Q 004388 521 -----------------------KPIIHRDMKPGNILLDHNLVSKIGDVGLSTM 551 (757)
Q Consensus 521 -----------------------~~ivHrDLKp~NILld~~~~~KL~DFGla~~ 551 (757)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 2389999999999999887778999988753
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=98.36 E-value=2e-08 Score=90.90 Aligned_cols=69 Identities=12% Similarity=0.015 Sum_probs=58.0
Q ss_pred HHHHHHHHHhHhhHHHHHHhhhcCceeeEEEeecccHHHHHHHHHHhcCCcEEEeeccCCCceehhhccC
Q 004388 34 YKQEEKWKTDRLLLPFRNMCAQRRVEVEVKVIESDDVAKAIADEVASCNINKLVIGAQSQGIFTWKFKKN 103 (757)
Q Consensus 34 ~~~~~~~~~~~ll~~~~~~c~~~~v~~~~~v~e~~~va~~I~~~i~~~~i~~LVmG~~~~~~~~r~~~~~ 103 (757)
..++.++++++.+..+..-+...++.++..+.+| ++++.|+++|.++++|.||||+++.+.+.|.+.+.
T Consensus 62 ~~e~~~~~~~~~l~~~~~~~~~~~~~~~~~v~~G-~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~ 130 (138)
T d1q77a_ 62 IKEESKKRIERRLREVWEKLTGSTEIPGVEYRIG-PLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGL 130 (138)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSCCCCCCEEEECS-CHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHS
T ss_pred hhhhhhhhccccchhhcccccccceeEEEeeecc-hhHHHHHHhhhhccCCEEEEecCCCcHHHHHhcCC
Confidence 3344456677778888888888899999988877 89999999999999999999999999999887543
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.30 E-value=7.9e-08 Score=73.22 Aligned_cols=52 Identities=19% Similarity=0.530 Sum_probs=48.3
Q ss_pred ccCccchhcccCCccc-CCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCch
Q 004388 693 FICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPN 744 (757)
Q Consensus 693 ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn 744 (757)
.+|||..++|.||++. ..|++|++..|..||..+.+||+++.+|...+|+|.
T Consensus 1 l~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~~~~CP~c~~~l~~~dLipi 53 (56)
T d2baya1 1 MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEI 53 (56)
T ss_dssp CCCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHHHSBCTTTCCBCCGGGCEEC
T ss_pred CCCccCCchHHhcCccCCCCCcccHHHHHHHHhhccCCCccCCcCCHHhceeC
Confidence 3799999999999987 579999999999999998999999999999999884
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.73 E-value=4.9e-05 Score=80.86 Aligned_cols=75 Identities=12% Similarity=0.004 Sum_probs=51.7
Q ss_pred eeeccCCcEEEEEEEEC--CeEEEEEEEccC-------CchhhHHHHHHHHHHHhcC---CCceeeecccccCCceEEEE
Q 004388 409 LRIGMGGYGTVYKGTFH--HTFAAVKVLQSK-------GNIQNKQFLQELEVLSKIR---HPHLLLLLGACPDHGCLVYE 476 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~--~~~vAvK~l~~~-------~~~~~~~f~~Ev~il~~l~---Hpniv~l~g~~~~~~~LV~E 476 (757)
..||.|....||++... +..++||.-... ......+...|.+.|..+. ...+.+++.+..+..++|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEEe
Confidence 46899999999999764 457888865431 1112344567888887663 24567788888888899999
Q ss_pred ecCCCCH
Q 004388 477 YMENGSL 483 (757)
Q Consensus 477 y~~~gsL 483 (757)
|+++..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred ccCCccc
Confidence 9987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.55 E-value=7.5e-05 Score=73.71 Aligned_cols=127 Identities=17% Similarity=0.110 Sum_probs=77.2
Q ss_pred eeccCCc-EEEEEEEECCe-EEEEEEEccCCchhhHHHHHHHHHHHhcCC--CceeeecccccCC--ceEEEEecCCCCH
Q 004388 410 RIGMGGY-GTVYKGTFHHT-FAAVKVLQSKGNIQNKQFLQELEVLSKIRH--PHLLLLLGACPDH--GCLVYEYMENGSL 483 (757)
Q Consensus 410 ~IG~G~~-G~Vyk~~~~~~-~vAvK~l~~~~~~~~~~f~~Ev~il~~l~H--pniv~l~g~~~~~--~~LV~Ey~~~gsL 483 (757)
.+..|.. +.||+....+. .+.+|....... ..+..|+..|+.+.. -.+.+++.++.+. .++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455543 68999887654 577887655432 236678888877642 2345566655443 3899999988654
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHH---------------------------------------------------
Q 004388 484 EDRLYRKNNTPPIPWFERYRIAWEVASAL--------------------------------------------------- 512 (757)
Q Consensus 484 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL--------------------------------------------------- 512 (757)
.+.. .. ...++.+++..|
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 2210 00 011122222222
Q ss_pred HHHhhCC----CCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 513 AFLHNTK----PKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 513 ~~LH~~~----~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
..+.... +..++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 3333221 1238999999999999988778899998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.75 E-value=0.0039 Score=63.19 Aligned_cols=157 Identities=11% Similarity=0.039 Sum_probs=83.4
Q ss_pred CCCHHHHHHhhcCCcccee-----eccCCcEEEEEEEECCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCc--eeeec
Q 004388 392 NLTWEEIESATLSFSENLR-----IGMGGYGTVYKGTFHHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPH--LLLLL 464 (757)
Q Consensus 392 ~~~~~ei~~at~~f~~~~~-----IG~G~~G~Vyk~~~~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpn--iv~l~ 464 (757)
.++.+|+.....+|..... |..|---+.|+...++..+++|+..... ....+..|+.+|..|...+ +...+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 3566777777777765433 4456668899998888889999986532 2234455677777664222 11111
Q ss_pred ccc--------cCCceEEEEecCCCCHH--------------HHHhhcCCC----C---CCCH-----------------
Q 004388 465 GAC--------PDHGCLVYEYMENGSLE--------------DRLYRKNNT----P---PIPW----------------- 498 (757)
Q Consensus 465 g~~--------~~~~~LV~Ey~~~gsL~--------------~~L~~~~~~----~---~l~~----------------- 498 (757)
-.. ......++.++.+.... ..++..... . ...+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 111 12224566666553221 111110000 0 0000
Q ss_pred HHHHHHHHHHHHHHHHHhh-CCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 499 FERYRIAWEVASALAFLHN-TKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 499 ~~~~~i~~qia~aL~~LH~-~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
......+..+...+.-.+. .-|.++||+|+.++|||++.+...-|.||+.|.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011122222222332222 235679999999999999999888899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.68 E-value=0.0052 Score=62.78 Aligned_cols=158 Identities=15% Similarity=0.126 Sum_probs=84.0
Q ss_pred cccCCCHHHHHHhhcCCc--c---ceeeccCCcEEEEEEEE-CCeEEEEEEEccCCchhhHHHHHHHHHHHhcCCCce--
Q 004388 389 RYRNLTWEEIESATLSFS--E---NLRIGMGGYGTVYKGTF-HHTFAAVKVLQSKGNIQNKQFLQELEVLSKIRHPHL-- 460 (757)
Q Consensus 389 ~~~~~~~~ei~~at~~f~--~---~~~IG~G~~G~Vyk~~~-~~~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~Hpni-- 460 (757)
.|..++.+-|..+...+. . ...|+ |---.||++.. ++..+++|+.++... ..+++..|...|..|..-.+
T Consensus 4 ~f~~L~pd~i~~al~~~g~~~~~~~~~L~-s~EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv 81 (325)
T d1zyla1 4 TFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPV 81 (325)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSB
T ss_pred CccccCHHHHHHHHHHcCCCCCcCccccc-cccceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCC
Confidence 456677777766654432 1 11122 22357999987 467899999876532 45668889988887742221
Q ss_pred eeecccc-------cCCceEEEEecCCCCHH--------------HHHhhc----C--CCCCCCHHH-------------
Q 004388 461 LLLLGAC-------PDHGCLVYEYMENGSLE--------------DRLYRK----N--NTPPIPWFE------------- 500 (757)
Q Consensus 461 v~l~g~~-------~~~~~LV~Ey~~~gsL~--------------~~L~~~----~--~~~~l~~~~------------- 500 (757)
+..+... .+..+.+++|++|..+. -.++.. . ....+++..
T Consensus 82 ~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~ 161 (325)
T d1zyla1 82 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 161 (325)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred CCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcC
Confidence 1111111 12226788998763221 111110 0 001111111
Q ss_pred ------HHHHHHHHHHHHHHHh----hCCCCCEEEcCCCCCCeeecCCCceEEeeecCcc
Q 004388 501 ------RYRIAWEVASALAFLH----NTKPKPIIHRDMKPGNILLDHNLVSKIGDVGLST 550 (757)
Q Consensus 501 ------~~~i~~qia~aL~~LH----~~~~~~ivHrDLKp~NILld~~~~~KL~DFGla~ 550 (757)
+..+...+...+..+. ...+.++||+|+.|.|||++++ ..++||+-|.
T Consensus 162 ~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 162 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 1111112222233332 2335679999999999999754 3588999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.53 E-value=0.0018 Score=68.21 Aligned_cols=71 Identities=15% Similarity=0.184 Sum_probs=48.1
Q ss_pred eeeccCCcEEEEEEEECC---------eEEEEEEEccCCchhhHHHHHHHHHHHhcC-CCceeeecccccCCceEEEEec
Q 004388 409 LRIGMGGYGTVYKGTFHH---------TFAAVKVLQSKGNIQNKQFLQELEVLSKIR-HPHLLLLLGACPDHGCLVYEYM 478 (757)
Q Consensus 409 ~~IG~G~~G~Vyk~~~~~---------~~vAvK~l~~~~~~~~~~f~~Ev~il~~l~-Hpniv~l~g~~~~~~~LV~Ey~ 478 (757)
..|+.|-.-.+|++.... ..|.+++.-. ... .-...+|..+++.+. +.-..+++++|. ..+||||+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~--~g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFS--GGRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET--TEEEECCC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC--CceEEEEe
Confidence 568889999999998643 3566776542 222 233557999988875 433447777775 46899999
Q ss_pred CCCCH
Q 004388 479 ENGSL 483 (757)
Q Consensus 479 ~~gsL 483 (757)
+|..|
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred ccccC
Confidence 87543
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.23 E-value=0.0014 Score=54.87 Aligned_cols=62 Identities=16% Similarity=0.185 Sum_probs=54.8
Q ss_pred CccCccchhcccCCccc-CCCcccchHHHHHHHHhCCCCCCCCCCCCCCCCCchHHHHHHHHHHh
Q 004388 692 HFICPILKEVMNEPCVA-ADGYTYDRKAIEEWLQENDKSPITDLPLPNKNLLPNYTLLSAILDWK 755 (757)
Q Consensus 692 ~ficPi~~evM~dp~ia-adG~tye~~aIe~wl~~~~~sP~t~~~l~~~~l~pn~~l~~~~~~w~ 755 (757)
.+.|||-.++|.+|... .=|++|-+.-|..|+. .+||+.+.++...+|.||++|+..|+.+.
T Consensus 22 ~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~--~~CP~Cr~~~~~~~l~~n~~l~~lv~~~~ 84 (97)
T d1jm7b_ 22 LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIG--TGCPVCYTPAWIQDLKINRQLDSMIQLCS 84 (97)
T ss_dssp TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTT--TBCSSSCCBCSCSSCCCCHHHHHHHHHHH
T ss_pred cCCCccCCchhhcCceeCCCCCchhHHHHHHHHh--ccccccCCcCchhhCcccHHHHHHHHHHH
Confidence 45799999999999865 5599999999999995 45999999999999999999999998764
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.44 E-value=0.0048 Score=51.98 Aligned_cols=64 Identities=14% Similarity=0.287 Sum_probs=57.0
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHhC---CCCCCCCCCCCCCCCCchHHHHHHHHHHh
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQEN---DKSPITDLPLPNKNLLPNYTLLSAILDWK 755 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~~---~~sP~t~~~l~~~~l~pn~~l~~~~~~w~ 755 (757)
.+.|||-.++|.+|+...=|++|=+.-|..|+... ..||+-+.++...+|.||+.|+..|+.++
T Consensus 21 ~l~CpIC~~~~~~pv~~~CgH~fC~~Ci~~~~~~~~~~~~CP~Cr~~~~~~~l~~n~~l~~~ve~l~ 87 (103)
T d1jm7a_ 21 ILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELL 87 (103)
T ss_dssp HTSCSSSCCCCSSCCBCTTSCCCCSHHHHHHHHSSSSSCCCTTTSCCCCTTTCBCCCSSSHHHHHHH
T ss_pred CcCCCccCchhCCeEEcCCCCchhhHHHHHHHHHCCCCCcCcCCCCcCChhhCCcCHHHHHHHHHHH
Confidence 35699999999999998889999999999999753 47999999999999999999998888775
|
| >d1rmda2 g.44.1.1 (A:1-86) V(D)J recombination activating protein 1 (RAG1), dimerization domain {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: V(D)J recombination activating protein 1 (RAG1), dimerization domain species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.04 E-value=0.043 Score=44.25 Aligned_cols=60 Identities=18% Similarity=0.301 Sum_probs=52.5
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCCC-chHHHHHHH
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNLL-PNYTLLSAI 751 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l~-pn~~l~~~~ 751 (757)
.+.|||=.+.|.+|.+..=|++|=+.-|+.|+.. +.+||+-+.++.-.+|. |..+++..+
T Consensus 23 ~l~C~IC~~~~~~pv~~~CgH~FC~~Ci~~~~~~~~~~CP~Cr~p~~~~~l~~P~~~~l~~l 84 (86)
T d1rmda2 23 SISCQICEHILADPVETSCKHLFCRICILRCLKVMGSYCPSCRYPCFPTDLESPVKSFLNIL 84 (86)
T ss_dssp HTBCTTTCSBCSSEEECTTSCEEEHHHHHHHHHHTCSBCTTTCCBCCGGGCBCCCHHHHHHH
T ss_pred CcCCccCCcchhcceecCCCChhhHHHHHHHHhhCCCcCcccCCCCChhhccCHHHHHHHHh
Confidence 4679999999999999999999999999999986 56899999999888876 788887654
|
| >d1fbva4 g.44.1.1 (A:356-434) CBL {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: CBL species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.84 E-value=0.5 Score=36.95 Aligned_cols=50 Identities=12% Similarity=0.238 Sum_probs=44.3
Q ss_pred CccCccchhcccCCcccCCCcccchHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 004388 692 HFICPILKEVMNEPCVAADGYTYDRKAIEEWLQE-NDKSPITDLPLPNKNL 741 (757)
Q Consensus 692 ~ficPi~~evM~dp~iaadG~tye~~aIe~wl~~-~~~sP~t~~~l~~~~l 741 (757)
..+|||-.+.+.+|.+..=|++|-..-|..||.. +++||+.+..+.....
T Consensus 23 ~~~C~IC~~~~~~~~~~~CgH~fC~~Ci~~wl~~~~~~CP~Cr~~i~~~~~ 73 (79)
T d1fbva4 23 FQLCKICAENDKDVKIEPCGHLMCTSCLTSWQESEGQGCPFCRCEIKGTEP 73 (79)
T ss_dssp TTBCTTTSSSBCCEECSSSCCEECHHHHHHHHHTTCCSCTTTCCCCCCCCC
T ss_pred CCCCccCCCcCCCeEEeCCCCeeeHHHHHHHHHHCcCcCCCCCcCccCCce
Confidence 4579999999999999999999999999999985 6789999999987653
|